ID	Relation	RelType	NE	X	Y	Y'	NEType	MeSH	Sent
2047	effect	neutral	mir-1894	1243.968	444.6964	444.6964	miRNA		These results suggested that the effect of knockdown of Trim46 alone was sufficient to recapitulate the effect of mmu-miR-1894 on the metastasis of the breast cancer cells in mouse and that Trim46 was involved in the proliferation and migration of mouse and human breast cancer cells .
2047	effect	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	These results suggested that the effect of knockdown of Trim46 alone was sufficient to recapitulate the effect of mmu-miR-1894 on the metastasis of the breast cancer cells in mouse and that Trim46 was involved in the proliferation and migration of mouse and human breast cancer cells .
2046	effect	neutral	mir-1894	1243.968	444.6964	444.6964	miRNA		Consistent with the effect of mmu-miR-1894-3p , knockdown of Trim46 inhibited the experimental lung metastasis of 4TO7 cells .
2046	effect	neutral	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Consistent with the effect of mmu-miR-1894-3p , knockdown of Trim46 inhibited the experimental lung metastasis of 4TO7 cells .
2045	suppress	negative	mir-136	1243.873	439.3936	439.3936	miRNA		Herein , we demonstrate that miR-136 is an anti-invasive microRNA in TNBC and suppresses mesenchymal invasion and metastasis .
2045	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Herein , we demonstrate that miR-136 is an anti-invasive microRNA in TNBC and suppresses mesenchymal invasion and metastasis .
2044	suppress	negative	mir-136	1243.873	439.3936	439.3936	miRNA		miR-136 suppresses tumor invasion and metastasis by targeting RASAL2 in triple-negative breast cancer .
2044	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-136 suppresses tumor invasion and metastasis by targeting RASAL2 in triple-negative breast cancer .
2036	inhibit	negative	mir-21/rasa	1243.715	434.0924	434.0924	miRNA		Circulating miR-21 in serum could be a promising biomarker in auxiliary diagnosis of lymph node metastasis in cervical cancer , and inhibition of miR-21/RASA1 axis could be a possible strategy to restrain migration of cervical cancer .
2036	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Circulating miR-21 in serum could be a promising biomarker in auxiliary diagnosis of lymph node metastasis in cervical cancer , and inhibition of miR-21/RASA1 axis could be a possible strategy to restrain migration of cervical cancer .
2030	react	neutral	mir-381	1243.493	428.7934	428.7934	miRNA		In the present study , the miR-381 expression was assessed in a cohort of 113 CRC specimens using real-time quantitative polymerase chain reaction ( RTq-PCR ) , which demonstrated that miR-381 was significantly downregulated in CRC and correlated with distant metastasis and tumor , node , and metastasis ( TNM ) stage .
2030	react	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In the present study , the miR-381 expression was assessed in a cohort of 113 CRC specimens using real-time quantitative polymerase chain reaction ( RTq-PCR ) , which demonstrated that miR-381 was significantly downregulated in CRC and correlated with distant metastasis and tumor , node , and metastasis ( TNM ) stage .
2029	react	neutral	mir-381	1243.493	428.7934	428.7934	miRNA		In the present study , the miR-381 expression was assessed in a cohort of 113 CRC specimens using real-time quantitative polymerase chain reaction ( RTq-PCR ) , which demonstrated that miR-381 was significantly downregulated in CRC and correlated with distant metastasis and tumor , node , and metastasis ( TNM ) stage .
2029	react	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In the present study , the miR-381 expression was assessed in a cohort of 113 CRC specimens using real-time quantitative polymerase chain reaction ( RTq-PCR ) , which demonstrated that miR-381 was significantly downregulated in CRC and correlated with distant metastasis and tumor , node , and metastasis ( TNM ) stage .
2014	regulate	positive	mir-302	1243.208	423.4974	423.4974	miRNA		In this article , I have focused on the role of HA interaction with CD44 and several important signaling molecules in the regulation of unique miRNAs ( e.g. , miR-21 , miR-302 and miR-10b ) and their downstream targets leading to multiple tumor cell-specific functions ( e.g. , tumor cell growth , drug resistance and metastasis ) and cancer progression .
2014	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In this article , I have focused on the role of HA interaction with CD44 and several important signaling molecules in the regulation of unique miRNAs ( e.g. , miR-21 , miR-302 and miR-10b ) and their downstream targets leading to multiple tumor cell-specific functions ( e.g. , tumor cell growth , drug resistance and metastasis ) and cancer progression .
2010	effect	neutral	mir-1976	1242.86	418.2052	418.2052	miRNA		Further study showed that PLCE1 could reverse the inhibitory effect of miR-1976 on growth and metastasis of NSCLC cells .
2010	effect	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Further study showed that PLCE1 could reverse the inhibitory effect of miR-1976 on growth and metastasis of NSCLC cells .
2009	promote	positive	mir-1976	1242.86	418.2052	418.2052	miRNA		The PLCE1 was a direct target of miR-1976 and promoted the growth and metastasis of NSCLC cells .
2009	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The PLCE1 was a direct target of miR-1976 and promoted the growth and metastasis of NSCLC cells .
2008	inhibit	negative	mir-1976	1242.86	418.2052	418.2052	miRNA		Overexpression of miR-1976 inhibited the growth and metastasis of NSCLC cells .
2008	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Overexpression of miR-1976 inhibited the growth and metastasis of NSCLC cells .
2002	downregulate	negative	mir-601	1242.449	412.9175	412.9175	miRNA		Moreover , we found that down-regulation of miR-601 was closely associated with distant metastasis and poor distant metastasis-free survival in breast cancer .
2002	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Moreover , we found that down-regulation of miR-601 was closely associated with distant metastasis and poor distant metastasis-free survival in breast cancer .
2001	regulate	positive	mir-32	1241.974	407.6351	407.6351	miRNA		Moreover , we identified and validated that TWIST1 was a direct target of miR-32 , and miR-32 regulated NSCLC cell proliferation , EMT , and metastasis , at least in part via modulation of TWIST1 .
2001	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Moreover , we identified and validated that TWIST1 was a direct target of miR-32 , and miR-32 regulated NSCLC cell proliferation , EMT , and metastasis , at least in part via modulation of TWIST1 .
2000	regulate	positive	mir-32	1241.974	407.6351	407.6351	miRNA		Moreover , we identified and validated that TWIST1 was a direct target of miR-32 , and miR-32 regulated NSCLC cell proliferation , EMT , and metastasis , at least in part via modulation of TWIST1 .
2000	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Moreover , we identified and validated that TWIST1 was a direct target of miR-32 , and miR-32 regulated NSCLC cell proliferation , EMT , and metastasis , at least in part via modulation of TWIST1 .
1999	upregulate	positive	mir-32	1241.974	407.6351	407.6351	miRNA		An inverse correlation existed between miR-32 expression level and NSCLC cell proliferation , EMT , and metastasis , and upregulation of miR-32 repressed NSCLC cell proliferation , EMT , and metastasis .
1999	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	An inverse correlation existed between miR-32 expression level and NSCLC cell proliferation , EMT , and metastasis , and upregulation of miR-32 repressed NSCLC cell proliferation , EMT , and metastasis .
1998	upregulate	positive	mir-32	1241.974	407.6351	407.6351	miRNA		An inverse correlation existed between miR-32 expression level and NSCLC cell proliferation , EMT , and metastasis , and upregulation of miR-32 repressed NSCLC cell proliferation , EMT , and metastasis .
1998	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	An inverse correlation existed between miR-32 expression level and NSCLC cell proliferation , EMT , and metastasis , and upregulation of miR-32 repressed NSCLC cell proliferation , EMT , and metastasis .
1997	effect	neutral	mir-32	1241.974	407.6351	407.6351	miRNA		MTT , transwell chamber , and Western blot assays were used to assess the effect of miR-32 on proliferation , EMT , and metastasis of NSCLC cells , respectively .
1997	effect	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	MTT , transwell chamber , and Western blot assays were used to assess the effect of miR-32 on proliferation , EMT , and metastasis of NSCLC cells , respectively .
1996	effect	neutral	mir-32	1241.974	407.6351	407.6351	miRNA		MTT , transwell chamber , and Western blot assays were used to assess the effect of miR-32 on proliferation , EMT , and metastasis of NSCLC cells , respectively .
1996	effect	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	MTT , transwell chamber , and Western blot assays were used to assess the effect of miR-32 on proliferation , EMT , and metastasis of NSCLC cells , respectively .
1995	effect	neutral	mir-32	1241.974	407.6351	407.6351	miRNA		Here , we report the effect of miR-32 on NSCLC cell proliferation , epithelial-mesenchymal transition ( EMT ) , and metastasis .
1995	effect	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we report the effect of miR-32 on NSCLC cell proliferation , epithelial-mesenchymal transition ( EMT ) , and metastasis .
1994	effect	neutral	mir-32	1241.974	407.6351	407.6351	miRNA		Here , we report the effect of miR-32 on NSCLC cell proliferation , epithelial-mesenchymal transition ( EMT ) , and metastasis .
1994	effect	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we report the effect of miR-32 on NSCLC cell proliferation , epithelial-mesenchymal transition ( EMT ) , and metastasis .
1993	inhibit	negative	mir-32	1241.974	407.6351	407.6351	miRNA		miR-32 inhibits proliferation , epithelial-mesenchymal transition , and metastasis by targeting TWIST1 in non-small-cell lung cancer cells .
1993	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-32 inhibits proliferation , epithelial-mesenchymal transition , and metastasis by targeting TWIST1 in non-small-cell lung cancer cells .
1991	inhibit	negative	mir-539	1241.437	402.3588	402.3588	miRNA		Ectopic overexpression of miR-539 can drastically inhibit SPAG5 expression and the restoration of SPAG5 expression can reverse the inhibitory effects of miR-539 on PCa cell proliferation and metastasis .
1991	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Ectopic overexpression of miR-539 can drastically inhibit SPAG5 expression and the restoration of SPAG5 expression can reverse the inhibitory effects of miR-539 on PCa cell proliferation and metastasis .
1988	upregulate	positive	microrna-130a	1240.836	397.0893	397.0893	miRNA		This study demonstrates for the first time that microRNA-130a ( miR-130a ) is significantly upregulated in osteosarcoma , and associated with the metastasis of osteosarcoma .
1988	upregulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	This study demonstrates for the first time that microRNA-130a ( miR-130a ) is significantly upregulated in osteosarcoma , and associated with the metastasis of osteosarcoma .
1987	promote	positive	microrna-130a	1240.836	397.0893	397.0893	miRNA		MicroRNA-130a promotes the metastasis and epithelial-mesenchymal transition of osteosarcoma by targeting PTEN .
1987	promote	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	MicroRNA-130a promotes the metastasis and epithelial-mesenchymal transition of osteosarcoma by targeting PTEN .
1977	control	neutral	microrna-491	1240.173	391.8273	391.8273	miRNA		This study aimed to explore the roles of microRNA-491-5p ( miR-491 ) and its target MMP9 in the control of metastasis of osteosarcoma ( OS ) as well as how the rs1056629 polymorphism in the 3 ' untranslated region ( 3'UTR ) of MMP9 compromises the interaction between miR-491 and MMP9 .
1977	control	neutral	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	This study aimed to explore the roles of microRNA-491-5p ( miR-491 ) and its target MMP9 in the control of metastasis of osteosarcoma ( OS ) as well as how the rs1056629 polymorphism in the 3 ' untranslated region ( 3'UTR ) of MMP9 compromises the interaction between miR-491 and MMP9 .
1976	downregulate	negative	mir-210/hif	1239.446	386.5736	386.5736	miRNA		Downregulation of TIMP2 via HIF-1帢/miR-210/HIF-3帢 regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma .
1976	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Downregulation of TIMP2 via HIF-1帢/miR-210/HIF-3帢 regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma .
1974	regulate	positive	microrna-421	1238.657	381.329	381.329	miRNA		MicroRNA-421 regulated by HIF-1帢 promotes metastasis , inhibits apoptosis , and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer .
1974	regulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	MicroRNA-421 regulated by HIF-1帢 promotes metastasis , inhibits apoptosis , and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer .
1963	inhibit	negative	mir-10a	1237.806	376.0941	376.0941	miRNA		Moreover , TUSC7 inhibited cell metastasis , invasion , and epithelial-to-mesenchymal transformation ( EMT ) through competitively binding miR-10a .
1963	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Moreover , TUSC7 inhibited cell metastasis , invasion , and epithelial-to-mesenchymal transformation ( EMT ) through competitively binding miR-10a .
1962	suppress	negative	mir-29a/c	1236.892	370.8698	370.8698	miRNA		By simulating the tumor microenvironment , the MV-delivered miR-29a/c significantly suppresses VEGF expression in GC cells , inhibiting vascular cell growth , metastasis , and tube formation .
1962	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	By simulating the tumor microenvironment , the MV-delivered miR-29a/c significantly suppresses VEGF expression in GC cells , inhibiting vascular cell growth , metastasis , and tube formation .
1959	suppress	negative	microrna-630	1235.915	365.6568	365.6568	miRNA		MicroRNA-630 suppresses tumor metastasis through the TGF-?] - miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma .
1959	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-630 suppresses tumor metastasis through the TGF-?] - miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma .
1949	inhibit	negative	mir-499	1234.877	360.4559	360.4559	miRNA		Furthermore , miR-499-5p overexpression also inhibited NSCLC metastasis in vitro and in vivo .
1949	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Furthermore , miR-499-5p overexpression also inhibited NSCLC metastasis in vitro and in vivo .
1948	inhibit	negative	mir-499	1234.877	360.4559	360.4559	miRNA		Overexpression of miR-499-5p inhibits non-small cell lung cancer proliferation and metastasis by targeting VAV3 .
1948	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Overexpression of miR-499-5p inhibits non-small cell lung cancer proliferation and metastasis by targeting VAV3 .
1945	regulate	positive	mir-543	1233.776	355.2677	355.2677	miRNA		Our study highlights a pivotal role for miR-543 as a suppressor in the regulation of CRC growth and metastasis and suggests that miR-543 may serve as a novel diagnostic and prognostic biomarker for CRC metastasis .
1945	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our study highlights a pivotal role for miR-543 as a suppressor in the regulation of CRC growth and metastasis and suggests that miR-543 may serve as a novel diagnostic and prognostic biomarker for CRC metastasis .
1944	inhibit	negative	mir-543	1233.776	355.2677	355.2677	miRNA		Collectively , these data show that miR-543 inhibits the proliferation and metastasis of CRC cells by targeting KRAS , MTA1 and HMGA2 .
1944	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Collectively , these data show that miR-543 inhibits the proliferation and metastasis of CRC cells by targeting KRAS , MTA1 and HMGA2 .
1943	promote	positive	mir-543	1233.776	355.2677	355.2677	miRNA		Conversely , miR-543 knockdown promoted the proliferation , migration and invasion of CRC cells in vitro and augmented tumor growth and metastasis in vivo .
1943	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Conversely , miR-543 knockdown promoted the proliferation , migration and invasion of CRC cells in vitro and augmented tumor growth and metastasis in vivo .
1942	inhibit	negative	mir-543	1233.776	355.2677	355.2677	miRNA		Moreover , ectopic expression of miR-543 inhibited the proliferation and metastasis of CRC cells in vitro and in vivo by targeting KRAS , MTA1 and HMGA2 .
1942	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Moreover , ectopic expression of miR-543 inhibited the proliferation and metastasis of CRC cells in vitro and in vivo by targeting KRAS , MTA1 and HMGA2 .
1941	suppress	negative	microrna-543	1232.614	350.093	350.093	miRNA		MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS , MTA1 and HMGA2 .
1941	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS , MTA1 and HMGA2 .
1933	regulate	positive	mir-548j	1231.389	344.9326	344.9326	miRNA		Our findings demonstrate that miR-548j functions as a metastasis-promoting miRNA to regulate breast cancer cell invasion and metastasis by targeting Tensin1 and activating Cdc42 , suggesting a potential therapeutic application in breast cancer .
1933	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our findings demonstrate that miR-548j functions as a metastasis-promoting miRNA to regulate breast cancer cell invasion and metastasis by targeting Tensin1 and activating Cdc42 , suggesting a potential therapeutic application in breast cancer .
1932	stimulate	positive	mir-548j	1231.389	344.9326	344.9326	miRNA		Moreover , miR-548j was shown to stimulate breast cancer cell invasion and metastasis in ? vitro and in ? vivo , but had no effect on proliferation .
1932	stimulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Moreover , miR-548j was shown to stimulate breast cancer cell invasion and metastasis in ? vitro and in ? vivo , but had no effect on proliferation .
1921	inhibit	negative	microrna-379	1230.104	339.7872	339.7872	miRNA		MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma .
1921	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma .
1918	control	neutral	mir-1284	1228.756	334.6575	334.6575	miRNA		In this study , the expression of miR-1284 was reduced in gastric cancer ( GC ) tissue specimens with metastasis and in vincristine-resistant ( VCR ) GC ? SGC7901 cells ( SGC-7901/VCR ) compared to that in the controls .
1918	control	neutral	gc	1242.449	487.0825	487.0825	Cancer	D061325	In this study , the expression of miR-1284 was reduced in gastric cancer ( GC ) tissue specimens with metastasis and in vincristine-resistant ( VCR ) GC ? SGC7901 cells ( SGC-7901/VCR ) compared to that in the controls .
1913	upregulate	positive	mir-652	1227.348	329.5443	329.5443	miRNA		Our results showed that the expression of miR-652-3p was significantly upregulated in tumor tissues of 50 patients with NSCLC , and it was significantly higher in patients with positive lymph node metastasis , advanced TNM stage and poor prognosis .
1913	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Our results showed that the expression of miR-652-3p was significantly upregulated in tumor tissues of 50 patients with NSCLC , and it was significantly higher in patients with positive lymph node metastasis , advanced TNM stage and poor prognosis .
1912	upregulate	positive	mir-652	1227.348	329.5443	329.5443	miRNA		Our results showed that the expression of miR-652-3p was significantly upregulated in tumor tissues of 50 patients with NSCLC , and it was significantly higher in patients with positive lymph node metastasis , advanced TNM stage and poor prognosis .
1912	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Our results showed that the expression of miR-652-3p was significantly upregulated in tumor tissues of 50 patients with NSCLC , and it was significantly higher in patients with positive lymph node metastasis , advanced TNM stage and poor prognosis .
1911	effect	neutral	mir-652	1227.348	329.5443	329.5443	miRNA		In this study , we detected the expression of miR-652-3p in NSCLC tumor tissues and cell lines and investigated the effect of miR-652-3p on the proliferation and metastasis of NSCLC cells .
1911	effect	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	In this study , we detected the expression of miR-652-3p in NSCLC tumor tissues and cell lines and investigated the effect of miR-652-3p on the proliferation and metastasis of NSCLC cells .
1910	upregulate	positive	mir-652	1227.348	329.5443	329.5443	miRNA		MiR-652-3p is upregulated in non-small cell lung cancer and promotes proliferation and metastasis by directly targeting Lgl1 .
1910	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-652-3p is upregulated in non-small cell lung cancer and promotes proliferation and metastasis by directly targeting Lgl1 .
1907	inhibit	negative	microrna-92b	1225.879	324.4482	324.4482	miRNA		Screening of the differentially expressed microRNAs identified that microRNA-92b-3p ( miR-92b ) could dramatically inhibit invasion and metastasis of ESCC cells in vitro and in vivo .
1907	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Screening of the differentially expressed microRNAs identified that microRNA-92b-3p ( miR-92b ) could dramatically inhibit invasion and metastasis of ESCC cells in vitro and in vivo .
1896	inhibit	negative	microrna-323	1224.349	319.3701	319.3701	miRNA		MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3 .
1896	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3 .
1889	suppress	negative	microrna-23b/	1222.758	314.3105	314.3105	miRNA		The microRNA-23b/-27b cluster suppresses prostate cancer metastasis via Huntingtin-interacting protein 1-related .
1889	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The microRNA-23b/-27b cluster suppresses prostate cancer metastasis via Huntingtin-interacting protein 1-related .
1882	promote	positive	mir-365a	1221.107	309.2704	309.2704	miRNA		The data suggest that miR-365a-3p may act as an oncomiR and may promote growth and metastasis in LSCC via the PI3K/AKT signaling pathway , and thus miR ? 365a-3p may be a potential therapeutic target for treatment of LSCC .
1882	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The data suggest that miR-365a-3p may act as an oncomiR and may promote growth and metastasis in LSCC via the PI3K/AKT signaling pathway , and thus miR ? 365a-3p may be a potential therapeutic target for treatment of LSCC .
1881	suppress	negative	mir-365a	1221.107	309.2704	309.2704	miRNA		We then investigated the role of miR-365a-3p in LSCC in ? vivo and found that miR-365a-3p inhibitor suppressed LSCC xenograft tumor growth and metastasis in xenograft mouse models .
1881	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We then investigated the role of miR-365a-3p in LSCC in ? vivo and found that miR-365a-3p inhibitor suppressed LSCC xenograft tumor growth and metastasis in xenograft mouse models .
1880	promote	positive	microrna-365a	1219.396	304.2504	304.2504	miRNA		MicroRNA-365a-3p promotes tumor growth and metastasis in laryngeal squamous cell carcinoma .
1880	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-365a-3p promotes tumor growth and metastasis in laryngeal squamous cell carcinoma .
1870	activate	positive	mir-21/nf	1217.625	299.2511	299.2511	miRNA		Here , we reported that high miR-21 expression was strongly associated with lymph node metastasis in breast cancer , and the activation of the miR-21/NF- ? B was required for the metastatic promoting effect of CAFs .
1870	activate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here , we reported that high miR-21 expression was strongly associated with lymph node metastasis in breast cancer , and the activation of the miR-21/NF- ? B was required for the metastatic promoting effect of CAFs .
1872	inhibit	negative	microrna-183	1215.795	294.2733	294.2733	miRNA		MicroRNA-183 functions as the tumor suppressor via inhibiting cellular invasion and metastasis by targeting MMP-9 in cervical cancer .
1872	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-183 functions as the tumor suppressor via inhibiting cellular invasion and metastasis by targeting MMP-9 in cervical cancer .
1860	promote	positive	microrna-183	1215.795	294.2733	294.2733	miRNA		MicroRNA-183-5p promotes the proliferation , invasion and metastasis of human pancreatic adenocarcinoma cells .
1860	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-183-5p promotes the proliferation , invasion and metastasis of human pancreatic adenocarcinoma cells .
1856	promote	positive	microrna-130b	1213.905	289.3178	289.3178	miRNA		MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1帢 signaling .
1856	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1帢 signaling .
2043	inhibit	negative	microrna-126	1211.956	284.3852	284.3852	miRNA		MicroRNA-126 inhibits tumor cell invasion and metastasis by downregulating ROCK1 in renal cell carcinoma .
2043	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-126 inhibits tumor cell invasion and metastasis by downregulating ROCK1 in renal cell carcinoma .
1841	downregulate	negative	microrna-126	1211.956	284.3852	284.3852	miRNA		Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer .
1841	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer .
1840	suppress	negative	mir-152	1209.948	279.4763	279.4763	miRNA		Together , these findings indicated that miR-152 suppression in NSCLC cells might promote neuropilin-1 mediated cancer metastasis and suggested a new therapeutic application of miR-152 in the treatment of NSCLC .
1840	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Together , these findings indicated that miR-152 suppression in NSCLC cells might promote neuropilin-1 mediated cancer metastasis and suggested a new therapeutic application of miR-152 in the treatment of NSCLC .
1836	downregulate	negative	mir-152	1209.948	279.4763	279.4763	miRNA		Our results proved that miR-152 expression was downregulated in CRC cell lines and tissue samples , and its expression was inversely correlated with advanced tumor-node-metastasis ( TNM ) stage ( P ? < ? 0.01 ) and lymph node metastasis ( P ? < ? 0.01 ) .
1836	downregulate	negative	colorectal cancer 	754.9962	891.7133	891.7133	Cancer	D001943|D009369	Our results proved that miR-152 expression was downregulated in CRC cell lines and tissue samples , and its expression was inversely correlated with advanced tumor-node-metastasis ( TNM ) stage ( P ? < ? 0.01 ) and lymph node metastasis ( P ? < ? 0.01 ) .
1835	downregulate	negative	mir-152	1209.948	279.4763	279.4763	miRNA		Our results proved that miR-152 expression was downregulated in CRC cell lines and tissue samples , and its expression was inversely correlated with advanced tumor-node-metastasis ( TNM ) stage ( P ? < ? 0.01 ) and lymph node metastasis ( P ? < ? 0.01 ) .
1835	downregulate	negative	colorectal cancer 	754.9962	891.7133	891.7133	Cancer	D001943|D009369	Our results proved that miR-152 expression was downregulated in CRC cell lines and tissue samples , and its expression was inversely correlated with advanced tumor-node-metastasis ( TNM ) stage ( P ? < ? 0.01 ) and lymph node metastasis ( P ? < ? 0.01 ) .
1834	downregulate	negative	mir-655	1207.882	274.5916	274.5916	miRNA		In this study , we found that miR-655 was down-regulated in TNBC , and its expression levels were associated with molecular-based classification and lymph node metastasis in breast cancer .
1834	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In this study , we found that miR-655 was down-regulated in TNBC , and its expression levels were associated with molecular-based classification and lymph node metastasis in breast cancer .
1833	downregulate	negative	mir-655	1207.882	274.5916	274.5916	miRNA		In this study , we found that miR-655 was down-regulated in TNBC , and its expression levels were associated with molecular-based classification and lymph node metastasis in breast cancer .
1833	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In this study , we found that miR-655 was down-regulated in TNBC , and its expression levels were associated with molecular-based classification and lymph node metastasis in breast cancer .
1826	inhibit	negative	mir-532	1205.758	269.732	269.732	miRNA		It was also verified that miR-532-5p inhibited cell proliferation and metastasis of HCC cells by inhibition CXCL2 .
1826	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	It was also verified that miR-532-5p inhibited cell proliferation and metastasis of HCC cells by inhibition CXCL2 .
1825	promote	positive	mir-532	1205.758	269.732	269.732	miRNA		Loss of miR-532-5p in vitro promotes cell proliferation and metastasis by influencing CXCL2 expression in HCC .
1825	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Loss of miR-532-5p in vitro promotes cell proliferation and metastasis by influencing CXCL2 expression in HCC .
1817	induce	positive	mir-522	1203.576	264.8981	264.8981	miRNA		DENND2D was involved in miR-522 induced proliferation and metastasis of NSCLC cells by a miRNA-masking antisense oligonucleotides ( miR-mask ) technology .
1817	induce	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	DENND2D was involved in miR-522 induced proliferation and metastasis of NSCLC cells by a miRNA-masking antisense oligonucleotides ( miR-mask ) technology .
1816	downregulate	negative	mir-522	1203.576	264.8981	264.8981	miRNA		Downregulation of miR-522 suppresses proliferation and metastasis of non-small cell lung cancer cells by directly targeting DENN/MADD domain containing 2D .
1816	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Downregulation of miR-522 suppresses proliferation and metastasis of non-small cell lung cancer cells by directly targeting DENN/MADD domain containing 2D .
1793	upregulate	positive	microrna-31	1201.336	260.0906	260.0906	miRNA		To verify the hypothesis that upregulation of microRNA-31 ( miR-31 ) targeting integrin 帢5 ( ITGA5 ) suppresses tumor cell invasion and metastasis by indirectly regulating phosphoinositide 3-kinase ( PI3K ) /protein kinase B ( AKT ) signaling pathway in human SGC7901 gastric cancer ( GC ) cells .
1793	upregulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	To verify the hypothesis that upregulation of microRNA-31 ( miR-31 ) targeting integrin 帢5 ( ITGA5 ) suppresses tumor cell invasion and metastasis by indirectly regulating phosphoinositide 3-kinase ( PI3K ) /protein kinase B ( AKT ) signaling pathway in human SGC7901 gastric cancer ( GC ) cells .
1792	upregulate	positive	microrna-31	1201.336	260.0906	260.0906	miRNA		Upregulation of microRNA-31 targeting integrin 帢5 suppresses tumor cell invasion and metastasis by indirectly regulating PI3K/AKT pathway in human gastric cancer SGC7901 cells .
1792	upregulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	Upregulation of microRNA-31 targeting integrin 帢5 suppresses tumor cell invasion and metastasis by indirectly regulating PI3K/AKT pathway in human gastric cancer SGC7901 cells .
1791	regulate	positive	mir-200/zeb	1199.039	255.3102	255.3102	miRNA		Our findings highlight the critical ECM-tumor cell interactions regulated by miR-200/Zeb1-dependent EMT that activate intracellular signaling pathways responsible for tumor cell invasion and metastasis .
1791	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Our findings highlight the critical ECM-tumor cell interactions regulated by miR-200/Zeb1-dependent EMT that activate intracellular signaling pathways responsible for tumor cell invasion and metastasis .
1783	inhibit	negative	microrna-452	1196.685	250.5576	250.5576	miRNA		Expression of microRNA-452 via adenoviral vector inhibits non-small cell lung cancer cells proliferation and metastasis .
1783	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Expression of microRNA-452 via adenoviral vector inhibits non-small cell lung cancer cells proliferation and metastasis .
1992	suppress	negative	mir-490	1194.274	245.8335	245.8335	miRNA		Gain- and loss-of-function assays in vitro and in vivo reveal that miR-490-3p suppresses cancer cell proliferation by inducing apoptosis and inhibits cell invasiveness by repressing the initiation of epithelial-to-mesenchymal transition ( EMT ) , a key mechanism in cancer cell invasiveness and metastasis .
1992	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Gain- and loss-of-function assays in vitro and in vivo reveal that miR-490-3p suppresses cancer cell proliferation by inducing apoptosis and inhibits cell invasiveness by repressing the initiation of epithelial-to-mesenchymal transition ( EMT ) , a key mechanism in cancer cell invasiveness and metastasis .
1779	influence	neutral	mir-490	1194.274	245.8335	245.8335	miRNA		In this study we purposed to investigate the expression and biological functions of miR-490-3p in CRC metastasis , as well as to identify its downstream target genes and influenced pathway .
1779	influence	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In this study we purposed to investigate the expression and biological functions of miR-490-3p in CRC metastasis , as well as to identify its downstream target genes and influenced pathway .
1778	inhibit	negative	microrna-490	1191.807	241.1385	241.1385	miRNA		MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGF?] R1 .
1778	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGF?] R1 .
1767	inhibit	negative	microrna-1225	1189.284	236.4733	236.4733	miRNA		MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of ?] -catenin signaling .
1767	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of ?] -catenin signaling .
1766	suppress	negative	mir-192	1186.706	231.8385	231.8385	miRNA		Gain and loss of function studies revealed that miR-192 significantly suppressed metastasis of HCC cells in vitro and in vivo .
1766	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Gain and loss of function studies revealed that miR-192 significantly suppressed metastasis of HCC cells in vitro and in vivo .
1762	upregulate	positive	mirna-210	1184.073	227.2349	227.2349	miRNA		In the present study , the expression levels of VEGF and miRNA-210 were upregulated in patients with MB and metastatic MB ; thus suggesting that miRNA-210 may promote the metastasis of MB primary tumors by regulating the expression of VEGF .
1762	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In the present study , the expression levels of VEGF and miRNA-210 were upregulated in patients with MB and metastatic MB ; thus suggesting that miRNA-210 may promote the metastasis of MB primary tumors by regulating the expression of VEGF .
1761	regulate	positive	mir-148b	1181.384	222.6631	222.6631	miRNA		BRG1 positively regulated the expression of miR-148b , leading to inhibition of cell proliferation , metastasis , restraint of EMT , and inactivation of the WNT/?] -catenin signaling pathway , which highlights potential therapeutic possibilities for the treatment of lung cancer .
1761	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	BRG1 positively regulated the expression of miR-148b , leading to inhibition of cell proliferation , metastasis , restraint of EMT , and inactivation of the WNT/?] -catenin signaling pathway , which highlights potential therapeutic possibilities for the treatment of lung cancer .
1760	regulate	positive	mir-148b	1181.384	222.6631	222.6631	miRNA		BRG1 positively regulated the expression of miR-148b , leading to inhibition of cell proliferation , metastasis , restraint of EMT , and inactivation of the WNT/?] -catenin signaling pathway , which highlights potential therapeutic possibilities for the treatment of lung cancer .
1760	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	BRG1 positively regulated the expression of miR-148b , leading to inhibition of cell proliferation , metastasis , restraint of EMT , and inactivation of the WNT/?] -catenin signaling pathway , which highlights potential therapeutic possibilities for the treatment of lung cancer .
1759	suppress	negative	mir-148b	1181.384	222.6631	222.6631	miRNA		Additionally , we suggested that miR-148b suppressed cell proliferation , metastasis , and EMT in lung cancer cells by directly binging to 3'-untranslated region of WNT1 , blocking the WNT1/?] -catenin signaling pathway .
1759	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Additionally , we suggested that miR-148b suppressed cell proliferation , metastasis , and EMT in lung cancer cells by directly binging to 3'-untranslated region of WNT1 , blocking the WNT1/?] -catenin signaling pathway .
1758	inhibit	negative	mir-148b	1181.384	222.6631	222.6631	miRNA		Restoration of BRG1 inhibits proliferation and metastasis of lung cancer by regulating tumor suppressor miR-148b .
1758	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Restoration of BRG1 inhibits proliferation and metastasis of lung cancer by regulating tumor suppressor miR-148b .
1750	suppress	negative	mir-874	1178.641	218.1237	218.1237	miRNA		Taken together , these findings suggested that miR-874 might suppress the growth and metastasis of OS cells partially by targeting E2F3 .
1750	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , these findings suggested that miR-874 might suppress the growth and metastasis of OS cells partially by targeting E2F3 .
1749	react	neutral	mir-874	1178.641	218.1237	218.1237	miRNA		Here , we found that miR-874 expression was significantly decreased in OS cell lines and tissues by quantitative reverse transcriptase polymerase chain reaction ( qRT-PCR ) , and its expression was correlated with tumor-node-metastasis ( TNM ) stage , tumor size , and lymph node metastasis ( all P ? < ? 0.01 ) .
1749	react	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we found that miR-874 expression was significantly decreased in OS cell lines and tissues by quantitative reverse transcriptase polymerase chain reaction ( qRT-PCR ) , and its expression was correlated with tumor-node-metastasis ( TNM ) stage , tumor size , and lymph node metastasis ( all P ? < ? 0.01 ) .
1748	suppress	negative	mir-874	1178.641	218.1237	218.1237	miRNA		miR-874 suppresses the proliferation and metastasis of osteosarcoma by targeting E2F3 .
1748	suppress	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	miR-874 suppresses the proliferation and metastasis of osteosarcoma by targeting E2F3 .
1743	inhibit	negative	mir-181c	1175.845	213.6174	213.6174	miRNA		These results indicate that miR-181c inhibits ovarian cancer metastasis and progression by targeting PRKCD expression .
1743	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	These results indicate that miR-181c inhibits ovarian cancer metastasis and progression by targeting PRKCD expression .
1742	inhibit	negative	mir-181c	1175.845	213.6174	213.6174	miRNA		In vitro , miR-181c significantly inhibited the proliferation , metastasis of A2780 cell line , and induced G1 phase arrest .
1742	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In vitro , miR-181c significantly inhibited the proliferation , metastasis of A2780 cell line , and induced G1 phase arrest .
1741	control	neutral	mir-181c	1175.845	213.6174	213.6174	miRNA		In this study , we found that the expression of the miR-181c was significantly decreased in ovarian cancer tissue and in tissues with lymph node metastasis when compared with their control samples , respectively .
1741	control	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In this study , we found that the expression of the miR-181c was significantly decreased in ovarian cancer tissue and in tissues with lymph node metastasis when compared with their control samples , respectively .
1740	inhibit	negative	mir181c	1172.994	209.1448	209.1448	miRNA		MiR181c inhibits ovarian cancer metastasis and progression by targeting PRKCD expression .
1740	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR181c inhibits ovarian cancer metastasis and progression by targeting PRKCD expression .
1731	inhibit	negative	microrna-370	1170.091	204.7066	204.7066	miRNA		MicroRNA-370 directly targets FOXM1 to inhibit cell growth and metastasis in osteosarcoma cells .
1731	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	MicroRNA-370 directly targets FOXM1 to inhibit cell growth and metastasis in osteosarcoma cells .
1725	inhibit	negative	microrna-22	1167.134	200.3034	200.3034	miRNA		MicroRNA-22 inhibits tumor growth and metastasis in gastric cancer by directly targeting MMP14 and Snail .
1725	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	MicroRNA-22 inhibits tumor growth and metastasis in gastric cancer by directly targeting MMP14 and Snail .
1716	regulate	positive	microrna-574	1164.125	195.9358	195.9358	miRNA		Tumor invasion and metastasis regulated by microRNA-184 and microRNA-574-5p in small-cell lung cancer .
1716	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Tumor invasion and metastasis regulated by microRNA-184 and microRNA-574-5p in small-cell lung cancer .
1715	regulate	positive	microrna-184	1161.065	191.6045	191.6045	miRNA		Tumor invasion and metastasis regulated by microRNA-184 and microRNA-574-5p in small-cell lung cancer .
1715	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Tumor invasion and metastasis regulated by microRNA-184 and microRNA-574-5p in small-cell lung cancer .
1709	downregulate	negative	mir-147	1157.953	187.31	187.31	miRNA		In addition , serum miR-147 was markedly down-regulated in advanced NSCLC patients and the patients with lymph node metastasis ( LNM ) .
1709	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In addition , serum miR-147 was markedly down-regulated in advanced NSCLC patients and the patients with lymph node metastasis ( LNM ) .
1707	downregulate	negative	mir-586	1154.789	183.0531	183.0531	miRNA		Downregulation of miR-586 expression in OS may inhibit cell proliferation , invasion and metastasis , and promote cell apoptosis .
1707	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Downregulation of miR-586 expression in OS may inhibit cell proliferation , invasion and metastasis , and promote cell apoptosis .
1706	downregulate	negative	microrna-586	1151.575	178.8342	178.8342	miRNA		Downregulation of microRNA-586 Inhibits Proliferation , Invasion and Metastasis and Promotes Apoptosis in Human Osteosarcoma U2-OS Cell Line .
1706	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Downregulation of microRNA-586 Inhibits Proliferation , Invasion and Metastasis and Promotes Apoptosis in Human Osteosarcoma U2-OS Cell Line .
1704	downregulate	negative	mir-203b	1148.311	174.654	174.654	miRNA		Downregulation and hypermethylation of miR-203a and miR-203b were associated with TNM stage , pathological differentiation , and lymph node metastasis .
1704	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Downregulation and hypermethylation of miR-203a and miR-203b were associated with TNM stage , pathological differentiation , and lymph node metastasis .
1703	downregulate	negative	mir-203a	1144.997	170.5131	170.5131	miRNA		Downregulation and hypermethylation of miR-203a and miR-203b were associated with TNM stage , pathological differentiation , and lymph node metastasis .
1703	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Downregulation and hypermethylation of miR-203a and miR-203b were associated with TNM stage , pathological differentiation , and lymph node metastasis .
1698	promote	positive	microrna-1246	1141.634	166.412	166.412	miRNA		MicroRNA-1246 promotes growth and metastasis of colorectal cancer cells involving CCNG2 reduction .
1698	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-1246 promotes growth and metastasis of colorectal cancer cells involving CCNG2 reduction .
2037	promote	positive	mir-181b	1138.222	162.3515	162.3515	miRNA		Taken together , our data suggest that miR-181b-3p functions as a metastasis activator by promoting Snail-induced EMT , and may therefore be a therapeutic target in metastatic cancers .
2037	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , our data suggest that miR-181b-3p functions as a metastasis activator by promoting Snail-induced EMT , and may therefore be a therapeutic target in metastatic cancers .
1737	regulate	positive	mir-181b	1138.222	162.3515	162.3515	miRNA		MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGF?] R1/Smad signaling pathway in NSCLC .
1737	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGF?] R1/Smad signaling pathway in NSCLC .
1696	promote	positive	mir-181b	1138.222	162.3515	162.3515	miRNA		The results of in vitro 3H thymidine incorporation and Transwell migration assay indicated that miR-181b overexpression markedly promoted the proliferation and metastasis of breast cancer cells .
1696	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The results of in vitro 3H thymidine incorporation and Transwell migration assay indicated that miR-181b overexpression markedly promoted the proliferation and metastasis of breast cancer cells .
1688	regulate	positive	mir-590	1134.762	158.3319	158.3319	miRNA		The purpose of this study was to determine the role of miR-590-3p in regulation of epithelial mesenchymal transition ( EMT ) and metastasis of GBM cells .
1688	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The purpose of this study was to determine the role of miR-590-3p in regulation of epithelial mesenchymal transition ( EMT ) and metastasis of GBM cells .
1687	regulate	positive	mir-590	1134.762	158.3319	158.3319	miRNA		The purpose of this study was to determine the role of miR-590-3p in regulation of epithelial mesenchymal transition ( EMT ) and metastasis of GBM cells .
1687	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The purpose of this study was to determine the role of miR-590-3p in regulation of epithelial mesenchymal transition ( EMT ) and metastasis of GBM cells .
1854	promote	positive	mir-1290	1131.254	154.354	154.354	miRNA		miR-1290 promotes gastric tumor cells proliferation and metastasis through FOXA1 , which could be used as a marker for diagnosis and a target for therapeutic intervention .
1854	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-1290 promotes gastric tumor cells proliferation and metastasis through FOXA1 , which could be used as a marker for diagnosis and a target for therapeutic intervention .
1678	upregulate	positive	mir-1290	1131.254	154.354	154.354	miRNA		Furthermore , the up-regulation of serum miR-1290 more frequently occurred in NSCLC patients with high TNM stage , positive lymph node metastasis ( P=0.022 and P=0.024 , respectively ) .
1678	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Furthermore , the up-regulation of serum miR-1290 more frequently occurred in NSCLC patients with high TNM stage , positive lymph node metastasis ( P=0.022 and P=0.024 , respectively ) .
1677	upregulate	positive	mir-1290	1131.254	154.354	154.354	miRNA		Furthermore , the up-regulation of serum miR-1290 more frequently occurred in NSCLC patients with high TNM stage , positive lymph node metastasis ( P=0.022 and P=0.024 , respectively ) .
1677	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Furthermore , the up-regulation of serum miR-1290 more frequently occurred in NSCLC patients with high TNM stage , positive lymph node metastasis ( P=0.022 and P=0.024 , respectively ) .
1672	upregulate	positive	let7e	1127.699	150.4183	150.4183	miRNA		In endometrial cancer cells , expression levels of miRNAs including miR-185 , miR-210 and miR-423 are upregulated and those of miR-let7e , miR-30c and miR-221 are downregulated compared to normal tissues , and these miRNAs are involved in carcinogenesis , invasion and metastasis .
1672	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In endometrial cancer cells , expression levels of miRNAs including miR-185 , miR-210 and miR-423 are upregulated and those of miR-let7e , miR-30c and miR-221 are downregulated compared to normal tissues , and these miRNAs are involved in carcinogenesis , invasion and metastasis .
1671	upregulate	positive	mir-423	1124.097	146.5253	146.5253	miRNA		In endometrial cancer cells , expression levels of miRNAs including miR-185 , miR-210 and miR-423 are upregulated and those of miR-let7e , miR-30c and miR-221 are downregulated compared to normal tissues , and these miRNAs are involved in carcinogenesis , invasion and metastasis .
1671	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In endometrial cancer cells , expression levels of miRNAs including miR-185 , miR-210 and miR-423 are upregulated and those of miR-let7e , miR-30c and miR-221 are downregulated compared to normal tissues , and these miRNAs are involved in carcinogenesis , invasion and metastasis .
1668	inhibit	negative	mir-148	1120.449	142.6757	142.6757	miRNA		These results suggested that miR-148 may represent a novel molecular marker and a potential molecular therapeutic for inhibiting metastasis of HCC .
1668	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	These results suggested that miR-148 may represent a novel molecular marker and a potential molecular therapeutic for inhibiting metastasis of HCC .
1666	suppress	negative	microrna-622	1116.755	138.8699	138.8699	miRNA		Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1帢 in ERK-responsive lung cancer .
1666	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1帢 in ERK-responsive lung cancer .
1665	inhibit	negative	mir-222	1113.016	135.1084	135.1084	miRNA		Moreover , miR-222 mimics and ABCG2 siRNA inhibited tumor growth and lung metastasis in vivo .
1665	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Moreover , miR-222 mimics and ABCG2 siRNA inhibited tumor growth and lung metastasis in vivo .
1661	downregulate	negative	mirna-146a	1109.233	131.3919	131.3919	miRNA		Here , we found that miRNA-146a expression is downregulated in both ESCC cell lines and tissues and obviously associated with pathological indicators , such as metastasis and stage of ESCC .
1661	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we found that miRNA-146a expression is downregulated in both ESCC cell lines and tissues and obviously associated with pathological indicators , such as metastasis and stage of ESCC .
2031	promote	positive	mir-24	1105.405	127.7209	127.7209	miRNA		Here we show , in the BON1 cell line derived from lymphnode metastasis of a human carcinoid tumour of the pancreas , that menin binds specifically to the primary RNA sequence pri-miR-24-1 by promoting the miR-24-1 biogenesis .
2031	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here we show , in the BON1 cell line derived from lymphnode metastasis of a human carcinoid tumour of the pancreas , that menin binds specifically to the primary RNA sequence pri-miR-24-1 by promoting the miR-24-1 biogenesis .
1655	inhibit	negative	mir-24	1105.405	127.7209	127.7209	miRNA		Ectopic expression of miR-24 inhibited the cell viability , proliferation , migration , and invasion in vitro ( all P ? < ? 0.05 ) , and suppressed the xenograft tumor growth and lung metastasis formation in vivo ( all P ? < ? 0.05 ) .
1655	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Ectopic expression of miR-24 inhibited the cell viability , proliferation , migration , and invasion in vitro ( all P ? < ? 0.05 ) , and suppressed the xenograft tumor growth and lung metastasis formation in vivo ( all P ? < ? 0.05 ) .
1651	upregulate	positive	mir-616	1101.534	124.0958	124.0958	miRNA		The present study demonstrated for the first time that microRNA-616 ( miR-616 ) was markedly upregulated in HCC tissues , and was associated with the recurrence and metastasis of HCC .
1651	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The present study demonstrated for the first time that microRNA-616 ( miR-616 ) was markedly upregulated in HCC tissues , and was associated with the recurrence and metastasis of HCC .
1650	upregulate	positive	microrna-616	1097.619	120.5173	120.5173	miRNA		The present study demonstrated for the first time that microRNA-616 ( miR-616 ) was markedly upregulated in HCC tissues , and was associated with the recurrence and metastasis of HCC .
1650	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The present study demonstrated for the first time that microRNA-616 ( miR-616 ) was markedly upregulated in HCC tissues , and was associated with the recurrence and metastasis of HCC .
1635	influence	neutral	mir-378g	1093.662	116.9858	116.9858	miRNA		To investigate the influence of microRNA-378g ( miR-378g ) on radiosensitivity and metastasis of nasopharyngeal carcinoma cells and study how miR-378g regulated Src homology region 2 domain-containing phosphatase-1 ( SHP-1 ) expression .
1635	influence	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	To investigate the influence of microRNA-378g ( miR-378g ) on radiosensitivity and metastasis of nasopharyngeal carcinoma cells and study how miR-378g regulated Src homology region 2 domain-containing phosphatase-1 ( SHP-1 ) expression .
1634	influence	neutral	mir-378g	1093.662	116.9858	116.9858	miRNA		To investigate the influence of microRNA-378g ( miR-378g ) on radiosensitivity and metastasis of nasopharyngeal carcinoma cells and study how miR-378g regulated Src homology region 2 domain-containing phosphatase-1 ( SHP-1 ) expression .
1634	influence	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	To investigate the influence of microRNA-378g ( miR-378g ) on radiosensitivity and metastasis of nasopharyngeal carcinoma cells and study how miR-378g regulated Src homology region 2 domain-containing phosphatase-1 ( SHP-1 ) expression .
1633	influence	neutral	microrna-378g	1089.663	113.5017	113.5017	miRNA		To investigate the influence of microRNA-378g ( miR-378g ) on radiosensitivity and metastasis of nasopharyngeal carcinoma cells and study how miR-378g regulated Src homology region 2 domain-containing phosphatase-1 ( SHP-1 ) expression .
1633	influence	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	To investigate the influence of microRNA-378g ( miR-378g ) on radiosensitivity and metastasis of nasopharyngeal carcinoma cells and study how miR-378g regulated Src homology region 2 domain-containing phosphatase-1 ( SHP-1 ) expression .
1632	inhibit	negative	mir-449a	1085.623	110.0657	110.0657	miRNA		In HCC cell lines , stable overexpression of miR-449a was sufficient to inhibit cell motility in vitro , and pulmonary metastasis in vivo .
1632	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In HCC cell lines , stable overexpression of miR-449a was sufficient to inhibit cell motility in vitro , and pulmonary metastasis in vivo .
1631	suppress	negative	mir-449a	1085.623	110.0657	110.0657	miRNA		MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets .
1631	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets .
1613	downregulate	negative	mir-573	1081.542	106.6782	106.6782	miRNA		Importantly , we showed that GATA3 directly increases miR-573 expression , and thus down-regulates FGFR1 expression , EMT and invasion of PCa cells in a miR-573-dependent manner , supporting the involvement of GATA3 , miR-573 and FGFR1 in controlling the EMT process during PCa metastasis .
1613	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Importantly , we showed that GATA3 directly increases miR-573 expression , and thus down-regulates FGFR1 expression , EMT and invasion of PCa cells in a miR-573-dependent manner , supporting the involvement of GATA3 , miR-573 and FGFR1 in controlling the EMT process during PCa metastasis .
1612	inhibit	negative	mir-573	1081.542	106.6782	106.6782	miRNA		Through gain- and loss-of function experiments , we demonstrated that miR-573 inhibits PCa cell migration , invasion and TGF-?] 1-induced epithelial-mesenchymal transition ( EMT ) in vitro and lung metastasis in vivo .
1612	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Through gain- and loss-of function experiments , we demonstrated that miR-573 inhibits PCa cell migration , invasion and TGF-?] 1-induced epithelial-mesenchymal transition ( EMT ) in vitro and lung metastasis in vivo .
1611	inhibit	negative	mir-573	1081.542	106.6782	106.6782	miRNA		Through gain- and loss-of function experiments , we demonstrated that miR-573 inhibits PCa cell migration , invasion and TGF-?] 1-induced epithelial-mesenchymal transition ( EMT ) in vitro and lung metastasis in vivo .
1611	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Through gain- and loss-of function experiments , we demonstrated that miR-573 inhibits PCa cell migration , invasion and TGF-?] 1-induced epithelial-mesenchymal transition ( EMT ) in vitro and lung metastasis in vivo .
1610	inhibit	negative	mir-573	1081.542	106.6782	106.6782	miRNA		MiR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition .
1610	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition .
1604	promote	positive	microrna-92a	1077.421	103.3397	103.3397	miRNA		MicroRNA-92a promotes growth , metastasis , and chemoresistance in non-small cell lung cancer cells by targeting PTEN .
1604	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-92a promotes growth , metastasis , and chemoresistance in non-small cell lung cancer cells by targeting PTEN .
1603	downregulate	negative	mir135b	1073.261	100.0507	100.0507	miRNA		The invasive and metastasis abilities were detected by Transwell ( TM ) assay in hepatocellular carcinoma cells with over-expressed or down-regulated miR135b .
1603	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The invasive and metastasis abilities were detected by Transwell ( TM ) assay in hepatocellular carcinoma cells with over-expressed or down-regulated miR135b .
1989	upregulate	positive	mir-130a	1069.061	96.81156	96.81156	miRNA		This study demonstrates for the first time that microRNA-130a ( miR-130a ) is significantly upregulated in osteosarcoma , and associated with the metastasis of osteosarcoma .
1989	upregulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	This study demonstrates for the first time that microRNA-130a ( miR-130a ) is significantly upregulated in osteosarcoma , and associated with the metastasis of osteosarcoma .
1590	downregulate	negative	mir-130a	1069.061	96.81156	96.81156	miRNA		In NSCLC patients , the results showed that miR-130a downregulation exhibited clinical relevance as it was correlated with poor prognosis and increased tumor stage and metastasis .
1590	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In NSCLC patients , the results showed that miR-130a downregulation exhibited clinical relevance as it was correlated with poor prognosis and increased tumor stage and metastasis .
1582	control	neutral	mir-212/132	1064.823	93.62284	93.62284	miRNA		Also , current study suggest a new miRNA-based mechanism elucidating the anti-metastatic properties of Ahr agonists , suggesting possibility of using miR-212/132 to control metastasis in breast cancer patients .
1582	control	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Also , current study suggest a new miRNA-based mechanism elucidating the anti-metastatic properties of Ahr agonists , suggesting possibility of using miR-212/132 to control metastasis in breast cancer patients .
1581	suppress	negative	microrna-212/132	1060.547	90.48497	90.48497	miRNA		Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4 .
1581	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4 .
1578	inhibit	negative	mirna-101	1056.234	87.3984	87.3984	miRNA		MiRNA-101 inhibits breast cancer growth and metastasis by targeting CX chemokine receptor 7 .
1578	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiRNA-101 inhibits breast cancer growth and metastasis by targeting CX chemokine receptor 7 .
1571	inhibit	negative	microrna-132	1051.885	84.36356	84.36356	miRNA		MicroRNA-132 inhibits cell growth and metastasis in osteosarcoma cell lines possibly by targeting Sox4 .
1571	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	MicroRNA-132 inhibits cell growth and metastasis in osteosarcoma cell lines possibly by targeting Sox4 .
1566	suppress	negative	microrna-128	1047.499	81.3809	81.3809	miRNA		MicroRNA-128 suppresses cell growth and metastasis in colorectal carcinoma by targeting IRS1 .
1566	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-128 suppresses cell growth and metastasis in colorectal carcinoma by targeting IRS1 .
1667	inhibit	negative	mir-622	1043.079	78.45084	78.45084	miRNA		These findings highlight the pivotal role of the FOXO3a/miR-622 axis in inhibiting HIF-1帢 to interfere with tumor metastasis , and this information may contribute to development of novel therapeutic strategies for treating aggressive lung cancer .
1667	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	These findings highlight the pivotal role of the FOXO3a/miR-622 axis in inhibiting HIF-1帢 to interfere with tumor metastasis , and this information may contribute to development of novel therapeutic strategies for treating aggressive lung cancer .
1557	inhibit	negative	mir-622	1043.079	78.45084	78.45084	miRNA		MiR-622 inhibited colorectal cancer occurrence and metastasis by suppressing K-Ras .
1557	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-622 inhibited colorectal cancer occurrence and metastasis by suppressing K-Ras .
1960	suppress	negative	mir-630	1038.623	75.57378	75.57378	miRNA		MicroRNA-630 suppresses tumor metastasis through the TGF-?] - miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma .
1960	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-630 suppresses tumor metastasis through the TGF-?] - miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma .
1718	suppress	negative	mir-630	1038.623	75.57378	75.57378	miRNA		Moreover , lentivirus delivered miR-630 bestows MDA-MB-231-luc cells with the ability to suppress cell colony formation in vitro and pulmonary metastasis in vivo .
1718	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Moreover , lentivirus delivered miR-630 bestows MDA-MB-231-luc cells with the ability to suppress cell colony formation in vitro and pulmonary metastasis in vivo .
1549	regulate	positive	mir-630	1038.623	75.57378	75.57378	miRNA		miR-630 targets LMO3 to regulate cell growth and metastasis in lung cancer .
1549	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-630 targets LMO3 to regulate cell growth and metastasis in lung cancer .
1546	promote	positive	mir-940	1034.134	72.75016	72.75016	miRNA		Mechanistically , we found that miR-940 promoted GC cell migration , invasion , and metastasis in vivo by directly and functionally repressing the expression of Zinc Finger Transcription Factor 24 ( ZNF24 ) .
1546	promote	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	Mechanistically , we found that miR-940 promoted GC cell migration , invasion , and metastasis in vivo by directly and functionally repressing the expression of Zinc Finger Transcription Factor 24 ( ZNF24 ) .
1545	promote	positive	microrna-940	1029.611	69.98036	69.98036	miRNA		MicroRNA-940 promotes tumor cell invasion and metastasis by downregulating ZNF24 in gastric cancer .
1545	promote	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	MicroRNA-940 promotes tumor cell invasion and metastasis by downregulating ZNF24 in gastric cancer .
1544	control	neutral	mir-143/mir	1025.055	67.26479	67.26479	miRNA		Overexpression of activin A in OSCCs , which is controlled by downregulation of miR-143/miR-145 cluster , regulates apoptosis , proliferation and invasiveness , and it is clinically correlated with lymph node metastasis and poor survival .
1544	control	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Overexpression of activin A in OSCCs , which is controlled by downregulation of miR-143/miR-145 cluster , regulates apoptosis , proliferation and invasiveness , and it is clinically correlated with lymph node metastasis and poor survival .
2016	regulate	positive	mir-452	1020.467	64.60383	64.60383	miRNA		Regulation of the miR-452-WWP1 axis contributed to PCa cell migration and invasion , and elucidation of downstream signalling of this axis will provide new insights into the mechanisms of PCa oncogenesis and metastasis .
2016	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Regulation of the miR-452-WWP1 axis contributed to PCa cell migration and invasion , and elucidation of downstream signalling of this axis will provide new insights into the mechanisms of PCa oncogenesis and metastasis .
1784	regulate	positive	mir-452	1020.467	64.60383	64.60383	miRNA		This study aims to identify how miR-452 acts in regulating non-small cell lung cancer ( NSCLC ) proliferation and metastasis .
1784	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	This study aims to identify how miR-452 acts in regulating non-small cell lung cancer ( NSCLC ) proliferation and metastasis .
1543	inhibit	negative	mir-452	1020.467	64.60383	64.60383	miRNA		Up-Regulation of MiR-452 Inhibits Metastasis of Non-Small Cell Lung Cancer by Regulating BMI1 .
1543	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Up-Regulation of MiR-452 Inhibits Metastasis of Non-Small Cell Lung Cancer by Regulating BMI1 .
1531	promote	positive	mir-944	1015.848	61.99785	61.99785	miRNA		We then demonstrated that miR-944 promotes cell proliferation and tumor metastasis in breast cancer cell lines .
1531	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We then demonstrated that miR-944 promotes cell proliferation and tumor metastasis in breast cancer cell lines .
1525	promote	positive	mir-761	1011.198	59.44725	59.44725	miRNA		miR-761 promotes progression and metastasis of NSCLC by targeting ING4 and TIMP2 .
1525	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-761 promotes progression and metastasis of NSCLC by targeting ING4 and TIMP2 .
1524	promote	positive	mir-761	1011.198	59.44725	59.44725	miRNA		Finally , we investigated whether miR-761 promotes proliferation and metastasis in NSCLC cell lines by targeting ING4 ( inhibitor of growth family , member 4 ) and TIMP2 ( tissue inhibitor of metalloproteinase 2 ) .
1524	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Finally , we investigated whether miR-761 promotes proliferation and metastasis in NSCLC cell lines by targeting ING4 ( inhibitor of growth family , member 4 ) and TIMP2 ( tissue inhibitor of metalloproteinase 2 ) .
1523	regulate	positive	mir-761	1011.198	59.44725	59.44725	miRNA		The aim of this study was to investigate the role of microRNA miR-761 in the progression and metastasis of non-small cell lung cancer ( NSCLC ) , and the mechanisms by which miR-761 regulates cell proliferation and metastatic activity of NSCLC cell lines .
1523	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The aim of this study was to investigate the role of microRNA miR-761 in the progression and metastasis of non-small cell lung cancer ( NSCLC ) , and the mechanisms by which miR-761 regulates cell proliferation and metastatic activity of NSCLC cell lines .
1522	promote	positive	mir-761	1011.198	59.44725	59.44725	miRNA		MiR-761 Promotes Progression and Metastasis of Non-Small Cell Lung Cancer by Targeting ING4 and TIMP2 .
1522	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-761 Promotes Progression and Metastasis of Non-Small Cell Lung Cancer by Targeting ING4 and TIMP2 .
1521	regulate	positive	microrna-203	1006.518	56.95236	56.95236	miRNA		MicroRNA-203 Regulates Growth and Metastasis of Breast Cancer .
1521	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-203 Regulates Growth and Metastasis of Breast Cancer .
1513	suppress	negative	mirna-99b	1001.808	54.51357	54.51357	miRNA		miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR .
1513	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR .
1508	upregulate	positive	microrna-24	997.0696	52.1312	52.1312	miRNA		MicroRNA-24 upregulation inhibits proliferation , metastasis and induces apoptosis in bladder cancer cells by targeting CARMA3 .
1508	upregulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	MicroRNA-24 upregulation inhibits proliferation , metastasis and induces apoptosis in bladder cancer cells by targeting CARMA3 .
1507	enhance	positive	mir27b	992.303	49.8056	49.8056	miRNA		More importantly , reduction in miR98 and miR27b enhances the epithelial-mesenchymal transition ( EMT ) of breast cancer cells , and thus promotes breast cancer metastasis .
1507	enhance	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	More importantly , reduction in miR98 and miR27b enhances the epithelial-mesenchymal transition ( EMT ) of breast cancer cells , and thus promotes breast cancer metastasis .
1506	enhance	positive	mir27b	992.303	49.8056	49.8056	miRNA		More importantly , reduction in miR98 and miR27b enhances the epithelial-mesenchymal transition ( EMT ) of breast cancer cells , and thus promotes breast cancer metastasis .
1506	enhance	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	More importantly , reduction in miR98 and miR27b enhances the epithelial-mesenchymal transition ( EMT ) of breast cancer cells , and thus promotes breast cancer metastasis .
1505	enhance	positive	mir27b	992.303	49.8056	49.8056	miRNA		More importantly , reduction in miR98 and miR27b enhances the epithelial-mesenchymal transition ( EMT ) of breast cancer cells , and thus promotes breast cancer metastasis .
1505	enhance	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	More importantly , reduction in miR98 and miR27b enhances the epithelial-mesenchymal transition ( EMT ) of breast cancer cells , and thus promotes breast cancer metastasis .
1501	downregulate	negative	mir27b	992.303	49.8056	49.8056	miRNA		CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis .
1501	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis .
1504	enhance	positive	mir98	987.509	47.5371	47.5371	miRNA		More importantly , reduction in miR98 and miR27b enhances the epithelial-mesenchymal transition ( EMT ) of breast cancer cells , and thus promotes breast cancer metastasis .
1504	enhance	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	More importantly , reduction in miR98 and miR27b enhances the epithelial-mesenchymal transition ( EMT ) of breast cancer cells , and thus promotes breast cancer metastasis .
1503	enhance	positive	mir98	987.509	47.5371	47.5371	miRNA		More importantly , reduction in miR98 and miR27b enhances the epithelial-mesenchymal transition ( EMT ) of breast cancer cells , and thus promotes breast cancer metastasis .
1503	enhance	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	More importantly , reduction in miR98 and miR27b enhances the epithelial-mesenchymal transition ( EMT ) of breast cancer cells , and thus promotes breast cancer metastasis .
1502	enhance	positive	mir98	987.509	47.5371	47.5371	miRNA		More importantly , reduction in miR98 and miR27b enhances the epithelial-mesenchymal transition ( EMT ) of breast cancer cells , and thus promotes breast cancer metastasis .
1502	enhance	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	More importantly , reduction in miR98 and miR27b enhances the epithelial-mesenchymal transition ( EMT ) of breast cancer cells , and thus promotes breast cancer metastasis .
1500	downregulate	negative	mir98	987.509	47.5371	47.5371	miRNA		CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis .
1500	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis .
1489	downregulate	negative	microrna-646	982.6882	45.32603	45.32603	miRNA		Downregulation of microRNA-217 and microRNA-646 acts as potential predictor biomarkers in progression , metastasis , and unfavorable prognosis of human osteosarcoma .
1489	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Downregulation of microRNA-217 and microRNA-646 acts as potential predictor biomarkers in progression , metastasis , and unfavorable prognosis of human osteosarcoma .
1481	suppress	negative	mir-26b/kpna	977.8414	43.17271	43.17271	miRNA		miR-26b/KPNA2 axis suppresses tumor proliferation and metastasis through decreasing OCT4 expression , which is indicative of the important role of miR-26b/KPNA2/OCT4 axis in EOC carcinogenesis and progression .
1481	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-26b/KPNA2 axis suppresses tumor proliferation and metastasis through decreasing OCT4 expression , which is indicative of the important role of miR-26b/KPNA2/OCT4 axis in EOC carcinogenesis and progression .
1480	inhibit	negative	mir-26b/kpna	977.8414	43.17271	43.17271	miRNA		MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4 .
1480	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4 .
1479	upregulate	positive	mir-504	972.9692	41.07743	41.07743	miRNA		Furthermore , serum from NPC patients showed that miR-504 was up-regulated during different weeks of radiotherapy and correlated with tumor , lymph nodes and metastasis ( TNM ) stages and total tumor volume .
1479	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Furthermore , serum from NPC patients showed that miR-504 was up-regulated during different weeks of radiotherapy and correlated with tumor , lymph nodes and metastasis ( TNM ) stages and total tumor volume .
1478	upregulate	positive	mir-504	972.9692	41.07743	41.07743	miRNA		Furthermore , serum from NPC patients showed that miR-504 was up-regulated during different weeks of radiotherapy and correlated with tumor , lymph nodes and metastasis ( TNM ) stages and total tumor volume .
1478	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Furthermore , serum from NPC patients showed that miR-504 was up-regulated during different weeks of radiotherapy and correlated with tumor , lymph nodes and metastasis ( TNM ) stages and total tumor volume .
1837	downregulate	negative	mir-187	968.0723	39.04049	39.04049	miRNA		Together with the fact that high SOX4 or NT5E levels were associated with poor prognosis , we also demonstrated that downregulation of miR-187 was closely related to tumor metastasis and poor prognosis in CRC .
1837	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Together with the fact that high SOX4 or NT5E levels were associated with poor prognosis , we also demonstrated that downregulation of miR-187 was closely related to tumor metastasis and poor prognosis in CRC .
1476	control	neutral	mir-187	968.0723	39.04049	39.04049	miRNA		Based on the results obtained in the last decade , some miRNAs are emerging as biomarkers of BC for diagnosis ( i.e. , miR-9 , miR-10b , and miR-17-5p ) , prognosis ( i.e. , miR-148a and miR-335 ) , and prediction of therapeutic outcomes ( i.e. , miR-30c , miR-187 , and miR-339-5p ) and have important roles in the control of BC hallmark functions such as invasion , metastasis , proliferation , resting death , apoptosis , and genomic instability .
1476	control	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Based on the results obtained in the last decade , some miRNAs are emerging as biomarkers of BC for diagnosis ( i.e. , miR-9 , miR-10b , and miR-17-5p ) , prognosis ( i.e. , miR-148a and miR-335 ) , and prediction of therapeutic outcomes ( i.e. , miR-30c , miR-187 , and miR-339-5p ) and have important roles in the control of BC hallmark functions such as invasion , metastasis , proliferation , resting death , apoptosis , and genomic instability .
1469	promote	positive	mir-302c/il	963.1514	37.0622	37.0622	miRNA		Loss of RACK1 Promotes Metastasis of Gastric Cancer by Inducing a miR-302c/IL8 Signaling Loop .
1469	promote	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	Loss of RACK1 Promotes Metastasis of Gastric Cancer by Inducing a miR-302c/IL8 Signaling Loop .
1598	suppress	negative	mir-365	958.2072	35.14283	35.14283	miRNA		We further identified a novel mechanism of miR-365 to suppress MM growth and metastasis .
1598	suppress	negative	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	We further identified a novel mechanism of miR-365 to suppress MM growth and metastasis .
1597	inhibit	negative	mir-365	958.2072	35.14283	35.14283	miRNA		We also found that ectopic expression of miR-365 inhibited MM cell proliferation and MM metastasis in vitro and in vivo .
1597	inhibit	negative	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	We also found that ectopic expression of miR-365 inhibited MM cell proliferation and MM metastasis in vitro and in vivo .
1596	downregulate	negative	mir-365	958.2072	35.14283	35.14283	miRNA		MiR-365 was strongly down-regulated in malignant melanoma ( MM ) tissues and cell lines , and its expression levels were associated with lymph node metastasis and clinical stage , as well as overall survival and replase-free survival of MM .
1596	downregulate	negative	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	MiR-365 was strongly down-regulated in malignant melanoma ( MM ) tissues and cell lines , and its expression levels were associated with lymph node metastasis and clinical stage , as well as overall survival and replase-free survival of MM .
1465	suppress	negative	mir-365	958.2072	35.14283	35.14283	miRNA		We further identified a novel mechanism of miR-365 to suppress MM growth and metastasis .
1465	suppress	negative	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	We further identified a novel mechanism of miR-365 to suppress MM growth and metastasis .
1464	inhibit	negative	mir-365	958.2072	35.14283	35.14283	miRNA		We also found that ectopic expression of miR-365 inhibited MM cell proliferation and MM metastasis in vitro and in vivo .
1464	inhibit	negative	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	We also found that ectopic expression of miR-365 inhibited MM cell proliferation and MM metastasis in vitro and in vivo .
1463	downregulate	negative	mir-365	958.2072	35.14283	35.14283	miRNA		MiR-365 was strongly down-regulated in malignant melanoma ( MM ) tissues and cell lines , and its expression levels were associated with lymph node metastasis and clinical stage , as well as overall survival and replase-free survival of MM .
1463	downregulate	negative	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	MiR-365 was strongly down-regulated in malignant melanoma ( MM ) tissues and cell lines , and its expression levels were associated with lymph node metastasis and clinical stage , as well as overall survival and replase-free survival of MM .
1595	inhibit	negative	microrna-365	953.2405	33.28265	33.28265	miRNA		MicroRNA-365 inhibits growth , invasion and metastasis of malignant melanoma by targeting NRP1 expression .
1595	inhibit	negative	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	MicroRNA-365 inhibits growth , invasion and metastasis of malignant melanoma by targeting NRP1 expression .
1462	inhibit	negative	microrna-365	953.2405	33.28265	33.28265	miRNA		MicroRNA-365 inhibits growth , invasion and metastasis of malignant melanoma by targeting NRP1 expression .
1462	inhibit	negative	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	MicroRNA-365 inhibits growth , invasion and metastasis of malignant melanoma by targeting NRP1 expression .
1457	regulate	positive	microrna-3178	948.2519	31.48193	31.48193	miRNA		Regulation of tumorigenesis and metastasis of hepatocellular carcinoma tumor endothelial cells by microRNA-3178 and underlying mechanism .
1457	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Regulation of tumorigenesis and metastasis of hepatocellular carcinoma tumor endothelial cells by microRNA-3178 and underlying mechanism .
1448	downregulate	negative	mir-551b	943.2422	29.74093	29.74093	miRNA		It was identified that the expression levels of miR-551b-3p , miR-133b , miR-100-5p and miR-363-3p were significantly downregulated in the gastric cancer tissues , and this downregulation was closely correlated with the degree of differentiation ( i.e. , tumor grade ) , TNM stage and lymph-node metastasis ( P < 0.05 ) .
1448	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	It was identified that the expression levels of miR-551b-3p , miR-133b , miR-100-5p and miR-363-3p were significantly downregulated in the gastric cancer tissues , and this downregulation was closely correlated with the degree of differentiation ( i.e. , tumor grade ) , TNM stage and lymph-node metastasis ( P < 0.05 ) .
1447	inhibit	negative	mir-324	938.212	28.0599	28.0599	miRNA		Finally , transfection of a miR-324-5p mimic inhibited the suppression of invasion and metastasis of MDA-MB-231 and 4T1 cell by sinomenine , providing evidence that sinomenine treatment suppressed breast cancer cell invasion and metastasis via regulation of the IL4/miR-324-5p/CUEDC2 axis .
1447	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Finally , transfection of a miR-324-5p mimic inhibited the suppression of invasion and metastasis of MDA-MB-231 and 4T1 cell by sinomenine , providing evidence that sinomenine treatment suppressed breast cancer cell invasion and metastasis via regulation of the IL4/miR-324-5p/CUEDC2 axis .
1764	enhance	positive	mir-425	933.162	26.43907	26.43907	miRNA		We found that enhanced expression of miR-425 in ESCC cell lines not only promoted cell proliferation and colony formation , but also increased cellular metastasis .
1764	enhance	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	We found that enhanced expression of miR-425 in ESCC cell lines not only promoted cell proliferation and colony formation , but also increased cellular metastasis .
1626	inhibit	negative	mir-425	933.162	26.43907	26.43907	miRNA		miR-425 inhibits melanoma metastasis through repression of PI3K-Akt pathway by targeting IGF-1 .
1626	inhibit	negative	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	miR-425 inhibits melanoma metastasis through repression of PI3K-Akt pathway by targeting IGF-1 .
1436	downregulate	negative	mir-425	933.162	26.43907	26.43907	miRNA		In the in vivo studies , downregulation of miR-425-5p expression suppressed pulmonary metastasis in the nude mice .
1436	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In the in vivo studies , downregulation of miR-425-5p expression suppressed pulmonary metastasis in the nude mice .
1435	upregulate	positive	microrna-425	928.0931	24.87867	24.87867	miRNA		microRNA-425-5p is upregulated in human gastric cancer and contributes to invasion and metastasis in vitro and in vivo .
1435	upregulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	microRNA-425-5p is upregulated in human gastric cancer and contributes to invasion and metastasis in vitro and in vivo .
1434	inhibit	negative	mir-99b	923.006	23.37894	23.37894	miRNA		Overexpression or knockdown of miR-99b expression increased or inhibited , respectively , the metastasis of HCC cells in ? vitro .
1434	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Overexpression or knockdown of miR-99b expression increased or inhibited , respectively , the metastasis of HCC cells in ? vitro .
1433	promote	positive	mir-99b	923.006	23.37894	23.37894	miRNA		miR-99b promotes metastasis of hepatocellular carcinoma through inhibition of claudin ? 11 expression and may serve as a prognostic marker .
1433	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-99b promotes metastasis of hepatocellular carcinoma through inhibition of claudin ? 11 expression and may serve as a prognostic marker .
1904	regulate	positive	mir-448	917.9012	21.94007	21.94007	miRNA		Our findings demonstrate the critical role of KDM5B and its negative regulator hsa-miR-448 in TNBC metastasis and progression .
1904	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Our findings demonstrate the critical role of KDM5B and its negative regulator hsa-miR-448 in TNBC metastasis and progression .
1429	regulate	positive	mir-448	917.9012	21.94007	21.94007	miRNA		miR-448 negatively regulates ovarian cancer cell growth and metastasis by targeting CXCL12 .
1429	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-448 negatively regulates ovarian cancer cell growth and metastasis by targeting CXCL12 .
1426	regulate	positive	mir-520d	912.7797	20.56229	20.56229	miRNA		In conclusion , our findings indicate that miR-520d-5p is significantly down-expressed and involved in CRC progression and metastasis by targeting CTHRC1 and regulated by SP1 , which provide new support for miR-520d-5p maybe as a novel anti-onco molecular target for the treatment of CRC in the future .
1426	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In conclusion , our findings indicate that miR-520d-5p is significantly down-expressed and involved in CRC progression and metastasis by targeting CTHRC1 and regulated by SP1 , which provide new support for miR-520d-5p maybe as a novel anti-onco molecular target for the treatment of CRC in the future .
1425	suppress	negative	microrna-520d	907.642	19.24578	19.24578	miRNA		SP1-mediated microRNA-520d-5p suppresses tumor growth and metastasis in colorectal cancer by targeting CTHRC1 .
1425	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	SP1-mediated microRNA-520d-5p suppresses tumor growth and metastasis in colorectal cancer by targeting CTHRC1 .
1418	suppress	negative	mir-337	902.489	17.99074	17.99074	miRNA		Gain- and loss-of-function studies demonstrated that miR-337-3p suppressed the growth , invasion , metastasis , and angiogenesis of NB cells in vitro and in vivo .
1418	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Gain- and loss-of-function studies demonstrated that miR-337-3p suppressed the growth , invasion , metastasis , and angiogenesis of NB cells in vitro and in vivo .
1407	control	neutral	mir-1246	897.3214	16.79733	16.79733	miRNA		Our data showed that the expression of miR-1246 was dramatically decreased in cervical cancer tissue , compared with normal control group ( p=0.0012 ) , and miR-1246 was negatively correlated with clinical stage and HPV16E6 infected status ( p=0.0410 ) , but no correlation was observed with age , tumor diameter , cervical invasion depth , lymph node metastasis , or vascular invasion ( p > 0.05 ) .
1407	control	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Our data showed that the expression of miR-1246 was dramatically decreased in cervical cancer tissue , compared with normal control group ( p=0.0012 ) , and miR-1246 was negatively correlated with clinical stage and HPV16E6 infected status ( p=0.0410 ) , but no correlation was observed with age , tumor diameter , cervical invasion depth , lymph node metastasis , or vascular invasion ( p > 0.05 ) .
1403	effect	neutral	mir-184	892.1398	15.66574	15.66574	miRNA		Orthotopic xenografts of breast cancer cells were used to assess the effect of miR-184 on tumourigenesis as well as distant metastasis .
1403	effect	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Orthotopic xenografts of breast cancer cells were used to assess the effect of miR-184 on tumourigenesis as well as distant metastasis .
1968	suppress	negative	mir-485	886.9452	14.59613	14.59613	miRNA		Overexpression of miR-485-3p and miR-485-5p suppressed mitochondrial respiration and potential for cell migration and invasion in vitro , and also inhibited spontaneous metastasis of breast cancer cells in vivo .
1968	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Overexpression of miR-485-3p and miR-485-5p suppressed mitochondrial respiration and potential for cell migration and invasion in vitro , and also inhibited spontaneous metastasis of breast cancer cells in vivo .
1967	suppress	negative	mir-485	886.9452	14.59613	14.59613	miRNA		MiR-485-3p and miR-485-5p suppress breast cancer cell metastasis by inhibiting PGC-1帢 expression .
1967	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-485-3p and miR-485-5p suppress breast cancer cell metastasis by inhibiting PGC-1帢 expression .
1966	suppress	negative	mir-485	886.9452	14.59613	14.59613	miRNA		MiR-485-3p and miR-485-5p suppress breast cancer cell metastasis by inhibiting PGC-1帢 expression .
1966	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-485-3p and miR-485-5p suppress breast cancer cell metastasis by inhibiting PGC-1帢 expression .
1824	suppress	negative	mir-485	886.9452	14.59613	14.59613	miRNA		We also found that miR-485-5p suppressed gastric cancer cell metastasis and sphere formation .
1824	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	We also found that miR-485-5p suppressed gastric cancer cell metastasis and sphere formation .
1396	inhibit	negative	mir-485	886.9452	14.59613	14.59613	miRNA		Results of cellular functions in HCC showed that miR-485-5p could inhibit cell proliferation and metastasis .
1396	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Results of cellular functions in HCC showed that miR-485-5p could inhibit cell proliferation and metastasis .
1395	downregulate	negative	mir-485	886.9452	14.59613	14.59613	miRNA		We found that miR-485-5p was significantly downregulated in HCC tissues and that its expression was inversely correlated with the TNM stage and metastasis in HCC samples .
1395	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We found that miR-485-5p was significantly downregulated in HCC tissues and that its expression was inversely correlated with the TNM stage and metastasis in HCC samples .
1394	downregulate	negative	mir-485	886.9452	14.59613	14.59613	miRNA		We found that miR-485-5p was significantly downregulated in HCC tissues and that its expression was inversely correlated with the TNM stage and metastasis in HCC samples .
1394	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We found that miR-485-5p was significantly downregulated in HCC tissues and that its expression was inversely correlated with the TNM stage and metastasis in HCC samples .
1393	suppress	negative	mir-584	881.7381	13.58863	13.58863	miRNA		Gain- and loss-of-function studies demonstrated that miR-584-5p suppressed the growth , invasion , metastasis , and angiogenesis of NB cells in vitro and in vivo .
1393	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Gain- and loss-of-function studies demonstrated that miR-584-5p suppressed the growth , invasion , metastasis , and angiogenesis of NB cells in vitro and in vivo .
2039	inhibit	negative	mir-1207	876.5193	12.64341	12.64341	miRNA		miR-1207-5p also significantly inhibited A549 cells metastasis in a nude mouse xenograft model .
2039	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-1207-5p also significantly inhibited A549 cells metastasis in a nude mouse xenograft model .
2038	suppress	negative	mir-1207	876.5193	12.64341	12.64341	miRNA		miR-1207-5p suppresses lung cancer growth and metastasis by targeting CSF1 .
2038	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-1207-5p suppresses lung cancer growth and metastasis by targeting CSF1 .
1388	suppress	negative	mir-1207	876.5193	12.64341	12.64341	miRNA		To our surprise , we found that miR-148a , miR-505 , and miR-1207-5p can suppress EMT and metastasis phenotypes in HK-1 cells both in vitro and in vivo , which may relate to their inhibition on EMT and Wnt signaling molecules .
1388	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	To our surprise , we found that miR-148a , miR-505 , and miR-1207-5p can suppress EMT and metastasis phenotypes in HK-1 cells both in vitro and in vivo , which may relate to their inhibition on EMT and Wnt signaling molecules .
1387	suppress	negative	mir-505	871.2897	11.7606	11.7606	miRNA		To our surprise , we found that miR-148a , miR-505 , and miR-1207-5p can suppress EMT and metastasis phenotypes in HK-1 cells both in vitro and in vivo , which may relate to their inhibition on EMT and Wnt signaling molecules .
1387	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	To our surprise , we found that miR-148a , miR-505 , and miR-1207-5p can suppress EMT and metastasis phenotypes in HK-1 cells both in vitro and in vivo , which may relate to their inhibition on EMT and Wnt signaling molecules .
1380	induction	positive	mirna-181a	866.0499	10.94031	10.94031	miRNA		Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer .
1380	induction	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer .
1366	suppress	negative	microrna-188	860.8007	10.18267	10.18267	miRNA		MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma .
1366	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma .
1920	regulate	positive	mir-1271	855.5427	9.487791	9.487791	miRNA		The purpose of this study was to determine the role of miR-1271 in regulation of epithelial mesenchymal transition ( EMT ) and metastasis of pancreatic cancer cells .
1920	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The purpose of this study was to determine the role of miR-1271 in regulation of epithelial mesenchymal transition ( EMT ) and metastasis of pancreatic cancer cells .
1919	regulate	positive	mir-1271	855.5427	9.487791	9.487791	miRNA		The purpose of this study was to determine the role of miR-1271 in regulation of epithelial mesenchymal transition ( EMT ) and metastasis of pancreatic cancer cells .
1919	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The purpose of this study was to determine the role of miR-1271 in regulation of epithelial mesenchymal transition ( EMT ) and metastasis of pancreatic cancer cells .
1365	inhibit	negative	mir-1271	855.5427	9.487791	9.487791	miRNA		miR-1271 inhibits OSCC cell growth and metastasis by targeting ALK .
1365	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-1271 inhibits OSCC cell growth and metastasis by targeting ALK .
1360	induction	positive	mir-302/367	850.2769	8.855764	8.855764	miRNA		The induction of the miR-302/367 cluster in U87MG glioblastoma cells suppresses the expression of multiple transformation related genes , abolishes the tumor and metastasis formation potential of these cells and can potentially become a new approach for cancer therapy .
1360	induction	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The induction of the miR-302/367 cluster in U87MG glioblastoma cells suppresses the expression of multiple transformation related genes , abolishes the tumor and metastasis formation potential of these cells and can potentially become a new approach for cancer therapy .
1358	promote	positive	mir-200s/zeb	845.0038	8.286683	8.286683	miRNA		LncRNA-ATB plays an important role in EMT to promote invasion and metastasis through the TGF-?] /miR-200s/ZEB axis , resulting in a poor prognosis in GC .
1358	promote	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	LncRNA-ATB plays an important role in EMT to promote invasion and metastasis through the TGF-?] /miR-200s/ZEB axis , resulting in a poor prognosis in GC .
1356	antagonize	negative	mir-473	839.7244	7.780628	7.780628	miRNA		Together , these data suggest that TR4 may increase PCa metastasis via a newly identified signal and targeting these TR4/miR-473-3p/TGF?] R2/p-Smad3 signals using TR4 antagonist or TR4-siRNA or miR-373-3p may allow us to develop a new potential therapeutic approach to better suppress PCa metastasis .
1356	antagonize	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Together , these data suggest that TR4 may increase PCa metastasis via a newly identified signal and targeting these TR4/miR-473-3p/TGF?] R2/p-Smad3 signals using TR4 antagonist or TR4-siRNA or miR-373-3p may allow us to develop a new potential therapeutic approach to better suppress PCa metastasis .
1354	inhibit	negative	mir-520a	834.4393	7.337672	7.337672	miRNA		Together , our data demonstrated that miR-520a-3p inhibits proliferation , apoptosis and metastasis in NSCLC by targeting MAP3K2 , and miR-520a-3p may be used as a prognosis marker for NSCLC in clinical research .
1354	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Together , our data demonstrated that miR-520a-3p inhibits proliferation , apoptosis and metastasis in NSCLC by targeting MAP3K2 , and miR-520a-3p may be used as a prognosis marker for NSCLC in clinical research .
1353	inhibit	negative	mir-520a	834.4393	7.337672	7.337672	miRNA		Inhibition of expression of miR-520a-3p can reduce in vitro NSCLC cell migration and invasion as well as in vivo metastasis .
1353	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Inhibition of expression of miR-520a-3p can reduce in vitro NSCLC cell migration and invasion as well as in vivo metastasis .
1352	inhibit	negative	microrna-520a	829.1492	6.957879	6.957879	miRNA		The microRNA-520a-3p inhibits proliferation , apoptosis and metastasis by targeting MAP3K2 in non-small cell lung cancer .
1352	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The microRNA-520a-3p inhibits proliferation , apoptosis and metastasis by targeting MAP3K2 in non-small cell lung cancer .
1775	inhibit	negative	microrna-124	823.855	6.641301	6.641301	miRNA		MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3 .
1775	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3 .
1350	downregulate	negative	microrna-124	823.855	6.641301	6.641301	miRNA		Down-regulation of microRNA-124 is correlated with tumor metastasis and poor prognosis in patients with lung cancer .
1350	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Down-regulation of microRNA-124 is correlated with tumor metastasis and poor prognosis in patients with lung cancer .
1348	inhibit	negative	mir-200a/b	818.5574	6.387984	6.387984	miRNA		Taken together , our results suggest that Restin inhibits EMT and tumor metastasis by controlling the expression of the tumor metastasis suppressor mir-200a/b via association with p73 .
1348	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , our results suggest that Restin inhibits EMT and tumor metastasis by controlling the expression of the tumor metastasis suppressor mir-200a/b via association with p73 .
1347	suppress	negative	mir-200a/b	818.5574	6.387984	6.387984	miRNA		Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73 .
1347	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73 .
1346	suppress	negative	mir-200a/b	818.5574	6.387984	6.387984	miRNA		Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73 .
1346	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73 .
1345	inhibit	negative	mir-361	813.2572	6.197965	6.197965	miRNA		Most interestingly , in vivo studies showed that restoration of miR-361-5p significantly inhibited tumor growth and especially the lung metastasis in nude mice .
1345	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Most interestingly , in vivo studies showed that restoration of miR-361-5p significantly inhibited tumor growth and especially the lung metastasis in nude mice .
1344	inhibit	negative	mir-361	813.2572	6.197965	6.197965	miRNA		MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1 .
1344	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1 .
1343	inhibit	negative	mir-361	813.2572	6.197965	6.197965	miRNA		MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1 .
1343	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1 .
1342	downregulate	negative	mir-95	807.9551	6.071271	6.071271	miRNA		It was concluded that hsa-miR-665 and hsa-miR-95 were downregulated in GSRCC but upregulated in intestinal gastric adenocarcinoma , and the relatively differential expression of the miRNAs negatively controlling their target genes could be closely related to the high invasive metastasis and chemoresistance of GSRCC .
1342	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	It was concluded that hsa-miR-665 and hsa-miR-95 were downregulated in GSRCC but upregulated in intestinal gastric adenocarcinoma , and the relatively differential expression of the miRNAs negatively controlling their target genes could be closely related to the high invasive metastasis and chemoresistance of GSRCC .
1341	downregulate	negative	mir-665	802.6518	6.007919	6.007919	miRNA		It was concluded that hsa-miR-665 and hsa-miR-95 were downregulated in GSRCC but upregulated in intestinal gastric adenocarcinoma , and the relatively differential expression of the miRNAs negatively controlling their target genes could be closely related to the high invasive metastasis and chemoresistance of GSRCC .
1341	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	It was concluded that hsa-miR-665 and hsa-miR-95 were downregulated in GSRCC but upregulated in intestinal gastric adenocarcinoma , and the relatively differential expression of the miRNAs negatively controlling their target genes could be closely related to the high invasive metastasis and chemoresistance of GSRCC .
1340	inhibit	negative	mir-433	797.3482	6.007919	6.007919	miRNA		miR-433 inhibits oral squamous cell carcinoma ( OSCC ) cell growth and metastasis by targeting HDAC6 .
1340	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-433 inhibits oral squamous cell carcinoma ( OSCC ) cell growth and metastasis by targeting HDAC6 .
1338	regulate	positive	mir-550a	792.0449	6.071271	6.071271	miRNA		Here we demonstrated that decreased Brg-1 regulates a novel miR-550a-5p/RNF43/Wnt/?] -catenin signaling pathway , to promote CRC metastasis in vitro and in vivo .
1338	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here we demonstrated that decreased Brg-1 regulates a novel miR-550a-5p/RNF43/Wnt/?] -catenin signaling pathway , to promote CRC metastasis in vitro and in vivo .
1337	regulate	positive	mir550a	786.7428	6.197965	6.197965	miRNA		Brg-1 targeting of novel miR550a-5p/RNF43/Wnt signaling axis regulates colorectal cancer metastasis .
1337	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Brg-1 targeting of novel miR550a-5p/RNF43/Wnt signaling axis regulates colorectal cancer metastasis .
1336	upregulate	positive	mir-744	781.4426	6.387984	6.387984	miRNA		In this study , we found that miR-744 expression was upregulated in NPC specimens compared to nasopharyngeal epithelium ( NPE ) tissue , and miR- 744 upregulation was significantly associated with TNM stage , tumorigenesis and metastasis .
1336	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In this study , we found that miR-744 expression was upregulated in NPC specimens compared to nasopharyngeal epithelium ( NPE ) tissue , and miR- 744 upregulation was significantly associated with TNM stage , tumorigenesis and metastasis .
1335	upregulate	positive	mir-744	781.4426	6.387984	6.387984	miRNA		In this study , we found that miR-744 expression was upregulated in NPC specimens compared to nasopharyngeal epithelium ( NPE ) tissue , and miR- 744 upregulation was significantly associated with TNM stage , tumorigenesis and metastasis .
1335	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In this study , we found that miR-744 expression was upregulated in NPC specimens compared to nasopharyngeal epithelium ( NPE ) tissue , and miR- 744 upregulation was significantly associated with TNM stage , tumorigenesis and metastasis .
1334	control	neutral	mir-744	781.4426	6.387984	6.387984	miRNA		MiR-744 functions as a proto-oncogene in nasopharyngeal carcinoma progression and metastasis via transcriptional control of ARHGAP5 .
1334	control	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-744 functions as a proto-oncogene in nasopharyngeal carcinoma progression and metastasis via transcriptional control of ARHGAP5 .
1333	inhibit	negative	microrna-216a	776.145	6.641301	6.641301	miRNA		MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B .
1333	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B .
1328	suppress	negative	microrna-429	770.8508	6.957879	6.957879	miRNA		MicroRNA-429 suppresses cell proliferation , epithelial-mesenchymal transition , and metastasis by direct targeting of BMI1 and E2F3 in renal cell carcinoma .
1328	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-429 suppresses cell proliferation , epithelial-mesenchymal transition , and metastasis by direct targeting of BMI1 and E2F3 in renal cell carcinoma .
1327	suppress	negative	microrna-429	770.8508	6.957879	6.957879	miRNA		MicroRNA-429 suppresses cell proliferation , epithelial-mesenchymal transition , and metastasis by direct targeting of BMI1 and E2F3 in renal cell carcinoma .
1327	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-429 suppresses cell proliferation , epithelial-mesenchymal transition , and metastasis by direct targeting of BMI1 and E2F3 in renal cell carcinoma .
1325	upregulate	positive	mir-330	765.5607	7.337672	7.337672	miRNA		Recent studies have indicated that miR-330-3p expression is up-regulated in NSCLC samples and in tissues of NSCLC brain metastasis .
1325	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Recent studies have indicated that miR-330-3p expression is up-regulated in NSCLC samples and in tissues of NSCLC brain metastasis .
1324	upregulate	positive	mir-330	765.5607	7.337672	7.337672	miRNA		Recent studies have indicated that miR-330-3p expression is up-regulated in NSCLC samples and in tissues of NSCLC brain metastasis .
1324	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Recent studies have indicated that miR-330-3p expression is up-regulated in NSCLC samples and in tissues of NSCLC brain metastasis .
1614	suppress	negative	microrna-506	760.2756	7.780628	7.780628	miRNA		MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2 .
1614	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2 .
1319	suppress	negative	microrna-506	760.2756	7.780628	7.780628	miRNA		MicroRNA-506 suppresses growth and metastasis of oral squamous cell carcinoma via targeting GATA6 .
1319	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-506 suppresses growth and metastasis of oral squamous cell carcinoma via targeting GATA6 .
1312	inhibit	negative	mir-320a	754.9962	8.286683	8.286683	miRNA		MiR-320a inhibits metastasis in SACCs by targeting ITGB3 and may serve as a therapeutic target and prognostic marker in salivary cancers .
1312	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-320a inhibits metastasis in SACCs by targeting ITGB3 and may serve as a therapeutic target and prognostic marker in salivary cancers .
1311	inhibit	negative	mir-320a	754.9962	8.286683	8.286683	miRNA		MiR-320a acts as a prognostic factor and Inhibits metastasis of salivary adenoid cystic carcinoma by targeting ITGB3 .
1311	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-320a acts as a prognostic factor and Inhibits metastasis of salivary adenoid cystic carcinoma by targeting ITGB3 .
1305	inhibit	negative	microrna-33b	749.7231	8.855764	8.855764	miRNA		MicroRNA-33b Inhibits Breast Cancer Metastasis by Targeting HMGA2 , SALL4 and Twist1 .
1305	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-33b Inhibits Breast Cancer Metastasis by Targeting HMGA2 , SALL4 and Twist1 .
1304	inhibit	negative	microrna-129	744.4573	9.487791	9.487791	miRNA		MicroRNA-129-5p inhibits hepatocellular carcinoma cell metastasis and invasion via targeting ETS1 .
1304	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-129-5p inhibits hepatocellular carcinoma cell metastasis and invasion via targeting ETS1 .
1314	inhibit	negative	microrna-144	739.1993	10.18267	10.18267	miRNA		MicroRNA-144 inhibits the metastasis of gastric cancer by targeting MET expression .
1314	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	MicroRNA-144 inhibits the metastasis of gastric cancer by targeting MET expression .
1303	suppress	negative	microrna-144	739.1993	10.18267	10.18267	miRNA		MicroRNA-144 suppresses osteosarcoma growth and metastasis by targeting ROCK1 and ROCK2 .
1303	suppress	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	MicroRNA-144 suppresses osteosarcoma growth and metastasis by targeting ROCK1 and ROCK2 .
1301	regulate	positive	mir-200b/200c	733.9501	10.94031	10.94031	miRNA		MiR-200b/200c/429 subfamily negatively regulates Rho/ROCK signaling pathway to suppress hepatocellular carcinoma metastasis .
1301	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-200b/200c/429 subfamily negatively regulates Rho/ROCK signaling pathway to suppress hepatocellular carcinoma metastasis .
1295	upregulate	positive	mirna-1307	728.7103	11.7606	11.7606	miRNA		The up-regulation of miRNA-1307 was not associated with menopause , tumor differentiation state , clinical stage , and lymph node metastasis of ovarian cancer .
1295	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The up-regulation of miRNA-1307 was not associated with menopause , tumor differentiation state , clinical stage , and lymph node metastasis of ovarian cancer .
1290	inhibit	negative	mirna-494	723.4807	12.64341	12.64341	miRNA		MiRNA-494 inhibits metastasis of cervical cancer through Pttg1 .
1290	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiRNA-494 inhibits metastasis of cervical cancer through Pttg1 .
1289	suppress	negative	mir-29b/c	718.2619	13.58863	13.58863	miRNA		First , wound healing and Transwell assays revealed that miR-29b/c suppresses tumor metastasis in GC .
1289	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	First , wound healing and Transwell assays revealed that miR-29b/c suppresses tumor metastasis in GC .
1288	induce	positive	microrna-15a	713.0548	14.59613	14.59613	miRNA		MicroRNA-15a induces cell apoptosis and inhibits metastasis by targeting BCL2L2 in non-small cell lung cancer .
1288	induce	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-15a induces cell apoptosis and inhibits metastasis by targeting BCL2L2 in non-small cell lung cancer .
1285	upregulate	positive	mir-1269a	707.8602	15.66574	15.66574	miRNA		miR-1269a is upregulated in late-stage CRCs , and long-term monitoring of 100 stage II CRC patients revealed that miR-1269a expression in their surgically removed primary tumours is strongly associated with risk of CRC relapse and metastasis .
1285	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-1269a is upregulated in late-stage CRCs , and long-term monitoring of 100 stage II CRC patients revealed that miR-1269a expression in their surgically removed primary tumours is strongly associated with risk of CRC relapse and metastasis .
1284	upregulate	positive	mir-1269a	707.8602	15.66574	15.66574	miRNA		miR-1269a is upregulated in late-stage CRCs , and long-term monitoring of 100 stage II CRC patients revealed that miR-1269a expression in their surgically removed primary tumours is strongly associated with risk of CRC relapse and metastasis .
1284	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-1269a is upregulated in late-stage CRCs , and long-term monitoring of 100 stage II CRC patients revealed that miR-1269a expression in their surgically removed primary tumours is strongly associated with risk of CRC relapse and metastasis .
1283	promote	positive	mir-1269a	707.8602	15.66574	15.66574	miRNA		Here we show that miR-1269a promotes colorectal cancer ( CRC ) metastasis and forms a positive feedback loop with TGF-?] signalling .
1283	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here we show that miR-1269a promotes colorectal cancer ( CRC ) metastasis and forms a positive feedback loop with TGF-?] signalling .
1973	upregulate	positive	mir-371	702.6786	16.79733	16.79733	miRNA		These results indicate that miR-371-5p expression is strongly upregulated in GC tissues and negatively correlated with SOX2 expression , while miR-371-5p expression is inversely related to proliferation , TNM stage , and LN metastasis of GC cells .
1973	upregulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	These results indicate that miR-371-5p expression is strongly upregulated in GC tissues and negatively correlated with SOX2 expression , while miR-371-5p expression is inversely related to proliferation , TNM stage , and LN metastasis of GC cells .
1972	upregulate	positive	mir-371	702.6786	16.79733	16.79733	miRNA		These results indicate that miR-371-5p expression is strongly upregulated in GC tissues and negatively correlated with SOX2 expression , while miR-371-5p expression is inversely related to proliferation , TNM stage , and LN metastasis of GC cells .
1972	upregulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	These results indicate that miR-371-5p expression is strongly upregulated in GC tissues and negatively correlated with SOX2 expression , while miR-371-5p expression is inversely related to proliferation , TNM stage , and LN metastasis of GC cells .
1971	upregulate	positive	mir-371	702.6786	16.79733	16.79733	miRNA		These results indicate that miR-371-5p expression is strongly upregulated in GC tissues and negatively correlated with SOX2 expression , while miR-371-5p expression is inversely related to proliferation , TNM stage , and LN metastasis of GC cells .
1971	upregulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	These results indicate that miR-371-5p expression is strongly upregulated in GC tissues and negatively correlated with SOX2 expression , while miR-371-5p expression is inversely related to proliferation , TNM stage , and LN metastasis of GC cells .
1970	upregulate	positive	mir-371	702.6786	16.79733	16.79733	miRNA		MiR-371-5p expression ( measured using qRT-PCR ) was upregulated in GC tissues and correlated positively with TNM staging and lymph node ( LN ) metastasis .
1970	upregulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	MiR-371-5p expression ( measured using qRT-PCR ) was upregulated in GC tissues and correlated positively with TNM staging and lymph node ( LN ) metastasis .
1969	upregulate	positive	mir-371	702.6786	16.79733	16.79733	miRNA		MiR-371-5p expression ( measured using qRT-PCR ) was upregulated in GC tissues and correlated positively with TNM staging and lymph node ( LN ) metastasis .
1969	upregulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	MiR-371-5p expression ( measured using qRT-PCR ) was upregulated in GC tissues and correlated positively with TNM staging and lymph node ( LN ) metastasis .
1281	inhibit	negative	mir-371	702.6786	16.79733	16.79733	miRNA		The SOX17/miR-371-5p/SOX2 axis inhibits EMT , stem cell properties and metastasis in colorectal cancer .
1281	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The SOX17/miR-371-5p/SOX2 axis inhibits EMT , stem cell properties and metastasis in colorectal cancer .
1280	suppress	negative	mir-33b/hmga	697.511	17.99074	17.99074	miRNA		We showed for the first time that targeting miRNA by cordycepin indicates a new mechanism of cordycepin-induced suppression of tumor metastasis and miR-33b/HMGA2/Twist1/ZEB1 axis plays critical roles in regulating melanoma dissemination .
1280	suppress	negative	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	We showed for the first time that targeting miRNA by cordycepin indicates a new mechanism of cordycepin-induced suppression of tumor metastasis and miR-33b/HMGA2/Twist1/ZEB1 axis plays critical roles in regulating melanoma dissemination .
1359	regulate	positive	mir-615	692.358	19.24578	19.24578	miRNA		PU.1 Is Identified as a Novel Metastasis Suppressor in Hepatocellular Carcinoma Regulating the miR-615-5p/IGF2 Axis .
1359	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	PU.1 Is Identified as a Novel Metastasis Suppressor in Hepatocellular Carcinoma Regulating the miR-615-5p/IGF2 Axis .
1270	inhibit	negative	mir-615	692.358	19.24578	19.24578	miRNA		miR-615-5p overexpression inhibited pancreatic cancer cell proliferation , migration , and invasion in vitro , and tumor growth and metastasis in vivo .
1270	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-615-5p overexpression inhibited pancreatic cancer cell proliferation , migration , and invasion in vitro , and tumor growth and metastasis in vivo .
1267	downregulate	negative	mir-154	687.2203	20.56229	20.56229	miRNA		miR-154 expression levels were significantly downregulated in the NSCLC compared to the corresponding non-cancerous lung tissues ( P < 0.05 ) , and decreased miR-154 expression was significantly associated with metastasis ( P < 0.001 ) , larger tumor size ( P < 0.001 ) and advanced TNM stage ( P < 0.001 ) .
1267	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-154 expression levels were significantly downregulated in the NSCLC compared to the corresponding non-cancerous lung tissues ( P < 0.05 ) , and decreased miR-154 expression was significantly associated with metastasis ( P < 0.001 ) , larger tumor size ( P < 0.001 ) and advanced TNM stage ( P < 0.001 ) .
1266	downregulate	negative	mir-154	687.2203	20.56229	20.56229	miRNA		miR-154 expression levels were significantly downregulated in the NSCLC compared to the corresponding non-cancerous lung tissues ( P < 0.05 ) , and decreased miR-154 expression was significantly associated with metastasis ( P < 0.001 ) , larger tumor size ( P < 0.001 ) and advanced TNM stage ( P < 0.001 ) .
1266	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-154 expression levels were significantly downregulated in the NSCLC compared to the corresponding non-cancerous lung tissues ( P < 0.05 ) , and decreased miR-154 expression was significantly associated with metastasis ( P < 0.001 ) , larger tumor size ( P < 0.001 ) and advanced TNM stage ( P < 0.001 ) .
1262	activate	positive	mir-21/cdk	682.0988	21.94007	21.94007	miRNA		Here we showed that abnormal activation of miR-21/CDK5 axis was associated with breast cancer lymph node metastasis , which was also contribute to high dose taxol-induced invasion and epithelial mesenchymal transition ( EMT ) in both breast cancer cell line MDA-MB-231 and glioblastoma cell line U87VIII .
1262	activate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here we showed that abnormal activation of miR-21/CDK5 axis was associated with breast cancer lymph node metastasis , which was also contribute to high dose taxol-induced invasion and epithelial mesenchymal transition ( EMT ) in both breast cancer cell line MDA-MB-231 and glioblastoma cell line U87VIII .
1261	activate	positive	mir-21/cdk	682.0988	21.94007	21.94007	miRNA		Here we showed that abnormal activation of miR-21/CDK5 axis was associated with breast cancer lymph node metastasis , which was also contribute to high dose taxol-induced invasion and epithelial mesenchymal transition ( EMT ) in both breast cancer cell line MDA-MB-231 and glioblastoma cell line U87VIII .
1261	activate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here we showed that abnormal activation of miR-21/CDK5 axis was associated with breast cancer lymph node metastasis , which was also contribute to high dose taxol-induced invasion and epithelial mesenchymal transition ( EMT ) in both breast cancer cell line MDA-MB-231 and glioblastoma cell line U87VIII .
1260	activate	positive	mir-21/cdk	682.0988	21.94007	21.94007	miRNA		Here we showed that abnormal activation of miR-21/CDK5 axis was associated with breast cancer lymph node metastasis , which was also contribute to high dose taxol-induced invasion and epithelial mesenchymal transition ( EMT ) in both breast cancer cell line MDA-MB-231 and glioblastoma cell line U87VIII .
1260	activate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here we showed that abnormal activation of miR-21/CDK5 axis was associated with breast cancer lymph node metastasis , which was also contribute to high dose taxol-induced invasion and epithelial mesenchymal transition ( EMT ) in both breast cancer cell line MDA-MB-231 and glioblastoma cell line U87VIII .
1253	regulate	positive	mir-709	676.994	23.37894	23.37894	miRNA		These results suggest that miR-709 may positively regulate invasion and metastasis of HCC through targeting GPC5 .
1253	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	These results suggest that miR-709 may positively regulate invasion and metastasis of HCC through targeting GPC5 .
1251	downregulate	negative	mir-518a	671.9069	24.87867	24.87867	miRNA		The downregulation of miR-518a-3p was associated with tumor size , distant metastasis and TNM stage in the patients with CRC .
1251	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The downregulation of miR-518a-3p was associated with tumor size , distant metastasis and TNM stage in the patients with CRC .
1248	promote	positive	microrna-1290	666.838	26.43907	26.43907	miRNA		MicroRNA-1290 promotes esophageal squamous cell carcinoma cell proliferation and metastasis .
1248	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-1290 promotes esophageal squamous cell carcinoma cell proliferation and metastasis .
1855	regulate	positive	mir-1	661.788	28.0599	28.0599	miRNA		miR-1 , regulated by LMP1 , suppresses tumour growth and metastasis by targeting K-ras in nasopharyngeal carcinoma .
1855	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-1 , regulated by LMP1 , suppresses tumour growth and metastasis by targeting K-ras in nasopharyngeal carcinoma .
1599	suppress	negative	mir-1	661.788	28.0599	28.0599	miRNA		miR-1 suppresses cell proliferation , invasiveness , metastasis , and progression of ESCC by binding its targeted genes LASP1 and TAGLN2 .
1599	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-1 suppresses cell proliferation , invasiveness , metastasis , and progression of ESCC by binding its targeted genes LASP1 and TAGLN2 .
1406	repress	negative	mir-1	661.788	28.0599	28.0599	miRNA		Our findings support a model in which nuclear EGFR acts as a transcriptional repressor to constrain the tumor-suppressive role of miR-1 and sustain oncogenic activation of TWIST1 , thereby leading to accelerated bone metastasis .
1406	repress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Our findings support a model in which nuclear EGFR acts as a transcriptional repressor to constrain the tumor-suppressive role of miR-1 and sustain oncogenic activation of TWIST1 , thereby leading to accelerated bone metastasis .
1405	promote	positive	mir-1	661.788	28.0599	28.0599	miRNA		EGF Receptor Promotes Prostate Cancer Bone Metastasis by Downregulating miR-1 and Activating TWIST1 .
1405	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	EGF Receptor Promotes Prostate Cancer Bone Metastasis by Downregulating miR-1 and Activating TWIST1 .
1404	promote	positive	mir-1	661.788	28.0599	28.0599	miRNA		EGF Receptor Promotes Prostate Cancer Bone Metastasis by Downregulating miR-1 and Activating TWIST1 .
1404	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	EGF Receptor Promotes Prostate Cancer Bone Metastasis by Downregulating miR-1 and Activating TWIST1 .
1392	promote	positive	mir-1	661.788	28.0599	28.0599	miRNA		Conversely , miR-1 inhibitor silencing miR-1 expression promoted cell proliferation and metastasis in ccRCC .
1392	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Conversely , miR-1 inhibitor silencing miR-1 expression promoted cell proliferation and metastasis in ccRCC .
1391	inhibit	negative	mir-1	661.788	28.0599	28.0599	miRNA		Functional study demonstrated that enforced overexpression of miR-1 in renal cancer cells inhibited proliferation and metastasis in vitro and in vivo .
1391	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Functional study demonstrated that enforced overexpression of miR-1 in renal cancer cells inhibited proliferation and metastasis in vitro and in vivo .
1390	downregulate	negative	mir-1	661.788	28.0599	28.0599	miRNA		MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis .
1390	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis .
1242	inhibit	negative	mir-1	661.788	28.0599	28.0599	miRNA		Ectopic miR-1 expression inhibited extracellular signal-regulated kinase ( ERK ) signaling and bone metastasis in a xenograft model .
1242	inhibit	negative	bone metastasis	366.2238	355.2677	355.2677	Cancer	D001859	Ectopic miR-1 expression inhibited extracellular signal-regulated kinase ( ERK ) signaling and bone metastasis in a xenograft model .
2021	inhibit	negative	microrna-26b	656.7578	29.74093	29.74093	miRNA		MicroRNA-26b inhibits tumor metastasis by targeting the KPNA2/c-jun pathway in human gastric cancer .
2021	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	MicroRNA-26b inhibits tumor metastasis by targeting the KPNA2/c-jun pathway in human gastric cancer .
1844	suppress	negative	microrna-26b	656.7578	29.74093	29.74093	miRNA		MicroRNA-26b suppresses the metastasis of non-small cell lung cancer by targeting MIEN1 via NF-庥B/MMP-9/VEGF pathways .
1844	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-26b suppresses the metastasis of non-small cell lung cancer by targeting MIEN1 via NF-庥B/MMP-9/VEGF pathways .
1214	inhibit	negative	microrna-26b	656.7578	29.74093	29.74093	miRNA		MicroRNA-26b inhibits metastasis of osteosarcoma via targeting CTGF and Smad1 .
1214	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	MicroRNA-26b inhibits metastasis of osteosarcoma via targeting CTGF and Smad1 .
1213	effect	neutral	mir-216b	651.7481	31.48193	31.48193	miRNA		In addition , UCA1 could reverse the inhibitory effect of miR-216b on the growth and metastasis of HCC cells , which might be involved in the derepression of fibroblast growth factor receptor 1 ( FGFR1 ) expression , a target gene of miR-216b , and the activation of ERK signaling pathway .
1213	effect	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	In addition , UCA1 could reverse the inhibitory effect of miR-216b on the growth and metastasis of HCC cells , which might be involved in the derepression of fibroblast growth factor receptor 1 ( FGFR1 ) expression , a target gene of miR-216b , and the activation of ERK signaling pathway .
1577	downregulate	negative	mir-326	646.7595	33.28265	33.28265	miRNA		Down-regulation of miR-326 is associated with poor prognosis and promotes growth and metastasis by targeting FSCN1 in gastric cancer .
1577	downregulate	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Down-regulation of miR-326 is associated with poor prognosis and promotes growth and metastasis by targeting FSCN1 in gastric cancer .
1212	downregulate	negative	mir-326	646.7595	33.28265	33.28265	miRNA		Thus , for the first time , we provide convincing evidence that downregulation of miR-326 inhibited tumor proliferation and tumor metastasis by directly targeting NOB1 in CRC .
1212	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Thus , for the first time , we provide convincing evidence that downregulation of miR-326 inhibited tumor proliferation and tumor metastasis by directly targeting NOB1 in CRC .
1208	regulate	positive	mir-221/222	641.7928	35.14283	35.14283	miRNA		Both gain- and loss-of-function studies showed that miR-221/222 regulate cell proliferation , the cell cycle and apoptosis , in addition to , invasion , metastasis , and angiogenesis in glioma cell lines .
1208	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Both gain- and loss-of-function studies showed that miR-221/222 regulate cell proliferation , the cell cycle and apoptosis , in addition to , invasion , metastasis , and angiogenesis in glioma cell lines .
1310	inhibit	negative	mir-33b	636.8486	37.0622	37.0622	miRNA		These data indicate that miR-33b acts as an onco-suppressive microRNA in breast cancer progression by inhibiting the stemness and metastasis of breast cancer cells .
1310	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	These data indicate that miR-33b acts as an onco-suppressive microRNA in breast cancer progression by inhibiting the stemness and metastasis of breast cancer cells .
1309	inhibit	negative	mir-33b	636.8486	37.0622	37.0622	miRNA		These data indicate that miR-33b acts as an onco-suppressive microRNA in breast cancer progression by inhibiting the stemness and metastasis of breast cancer cells .
1309	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	These data indicate that miR-33b acts as an onco-suppressive microRNA in breast cancer progression by inhibiting the stemness and metastasis of breast cancer cells .
1308	suppress	negative	mir-33b	636.8486	37.0622	37.0622	miRNA		Ectopic overexpression of miR-33b in highly metastatic breast cancer cells suppresses cell self-renewal , migration and invasion in vitro and inhibits lung metastasis in vivo .
1308	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Ectopic overexpression of miR-33b in highly metastatic breast cancer cells suppresses cell self-renewal , migration and invasion in vitro and inhibits lung metastasis in vivo .
1307	suppress	negative	mir-33b	636.8486	37.0622	37.0622	miRNA		Ectopic overexpression of miR-33b in highly metastatic breast cancer cells suppresses cell self-renewal , migration and invasion in vitro and inhibits lung metastasis in vivo .
1307	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Ectopic overexpression of miR-33b in highly metastatic breast cancer cells suppresses cell self-renewal , migration and invasion in vitro and inhibits lung metastasis in vivo .
1306	regulate	positive	mir-33b	636.8486	37.0622	37.0622	miRNA		Here , we report the identification of miR-33b as a negative regulator of cell stemness and metastasis in breast cancer .
1306	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here , we report the identification of miR-33b as a negative regulator of cell stemness and metastasis in breast cancer .
1279	suppress	negative	mir-33b	636.8486	37.0622	37.0622	miRNA		Cordycepin ( 3'-deoxyadenosine ) suppressed HMGA2 , Twist1 and ZEB1-dependent melanoma invasion and metastasis by targeting miR-33b .
1279	suppress	negative	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	Cordycepin ( 3'-deoxyadenosine ) suppressed HMGA2 , Twist1 and ZEB1-dependent melanoma invasion and metastasis by targeting miR-33b .
1205	suppress	negative	mir-33b	636.8486	37.0622	37.0622	miRNA		Thus , the results suggest that EF24 suppresses melanoma metastasis via upregulating miR-33b and concomitantly reducing HMGA2 expression .
1205	suppress	negative	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	Thus , the results suggest that EF24 suppresses melanoma metastasis via upregulating miR-33b and concomitantly reducing HMGA2 expression .
1368	inhibit	negative	mir-188	631.9277	39.04049	39.04049	miRNA		Enforced expression of miR-188-5p inhibited the expression of FGF5 significantly and the restoration of FGF5 expression reversed the inhibitory effects of miR-188-5p on HCC cell proliferation and metastasis .
1368	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Enforced expression of miR-188-5p inhibited the expression of FGF5 significantly and the restoration of FGF5 expression reversed the inhibitory effects of miR-188-5p on HCC cell proliferation and metastasis .
1367	suppress	negative	mir-188	631.9277	39.04049	39.04049	miRNA		Ectopic expression of miR-188-5p suppressed HCC cell proliferation and metastasis in vitro and in vivo .
1367	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Ectopic expression of miR-188-5p suppressed HCC cell proliferation and metastasis in vitro and in vivo .
1200	suppress	negative	mir-188	631.9277	39.04049	39.04049	miRNA		Restoration of miR-188-5p in PCa cells ( PC-3 and LNCaP ) significantly suppresses proliferation , migration and invasion in vitro and inhibits tumour growth and metastasis in vivo .
1200	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Restoration of miR-188-5p in PCa cells ( PC-3 and LNCaP ) significantly suppresses proliferation , migration and invasion in vitro and inhibits tumour growth and metastasis in vivo .
1199	inhibit	negative	mir-188	631.9277	39.04049	39.04049	miRNA		miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression .
1199	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression .
1195	downregulate	negative	mirna-1207	627.0308	41.07743	41.07743	miRNA		We found that miRNA-1207-5p ( miR ? 1207-5p ) was markedly downregulated in esophageal carcinoma ( EC ) tissues , and was correlated with EC differentiation , pathological stage and lymph node metastasis .
1195	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We found that miRNA-1207-5p ( miR ? 1207-5p ) was markedly downregulated in esophageal carcinoma ( EC ) tissues , and was correlated with EC differentiation , pathological stage and lymph node metastasis .
1684	enhance	positive	mir-218	622.1586	43.17271	43.17271	miRNA		ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis .
1684	enhance	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis .
1377	block	negative	mir-218	622.1586	43.17271	43.17271	miRNA		Blocking the activation of the POU2F2-oriented metastasis network using miR-218 precursors exemplified a promising approach that sheds light on new strategies for GC treatment .
1377	block	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Blocking the activation of the POU2F2-oriented metastasis network using miR-218 precursors exemplified a promising approach that sheds light on new strategies for GC treatment .
1376	suppress	negative	mir-218	622.1586	43.17271	43.17271	miRNA		Finally , miR-218 was found to suppress GC metastasis by simultaneously mediating multiple molecules in the POU2F2-oriented network .
1376	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Finally , miR-218 was found to suppress GC metastasis by simultaneously mediating multiple molecules in the POU2F2-oriented network .
1375	influence	neutral	mir-218	622.1586	43.17271	43.17271	miRNA		The influence of miR-218 on its putative target genes ( POU2F2 , ROBO1 and IKK-?] ) and GC metastasis was further explored via in vitro and in vivo approaches .
1375	influence	neutral	gc	1242.449	487.0825	487.0825	Cancer	D061325	The influence of miR-218 on its putative target genes ( POU2F2 , ROBO1 and IKK-?] ) and GC metastasis was further explored via in vitro and in vivo approaches .
1370	enhance	positive	mir-218	622.1586	43.17271	43.17271	miRNA		Furthermore , the decreased expression of miR-218 was found to be associated with an enhanced ESCC cell proliferation and metastasis .
1370	enhance	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Furthermore , the decreased expression of miR-218 was found to be associated with an enhanced ESCC cell proliferation and metastasis .
1250	downregulate	negative	mir-218	622.1586	43.17271	43.17271	miRNA		The serum expression of miR-218 is downregulated in esophageal cancer patients and is correlated with tumor differentiation , stage , and lymph node metastasis .
1250	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The serum expression of miR-218 is downregulated in esophageal cancer patients and is correlated with tumor differentiation , stage , and lymph node metastasis .
1194	downregulate	negative	mir-218	622.1586	43.17271	43.17271	miRNA		The results demonstrated that expression of miR-218 was downregulated in gastric cancer tissues , which had a positive correlation with tumor invasion and metastasis .
1194	downregulate	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	The results demonstrated that expression of miR-218 was downregulated in gastric cancer tissues , which had a positive correlation with tumor invasion and metastasis .
1190	inhibit	negative	mir-512	617.3118	45.32603	45.32603	miRNA		Inhibition of RAC1-GEF DOCK3 by miR-512-3p contributes to suppression of metastasis in non-small cell lung cancer .
1190	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Inhibition of RAC1-GEF DOCK3 by miR-512-3p contributes to suppression of metastasis in non-small cell lung cancer .
1189	enhance	positive	mir-455	612.491	47.5371	47.5371	miRNA		Moreover , wild-type miR-455 enhances melanoma growth and metastasis in ? vivo , whereas the edited form inhibits these features .
1189	enhance	positive	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	Moreover , wild-type miR-455 enhances melanoma growth and metastasis in ? vivo , whereas the edited form inhibits these features .
1188	promote	positive	mir-455	612.491	47.5371	47.5371	miRNA		Indeed , wild-type miR-455-5p promotes melanoma metastasis through inhibition of the tumour suppressor gene CPEB1 .
1188	promote	positive	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	Indeed , wild-type miR-455-5p promotes melanoma metastasis through inhibition of the tumour suppressor gene CPEB1 .
1187	promote	positive	mir-455	612.491	47.5371	47.5371	miRNA		Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis .
1187	promote	positive	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis .
1848	upregulate	positive	mir-23b	607.697	49.8056	49.8056	miRNA		The expression levels of miR-23b were upregulated in plasma samples from GC patients ( P < 0.01 ) and were significantly associated with T stage , distant metastasis , and differentiation .
1848	upregulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	The expression levels of miR-23b were upregulated in plasma samples from GC patients ( P < 0.01 ) and were significantly associated with T stage , distant metastasis , and differentiation .
1183	coexpress	neutral	mir-23b	607.697	49.8056	49.8056	miRNA		Then , the coexpression of miR-23a and miR-23b ( miR-23a-high/miR-23b-high ) in GC tissues was significantly associated with the advanced TNM stage ( P < 0.001 ) , the presence of lymph node metastasis ( P = 0.008 ) and the great depth of invasion ( P = 0.02 ) .
1183	coexpress	neutral	gc	1242.449	487.0825	487.0825	Cancer	D061325	Then , the coexpression of miR-23a and miR-23b ( miR-23a-high/miR-23b-high ) in GC tissues was significantly associated with the advanced TNM stage ( P < 0.001 ) , the presence of lymph node metastasis ( P = 0.008 ) and the great depth of invasion ( P = 0.02 ) .
1182	coexpress	neutral	mir-23b	607.697	49.8056	49.8056	miRNA		Then , the coexpression of miR-23a and miR-23b ( miR-23a-high/miR-23b-high ) in GC tissues was significantly associated with the advanced TNM stage ( P < 0.001 ) , the presence of lymph node metastasis ( P = 0.008 ) and the great depth of invasion ( P = 0.02 ) .
1182	coexpress	neutral	gc	1242.449	487.0825	487.0825	Cancer	D061325	Then , the coexpression of miR-23a and miR-23b ( miR-23a-high/miR-23b-high ) in GC tissues was significantly associated with the advanced TNM stage ( P < 0.001 ) , the presence of lymph node metastasis ( P = 0.008 ) and the great depth of invasion ( P = 0.02 ) .
1179	inhibit	negative	mir-873	602.9304	52.1312	52.1312	miRNA		Our further investigations of the inhibition mechanism indicated that miR-873 negatively affected the carcinogenesis and metastasis of GBM by down-regulating the expression of IGF2BP1 , which stabilizes the mRNA transcripts of its target genes .
1179	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Our further investigations of the inhibition mechanism indicated that miR-873 negatively affected the carcinogenesis and metastasis of GBM by down-regulating the expression of IGF2BP1 , which stabilizes the mRNA transcripts of its target genes .
1178	inhibit	negative	mirna-873	598.192	54.51357	54.51357	miRNA		MicroRNA-873 ( miRNA-873 ) inhibits glioblastoma tumorigenesis and metastasis by suppressing the expression of IGF2BP1 .
1178	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-873 ( miRNA-873 ) inhibits glioblastoma tumorigenesis and metastasis by suppressing the expression of IGF2BP1 .
1177	inhibit	negative	microrna-873	593.4823	56.95236	56.95236	miRNA		MicroRNA-873 ( miRNA-873 ) inhibits glioblastoma tumorigenesis and metastasis by suppressing the expression of IGF2BP1 .
1177	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-873 ( miRNA-873 ) inhibits glioblastoma tumorigenesis and metastasis by suppressing the expression of IGF2BP1 .
1176	regulate	positive	mir-26a/b	588.8021	59.44725	59.44725	miRNA		Our data describing pathways regulated by tumour-suppressive miR-26a/b provide new insights into the potential mechanisms of OSCC oncogenesis and metastasis .
1176	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Our data describing pathways regulated by tumour-suppressive miR-26a/b provide new insights into the potential mechanisms of OSCC oncogenesis and metastasis .
1990	inhibit	negative	mir-509	584.152	61.99785	61.99785	miRNA		Our data suggest that the miR-509-3p/YAP1 axis may be a new druggable target in cancers with high YAP1 , and we propose that therapeutically targeting the miR-509-3p/YAP1/ECM axis may disrupt early steps in multi-cellular spheroid formation , and so inhibit metastasis in epithelial ovarian cancer and potentially in other cancers .
1990	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our data suggest that the miR-509-3p/YAP1 axis may be a new druggable target in cancers with high YAP1 , and we propose that therapeutically targeting the miR-509-3p/YAP1/ECM axis may disrupt early steps in multi-cellular spheroid formation , and so inhibit metastasis in epithelial ovarian cancer and potentially in other cancers .
1174	suppress	negative	mir-509	584.152	61.99785	61.99785	miRNA		miR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF-帢 .
1174	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF-帢 .
1326	induce	positive	mir-638	579.5328	64.60383	64.60383	miRNA		In vivo data further revealed that cisplatin induced miR-638 upregulation in the serum derived from mice xenograft models , and in NSCLC patient sera , miR-638 expression patterns after chemotherapy significantly correlated with lymph node metastasis .
1326	induce	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In vivo data further revealed that cisplatin induced miR-638 upregulation in the serum derived from mice xenograft models , and in NSCLC patient sera , miR-638 expression patterns after chemotherapy significantly correlated with lymph node metastasis .
1164	promote	positive	mir-638	579.5328	64.60383	64.60383	miRNA		miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy .
1164	promote	positive	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy .
1156	suppress	negative	mirna-29c/catenin	574.945	67.26479	67.26479	miRNA		Chemotherapy-Induced miRNA-29c/Catenin-帤 Signaling Suppresses Metastasis in Gastric Cancer .
1156	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Chemotherapy-Induced miRNA-29c/Catenin-帤 Signaling Suppresses Metastasis in Gastric Cancer .
1154	inhibit	negative	microrna-141	570.3893	69.98036	69.98036	miRNA		MicroRNA-141 inhibits tumor growth and metastasis in gastric cancer by directly targeting transcriptional co-activator with PDZ-binding motif , TAZ .
1154	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	MicroRNA-141 inhibits tumor growth and metastasis in gastric cancer by directly targeting transcriptional co-activator with PDZ-binding motif , TAZ .
1138	inhibit	negative	mir-511	565.8664	72.75016	72.75016	miRNA		MiR-511 inhibits growth and metastasis of human hepatocellular carcinoma cells by targeting PIK3R3 .
1138	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-511 inhibits growth and metastasis of human hepatocellular carcinoma cells by targeting PIK3R3 .
1133	suppress	negative	mir-551a	561.3768	75.57378	75.57378	miRNA		Combinatorial therapeutic viral delivery of miR-551a and miR-483-5p through single-dose adeno-associated viral ( AAV ) delivery significantly suppressed colon cancer metastasis , as did CKB inhibition with a small-molecule inhibitor .
1133	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Combinatorial therapeutic viral delivery of miR-551a and miR-483-5p through single-dose adeno-associated viral ( AAV ) delivery significantly suppressed colon cancer metastasis , as did CKB inhibition with a small-molecule inhibitor .
1540	affect	neutral	mir-197	556.9214	78.45084	78.45084	miRNA		Further , miR-197 has been identified to affect uterine leiomyoma cell proliferation , apoptosis , and metastasis ability , though the responsible molecular mechanism has not been well elucidated .
1540	affect	neutral	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Further , miR-197 has been identified to affect uterine leiomyoma cell proliferation , apoptosis , and metastasis ability , though the responsible molecular mechanism has not been well elucidated .
1132	downregulate	negative	mir-197	556.9214	78.45084	78.45084	miRNA		miR-197 is downregulated in platinum-resistant NSCLC specimens , resulting in the promotion of chemoresistance , tumorigenicity , and pulmonary metastasis in vitro and in vivo .
1132	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-197 is downregulated in platinum-resistant NSCLC specimens , resulting in the promotion of chemoresistance , tumorigenicity , and pulmonary metastasis in vitro and in vivo .
1131	downregulate	negative	mir-197	556.9214	78.45084	78.45084	miRNA		miR-197 is downregulated in platinum-resistant NSCLC specimens , resulting in the promotion of chemoresistance , tumorigenicity , and pulmonary metastasis in vitro and in vivo .
1131	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-197 is downregulated in platinum-resistant NSCLC specimens , resulting in the promotion of chemoresistance , tumorigenicity , and pulmonary metastasis in vitro and in vivo .
1126	suppress	negative	mir-708	552.5006	81.3809	81.3809	miRNA		Restoring Rap1B expression reverts glucocorticoid-miR-708 cascade-mediated suppression of ovarian cancer cell invasion and metastasis .
1126	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Restoring Rap1B expression reverts glucocorticoid-miR-708 cascade-mediated suppression of ovarian cancer cell invasion and metastasis .
1125	induce	positive	mir-708	552.5006	81.3809	81.3809	miRNA		Glucocorticoid treatments induce the expression of miR-708 , leading to the suppression of Rap1B , which result in the reduction of integrin-mediated focal adhesion formation , inhibition of ovarian cancer cell migration/invasion and impaired abdominal metastasis in an orthotopic xenograft mouse model .
1125	induce	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Glucocorticoid treatments induce the expression of miR-708 , leading to the suppression of Rap1B , which result in the reduction of integrin-mediated focal adhesion formation , inhibition of ovarian cancer cell migration/invasion and impaired abdominal metastasis in an orthotopic xenograft mouse model .
1124	mediate	neutral	microrna-708	548.1151	84.36356	84.36356	miRNA		Glucocorticoids mediate induction of microRNA-708 to suppress ovarian cancer metastasis through targeting Rap1B .
1124	mediate	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Glucocorticoids mediate induction of microRNA-708 to suppress ovarian cancer metastasis through targeting Rap1B .
1116	inhibit	negative	mir34a	543.7656	87.3984	87.3984	miRNA		In vivo metastasis , assays also demonstrated that overexpression of mir34a markedly inhibited bladder cancer metastasis .
1116	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	In vivo metastasis , assays also demonstrated that overexpression of mir34a markedly inhibited bladder cancer metastasis .
1682	promote	positive	mir-146b	539.4526	90.48497	90.48497	miRNA		miR-146b-5p promotes invasion and metastasis contributing to chemoresistance in osteosarcoma by targeting zinc and ring finger 3 .
1682	promote	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	miR-146b-5p promotes invasion and metastasis contributing to chemoresistance in osteosarcoma by targeting zinc and ring finger 3 .
1115	induce	positive	mir-146b	539.4526	90.48497	90.48497	miRNA		These results indicate that miR-146b-5p induces EMT and may promote PTC metastasis through the regulation of Wnt/?] -catenin signaling , and suggest novel potential therapeutic targets for the treatment of PTC .
1115	induce	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	These results indicate that miR-146b-5p induces EMT and may promote PTC metastasis through the regulation of Wnt/?] -catenin signaling , and suggest novel potential therapeutic targets for the treatment of PTC .
1114	upregulate	positive	mir-146b	539.4526	90.48497	90.48497	miRNA		In the present study , we showed that miR-146b-5p is upregulated in PTC with lymph node metastasis .
1114	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In the present study , we showed that miR-146b-5p is upregulated in PTC with lymph node metastasis .
1113	upregulate	positive	mir-146b	539.4526	90.48497	90.48497	miRNA		In the present study , we showed that miR-146b-5p is upregulated in PTC with lymph node metastasis .
1113	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In the present study , we showed that miR-146b-5p is upregulated in PTC with lymph node metastasis .
1112	promote	positive	mir-146b	539.4526	90.48497	90.48497	miRNA		MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3 .
1112	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3 .
1111	promote	positive	mir-146b	539.4526	90.48497	90.48497	miRNA		MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3 .
1111	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3 .
2033	repress	negative	mir-92b	535.1768	93.62284	93.62284	miRNA		Furthermore , long non-coding RNA ( lncRNA ) X-inactive specific transcript ( XIST ) and miR-92b could directly interact with and repress each other , and XIST could inhibit HCC cell proliferation and metastasis by targeting miR-92b .
2033	repress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Furthermore , long non-coding RNA ( lncRNA ) X-inactive specific transcript ( XIST ) and miR-92b could directly interact with and repress each other , and XIST could inhibit HCC cell proliferation and metastasis by targeting miR-92b .
2032	promote	positive	mir-92b	535.1768	93.62284	93.62284	miRNA		Functionally , miR-92b could promote cell proliferation and metastasis of HCC in vitro and in vivo .
2032	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Functionally , miR-92b could promote cell proliferation and metastasis of HCC in vitro and in vivo .
1909	suppress	negative	mir-92b	535.1768	93.62284	93.62284	miRNA		Together , these results for the first time describe how miR-92b suppresses the motility of ESCC cells and provide a promise for diagnosis or therapy of ESCC invasion and metastasis .
1909	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Together , these results for the first time describe how miR-92b suppresses the motility of ESCC cells and provide a promise for diagnosis or therapy of ESCC invasion and metastasis .
1908	inhibit	negative	mir-92b	535.1768	93.62284	93.62284	miRNA		Screening of the differentially expressed microRNAs identified that microRNA-92b-3p ( miR-92b ) could dramatically inhibit invasion and metastasis of ESCC cells in vitro and in vivo .
1908	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Screening of the differentially expressed microRNAs identified that microRNA-92b-3p ( miR-92b ) could dramatically inhibit invasion and metastasis of ESCC cells in vitro and in vivo .
1110	promote	positive	mir-92b	535.1768	93.62284	93.62284	miRNA		miR-92b promotes the migration , adhesion and invasion of human gastric cancer cell line SGC7901 by mediating epithelial-mesenchymal transition , and may accelerate tumor cell metastasis via signaling pathways other than PI3K/Akt pathway .
1110	promote	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	miR-92b promotes the migration , adhesion and invasion of human gastric cancer cell line SGC7901 by mediating epithelial-mesenchymal transition , and may accelerate tumor cell metastasis via signaling pathways other than PI3K/Akt pathway .
1863	downregulate	negative	mir-135b	530.9388	96.81156	96.81156	miRNA		A previous microarray study demonstrated that miR-135b is downregulated in prostate cancer ( PCa ) cells , but the role and molecular mechanism of miR-135b in the regulation of tumour metastasis remain to be elucidated .
1863	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	A previous microarray study demonstrated that miR-135b is downregulated in prostate cancer ( PCa ) cells , but the role and molecular mechanism of miR-135b in the regulation of tumour metastasis remain to be elucidated .
1862	inhibit	negative	mir-135b	530.9388	96.81156	96.81156	miRNA		miR-135b inhibits tumour metastasis in prostate cancer by targeting STAT6 .
1862	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-135b inhibits tumour metastasis in prostate cancer by targeting STAT6 .
1602	effect	neutral	mir-135b	530.9388	96.81156	96.81156	miRNA		To explore the effect of miR-135b on the invasion and metastasis of hepatocellular carcinoma cells and the underlying molecular mechanism .
1602	effect	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	To explore the effect of miR-135b on the invasion and metastasis of hepatocellular carcinoma cells and the underlying molecular mechanism .
1601	promote	positive	mir-135b	530.9388	96.81156	96.81156	miRNA		[ miR-135b promotes the invasion and metastasis of hepatocellular carcinoma cells ] .
1601	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	[ miR-135b promotes the invasion and metastasis of hepatocellular carcinoma cells ] .
1109	promote	positive	mir-135b	530.9388	96.81156	96.81156	miRNA		In addition , miR-135b promoted HCC cell migration and invasion in vitro and metastasis in vivo .
1109	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In addition , miR-135b promoted HCC cell migration and invasion in vitro and metastasis in vivo .
1107	activate	positive	mir562	526.7392	100.0507	100.0507	miRNA		As ANXA1 constitutively activates NF-庥B activity to modulate breast cancer metastasis , we found that miR26b* and miR562 directly targeted the canonical NF-庥B pathway by targeting the 3 ' UTR and inhibiting expression of Rel A ( p65 ) and NF-庥B1 ( p105 ) respectively .
1107	activate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	As ANXA1 constitutively activates NF-庥B activity to modulate breast cancer metastasis , we found that miR26b* and miR562 directly targeted the canonical NF-庥B pathway by targeting the 3 ' UTR and inhibiting expression of Rel A ( p65 ) and NF-庥B1 ( p105 ) respectively .
1106	activate	positive	mir26b*	522.5786	103.3397	103.3397	miRNA		As ANXA1 constitutively activates NF-庥B activity to modulate breast cancer metastasis , we found that miR26b* and miR562 directly targeted the canonical NF-庥B pathway by targeting the 3 ' UTR and inhibiting expression of Rel A ( p65 ) and NF-庥B1 ( p105 ) respectively .
1106	activate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	As ANXA1 constitutively activates NF-庥B activity to modulate breast cancer metastasis , we found that miR26b* and miR562 directly targeted the canonical NF-庥B pathway by targeting the 3 ' UTR and inhibiting expression of Rel A ( p65 ) and NF-庥B1 ( p105 ) respectively .
1105	regulate	positive	mir-518c	518.4575	106.6782	106.6782	miRNA		These results indicated that miR-518c-5p regulates the growth and metastasis of oral cancer as a downstream target of the SDF-1/CXCR4 system .
1105	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	These results indicated that miR-518c-5p regulates the growth and metastasis of oral cancer as a downstream target of the SDF-1/CXCR4 system .
1102	promote	positive	microrna-185	514.3766	110.0657	110.0657	miRNA		STIM1 , a direct target of microRNA-185 , promotes tumor metastasis and is associated with poor prognosis in colorectal cancer .
1102	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	STIM1 , a direct target of microRNA-185 , promotes tumor metastasis and is associated with poor prognosis in colorectal cancer .
1099	regulate	positive	microrna-96	510.3365	113.5017	113.5017	miRNA		Here , we demonstrate that TGF?] regulates the level of microRNA-96 ( miR-96 ) through Smad-dependent transcription and that miR-96 promotes the bone metastasis in prostate cancer .
1099	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here , we demonstrate that TGF?] regulates the level of microRNA-96 ( miR-96 ) through Smad-dependent transcription and that miR-96 promotes the bone metastasis in prostate cancer .
1095	upregulate	positive	mir-374b	506.3377	116.9858	116.9858	miRNA		These findings indicate that upregulation of miR-374b-5p contributes to gastric cancer cell metastasis and invasion through inhibition of RECK expression .
1095	upregulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	These findings indicate that upregulation of miR-374b-5p contributes to gastric cancer cell metastasis and invasion through inhibition of RECK expression .
1094	control	neutral	mir-374b	506.3377	116.9858	116.9858	miRNA		Compared with the control groups , the restoration of miR-374b-5p expression with anti-miR-374b-5p significantly suppressed the metastasis , invasion and proliferation of MGC-803 cells .
1094	control	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Compared with the control groups , the restoration of miR-374b-5p expression with anti-miR-374b-5p significantly suppressed the metastasis , invasion and proliferation of MGC-803 cells .
1093	effect	neutral	mir-374b	506.3377	116.9858	116.9858	miRNA		To profile expression of microRNAs ( miRNAs ) in gastric cancer cells and investigate the effect of miR-374b-5p on gastric cancer cell invasion and metastasis .
1093	effect	neutral	gc	1242.449	487.0825	487.0825	Cancer	D061325	To profile expression of microRNAs ( miRNAs ) in gastric cancer cells and investigate the effect of miR-374b-5p on gastric cancer cell invasion and metastasis .
1092	suppress	negative	mir-374b	506.3377	116.9858	116.9858	miRNA		MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis .
1092	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis .
1278	promote	positive	mir-367	502.3809	120.5173	120.5173	miRNA		Functional studies showed that miR-367 promoted pancreatic cancer invasion in vitro and metastasis in vivo through downregulating Smad7 .
1278	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Functional studies showed that miR-367 promoted pancreatic cancer invasion in vitro and metastasis in vivo through downregulating Smad7 .
1088	regulate	positive	mir-367	502.3809	120.5173	120.5173	miRNA		Our study shows that miR-367 is a key negative regulator of the invasion and metastasis of gastric cancer and establishes a strong rationale for developing miR-367 as a novel therapeutic agent against gastric cancer .
1088	regulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	Our study shows that miR-367 is a key negative regulator of the invasion and metastasis of gastric cancer and establishes a strong rationale for developing miR-367 as a novel therapeutic agent against gastric cancer .
1087	inhibit	negative	microrna-367	498.4665	124.0958	124.0958	miRNA		The microRNA-367 inhibits the invasion and metastasis of gastric cancer by directly repressing Rab23 .
1087	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	The microRNA-367 inhibits the invasion and metastasis of gastric cancer by directly repressing Rab23 .
2025	suppress	negative	mir-26b	494.5951	127.7209	127.7209	miRNA		Based on the study findings , we propose that miR-26b overexpression or KPNA2/c-jun suppression may have therapeutic potential in inhibiting GC metastasis .
2025	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Based on the study findings , we propose that miR-26b overexpression or KPNA2/c-jun suppression may have therapeutic potential in inhibiting GC metastasis .
2024	affect	neutral	mir-26b	494.5951	127.7209	127.7209	miRNA		Additionally , miR-26b affected GC cell behavior through negative regulation of the metastasis promoter , karyopherin alpha 2 ( KPNA2 ) .
2024	affect	neutral	gc	1242.449	487.0825	487.0825	Cancer	D061325	Additionally , miR-26b affected GC cell behavior through negative regulation of the metastasis promoter , karyopherin alpha 2 ( KPNA2 ) .
2023	inhibit	negative	mir-26b	494.5951	127.7209	127.7209	miRNA		Forced expression of miR-26b led to inhibition of GC cell migration and invasion in vitro and lung metastasis formation in vivo .
2023	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Forced expression of miR-26b led to inhibition of GC cell migration and invasion in vitro and lung metastasis formation in vivo .
2022	inhibit	negative	mir-26b	494.5951	127.7209	127.7209	miRNA		Forced expression of miR-26b led to inhibition of GC cell migration and invasion in vitro and lung metastasis formation in vivo .
2022	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Forced expression of miR-26b led to inhibition of GC cell migration and invasion in vitro and lung metastasis formation in vivo .
1980	suppress	negative	mir-26b	494.5951	127.7209	127.7209	miRNA		miR-26b-5p suppresses Twist1-induced EMT , invasion , and metastasis of HCC cells by targeting SMAD1 and BMP4/Smad1 signaling .
1980	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-26b-5p suppresses Twist1-induced EMT , invasion , and metastasis of HCC cells by targeting SMAD1 and BMP4/Smad1 signaling .
1953	promote	positive	mir-26b	494.5951	127.7209	127.7209	miRNA		Thus , our data showed that two genes promoting metastasis , LOXL2 and PLOD2 , were epigenetically regulated by tumor-suppressive microRNAs , miR-26a and miR-26b , providing important insights into the molecular mechanisms of RCC metastasis .
1953	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Thus , our data showed that two genes promoting metastasis , LOXL2 and PLOD2 , were epigenetically regulated by tumor-suppressive microRNAs , miR-26a and miR-26b , providing important insights into the molecular mechanisms of RCC metastasis .
1846	suppress	negative	mir-26b	494.5951	127.7209	127.7209	miRNA		In conclusion , this study revealed that miR-26b suppresses NSCLC metastasis by targeting MIEN1 via NF-庥B/MMP-9/VEGF pathways , implicating a potential prognostic biomarker and therapeutic target for NSCLC treatment .
1846	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In conclusion , this study revealed that miR-26b suppresses NSCLC metastasis by targeting MIEN1 via NF-庥B/MMP-9/VEGF pathways , implicating a potential prognostic biomarker and therapeutic target for NSCLC treatment .
1845	suppress	negative	mir-26b	494.5951	127.7209	127.7209	miRNA		In the present study , we report that miR-26b suppresses cell metastasis in NSCLC through targeting migration and invasion enhancer 1 ( MIEN1 ) .
1845	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In the present study , we report that miR-26b suppresses cell metastasis in NSCLC through targeting migration and invasion enhancer 1 ( MIEN1 ) .
1217	downregulate	negative	mir-26b	494.5951	127.7209	127.7209	miRNA		Our data indicated that downregulation of miR-26b in osteosarcoma elevated the levels of CTGF and Smad1 , facilitating osteosarcoma metastasis .
1217	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Our data indicated that downregulation of miR-26b in osteosarcoma elevated the levels of CTGF and Smad1 , facilitating osteosarcoma metastasis .
1216	inhibit	negative	mir-26b	494.5951	127.7209	127.7209	miRNA		Furthermore , miR-26b inhibited lung metastasis of osteosarcoma in vivo .
1216	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Furthermore , miR-26b inhibited lung metastasis of osteosarcoma in vivo .
1215	inhibit	negative	mir-26b	494.5951	127.7209	127.7209	miRNA		Furthermore , miR-26b inhibited lung metastasis of osteosarcoma in vivo .
1215	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Furthermore , miR-26b inhibited lung metastasis of osteosarcoma in vivo .
1084	inhibit	negative	mir-26b	494.5951	127.7209	127.7209	miRNA		Specific inhibition of COX-2 activity by nimesulide further confirmed that miR-26b was able to regulate the cell proliferation and metastasis of the human tongue squamous cell carcinoma cells through a COX-2-dependent mechanism .
1084	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Specific inhibition of COX-2 activity by nimesulide further confirmed that miR-26b was able to regulate the cell proliferation and metastasis of the human tongue squamous cell carcinoma cells through a COX-2-dependent mechanism .
1083	suppress	negative	mir-26b	494.5951	127.7209	127.7209	miRNA		Ectopic expression of miR-26b suppressed the proliferation and metastasis of human tongue squamous cell carcinoma cells .
1083	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Ectopic expression of miR-26b suppressed the proliferation and metastasis of human tongue squamous cell carcinoma cells .
1082	downregulate	negative	mir-26b	494.5951	127.7209	127.7209	miRNA		miR-26b is downregulated in human tongue squamous cell carcinoma and regulates cell proliferation and metastasis through a COX-2-dependent mechanism .
1082	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-26b is downregulated in human tongue squamous cell carcinoma and regulates cell proliferation and metastasis through a COX-2-dependent mechanism .
1078	regulate	positive	mir-495	490.7672	131.3919	131.3919	miRNA		However , the molecular regulation mechanisms by which endogenous miR-495 expression is down-regulated and PRL-3 promotes GC peritoneal metastasis remain to be clearly elucidated .
1078	regulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	However , the molecular regulation mechanisms by which endogenous miR-495 expression is down-regulated and PRL-3 promotes GC peritoneal metastasis remain to be clearly elucidated .
1077	downregulate	negative	mir-495	490.7672	131.3919	131.3919	miRNA		Moreover , we further found that the down-regulation of endogenous miR-495 expression plays a causative role in over expression of PRL-3 in GC peritoneal metastasis .
1077	downregulate	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Moreover , we further found that the down-regulation of endogenous miR-495 expression plays a causative role in over expression of PRL-3 in GC peritoneal metastasis .
1369	inhibit	negative	microrna-218	486.9836	135.1084	135.1084	miRNA		MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1 .
1369	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1 .
1074	regulate	positive	microrna-218	486.9836	135.1084	135.1084	miRNA		The microRNA-218~Survivin axis regulates migration , invasion , and lymph node metastasis in cervical cancer .
1074	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The microRNA-218~Survivin axis regulates migration , invasion , and lymph node metastasis in cervical cancer .
2017	suppress	negative	mir-373	483.2445	138.8699	138.8699	miRNA		Moreover , we found that TIMP3 , which was reported to suppress invasion and metastasis of ESCC , was a direct target of miR-373 .
2017	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Moreover , we found that TIMP3 , which was reported to suppress invasion and metastasis of ESCC , was a direct target of miR-373 .
1947	downregulate	negative	mir-373	483.2445	138.8699	138.8699	miRNA		Taken together , we consider that down-regulation of TRPS1 by miR-373 , acting as a transcriptional activator , promotes EMT and metastasis by repressing FOXA1 transcription , expanding upon its previously reported role as a transcription repressor .
1947	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , we consider that down-regulation of TRPS1 by miR-373 , acting as a transcriptional activator , promotes EMT and metastasis by repressing FOXA1 transcription , expanding upon its previously reported role as a transcription repressor .
1468	coexpress	neutral	mir-373	483.2445	138.8699	138.8699	miRNA		TXNIP co-expression , but not the TXNIP-3'UTR , reverses the enhancement of EMT , migration , invasion and metastasis induced by miR-373 .
1468	coexpress	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	TXNIP co-expression , but not the TXNIP-3'UTR , reverses the enhancement of EMT , migration , invasion and metastasis induced by miR-373 .
1467	suppress	negative	mir-373	483.2445	138.8699	138.8699	miRNA		MiR-373 suppresses TXNIP by binding to the 3'UTR of TXNIP , which in turn , induces cancer cell EMT and metastasis .
1467	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-373 suppresses TXNIP by binding to the 3'UTR of TXNIP , which in turn , induces cancer cell EMT and metastasis .
1456	upregulate	positive	mir-373	483.2445	138.8699	138.8699	miRNA		Our results demonstrated that miR-373-3p participated in the invasion and metastasis of lung adenocarcinoma cells , partly by upregulation of MMP-9 and MMP-14 .
1456	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our results demonstrated that miR-373-3p participated in the invasion and metastasis of lung adenocarcinoma cells , partly by upregulation of MMP-9 and MMP-14 .
1455	promote	positive	mir-373	483.2445	138.8699	138.8699	miRNA		[ MiR-373-3p Promotes Invasion and Metastasis of Lung Adenocarcinoma Cells ] .
1455	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	[ MiR-373-3p Promotes Invasion and Metastasis of Lung Adenocarcinoma Cells ] .
1357	antagonize	negative	mir-373	483.2445	138.8699	138.8699	miRNA		Together , these data suggest that TR4 may increase PCa metastasis via a newly identified signal and targeting these TR4/miR-473-3p/TGF?] R2/p-Smad3 signals using TR4 antagonist or TR4-siRNA or miR-373-3p may allow us to develop a new potential therapeutic approach to better suppress PCa metastasis .
1357	antagonize	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Together , these data suggest that TR4 may increase PCa metastasis via a newly identified signal and targeting these TR4/miR-473-3p/TGF?] R2/p-Smad3 signals using TR4 antagonist or TR4-siRNA or miR-373-3p may allow us to develop a new potential therapeutic approach to better suppress PCa metastasis .
1072	suppress	negative	mir-373	483.2445	138.8699	138.8699	miRNA		Taken together , these results demonstrate that miR-373 suppresses EOC invasion and metastasis by directly targeting Rab22a gene , a new potential therapeutic target in EOC .
1072	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , these results demonstrate that miR-373 suppresses EOC invasion and metastasis by directly targeting Rab22a gene , a new potential therapeutic target in EOC .
1071	suppress	negative	mir-373	483.2445	138.8699	138.8699	miRNA		Ectopic overexpression of miR-373 in human EOC cells suppressed cell invasion in vitro and metastasis in vivo , and the epithelial-mesenchymal transition process .
1071	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Ectopic overexpression of miR-373 in human EOC cells suppressed cell invasion in vitro and metastasis in vivo , and the epithelial-mesenchymal transition process .
1070	suppress	negative	mir-373	483.2445	138.8699	138.8699	miRNA		Ectopic overexpression of miR-373 in human EOC cells suppressed cell invasion in vitro and metastasis in vivo , and the epithelial-mesenchymal transition process .
1070	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Ectopic overexpression of miR-373 in human EOC cells suppressed cell invasion in vitro and metastasis in vivo , and the epithelial-mesenchymal transition process .
1069	suppress	negative	mir-373	483.2445	138.8699	138.8699	miRNA		MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer .
1069	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer .
1067	inhibit	negative	mir-362	479.5507	142.6757	142.6757	miRNA		Inhibition of miR-362-5p in HCC cells dramatically decreased cell proliferation , clonogenicity , migration and invasion in vitro as well as tumor growth and metastasis in vivo .
1067	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Inhibition of miR-362-5p in HCC cells dramatically decreased cell proliferation , clonogenicity , migration and invasion in vitro as well as tumor growth and metastasis in vivo .
1066	promote	positive	microrna-362	475.9026	146.5253	146.5253	miRNA		MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma .
1066	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma .
1059	induce	positive	microrna-520g	472.3007	150.4183	150.4183	miRNA		MicroRNA-520g induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7 .
1059	induce	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-520g induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7 .
1058	induce	positive	microrna-520g	472.3007	150.4183	150.4183	miRNA		MicroRNA-520g induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7 .
1058	induce	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-520g induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7 .
1649	inhibit	negative	mir-16	468.7456	154.354	154.354	miRNA		miR-16 is known to be abnormally expressed in hepatocellular carcinoma ( HCC ) cells , and the overexpression of miR-16 inhibits the proliferation , invasion and metastasis of various cancer cells .
1649	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-16 is known to be abnormally expressed in hepatocellular carcinoma ( HCC ) cells , and the overexpression of miR-16 inhibits the proliferation , invasion and metastasis of various cancer cells .
1056	downregulate	negative	mir-16	468.7456	154.354	154.354	miRNA		In addition , miR-15a and/or miR-16 downregulation were all significantly associated with advanced TNM stage ( all P < 0.05 ) , poorly histological grade ( all P < 0.05 ) , and positive lymph node metastasis ( all P < 0.05 ) .
1056	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In addition , miR-15a and/or miR-16 downregulation were all significantly associated with advanced TNM stage ( all P < 0.05 ) , poorly histological grade ( all P < 0.05 ) , and positive lymph node metastasis ( all P < 0.05 ) .
1055	downregulate	negative	mir-15a	465.2378	158.3319	158.3319	miRNA		In addition , miR-15a and/or miR-16 downregulation were all significantly associated with advanced TNM stage ( all P < 0.05 ) , poorly histological grade ( all P < 0.05 ) , and positive lymph node metastasis ( all P < 0.05 ) .
1055	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In addition , miR-15a and/or miR-16 downregulation were all significantly associated with advanced TNM stage ( all P < 0.05 ) , poorly histological grade ( all P < 0.05 ) , and positive lymph node metastasis ( all P < 0.05 ) .
1515	promote	positive	mir-1228	461.7777	162.3515	162.3515	miRNA		MiR-1228 promotes breast cancer cell growth and metastasis through targeting SCAI protein .
1515	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-1228 promotes breast cancer cell growth and metastasis through targeting SCAI protein .
1048	promote	positive	mir-1228	461.7777	162.3515	162.3515	miRNA		miR-1228 promoted proliferation and metastasis , and facilitated the transition of cell cycle in hepatoma cells .
1048	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-1228 promoted proliferation and metastasis , and facilitated the transition of cell cycle in hepatoma cells .
1047	promote	positive	mir-1228	461.7777	162.3515	162.3515	miRNA		miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop .
1047	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop .
1039	regulate	positive	mir-23b/27b	458.3659	166.412	166.412	miRNA		Our data on RNA networks regulated by tumor-suppressive miR-23b/27b provide new insights into the potential mechanisms of BC oncogenesis and metastasis .
1039	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our data on RNA networks regulated by tumor-suppressive miR-23b/27b provide new insights into the potential mechanisms of BC oncogenesis and metastasis .
1038	regulate	positive	mir-23b/27b	458.3659	166.412	166.412	miRNA		Thus , the aim of the present study was to investigate the functional significance of the miR-23b/27b cluster and its regulated molecular targets , with an emphasis on its contributions to BC oncogenesis and metastasis .
1038	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Thus , the aim of the present study was to investigate the functional significance of the miR-23b/27b cluster and its regulated molecular targets , with an emphasis on its contributions to BC oncogenesis and metastasis .
1034	suppress	negative	mirna-646	455.0028	170.5131	170.5131	miRNA		miRNA-646 suppresses osteosarcoma cell metastasis by downregulating fibroblast growth factor 2 ( FGF2 ) .
1034	suppress	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	miRNA-646 suppresses osteosarcoma cell metastasis by downregulating fibroblast growth factor 2 ( FGF2 ) .
1020	inhibit	negative	mir-129*	451.689	174.654	174.654	miRNA		MCRS1 overexpression , which is specifically inhibited by miR-129* , promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer .
1020	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MCRS1 overexpression , which is specifically inhibited by miR-129* , promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer .
1012	downregulate	negative	microrna-100	448.4248	178.8342	178.8342	miRNA		Downregulation of microRNA-100 enhances the ICMT-Rac1 signaling and promotes metastasis of hepatocellular carcinoma cells .
1012	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Downregulation of microRNA-100 enhances the ICMT-Rac1 signaling and promotes metastasis of hepatocellular carcinoma cells .
1007	regulate	positive	microrna-200/zeb	445.2109	183.0531	183.0531	miRNA		Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression .
1007	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression .
1004	induce	positive	mir-224/452	442.0475	187.31	187.31	miRNA		We identify the metastasis suppressor TXNIP as new target of miR-224/miR-452 that induces feedback inhibition of E2F1 and show that miR-224/452-mediated downregulation of TXNIP is essential for E2F1-induced EMT and invasion .
1004	induce	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	We identify the metastasis suppressor TXNIP as new target of miR-224/miR-452 that induces feedback inhibition of E2F1 and show that miR-224/452-mediated downregulation of TXNIP is essential for E2F1-induced EMT and invasion .
1003	induce	positive	mir-224/mir	438.9352	191.6045	191.6045	miRNA		We identify the metastasis suppressor TXNIP as new target of miR-224/miR-452 that induces feedback inhibition of E2F1 and show that miR-224/452-mediated downregulation of TXNIP is essential for E2F1-induced EMT and invasion .
1003	induce	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	We identify the metastasis suppressor TXNIP as new target of miR-224/miR-452 that induces feedback inhibition of E2F1 and show that miR-224/452-mediated downregulation of TXNIP is essential for E2F1-induced EMT and invasion .
1927	regulate	positive	mir-379	435.8745	195.9358	195.9358	miRNA		Taken together , our findings highlight the important role of miR-379-5p in regulating the EMT and metastasis of HCC by targeting FAK/AKT signaling , suggesting that miR-379-5p may represent a novel potential therapeutic target and prognostic marker for HCC .
1927	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , our findings highlight the important role of miR-379-5p in regulating the EMT and metastasis of HCC by targeting FAK/AKT signaling , suggesting that miR-379-5p may represent a novel potential therapeutic target and prognostic marker for HCC .
1926	regulate	positive	mir-379	435.8745	195.9358	195.9358	miRNA		Taken together , our findings highlight the important role of miR-379-5p in regulating the EMT and metastasis of HCC by targeting FAK/AKT signaling , suggesting that miR-379-5p may represent a novel potential therapeutic target and prognostic marker for HCC .
1926	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , our findings highlight the important role of miR-379-5p in regulating the EMT and metastasis of HCC by targeting FAK/AKT signaling , suggesting that miR-379-5p may represent a novel potential therapeutic target and prognostic marker for HCC .
1925	inhibit	negative	mir-379	435.8745	195.9358	195.9358	miRNA		The ectopic overexpression of miR-379-5p inhibited HCC cell migration , invasion , epithelial-to-mesenchymal transition ( EMT ) and metastasis both in vitro and in vivo .
1925	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The ectopic overexpression of miR-379-5p inhibited HCC cell migration , invasion , epithelial-to-mesenchymal transition ( EMT ) and metastasis both in vitro and in vivo .
1924	inhibit	negative	mir-379	435.8745	195.9358	195.9358	miRNA		The ectopic overexpression of miR-379-5p inhibited HCC cell migration , invasion , epithelial-to-mesenchymal transition ( EMT ) and metastasis both in vitro and in vivo .
1924	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The ectopic overexpression of miR-379-5p inhibited HCC cell migration , invasion , epithelial-to-mesenchymal transition ( EMT ) and metastasis both in vitro and in vivo .
1923	downregulate	negative	mir-379	435.8745	195.9358	195.9358	miRNA		Here , we report that miR-379-5p , which is down-regulated in HCC tissues and cell lines , is associated with advanced TNM stage and metastasis in HCC .
1923	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we report that miR-379-5p , which is down-regulated in HCC tissues and cell lines , is associated with advanced TNM stage and metastasis in HCC .
1922	downregulate	negative	mir-379	435.8745	195.9358	195.9358	miRNA		Here , we report that miR-379-5p , which is down-regulated in HCC tissues and cell lines , is associated with advanced TNM stage and metastasis in HCC .
1922	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we report that miR-379-5p , which is down-regulated in HCC tissues and cell lines , is associated with advanced TNM stage and metastasis in HCC .
996	regulate	positive	mir-379	435.8745	195.9358	195.9358	miRNA		miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer .
996	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer .
995	regulate	positive	mir-154*	432.8657	200.3034	200.3034	miRNA		miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer .
995	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer .
991	activate	positive	mir-568	429.9093	204.7066	204.7066	miRNA		Nuclear factor of activated T cells 5 maintained by Hotair suppression of miR-568 upregulates S100 calcium binding protein A4 to promote breast cancer metastasis .
991	activate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Nuclear factor of activated T cells 5 maintained by Hotair suppression of miR-568 upregulates S100 calcium binding protein A4 to promote breast cancer metastasis .
986	upregulate	positive	mir-545/374a	427.0056	209.1448	209.1448	miRNA		Our results showed that the miR-545/374a cluster was upregulated in HBV-HCC tissue and significantly correlated with prognosis-related clinical features , including histological grade , metastasis and tumor capsule .
986	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Our results showed that the miR-545/374a cluster was upregulated in HBV-HCC tissue and significantly correlated with prognosis-related clinical features , including histological grade , metastasis and tumor capsule .
1186	inhibit	negative	mir-382	424.1553	213.6174	213.6174	miRNA		Inhibition of miR-382 in a weakly tumorigenic melanoma cell line increased tumor progression and metastasis in vivo .
1186	inhibit	negative	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	Inhibition of miR-382 in a weakly tumorigenic melanoma cell line increased tumor progression and metastasis in vivo .
984	inhibit	negative	mir-382	424.1553	213.6174	213.6174	miRNA		Taken together , our findings suggest that miR-382 functions as a tumor suppressor function and that the overexpression of miR-382 is a novel strategy to inhibit tumor metastasis and prevent CSC-induced relapse in OS .
984	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , our findings suggest that miR-382 functions as a tumor suppressor function and that the overexpression of miR-382 is a novel strategy to inhibit tumor metastasis and prevent CSC-induced relapse in OS .
983	inhibit	negative	mir-382	424.1553	213.6174	213.6174	miRNA		In contrast , inhibition of miR-382 stimulated EMT and metastasis and increased CSC population in OS cells .
983	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In contrast , inhibition of miR-382 stimulated EMT and metastasis and increased CSC population in OS cells .
982	inhibit	negative	mir-382	424.1553	213.6174	213.6174	miRNA		In contrast , inhibition of miR-382 stimulated EMT and metastasis and increased CSC population in OS cells .
982	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In contrast , inhibition of miR-382 stimulated EMT and metastasis and increased CSC population in OS cells .
981	inhibit	negative	mir-382	424.1553	213.6174	213.6174	miRNA		In contrast , inhibition of miR-382 stimulated EMT and metastasis and increased CSC population in OS cells .
981	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In contrast , inhibition of miR-382 stimulated EMT and metastasis and increased CSC population in OS cells .
980	suppress	negative	mir-382	424.1553	213.6174	213.6174	miRNA		The overexpression of miR-382 suppressed epithelial-mesenchymal transition ( EMT ) and metastasis .
980	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The overexpression of miR-382 suppressed epithelial-mesenchymal transition ( EMT ) and metastasis .
979	inhibit	negative	mir-382	424.1553	213.6174	213.6174	miRNA		miR-382 inhibits osteosarcoma metastasis and relapse by targeting Y box-binding protein 1 .
979	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	miR-382 inhibits osteosarcoma metastasis and relapse by targeting Y box-binding protein 1 .
1488	downregulate	negative	microrna-217	421.3585	218.1237	218.1237	miRNA		Downregulation of microRNA-217 and microRNA-646 acts as potential predictor biomarkers in progression , metastasis , and unfavorable prognosis of human osteosarcoma .
1488	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Downregulation of microRNA-217 and microRNA-646 acts as potential predictor biomarkers in progression , metastasis , and unfavorable prognosis of human osteosarcoma .
1282	inhibit	negative	microrna-217	421.3585	218.1237	218.1237	miRNA		microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer .
1282	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer .
978	regulate	positive	microrna-217	421.3585	218.1237	218.1237	miRNA		MicroRNA-217 regulates WASF3 expression and suppresses tumor growth and metastasis in osteosarcoma .
978	regulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	MicroRNA-217 regulates WASF3 expression and suppresses tumor growth and metastasis in osteosarcoma .
1146	inhibit	negative	let-7b	418.6158	222.6631	222.6631	miRNA		Nude mice with xenograft models of gastric cancer confirmed that let-7b could inhibit gastric cancer metastasis in vivo after transfection by the lentivirus pGCsil-GFP- let-7b .
1146	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Nude mice with xenograft models of gastric cancer confirmed that let-7b could inhibit gastric cancer metastasis in vivo after transfection by the lentivirus pGCsil-GFP- let-7b .
1145	inhibit	negative	let-7b	418.6158	222.6631	222.6631	miRNA		In this study , we investigate whether let-7b acts as a tumor suppressor to inhibit invasion and metastasis in gastric cancers .
1145	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	In this study , we investigate whether let-7b acts as a tumor suppressor to inhibit invasion and metastasis in gastric cancers .
1090	downregulate	negative	let-7b	418.6158	222.6631	222.6631	miRNA		Let-7b was found downregulated remarkably in gastric cancer tissues and was correlated with Helicobacter pylori infection , tumor stage , and lymphatic metastasis .
1090	downregulate	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Let-7b was found downregulated remarkably in gastric cancer tissues and was correlated with Helicobacter pylori infection , tumor stage , and lymphatic metastasis .
977	downregulate	negative	let-7b	418.6158	222.6631	222.6631	miRNA		let-7b/g was found down-regulated in gastric cancer and its downregulation was associated with poor survival and correlated with lymph node metastasis .
977	downregulate	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	let-7b/g was found down-regulated in gastric cancer and its downregulation was associated with poor survival and correlated with lymph node metastasis .
966	inhibit	negative	mir23b	415.9275	227.2349	227.2349	miRNA		Ectopic expression of miR23b inhibited invasion , anoikis , angiogenesis , and pulmonary metastasis .
966	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Ectopic expression of miR23b inhibited invasion , anoikis , angiogenesis , and pulmonary metastasis .
965	inhibit	negative	mir-422a	413.2939	231.8385	231.8385	miRNA		At the same time , the overexpression of miR-422a in HCC tumor cells significantly inhibits tumor growth and liver metastasis in xenograft tumor models .
965	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	At the same time , the overexpression of miR-422a in HCC tumor cells significantly inhibits tumor growth and liver metastasis in xenograft tumor models .
964	downregulate	negative	mir-422a	413.2939	231.8385	231.8385	miRNA		In this study , we report that microRNA-422a ( miR-422a ) is significantly down-regulated in HCC tumor samples and cell lines compared with normal controls , and its expression level is negatively correlated with pathological grading , recurrence , and metastasis .
964	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In this study , we report that microRNA-422a ( miR-422a ) is significantly down-regulated in HCC tumor samples and cell lines compared with normal controls , and its expression level is negatively correlated with pathological grading , recurrence , and metastasis .
963	downregulate	negative	mir-422a	413.2939	231.8385	231.8385	miRNA		In this study , we report that microRNA-422a ( miR-422a ) is significantly down-regulated in HCC tumor samples and cell lines compared with normal controls , and its expression level is negatively correlated with pathological grading , recurrence , and metastasis .
963	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In this study , we report that microRNA-422a ( miR-422a ) is significantly down-regulated in HCC tumor samples and cell lines compared with normal controls , and its expression level is negatively correlated with pathological grading , recurrence , and metastasis .
962	downregulate	negative	microrna-422a	410.7156	236.4733	236.4733	miRNA		In this study , we report that microRNA-422a ( miR-422a ) is significantly down-regulated in HCC tumor samples and cell lines compared with normal controls , and its expression level is negatively correlated with pathological grading , recurrence , and metastasis .
962	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In this study , we report that microRNA-422a ( miR-422a ) is significantly down-regulated in HCC tumor samples and cell lines compared with normal controls , and its expression level is negatively correlated with pathological grading , recurrence , and metastasis .
961	downregulate	negative	microrna-422a	410.7156	236.4733	236.4733	miRNA		In this study , we report that microRNA-422a ( miR-422a ) is significantly down-regulated in HCC tumor samples and cell lines compared with normal controls , and its expression level is negatively correlated with pathological grading , recurrence , and metastasis .
961	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In this study , we report that microRNA-422a ( miR-422a ) is significantly down-regulated in HCC tumor samples and cell lines compared with normal controls , and its expression level is negatively correlated with pathological grading , recurrence , and metastasis .
960	regulate	positive	microrna-422a	410.7156	236.4733	236.4733	miRNA		Double-negative feedback loop between microRNA-422a and forkhead box ( FOX ) G1/Q1/E1 regulates hepatocellular carcinoma tumor growth and metastasis .
960	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Double-negative feedback loop between microRNA-422a and forkhead box ( FOX ) G1/Q1/E1 regulates hepatocellular carcinoma tumor growth and metastasis .
959	induce	positive	mir21	408.1928	241.1385	241.1385	miRNA		Overexpression of PTENP1 in cells expressing miR21 reduces cell proliferation , invasion , tumor growth , and metastasis , recapitulating the phenotypes induced by PTEN expression .
959	induce	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Overexpression of PTENP1 in cells expressing miR21 reduces cell proliferation , invasion , tumor growth , and metastasis , recapitulating the phenotypes induced by PTEN expression .
958	promote	positive	mir21	408.1928	241.1385	241.1385	miRNA		miR21 expression promotes ccRCC cell proliferation , migration , invasion in vitro , and tumor growth and metastasis in vivo .
958	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR21 expression promotes ccRCC cell proliferation , migration , invasion in vitro , and tumor growth and metastasis in vivo .
1883	suppress	negative	mir-506	405.7259	245.8335	245.8335	miRNA		Together , our data suggest that miR-506 suppression in OS cells may promote Snail2-mediated cancer metastasis .
1883	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Together , our data suggest that miR-506 suppression in OS cells may promote Snail2-mediated cancer metastasis .
1617	inhibit	negative	mir-506	405.7259	245.8335	245.8335	miRNA		In vitro and in vivo experiments confirmed that miR-506 inhibits the proliferation and metastasis of colon cancer , and a luciferase reporter assay confirmed that EZH2 is a direct and functional target of miR-506 via the 3'UTR of EZH2 .
1617	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In vitro and in vivo experiments confirmed that miR-506 inhibits the proliferation and metastasis of colon cancer , and a luciferase reporter assay confirmed that EZH2 is a direct and functional target of miR-506 via the 3'UTR of EZH2 .
1616	downregulate	negative	mir-506	405.7259	245.8335	245.8335	miRNA		Here , we demonstrated that miR-506 was down-regulated in colon cancer tissue and cells and that miR-506 expression was inversely correlated with EZH2 expression , tumor size , lymph node invasion , TNM stage and metastasis .
1616	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we demonstrated that miR-506 was down-regulated in colon cancer tissue and cells and that miR-506 expression was inversely correlated with EZH2 expression , tumor size , lymph node invasion , TNM stage and metastasis .
1615	downregulate	negative	mir-506	405.7259	245.8335	245.8335	miRNA		Here , we demonstrated that miR-506 was down-regulated in colon cancer tissue and cells and that miR-506 expression was inversely correlated with EZH2 expression , tumor size , lymph node invasion , TNM stage and metastasis .
1615	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we demonstrated that miR-506 was down-regulated in colon cancer tissue and cells and that miR-506 expression was inversely correlated with EZH2 expression , tumor size , lymph node invasion , TNM stage and metastasis .
1591	regulate	positive	mir-506	405.7259	245.8335	245.8335	miRNA		miR-506 regulates breast cancer cell metastasis by targeting IQGAP1 .
1591	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-506 regulates breast cancer cell metastasis by targeting IQGAP1 .
1398	inhibit	negative	mir-506	405.7259	245.8335	245.8335	miRNA		MiR-506 Over-Expression Inhibits Proliferation and Metastasis of Breast Cancer Cells .
1398	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-506 Over-Expression Inhibits Proliferation and Metastasis of Breast Cancer Cells .
1384	suppress	negative	mir-506	405.7259	245.8335	245.8335	miRNA		Thus , miR-506 possesses a multitasking property in the suppression of EMT and metastasis and thus may represent a promising tool in cancer therapeutics .
1384	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Thus , miR-506 possesses a multitasking property in the suppression of EMT and metastasis and thus may represent a promising tool in cancer therapeutics .
1371	inhibit	negative	mir-506	405.7259	245.8335	245.8335	miRNA		Correction : MiR-506 Is Down-Regulated in Clear Cell Renal Cell Carcinoma and Inhibits Cell Growth and Metastasis via Targeting FLOT1 .
1371	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Correction : MiR-506 Is Down-Regulated in Clear Cell Renal Cell Carcinoma and Inhibits Cell Growth and Metastasis via Targeting FLOT1 .
1229	downregulate	negative	mir-506	405.7259	245.8335	245.8335	miRNA		Over-expression of miR-506 in renal cancer cells decreased cell growth and metastasis , In contrast , down-regulation of miR-506 expression promoted renal cancer cell growth and metastasis .
1229	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Over-expression of miR-506 in renal cancer cells decreased cell growth and metastasis , In contrast , down-regulation of miR-506 expression promoted renal cancer cell growth and metastasis .
1228	downregulate	negative	mir-506	405.7259	245.8335	245.8335	miRNA		MiR-506 is down-regulated in clear cell renal cell carcinoma and inhibits cell growth and metastasis via targeting FLOT1 .
1228	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-506 is down-regulated in clear cell renal cell carcinoma and inhibits cell growth and metastasis via targeting FLOT1 .
952	regulate	positive	mir-506	405.7259	245.8335	245.8335	miRNA		Thus , miR-506 represents a new class of miRNA that regulates both E-cad and vimentin/N-cad in the suppression of EMT and metastasis .
952	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Thus , miR-506 represents a new class of miRNA that regulates both E-cad and vimentin/N-cad in the suppression of EMT and metastasis .
1022	downregulate	negative	mir-338	403.3153	250.5576	250.5576	miRNA		miR-338-3p was shown to be downregulated in NSCLC tissues , and the expression levels of miR ? 338 ? 3p were significantly correlated with NSCLC cancer differentiation , pathological stage and lymph ? node metastasis .
1022	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-338-3p was shown to be downregulated in NSCLC tissues , and the expression levels of miR ? 338 ? 3p were significantly correlated with NSCLC cancer differentiation , pathological stage and lymph ? node metastasis .
940	inhibit	negative	mir-338	403.3153	250.5576	250.5576	miRNA		Taken together , miR-338 might inhibit growth and metastasis of OSCC cells by targeting NRP1 .
940	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , miR-338 might inhibit growth and metastasis of OSCC cells by targeting NRP1 .
939	suppress	negative	mir-338	403.3153	250.5576	250.5576	miRNA		MiR-338 suppresses the growth and metastasis of OSCC cells by targeting NRP1 .
939	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-338 suppresses the growth and metastasis of OSCC cells by targeting NRP1 .
1946	suppress	negative	mir-101	400.9613	255.3102	255.3102	miRNA		miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and smad pathways in gallbladder carcinoma .
1946	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and smad pathways in gallbladder carcinoma .
1772	downregulate	negative	mir-101	400.9613	255.3102	255.3102	miRNA		In this study , down-regulated miR-101-3p expression was detected in ACC tissues and ACC cell lines with high potential for metastasis .
1772	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In this study , down-regulated miR-101-3p expression was detected in ACC tissues and ACC cell lines with high potential for metastasis .
1689	inhibit	negative	mir-101	400.9613	255.3102	255.3102	miRNA		Overexpression of miR-101 in ESCC inhibits proliferation and metastasis .
1689	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Overexpression of miR-101 in ESCC inhibits proliferation and metastasis .
1580	inhibit	negative	mir-101	400.9613	255.3102	255.3102	miRNA		Introduction of miR-101 inhibited breast cancer cell proliferation and invasion in vitro and suppressed tumor growth and lung metastasis of in vivo .
1580	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Introduction of miR-101 inhibited breast cancer cell proliferation and invasion in vitro and suppressed tumor growth and lung metastasis of in vivo .
1579	inhibit	negative	mir-101	400.9613	255.3102	255.3102	miRNA		Introduction of miR-101 inhibited breast cancer cell proliferation and invasion in vitro and suppressed tumor growth and lung metastasis of in vivo .
1579	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Introduction of miR-101 inhibited breast cancer cell proliferation and invasion in vitro and suppressed tumor growth and lung metastasis of in vivo .
1565	downregulate	negative	mir-101	400.9613	255.3102	255.3102	miRNA		These findings provide new insights miR-101 down-regulation in CAFs could inhibit lung cancer proliferation and metastasis via targeting CXCL12 .
1565	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	These findings provide new insights miR-101 down-regulation in CAFs could inhibit lung cancer proliferation and metastasis via targeting CXCL12 .
1527	downregulate	negative	mir-101	400.9613	255.3102	255.3102	miRNA		Furthermore , downregulation of miR-101 correlated with T3-4 tumour grade , lymph node metastasis , and an advanced clinical stage in the LSCC patients examined ( P ? < ? 0.05 ) .
1527	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Furthermore , downregulation of miR-101 correlated with T3-4 tumour grade , lymph node metastasis , and an advanced clinical stage in the LSCC patients examined ( P ? < ? 0.05 ) .
1193	suppress	negative	mir-101	400.9613	255.3102	255.3102	miRNA		In an animal model of HCC , we demonstrated that systemic delivery of lentivirus-mediated miR-101 abrogated HCC growth in the liver , intrahepatic metastasis and distant metastasis to the lung and to the mediastinum , resulting in a dramatic suppression of HCC development and metastasis in mice without toxicity and extending life expectancy .
1193	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In an animal model of HCC , we demonstrated that systemic delivery of lentivirus-mediated miR-101 abrogated HCC growth in the liver , intrahepatic metastasis and distant metastasis to the lung and to the mediastinum , resulting in a dramatic suppression of HCC development and metastasis in mice without toxicity and extending life expectancy .
1192	downregulate	negative	mir-101	400.9613	255.3102	255.3102	miRNA		In the current study , we first observed that plasma levels of miR-101 were significantly lower in distant metastatic HCC patients than in HCCs without distant metastasis , and down-regulation of plasma miR-101 predicted a worse disease-free survival ( DFS , P < 0.05 ) .
1192	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In the current study , we first observed that plasma levels of miR-101 were significantly lower in distant metastatic HCC patients than in HCCs without distant metastasis , and down-regulation of plasma miR-101 predicted a worse disease-free survival ( DFS , P < 0.05 ) .
1191	downregulate	negative	mir-101	400.9613	255.3102	255.3102	miRNA		In the current study , we first observed that plasma levels of miR-101 were significantly lower in distant metastatic HCC patients than in HCCs without distant metastasis , and down-regulation of plasma miR-101 predicted a worse disease-free survival ( DFS , P < 0.05 ) .
1191	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In the current study , we first observed that plasma levels of miR-101 were significantly lower in distant metastatic HCC patients than in HCCs without distant metastasis , and down-regulation of plasma miR-101 predicted a worse disease-free survival ( DFS , P < 0.05 ) .
1030	promote	positive	mir-101	400.9613	255.3102	255.3102	miRNA		These findings suggest that decreased expression of miR-101 might promote metastasis of human ESCC by inducing accumulation of EZH2 protein .
1030	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	These findings suggest that decreased expression of miR-101 might promote metastasis of human ESCC by inducing accumulation of EZH2 protein .
942	trigger	positive	mir-101	400.9613	255.3102	255.3102	miRNA		Importantly , ectopic miR-101 expression was sufficient to trigger in vivo lung tumor regression and the blockage of metastasis .
942	trigger	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Importantly , ectopic miR-101 expression was sufficient to trigger in vivo lung tumor regression and the blockage of metastasis .
938	downregulate	negative	mir-101	400.9613	255.3102	255.3102	miRNA		This study revealed that miR-101 is significantly downregulated in papillary thyroid carcinoma ( PTC ) tissue and thyroid cancer cell lines , and that the downregulated miR-101 is associated with lymph node metastasis .
938	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	This study revealed that miR-101 is significantly downregulated in papillary thyroid carcinoma ( PTC ) tissue and thyroid cancer cell lines , and that the downregulated miR-101 is associated with lymph node metastasis .
934	suppress	negative	let-7d	398.6642	260.0906	260.0906	miRNA		These results suggest that let-7d may suppress RCC growth , metastasis , and tumor macrophage infiltration at least partially through targeting COL3A1 and CCL7 .
934	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	These results suggest that let-7d may suppress RCC growth , metastasis , and tumor macrophage infiltration at least partially through targeting COL3A1 and CCL7 .
933	inhibit	negative	let-7d	398.6642	260.0906	260.0906	miRNA		Functional studies indicated that ectopic expression of let-7d significantly inhibited RCC cell proliferation , migration , and peripheral blood monocyte ( PBMC ) recruitment in vitro , as well as tumor growth , metastasis , and tumor macrophage infiltration in vivo .
933	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Functional studies indicated that ectopic expression of let-7d significantly inhibited RCC cell proliferation , migration , and peripheral blood monocyte ( PBMC ) recruitment in vitro , as well as tumor growth , metastasis , and tumor macrophage infiltration in vivo .
932	suppress	negative	let-7d	398.6642	260.0906	260.0906	miRNA		Let-7d suppresses growth , metastasis , and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7 .
932	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Let-7d suppresses growth , metastasis , and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7 .
930	inhibit	negative	microrna-101	396.4244	264.8981	264.8981	miRNA		MicroRNA-101 inhibits the metastasis of osteosarcoma cells by downregulation of EZH2 expression .
930	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	MicroRNA-101 inhibits the metastasis of osteosarcoma cells by downregulation of EZH2 expression .
925	repress	negative	mir-198	394.2421	269.732	269.732	miRNA		MiR-198 represses tumor growth and metastasis in colorectal cancer by targeting fucosyl transferase 8 .
925	repress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-198 represses tumor growth and metastasis in colorectal cancer by targeting fucosyl transferase 8 .
1777	downregulate	negative	mir-217	392.1178	274.5916	274.5916	miRNA		Here , we report that miR-217 expression was downregulated in EOC tissue and inversely correlated with advanced FIGO stage , high histological grading and lymph node metastasis ( P < 0.01 ) .
1777	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we report that miR-217 expression was downregulated in EOC tissue and inversely correlated with advanced FIGO stage , high histological grading and lymph node metastasis ( P < 0.01 ) .
1776	downregulate	negative	mir-217	392.1178	274.5916	274.5916	miRNA		Here , we report that miR-217 expression was downregulated in EOC tissue and inversely correlated with advanced FIGO stage , high histological grading and lymph node metastasis ( P < 0.01 ) .
1776	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we report that miR-217 expression was downregulated in EOC tissue and inversely correlated with advanced FIGO stage , high histological grading and lymph node metastasis ( P < 0.01 ) .
924	downregulate	negative	mir-217	392.1178	274.5916	274.5916	miRNA		Clinical information from a cohort of 54 PC patients demonstrated that down-regulated miR-217 was positively correlated with late tumor stage , lymphatic invasion , vascular infiltration and distant metastasis .
924	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Clinical information from a cohort of 54 PC patients demonstrated that down-regulated miR-217 was positively correlated with late tumor stage , lymphatic invasion , vascular infiltration and distant metastasis .
923	mediate	neutral	mir424	390.0516	279.4763	279.4763	miRNA		Overall , our findings demonstrate a novel mechanism , mediated by elevated expression of the miR424-503 cluster , underlying TGF?] activation and metastasis of human breast cancer .
923	mediate	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Overall , our findings demonstrate a novel mechanism , mediated by elevated expression of the miR424-503 cluster , underlying TGF?] activation and metastasis of human breast cancer .
922	antagonize	negative	mir424	390.0516	279.4763	279.4763	miRNA		Moreover , antagonizing miR424-503 in breast cancer cells suppressed metastasis in vivo and increased overall host survival .
922	antagonize	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Moreover , antagonizing miR424-503 in breast cancer cells suppressed metastasis in vivo and increased overall host survival .
921	suppress	negative	mir424	390.0516	279.4763	279.4763	miRNA		To better understand how the TGF?] inhibitors are suppressed in metastatic breast cancer cells , we compared miRNA expression profiles between breast cancers with or without metastasis and found that the miR424-503 cluster was markedly overexpressed in metastatic breast cancer .
921	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	To better understand how the TGF?] inhibitors are suppressed in metastatic breast cancer cells , we compared miRNA expression profiles between breast cancers with or without metastasis and found that the miR424-503 cluster was markedly overexpressed in metastatic breast cancer .
920	suppress	negative	mir424	390.0516	279.4763	279.4763	miRNA		To better understand how the TGF?] inhibitors are suppressed in metastatic breast cancer cells , we compared miRNA expression profiles between breast cancers with or without metastasis and found that the miR424-503 cluster was markedly overexpressed in metastatic breast cancer .
920	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	To better understand how the TGF?] inhibitors are suppressed in metastatic breast cancer cells , we compared miRNA expression profiles between breast cancers with or without metastasis and found that the miR424-503 cluster was markedly overexpressed in metastatic breast cancer .
1858	promote	positive	mir-130b	388.044	284.3852	284.3852	miRNA		Next , using a gain and loss assay and epithelial-mesenchymal transition ( EMT ) relative assays , we show that miR-130b may promote proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1帢 signaling .
1858	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Next , using a gain and loss assay and epithelial-mesenchymal transition ( EMT ) relative assays , we show that miR-130b may promote proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1帢 signaling .
1857	inhibit	negative	mir-130b	388.044	284.3852	284.3852	miRNA		Moreover , high levels of miR-130b predicted poor overall and disease-free survival of HCC patients , and in vitro and in vivo research revealed that knockdown or overexpression of miR-130b inhibited and promoted proliferation and metastasis of HCC cells , respectively .
1857	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Moreover , high levels of miR-130b predicted poor overall and disease-free survival of HCC patients , and in vitro and in vivo research revealed that knockdown or overexpression of miR-130b inhibited and promoted proliferation and metastasis of HCC cells , respectively .
919	antagonize	negative	mir-130b	388.044	284.3852	284.3852	miRNA		Ectopic expression of MMP2 rescued miR-130b-suppressed cell migration and invasion , and knock-down of MMP2 antagonized the effect of silencing miR-130b.Taken together , our data reveal for the first time that miR-130b exerts a suppressive effect in prostate cancer metastasis through down-regulation of MMP2 .
919	antagonize	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Ectopic expression of MMP2 rescued miR-130b-suppressed cell migration and invasion , and knock-down of MMP2 antagonized the effect of silencing miR-130b.Taken together , our data reveal for the first time that miR-130b exerts a suppressive effect in prostate cancer metastasis through down-regulation of MMP2 .
918	suppress	negative	mir-130b	388.044	284.3852	284.3852	miRNA		MiR-130b suppresses prostate cancer metastasis through down-regulation of MMP2 .
918	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-130b suppresses prostate cancer metastasis through down-regulation of MMP2 .
916	regulate	positive	mir-144/451	386.0951	289.3178	289.3178	miRNA		This discovery suggests that a PAX4-miR-144/451-ADAMs axis regulates human epithelial cancer metastasis , thus opening up therapeutic possibilities and predicting prognosis for those cancer types .
916	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	This discovery suggests that a PAX4-miR-144/451-ADAMs axis regulates human epithelial cancer metastasis , thus opening up therapeutic possibilities and predicting prognosis for those cancer types .
1899	promote	positive	mir-410	384.2053	294.2733	294.2733	miRNA		An orthotopic xenograft nude mouse model further affirmed that miR-410 promoted NSCLC cell growth and metastasis in vivo .
1899	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	An orthotopic xenograft nude mouse model further affirmed that miR-410 promoted NSCLC cell growth and metastasis in vivo .
906	control	neutral	mir-410	384.2053	294.2733	294.2733	miRNA		In this study , we found that the levels of miR-410 in gastric cancer and cell lines were much lower than that in the normal control , respectively , and the lower level of miR-410 was significantly associated with lymph-node metastasis .
906	control	neutral	gc	1242.449	487.0825	487.0825	Cancer	D061325	In this study , we found that the levels of miR-410 in gastric cancer and cell lines were much lower than that in the normal control , respectively , and the lower level of miR-410 was significantly associated with lymph-node metastasis .
905	control	neutral	mir-410	384.2053	294.2733	294.2733	miRNA		In this study , we found that the levels of miR-410 in gastric cancer and cell lines were much lower than that in the normal control , respectively , and the lower level of miR-410 was significantly associated with lymph-node metastasis .
905	control	neutral	gc	1242.449	487.0825	487.0825	Cancer	D061325	In this study , we found that the levels of miR-410 in gastric cancer and cell lines were much lower than that in the normal control , respectively , and the lower level of miR-410 was significantly associated with lymph-node metastasis .
904	promote	positive	mirna-541	382.3748	299.2511	299.2511	miRNA		Together , these results concluded that infiltrating CD4 ( + ) T cells could promote PCa metastasis via modulation of FGF11?iRNA-541?R?MP9 signaling .
904	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Together , these results concluded that infiltrating CD4 ( + ) T cells could promote PCa metastasis via modulation of FGF11?iRNA-541?R?MP9 signaling .
903	promote	positive	mirna-541	382.3748	299.2511	299.2511	miRNA		Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11?iRNA-541?ndrogen receptor ( AR ) ?MP9 signaling .
903	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11?iRNA-541?ndrogen receptor ( AR ) ?MP9 signaling .
896	suppress	negative	microrna-493	380.6039	304.2504	304.2504	miRNA		MicroRNA-493 suppresses tumor growth , invasion and metastasis of lung cancer by regulating E2F1 .
896	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-493 suppresses tumor growth , invasion and metastasis of lung cancer by regulating E2F1 .
890	suppress	negative	microrna-194	378.8929	309.2704	309.2704	miRNA		microRNA-194 suppresses osteosarcoma cell proliferation and metastasis in vitro and in vivo by targeting CDH2 and IGF1R .
890	suppress	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	microRNA-194 suppresses osteosarcoma cell proliferation and metastasis in vitro and in vivo by targeting CDH2 and IGF1R .
883	upregulate	positive	microrna-10b	377.2419	314.3105	314.3105	miRNA		Up-regulation of microRNA-10b is associated with the development of breast cancer brain metastasis .
883	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Up-regulation of microRNA-10b is associated with the development of breast cancer brain metastasis .
882	upregulate	positive	microrna-10b	377.2419	314.3105	314.3105	miRNA		Up-regulation of microRNA-10b is associated with the development of breast cancer brain metastasis .
882	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Up-regulation of microRNA-10b is associated with the development of breast cancer brain metastasis .
2012	suppress	negative	mir-144	375.6513	319.3701	319.3701	miRNA		miR-144 suppresses the growth and metastasis of laryngeal squamous cell carcinoma by targeting IRS1 .
2012	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-144 suppresses the growth and metastasis of laryngeal squamous cell carcinoma by targeting IRS1 .
1937	coexpress	neutral	mir-144	375.6513	319.3701	319.3701	miRNA		Co-expression of miR-26a and miR-144 in ESCC cells resulted in inhibition of proliferation and metastasis in vitro and in vivo , suggesting that targeting COX-2 may be the mechanism of these two miRNAs .
1937	coexpress	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Co-expression of miR-26a and miR-144 in ESCC cells resulted in inhibition of proliferation and metastasis in vitro and in vivo , suggesting that targeting COX-2 may be the mechanism of these two miRNAs .
1935	inhibit	negative	mir-144	375.6513	319.3701	319.3701	miRNA		MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2 .
1935	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2 .
1316	block	negative	mir-144	375.6513	319.3701	319.3701	miRNA		Reintroduction of miR-144 expression in GC cells presents an attractive therapeutic approach to block the metastasis of gastric cancer .
1316	block	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Reintroduction of miR-144 expression in GC cells presents an attractive therapeutic approach to block the metastasis of gastric cancer .
1315	block	negative	mir-144	375.6513	319.3701	319.3701	miRNA		Reintroduction of miR-144 expression in GC cells presents an attractive therapeutic approach to block the metastasis of gastric cancer .
1315	block	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Reintroduction of miR-144 expression in GC cells presents an attractive therapeutic approach to block the metastasis of gastric cancer .
1269	regulate	positive	mir-144	375.6513	319.3701	319.3701	miRNA		Our study supports the view that the miR-144 may regulate Ezrin protein expression by inhibiting the invasion and metastasis of osteosarcoma cells .
1269	regulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Our study supports the view that the miR-144 may regulate Ezrin protein expression by inhibiting the invasion and metastasis of osteosarcoma cells .
881	suppress	negative	mir-144	375.6513	319.3701	319.3701	miRNA		miR-144 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting E2F3 .
881	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-144 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting E2F3 .
873	inhibit	negative	microrna-18a	374.1212	324.4482	324.4482	miRNA		MicroRNA-18a inhibits hypoxia-inducible factor 1帢 activity and lung metastasis in basal breast cancers .
873	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-18a inhibits hypoxia-inducible factor 1帢 activity and lung metastasis in basal breast cancers .
872	inhibit	negative	microrna-18a	374.1212	324.4482	324.4482	miRNA		MicroRNA-18a inhibits hypoxia-inducible factor 1帢 activity and lung metastasis in basal breast cancers .
872	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-18a inhibits hypoxia-inducible factor 1帢 activity and lung metastasis in basal breast cancers .
868	suppress	negative	mir-941	372.6519	329.5443	329.5443	miRNA		The overexpression of miR-941 suppressed in vitro cell proliferation , migration , and invasion and inhibited the metastasis of HCC cells in vivo .
868	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The overexpression of miR-941 suppressed in vitro cell proliferation , migration , and invasion and inhibited the metastasis of HCC cells in vivo .
867	inhibit	negative	mir-520h/pp	371.2435	334.6575	334.6575	miRNA		Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-庥B signaling in cervical cancer .
867	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-庥B signaling in cervical cancer .
861	inhibit	negative	mir-302a	369.8964	339.7872	339.7872	miRNA		Our findings demonstrated that the repression of miR-302a levels contributes to breast cancer metastasis and restoration of miR-302a baseline expression inhibits the invasion and metastasis of breast cancer cells .
861	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our findings demonstrated that the repression of miR-302a levels contributes to breast cancer metastasis and restoration of miR-302a baseline expression inhibits the invasion and metastasis of breast cancer cells .
860	inhibit	negative	mir-302a	369.8964	339.7872	339.7872	miRNA		Our findings demonstrated that the repression of miR-302a levels contributes to breast cancer metastasis and restoration of miR-302a baseline expression inhibits the invasion and metastasis of breast cancer cells .
860	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our findings demonstrated that the repression of miR-302a levels contributes to breast cancer metastasis and restoration of miR-302a baseline expression inhibits the invasion and metastasis of breast cancer cells .
859	inhibit	negative	mir-302a	369.8964	339.7872	339.7872	miRNA		More promisingly , miR-302a inhibited the invasion and metastasis of breast cancer cells in vitro and in vivo and reduced the expression of CXCR4 .
859	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	More promisingly , miR-302a inhibited the invasion and metastasis of breast cancer cells in vitro and in vivo and reduced the expression of CXCR4 .
858	mediate	neutral	mir-302a	369.8964	339.7872	339.7872	miRNA		The purpose of this study is to investigate the role of miR-302a in the development of breast cancer metastasis mediated by CXCR4 , a critical regulator of metastasis , and to identify miR-302a as an effective therapeutic agent for therapy and prevention of breast cancer metastasis .
858	mediate	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The purpose of this study is to investigate the role of miR-302a in the development of breast cancer metastasis mediated by CXCR4 , a critical regulator of metastasis , and to identify miR-302a as an effective therapeutic agent for therapy and prevention of breast cancer metastasis .
857	inhibit	negative	microrna-302a	368.6106	344.9326	344.9326	miRNA		Inhibition of breast cancer metastasis with microRNA-302a by downregulation of CXCR4 expression .
857	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Inhibition of breast cancer metastasis with microRNA-302a by downregulation of CXCR4 expression .
851	downregulate	negative	mir-646	367.3863	350.093	350.093	miRNA		Downregulated miR-646 in ccRCC was associated with tumour metastasis through MAPK pathway by targeting NOB1 .
851	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Downregulated miR-646 in ccRCC was associated with tumour metastasis through MAPK pathway by targeting NOB1 .
850	downregulate	negative	mir-646	367.3863	350.093	350.093	miRNA		Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein ( NOB1 ) .
850	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein ( NOB1 ) .
1153	induce	positive	mir-204	617.3118	854.674	854.674	miRNA		In this regulatory circuitry among miR-204 , c-MYB , RUNX2 and ETS1 , the c-MYB was found to induce all three other members , but its expression was differentially affected by the methylation status in lymph node vs. bone metastasis .
1153	induce	positive	bone metastasis	366.2238	355.2677	355.2677	Cancer	D001859	In this regulatory circuitry among miR-204 , c-MYB , RUNX2 and ETS1 , the c-MYB was found to induce all three other members , but its expression was differentially affected by the methylation status in lymph node vs. bone metastasis .
1062	inhibit	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		Ectopic miR-34a expression inhibited bone metastasis and reduced cancer cell proliferation in a Ras-dependent xenograft model .
1062	inhibit	negative	bone metastasis	366.2238	355.2677	355.2677	Cancer	D001859	Ectopic miR-34a expression inhibited bone metastasis and reduced cancer cell proliferation in a Ras-dependent xenograft model .
865	block	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2 .
865	block	negative	bone metastasis	366.2238	355.2677	355.2677	Cancer	D001859	miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2 .
864	block	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2 .
864	block	negative	bone metastasis	366.2238	355.2677	355.2677	Cancer	D001859	miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2 .
845	induction	positive	mir-203	627.0308	858.9225	858.9225	miRNA		Our results demonstrate that the induction of bone metastasis and TKI resistance require miR-203 down regulation , activation of the EGFR pathway via altered expression of EGFR ligands ( EREG and TGFA ) and anti-apoptotic proteins ( API5 , BIRC2 , and TRIAP1 ) .
845	induction	positive	bone metastasis	366.2238	355.2677	355.2677	Cancer	D001859	Our results demonstrate that the induction of bone metastasis and TKI resistance require miR-203 down regulation , activation of the EGFR pathway via altered expression of EGFR ligands ( EREG and TGFA ) and anti-apoptotic proteins ( API5 , BIRC2 , and TRIAP1 ) .
844	induction	positive	mir-203	627.0308	858.9225	858.9225	miRNA		Our results demonstrate that the induction of bone metastasis and TKI resistance require miR-203 down regulation , activation of the EGFR pathway via altered expression of EGFR ligands ( EREG and TGFA ) and anti-apoptotic proteins ( API5 , BIRC2 , and TRIAP1 ) .
844	induction	positive	bone metastasis	366.2238	355.2677	355.2677	Cancer	D001859	Our results demonstrate that the induction of bone metastasis and TKI resistance require miR-203 down regulation , activation of the EGFR pathway via altered expression of EGFR ligands ( EREG and TGFA ) and anti-apoptotic proteins ( API5 , BIRC2 , and TRIAP1 ) .
843	induce	positive	mir-203	627.0308	858.9225	858.9225	miRNA		Here we show that ectopic miR-203 expression displayed reduced bone metastasis and induced sensitivity to tyrosine kinase inhibitors ( TKIs ) treatment in a xenograft model .
843	induce	positive	bone metastasis	366.2238	355.2677	355.2677	Cancer	D001859	Here we show that ectopic miR-203 expression displayed reduced bone metastasis and induced sensitivity to tyrosine kinase inhibitors ( TKIs ) treatment in a xenograft model .
1964	promote	positive	mir-519d	365.1232	360.4559	360.4559	miRNA		Taken together , these findings implicated that miR-519d promoted the progression and metastasis of cervical cancer through targeting Smad7 .
1964	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , these findings implicated that miR-519d promoted the progression and metastasis of cervical cancer through targeting Smad7 .
1037	promote	positive	mir-519d	365.1232	360.4559	360.4559	miRNA		Taken together , our results indicate that resistin promotes chondrosarcoma metastasis and MMP-2 expression through activation of the AMPK/p38 signaling pathway and down-regulation of miR-519d expression .
1037	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , our results indicate that resistin promotes chondrosarcoma metastasis and MMP-2 expression through activation of the AMPK/p38 signaling pathway and down-regulation of miR-519d expression .
1036	suppress	negative	mir-519d	365.1232	360.4559	360.4559	miRNA		Additionally , AMP-activated protein kinase ( AMPK ) and p38 inhibitors or siRNAs reduced the resistin-increased cell migration and miR-519d suppression , and inhibition of resistin expression resulted in suppression of MMP-2 expression and lung metastasis in vivo .
1036	suppress	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Additionally , AMP-activated protein kinase ( AMPK ) and p38 inhibitors or siRNAs reduced the resistin-increased cell migration and miR-519d suppression , and inhibition of resistin expression resulted in suppression of MMP-2 expression and lung metastasis in vivo .
1035	promote	positive	mir-519d	365.1232	360.4559	360.4559	miRNA		Resistin promotes tumor metastasis by down-regulation of miR-519d through the AMPK/p38 signaling pathway in human chondrosarcoma cells .
1035	promote	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Resistin promotes tumor metastasis by down-regulation of miR-519d through the AMPK/p38 signaling pathway in human chondrosarcoma cells .
839	promote	positive	mir-519d	365.1232	360.4559	360.4559	miRNA		Taken together , data show CTGF elevating MMPs expression and subsequently promoting tumor metastasis in human osteosarcoma , down-regulating miR-519d via MEK and ERK pathways , making CTGF a new molecular therapeutic target in osteosarcoma metastasis .
839	promote	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Taken together , data show CTGF elevating MMPs expression and subsequently promoting tumor metastasis in human osteosarcoma , down-regulating miR-519d via MEK and ERK pathways , making CTGF a new molecular therapeutic target in osteosarcoma metastasis .
838	promote	positive	mir-519d	365.1232	360.4559	360.4559	miRNA		CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d .
838	promote	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d .
1788	regulate	positive	mir-128	364.0846	365.6568	365.6568	miRNA		To investigate the regulation of miR-128 on VEGF-C expression and their effects on proliferation and metastasis of bladder cancer , T24 and 5637 BC cells were transfected with pre-miR-128 , anti-miR-128 and their respective negative control .
1788	regulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	To investigate the regulation of miR-128 on VEGF-C expression and their effects on proliferation and metastasis of bladder cancer , T24 and 5637 BC cells were transfected with pre-miR-128 , anti-miR-128 and their respective negative control .
1787	downregulate	negative	mir-128	364.0846	365.6568	365.6568	miRNA		miR-128 downregulation promotes growth and metastasis of bladder cancer cells and involves VEGF-C upregulation .
1787	downregulate	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	miR-128 downregulation promotes growth and metastasis of bladder cancer cells and involves VEGF-C upregulation .
1683	inhibit	negative	mir-128	364.0846	365.6568	365.6568	miRNA		Importantly , we demonstrate that the overexpression of miR-128 significantly inhibits HCC cell metastasis and stem-cell like properties via ITGA2 and ITGA5 .
1683	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Importantly , we demonstrate that the overexpression of miR-128 significantly inhibits HCC cell metastasis and stem-cell like properties via ITGA2 and ITGA5 .
1567	block	negative	mir-128	364.0846	365.6568	365.6568	miRNA		Taken together , these data suggested that miR-128 serves as a tumor suppressor and blocks CRC growth and metastasis by targeting IRS1 .
1567	block	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Taken together , these data suggested that miR-128 serves as a tumor suppressor and blocks CRC growth and metastasis by targeting IRS1 .
829	downregulate	negative	mir-128	364.0846	365.6568	365.6568	miRNA		In this study , we showed that the expression level of miR-128 was significantly downregulated in non-small cell lung cancer ( NSCLC ) tissues and cancer cells , and was significantly correlated with NSCLC differentiation , pathological stage and lymph node metastasis .
829	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In this study , we showed that the expression level of miR-128 was significantly downregulated in non-small cell lung cancer ( NSCLC ) tissues and cancer cells , and was significantly correlated with NSCLC differentiation , pathological stage and lymph node metastasis .
2049	downregulate	negative	mir-675	363.1082	370.8698	370.8698	miRNA		We also showed here that down-regulation of miR-675-5p in ESCC cells dramatically induced cell G1 arrest and reduced cell proliferation , colony formation , migration and invasion in vitro as well as tumorigenesis and tumor metastasis in vivo .
2049	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We also showed here that down-regulation of miR-675-5p in ESCC cells dramatically induced cell G1 arrest and reduced cell proliferation , colony formation , migration and invasion in vitro as well as tumorigenesis and tumor metastasis in vivo .
2048	enhance	positive	mir-675	363.1082	370.8698	370.8698	miRNA		miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2 .
2048	enhance	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2 .
1739	regulate	positive	mir-675	363.1082	370.8698	370.8698	miRNA		Current evidence indicate that H19 lncRNA and the microRNA ( miRNA ) miR-675 , which is processed from it , play crucial roles in metastasis , through the regulation of critical events specifically the epithelial to mesenchymal ( EMT ) and the mesenchymal to epithelial transitions ( MET ) .
1739	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Current evidence indicate that H19 lncRNA and the microRNA ( miRNA ) miR-675 , which is processed from it , play crucial roles in metastasis , through the regulation of critical events specifically the epithelial to mesenchymal ( EMT ) and the mesenchymal to epithelial transitions ( MET ) .
1738	regulate	positive	mir-675	363.1082	370.8698	370.8698	miRNA		Current evidence indicate that H19 lncRNA and the microRNA ( miRNA ) miR-675 , which is processed from it , play crucial roles in metastasis , through the regulation of critical events specifically the epithelial to mesenchymal ( EMT ) and the mesenchymal to epithelial transitions ( MET ) .
1738	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Current evidence indicate that H19 lncRNA and the microRNA ( miRNA ) miR-675 , which is processed from it , play crucial roles in metastasis , through the regulation of critical events specifically the epithelial to mesenchymal ( EMT ) and the mesenchymal to epithelial transitions ( MET ) .
1575	enhance	positive	mir-675	363.1082	370.8698	370.8698	miRNA		We showed that overexpression of H19/miR-675 enhanced the aggressive phenotype of breast cancer cells including increased cell proliferation and migration in vitro , and increased tumor growth and metastasis in vivo .
1575	enhance	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We showed that overexpression of H19/miR-675 enhanced the aggressive phenotype of breast cancer cells including increased cell proliferation and migration in vitro , and increased tumor growth and metastasis in vivo .
1574	enhance	positive	mir-675	363.1082	370.8698	370.8698	miRNA		H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b .
1574	enhance	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b .
822	repress	negative	mir-675	363.1082	370.8698	370.8698	miRNA		lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI .
822	repress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI .
815	promote	positive	microrna-23b/27b	362.1942	376.0941	376.0941	miRNA		The microRNA-23b/27b/24 cluster promotes breast cancer lung metastasis by targeting metastasis-suppressive gene prosaposin .
815	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The microRNA-23b/27b/24 cluster promotes breast cancer lung metastasis by targeting metastasis-suppressive gene prosaposin .
810	inhibit	negative	mir216a	361.3426	381.329	381.329	miRNA		In contrast , inhibition of miR216a stimulates NSCLC cell growth and metastasis , and suppresses cisplatin-induced cell growth inhibition and apoptosis .
810	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In contrast , inhibition of miR216a stimulates NSCLC cell growth and metastasis , and suppresses cisplatin-induced cell growth inhibition and apoptosis .
809	suppress	negative	mir216a	361.3426	381.329	381.329	miRNA		Our data also show that overexpression of miR216a suppresses NSCLC cell growth and metastasis , and enhances cisplatin-induced cell growth inhibition and apoptosis .
809	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Our data also show that overexpression of miR216a suppresses NSCLC cell growth and metastasis , and enhances cisplatin-induced cell growth inhibition and apoptosis .
808	inhibit	negative	mir216a	361.3426	381.329	381.329	miRNA		The effects of miR216a on NSCLC cell growth and metastasis were examined both in vitro and in vivo by overexpressing or inhibiting miR216a .
808	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The effects of miR216a on NSCLC cell growth and metastasis were examined both in vitro and in vivo by overexpressing or inhibiting miR216a .
2004	influence	neutral	mir-574	360.5536	386.5736	386.5736	miRNA		Part of the common nursing methods had a certain influence on miR-574-5p expression , HeLa reproduction and metastasis , and even cell cycle .
2004	influence	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Part of the common nursing methods had a certain influence on miR-574-5p expression , HeLa reproduction and metastasis , and even cell cycle .
1717	enhance	positive	mir-574	360.5536	386.5736	386.5736	miRNA		We showed thatmiR-184 significantly attenuated the metastasis of SCLC , whereas miR-574-5p enhanced it .
1717	enhance	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	We showed thatmiR-184 significantly attenuated the metastasis of SCLC , whereas miR-574-5p enhanced it .
799	regulate	positive	mir-574	360.5536	386.5736	386.5736	miRNA		Hsa-miR-574-5p negatively regulates MACC-1 expression to suppress colorectal cancer liver metastasis .
799	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Hsa-miR-574-5p negatively regulates MACC-1 expression to suppress colorectal cancer liver metastasis .
798	regulate	positive	mir-574	360.5536	386.5736	386.5736	miRNA		Hsa-miR-574-5p negatively regulates MACC-1 expression to suppress colorectal cancer liver metastasis .
798	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Hsa-miR-574-5p negatively regulates MACC-1 expression to suppress colorectal cancer liver metastasis .
797	suppress	negative	mir-196a/	359.8274	391.8273	391.8273	miRNA		Together , miR-196a/-196b inhibitory oligonucleotides or overexpression of the radixin may thus have therapeutic potential in suppressing GC metastasis .
797	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Together , miR-196a/-196b inhibitory oligonucleotides or overexpression of the radixin may thus have therapeutic potential in suppressing GC metastasis .
796	promote	positive	microrna-196a/	359.1639	397.0893	397.0893	miRNA		MicroRNA-196a/-196b promote cell metastasis via negative regulation of radixin in human gastric cancer .
796	promote	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	MicroRNA-196a/-196b promote cell metastasis via negative regulation of radixin in human gastric cancer .
1915	suppress	negative	microrna-200b	358.5634	402.3588	402.3588	miRNA		MicroRNA-200b suppresses cell invasion and metastasis by inhibiting the epithelial-mesenchymal transition in cervical carcinoma .
1915	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-200b suppresses cell invasion and metastasis by inhibiting the epithelial-mesenchymal transition in cervical carcinoma .
1914	suppress	negative	microrna-200b	358.5634	402.3588	402.3588	miRNA		MicroRNA-200b suppresses cell invasion and metastasis by inhibiting the epithelial-mesenchymal transition in cervical carcinoma .
1914	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-200b suppresses cell invasion and metastasis by inhibiting the epithelial-mesenchymal transition in cervical carcinoma .
1755	inhibit	negative	microrna-200b	358.5634	402.3588	402.3588	miRNA		MicroRNA-200b inhibits the growth and metastasis of glioma cells via targeting ZEB2 .
1755	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-200b inhibits the growth and metastasis of glioma cells via targeting ZEB2 .
787	suppress	negative	microrna-200b	358.5634	402.3588	402.3588	miRNA		MicroRNA-200b targets protein kinase C帢 and suppresses triple-negative breast cancer metastasis .
787	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-200b targets protein kinase C帢 and suppresses triple-negative breast cancer metastasis .
784	upregulate	positive	mir-639	358.0258	407.6351	407.6351	miRNA		Furthermore , we provided evidence to demonstrate that up-regulation of miR-639 contributes breast cancer invasion and metastasis .
784	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Furthermore , we provided evidence to demonstrate that up-regulation of miR-639 contributes breast cancer invasion and metastasis .
1859	downregulate	negative	mir-132	357.5513	412.9175	412.9175	miRNA		MiR-132 was significantly down-regulated in primary CRC tissues with liver metastasis and liver metastatic lesions compared to primary lesions without liver metastasis .
1859	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-132 was significantly down-regulated in primary CRC tissues with liver metastasis and liver metastatic lesions compared to primary lesions without liver metastasis .
1573	inhibit	negative	mir-132	357.5513	412.9175	412.9175	miRNA		In conclusion , miR ? 132 inhibited cell growth and metastasis in osteosarcoma cells by downregulation of Sox4 , and knockdown of Sox4 was essential for the miR-132-inhibited cell growth and metastasis in osteosarcoma cells .
1573	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	In conclusion , miR ? 132 inhibited cell growth and metastasis in osteosarcoma cells by downregulation of Sox4 , and knockdown of Sox4 was essential for the miR-132-inhibited cell growth and metastasis in osteosarcoma cells .
1572	control	neutral	mir-132	357.5513	412.9175	412.9175	miRNA		miR-132 mimic , miR ? 132 inhibitor and negative control were transfected into osteosarcoma cells and the effects of miR ? 132 on the cell growth and metastasis were investigated .
1572	control	neutral	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	miR-132 mimic , miR ? 132 inhibitor and negative control were transfected into osteosarcoma cells and the effects of miR ? 132 on the cell growth and metastasis were investigated .
1068	suppress	negative	mir-132	357.5513	412.9175	412.9175	miRNA		Taken together , our data demonstrate a critical role of miR-132 in prohibiting cell proliferation , invasion , migration and metastasis in breast cancer through direct suppression of HN1 , supporting the potential utility of miR-132 as a novel therapeutic strategy against breast cancer .
1068	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Taken together , our data demonstrate a critical role of miR-132 in prohibiting cell proliferation , invasion , migration and metastasis in breast cancer through direct suppression of HN1 , supporting the potential utility of miR-132 as a novel therapeutic strategy against breast cancer .
783	downregulate	negative	mir-132	357.5513	412.9175	412.9175	miRNA		Down-regulation of miR-132 was associated with tumor size ( P = 0.016 ) , distant metastasis ( P = 0.002 ) , and TNM stage ( P = 0.020 ) in CRC patients .
783	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Down-regulation of miR-132 was associated with tumor size ( P = 0.016 ) , distant metastasis ( P = 0.002 ) , and TNM stage ( P = 0.020 ) in CRC patients .
782	inhibit	negative	mir-132	357.5513	412.9175	412.9175	miRNA		miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting ZEB2 .
782	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting ZEB2 .
780	promote	positive	microrna-17	357.1399	418.2052	418.2052	miRNA		MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression .
780	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression .
1695	downregulate	negative	mir-186	356.7917	423.4974	423.4974	miRNA		In the present study , we found that the expression level of miR-186 was downregulated in ESCC in comparison with the adjacent normal tissues and was significantly associated with differentiation level , TNM stage , and lymph node metastasis of ESCC .
1695	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In the present study , we found that the expression level of miR-186 was downregulated in ESCC in comparison with the adjacent normal tissues and was significantly associated with differentiation level , TNM stage , and lymph node metastasis of ESCC .
1694	downregulate	negative	mir-186	356.7917	423.4974	423.4974	miRNA		In the present study , we found that the expression level of miR-186 was downregulated in ESCC in comparison with the adjacent normal tissues and was significantly associated with differentiation level , TNM stage , and lymph node metastasis of ESCC .
1694	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In the present study , we found that the expression level of miR-186 was downregulated in ESCC in comparison with the adjacent normal tissues and was significantly associated with differentiation level , TNM stage , and lymph node metastasis of ESCC .
1530	suppress	negative	mir-186	356.7917	423.4974	423.4974	miRNA		MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1 .
1530	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1 .
1209	control	neutral	mir-186	356.7917	423.4974	423.4974	miRNA		miR-186 was over-expressed in PDAC patients compared with controls , especially in patients with large tumors ( > 2 cm ) , lymph node metastasis , or short-term survival ( < 24 months ) .
1209	control	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-186 was over-expressed in PDAC patients compared with controls , especially in patients with large tumors ( > 2 cm ) , lymph node metastasis , or short-term survival ( < 24 months ) .
767	suppress	negative	mir-186	356.7917	423.4974	423.4974	miRNA		MiR-186 targets ROCK1 to suppress the growth and metastasis of NSCLC cells .
767	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-186 targets ROCK1 to suppress the growth and metastasis of NSCLC cells .
1555	upregulate	positive	mir-300	356.5067	428.7934	428.7934	miRNA		On the other hand , miR-300 expression was significantly upregulated in OS bone tissue than noncancerous bone tissues.Our findings suggested that a lower expression level of miR-125b was linked to advanced clinical stage ( P ? = ? 0.005 ) , metastasis ( P ? = ? 0.004 ) , and a large size of tumor ( P ? = ? 0.023 ) .
1555	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	On the other hand , miR-300 expression was significantly upregulated in OS bone tissue than noncancerous bone tissues.Our findings suggested that a lower expression level of miR-125b was linked to advanced clinical stage ( P ? = ? 0.005 ) , metastasis ( P ? = ? 0.004 ) , and a large size of tumor ( P ? = ? 0.023 ) .
1553	upregulate	positive	mir-300	356.5067	428.7934	428.7934	miRNA		Upregulation of miR-300 and downregulation of miR-125b act as potential predictor biomarkers in progression , metastasis , and poor prognosis of osteosarcoma .
1553	upregulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Upregulation of miR-300 and downregulation of miR-125b act as potential predictor biomarkers in progression , metastasis , and poor prognosis of osteosarcoma .
765	regulate	positive	mir-300	356.5067	428.7934	428.7934	miRNA		MiR-300 may negatively regulate EMT by direct targeting Twist and therefore inhibit cancer cell invasion and metastasis , which implicates miR-300 as an attractive candidate for cancer therapy .
765	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-300 may negatively regulate EMT by direct targeting Twist and therefore inhibit cancer cell invasion and metastasis , which implicates miR-300 as an attractive candidate for cancer therapy .
764	regulate	positive	mir-300	356.5067	428.7934	428.7934	miRNA		MiR-300 may negatively regulate EMT by direct targeting Twist and therefore inhibit cancer cell invasion and metastasis , which implicates miR-300 as an attractive candidate for cancer therapy .
764	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-300 may negatively regulate EMT by direct targeting Twist and therefore inhibit cancer cell invasion and metastasis , which implicates miR-300 as an attractive candidate for cancer therapy .
763	inhibit	negative	mir-300	356.5067	428.7934	428.7934	miRNA		miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer .
763	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer .
757	suppress	negative	mirna-34a	356.2851	434.0924	434.0924	miRNA		miRNA-34a suppresses cell proliferation and metastasis by targeting CD44 in human renal carcinoma cells .
757	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miRNA-34a suppresses cell proliferation and metastasis by targeting CD44 in human renal carcinoma cells .
1875	effect	neutral	microrna-206	356.1267	439.3936	439.3936	miRNA		Mechanism of Regulatory Effect of MicroRNA-206 on Connexin 43 in Distant Metastasis of Breast Cancer .
1875	effect	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Mechanism of Regulatory Effect of MicroRNA-206 on Connexin 43 in Distant Metastasis of Breast Cancer .
750	suppress	negative	microrna-206	356.1267	439.3936	439.3936	miRNA		MicroRNA-206 suppresses gastric cancer cell growth and metastasis .
750	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	MicroRNA-206 suppresses gastric cancer cell growth and metastasis .
747	downregulate	negative	mir-142	356.0317	444.6964	444.6964	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
747	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
746	downregulate	negative	mir-142	356.0317	444.6964	444.6964	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
746	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
745	downregulate	negative	mir-191	356	450	450	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
745	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
744	downregulate	negative	mir-191	356	450	450	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
744	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
1673	upregulate	positive	mir-30c	356.0317	455.3036	455.3036	miRNA		In endometrial cancer cells , expression levels of miRNAs including miR-185 , miR-210 and miR-423 are upregulated and those of miR-let7e , miR-30c and miR-221 are downregulated compared to normal tissues , and these miRNAs are involved in carcinogenesis , invasion and metastasis .
1673	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In endometrial cancer cells , expression levels of miRNAs including miR-185 , miR-210 and miR-423 are upregulated and those of miR-let7e , miR-30c and miR-221 are downregulated compared to normal tissues , and these miRNAs are involved in carcinogenesis , invasion and metastasis .
1475	control	neutral	mir-30c	356.0317	455.3036	455.3036	miRNA		Based on the results obtained in the last decade , some miRNAs are emerging as biomarkers of BC for diagnosis ( i.e. , miR-9 , miR-10b , and miR-17-5p ) , prognosis ( i.e. , miR-148a and miR-335 ) , and prediction of therapeutic outcomes ( i.e. , miR-30c , miR-187 , and miR-339-5p ) and have important roles in the control of BC hallmark functions such as invasion , metastasis , proliferation , resting death , apoptosis , and genomic instability .
1475	control	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Based on the results obtained in the last decade , some miRNAs are emerging as biomarkers of BC for diagnosis ( i.e. , miR-9 , miR-10b , and miR-17-5p ) , prognosis ( i.e. , miR-148a and miR-335 ) , and prediction of therapeutic outcomes ( i.e. , miR-30c , miR-187 , and miR-339-5p ) and have important roles in the control of BC hallmark functions such as invasion , metastasis , proliferation , resting death , apoptosis , and genomic instability .
1424	regulate	positive	mir-30c	356.0317	455.3036	455.3036	miRNA		miR-30c has been reported to act as a tumor suppressor and negatively regulate cancer metastasis by directly targeting metastasis associated genes ; however , miR-30c has also been shown to promote the invasion of metastatic breast cancer cells , suggesting that miR-30c might be involved in cancer cell metastasis in different ways via targeting different genes .
1424	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-30c has been reported to act as a tumor suppressor and negatively regulate cancer metastasis by directly targeting metastasis associated genes ; however , miR-30c has also been shown to promote the invasion of metastatic breast cancer cells , suggesting that miR-30c might be involved in cancer cell metastasis in different ways via targeting different genes .
1241	inhibit	negative	mir-30c	356.0317	455.3036	455.3036	miRNA		Consistently , stable over-expression of miR-30c inhibited the growth and lung metastasis of colon cancer cell xenografts in vivo .
1241	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Consistently , stable over-expression of miR-30c inhibited the growth and lung metastasis of colon cancer cell xenografts in vivo .
1240	inhibit	negative	mir-30c	356.0317	455.3036	455.3036	miRNA		Consistently , stable over-expression of miR-30c inhibited the growth and lung metastasis of colon cancer cell xenografts in vivo .
1240	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Consistently , stable over-expression of miR-30c inhibited the growth and lung metastasis of colon cancer cell xenografts in vivo .
1002	suppress	negative	mir-30c	356.0317	455.3036	455.3036	miRNA		Specifically , miR-30c , a FHIT-upregulated microRNA , contributes to FHIT function in suppression of EMT and metastasis by directly targeting metastasis genes Metadherin ( MTDH ) , High-mobility group AT-hook 2 ( HMGA2 ) , and the mesenchymal markers , Vimentin ( VIM ) and Fibronectin ( FN1 ) , in human lung cancer .
1002	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Specifically , miR-30c , a FHIT-upregulated microRNA , contributes to FHIT function in suppression of EMT and metastasis by directly targeting metastasis genes Metadherin ( MTDH ) , High-mobility group AT-hook 2 ( HMGA2 ) , and the mesenchymal markers , Vimentin ( VIM ) and Fibronectin ( FN1 ) , in human lung cancer .
741	downregulate	negative	mir-30c	356.0317	455.3036	455.3036	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
741	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
740	downregulate	negative	mir-30c	356.0317	455.3036	455.3036	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
740	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
729	downregulate	negative	mir-3196	356.1267	460.6064	460.6064	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
729	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
728	downregulate	negative	mir-3196	356.1267	460.6064	460.6064	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
728	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
1975	promote	positive	mir-421	356.2851	465.9076	465.9076	miRNA		Overexpression of miR-421 promoted metastasis , inhibited apoptosis , and induced cisplatin resistance in gastric cancer in vivo and in vitro .
1975	promote	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	Overexpression of miR-421 promoted metastasis , inhibited apoptosis , and induced cisplatin resistance in gastric cancer in vivo and in vitro .
725	downregulate	negative	mir-421	356.2851	465.9076	465.9076	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
725	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
724	downregulate	negative	mir-421	356.2851	465.9076	465.9076	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
724	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
719	downregulate	negative	mir-3923	356.5067	471.2066	471.2066	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
719	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
718	downregulate	negative	mir-3923	356.5067	471.2066	471.2066	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
718	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
715	regulate	positive	mir-888	356.7917	476.5026	476.5026	miRNA		In conclusion , miR-888 maintains SP properties and regulates EMT and metastasis in MCF-7 cells , potentially by targeting E-Cadherin expression .
715	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In conclusion , miR-888 maintains SP properties and regulates EMT and metastasis in MCF-7 cells , potentially by targeting E-Cadherin expression .
714	regulate	positive	mir-888	356.7917	476.5026	476.5026	miRNA		In conclusion , miR-888 maintains SP properties and regulates EMT and metastasis in MCF-7 cells , potentially by targeting E-Cadherin expression .
714	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In conclusion , miR-888 maintains SP properties and regulates EMT and metastasis in MCF-7 cells , potentially by targeting E-Cadherin expression .
713	upregulate	positive	mir-888	356.7917	476.5026	476.5026	miRNA		miR-888 was found in our previous study to be up-regulated in SP cells and predicted to target E-Cadherin directly , indicating a potential role in maintaining SP properties and regulating the epithelial-mesenchymal transition ( EMT ) and cancer metastasis .
713	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-888 was found in our previous study to be up-regulated in SP cells and predicted to target E-Cadherin directly , indicating a potential role in maintaining SP properties and regulating the epithelial-mesenchymal transition ( EMT ) and cancer metastasis .
712	upregulate	positive	mir-888	356.7917	476.5026	476.5026	miRNA		miR-888 was found in our previous study to be up-regulated in SP cells and predicted to target E-Cadherin directly , indicating a potential role in maintaining SP properties and regulating the epithelial-mesenchymal transition ( EMT ) and cancer metastasis .
712	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-888 was found in our previous study to be up-regulated in SP cells and predicted to target E-Cadherin directly , indicating a potential role in maintaining SP properties and regulating the epithelial-mesenchymal transition ( EMT ) and cancer metastasis .
711	regulate	positive	mir-888	356.7917	476.5026	476.5026	miRNA		MiR-888 regulates side population properties and cancer metastasis in breast cancer cells .
711	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-888 regulates side population properties and cancer metastasis in breast cancer cells .
702	regulate	positive	mir182	357.1399	481.7948	481.7948	miRNA		MicroRNA-182 ( miR182 ) overexpression contributes to aggressive ovarian cancer , largely by its negative regulation of multiple tumor suppressor genes involved in tumor growth , invasion , metastasis , and DNA instability .
702	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-182 ( miR182 ) overexpression contributes to aggressive ovarian cancer , largely by its negative regulation of multiple tumor suppressor genes involved in tumor growth , invasion , metastasis , and DNA instability .
700	promote	positive	mir-331	357.5513	487.0825	487.0825	miRNA		miR-331-3p promotes proliferation and EMT-mediated metastasis of HCC through suppression of PHLPP-mediated dephosphorylation of AKT .
700	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-331-3p promotes proliferation and EMT-mediated metastasis of HCC through suppression of PHLPP-mediated dephosphorylation of AKT .
699	inhibit	negative	mir-331	357.5513	487.0825	487.0825	miRNA		Finally , inhibition of miR-331-3p through a jetPEI-mediated delivery of anti-miR-331-3p vector resulted in marked inhibition of proliferation and metastasis of HCC in xenograft mice .
699	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Finally , inhibition of miR-331-3p through a jetPEI-mediated delivery of anti-miR-331-3p vector resulted in marked inhibition of proliferation and metastasis of HCC in xenograft mice .
698	promote	positive	mir-331	357.5513	487.0825	487.0825	miRNA		We provided both in vivo and in vitro evidence demonstrating that miR-331-3p promoted proliferation and metastasis of HCC cells .
698	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	We provided both in vivo and in vitro evidence demonstrating that miR-331-3p promoted proliferation and metastasis of HCC cells .
697	promote	positive	microrna-331	358.0258	492.3649	492.3649	miRNA		MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase .
697	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase .
683	suppress	negative	mir-141/zeb	358.5634	497.6412	497.6412	miRNA		Honokiol suppresses renal cancer cells ' metastasis via dual-blocking epithelial-mesenchymal transition and cancer stem cell properties through modulating miR-141/ZEB2 signaling .
683	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Honokiol suppresses renal cancer cells ' metastasis via dual-blocking epithelial-mesenchymal transition and cancer stem cell properties through modulating miR-141/ZEB2 signaling .
682	promote	positive	mir-100/ago	359.1639	502.9107	502.9107	miRNA		Taken together , our findings indicate that loss of miR-100 promotes the metastatic ability of prostate cancer cells at least partially by upregulating AGO2 expression through modulating migration , invasion , EMT and stemness of cancer cells , and suggest that miR-100/AGO2 may play an important role in regulating the metastasis of prostate cancer and is a potential target of prevention and therapy .
682	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Taken together , our findings indicate that loss of miR-100 promotes the metastatic ability of prostate cancer cells at least partially by upregulating AGO2 expression through modulating migration , invasion , EMT and stemness of cancer cells , and suggest that miR-100/AGO2 may play an important role in regulating the metastasis of prostate cancer and is a potential target of prevention and therapy .
665	inhibit	negative	mirna-200	359.8274	508.1727	508.1727	miRNA		The miRNA-200 family , which is frequently expressed at low levels in triple negative breast cancers , inhibits metastasis by blocking the epithelial-mesenchymal transition .
665	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The miRNA-200 family , which is frequently expressed at low levels in triple negative breast cancers , inhibits metastasis by blocking the epithelial-mesenchymal transition .
1782	promote	positive	mir-215	360.5536	513.4264	513.4264	miRNA		Ectopic expression of miR-215 in GES-1 and HGC-27 cells ( low miR-215 expression ) promoted cell growth , migration , invasion , and metastasis , and these were reversed in NCI-N87 cells ( high miR-215 expression ) after miR-215 downregulation .
1782	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Ectopic expression of miR-215 in GES-1 and HGC-27 cells ( low miR-215 expression ) promoted cell growth , migration , invasion , and metastasis , and these were reversed in NCI-N87 cells ( high miR-215 expression ) after miR-215 downregulation .
1453	upregulate	positive	mir-215	360.5536	513.4264	513.4264	miRNA		By contrast , the expression of miR-215 was significantly upregulated in the gastric cancer tissues , and its expression level was correlated with tumor differentiation , TNM stage and lymph-node metastasis ( P < 0.05 ) .
1453	upregulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	By contrast , the expression of miR-215 was significantly upregulated in the gastric cancer tissues , and its expression level was correlated with tumor differentiation , TNM stage and lymph-node metastasis ( P < 0.05 ) .
1452	upregulate	positive	mir-215	360.5536	513.4264	513.4264	miRNA		By contrast , the expression of miR-215 was significantly upregulated in the gastric cancer tissues , and its expression level was correlated with tumor differentiation , TNM stage and lymph-node metastasis ( P < 0.05 ) .
1452	upregulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	By contrast , the expression of miR-215 was significantly upregulated in the gastric cancer tissues , and its expression level was correlated with tumor differentiation , TNM stage and lymph-node metastasis ( P < 0.05 ) .
821	upregulate	positive	mir-215	360.5536	513.4264	513.4264	miRNA		The up-regulation of miR-215 or -192 was related with the clinical characteristics of gastric cancer , such as lymph node metastasis .
821	upregulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	The up-regulation of miR-215 or -192 was related with the clinical characteristics of gastric cancer , such as lymph node metastasis .
656	effect	neutral	mir-215	360.5536	513.4264	513.4264	miRNA		Moreover , cervical cancer HeLa cells overexpressing miR-215 ( HeLa-miR-215 ) were constructed and subcutaneously injected into the nude mice to examine the effect of miR-215 on tumor growth and metastasis in vivo .
656	effect	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Moreover , cervical cancer HeLa cells overexpressing miR-215 ( HeLa-miR-215 ) were constructed and subcutaneously injected into the nude mice to examine the effect of miR-215 on tumor growth and metastasis in vivo .
1134	suppress	negative	mir-483	361.3426	518.671	518.671	miRNA		Combinatorial therapeutic viral delivery of miR-551a and miR-483-5p through single-dose adeno-associated viral ( AAV ) delivery significantly suppressed colon cancer metastasis , as did CKB inhibition with a small-molecule inhibitor .
1134	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Combinatorial therapeutic viral delivery of miR-551a and miR-483-5p through single-dose adeno-associated viral ( AAV ) delivery significantly suppressed colon cancer metastasis , as did CKB inhibition with a small-molecule inhibitor .
653	promote	positive	mir-483	361.3426	518.671	518.671	miRNA		miR-483-5p promotes invasion and metastasis of lung adenocarcinoma by targeting RhoGDI1 and ALCAM .
653	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-483-5p promotes invasion and metastasis of lung adenocarcinoma by targeting RhoGDI1 and ALCAM .
652	regulate	positive	microrna-199a	362.1942	523.9059	523.9059	miRNA		Dynamin 2 along with microRNA-199a reciprocally regulate hypoxia-inducible factors and ovarian cancer metastasis .
652	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Dynamin 2 along with microRNA-199a reciprocally regulate hypoxia-inducible factors and ovarian cancer metastasis .
1440	regulate	positive	mir-612	363.1082	529.1302	529.1302	miRNA		miR-612 negatively regulates colorectal cancer growth and metastasis by targeting AKT2 .
1440	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-612 negatively regulates colorectal cancer growth and metastasis by targeting AKT2 .
651	inhibit	negative	mir-612	363.1082	529.1302	529.1302	miRNA		AKT2 was confirmed to be a direct target of miR-612 , through which the epithelial-mesenchymal transition ( EMT ) and metastasis of HCC were inhibited .
651	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	AKT2 was confirmed to be a direct target of miR-612 , through which the epithelial-mesenchymal transition ( EMT ) and metastasis of HCC were inhibited .
650	inhibit	negative	mir-612	363.1082	529.1302	529.1302	miRNA		AKT2 was confirmed to be a direct target of miR-612 , through which the epithelial-mesenchymal transition ( EMT ) and metastasis of HCC were inhibited .
650	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	AKT2 was confirmed to be a direct target of miR-612 , through which the epithelial-mesenchymal transition ( EMT ) and metastasis of HCC were inhibited .
1983	induction	positive	mir-18a	364.0846	534.3431	534.3431	miRNA		Taken together our results indicate that miR-18a can act as an inhibitor for liver metastasis through induction of M1 macrophages .
1983	induction	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Taken together our results indicate that miR-18a can act as an inhibitor for liver metastasis through induction of M1 macrophages .
1982	mediate	neutral	mir-18a	364.0846	534.3431	534.3431	miRNA		We found that miR-18a encapsulated in grapefruit-derived nanovector ( GNV ) mediated inhibition of liver metastasis that is dependent upon the induction of M1 ( F4/80+IFN帠+IL-12+ ) macrophages ; depletion of macrophages eliminated its anti-metastasis effect .
1982	mediate	neutral	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	We found that miR-18a encapsulated in grapefruit-derived nanovector ( GNV ) mediated inhibition of liver metastasis that is dependent upon the induction of M1 ( F4/80+IFN帠+IL-12+ ) macrophages ; depletion of macrophages eliminated its anti-metastasis effect .
1981	induction	positive	mir-18a	364.0846	534.3431	534.3431	miRNA		Grapefruit-derived nanovectors deliver miR-18a for treatment of liver metastasis of colon cancer by induction of M1 macrophages .
1981	induction	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Grapefruit-derived nanovectors deliver miR-18a for treatment of liver metastasis of colon cancer by induction of M1 macrophages .
877	repress	negative	mir-18a	364.0846	534.3431	534.3431	miRNA		The results of this study reveal a novel role for miR-18a in targeting HIF1A and repressing metastasis of basal-like breast tumors .
877	repress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The results of this study reveal a novel role for miR-18a in targeting HIF1A and repressing metastasis of basal-like breast tumors .
876	inhibit	negative	mir-18a	364.0846	534.3431	534.3431	miRNA		Ectopic expression of miR-18a , a MIR17HG family member , in a metastatic variant of MDA-MB-231 cells reduced primary tumor growth and lung metastasis , whereas miR-18a inhibition in the parental cells promoted tumor growth and lung metastasis .
876	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Ectopic expression of miR-18a , a MIR17HG family member , in a metastatic variant of MDA-MB-231 cells reduced primary tumor growth and lung metastasis , whereas miR-18a inhibition in the parental cells promoted tumor growth and lung metastasis .
875	effect	neutral	mir-18a	364.0846	534.3431	534.3431	miRNA		miRNA-mRNA interactions ( AGO2 immunoprecipitation and 3 ' untranslated region Luciferase reporter assays ) , gene expression ( quantitative PCR and microarray ) , cell migration and invasion , and cell growth were assessed under normoxic or hypoxic conditions , complemented by orthotopic xenograft of tumor cells to the mammary fat pad to investigate the effect of modulating miR-18a expression on primary tumor growth and lung metastasis .
875	effect	neutral	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	miRNA-mRNA interactions ( AGO2 immunoprecipitation and 3 ' untranslated region Luciferase reporter assays ) , gene expression ( quantitative PCR and microarray ) , cell migration and invasion , and cell growth were assessed under normoxic or hypoxic conditions , complemented by orthotopic xenograft of tumor cells to the mammary fat pad to investigate the effect of modulating miR-18a expression on primary tumor growth and lung metastasis .
874	regulate	positive	mir-18a	364.0846	534.3431	534.3431	miRNA		In this study , we investigated the function of miR-18a in regulating breast cancer metastasis through the hypoxia-inducible factor 1帢 ( HIF1A ) -dependent hypoxic response .
874	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In this study , we investigated the function of miR-18a in regulating breast cancer metastasis through the hypoxia-inducible factor 1帢 ( HIF1A ) -dependent hypoxic response .
807	promote	positive	mir-18a	364.0846	534.3431	534.3431	miRNA		These findings suggest that miR-18a expression can promote proliferation and metastasis of nasopharyngeal carcinoma cells and that these activities may occur through its regulation of DICER1 .
807	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	These findings suggest that miR-18a expression can promote proliferation and metastasis of nasopharyngeal carcinoma cells and that these activities may occur through its regulation of DICER1 .
806	control	neutral	mir-18a	364.0846	534.3431	534.3431	miRNA		In situ hybridization revealed that miR-18a was more highly expressed in nasopharyngeal carcinoma tissues than in control tissues ( P < 0.05 ) , and the overexpression correlated with clinical stage and lymph node metastasis ( P < 0.05 ) , but not with age and gender ( P > 0.05 ) .
806	control	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	In situ hybridization revealed that miR-18a was more highly expressed in nasopharyngeal carcinoma tissues than in control tissues ( P < 0.05 ) , and the overexpression correlated with clinical stage and lymph node metastasis ( P < 0.05 ) , but not with age and gender ( P > 0.05 ) .
805	downregulate	negative	mir-18a	364.0846	534.3431	534.3431	miRNA		miR-18a downregulates DICER1 and promotes proliferation and metastasis of nasopharyngeal carcinoma .
805	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-18a downregulates DICER1 and promotes proliferation and metastasis of nasopharyngeal carcinoma .
646	inhibit	negative	mir-18a	364.0846	534.3431	534.3431	miRNA		However , higher levels of the miR-17~92 cluster switched from PTEN to oncogenes , including Ctnnb1 ( ?] -catenin ) via miR-18a , which resulted in inhibition of tumor growth and metastasis .
646	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	However , higher levels of the miR-17~92 cluster switched from PTEN to oncogenes , including Ctnnb1 ( ?] -catenin ) via miR-18a , which resulted in inhibition of tumor growth and metastasis .
642	antagonize	negative	mir-19a/b	365.1232	539.5441	539.5441	miRNA		In conclusion , miR-17-92 cluster members miR-19a/b facilitated gastric cancer cell migration , invasion and metastasis through targeting the antagonist of c-Myc -- MXD1 , implicating a novel mechanism for the malignant phenotypes of gastric cancer .
642	antagonize	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	In conclusion , miR-17-92 cluster members miR-19a/b facilitated gastric cancer cell migration , invasion and metastasis through targeting the antagonist of c-Myc -- MXD1 , implicating a novel mechanism for the malignant phenotypes of gastric cancer .
640	downregulate	negative	mir-99a/b	366.2238	544.7323	544.7323	miRNA		Here , we showed that miR-99a and -99b ( miR-99a/b ) were down-regulated in human cervical cancer patient tissues and were negatively related with lymphatic metastasis .
640	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we showed that miR-99a and -99b ( miR-99a/b ) were down-regulated in human cervical cancer patient tissues and were negatively related with lymphatic metastasis .
639	downregulate	negative	mir-99a/b	366.2238	544.7323	544.7323	miRNA		Here , we showed that miR-99a and -99b ( miR-99a/b ) were down-regulated in human cervical cancer patient tissues and were negatively related with lymphatic metastasis .
639	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we showed that miR-99a and -99b ( miR-99a/b ) were down-regulated in human cervical cancer patient tissues and were negatively related with lymphatic metastasis .
636	inhibit	negative	let-7i	958.2072	864.8572	864.8572	miRNA		Introduction of let-7i to mutant p53 cells significantly inhibited migration , invasion and metastasis by repressing a network of oncogenes including E2F5 , LIN28B , MYC and NRAS .
636	inhibit	negative	myc	367.3863	549.907	549.907	Cancer	D007938	Introduction of let-7i to mutant p53 cells significantly inhibited migration , invasion and metastasis by repressing a network of oncogenes including E2F5 , LIN28B , MYC and NRAS .
635	inhibit	negative	let-7i	958.2072	864.8572	864.8572	miRNA		Introduction of let-7i to mutant p53 cells significantly inhibited migration , invasion and metastasis by repressing a network of oncogenes including E2F5 , LIN28B , MYC and NRAS .
635	inhibit	negative	myc	367.3863	549.907	549.907	Cancer	D007938	Introduction of let-7i to mutant p53 cells significantly inhibited migration , invasion and metastasis by repressing a network of oncogenes including E2F5 , LIN28B , MYC and NRAS .
630	induce	positive	mir-9s	368.6106	555.0674	555.0674	miRNA		miR-9s methylation which induces expression silencing is common in NSCLC cases without lymph nodal metastasis , suggesting that miR-9s are oncogenically involved in NSCLC carcinogenesis through the promotion of tumor metastasis .
630	induce	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-9s methylation which induces expression silencing is common in NSCLC cases without lymph nodal metastasis , suggesting that miR-9s are oncogenically involved in NSCLC carcinogenesis through the promotion of tumor metastasis .
629	induce	positive	mir-9s	368.6106	555.0674	555.0674	miRNA		miR-9s methylation which induces expression silencing is common in NSCLC cases without lymph nodal metastasis , suggesting that miR-9s are oncogenically involved in NSCLC carcinogenesis through the promotion of tumor metastasis .
629	induce	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-9s methylation which induces expression silencing is common in NSCLC cases without lymph nodal metastasis , suggesting that miR-9s are oncogenically involved in NSCLC carcinogenesis through the promotion of tumor metastasis .
621	affect	neutral	mir-202	369.8964	560.2128	560.2128	miRNA		MiR-202 and miR-9 are potential key factors affecting the metastasis of OS and CALD1 and STX1A may be possible targets beneficial for the treatment of metastatic OS .
621	affect	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-202 and miR-9 are potential key factors affecting the metastasis of OS and CALD1 and STX1A may be possible targets beneficial for the treatment of metastatic OS .
611	promote	positive	mir-200c/znf	371.2435	565.3425	565.3425	miRNA		Therefore , our study unraveled nested regulatory circuits of miR-200c/ZEB1 and miR-200c/ZNF217/TGF-?] /ZEB1 in synergistically promoting trastuzumab resistance and metastasis of breast cancer cells .
611	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Therefore , our study unraveled nested regulatory circuits of miR-200c/ZEB1 and miR-200c/ZNF217/TGF-?] /ZEB1 in synergistically promoting trastuzumab resistance and metastasis of breast cancer cells .
610	promote	positive	mir-200c/zeb	372.6519	570.4557	570.4557	miRNA		Therefore , our study unraveled nested regulatory circuits of miR-200c/ZEB1 and miR-200c/ZNF217/TGF-?] /ZEB1 in synergistically promoting trastuzumab resistance and metastasis of breast cancer cells .
610	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Therefore , our study unraveled nested regulatory circuits of miR-200c/ZEB1 and miR-200c/ZNF217/TGF-?] /ZEB1 in synergistically promoting trastuzumab resistance and metastasis of breast cancer cells .
1646	inhibit	negative	mir-149	374.1212	575.5518	575.5518	miRNA		In vivo studies confirm inhibition of HCC metastasis by miR-149 .
1646	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In vivo studies confirm inhibition of HCC metastasis by miR-149 .
1645	downregulate	negative	mir-149	374.1212	575.5518	575.5518	miRNA		Here , we demonstrated that miR-149 was significantly down-regulated in HCC , which was correlated with distant metastasis and TNM stage with statistical significance .
1645	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we demonstrated that miR-149 was significantly down-regulated in HCC , which was correlated with distant metastasis and TNM stage with statistical significance .
1644	downregulate	negative	mir-149	374.1212	575.5518	575.5518	miRNA		Here , we demonstrated that miR-149 was significantly down-regulated in HCC , which was correlated with distant metastasis and TNM stage with statistical significance .
1644	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we demonstrated that miR-149 was significantly down-regulated in HCC , which was correlated with distant metastasis and TNM stage with statistical significance .
1643	repress	negative	mir-149	374.1212	575.5518	575.5518	miRNA		miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F .
1643	repress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F .
1148	downregulate	negative	mir-149	374.1212	575.5518	575.5518	miRNA		miR-149 was significantly downregulated in CRC tissues , and low miR-149 expression was observed to be significantly correlated with lymph node or distant metastasis and advanced TNM stage of CRC patients .
1148	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-149 was significantly downregulated in CRC tissues , and low miR-149 expression was observed to be significantly correlated with lymph node or distant metastasis and advanced TNM stage of CRC patients .
1147	downregulate	negative	mir-149	374.1212	575.5518	575.5518	miRNA		miR-149 was significantly downregulated in CRC tissues , and low miR-149 expression was observed to be significantly correlated with lymph node or distant metastasis and advanced TNM stage of CRC patients .
1147	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-149 was significantly downregulated in CRC tissues , and low miR-149 expression was observed to be significantly correlated with lymph node or distant metastasis and advanced TNM stage of CRC patients .
605	suppress	negative	mir-149	374.1212	575.5518	575.5518	miRNA		We conclude that miR-149 suppresses breast cancer cell migration/invasion and metastasis by targeting GIT1 , suggesting potential applications of the miR-149-GIT1 pathway in clinical diagnosis and therapeutics .
605	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We conclude that miR-149 suppresses breast cancer cell migration/invasion and metastasis by targeting GIT1 , suggesting potential applications of the miR-149-GIT1 pathway in clinical diagnosis and therapeutics .
604	suppress	negative	microrna-149	375.6513	580.6299	580.6299	miRNA		MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis .
604	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis .
1711	promote	positive	mir-93	377.2419	585.6895	585.6895	miRNA		Considering that the most devastating aspect of lung cancer is metastasis , which can be promoted by transforming growth factor-?] ( TGF-?] ) -induced epithelial-to-mesenchymal transition ( EMT ) , we sought to determine whether miR-93 is involved in this process .
1711	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Considering that the most devastating aspect of lung cancer is metastasis , which can be promoted by transforming growth factor-?] ( TGF-?] ) -induced epithelial-to-mesenchymal transition ( EMT ) , we sought to determine whether miR-93 is involved in this process .
1710	promote	positive	mir-93	377.2419	585.6895	585.6895	miRNA		Considering that the most devastating aspect of lung cancer is metastasis , which can be promoted by transforming growth factor-?] ( TGF-?] ) -induced epithelial-to-mesenchymal transition ( EMT ) , we sought to determine whether miR-93 is involved in this process .
1710	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Considering that the most devastating aspect of lung cancer is metastasis , which can be promoted by transforming growth factor-?] ( TGF-?] ) -induced epithelial-to-mesenchymal transition ( EMT ) , we sought to determine whether miR-93 is involved in this process .
956	promote	positive	mir-93	377.2419	585.6895	585.6895	miRNA		The potentials of proliferation , invasion , and metastasis in breast cancer MCF-7 cells were promoted by ectopic transfection of miR-93 .
956	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The potentials of proliferation , invasion , and metastasis in breast cancer MCF-7 cells were promoted by ectopic transfection of miR-93 .
603	activate	positive	mir-93	377.2419	585.6895	585.6895	miRNA		Moreover , miR-93 resulted in the attenuation of Smad-dependent TGF-?] signaling and the activation of PI3K/Akt pathway by suppressing TGF?] R2 , further promoting NPC cell uncontrolled growth , invasion , metastasis and EMT-like process .
603	activate	positive	npc	744.4573	890.5122	890.5122	Cancer	D010181	Moreover , miR-93 resulted in the attenuation of Smad-dependent TGF-?] signaling and the activation of PI3K/Akt pathway by suppressing TGF?] R2 , further promoting NPC cell uncontrolled growth , invasion , metastasis and EMT-like process .
602	induce	positive	mir-208	378.8929	590.7296	590.7296	miRNA		miR-208 induces epithelial to mesenchymal transition of pancreatic cancer cell line BxPC3 by activating AKT/GSK-3?] /snail signaling pathway and thereby promotes cell metastasis and invasion .
602	induce	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-208 induces epithelial to mesenchymal transition of pancreatic cancer cell line BxPC3 by activating AKT/GSK-3?] /snail signaling pathway and thereby promotes cell metastasis and invasion .
601	promote	positive	mir-208	378.8929	590.7296	590.7296	miRNA		miR-208-induced epithelial to mesenchymal transition of pancreatic cancer cells promotes cell metastasis and invasion .
601	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-208-induced epithelial to mesenchymal transition of pancreatic cancer cells promotes cell metastasis and invasion .
1586	upregulate	positive	mir-30b	380.6039	595.7496	595.7496	miRNA		Up-regulation of miR-30b or down-regulation of Cthrc1 had potential significance in the invasion and metastasis of NSCLC .
1586	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Up-regulation of miR-30b or down-regulation of Cthrc1 had potential significance in the invasion and metastasis of NSCLC .
1538	inhibit	negative	mir-30b	380.6039	595.7496	595.7496	miRNA		To elucidate the potential biological role of miR-30b in gastric cancer and investigate the underlying molecular mechanisms of miR-30b to inhibit metastasis of gastric cancer cells .
1538	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	To elucidate the potential biological role of miR-30b in gastric cancer and investigate the underlying molecular mechanisms of miR-30b to inhibit metastasis of gastric cancer cells .
781	regulate	positive	mir-30b	380.6039	595.7496	595.7496	miRNA		Decreased miR-30b-5p expression by DNMT1 methylation regulation involved in gastric cancer metastasis .
781	regulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	Decreased miR-30b-5p expression by DNMT1 methylation regulation involved in gastric cancer metastasis .
597	regulate	positive	mir-30b	380.6039	595.7496	595.7496	miRNA		In the present study , we show that miR-30b is an important regulator in human CRC migration and invasion , which are vital steps in CRC liver metastasis .
597	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In the present study , we show that miR-30b is an important regulator in human CRC migration and invasion , which are vital steps in CRC liver metastasis .
593	inhibit	negative	mir-10b/hoxd	382.3748	600.7489	600.7489	miRNA		Targeting these novel strategies , inhibition of miR-10b/KLF4/E-cadherin axis and miR-10b/HOXD10/MMP14 axis may be helpful as a therapeutic approach to block BC cell metastasis .
593	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Targeting these novel strategies , inhibition of miR-10b/KLF4/E-cadherin axis and miR-10b/HOXD10/MMP14 axis may be helpful as a therapeutic approach to block BC cell metastasis .
592	inhibit	negative	mir-10b/klf	384.2053	605.7266	605.7266	miRNA		Targeting these novel strategies , inhibition of miR-10b/KLF4/E-cadherin axis and miR-10b/HOXD10/MMP14 axis may be helpful as a therapeutic approach to block BC cell metastasis .
592	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Targeting these novel strategies , inhibition of miR-10b/KLF4/E-cadherin axis and miR-10b/HOXD10/MMP14 axis may be helpful as a therapeutic approach to block BC cell metastasis .
588	regulate	positive	mir-1236	386.0951	610.6822	610.6822	miRNA		Taken together , our results indicate that miR-1236-3p regulates ovarian cancer metastasis by directly targeting ZEB1 , and it may play an important role in the diagnosis and treatment of ovarian cancer .
588	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Taken together , our results indicate that miR-1236-3p regulates ovarian cancer metastasis by directly targeting ZEB1 , and it may play an important role in the diagnosis and treatment of ovarian cancer .
1437	upregulate	positive	mir-372	388.044	615.6148	615.6148	miRNA		Upregulation of miR-372 and -373 associates with lymph node metastasis and poor prognosis of oral carcinomas .
1437	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Upregulation of miR-372 and -373 associates with lymph node metastasis and poor prognosis of oral carcinomas .
1293	control	neutral	mir-372	388.044	615.6148	615.6148	miRNA		miR-372 was expressed at lower levels in HCC tissues compared with controls and was related to tumor metastasis and poor prognosis .
1293	control	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-372 was expressed at lower levels in HCC tissues compared with controls and was related to tumor metastasis and poor prognosis .
587	downregulate	negative	mir-372	388.044	615.6148	615.6148	miRNA		miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis .
587	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis .
583	downregulate	negative	mir-195/497	390.0516	620.5237	620.5237	miRNA		In conclusion , aberrant expression of clustered miRNAs was identified by deep sequencing , and downregulation of miR-195/497 contributed to BC progression and metastasis .
583	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In conclusion , aberrant expression of clustered miRNAs was identified by deep sequencing , and downregulation of miR-195/497 contributed to BC progression and metastasis .
1198	downregulate	negative	microrna-23a	392.1178	625.4084	625.4084	miRNA		Downregulation of microRNA-23a suppresses prostate cancer metastasis by targeting the PAK6-LIMK1 signaling pathway .
1198	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Downregulation of microRNA-23a suppresses prostate cancer metastasis by targeting the PAK6-LIMK1 signaling pathway .
581	promote	positive	microrna-23a	392.1178	625.4084	625.4084	miRNA		MicroRNA-23a promotes neuroblastoma cell metastasis by targeting CDH1 .
581	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-23a promotes neuroblastoma cell metastasis by targeting CDH1 .
577	inhibit	negative	mir181b	394.2421	630.268	630.268	miRNA		Importantly , over-expression of miR181b in metastatic breast cancer cells inhibits metastasis formation in ? vivo in immunodeficient mice .
577	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Importantly , over-expression of miR181b in metastatic breast cancer cells inhibits metastasis formation in ? vivo in immunodeficient mice .
576	induce	positive	mir181b	394.2421	630.268	630.268	miRNA		miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2 .
576	induce	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2 .
1903	downregulate	negative	mir-193a	396.4244	635.1019	635.1019	miRNA		MiR-193a-3p and miR-193a-5p play important roles in osteosarcoma metastasis through down-regulation of the Rab27B and SRR genes and therefore may serve as useful biomarkers for the diagnosis of osteosarcoma and as potential candidates for the treatment of metastatic osteosarcoma .
1903	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	MiR-193a-3p and miR-193a-5p play important roles in osteosarcoma metastasis through down-regulation of the Rab27B and SRR genes and therefore may serve as useful biomarkers for the diagnosis of osteosarcoma and as potential candidates for the treatment of metastatic osteosarcoma .
1902	downregulate	negative	mir-193a	396.4244	635.1019	635.1019	miRNA		MiR-193a-3p and miR-193a-5p play important roles in osteosarcoma metastasis through down-regulation of the Rab27B and SRR genes and therefore may serve as useful biomarkers for the diagnosis of osteosarcoma and as potential candidates for the treatment of metastatic osteosarcoma .
1902	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	MiR-193a-3p and miR-193a-5p play important roles in osteosarcoma metastasis through down-regulation of the Rab27B and SRR genes and therefore may serve as useful biomarkers for the diagnosis of osteosarcoma and as potential candidates for the treatment of metastatic osteosarcoma .
1901	suppress	negative	mir-193a	396.4244	635.1019	635.1019	miRNA		MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR , respectively .
1901	suppress	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR , respectively .
1900	suppress	negative	mir-193a	396.4244	635.1019	635.1019	miRNA		MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR , respectively .
1900	suppress	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR , respectively .
1264	inhibit	negative	mir-193a	396.4244	635.1019	635.1019	miRNA		miR-193a-3p inhibited the metastasis of lung cancer cells by deregulating the expression of tumor-related proteins .
1264	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-193a-3p inhibited the metastasis of lung cancer cells by deregulating the expression of tumor-related proteins .
1263	inhibit	negative	mir-193a	396.4244	635.1019	635.1019	miRNA		To explore the molecular mechanisms by which miR-193a-3p inhibited NSCLC metastasis , we investigated the changes in the protein profile of SPC-A-1sci ( highly metastatic ) cells in response to the up-regulation of miR-193a-3p expression using a proteomics approach ( iTRAQ combined with NanoLC-MS/MS ) .
1263	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	To explore the molecular mechanisms by which miR-193a-3p inhibited NSCLC metastasis , we investigated the changes in the protein profile of SPC-A-1sci ( highly metastatic ) cells in response to the up-regulation of miR-193a-3p expression using a proteomics approach ( iTRAQ combined with NanoLC-MS/MS ) .
955	downregulate	negative	mir-193a	396.4244	635.1019	635.1019	miRNA		Downregulation of miR-193a-5p correlates with lymph node metastasis and poor survival of CRC .
955	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Downregulation of miR-193a-5p correlates with lymph node metastasis and poor survival of CRC .
954	downregulate	negative	mir-193a	396.4244	635.1019	635.1019	miRNA		Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer .
954	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer .
575	inhibit	negative	mir-193a	396.4244	635.1019	635.1019	miRNA		Furthermore , functional assays showed that the overexpression of miR-193a-3p/5p inhibited NSCLC cell migration , invasion and epithelial-mesenchymal transition ( EMT ) in vitro and lung metastasis formation in vivo .
575	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Furthermore , functional assays showed that the overexpression of miR-193a-3p/5p inhibited NSCLC cell migration , invasion and epithelial-mesenchymal transition ( EMT ) in vitro and lung metastasis formation in vivo .
574	inhibit	negative	mir-193a	396.4244	635.1019	635.1019	miRNA		Furthermore , functional assays showed that the overexpression of miR-193a-3p/5p inhibited NSCLC cell migration , invasion and epithelial-mesenchymal transition ( EMT ) in vitro and lung metastasis formation in vivo .
574	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Furthermore , functional assays showed that the overexpression of miR-193a-3p/5p inhibited NSCLC cell migration , invasion and epithelial-mesenchymal transition ( EMT ) in vitro and lung metastasis formation in vivo .
573	downregulate	negative	mir-193a	396.4244	635.1019	635.1019	miRNA		In this study , by comparing the miRNA expression profiles of SPC-A-1sci ( high metastatic ) and SPC-A-1 ( weakly metastatic ) cells , we demonstrated that the downregulation and function of miR-193a-3p and miR-193a-5p in NSCLC metastasis and the expression of these miRNAs was suppressed in NSCLC compared with corresponding non-tumorous tissues .
573	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In this study , by comparing the miRNA expression profiles of SPC-A-1sci ( high metastatic ) and SPC-A-1 ( weakly metastatic ) cells , we demonstrated that the downregulation and function of miR-193a-3p and miR-193a-5p in NSCLC metastasis and the expression of these miRNAs was suppressed in NSCLC compared with corresponding non-tumorous tissues .
572	suppress	negative	microrna-193a	398.6642	639.9094	639.9094	miRNA		MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway .
572	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway .
571	downregulate	negative	mirna-135a	400.9613	644.6898	644.6898	miRNA		In a multivariate analysis , down-regulation of miRNA-135a was an independent risk factor for LN metastasis ( adjusted odds ratio , 8.04 ; 95 % confidence interval , 1.08-59.81 ; p ? = ? 0.042 ) .
571	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	In a multivariate analysis , down-regulation of miRNA-135a was an independent risk factor for LN metastasis ( adjusted odds ratio , 8.04 ; 95 % confidence interval , 1.08-59.81 ; p ? = ? 0.042 ) .
570	upregulate	positive	mirna-135a	400.9613	644.6898	644.6898	miRNA		These patients showed a significantly more advanced stage ( TNM stage ? IB , 35.0 % vs. 12.8 % , p ? = ? 0.045 ) and higher rate of LN metastasis ( 30.0 % vs. 5.1 % , p ? = ? 0.014 ) than those with up-regulation of miRNA-135a expression .
570	upregulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	These patients showed a significantly more advanced stage ( TNM stage ? IB , 35.0 % vs. 12.8 % , p ? = ? 0.045 ) and higher rate of LN metastasis ( 30.0 % vs. 5.1 % , p ? = ? 0.014 ) than those with up-regulation of miRNA-135a expression .
1422	inhibit	negative	mir-106a	403.3153	649.4424	649.4424	miRNA		Overall , this study suggested that miR-106a inhibited the growth and metastasis of NSCLC cells by decreasing PTEN expression .
1422	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Overall , this study suggested that miR-106a inhibited the growth and metastasis of NSCLC cells by decreasing PTEN expression .
1421	promote	positive	mir-106a	403.3153	649.4424	649.4424	miRNA		miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN .
1421	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN .
560	upregulate	positive	mir-106a	403.3153	649.4424	649.4424	miRNA		Here , we report that miR-106a is frequently up-regulated in gastric cancer tissues and positively correlates with metastasis .
560	upregulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	Here , we report that miR-106a is frequently up-regulated in gastric cancer tissues and positively correlates with metastasis .
559	regulate	positive	microrna-106a	405.7259	654.1665	654.1665	miRNA		MicroRNA-106a targets TIMP2 to regulate invasion and metastasis of gastric cancer .
559	regulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	MicroRNA-106a targets TIMP2 to regulate invasion and metastasis of gastric cancer .
1512	inhibit	negative	mir-302b	408.1928	658.8615	658.8615	miRNA		Taken together , our findings indicate that miR-302b inhibits SMMC-7721 cell invasion and metastasis by targeting AKT2 , suggesting that miR-302b might represent a potential therapeutic target for HCC intervention .
1512	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , our findings indicate that miR-302b inhibits SMMC-7721 cell invasion and metastasis by targeting AKT2 , suggesting that miR-302b might represent a potential therapeutic target for HCC intervention .
1511	suppress	negative	mir-302b	408.1928	658.8615	658.8615	miRNA		Overexpression of miR-302b suppressed HCC cell invasion and metastasis .
1511	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Overexpression of miR-302b suppressed HCC cell invasion and metastasis .
1510	suppress	negative	mir-302b	408.1928	658.8615	658.8615	miRNA		miR-302b suppresses cell invasion and metastasis by directly targeting AKT2 in human hepatocellular carcinoma cells .
1510	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-302b suppresses cell invasion and metastasis by directly targeting AKT2 in human hepatocellular carcinoma cells .
558	downregulate	negative	mir-302b	408.1928	658.8615	658.8615	miRNA		miR-302b was significantly down-regulated and correlated with tumor differentiation and lymph node metastasis in ESCC .
558	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-302b was significantly down-regulated and correlated with tumor differentiation and lymph node metastasis in ESCC .
1955	downregulate	negative	mir-99a	410.7156	663.5267	663.5267	miRNA		Downregulation of miR-99a was significantly associated with advanced stage and tumor metastasis in lung adenocarcinoma patients , and it was found to be a poor prognostic factor in lung adenocarcinoma .
1955	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Downregulation of miR-99a was significantly associated with advanced stage and tumor metastasis in lung adenocarcinoma patients , and it was found to be a poor prognostic factor in lung adenocarcinoma .
929	inhibit	negative	mir-99a	410.7156	663.5267	663.5267	miRNA		Further functional experiments found that overexpression of miR-99a inhibit cell proliferation , migration , and invasion of NSCLC cells in vitro and tumor metastasis of NSCLC in vivo .
929	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Further functional experiments found that overexpression of miR-99a inhibit cell proliferation , migration , and invasion of NSCLC cells in vitro and tumor metastasis of NSCLC in vivo .
928	downregulate	negative	mir-99a	410.7156	663.5267	663.5267	miRNA		Down-regulation of miR-99a is significantly associated with last-stage and tumor metastasis in NSCLC patients .
928	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Down-regulation of miR-99a is significantly associated with last-stage and tumor metastasis in NSCLC patients .
927	downregulate	negative	mir-99a	410.7156	663.5267	663.5267	miRNA		Herein , we found that miR-99a was downregulated in NSCLC tissues and suppressed tumor metastasis of NSCLC cells .
927	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Herein , we found that miR-99a was downregulated in NSCLC tissues and suppressed tumor metastasis of NSCLC cells .
926	suppress	negative	mir-99a	410.7156	663.5267	663.5267	miRNA		miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway .
926	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway .
638	downregulate	negative	mir-99a	410.7156	663.5267	663.5267	miRNA		Here , we showed that miR-99a and -99b ( miR-99a/b ) were down-regulated in human cervical cancer patient tissues and were negatively related with lymphatic metastasis .
638	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we showed that miR-99a and -99b ( miR-99a/b ) were down-regulated in human cervical cancer patient tissues and were negatively related with lymphatic metastasis .
637	downregulate	negative	mir-99a	410.7156	663.5267	663.5267	miRNA		Here , we showed that miR-99a and -99b ( miR-99a/b ) were down-regulated in human cervical cancer patient tissues and were negatively related with lymphatic metastasis .
637	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we showed that miR-99a and -99b ( miR-99a/b ) were down-regulated in human cervical cancer patient tissues and were negatively related with lymphatic metastasis .
556	regulate	positive	mir-99a	410.7156	663.5267	663.5267	miRNA		Overall , results indicate that miR-99a functions as a tumor metastasis suppressor in OSCC cells and mutually regulates IGF1R expression in a reciprocal regulation .
556	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Overall , results indicate that miR-99a functions as a tumor metastasis suppressor in OSCC cells and mutually regulates IGF1R expression in a reciprocal regulation .
1811	regulate	positive	mir-340	413.2939	668.1614	668.1614	miRNA		By bioinformatic analysis , we confirmed the important role of miR-340 as a pivotal regulator of breast cancer metastasis in targeting previously validated ( ROCK1 ) and potentially novel genes , i.e. , ( CTNNB1 and c-MYC ) .
1811	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	By bioinformatic analysis , we confirmed the important role of miR-340 as a pivotal regulator of breast cancer metastasis in targeting previously validated ( ROCK1 ) and potentially novel genes , i.e. , ( CTNNB1 and c-MYC ) .
1810	suppress	negative	mir-340	413.2939	668.1614	668.1614	miRNA		We found that restoration of miR-340 in the invasive breast cancer cell line , MDA-MB-231 , suppresses the expression of the target genes ' messenger RNA ( mRNA ) and protein and , as a result , inhibits tumor cell invasion and metastasis .
1810	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We found that restoration of miR-340 in the invasive breast cancer cell line , MDA-MB-231 , suppresses the expression of the target genes ' messenger RNA ( mRNA ) and protein and , as a result , inhibits tumor cell invasion and metastasis .
1809	downregulate	negative	mir-340	413.2939	668.1614	668.1614	miRNA		By applying bioinformatic approaches for the prediction of miRNAs targeting 3'-UTRs of CTNNB1 , c-MYC , and ROCK1 , we found out that miR-340 could dramatically down-regulate metastasis by targeting Wnt signaling in breast cancer cells .
1809	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	By applying bioinformatic approaches for the prediction of miRNAs targeting 3'-UTRs of CTNNB1 , c-MYC , and ROCK1 , we found out that miR-340 could dramatically down-regulate metastasis by targeting Wnt signaling in breast cancer cells .
564	regulate	positive	mir-340	413.2939	668.1614	668.1614	miRNA		Our data suggest that miR-340 in bone marrow may play an important role in regulating the metastasis cascade of colorectal cancer .
564	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our data suggest that miR-340 in bone marrow may play an important role in regulating the metastasis cascade of colorectal cancer .
550	downregulate	negative	mir-340	413.2939	668.1614	668.1614	miRNA		In addition , the combined miR-340 downregulation and ROCK1 upregulation ( miR-340-low/ROCK1-high ) occurred more frequently in osteosarcoma tissues with positive metastasis ( p < 0.001 ) and poor response to pre-operative chemotherapy ( p = 0.002 ) .
550	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	In addition , the combined miR-340 downregulation and ROCK1 upregulation ( miR-340-low/ROCK1-high ) occurred more frequently in osteosarcoma tissues with positive metastasis ( p < 0.001 ) and poor response to pre-operative chemotherapy ( p = 0.002 ) .
1864	suppress	negative	microrna-150	415.9275	672.7651	672.7651	miRNA		MicroRNA-150 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting the GAB1-ERK axis .
1864	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-150 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting the GAB1-ERK axis .
889	inhibit	negative	microrna-150	415.9275	672.7651	672.7651	miRNA		MicroRNA-150 predicts a favorable prognosis in patients with epithelial ovarian cancer , and inhibits cell invasion and metastasis by suppressing transcriptional repressor ZEB1 .
889	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-150 predicts a favorable prognosis in patients with epithelial ovarian cancer , and inhibits cell invasion and metastasis by suppressing transcriptional repressor ZEB1 .
545	inhibit	negative	microrna-150	415.9275	672.7651	672.7651	miRNA		MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6 , in advanced cutaneous T-cell lymphoma .
545	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6 , in advanced cutaneous T-cell lymphoma .
1763	induce	positive	mir-497	418.6158	677.3369	677.3369	miRNA		Taken together , these results revealed that lower miR-497 levels in human CRC tissues induce KSR1 expression which is associated with CRC cancer occurrence , advanced stages , metastasis and chemoresistance .
1763	induce	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Taken together , these results revealed that lower miR-497 levels in human CRC tissues induce KSR1 expression which is associated with CRC cancer occurrence , advanced stages , metastasis and chemoresistance .
1561	downregulate	negative	mir-497	418.6158	677.3369	677.3369	miRNA		In conclusion , our findings indicate that miR-497 downregulation contributes to angiogenesis and metastasis in HCC .
1561	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In conclusion , our findings indicate that miR-497 downregulation contributes to angiogenesis and metastasis in HCC .
1560	repress	negative	mir-497	418.6158	677.3369	677.3369	miRNA		Based on nude mouse models , we demonstrated that overexpression of miR-497 significantly repressed microvessel densities in xenograft tumors and reduced pulmonary metastasis .
1560	repress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Based on nude mouse models , we demonstrated that overexpression of miR-497 significantly repressed microvessel densities in xenograft tumors and reduced pulmonary metastasis .
1559	regulate	positive	mir-497	418.6158	677.3369	677.3369	miRNA		MicroRNAs ( miRNAs ) have been shown to play important roles in regulating tumor properties in cancer , however , whether miR-497 contributes to HCC angiogenesis or metastasis remains unclear .
1559	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNAs ( miRNAs ) have been shown to play important roles in regulating tumor properties in cancer , however , whether miR-497 contributes to HCC angiogenesis or metastasis remains unclear .
1558	suppress	negative	mir-497	418.6158	677.3369	677.3369	miRNA		MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1 .
1558	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1 .
1313	promote	positive	mir-497	418.6158	677.3369	677.3369	miRNA		MiR-497 promotes metastasis of colorectal cancer cells through Nrdp1 inhibition .
1313	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-497 promotes metastasis of colorectal cancer cells through Nrdp1 inhibition .
754	downregulate	negative	mir-497	418.6158	677.3369	677.3369	miRNA		Our results indicate that down-regulation of miR-497 in ovarian cancer may facilitate tumor metastasis .
754	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our results indicate that down-regulation of miR-497 in ovarian cancer may facilitate tumor metastasis .
543	inhibit	negative	mir-497	418.6158	677.3369	677.3369	miRNA		This study revealed that bufalin inhibited angiogenesis and regulated miR-497 expression and that bufalin and miR-497 acted in synergy to inhibit colorectal cancer metastasis , resulting in improved quality of life in a nude mouse model .
543	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	This study revealed that bufalin inhibited angiogenesis and regulated miR-497 expression and that bufalin and miR-497 acted in synergy to inhibit colorectal cancer metastasis , resulting in improved quality of life in a nude mouse model .
542	effect	neutral	mir-497	418.6158	677.3369	677.3369	miRNA		The effect of both bufalin treatment and miR-497 overexpression on colorectal cancer metastasis was measured using an animal tumor model together with in vivo imaging .
542	effect	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The effect of both bufalin treatment and miR-497 overexpression on colorectal cancer metastasis was measured using an animal tumor model together with in vivo imaging .
541	effect	neutral	mir-497	418.6158	677.3369	677.3369	miRNA		The study aims to investigate the effect of microRNA-497 ( miR-497 ) expression and bufalin treatment in regulating colorectal cancer invasion and metastasis .
541	effect	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The study aims to investigate the effect of microRNA-497 ( miR-497 ) expression and bufalin treatment in regulating colorectal cancer invasion and metastasis .
1849	inhibit	negative	microrna-497	421.3585	681.8763	681.8763	miRNA		microRNA-497 inhibits invasion and metastasis of colorectal cancer cells by targeting vascular endothelial growth factor-A .
1849	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	microRNA-497 inhibits invasion and metastasis of colorectal cancer cells by targeting vascular endothelial growth factor-A .
540	effect	neutral	microrna-497	421.3585	681.8763	681.8763	miRNA		The study aims to investigate the effect of microRNA-497 ( miR-497 ) expression and bufalin treatment in regulating colorectal cancer invasion and metastasis .
540	effect	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The study aims to investigate the effect of microRNA-497 ( miR-497 ) expression and bufalin treatment in regulating colorectal cancer invasion and metastasis .
539	inhibit	negative	microrna-497	421.3585	681.8763	681.8763	miRNA		MicroRNA-497 and bufalin act synergistically to inhibit colorectal cancer metastasis .
539	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-497 and bufalin act synergistically to inhibit colorectal cancer metastasis .
1669	upregulate	positive	mir-185	424.1553	686.3826	686.3826	miRNA		In endometrial cancer cells , expression levels of miRNAs including miR-185 , miR-210 and miR-423 are upregulated and those of miR-let7e , miR-30c and miR-221 are downregulated compared to normal tissues , and these miRNAs are involved in carcinogenesis , invasion and metastasis .
1669	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In endometrial cancer cells , expression levels of miRNAs including miR-185 , miR-210 and miR-423 are upregulated and those of miR-let7e , miR-30c and miR-221 are downregulated compared to normal tissues , and these miRNAs are involved in carcinogenesis , invasion and metastasis .
1103	promote	positive	mir-185	424.1553	686.3826	686.3826	miRNA		This novel miR-185-STIM1 axis promotes CRC metastasis and may be a candidate biomarker for prognosis and a target for new therapies .
1103	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	This novel miR-185-STIM1 axis promotes CRC metastasis and may be a candidate biomarker for prognosis and a target for new therapies .
992	downregulate	negative	mir-185	424.1553	686.3826	686.3826	miRNA		In this study , we found that miR-185 was strongly downregulated in TNBC tissues and cell lines and that its expression levels were associated with lymph node metastasis , clinical stage , overall survival , and relapse-free survival in TNBC .
992	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In this study , we found that miR-185 was strongly downregulated in TNBC tissues and cell lines and that its expression levels were associated with lymph node metastasis , clinical stage , overall survival , and relapse-free survival in TNBC .
749	downregulate	negative	mir-185	424.1553	686.3826	686.3826	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
749	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
748	downregulate	negative	mir-185	424.1553	686.3826	686.3826	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
748	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
538	upregulate	positive	mir-185	424.1553	686.3826	686.3826	miRNA		We further found that upregulation of miR-185 inhibited the proliferation and metastasis of gastric cancer cells in vitro and in vivo .
538	upregulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	We further found that upregulation of miR-185 inhibited the proliferation and metastasis of gastric cancer cells in vitro and in vivo .
537	suppress	negative	mir-185	424.1553	686.3826	686.3826	miRNA		miR-185 is an independent prognosis factor and suppresses tumor metastasis in gastric cancer .
537	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	miR-185 is an independent prognosis factor and suppresses tumor metastasis in gastric cancer .
1956	effect	neutral	mir-301a	427.0056	690.8552	690.8552	miRNA		We examined the effect of miR-301a expression on biochemical recurrence and metastasis among 585 men treated with radical prostatectomy for prostate cancer .
1956	effect	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We examined the effect of miR-301a expression on biochemical recurrence and metastasis among 585 men treated with radical prostatectomy for prostate cancer .
527	activate	positive	mir-301a	427.0056	690.8552	690.8552	miRNA		These results demonstrate that miR-301a maintains constitutively activated Wnt/?] -catenin signaling by directly targeting PTEN , which promotes breast cancer invasion and metastasis .
527	activate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	These results demonstrate that miR-301a maintains constitutively activated Wnt/?] -catenin signaling by directly targeting PTEN , which promotes breast cancer invasion and metastasis .
526	mediate	neutral	mir-301a	427.0056	690.8552	690.8552	miRNA		Notably , Wnt/?] -catenin signaling was hyperactivated in metastatic breast cancer cells that express miR-301a , and mediated miR-301a-induced invasion and metastasis .
526	mediate	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Notably , Wnt/?] -catenin signaling was hyperactivated in metastatic breast cancer cells that express miR-301a , and mediated miR-301a-induced invasion and metastasis .
525	promote	positive	mir-301a	427.0056	690.8552	690.8552	miRNA		Gain-of-function and loss-of-function studies showed that ectopic overexpression of miR-301a promoted breast cancer cell migration , invasion and metastasis both in vitro and in vivo .
525	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Gain-of-function and loss-of-function studies showed that ectopic overexpression of miR-301a promoted breast cancer cell migration , invasion and metastasis both in vitro and in vivo .
524	upregulate	positive	microrna-301a	429.9093	695.2934	695.2934	miRNA		Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/?] -catenin signaling .
524	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/?] -catenin signaling .
518	regulate	positive	mir-15a/16	432.8657	699.6966	699.6966	miRNA		p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer .
518	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer .
517	regulate	positive	mir-143/145	435.8745	704.0642	704.0642	miRNA		Our data on target genes regulated by the tumor-suppressive miR-143/145 cluster provide new insights into the potential mechanisms of PCa oncogenesis and metastasis .
517	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our data on target genes regulated by the tumor-suppressive miR-143/145 cluster provide new insights into the potential mechanisms of PCa oncogenesis and metastasis .
1893	mediate	neutral	microrna-29a	438.9352	708.3955	708.3955	miRNA		hTERT mediates gastric cancer metastasis partially through the indirect targeting of ITGB1 by microRNA-29a .
1893	mediate	neutral	gc	1242.449	487.0825	487.0825	Cancer	D061325	hTERT mediates gastric cancer metastasis partially through the indirect targeting of ITGB1 by microRNA-29a .
514	promote	positive	microrna-29a	438.9352	708.3955	708.3955	miRNA		MicroRNA-29a promotes colorectal cancer metastasis by regulating matrix metalloproteinase 2 and E-cadherin via KLF4 .
514	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-29a promotes colorectal cancer metastasis by regulating matrix metalloproteinase 2 and E-cadherin via KLF4 .
664	inhibit	negative	microrna-338	442.0475	712.69	712.69	miRNA		MicroRNA-338 inhibits growth , invasion and metastasis of gastric cancer by targeting NRP1 expression .
664	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	MicroRNA-338 inhibits growth , invasion and metastasis of gastric cancer by targeting NRP1 expression .
511	downregulate	negative	microrna-338	442.0475	712.69	712.69	miRNA		The expression of microRNA-338-3p was significantly down-regulated in colorectal carcinoma tissues in comparison with those in the adjacent non-tumorous tissues , and the value was negatively related to advanced tumor , node , metastasis stage and local invasion .
511	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The expression of microRNA-338-3p was significantly down-regulated in colorectal carcinoma tissues in comparison with those in the adjacent non-tumorous tissues , and the value was negatively related to advanced tumor , node , metastasis stage and local invasion .
1159	inhibit	negative	microrna-221	445.2109	716.947	716.947	miRNA		Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis , metastasis , and chemotherapy resistance in pancreatic cancer .
1159	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis , metastasis , and chemotherapy resistance in pancreatic cancer .
509	promote	positive	microrna-221	445.2109	716.947	716.947	miRNA		MicroRNA-221 promotes colorectal cancer cell invasion and metastasis by targeting RECK .
509	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-221 promotes colorectal cancer cell invasion and metastasis by targeting RECK .
508	promote	positive	microrna-221	445.2109	716.947	716.947	miRNA		MicroRNA-221 promotes colorectal cancer cell invasion and metastasis by targeting RECK .
508	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-221 promotes colorectal cancer cell invasion and metastasis by targeting RECK .
507	mediate	neutral	mir-296	448.4248	721.1658	721.1658	miRNA		Above results suggest that this newly identified miR-296-3p-ICAM-1 axis has a pivotal role in mediating PCa metastasis by possible enhancing survival of NK cell-resistant CTC .
507	mediate	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Above results suggest that this newly identified miR-296-3p-ICAM-1 axis has a pivotal role in mediating PCa metastasis by possible enhancing survival of NK cell-resistant CTC .
506	promote	positive	mirna-296	451.689	725.346	725.346	miRNA		MiRNA-296-3p-ICAM-1 axis promotes metastasis of prostate cancer by possible enhancing survival of natural killer cell-resistant circulating tumour cells .
506	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiRNA-296-3p-ICAM-1 axis promotes metastasis of prostate cancer by possible enhancing survival of natural killer cell-resistant circulating tumour cells .
1708	promote	positive	microrna-192	455.0028	729.4869	729.4869	miRNA		MicroRNA-192-5p Promote the Proliferation and Metastasis of Hepatocellular Carcinoma Cell by Targeting SEMA3A .
1708	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-192-5p Promote the Proliferation and Metastasis of Hepatocellular Carcinoma Cell by Targeting SEMA3A .
504	suppress	negative	microrna-192	455.0028	729.4869	729.4869	miRNA		MicroRNA-192 suppresses liver metastasis of colon cancer .
504	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-192 suppresses liver metastasis of colon cancer .
1203	repress	negative	mir-424	458.3659	733.588	733.588	miRNA		These findings suggest miR-424 plays distinct roles in tumor progression , potentially facilitating earlier , but repressing later , stages of metastasis by regulating an EMT-MET axis .
1203	repress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	These findings suggest miR-424 plays distinct roles in tumor progression , potentially facilitating earlier , but repressing later , stages of metastasis by regulating an EMT-MET axis .
1202	repress	negative	mir-424	458.3659	733.588	733.588	miRNA		These findings suggest miR-424 plays distinct roles in tumor progression , potentially facilitating earlier , but repressing later , stages of metastasis by regulating an EMT-MET axis .
1202	repress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	These findings suggest miR-424 plays distinct roles in tumor progression , potentially facilitating earlier , but repressing later , stages of metastasis by regulating an EMT-MET axis .
502	regulate	positive	mir-424	458.3659	733.588	733.588	miRNA		Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model .
502	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model .
495	inhibit	negative	mir-200b/c	461.7777	737.6486	737.6486	miRNA		Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis .
495	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis .
494	inhibit	negative	mir-106b/mmp	465.2378	741.668	741.668	miRNA		The miR-106b/MMP2/ERK pathway may be a promising therapeutic target for inhibiting BC bone metastasis .
494	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The miR-106b/MMP2/ERK pathway may be a promising therapeutic target for inhibiting BC bone metastasis .
1079	downregulate	negative	mir-127	468.7456	745.6459	745.6459	miRNA		miR-127 was significantly downregulated in BC tissues , and low miR-127 expression was significantly correlated with lymph node metastasis and advanced clinical stage .
1079	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-127 was significantly downregulated in BC tissues , and low miR-127 expression was significantly correlated with lymph node metastasis and advanced clinical stage .
491	promote	positive	mir-127	468.7456	745.6459	745.6459	miRNA		Collectively , our results suggested a novel mechanism that Tudor-SN promoted metastasis and proliferation of breast cancer cells via downregulating the miR-127 expression .
491	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Collectively , our results suggested a novel mechanism that Tudor-SN promoted metastasis and proliferation of breast cancer cells via downregulating the miR-127 expression .
490	downregulate	negative	microrna-127	472.3007	749.5817	749.5817	miRNA		MicroRNA-127 is downregulated by Tudor-SN protein and contributes to metastasis and proliferation in breast cancer cell line MDA-MB-231 .
490	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-127 is downregulated by Tudor-SN protein and contributes to metastasis and proliferation in breast cancer cell line MDA-MB-231 .
480	affect	neutral	mirna-205	475.9026	753.4747	753.4747	miRNA		miRNA-205 affects infiltration and metastasis of breast cancer .
480	affect	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miRNA-205 affects infiltration and metastasis of breast cancer .
1843	inhibit	negative	mir-122	479.5507	757.3243	757.3243	miRNA		Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122 .
1843	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122 .
1722	mediate	neutral	mir-122	479.5507	757.3243	757.3243	miRNA		miR-122 attenuates the epithelial-mesenchymal transition process , which mediates cancer cells metastasis in NSCLC cells A549 and H460 .
1722	mediate	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-122 attenuates the epithelial-mesenchymal transition process , which mediates cancer cells metastasis in NSCLC cells A549 and H460 .
1721	mediate	neutral	mir-122	479.5507	757.3243	757.3243	miRNA		miR-122 attenuates the epithelial-mesenchymal transition process , which mediates cancer cells metastasis in NSCLC cells A549 and H460 .
1721	mediate	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-122 attenuates the epithelial-mesenchymal transition process , which mediates cancer cells metastasis in NSCLC cells A549 and H460 .
1720	inhibit	negative	mir-122	479.5507	757.3243	757.3243	miRNA		miR-122 inhibits metastasis and epithelial-mesenchymal transition of non-small-cell lung cancer cells .
1720	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-122 inhibits metastasis and epithelial-mesenchymal transition of non-small-cell lung cancer cells .
1719	inhibit	negative	mir-122	479.5507	757.3243	757.3243	miRNA		miR-122 inhibits metastasis and epithelial-mesenchymal transition of non-small-cell lung cancer cells .
1719	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-122 inhibits metastasis and epithelial-mesenchymal transition of non-small-cell lung cancer cells .
1681	effect	neutral	mir-122	479.5507	757.3243	757.3243	miRNA		The exogenous introduction of miR-122 exhibits multiple antitumor effect in GBC cell proliferation , invasion , and metastasis .
1681	effect	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The exogenous introduction of miR-122 exhibits multiple antitumor effect in GBC cell proliferation , invasion , and metastasis .
1151	promote	positive	mir-122	479.5507	757.3243	757.3243	miRNA		Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis .
1151	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis .
479	upregulate	positive	mir-122	479.5507	757.3243	757.3243	miRNA		Collectively , miR-122 depletion facilitates cystogenesis and hepatocarcinogenesis in mice on DEN challenge by up-regulating several genes involved in proliferation , growth factor signaling , neovascularization , and metastasis .
479	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Collectively , miR-122 depletion facilitates cystogenesis and hepatocarcinogenesis in mice on DEN challenge by up-regulating several genes involved in proliferation , growth factor signaling , neovascularization , and metastasis .
478	upregulate	positive	mir-122	479.5507	757.3243	757.3243	miRNA		Collectively , miR-122 depletion facilitates cystogenesis and hepatocarcinogenesis in mice on DEN challenge by up-regulating several genes involved in proliferation , growth factor signaling , neovascularization , and metastasis .
478	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Collectively , miR-122 depletion facilitates cystogenesis and hepatocarcinogenesis in mice on DEN challenge by up-regulating several genes involved in proliferation , growth factor signaling , neovascularization , and metastasis .
976	upregulate	positive	mir-720	483.2445	761.1301	761.1301	miRNA		Our data showed that miR-720 level was significantly upregulated in CRC tissues than that in corresponding normal-appearing tissues ( NATs ) ( p ? < ? 0.05 ) , and high miR-720 correlated with the tumor size ( p ? = ? 0.014 ) , tumor-node-metastasis ( TNM ) stage ( p ? = ? 0.040 ) , lymphatic metastasis ( p ? = ? 0.008 ) , and distant metastasis ( p ? = ? 0.016 ) , which led to a poorer 5-year overall survival rate in CRC patients ( p ? < ? 0.05 ) .
976	upregulate	positive	colorectal cancer 	754.9962	891.7133	891.7133	Cancer	D001943|D009369	Our data showed that miR-720 level was significantly upregulated in CRC tissues than that in corresponding normal-appearing tissues ( NATs ) ( p ? < ? 0.05 ) , and high miR-720 correlated with the tumor size ( p ? = ? 0.014 ) , tumor-node-metastasis ( TNM ) stage ( p ? = ? 0.040 ) , lymphatic metastasis ( p ? = ? 0.008 ) , and distant metastasis ( p ? = ? 0.016 ) , which led to a poorer 5-year overall survival rate in CRC patients ( p ? < ? 0.05 ) .
975	upregulate	positive	mir-720	483.2445	761.1301	761.1301	miRNA		Our data showed that miR-720 level was significantly upregulated in CRC tissues than that in corresponding normal-appearing tissues ( NATs ) ( p ? < ? 0.05 ) , and high miR-720 correlated with the tumor size ( p ? = ? 0.014 ) , tumor-node-metastasis ( TNM ) stage ( p ? = ? 0.040 ) , lymphatic metastasis ( p ? = ? 0.008 ) , and distant metastasis ( p ? = ? 0.016 ) , which led to a poorer 5-year overall survival rate in CRC patients ( p ? < ? 0.05 ) .
975	upregulate	positive	colorectal cancer 	754.9962	891.7133	891.7133	Cancer	D001943|D009369	Our data showed that miR-720 level was significantly upregulated in CRC tissues than that in corresponding normal-appearing tissues ( NATs ) ( p ? < ? 0.05 ) , and high miR-720 correlated with the tumor size ( p ? = ? 0.014 ) , tumor-node-metastasis ( TNM ) stage ( p ? = ? 0.040 ) , lymphatic metastasis ( p ? = ? 0.008 ) , and distant metastasis ( p ? = ? 0.016 ) , which led to a poorer 5-year overall survival rate in CRC patients ( p ? < ? 0.05 ) .
974	upregulate	positive	mir-720	483.2445	761.1301	761.1301	miRNA		Our data showed that miR-720 level was significantly upregulated in CRC tissues than that in corresponding normal-appearing tissues ( NATs ) ( p ? < ? 0.05 ) , and high miR-720 correlated with the tumor size ( p ? = ? 0.014 ) , tumor-node-metastasis ( TNM ) stage ( p ? = ? 0.040 ) , lymphatic metastasis ( p ? = ? 0.008 ) , and distant metastasis ( p ? = ? 0.016 ) , which led to a poorer 5-year overall survival rate in CRC patients ( p ? < ? 0.05 ) .
974	upregulate	positive	colorectal cancer 	754.9962	891.7133	891.7133	Cancer	D001943|D009369	Our data showed that miR-720 level was significantly upregulated in CRC tissues than that in corresponding normal-appearing tissues ( NATs ) ( p ? < ? 0.05 ) , and high miR-720 correlated with the tumor size ( p ? = ? 0.014 ) , tumor-node-metastasis ( TNM ) stage ( p ? = ? 0.040 ) , lymphatic metastasis ( p ? = ? 0.008 ) , and distant metastasis ( p ? = ? 0.016 ) , which led to a poorer 5-year overall survival rate in CRC patients ( p ? < ? 0.05 ) .
476	downregulate	negative	mir-720	483.2445	761.1301	761.1301	miRNA		Collectively , our data indicate that miR-720 is frequently decreased in breast cancer and manifests antimetastatic activity by downregulating TWIST1 , presenting a novel mechanism of miRNA-mediated regulation of tumor metastasis .
476	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Collectively , our data indicate that miR-720 is frequently decreased in breast cancer and manifests antimetastatic activity by downregulating TWIST1 , presenting a novel mechanism of miRNA-mediated regulation of tumor metastasis .
473	downregulate	negative	mirna-200b	486.9836	764.8916	764.8916	miRNA		We also found that expression of miRNA-200b is down-regulated in human breast cancer during lymph node metastasis , which has a significant negative correlation with Pin1 expression .
473	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We also found that expression of miRNA-200b is down-regulated in human breast cancer during lymph node metastasis , which has a significant negative correlation with Pin1 expression .
472	activate	positive	mir141	490.7672	768.6081	768.6081	miRNA		Here , we demonstrate by ectopic expression and gene silencing that the proto-oncogene c-Myb activates the expression of the 5 members of miR200 family ( miR200b , miR200a , miR429 , miR200c and miR141 ) that are involved in the control of epithelial-mesenchymal transition ( EMT ) and metastasis in many types of cancers .
472	activate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we demonstrate by ectopic expression and gene silencing that the proto-oncogene c-Myb activates the expression of the 5 members of miR200 family ( miR200b , miR200a , miR429 , miR200c and miR141 ) that are involved in the control of epithelial-mesenchymal transition ( EMT ) and metastasis in many types of cancers .
941	inhibit	negative	mir200c	494.5951	772.2791	772.2791	miRNA		Moreover , in an orthotopic MDR colorectal cancer mouse model , we demonstrated that overexpression of miR200c effectively inhibited the tumor growth and metastasis .
941	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Moreover , in an orthotopic MDR colorectal cancer mouse model , we demonstrated that overexpression of miR200c effectively inhibited the tumor growth and metastasis .
618	inhibit	negative	mir200c	494.5951	772.2791	772.2791	miRNA		These results indicate that the tumor vaccine B16F10/GPI-IL-21 in combination with miR200c overexpression or ZEB1 knockdown effectively inhibited melanoma growth and metastasis a murine model .
618	inhibit	negative	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	These results indicate that the tumor vaccine B16F10/GPI-IL-21 in combination with miR200c overexpression or ZEB1 knockdown effectively inhibited melanoma growth and metastasis a murine model .
617	regulate	positive	mir200c	494.5951	772.2791	772.2791	miRNA		Regulation gene expression of miR200c and ZEB1 positively enhances effect of tumor vaccine B16F10/GPI-IL-21 on inhibition of melanoma growth and metastasis .
617	regulate	positive	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	Regulation gene expression of miR200c and ZEB1 positively enhances effect of tumor vaccine B16F10/GPI-IL-21 on inhibition of melanoma growth and metastasis .
471	activate	positive	mir200c	494.5951	772.2791	772.2791	miRNA		Here , we demonstrate by ectopic expression and gene silencing that the proto-oncogene c-Myb activates the expression of the 5 members of miR200 family ( miR200b , miR200a , miR429 , miR200c and miR141 ) that are involved in the control of epithelial-mesenchymal transition ( EMT ) and metastasis in many types of cancers .
471	activate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we demonstrate by ectopic expression and gene silencing that the proto-oncogene c-Myb activates the expression of the 5 members of miR200 family ( miR200b , miR200a , miR429 , miR200c and miR141 ) that are involved in the control of epithelial-mesenchymal transition ( EMT ) and metastasis in many types of cancers .
470	activate	positive	mir429	498.4665	775.9042	775.9042	miRNA		Here , we demonstrate by ectopic expression and gene silencing that the proto-oncogene c-Myb activates the expression of the 5 members of miR200 family ( miR200b , miR200a , miR429 , miR200c and miR141 ) that are involved in the control of epithelial-mesenchymal transition ( EMT ) and metastasis in many types of cancers .
470	activate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we demonstrate by ectopic expression and gene silencing that the proto-oncogene c-Myb activates the expression of the 5 members of miR200 family ( miR200b , miR200a , miR429 , miR200c and miR141 ) that are involved in the control of epithelial-mesenchymal transition ( EMT ) and metastasis in many types of cancers .
469	activate	positive	mir200a	502.3809	779.4827	779.4827	miRNA		Here , we demonstrate by ectopic expression and gene silencing that the proto-oncogene c-Myb activates the expression of the 5 members of miR200 family ( miR200b , miR200a , miR429 , miR200c and miR141 ) that are involved in the control of epithelial-mesenchymal transition ( EMT ) and metastasis in many types of cancers .
469	activate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we demonstrate by ectopic expression and gene silencing that the proto-oncogene c-Myb activates the expression of the 5 members of miR200 family ( miR200b , miR200a , miR429 , miR200c and miR141 ) that are involved in the control of epithelial-mesenchymal transition ( EMT ) and metastasis in many types of cancers .
468	activate	positive	mir200b	506.3377	783.0142	783.0142	miRNA		Here , we demonstrate by ectopic expression and gene silencing that the proto-oncogene c-Myb activates the expression of the 5 members of miR200 family ( miR200b , miR200a , miR429 , miR200c and miR141 ) that are involved in the control of epithelial-mesenchymal transition ( EMT ) and metastasis in many types of cancers .
468	activate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we demonstrate by ectopic expression and gene silencing that the proto-oncogene c-Myb activates the expression of the 5 members of miR200 family ( miR200b , miR200a , miR429 , miR200c and miR141 ) that are involved in the control of epithelial-mesenchymal transition ( EMT ) and metastasis in many types of cancers .
898	inhibit	negative	mir200	510.3365	786.4982	786.4982	miRNA		Taken together , our data suggest that miR200 family inhibited ovarian cancer cell invasiveness and metastasis by downregulating MMP3 , possibly through ZEB1/pSMAD3 .
898	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Taken together , our data suggest that miR200 family inhibited ovarian cancer cell invasiveness and metastasis by downregulating MMP3 , possibly through ZEB1/pSMAD3 .
467	activate	positive	mir200	510.3365	786.4982	786.4982	miRNA		Here , we demonstrate by ectopic expression and gene silencing that the proto-oncogene c-Myb activates the expression of the 5 members of miR200 family ( miR200b , miR200a , miR429 , miR200c and miR141 ) that are involved in the control of epithelial-mesenchymal transition ( EMT ) and metastasis in many types of cancers .
467	activate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we demonstrate by ectopic expression and gene silencing that the proto-oncogene c-Myb activates the expression of the 5 members of miR200 family ( miR200b , miR200a , miR429 , miR200c and miR141 ) that are involved in the control of epithelial-mesenchymal transition ( EMT ) and metastasis in many types of cancers .
459	downregulate	negative	mir-519b	514.3766	789.9343	789.9343	miRNA		Downregulation of both miR-223-5p and miR-19-b1-5p were correlated with the presence of lymph node metastasis ; downregulation of miR-100-3p and miR-19-b1-5p were correlated with presence of vascular invasion ; overexpression of miR-519b and miR-133a were associated with advanced FIGO staging .
459	downregulate	negative	 figo staging	522.5786	796.6603	796.6603	Cancer	D016609	Downregulation of both miR-223-5p and miR-19-b1-5p were correlated with the presence of lymph node metastasis ; downregulation of miR-100-3p and miR-19-b1-5p were correlated with presence of vascular invasion ; overexpression of miR-519b and miR-133a were associated with advanced FIGO staging .
1323	amplify	positive	mir-19	518.4575	793.3218	793.3218	miRNA		Chromosome-13 amplification in advanced colorectal cancer contributes to invasion and metastasis by upregulating miR-19 , which targets TG2 .
1323	amplify	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Chromosome-13 amplification in advanced colorectal cancer contributes to invasion and metastasis by upregulating miR-19 , which targets TG2 .
1322	inhibit	negative	mir-19	518.4575	793.3218	793.3218	miRNA		miR-19-Mediated Inhibition of Transglutaminase-2 Leads to Enhanced Invasion and Metastasis in Colorectal Cancer .
1322	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-19-Mediated Inhibition of Transglutaminase-2 Leads to Enhanced Invasion and Metastasis in Colorectal Cancer .
643	promote	positive	mir-19	518.4575	793.3218	793.3218	miRNA		miR-19 in the context of the miR-17~92 cluster at medium levels promoted tumor metastasis through induction of Wnt/?] -catenin-mediated epithelial-mesenchymal transition by targeting to the tumor-suppressor gene , PTEN .
643	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-19 in the context of the miR-17~92 cluster at medium levels promoted tumor metastasis through induction of Wnt/?] -catenin-mediated epithelial-mesenchymal transition by targeting to the tumor-suppressor gene , PTEN .
458	downregulate	negative	mir-19	518.4575	793.3218	793.3218	miRNA		Downregulation of both miR-223-5p and miR-19-b1-5p were correlated with the presence of lymph node metastasis ; downregulation of miR-100-3p and miR-19-b1-5p were correlated with presence of vascular invasion ; overexpression of miR-519b and miR-133a were associated with advanced FIGO staging .
458	downregulate	negative	 figo staging	522.5786	796.6603	796.6603	Cancer	D016609	Downregulation of both miR-223-5p and miR-19-b1-5p were correlated with the presence of lymph node metastasis ; downregulation of miR-100-3p and miR-19-b1-5p were correlated with presence of vascular invasion ; overexpression of miR-519b and miR-133a were associated with advanced FIGO staging .
456	downregulate	negative	mir-19	518.4575	793.3218	793.3218	miRNA		Downregulation of both miR-223-5p and miR-19-b1-5p were correlated with the presence of lymph node metastasis ; downregulation of miR-100-3p and miR-19-b1-5p were correlated with presence of vascular invasion ; overexpression of miR-519b and miR-133a were associated with advanced FIGO staging .
456	downregulate	negative	 figo staging	522.5786	796.6603	796.6603	Cancer	D016609	Downregulation of both miR-223-5p and miR-19-b1-5p were correlated with the presence of lymph node metastasis ; downregulation of miR-100-3p and miR-19-b1-5p were correlated with presence of vascular invasion ; overexpression of miR-519b and miR-133a were associated with advanced FIGO staging .
579	induction	positive	mir-9	1134.762	741.668	741.668	miRNA		Furthermore , dysregulation of miR-9 is associated with MCT metastasis potentially through the induction of an invasive phenotype , identifying a potentially novel pathway for therapeutic intervention .
579	induction	positive	 figo staging	522.5786	796.6603	796.6603	Cancer	D016609	Furthermore , dysregulation of miR-9 is associated with MCT metastasis potentially through the induction of an invasive phenotype , identifying a potentially novel pathway for therapeutic intervention .
460	downregulate	negative	mir-133a	539.4526	809.515	809.515	miRNA		Downregulation of both miR-223-5p and miR-19-b1-5p were correlated with the presence of lymph node metastasis ; downregulation of miR-100-3p and miR-19-b1-5p were correlated with presence of vascular invasion ; overexpression of miR-519b and miR-133a were associated with advanced FIGO staging .
460	downregulate	negative	 figo staging	522.5786	796.6603	796.6603	Cancer	D016609	Downregulation of both miR-223-5p and miR-19-b1-5p were correlated with the presence of lymph node metastasis ; downregulation of miR-100-3p and miR-19-b1-5p were correlated with presence of vascular invasion ; overexpression of miR-519b and miR-133a were associated with advanced FIGO staging .
457	downregulate	negative	mir-100	1186.706	668.1614	668.1614	miRNA		Downregulation of both miR-223-5p and miR-19-b1-5p were correlated with the presence of lymph node metastasis ; downregulation of miR-100-3p and miR-19-b1-5p were correlated with presence of vascular invasion ; overexpression of miR-519b and miR-133a were associated with advanced FIGO staging .
457	downregulate	negative	 figo staging	522.5786	796.6603	796.6603	Cancer	D016609	Downregulation of both miR-223-5p and miR-19-b1-5p were correlated with the presence of lymph node metastasis ; downregulation of miR-100-3p and miR-19-b1-5p were correlated with presence of vascular invasion ; overexpression of miR-519b and miR-133a were associated with advanced FIGO staging .
455	downregulate	negative	mir-223	526.7392	799.9493	799.9493	miRNA		Downregulation of both miR-223-5p and miR-19-b1-5p were correlated with the presence of lymph node metastasis ; downregulation of miR-100-3p and miR-19-b1-5p were correlated with presence of vascular invasion ; overexpression of miR-519b and miR-133a were associated with advanced FIGO staging .
455	downregulate	negative	 figo staging	522.5786	796.6603	796.6603	Cancer	D016609	Downregulation of both miR-223-5p and miR-19-b1-5p were correlated with the presence of lymph node metastasis ; downregulation of miR-100-3p and miR-19-b1-5p were correlated with presence of vascular invasion ; overexpression of miR-519b and miR-133a were associated with advanced FIGO staging .
1736	inhibit	negative	mir-223	526.7392	799.9493	799.9493	miRNA		In conclusion , miR-223 inhibited cell metastasis of human cervical cancer by modulating epithelial-mesenchymal transition .
1736	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In conclusion , miR-223 inhibited cell metastasis of human cervical cancer by modulating epithelial-mesenchymal transition .
1735	inhibit	negative	mir-223	526.7392	799.9493	799.9493	miRNA		In conclusion , miR-223 inhibited cell metastasis of human cervical cancer by modulating epithelial-mesenchymal transition .
1735	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In conclusion , miR-223 inhibited cell metastasis of human cervical cancer by modulating epithelial-mesenchymal transition .
1734	inhibit	negative	mir-223	526.7392	799.9493	799.9493	miRNA		MiR-223 inhibited cell metastasis of human cervical cancer by modulating epithelial-mesenchymal transition .
1734	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-223 inhibited cell metastasis of human cervical cancer by modulating epithelial-mesenchymal transition .
531	downregulate	negative	mir-223	526.7392	799.9493	799.9493	miRNA		Downregulation of miR-223 in HCC is associated with the epigenetic regulation by highly expressed sulfatide and involved in tumor metastasis .
531	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Downregulation of miR-223 in HCC is associated with the epigenetic regulation by highly expressed sulfatide and involved in tumor metastasis .
530	inhibit	negative	mir-223	526.7392	799.9493	799.9493	miRNA		In vivo assays of metastasis in an orthotopically implanted model demonstrated that miR-223 effectively inhibited HCC metastasis .
530	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In vivo assays of metastasis in an orthotopically implanted model demonstrated that miR-223 effectively inhibited HCC metastasis .
1652	control	neutral	mir-92a	530.9388	803.1884	803.1884	miRNA		We found that rs9589207 in miR-92a was involved in the occurrence of GC by acting as a tumor protective factor and was highly associated with tumor size in GC patients instead of tumor number or metastasis in 554 GC patients and 531 cancer-free controls .
1652	control	neutral	gc	1242.449	487.0825	487.0825	Cancer	D061325	We found that rs9589207 in miR-92a was involved in the occurrence of GC by acting as a tumor protective factor and was highly associated with tumor size in GC patients instead of tumor number or metastasis in 554 GC patients and 531 cancer-free controls .
1607	promote	positive	mir-92a	530.9388	803.1884	803.1884	miRNA		Taken together , these findings suggested that miR-92a could promote growth , metastasis , and chemoresistance in NSCLC cells at least partially by targeting PTEN .
1607	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , these findings suggested that miR-92a could promote growth , metastasis , and chemoresistance in NSCLC cells at least partially by targeting PTEN .
1606	upregulate	positive	mir-92a	530.9388	803.1884	803.1884	miRNA		We found that miR-92a was significantly upregulated in NSCLC tissues compared to matched adjacent normal lung tissues , and its expression is significantly associated with clinical characteristics of patients , including tumor , node , and metastasis ( TNM ) stage ; tumor size ; and lymph node metastasis ( all P ? < ? 0.01 ) .
1606	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	We found that miR-92a was significantly upregulated in NSCLC tissues compared to matched adjacent normal lung tissues , and its expression is significantly associated with clinical characteristics of patients , including tumor , node , and metastasis ( TNM ) stage ; tumor size ; and lymph node metastasis ( all P ? < ? 0.01 ) .
1605	upregulate	positive	mir-92a	530.9388	803.1884	803.1884	miRNA		We found that miR-92a was significantly upregulated in NSCLC tissues compared to matched adjacent normal lung tissues , and its expression is significantly associated with clinical characteristics of patients , including tumor , node , and metastasis ( TNM ) stage ; tumor size ; and lymph node metastasis ( all P ? < ? 0.01 ) .
1605	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	We found that miR-92a was significantly upregulated in NSCLC tissues compared to matched adjacent normal lung tissues , and its expression is significantly associated with clinical characteristics of patients , including tumor , node , and metastasis ( TNM ) stage ; tumor size ; and lymph node metastasis ( all P ? < ? 0.01 ) .
1091	promote	positive	mir-92a	530.9388	803.1884	803.1884	miRNA		MiR-92a Promotes Cell Metastasis of Colorectal Cancer Through PTEN-Mediated PI3K/AKT Pathway .
1091	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-92a Promotes Cell Metastasis of Colorectal Cancer Through PTEN-Mediated PI3K/AKT Pathway .
723	downregulate	negative	mir-92a	530.9388	803.1884	803.1884	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
723	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
722	downregulate	negative	mir-92a	530.9388	803.1884	803.1884	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
722	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
450	upregulate	positive	mir-92a	530.9388	803.1884	803.1884	miRNA		The expression of miR-92a was significantly up-regulated in the tissues of CRC patients with lymph node metastasis .
450	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The expression of miR-92a was significantly up-regulated in the tissues of CRC patients with lymph node metastasis .
1197	inhibit	negative	mir-146a/b	535.1768	806.3771	806.3771	miRNA		Although FOXP3 significantly inhibited breast tumor growth and migration in vitro and metastasis in vivo , FOXP3-induced miR-146a/b contributed only to the inhibition of breast tumor growth .
1197	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Although FOXP3 significantly inhibited breast tumor growth and migration in vitro and metastasis in vivo , FOXP3-induced miR-146a/b contributed only to the inhibition of breast tumor growth .
430	block	negative	mir-146a/b	535.1768	806.3771	806.3771	miRNA		The newly identified miR-146a/b/UHRF1 axis provides insight into the GC metastasis process , and targeting this novel axis represents a therapeutic approach to blocking GC metastasis .
430	block	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	The newly identified miR-146a/b/UHRF1 axis provides insight into the GC metastasis process , and targeting this novel axis represents a therapeutic approach to blocking GC metastasis .
429	regulate	positive	mir-146a/b	535.1768	806.3771	806.3771	miRNA		Regulation of UHRF1 by miR-146a/b modulates gastric cancer invasion and metastasis .
429	regulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	Regulation of UHRF1 by miR-146a/b modulates gastric cancer invasion and metastasis .
1851	suppress	negative	mir-133a	539.4526	809.515	809.515	miRNA		MiR-133a suppresses osteosarcoma progression and metastasis by targeting IGF-1R in human osteosarcoma cells , providing a novel candidate prognostic factor and a potential anti-metastasis therapeutic target in osteosarcoma .
1851	suppress	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	MiR-133a suppresses osteosarcoma progression and metastasis by targeting IGF-1R in human osteosarcoma cells , providing a novel candidate prognostic factor and a potential anti-metastasis therapeutic target in osteosarcoma .
1850	effect	neutral	mir-133a	539.4526	809.515	809.515	miRNA		MiR-133a was lower expressed in human osteosarcoma cell lines than human normal osteoblastic cell line hFOB and its effect on inhibiting proliferation , invasion and metastasis is mediated by its direct interaction with the IGF-1R .
1850	effect	neutral	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	MiR-133a was lower expressed in human osteosarcoma cell lines than human normal osteoblastic cell line hFOB and its effect on inhibiting proliferation , invasion and metastasis is mediated by its direct interaction with the IGF-1R .
1583	inhibit	negative	mir-133a	539.4526	809.515	809.515	miRNA		In conclusion , matrine inhibited the invasion and metastasis of lung cancer cell by elevating expression of miR-133a which further suppressed activation of EGFR/Akt/MMP-9 pathway .
1583	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In conclusion , matrine inhibited the invasion and metastasis of lung cancer cell by elevating expression of miR-133a which further suppressed activation of EGFR/Akt/MMP-9 pathway .
1439	downregulate	negative	mir-133a	539.4526	809.515	809.515	miRNA		We find that miR-133a was downregulated in HCC tissues and cell lines and that miR-133a expression negatively correlated with tumor differentiation ( P ? < ? 0.01 ) , TNM stage ( P ? < ? 0.01 ) , and lymph node metastasis ( P ? < ? 0.01 ) .
1439	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We find that miR-133a was downregulated in HCC tissues and cell lines and that miR-133a expression negatively correlated with tumor differentiation ( P ? < ? 0.01 ) , TNM stage ( P ? < ? 0.01 ) , and lymph node metastasis ( P ? < ? 0.01 ) .
1438	downregulate	negative	mir-133a	539.4526	809.515	809.515	miRNA		We find that miR-133a was downregulated in HCC tissues and cell lines and that miR-133a expression negatively correlated with tumor differentiation ( P ? < ? 0.01 ) , TNM stage ( P ? < ? 0.01 ) , and lymph node metastasis ( P ? < ? 0.01 ) .
1438	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We find that miR-133a was downregulated in HCC tissues and cell lines and that miR-133a expression negatively correlated with tumor differentiation ( P ? < ? 0.01 ) , TNM stage ( P ? < ? 0.01 ) , and lymph node metastasis ( P ? < ? 0.01 ) .
1431	downregulate	negative	mir-133a	539.4526	809.515	809.515	miRNA		We found that the expression level of miR ? 133a was significantly downregulated in cervical cancer tissues and cervical cancer cell lines , and the aberrant expression of miR-133a was correlated with lymph node metastasis , histological grade and FIGO ? stage .
1431	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We found that the expression level of miR ? 133a was significantly downregulated in cervical cancer tissues and cervical cancer cell lines , and the aberrant expression of miR-133a was correlated with lymph node metastasis , histological grade and FIGO ? stage .
802	downregulate	negative	mir-133a	539.4526	809.515	809.515	miRNA		Marked downregulation of miR-133a was observed in the OVCAR-3 cell line and primary tumor samples , and it was found that reduced miR-133a expression significantly correlated with advanced clinical stages , poor histological differentiation and lymph node metastasis .
802	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Marked downregulation of miR-133a was observed in the OVCAR-3 cell line and primary tumor samples , and it was found that reduced miR-133a expression significantly correlated with advanced clinical stages , poor histological differentiation and lymph node metastasis .
658	suppress	negative	mir-133a	539.4526	809.515	809.515	miRNA		Silencing of miR-133a with locked nucleic acid ( LNA ) reduced cell invasion of this cell population , and systemic administration of LNA along with chemotherapy suppressed lung metastasis and prolonged the survival of osteosarcoma-bearing mice .
658	suppress	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Silencing of miR-133a with locked nucleic acid ( LNA ) reduced cell invasion of this cell population , and systemic administration of LNA along with chemotherapy suppressed lung metastasis and prolonged the survival of osteosarcoma-bearing mice .
657	suppress	negative	mir-133a	539.4526	809.515	809.515	miRNA		Silencing of miR-133a with locked nucleic acid ( LNA ) reduced cell invasion of this cell population , and systemic administration of LNA along with chemotherapy suppressed lung metastasis and prolonged the survival of osteosarcoma-bearing mice .
657	suppress	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Silencing of miR-133a with locked nucleic acid ( LNA ) reduced cell invasion of this cell population , and systemic administration of LNA along with chemotherapy suppressed lung metastasis and prolonged the survival of osteosarcoma-bearing mice .
425	repress	negative	mir-133a	539.4526	809.515	809.515	miRNA		miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway .
425	repress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway .
1619	promote	positive	microrna-214	543.7656	812.6016	812.6016	miRNA		microRNA-214 promotes epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressor-of-fused protein ( Sufu ) .
1619	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	microRNA-214 promotes epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressor-of-fused protein ( Sufu ) .
1618	promote	positive	microrna-214	543.7656	812.6016	812.6016	miRNA		microRNA-214 promotes epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressor-of-fused protein ( Sufu ) .
1618	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	microRNA-214 promotes epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressor-of-fused protein ( Sufu ) .
613	regulate	positive	microrna-214	543.7656	812.6016	812.6016	miRNA		Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression .
613	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression .
612	regulate	positive	microrna-214	543.7656	812.6016	812.6016	miRNA		Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression .
612	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression .
608	downregulate	negative	microrna-214	543.7656	812.6016	812.6016	miRNA		Stepwise downregulation of microRNA-214 expression was observed among nontumourous gastric mucosa , nonmetastasis gastric cancer tissues , and metastasis gastric cancer tissues .
608	downregulate	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Stepwise downregulation of microRNA-214 expression was observed among nontumourous gastric mucosa , nonmetastasis gastric cancer tissues , and metastasis gastric cancer tissues .
607	downregulate	negative	microrna-214	543.7656	812.6016	812.6016	miRNA		Stepwise downregulation of microRNA-214 expression was observed among nontumourous gastric mucosa , nonmetastasis gastric cancer tissues , and metastasis gastric cancer tissues .
607	downregulate	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Stepwise downregulation of microRNA-214 expression was observed among nontumourous gastric mucosa , nonmetastasis gastric cancer tissues , and metastasis gastric cancer tissues .
424	downregulate	negative	microrna-214	543.7656	812.6016	812.6016	miRNA		Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis .
424	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis .
411	suppress	negative	mirna-29c	548.1151	815.6364	815.6364	miRNA		miRNA-29c suppresses lung cancer cell adhesion to extracellular matrix and metastasis by targeting integrin ?] 1 and matrix metalloproteinase2 ( MMP2 ) .
411	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miRNA-29c suppresses lung cancer cell adhesion to extracellular matrix and metastasis by targeting integrin ?] 1 and matrix metalloproteinase2 ( MMP2 ) .
410	regulate	positive	mirna-768	552.5006	818.6191	818.6191	miRNA		The brain microenvironment negatively regulates miRNA-768-3p to promote K-ras expression and lung cancer metastasis .
410	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The brain microenvironment negatively regulates miRNA-768-3p to promote K-ras expression and lung cancer metastasis .
1520	promote	positive	mir-205	556.9214	821.5492	821.5492	miRNA		MiR-205 , acting as an oncogenic miRNA , may promote the clinical progression of EOC patients and enhance the cellular motility in vitro by directly and negatively regulating ZEB1 , providing a potential therapeutic strategy for suppression of EOC metastasis .
1520	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-205 , acting as an oncogenic miRNA , may promote the clinical progression of EOC patients and enhance the cellular motility in vitro by directly and negatively regulating ZEB1 , providing a potential therapeutic strategy for suppression of EOC metastasis .
1227	suppress	negative	mir-205	556.9214	821.5492	821.5492	miRNA		Importantly , pterostilbene suppressed tumor growth and metastasis in MDA-MB-231-bearing NOD/SCID mice by reducing Src/Fak signaling ; this observation was consistent with the negative correlations between miR-205 and Src expression in both normal and malignant breast tissues .
1227	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Importantly , pterostilbene suppressed tumor growth and metastasis in MDA-MB-231-bearing NOD/SCID mice by reducing Src/Fak signaling ; this observation was consistent with the negative correlations between miR-205 and Src expression in both normal and malignant breast tissues .
1225	upregulate	positive	mir-205	556.9214	821.5492	821.5492	miRNA		Serum miR-205 was significantly upregulated in cervical cancer patients compared with healthy donors ( p ? < ? 0.01 ) , and a high level of miR-205 expression was correlated with poor tumor differentiation ( p ? = ? 0.009 ) , lymph node metastasis ( p ? = ? 0.015 ) and increased tumor stage ( p ? = ? 0.001 ) .
1225	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Serum miR-205 was significantly upregulated in cervical cancer patients compared with healthy donors ( p ? < ? 0.01 ) , and a high level of miR-205 expression was correlated with poor tumor differentiation ( p ? = ? 0.009 ) , lymph node metastasis ( p ? = ? 0.015 ) and increased tumor stage ( p ? = ? 0.001 ) .
557	regulate	positive	mir-205	556.9214	821.5492	821.5492	miRNA		TMPRSS4 regulates levels of integrin 帢5 in NSCLC through miR-205 activity to promote metastasis .
557	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	TMPRSS4 regulates levels of integrin 帢5 in NSCLC through miR-205 activity to promote metastasis .
501	downregulate	negative	mir-205	556.9214	821.5492	821.5492	miRNA		Nevertheless , down-regulation of miR-205 in primary PCa was not correlated to the synchronous presence of metastasis and failed to predict the outcome for HRPCa patients .
501	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Nevertheless , down-regulation of miR-205 in primary PCa was not correlated to the synchronous presence of metastasis and failed to predict the outcome for HRPCa patients .
500	downregulate	negative	mir-205	556.9214	821.5492	821.5492	miRNA		Nevertheless , down-regulation of miR-205 in primary PCa was not correlated to the synchronous presence of metastasis and failed to predict the outcome for HRPCa patients .
500	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Nevertheless , down-regulation of miR-205 in primary PCa was not correlated to the synchronous presence of metastasis and failed to predict the outcome for HRPCa patients .
499	downregulate	negative	mir-205	556.9214	821.5492	821.5492	miRNA		MiR-205 is progressively down-regulated in lymph node metastasis but fails as a prognostic biomarker in high-risk prostate cancer .
499	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-205 is progressively down-regulated in lymph node metastasis but fails as a prognostic biomarker in high-risk prostate cancer .
475	promote	positive	mir-205	556.9214	821.5492	821.5492	miRNA		miR-205 promotes the growth , metastasis and chemoresistance of NSCLC cells by targeting PTEN .
475	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-205 promotes the growth , metastasis and chemoresistance of NSCLC cells by targeting PTEN .
474	promote	positive	mir-205	556.9214	821.5492	821.5492	miRNA		miR-205 promotes the growth , metastasis and chemoresistance of NSCLC cells by targeting PTEN .
474	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-205 promotes the growth , metastasis and chemoresistance of NSCLC cells by targeting PTEN .
409	block	negative	mir-205	556.9214	821.5492	821.5492	miRNA		Overall , such findings suggest miR-205 as a brake against PCa metastasis by blocking both the afferent and efferent arms of the circuit between tumor cells and associated fibroblasts , thus interrupting the pro-oxidant and pro-inflammatory circuitries engaged by reactive stroma .
409	block	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Overall , such findings suggest miR-205 as a brake against PCa metastasis by blocking both the afferent and efferent arms of the circuit between tumor cells and associated fibroblasts , thus interrupting the pro-oxidant and pro-inflammatory circuitries engaged by reactive stroma .
1196	inhibit	negative	microrna-181a	561.3768	824.4262	824.4262	miRNA		MicroRNA-181a inhibits tumor proliferation , invasiveness , and metastasis and is downregulated in gastric cancer .
1196	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	MicroRNA-181a inhibits tumor proliferation , invasiveness , and metastasis and is downregulated in gastric cancer .
666	promote	positive	microrna-181a	561.3768	824.4262	824.4262	miRNA		MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1 .
666	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1 .
407	suppress	negative	microrna-181a	561.3768	824.4262	824.4262	miRNA		MicroRNA-181a suppresses salivary adenoid cystic carcinoma metastasis by targeting MAPK-Snai2 pathway .
407	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-181a suppresses salivary adenoid cystic carcinoma metastasis by targeting MAPK-Snai2 pathway .
1879	regulate	positive	mir-206	565.8664	827.2498	827.2498	miRNA		MiR-206 can regulate the expression of Cx43 , the cytobiological activity , and the metastasis of breast cancer through binding to the two binding sites in Cx43-3'UTR : position 478-484 and position 1609-1615 .
1879	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-206 can regulate the expression of Cx43 , the cytobiological activity , and the metastasis of breast cancer through binding to the two binding sites in Cx43-3'UTR : position 478-484 and position 1609-1615 .
1878	react	neutral	mir-206	565.8664	827.2498	827.2498	miRNA		Using quantitative real-time polymerase chain reaction and Western blot , the expressions of miR-206 and Cx43 were determined in breast cancer tissues , hepatic and pulmonary metastasis ( PM ) , and cell lines ( MCF-10A , MCF-7 , and MDA-MB-231 ) .
1878	react	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Using quantitative real-time polymerase chain reaction and Western blot , the expressions of miR-206 and Cx43 were determined in breast cancer tissues , hepatic and pulmonary metastasis ( PM ) , and cell lines ( MCF-10A , MCF-7 , and MDA-MB-231 ) .
1877	react	neutral	mir-206	565.8664	827.2498	827.2498	miRNA		Using quantitative real-time polymerase chain reaction and Western blot , the expressions of miR-206 and Cx43 were determined in breast cancer tissues , hepatic and pulmonary metastasis ( PM ) , and cell lines ( MCF-10A , MCF-7 , and MDA-MB-231 ) .
1877	react	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Using quantitative real-time polymerase chain reaction and Western blot , the expressions of miR-206 and Cx43 were determined in breast cancer tissues , hepatic and pulmonary metastasis ( PM ) , and cell lines ( MCF-10A , MCF-7 , and MDA-MB-231 ) .
1876	effect	neutral	mir-206	565.8664	827.2498	827.2498	miRNA		It remains unclear whether the regulatory effect of miR-206 on Cx43 is involved in metastasis of breast cancer .
1876	effect	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	It remains unclear whether the regulatory effect of miR-206 on Cx43 is involved in metastasis of breast cancer .
1664	inhibit	negative	mir-206	565.8664	827.2498	827.2498	miRNA		miR-206 also inhibited cell invasion and lung metastasis in CRC cells .
1664	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-206 also inhibited cell invasion and lung metastasis in CRC cells .
1663	downregulate	negative	mir-206	565.8664	827.2498	827.2498	miRNA		miR-206 was significantly down-regulated in CRC tissues and correlated closely with differentiation , lymphatic metastasis and serosal invasion .
1663	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-206 was significantly down-regulated in CRC tissues and correlated closely with differentiation , lymphatic metastasis and serosal invasion .
1662	effect	neutral	mir-206	565.8664	827.2498	827.2498	miRNA		A series of loss-of-function and gain-of-function assays were performed to evaluate the effect of miR-206 on the proliferation , invasion and metastasis of CRC cells .
1662	effect	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	A series of loss-of-function and gain-of-function assays were performed to evaluate the effect of miR-206 on the proliferation , invasion and metastasis of CRC cells .
1413	enhance	positive	mir-206	565.8664	827.2498	827.2498	miRNA		In conclusion , our study provided a miRNA-gene regulatory network in lung cancer metastasis and further demonstrated the roles of miR-206 and MET in this process , which enhances the understanding of the regulatory mechanism in lung cancer metastasis .
1413	enhance	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In conclusion , our study provided a miRNA-gene regulatory network in lung cancer metastasis and further demonstrated the roles of miR-206 and MET in this process , which enhances the understanding of the regulatory mechanism in lung cancer metastasis .
1412	inhibit	negative	mir-206	565.8664	827.2498	827.2498	miRNA		Finally , we also demonstrated that miR-206 can significantly inhibit lung cancer proliferation and metastasis in mouse models .
1412	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Finally , we also demonstrated that miR-206 can significantly inhibit lung cancer proliferation and metastasis in mouse models .
1411	effect	neutral	mir-206	565.8664	827.2498	827.2498	miRNA		Furthermore , MET gene silence showed a similar anti-migration and anti-invasion effect with miR-206 mimics in 95D cells and could partially attenuate the migration- and invasion-promoting effect of miR-206 inhibitors in 95C cells , suggesting that miR-206 targets MET in lung cancer metastasis .
1411	effect	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Furthermore , MET gene silence showed a similar anti-migration and anti-invasion effect with miR-206 mimics in 95D cells and could partially attenuate the migration- and invasion-promoting effect of miR-206 inhibitors in 95C cells , suggesting that miR-206 targets MET in lung cancer metastasis .
1410	effect	neutral	mir-206	565.8664	827.2498	827.2498	miRNA		Furthermore , MET gene silence showed a similar anti-migration and anti-invasion effect with miR-206 mimics in 95D cells and could partially attenuate the migration- and invasion-promoting effect of miR-206 inhibitors in 95C cells , suggesting that miR-206 targets MET in lung cancer metastasis .
1410	effect	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Furthermore , MET gene silence showed a similar anti-migration and anti-invasion effect with miR-206 mimics in 95D cells and could partially attenuate the migration- and invasion-promoting effect of miR-206 inhibitors in 95C cells , suggesting that miR-206 targets MET in lung cancer metastasis .
1409	inhibit	negative	mir-206	565.8664	827.2498	827.2498	miRNA		Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis .
1409	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis .
1408	inhibit	negative	mir-206	565.8664	827.2498	827.2498	miRNA		Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis .
1408	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis .
1332	inhibit	negative	mir-206	565.8664	827.2498	827.2498	miRNA		Thus , we concluded that miR-206 inhibited invasion and metastasis by degrading MRTF-A in anaplastic thyroid cancer .
1332	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Thus , we concluded that miR-206 inhibited invasion and metastasis by degrading MRTF-A in anaplastic thyroid cancer .
1172	inhibit	negative	mir-206	565.8664	827.2498	827.2498	miRNA		MiR-206 inhibited GC metastasis by negatively regulating expression of PAX3 .
1172	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	MiR-206 inhibited GC metastasis by negatively regulating expression of PAX3 .
1171	suppress	negative	mir-206	565.8664	827.2498	827.2498	miRNA		Both gain- and loss-of-function studies confirmed that miR-206 significantly suppressed GC cell invasion and metastasis both in vitro and in vivo .
1171	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Both gain- and loss-of-function studies confirmed that miR-206 significantly suppressed GC cell invasion and metastasis both in vitro and in vivo .
1170	regulate	positive	mir-206	565.8664	827.2498	827.2498	miRNA		Here , we describe the function and regulation network of miR-206 in gastric cancer ( GC ) metastasis .
1170	regulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	Here , we describe the function and regulation network of miR-206 in gastric cancer ( GC ) metastasis .
1169	activate	positive	mir-206	565.8664	827.2498	827.2498	miRNA		Activation of PAX3-MET pathways due to miR-206 loss promotes gastric cancer metastasis .
1169	activate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	Activation of PAX3-MET pathways due to miR-206 loss promotes gastric cancer metastasis .
900	downregulate	negative	mir-206	565.8664	827.2498	827.2498	miRNA		Then , the downregulation of miR-133b and miR-206 both more frequently occurred in osteosarcoma patients with high tumor grade ( both P=0.01 ) , positive metastasis ( both P < 0.001 ) and recurrence ( both P < 0.001 ) .
900	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Then , the downregulation of miR-133b and miR-206 both more frequently occurred in osteosarcoma patients with high tumor grade ( both P=0.01 ) , positive metastasis ( both P < 0.001 ) and recurrence ( both P < 0.001 ) .
753	regulate	positive	mir-206	565.8664	827.2498	827.2498	miRNA		Taken together , our results indicate that miR-206 is a tumor suppressor of gastric cancer acting at steps that regulate metastasis .
753	regulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	Taken together , our results indicate that miR-206 is a tumor suppressor of gastric cancer acting at steps that regulate metastasis .
752	downregulate	negative	mir-206	565.8664	827.2498	827.2498	miRNA		Down-regulation of miR-206 was particularly significant in tumors with lymphatic metastasis , local invasion , and advanced TNM staging .
752	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Down-regulation of miR-206 was particularly significant in tumors with lymphatic metastasis , local invasion , and advanced TNM staging .
751	downregulate	negative	mir-206	565.8664	827.2498	827.2498	miRNA		Down-regulation of miR-206 was particularly significant in tumors with lymphatic metastasis , local invasion , and advanced TNM staging .
751	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Down-regulation of miR-206 was particularly significant in tumors with lymphatic metastasis , local invasion , and advanced TNM staging .
717	downregulate	negative	mir-206	565.8664	827.2498	827.2498	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
717	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
716	downregulate	negative	mir-206	565.8664	827.2498	827.2498	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
716	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
403	downregulate	negative	mir-206	565.8664	827.2498	827.2498	miRNA		We found that miR-206 was down-regulated in the osteosarcoma cell line MG63 and primary tumor samples , and decreased miR-206 expression was significantly associated with advanced clinical stage , T classification , metastasis and poor histological differentiation .
403	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	We found that miR-206 was down-regulated in the osteosarcoma cell line MG63 and primary tumor samples , and decreased miR-206 expression was significantly associated with advanced clinical stage , T classification , metastasis and poor histological differentiation .
1712	suppress	negative	microrna-148a	570.3893	830.0197	830.0197	miRNA		MicroRNA-148a Suppresses Invasion and Metastasis of Human Non-Small-Cell Lung Cancer .
1712	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-148a Suppresses Invasion and Metastasis of Human Non-Small-Cell Lung Cancer .
439	suppress	negative	microrna-148a	570.3893	830.0197	830.0197	miRNA		MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling .
439	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling .
397	suppress	negative	microrna-148a	570.3893	830.0197	830.0197	miRNA		microRNA-148a suppresses human gastric cancer cell metastasis by reversing epithelial-to-mesenchymal transition .
397	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	microRNA-148a suppresses human gastric cancer cell metastasis by reversing epithelial-to-mesenchymal transition .
1808	inhibit	negative	microrna-340	574.945	832.7352	832.7352	miRNA		MicroRNA-340 inhibits the migration , invasion , and metastasis of breast cancer cells by targeting Wnt pathway .
1808	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-340 inhibits the migration , invasion , and metastasis of breast cancer cells by targeting Wnt pathway .
1785	inhibit	negative	microrna-340	574.945	832.7352	832.7352	miRNA		MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway .
1785	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway .
396	suppress	negative	microrna-340	574.945	832.7352	832.7352	miRNA		MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1 .
396	suppress	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1 .
1905	suppress	negative	microrna-30a	579.5328	835.3962	835.3962	miRNA		MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer .
1905	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer .
685	regulate	positive	microrna-30a	579.5328	835.3962	835.3962	miRNA		Although microRNA-30a ( miR-30a ) has been shown to regulate cancer metastasis , the molecular mechanism has not yet been clearly elucidated in nasopharyngeal carcinoma ( NPC ) .
685	regulate	positive	npc	744.4573	890.5122	890.5122	Cancer	D010181	Although microRNA-30a ( miR-30a ) has been shown to regulate cancer metastasis , the molecular mechanism has not yet been clearly elucidated in nasopharyngeal carcinoma ( NPC ) .
684	promote	positive	microrna-30a	579.5328	835.3962	835.3962	miRNA		MicroRNA-30a promotes invasiveness and metastasis in ? vitro and in ? vivo through epithelial-mesenchymal transition and results in poor survival of nasopharyngeal carcinoma patients .
684	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-30a promotes invasiveness and metastasis in ? vitro and in ? vivo through epithelial-mesenchymal transition and results in poor survival of nasopharyngeal carcinoma patients .
522	inhibit	negative	microrna-30a	579.5328	835.3962	835.3962	miRNA		MicroRNA-30a-3p inhibits tumor proliferation , invasiveness and metastasis and is downregulated in hepatocellular carcinoma .
522	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-30a-3p inhibits tumor proliferation , invasiveness and metastasis and is downregulated in hepatocellular carcinoma .
389	suppress	negative	microrna-30a	579.5328	835.3962	835.3962	miRNA		MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin .
389	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin .
387	suppress	negative	mir30	584.152	838.0021	838.0021	miRNA		Lentiviral miR30-based RNA interference against heparanase suppresses melanoma metastasis with lower liver and lung toxicity .
387	suppress	negative	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	Lentiviral miR30-based RNA interference against heparanase suppresses melanoma metastasis with lower liver and lung toxicity .
386	suppress	negative	mirna-148a	588.8021	840.5527	840.5527	miRNA		By understanding the function and molecular mechanism of miRNA-148a in NSCLC , miRNA-148a may have therapeutic potential to suppress lung cancer metastasis .
386	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	By understanding the function and molecular mechanism of miRNA-148a in NSCLC , miRNA-148a may have therapeutic potential to suppress lung cancer metastasis .
825	inhibit	negative	mirna-200c	593.4823	843.0476	843.0476	miRNA		miRNA-200c inhibits invasion and metastasis of human non-small cell lung cancer by directly targeting ubiquitin specific peptidase 25 .
825	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miRNA-200c inhibits invasion and metastasis of human non-small cell lung cancer by directly targeting ubiquitin specific peptidase 25 .
384	effect	neutral	mirna-200c	593.4823	843.0476	843.0476	miRNA		The goal of this study was to investigate the effect of miRNA-200c overexpression on the EMT , tumorigenicity and metastasis of epithelial ovarian cancer ( EOC ) CSCs .
384	effect	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	The goal of this study was to investigate the effect of miRNA-200c overexpression on the EMT , tumorigenicity and metastasis of epithelial ovarian cancer ( EOC ) CSCs .
383	effect	neutral	mirna-200c	593.4823	843.0476	843.0476	miRNA		The goal of this study was to investigate the effect of miRNA-200c overexpression on the EMT , tumorigenicity and metastasis of epithelial ovarian cancer ( EOC ) CSCs .
383	effect	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	The goal of this study was to investigate the effect of miRNA-200c overexpression on the EMT , tumorigenicity and metastasis of epithelial ovarian cancer ( EOC ) CSCs .
1917	inhibit	negative	microrna-200c	598.192	845.4865	845.4865	miRNA		MicroRNA-200c inhibits the metastasis of non-small cell lung cancer cells by targeting ZEB2 , an epithelial-mesenchymal transition regulator .
1917	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-200c inhibits the metastasis of non-small cell lung cancer cells by targeting ZEB2 , an epithelial-mesenchymal transition regulator .
1916	inhibit	negative	microrna-200c	598.192	845.4865	845.4865	miRNA		MicroRNA-200c inhibits the metastasis of non-small cell lung cancer cells by targeting ZEB2 , an epithelial-mesenchymal transition regulator .
1916	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-200c inhibits the metastasis of non-small cell lung cancer cells by targeting ZEB2 , an epithelial-mesenchymal transition regulator .
661	inhibit	negative	microrna-200c	598.192	845.4865	845.4865	miRNA		The microRNA-200c ( miR-200c ) , which is frequently lowly expressed in triple negative breast cancers ( TNBCs ) , inhibits metastasis by inducing the mesenchymal to epithelial transition ( MET ) .
661	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The microRNA-200c ( miR-200c ) , which is frequently lowly expressed in triple negative breast cancers ( TNBCs ) , inhibits metastasis by inducing the mesenchymal to epithelial transition ( MET ) .
660	inhibit	negative	microrna-200c	598.192	845.4865	845.4865	miRNA		The microRNA-200c ( miR-200c ) , which is frequently lowly expressed in triple negative breast cancers ( TNBCs ) , inhibits metastasis by inducing the mesenchymal to epithelial transition ( MET ) .
660	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The microRNA-200c ( miR-200c ) , which is frequently lowly expressed in triple negative breast cancers ( TNBCs ) , inhibits metastasis by inducing the mesenchymal to epithelial transition ( MET ) .
382	inhibit	negative	microrna-200c	598.192	845.4865	845.4865	miRNA		MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition .
382	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition .
381	inhibit	negative	microrna-19a	602.9304	847.8688	847.8688	miRNA		MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene .
381	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene .
1640	inhibit	negative	mir-134	607.697	850.1944	850.1944	miRNA		We found that HIFU treatment decreased circulating B16F10 cells and pulmonary metastasis nodules while increased IFN-帠 and TNF-帢 in the peripheral blood and cumulative mouse survival , which was associated with inhibition of miR-134 expression and activation of CD86 expression in tumor tissues .
1640	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We found that HIFU treatment decreased circulating B16F10 cells and pulmonary metastasis nodules while increased IFN-帠 and TNF-帢 in the peripheral blood and cumulative mouse survival , which was associated with inhibition of miR-134 expression and activation of CD86 expression in tumor tissues .
1639	inhibit	negative	mir-134	607.697	850.1944	850.1944	miRNA		We found that HIFU treatment decreased circulating B16F10 cells and pulmonary metastasis nodules while increased IFN-帠 and TNF-帢 in the peripheral blood and cumulative mouse survival , which was associated with inhibition of miR-134 expression and activation of CD86 expression in tumor tissues .
1639	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We found that HIFU treatment decreased circulating B16F10 cells and pulmonary metastasis nodules while increased IFN-帠 and TNF-帢 in the peripheral blood and cumulative mouse survival , which was associated with inhibition of miR-134 expression and activation of CD86 expression in tumor tissues .
1249	affect	neutral	mir-134	607.697	850.1944	850.1944	miRNA		Western blot was used to identify the potential signaling pathways that had an impact on RCC cell growth and alterations of markers for epithelial-mesenchymal transition ( EMT ) , which affected metastasis by miR-134 .
1249	affect	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Western blot was used to identify the potential signaling pathways that had an impact on RCC cell growth and alterations of markers for epithelial-mesenchymal transition ( EMT ) , which affected metastasis by miR-134 .
578	suppress	negative	mir-134	607.697	850.1944	850.1944	miRNA		Further investigation revealed that miR-134 suppressed the invasion and metastasis of HCC cells in vitro and in vivo , and integrin beta 1 ( ITGB1 ) was a direct and functional target gene of miR-134 .
578	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Further investigation revealed that miR-134 suppressed the invasion and metastasis of HCC cells in vitro and in vivo , and integrin beta 1 ( ITGB1 ) was a direct and functional target gene of miR-134 .
378	enhance	positive	mir-134	607.697	850.1944	850.1944	miRNA		Ectopic miR-134 expression significantly enhanced in vitro oncogenic phenotypes and the orthotopic growth and metastasis of HNSCC cells .
378	enhance	positive	hnscc	1221.107	590.7296	590.7296	Cancer	D006258	Ectopic miR-134 expression significantly enhanced in vitro oncogenic phenotypes and the orthotopic growth and metastasis of HNSCC cells .
377	induce	positive	mir-134	607.697	850.1944	850.1944	miRNA		miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene .
377	induce	positive	hnscc	1221.107	590.7296	590.7296	Cancer	D006258	miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene .
1674	upregulate	positive	mir-221	612.491	852.4629	852.4629	miRNA		In endometrial cancer cells , expression levels of miRNAs including miR-185 , miR-210 and miR-423 are upregulated and those of miR-let7e , miR-30c and miR-221 are downregulated compared to normal tissues , and these miRNAs are involved in carcinogenesis , invasion and metastasis .
1674	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In endometrial cancer cells , expression levels of miRNAs including miR-185 , miR-210 and miR-423 are upregulated and those of miR-let7e , miR-30c and miR-221 are downregulated compared to normal tissues , and these miRNAs are involved in carcinogenesis , invasion and metastasis .
1654	promote	positive	mir-221	612.491	852.4629	852.4629	miRNA		In the present study we demonstrated that miR-221 promoted EHCC invasion and metastasis through targeting PTEN and formed a positive feedback loop with ?] -catenin/c-Jun signaling pathway .
1654	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In the present study we demonstrated that miR-221 promoted EHCC invasion and metastasis through targeting PTEN and formed a positive feedback loop with ?] -catenin/c-Jun signaling pathway .
1653	promote	positive	mir-221	612.491	852.4629	852.4629	miRNA		In the present study we demonstrated that miR-221 promoted EHCC invasion and metastasis through targeting PTEN and formed a positive feedback loop with ?] -catenin/c-Jun signaling pathway .
1653	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In the present study we demonstrated that miR-221 promoted EHCC invasion and metastasis through targeting PTEN and formed a positive feedback loop with ?] -catenin/c-Jun signaling pathway .
1057	upregulate	positive	mir-221	612.491	852.4629	852.4629	miRNA		In HCC , miR-221 was shown to be up-regulated in more than 70 % of the cases and was associated with higher tumor stage , metastasis and a shorter time to recurrence after surgery , suggesting an important pathogenic role .
1057	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In HCC , miR-221 was shown to be up-regulated in more than 70 % of the cases and was associated with higher tumor stage , metastasis and a shorter time to recurrence after surgery , suggesting an important pathogenic role .
521	promote	positive	mir-221	612.491	852.4629	852.4629	miRNA		These findings indicate that miR-221 may promote trastuzumab resistance and metastasis of HER2-positive breast cancers by targeting PTEN , suggesting its role as a potential biomarker for progression and poor prognosis , and as a novel target for trastuzumab-combined treatment of breast cancers .
521	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	These findings indicate that miR-221 may promote trastuzumab resistance and metastasis of HER2-positive breast cancers by targeting PTEN , suggesting its role as a potential biomarker for progression and poor prognosis , and as a novel target for trastuzumab-combined treatment of breast cancers .
520	inhibit	negative	mir-221	612.491	852.4629	852.4629	miRNA		Here , we found that the oncogenic miRNA , miR-221 , inhibited apoptosis , induced trastuzumab resistance and promoted metastasis of HER2-positive breast cancers .
520	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here , we found that the oncogenic miRNA , miR-221 , inhibited apoptosis , induced trastuzumab resistance and promoted metastasis of HER2-positive breast cancers .
519	promote	positive	mir-221	612.491	852.4629	852.4629	miRNA		MiR-221 promotes trastuzumab-resistance and metastasis in HER2-positive breast cancers by targeting PTEN .
519	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-221 promotes trastuzumab-resistance and metastasis in HER2-positive breast cancers by targeting PTEN .
510	upregulate	positive	mir-221	612.491	852.4629	852.4629	miRNA		We provide insight into the behavior of miR-221 in colorectal cancer ( CRC ) metastasis by showing that miR-221 is significantly upregulated in metastatic CRC cell lines and tissues .
510	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We provide insight into the behavior of miR-221 in colorectal cancer ( CRC ) metastasis by showing that miR-221 is significantly upregulated in metastatic CRC cell lines and tissues .
373	suppress	negative	mir-221	612.491	852.4629	852.4629	miRNA		Decreased levels of miR-224 and the passenger strand of miR-221 increase MBD2 , suppressing maspin and promoting colorectal tumor growth and metastasis in mice .
373	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Decreased levels of miR-224 and the passenger strand of miR-221 increase MBD2 , suppressing maspin and promoting colorectal tumor growth and metastasis in mice .
1906	suppress	negative	mir-204	617.3118	854.674	854.674	miRNA		Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness , EMT traits , and lymph node metastasis .
1906	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness , EMT traits , and lymph node metastasis .
1798	suppress	negative	mir-204	617.3118	854.674	854.674	miRNA		Our study provided evidence that miR-204 may suppress the metastasis and invasion of GC cells through the regulation of the EMT process by targeting snai1 .
1798	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Our study provided evidence that miR-204 may suppress the metastasis and invasion of GC cells through the regulation of the EMT process by targeting snai1 .
1797	suppress	negative	mir-204	617.3118	854.674	854.674	miRNA		Our study provided evidence that miR-204 may suppress the metastasis and invasion of GC cells through the regulation of the EMT process by targeting snai1 .
1797	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Our study provided evidence that miR-204 may suppress the metastasis and invasion of GC cells through the regulation of the EMT process by targeting snai1 .
1796	downregulate	negative	mir-204	617.3118	854.674	854.674	miRNA		The over-expression of miR-204 or downregulation of snai1 could significantly inhibit the metastasis and invasion of GC cells both in vitro and in vivo .
1796	downregulate	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	The over-expression of miR-204 or downregulation of snai1 could significantly inhibit the metastasis and invasion of GC cells both in vitro and in vivo .
1705	inhibit	negative	mir-204	617.3118	854.674	854.674	miRNA		Furthermore , candidate biomarkers such as SOX11 and hsa-miR-204 which could cause cell proliferation but inhibit invasion or metastasis may be of importance in understanding the molecular mechanism of pancreatic oncogenesis and could be possible therapeutic targets for malignant pancreatic tumors .
1705	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Furthermore , candidate biomarkers such as SOX11 and hsa-miR-204 which could cause cell proliferation but inhibit invasion or metastasis may be of importance in understanding the molecular mechanism of pancreatic oncogenesis and could be possible therapeutic targets for malignant pancreatic tumors .
1432	inhibit	negative	mir-204	617.3118	854.674	854.674	miRNA		The effects of miR-204-5p on glioma cell growth and metastasis were examined by overexpressing or inhibiting miR-204-5p .
1432	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The effects of miR-204-5p on glioma cell growth and metastasis were examined by overexpressing or inhibiting miR-204-5p .
1152	effect	neutral	mir-204	617.3118	854.674	854.674	miRNA		We studied the effect of miR-204 modulation on master transcription factors important for lineage development , cell differentiation and prostate cancer bone marrow metastasis .
1152	effect	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We studied the effect of miR-204 modulation on master transcription factors important for lineage development , cell differentiation and prostate cancer bone marrow metastasis .
1042	inhibit	negative	mir-204	617.3118	854.674	854.674	miRNA		MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1 .
1042	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1 .
606	inhibit	negative	mir-204	617.3118	854.674	854.674	miRNA		Mir-204 inhibited EBV positive C666-1 cell invasion and metastasis partly through targeting cdc42 .
606	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Mir-204 inhibited EBV positive C666-1 cell invasion and metastasis partly through targeting cdc42 .
513	downregulate	negative	mir-204	617.3118	854.674	854.674	miRNA		miR-204 was frequently downregulated in human ICC , and the low-level expression of miR-204 was significantly associated with lymph node metastasis .
513	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-204 was frequently downregulated in human ICC , and the low-level expression of miR-204 was significantly associated with lymph node metastasis .
371	regulate	positive	mir-204	617.3118	854.674	854.674	miRNA		These data demonstrate that miR-204 plays an important role in regulating metastasis of gastric cancer , which is involved in post-transcriptional repression of SIRT1 .
371	regulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	These data demonstrate that miR-204 plays an important role in regulating metastasis of gastric cancer , which is involved in post-transcriptional repression of SIRT1 .
370	regulate	positive	mir-204	617.3118	854.674	854.674	miRNA		These data demonstrate that miR-204 plays an important role in regulating metastasis of gastric cancer , which is involved in post-transcriptional repression of SIRT1 .
370	regulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	These data demonstrate that miR-204 plays an important role in regulating metastasis of gastric cancer , which is involved in post-transcriptional repression of SIRT1 .
1979	control	neutral	mir-491	622.1586	856.8273	856.8273	miRNA		This study aimed to explore the roles of microRNA-491-5p ( miR-491 ) and its target MMP9 in the control of metastasis of osteosarcoma ( OS ) as well as how the rs1056629 polymorphism in the 3 ' untranslated region ( 3'UTR ) of MMP9 compromises the interaction between miR-491 and MMP9 .
1979	control	neutral	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	This study aimed to explore the roles of microRNA-491-5p ( miR-491 ) and its target MMP9 in the control of metastasis of osteosarcoma ( OS ) as well as how the rs1056629 polymorphism in the 3 ' untranslated region ( 3'UTR ) of MMP9 compromises the interaction between miR-491 and MMP9 .
1978	control	neutral	mir-491	622.1586	856.8273	856.8273	miRNA		This study aimed to explore the roles of microRNA-491-5p ( miR-491 ) and its target MMP9 in the control of metastasis of osteosarcoma ( OS ) as well as how the rs1056629 polymorphism in the 3 ' untranslated region ( 3'UTR ) of MMP9 compromises the interaction between miR-491 and MMP9 .
1978	control	neutral	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	This study aimed to explore the roles of microRNA-491-5p ( miR-491 ) and its target MMP9 in the control of metastasis of osteosarcoma ( OS ) as well as how the rs1056629 polymorphism in the 3 ' untranslated region ( 3'UTR ) of MMP9 compromises the interaction between miR-491 and MMP9 .
1389	downregulate	negative	mir-491	622.1586	856.8273	856.8273	miRNA		The results showed that miR-491-5p expression was significantly downregulated in cervical cancer tissues when compared with the corresponding adjacent normal tissues ( P < 0.001 ) , and the value was negatively associated with advanced International Federation of Gynecology and Obstetrics ( FIGO ) stage , high histological grading and lymph node metastasis ( P < 0.01 ) .
1389	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The results showed that miR-491-5p expression was significantly downregulated in cervical cancer tissues when compared with the corresponding adjacent normal tissues ( P < 0.001 ) , and the value was negatively associated with advanced International Federation of Gynecology and Obstetrics ( FIGO ) stage , high histological grading and lymph node metastasis ( P < 0.01 ) .
533	inhibit	negative	mir-491	622.1586	856.8273	856.8273	miRNA		Conversely , GIT1 silencing phenocopied the ability of miR-491-5p to inhibit migration/invasion and metastasis of OSCC cells .
533	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Conversely , GIT1 silencing phenocopied the ability of miR-491-5p to inhibit migration/invasion and metastasis of OSCC cells .
532	inhibit	negative	mir-491	622.1586	856.8273	856.8273	miRNA		GIT1 overexpression was sufficient to rescue miR-491-5p-mediated inhibition of migration/invasion and lung metastasis .
532	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	GIT1 overexpression was sufficient to rescue miR-491-5p-mediated inhibition of migration/invasion and lung metastasis .
365	block	negative	mir-491	622.1586	856.8273	856.8273	miRNA		Our results suggest that miR-491 is involved in metastasis of HCC by blocking EMT and decreasing MMP-9 levels , which may provide a new clue for preventing tumour metastasis of HCC .
365	block	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Our results suggest that miR-491 is involved in metastasis of HCC by blocking EMT and decreasing MMP-9 levels , which may provide a new clue for preventing tumour metastasis of HCC .
364	block	negative	mir-491	622.1586	856.8273	856.8273	miRNA		Our results suggest that miR-491 is involved in metastasis of HCC by blocking EMT and decreasing MMP-9 levels , which may provide a new clue for preventing tumour metastasis of HCC .
364	block	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Our results suggest that miR-491 is involved in metastasis of HCC by blocking EMT and decreasing MMP-9 levels , which may provide a new clue for preventing tumour metastasis of HCC .
1984	induction	positive	mir-203	627.0308	858.9225	858.9225	miRNA		We suggest that the induction of SRC results in increased PCa metastasis that is linked to the dysregulation of the AR signaling pathway through the inactivation of miR-203 .
1984	induction	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We suggest that the induction of SRC results in increased PCa metastasis that is linked to the dysregulation of the AR signaling pathway through the inactivation of miR-203 .
1821	promote	positive	mir-203	627.0308	858.9225	858.9225	miRNA		We have thus identified panels of miRNAs , which include metastasis promoting miR-200 family and miR-203 , as well as oncogenic and tumor-suppressive miRNAs , that can serve as prognostic markers for MBC , and early detection markers of metastasis in BC .
1821	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We have thus identified panels of miRNAs , which include metastasis promoting miR-200 family and miR-203 , as well as oncogenic and tumor-suppressive miRNAs , that can serve as prognostic markers for MBC , and early detection markers of metastasis in BC .
1820	promote	positive	mir-203	627.0308	858.9225	858.9225	miRNA		We have thus identified panels of miRNAs , which include metastasis promoting miR-200 family and miR-203 , as well as oncogenic and tumor-suppressive miRNAs , that can serve as prognostic markers for MBC , and early detection markers of metastasis in BC .
1820	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We have thus identified panels of miRNAs , which include metastasis promoting miR-200 family and miR-203 , as well as oncogenic and tumor-suppressive miRNAs , that can serve as prognostic markers for MBC , and early detection markers of metastasis in BC .
1781	enhance	positive	mir-203	627.0308	858.9225	858.9225	miRNA		MiR-203 may contribute to the metastasis and enhance apoptosis of HCC cells by regulating EZH2 and Bmi-1 .
1781	enhance	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-203 may contribute to the metastasis and enhance apoptosis of HCC cells by regulating EZH2 and Bmi-1 .
1526	regulate	positive	mir-203	627.0308	858.9225	858.9225	miRNA		From the miRNAs comprehensive regulatory network , we found that has-miR-203 regulated a large number of target genes and lncRNAs , including suppressor of cytokine signaling 3 ( SOCS3 ) and metastasis associated in lung adenocarcinoma transcript 1 ( MALAT1 ) .
1526	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	From the miRNAs comprehensive regulatory network , we found that has-miR-203 regulated a large number of target genes and lncRNAs , including suppressor of cytokine signaling 3 ( SOCS3 ) and metastasis associated in lung adenocarcinoma transcript 1 ( MALAT1 ) .
1466	suppress	negative	mir-203	627.0308	858.9225	858.9225	miRNA		miR-203 suppression in gastric carcinoma promotes Slug-mediated cancer metastasis .
1466	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-203 suppression in gastric carcinoma promotes Slug-mediated cancer metastasis .
1454	suppress	negative	mir-203	627.0308	858.9225	858.9225	miRNA		miR-203 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting oncogene ADAM9 and oncogenic long non-coding RNA HULC .
1454	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-203 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting oncogene ADAM9 and oncogenic long non-coding RNA HULC .
1298	downregulate	negative	mir-203	627.0308	858.9225	858.9225	miRNA		In contrast , down-regulation of miR-203 expression promoted renal cancer cell growth and metastasis ( P ? < ? 0.05 ) .
1298	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In contrast , down-regulation of miR-203 expression promoted renal cancer cell growth and metastasis ( P ? < ? 0.05 ) .
1297	inhibit	negative	mir-203	627.0308	858.9225	858.9225	miRNA		Transient forced expression of miR-203 inhibited renal cancer cell growth and metastasis ( P ? < ? 0.05 ) .
1297	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Transient forced expression of miR-203 inhibited renal cancer cell growth and metastasis ( P ? < ? 0.05 ) .
1157	inhibit	negative	mir-203	627.0308	858.9225	858.9225	miRNA		These findings provide further evidence that a crucial role for miR-203 in inhibiting metastasis of PCa through the suppression of Rap1A expression .
1157	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	These findings provide further evidence that a crucial role for miR-203 in inhibiting metastasis of PCa through the suppression of Rap1A expression .
1076	regulate	positive	mir-203	627.0308	858.9225	858.9225	miRNA		Taken together , our results demonstrated that miR-203 regulated melanoma invasive and proliferative abilities in part by targeting BMI1 , providing new insights into potential mechanisms of melanoma metastasis .
1076	regulate	positive	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	Taken together , our results demonstrated that miR-203 regulated melanoma invasive and proliferative abilities in part by targeting BMI1 , providing new insights into potential mechanisms of melanoma metastasis .
1075	regulate	positive	mir-203	627.0308	858.9225	858.9225	miRNA		In this study , we revealed a miR-203-BMI1 axis that regulated melanoma metastasis .
1075	regulate	positive	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	In this study , we revealed a miR-203-BMI1 axis that regulated melanoma metastasis .
973	inhibit	negative	mir-203	627.0308	858.9225	858.9225	miRNA		In vivo genetic reconstitution experiments show that miR-203 inhibits lung metastasis by suppressing the prometastatic activities of three factors involved in cytoskeletal dynamics ( LASP1 ) , extracellular matrix remodeling ( SPARC ) , and cell metabolism ( NUAK1 ) .
973	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	In vivo genetic reconstitution experiments show that miR-203 inhibits lung metastasis by suppressing the prometastatic activities of three factors involved in cytoskeletal dynamics ( LASP1 ) , extracellular matrix remodeling ( SPARC ) , and cell metabolism ( NUAK1 ) .
972	trigger	positive	mir-203	627.0308	858.9225	858.9225	miRNA		We report that miR-203 , a miRNA that triggers differentiation in multilayered epithelia , inhibits multiple postextravasation events during HNSCC lung metastasis .
972	trigger	positive	hnscc	1221.107	590.7296	590.7296	Cancer	D006258	We report that miR-203 , a miRNA that triggers differentiation in multilayered epithelia , inhibits multiple postextravasation events during HNSCC lung metastasis .
971	inhibit	negative	mir-203	627.0308	858.9225	858.9225	miRNA		Rewiring of an epithelial differentiation factor , miR-203 , to inhibit human squamous cell carcinoma metastasis .
971	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Rewiring of an epithelial differentiation factor , miR-203 , to inhibit human squamous cell carcinoma metastasis .
847	activate	positive	mir-203	627.0308	858.9225	858.9225	miRNA		We propose that the loss of miR-203 is a molecular link in the progression of prostate cancer metastasis and TKIs resistance characterized by high EGFR ligands output and anti-apoptotic proteins activation .
847	activate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We propose that the loss of miR-203 is a molecular link in the progression of prostate cancer metastasis and TKIs resistance characterized by high EGFR ligands output and anti-apoptotic proteins activation .
846	activate	positive	mir-203	627.0308	858.9225	858.9225	miRNA		We propose that the loss of miR-203 is a molecular link in the progression of prostate cancer metastasis and TKIs resistance characterized by high EGFR ligands output and anti-apoptotic proteins activation .
846	activate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We propose that the loss of miR-203 is a molecular link in the progression of prostate cancer metastasis and TKIs resistance characterized by high EGFR ligands output and anti-apoptotic proteins activation .
842	regulate	positive	mir-203	627.0308	858.9225	858.9225	miRNA		Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance .
842	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance .
841	regulate	positive	mir-203	627.0308	858.9225	858.9225	miRNA		Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance .
841	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance .
824	downregulate	negative	mir-203	627.0308	858.9225	858.9225	miRNA		In conclusion , our results have revealed a new regulatory mechanism that involves C/EBP?] -LIP-mediated downregulation of miR-203 , which plays a key role in EMT and metastasis .
824	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In conclusion , our results have revealed a new regulatory mechanism that involves C/EBP?] -LIP-mediated downregulation of miR-203 , which plays a key role in EMT and metastasis .
801	effect	neutral	mir-203	627.0308	858.9225	858.9225	miRNA		Therefore , the results demonstrated that miR-203 exhibited an inhibitory effect on MM cell migration via directly targeting versican , thus , may become an effective inhibitor for MM metastasis .
801	effect	neutral	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	Therefore , the results demonstrated that miR-203 exhibited an inhibitory effect on MM cell migration via directly targeting versican , thus , may become an effective inhibitor for MM metastasis .
363	downregulate	negative	mir-203	627.0308	858.9225	858.9225	miRNA		Aberrant expression of miR-20a was correlated with lymph node metastasis ( LNM ) , histological grade and tumor diameter , but down-regulated miR-203 was correlated with LNM only .
363	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Aberrant expression of miR-20a was correlated with lymph node metastasis ( LNM ) , histological grade and tumor diameter , but down-regulated miR-203 was correlated with LNM only .
1786	inhibit	negative	mir-339	631.9277	860.9595	860.9595	miRNA		miR-339-3p inhibits proliferation and metastasis of colorectal cancer .
1786	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-339-3p inhibits proliferation and metastasis of colorectal cancer .
1477	control	neutral	mir-339	631.9277	860.9595	860.9595	miRNA		Based on the results obtained in the last decade , some miRNAs are emerging as biomarkers of BC for diagnosis ( i.e. , miR-9 , miR-10b , and miR-17-5p ) , prognosis ( i.e. , miR-148a and miR-335 ) , and prediction of therapeutic outcomes ( i.e. , miR-30c , miR-187 , and miR-339-5p ) and have important roles in the control of BC hallmark functions such as invasion , metastasis , proliferation , resting death , apoptosis , and genomic instability .
1477	control	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Based on the results obtained in the last decade , some miRNAs are emerging as biomarkers of BC for diagnosis ( i.e. , miR-9 , miR-10b , and miR-17-5p ) , prognosis ( i.e. , miR-148a and miR-335 ) , and prediction of therapeutic outcomes ( i.e. , miR-30c , miR-187 , and miR-339-5p ) and have important roles in the control of BC hallmark functions such as invasion , metastasis , proliferation , resting death , apoptosis , and genomic instability .
849	inhibit	negative	mir-339	631.9277	860.9595	860.9595	miRNA		miR-339-5p inhibits cell migration and invasion in vitro and may be associated with the tumor-node-metastasis staging and lymph node metastasis of non-small cell lung cancer .
849	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-339-5p inhibits cell migration and invasion in vitro and may be associated with the tumor-node-metastasis staging and lymph node metastasis of non-small cell lung cancer .
848	inhibit	negative	mir-339	631.9277	860.9595	860.9595	miRNA		miR-339-5p inhibits cell migration and invasion in vitro and may be associated with the tumor-node-metastasis staging and lymph node metastasis of non-small cell lung cancer .
848	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-339-5p inhibits cell migration and invasion in vitro and may be associated with the tumor-node-metastasis staging and lymph node metastasis of non-small cell lung cancer .
727	downregulate	negative	mir-339	631.9277	860.9595	860.9595	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
727	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
726	downregulate	negative	mir-339	631.9277	860.9595	860.9595	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
726	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
356	inhibit	negative	mir-339	631.9277	860.9595	860.9595	miRNA		In conclusion , our results demonstrate that miR-339-5p functions as a tumor suppressor and plays a role in inhibiting growth and metastasis of CRC cells through targeting PRL-1 and regulating p-ERK1/2 .These findings suggest that miR-339-5p may be useful as a new potential therapeutic target for CRC .
356	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In conclusion , our results demonstrate that miR-339-5p functions as a tumor suppressor and plays a role in inhibiting growth and metastasis of CRC cells through targeting PRL-1 and regulating p-ERK1/2 .These findings suggest that miR-339-5p may be useful as a new potential therapeutic target for CRC .
355	regulate	positive	mir-339	631.9277	860.9595	860.9595	miRNA		MiR-339-5p regulates the growth , colony formation and metastasis of colorectal cancer cells by targeting PRL-1 .
355	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-339-5p regulates the growth , colony formation and metastasis of colorectal cancer cells by targeting PRL-1 .
1108	promote	positive	microrna-135b	636.8486	862.9378	862.9378	miRNA		MicroRNA-135b , a HSF1 target , promotes tumor invasion and metastasis by regulating RECK and EVI5 in hepatocellular carcinoma .
1108	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-135b , a HSF1 target , promotes tumor invasion and metastasis by regulating RECK and EVI5 in hepatocellular carcinoma .
534	regulate	positive	microrna-135b	636.8486	862.9378	862.9378	miRNA		MicroRNA-135b regulates metastasis suppressor 1 expression and promotes migration and invasion in colorectal cancer .
534	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-135b regulates metastasis suppressor 1 expression and promotes migration and invasion in colorectal cancer .
354	promote	positive	microrna-135b	636.8486	862.9378	862.9378	miRNA		MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1 .
354	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1 .
353	regulate	positive	mir-320a/c	641.7928	864.8572	864.8572	miRNA		Regulation of GNAI1 by miR-320a/c/d indicates new therapeutic avenues for targeting HCC metastasis .
353	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Regulation of GNAI1 by miR-320a/c/d indicates new therapeutic avenues for targeting HCC metastasis .
352	enhance	positive	mirna-222	646.7595	866.7173	866.7173	miRNA		In addition , enhanced expression of miRNA-221 and miRNA-222 was found in patients with cervical lymph node metastasis and advanced TNM stage .
352	enhance	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In addition , enhanced expression of miRNA-221 and miRNA-222 was found in patients with cervical lymph node metastasis and advanced TNM stage .
1161	inhibit	negative	mirna-221	651.7481	868.5181	868.5181	miRNA		Combination of ASOs therapy against miRNA-21 and miRNA-221 significantly inhibited primary tumor growth and metastasis compared to single antagomir treatment , especially , in L3.6plGres-SP-induced pancreatic tumor growth in vivo .
1161	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Combination of ASOs therapy against miRNA-21 and miRNA-221 significantly inhibited primary tumor growth and metastasis compared to single antagomir treatment , especially , in L3.6plGres-SP-induced pancreatic tumor growth in vivo .
351	enhance	positive	mirna-221	651.7481	868.5181	868.5181	miRNA		In addition , enhanced expression of miRNA-221 and miRNA-222 was found in patients with cervical lymph node metastasis and advanced TNM stage .
351	enhance	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In addition , enhanced expression of miRNA-221 and miRNA-222 was found in patients with cervical lymph node metastasis and advanced TNM stage .
350	upregulate	positive	mirna-214	656.7578	870.2591	870.2591	miRNA		Ours is the first report that demonstrates significant up-regulation of miRNA-21 and miRNA-214 in tumor cells from ascites of patients with EOC compared to omental metastasis .
350	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Ours is the first report that demonstrates significant up-regulation of miRNA-21 and miRNA-214 in tumor cells from ascites of patients with EOC compared to omental metastasis .
1160	inhibit	negative	mirna-21	661.788	871.9401	871.9401	miRNA		Combination of ASOs therapy against miRNA-21 and miRNA-221 significantly inhibited primary tumor growth and metastasis compared to single antagomir treatment , especially , in L3.6plGres-SP-induced pancreatic tumor growth in vivo .
1160	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Combination of ASOs therapy against miRNA-21 and miRNA-221 significantly inhibited primary tumor growth and metastasis compared to single antagomir treatment , especially , in L3.6plGres-SP-induced pancreatic tumor growth in vivo .
349	upregulate	positive	mirna-21	661.788	871.9401	871.9401	miRNA		Ours is the first report that demonstrates significant up-regulation of miRNA-21 and miRNA-214 in tumor cells from ascites of patients with EOC compared to omental metastasis .
349	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Ours is the first report that demonstrates significant up-regulation of miRNA-21 and miRNA-214 in tumor cells from ascites of patients with EOC compared to omental metastasis .
1965	promote	positive	mir-200s	666.838	873.5609	873.5609	miRNA		H19 Functions as a ceRNA in Promoting Metastasis Through Decreasing miR-200s Activity in Osteosarcoma .
1965	promote	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	H19 Functions as a ceRNA in Promoting Metastasis Through Decreasing miR-200s Activity in Osteosarcoma .
696	stimulate	positive	mir-200s	666.838	873.5609	873.5609	miRNA		In this issue of Cancer Cell , Yuan and colleagues discover a novel TGF-?] -induced lncRNA , lncRNA-ATB , which stimulates EMT through sequestering miR-200s and facilitates colonization by stabilizing IL-11 mRNA , thus promoting both early and late steps of cancer metastasis .
696	stimulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In this issue of Cancer Cell , Yuan and colleagues discover a novel TGF-?] -induced lncRNA , lncRNA-ATB , which stimulates EMT through sequestering miR-200s and facilitates colonization by stabilizing IL-11 mRNA , thus promoting both early and late steps of cancer metastasis .
675	enhance	positive	mir-200s	666.838	873.5609	873.5609	miRNA		Loss of miR-200s has been shown to enhance cancer aggressiveness and metastasis , whereas replacement of miR-200 miRNAs has been shown to inhibit cell growth in several types of tumors , including lung cancer .
675	enhance	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Loss of miR-200s has been shown to enhance cancer aggressiveness and metastasis , whereas replacement of miR-200 miRNAs has been shown to inhibit cell growth in several types of tumors , including lung cancer .
404	recognize	neutral	mir-200s	666.838	873.5609	873.5609	miRNA		ZEB1 , ZEB2 and SLUG , miR-200s are currently recognized as master regulators of EMT , thereby suppressing cancer invasion and metastasis .
404	recognize	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	ZEB1 , ZEB2 and SLUG , miR-200s are currently recognized as master regulators of EMT , thereby suppressing cancer invasion and metastasis .
346	induce	positive	mir-200s	666.838	873.5609	873.5609	miRNA		The ZEB1 transcription factor is best known as an inducer of epithelial-mesenchymal transitions ( EMT ) in cancer metastasis , acting through transcriptional repression of CDH1 ( encoding E-cadherin ) and the EMT-suppressing microRNA-200s ( miR-200s ) .
346	induce	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The ZEB1 transcription factor is best known as an inducer of epithelial-mesenchymal transitions ( EMT ) in cancer metastasis , acting through transcriptional repression of CDH1 ( encoding E-cadherin ) and the EMT-suppressing microRNA-200s ( miR-200s ) .
345	induce	positive	microrna-200s	671.9069	875.1213	875.1213	miRNA		The ZEB1 transcription factor is best known as an inducer of epithelial-mesenchymal transitions ( EMT ) in cancer metastasis , acting through transcriptional repression of CDH1 ( encoding E-cadherin ) and the EMT-suppressing microRNA-200s ( miR-200s ) .
345	induce	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The ZEB1 transcription factor is best known as an inducer of epithelial-mesenchymal transitions ( EMT ) in cancer metastasis , acting through transcriptional repression of CDH1 ( encoding E-cadherin ) and the EMT-suppressing microRNA-200s ( miR-200s ) .
1815	affect	neutral	mir-20a	676.994	876.621	876.621	miRNA		The aim of this research was to study how HPV-16 E7 affects the proliferation , invasion , and metastasis of oral squamous cell carcinoma ( OSCC ) cells by upregulating the expression of miR-20a .
1815	affect	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	The aim of this research was to study how HPV-16 E7 affects the proliferation , invasion , and metastasis of oral squamous cell carcinoma ( OSCC ) cells by upregulating the expression of miR-20a .
1814	inhibit	negative	mir-20a	676.994	876.621	876.621	miRNA		HPV 16 E7 inhibits OSCC cell proliferation , invasion , and metastasis by upregulating the expression of miR-20a .
1814	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	HPV 16 E7 inhibits OSCC cell proliferation , invasion , and metastasis by upregulating the expression of miR-20a .
1272	promote	positive	mir-20a	676.994	876.621	876.621	miRNA		Our results suggest microRNA involvement in malignant pituitary progression , whereby increased miR-20a , miR-106b and miR-17-5p promote metastasis by attenuating PTEN and TIMP2 in pituitary carcinoma .
1272	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Our results suggest microRNA involvement in malignant pituitary progression , whereby increased miR-20a , miR-106b and miR-17-5p promote metastasis by attenuating PTEN and TIMP2 in pituitary carcinoma .
1244	control	neutral	mir-20a	676.994	876.621	876.621	miRNA		In this study , we detected the relationship between miR-20a and the development of cervical cancer by qRT-PCR , we found that the expression level of miR-20a was significantly higher in cervical cancer patients than in normal controls , the aberrant expression of miR-20a was correlated with lymph node metastasis , histological grade and tumor diameter .
1244	control	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	In this study , we detected the relationship between miR-20a and the development of cervical cancer by qRT-PCR , we found that the expression level of miR-20a was significantly higher in cervical cancer patients than in normal controls , the aberrant expression of miR-20a was correlated with lymph node metastasis , histological grade and tumor diameter .
1243	promote	positive	mir-20a	676.994	876.621	876.621	miRNA		MiR-20a promotes cervical cancer proliferation and metastasis in vitro and in vivo .
1243	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-20a promotes cervical cancer proliferation and metastasis in vitro and in vivo .
854	inhibit	negative	mir-20a	676.994	876.621	876.621	miRNA		MiR-20a inhibits cutaneous squamous cell carcinoma metastasis and proliferation by directly targeting LIMK1 .
854	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-20a inhibits cutaneous squamous cell carcinoma metastasis and proliferation by directly targeting LIMK1 .
362	downregulate	negative	mir-20a	676.994	876.621	876.621	miRNA		Aberrant expression of miR-20a was correlated with lymph node metastasis ( LNM ) , histological grade and tumor diameter , but down-regulated miR-203 was correlated with LNM only .
362	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Aberrant expression of miR-20a was correlated with lymph node metastasis ( LNM ) , histological grade and tumor diameter , but down-regulated miR-203 was correlated with LNM only .
343	induce	positive	mir-20a	676.994	876.621	876.621	miRNA		The ectopic expression of miR-20a could induce epithelial-mesenchymal transition and enhance metastasis of GBC cells in vitro and in vivo , by directly targeting the 3 ' UTR of Smad7 , and subsequently promoting nuclear translocation of ?] -catenin .
343	induce	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The ectopic expression of miR-20a could induce epithelial-mesenchymal transition and enhance metastasis of GBC cells in vitro and in vivo , by directly targeting the 3 ' UTR of Smad7 , and subsequently promoting nuclear translocation of ?] -catenin .
342	upregulate	positive	mir-20a	676.994	876.621	876.621	miRNA		Among them , the upregulation of pro-metastatic miR-20a was closely associated with local invasion , distant metastasis , and poor prognosis of 67 followed-up GBC patients , clinically .
342	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Among them , the upregulation of pro-metastatic miR-20a was closely associated with local invasion , distant metastasis , and poor prognosis of 67 followed-up GBC patients , clinically .
341	trigger	positive	mir-20a	676.994	876.621	876.621	miRNA		MiR-20a triggers metastasis of gallbladder carcinoma .
341	trigger	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-20a triggers metastasis of gallbladder carcinoma .
340	promote	positive	mir-23a/24	682.0988	878.0599	878.0599	miRNA		Forced expression of the miR-23a/24-2/27a cluster promoted mammary carcinoma cell migration , invasion , and hepatic metastasis , through targeting Sprouty2 ( SPRY2 ) and consequent activation of p44/42 MAPK .
340	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Forced expression of the miR-23a/24-2/27a cluster promoted mammary carcinoma cell migration , invasion , and hepatic metastasis , through targeting Sprouty2 ( SPRY2 ) and consequent activation of p44/42 MAPK .
339	promote	positive	mir-23a/24	682.0988	878.0599	878.0599	miRNA		c-MYC-regulated miR-23a/24-2/27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2 .
339	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	c-MYC-regulated miR-23a/24-2/27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2 .
1011	inhibit	negative	mir-219	687.2203	879.4377	879.4377	miRNA		Taken together , miR-219 inhibited growth and metastasis by targeting PRKCI and might be used as a potential target for the treatment of TSCC .
1011	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , miR-219 inhibited growth and metastasis by targeting PRKCI and might be used as a potential target for the treatment of TSCC .
1010	inhibit	negative	mir-219	687.2203	879.4377	879.4377	miRNA		miR-219 inhibits the growth and metastasis of TSCC cells by targeting PRKCI .
1010	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-219 inhibits the growth and metastasis of TSCC cells by targeting PRKCI .
336	regulate	positive	mir-219	687.2203	879.4377	879.4377	miRNA		miR-219-2-3p is potentially involved in gastric cancer progression and metastasis by regulating ERK1/2-related signal pathways , which may provide a novel therapeutic strategy for treatment of gastric cancer .
336	regulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	miR-219-2-3p is potentially involved in gastric cancer progression and metastasis by regulating ERK1/2-related signal pathways , which may provide a novel therapeutic strategy for treatment of gastric cancer .
737	downregulate	negative	mir-564	692.358	880.7542	880.7542	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
737	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
736	downregulate	negative	mir-564	692.358	880.7542	880.7542	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
736	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
323	upregulate	positive	mir-564	692.358	880.7542	880.7542	miRNA		The miRNA microarray results showed that compared to the NLN group , upregulation of four miRNAs including miR-2861 , miR-451 , miR-193b , and miR-1202 was associated with LN metastasis , whereas four other miRNAs including miR-let-7i , miR-542-5p , miR-664* , and miR-564 were downregulated in the LN group .
323	upregulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray results showed that compared to the NLN group , upregulation of four miRNAs including miR-2861 , miR-451 , miR-193b , and miR-1202 was associated with LN metastasis , whereas four other miRNAs including miR-let-7i , miR-542-5p , miR-664* , and miR-564 were downregulated in the LN group .
322	upregulate	positive	mir-664*	697.511	882.0093	882.0093	miRNA		The miRNA microarray results showed that compared to the NLN group , upregulation of four miRNAs including miR-2861 , miR-451 , miR-193b , and miR-1202 was associated with LN metastasis , whereas four other miRNAs including miR-let-7i , miR-542-5p , miR-664* , and miR-564 were downregulated in the LN group .
322	upregulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray results showed that compared to the NLN group , upregulation of four miRNAs including miR-2861 , miR-451 , miR-193b , and miR-1202 was associated with LN metastasis , whereas four other miRNAs including miR-let-7i , miR-542-5p , miR-664* , and miR-564 were downregulated in the LN group .
2042	inhibit	negative	mir-542	702.6786	883.2026	883.2026	miRNA		Exogenous expression of miR-542-3p resulted in marked inhibition of melanoma cell migration , invasion and epithelial-mesenchymal transition ( EMT ) in ? vitro and lung metastasis in ? vivo .
2042	inhibit	negative	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	Exogenous expression of miR-542-3p resulted in marked inhibition of melanoma cell migration , invasion and epithelial-mesenchymal transition ( EMT ) in ? vitro and lung metastasis in ? vivo .
2041	inhibit	negative	mir-542	702.6786	883.2026	883.2026	miRNA		Exogenous expression of miR-542-3p resulted in marked inhibition of melanoma cell migration , invasion and epithelial-mesenchymal transition ( EMT ) in ? vitro and lung metastasis in ? vivo .
2041	inhibit	negative	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	Exogenous expression of miR-542-3p resulted in marked inhibition of melanoma cell migration , invasion and epithelial-mesenchymal transition ( EMT ) in ? vitro and lung metastasis in ? vivo .
2040	suppress	negative	mir-542	702.6786	883.2026	883.2026	miRNA		miR-542-3p suppresses invasion and metastasis by targeting the proto-oncogene serine/threonine protein kinase , PIM1 , in melanoma .
2040	suppress	negative	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	miR-542-3p suppresses invasion and metastasis by targeting the proto-oncogene serine/threonine protein kinase , PIM1 , in melanoma .
733	downregulate	negative	mir-542	702.6786	883.2026	883.2026	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
733	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
732	downregulate	negative	mir-542	702.6786	883.2026	883.2026	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
732	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
321	upregulate	positive	mir-542	702.6786	883.2026	883.2026	miRNA		The miRNA microarray results showed that compared to the NLN group , upregulation of four miRNAs including miR-2861 , miR-451 , miR-193b , and miR-1202 was associated with LN metastasis , whereas four other miRNAs including miR-let-7i , miR-542-5p , miR-664* , and miR-564 were downregulated in the LN group .
321	upregulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray results showed that compared to the NLN group , upregulation of four miRNAs including miR-2861 , miR-451 , miR-193b , and miR-1202 was associated with LN metastasis , whereas four other miRNAs including miR-let-7i , miR-542-5p , miR-664* , and miR-564 were downregulated in the LN group .
319	upregulate	positive	mir-1202	707.8602	884.3342	884.3342	miRNA		The miRNA microarray results showed that compared to the NLN group , upregulation of four miRNAs including miR-2861 , miR-451 , miR-193b , and miR-1202 was associated with LN metastasis , whereas four other miRNAs including miR-let-7i , miR-542-5p , miR-664* , and miR-564 were downregulated in the LN group .
319	upregulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray results showed that compared to the NLN group , upregulation of four miRNAs including miR-2861 , miR-451 , miR-193b , and miR-1202 was associated with LN metastasis , whereas four other miRNAs including miR-let-7i , miR-542-5p , miR-664* , and miR-564 were downregulated in the LN group .
325	upregulate	positive	mir-2861	713.0548	885.4039	885.4039	miRNA		Upregulated expression of miR-2861 and miR-451 in PTC with LN metastasis represents a unique miRNA signature associated with the prognosis and progression of PTC .
325	upregulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Upregulated expression of miR-2861 and miR-451 in PTC with LN metastasis represents a unique miRNA signature associated with the prognosis and progression of PTC .
324	upregulate	positive	mir-2861	713.0548	885.4039	885.4039	miRNA		Upregulated expression of miR-2861 and miR-451 in PTC with LN metastasis represents a unique miRNA signature associated with the prognosis and progression of PTC .
324	upregulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Upregulated expression of miR-2861 and miR-451 in PTC with LN metastasis represents a unique miRNA signature associated with the prognosis and progression of PTC .
316	upregulate	positive	mir-2861	713.0548	885.4039	885.4039	miRNA		The miRNA microarray results showed that compared to the NLN group , upregulation of four miRNAs including miR-2861 , miR-451 , miR-193b , and miR-1202 was associated with LN metastasis , whereas four other miRNAs including miR-let-7i , miR-542-5p , miR-664* , and miR-564 were downregulated in the LN group .
316	upregulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray results showed that compared to the NLN group , upregulation of four miRNAs including miR-2861 , miR-451 , miR-193b , and miR-1202 was associated with LN metastasis , whereas four other miRNAs including miR-let-7i , miR-542-5p , miR-664* , and miR-564 were downregulated in the LN group .
1898	inhibit	negative	mir-194	718.2619	886.4114	886.4114	miRNA		These findings suggested that miR-194 inhibits proliferation and metastasis and reverses cisplatin-resistance of NSCLC cells and may be useful as a new potential therapeutic target for NSCLC .
1898	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	These findings suggested that miR-194 inhibits proliferation and metastasis and reverses cisplatin-resistance of NSCLC cells and may be useful as a new potential therapeutic target for NSCLC .
1897	suppress	negative	mir-194	718.2619	886.4114	886.4114	miRNA		Both in vitro and in vivo experiments showed that ectopic stable expression miR-194 suppressed proliferation , migration , invasion and metastasis and induced apoptosis in NSCLC cells and that this suppression could be reversed by reintroducing forkhead box A1 ( FOXA1 ) , a functional target of miR-194 .
1897	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Both in vitro and in vivo experiments showed that ectopic stable expression miR-194 suppressed proliferation , migration , invasion and metastasis and induced apoptosis in NSCLC cells and that this suppression could be reversed by reintroducing forkhead box A1 ( FOXA1 ) , a functional target of miR-194 .
1486	regulate	positive	mir-194	718.2619	886.4114	886.4114	miRNA		Thus , we identified a pathway in which TNF帢-NF-庥B signaling switches off negative regulation by suppressing HNF-1帢-mediated expression of miR-194 , revealing insight into the mechanisms linking inflammatory pathways , miRNA , and HCC metastasis .
1486	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Thus , we identified a pathway in which TNF帢-NF-庥B signaling switches off negative regulation by suppressing HNF-1帢-mediated expression of miR-194 , revealing insight into the mechanisms linking inflammatory pathways , miRNA , and HCC metastasis .
1043	downregulate	negative	mir-194	718.2619	886.4114	886.4114	miRNA		Then , we found that miR-194 was significantly downregulated and RBX1 upregulated in GC tissues ; both of which showed significant association with tumor size , location , invasion , and tumor node metastasis .
1043	downregulate	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Then , we found that miR-194 was significantly downregulated and RBX1 upregulated in GC tissues ; both of which showed significant association with tumor size , location , invasion , and tumor node metastasis .
894	inhibit	negative	mir-194	718.2619	886.4114	886.4114	miRNA		Overexpression of miR-194 inhibited tumor growth and metastasis of osteosarcoma probably by downregulating CDH2 and IGF1R .
894	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Overexpression of miR-194 inhibited tumor growth and metastasis of osteosarcoma probably by downregulating CDH2 and IGF1R .
893	inhibit	negative	mir-194	718.2619	886.4114	886.4114	miRNA		Overexpression of miR-194 partially inhibited the proliferation , migration , and invasion of osteosarcoma cells in ? vitro , as well as tumor growth and pulmonary metastasis of osteosarcoma cells in ? vivo .
893	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Overexpression of miR-194 partially inhibited the proliferation , migration , and invasion of osteosarcoma cells in ? vitro , as well as tumor growth and pulmonary metastasis of osteosarcoma cells in ? vivo .
892	inhibit	negative	mir-194	718.2619	886.4114	886.4114	miRNA		Overexpression of miR-194 partially inhibited the proliferation , migration , and invasion of osteosarcoma cells in ? vitro , as well as tumor growth and pulmonary metastasis of osteosarcoma cells in ? vivo .
892	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Overexpression of miR-194 partially inhibited the proliferation , migration , and invasion of osteosarcoma cells in ? vitro , as well as tumor growth and pulmonary metastasis of osteosarcoma cells in ? vivo .
891	affect	neutral	mir-194	718.2619	886.4114	886.4114	miRNA		We studied the effects of miR-194 in osteosarcoma and the possible mechanism by which miR-194 affected the survival , apoptosis and metastasis of osteosarcoma .
891	affect	neutral	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	We studied the effects of miR-194 in osteosarcoma and the possible mechanism by which miR-194 affected the survival , apoptosis and metastasis of osteosarcoma .
313	suppress	negative	mir-194	718.2619	886.4114	886.4114	miRNA		Here , we show that overexpression of miR-194 in lung cancer cell lines , results in suppressing metastasis of lung cancer cells , while inhibiting its expression through 'miRNA sponge ' promotes the cancer cells to metastasize .
313	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we show that overexpression of miR-194 in lung cancer cell lines , results in suppressing metastasis of lung cancer cells , while inhibiting its expression through 'miRNA sponge ' promotes the cancer cells to metastasize .
312	suppress	negative	mir-194	718.2619	886.4114	886.4114	miRNA		miR-194 suppresses metastasis of non-small cell lung cancer through regulating expression of BMP1 and p27 ( kip1 ) .
312	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-194 suppresses metastasis of non-small cell lung cancer through regulating expression of BMP1 and p27 ( kip1 ) .
1771	induce	positive	mir-212	723.4807	887.3566	887.3566	miRNA		Taken together , our results clearly show that overexpression of PXN induced by methylationsuppressed miR-212 promotes tumor metastasis and invasion , and regulation of miR-212 expression may be a novel therapeutic strategy for gastric cancer .
1771	induce	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	Taken together , our results clearly show that overexpression of PXN induced by methylationsuppressed miR-212 promotes tumor metastasis and invasion , and regulation of miR-212 expression may be a novel therapeutic strategy for gastric cancer .
1770	effect	neutral	mir-212	723.4807	887.3566	887.3566	miRNA		Restoring mir-212 expression by exogenous mirprecursor molecules transfection or reexpression of endogenous miR-212 treated by 5-aza-2'-deoxycytidine ( 5-aza ) can exert similar effect that reduce GC cells invasion and metastasis abilities in vitro by interacting PXN gene .
1770	effect	neutral	gc	1242.449	487.0825	487.0825	Cancer	D061325	Restoring mir-212 expression by exogenous mirprecursor molecules transfection or reexpression of endogenous miR-212 treated by 5-aza-2'-deoxycytidine ( 5-aza ) can exert similar effect that reduce GC cells invasion and metastasis abilities in vitro by interacting PXN gene .
1769	effect	neutral	mir-212	723.4807	887.3566	887.3566	miRNA		Restoring mir-212 expression by exogenous mirprecursor molecules transfection or reexpression of endogenous miR-212 treated by 5-aza-2'-deoxycytidine ( 5-aza ) can exert similar effect that reduce GC cells invasion and metastasis abilities in vitro by interacting PXN gene .
1769	effect	neutral	gc	1242.449	487.0825	487.0825	Cancer	D061325	Restoring mir-212 expression by exogenous mirprecursor molecules transfection or reexpression of endogenous miR-212 treated by 5-aza-2'-deoxycytidine ( 5-aza ) can exert similar effect that reduce GC cells invasion and metastasis abilities in vitro by interacting PXN gene .
311	inhibit	negative	mir-212	723.4807	887.3566	887.3566	miRNA		Overexpression of miR-212 inhibited CRC cell migration and invasion in vitro and formation of intrahepatic and pulmonary metastasis in vivo .
311	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Overexpression of miR-212 inhibited CRC cell migration and invasion in vitro and formation of intrahepatic and pulmonary metastasis in vivo .
310	inhibit	negative	mir-212	723.4807	887.3566	887.3566	miRNA		Overexpression of miR-212 inhibited CRC cell migration and invasion in vitro and formation of intrahepatic and pulmonary metastasis in vivo .
310	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Overexpression of miR-212 inhibited CRC cell migration and invasion in vitro and formation of intrahepatic and pulmonary metastasis in vivo .
1768	downregulate	negative	microrna-212	728.7103	888.2394	888.2394	miRNA		MicroRNA-212 functions as an epigenetic-silenced tumor suppressor involving in tumor metastasis and invasion of gastric cancer through down-regulating PXN expression .
1768	downregulate	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	MicroRNA-212 functions as an epigenetic-silenced tumor suppressor involving in tumor metastasis and invasion of gastric cancer through down-regulating PXN expression .
309	downregulate	negative	microrna-212	728.7103	888.2394	888.2394	miRNA		Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD .
309	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD .
1493	inhibit	negative	mir-503	733.9501	889.0597	889.0597	miRNA		Enforced expression of miR-503 inhibited the expression of RNF31 significantly and the restoration of RNF31 expression reversed the inhibitory effects of miR-503 on PCa cell proliferation and metastasis .
1493	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Enforced expression of miR-503 inhibited the expression of RNF31 significantly and the restoration of RNF31 expression reversed the inhibitory effects of miR-503 on PCa cell proliferation and metastasis .
1492	suppress	negative	mir-503	733.9501	889.0597	889.0597	miRNA		miR-503 suppresses tumor cell proliferation and metastasis by directly targeting RNF31 in prostate cancer .
1492	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-503 suppresses tumor cell proliferation and metastasis by directly targeting RNF31 in prostate cancer .
1443	suppress	negative	mir-503	733.9501	889.0597	889.0597	miRNA		In the present study , we report that miR-503 suppresses cell metastasis in HCC through targeting the protein arginine methyl transferase 1 ( PRMT1 ) mRNA .
1443	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In the present study , we report that miR-503 suppresses cell metastasis in HCC through targeting the protein arginine methyl transferase 1 ( PRMT1 ) mRNA .
1442	suppress	negative	mir-503	733.9501	889.0597	889.0597	miRNA		miR-503 suppresses metastasis of hepatocellular carcinoma cell by targeting PRMT1 .
1442	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-503 suppresses metastasis of hepatocellular carcinoma cell by targeting PRMT1 .
555	inhibit	negative	mir-503	733.9501	889.0597	889.0597	miRNA		Our results suggest an important role of miR-503 in inhibiting metastasis of HCC through deregulating ARHGEF19 .
555	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Our results suggest an important role of miR-503 in inhibiting metastasis of HCC through deregulating ARHGEF19 .
554	inhibit	negative	mir-503	733.9501	889.0597	889.0597	miRNA		We also showed that overexpression of miR-503 resulted in inhibition of proliferation and metastasis of HCC in ? vivo .
554	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We also showed that overexpression of miR-503 resulted in inhibition of proliferation and metastasis of HCC in ? vivo .
553	regulate	positive	mir-503	733.9501	889.0597	889.0597	miRNA		Furthermore , luciferase activity of reporter gene , 3- ( 4 , 5-Dimethylthiazol-2-yl ) -2 , 5-diphenyltetrazolium bromide ( MTT ) , fluorescence-activated cell sorting analysis ( FACS ) , and invasion assay were carried out to characterize the mechanism of miR-503 regulating metastasis in HCC .
553	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Furthermore , luciferase activity of reporter gene , 3- ( 4 , 5-Dimethylthiazol-2-yl ) -2 , 5-diphenyltetrazolium bromide ( MTT ) , fluorescence-activated cell sorting analysis ( FACS ) , and invasion assay were carried out to characterize the mechanism of miR-503 regulating metastasis in HCC .
552	regulate	positive	mir-503	733.9501	889.0597	889.0597	miRNA		Meanwhile , a metastatic human HCC cell BALB/c nude mice model was used to investigate whether miR-503 regulates metastasis of HCC in ? vivo .
552	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Meanwhile , a metastatic human HCC cell BALB/c nude mice model was used to investigate whether miR-503 regulates metastasis of HCC in ? vivo .
551	regulate	positive	mir-503	733.9501	889.0597	889.0597	miRNA		Here , we investigate to define the mechanism of miR-503 regulating metastasis in HCC .
551	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we investigate to define the mechanism of miR-503 regulating metastasis in HCC .
306	upregulate	positive	mir-503	733.9501	889.0597	889.0597	miRNA		Upregulation of ALDH1 ( p ? = ? 0.019 ) and miR-503 ( p ? = ? 0.033 ) correlated with high clinical stage , and upregulation of miR-27a was related with distant metastasis ( p ? = ? 0.046 ) in patients with ovarian cancer .
306	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Upregulation of ALDH1 ( p ? = ? 0.019 ) and miR-503 ( p ? = ? 0.033 ) correlated with high clinical stage , and upregulation of miR-27a was related with distant metastasis ( p ? = ? 0.046 ) in patients with ovarian cancer .
1729	downregulate	negative	mir-22	739.1993	889.8173	889.8173	miRNA		MiR-22 downregulation promotes GC invasion and metastasis by upregulating MMP14 and Snail , and then inducing ECM remodeling and EMT .
1729	downregulate	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	MiR-22 downregulation promotes GC invasion and metastasis by upregulating MMP14 and Snail , and then inducing ECM remodeling and EMT .
1728	downregulate	negative	mir-22	739.1993	889.8173	889.8173	miRNA		MiR-22 downregulation promotes GC invasion and metastasis by upregulating MMP14 and Snail , and then inducing ECM remodeling and EMT .
1728	downregulate	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	MiR-22 downregulation promotes GC invasion and metastasis by upregulating MMP14 and Snail , and then inducing ECM remodeling and EMT .
1727	downregulate	negative	mir-22	739.1993	889.8173	889.8173	miRNA		MiR-22 downregulation promotes GC invasion and metastasis by upregulating MMP14 and Snail , and then inducing ECM remodeling and EMT .
1727	downregulate	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	MiR-22 downregulation promotes GC invasion and metastasis by upregulating MMP14 and Snail , and then inducing ECM remodeling and EMT .
1726	suppress	negative	mir-22	739.1993	889.8173	889.8173	miRNA		Finally , overexpression of miR-22 suppressed tumor growth , peritoneal dissemination and pulmonary metastasis in vivo .
1726	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Finally , overexpression of miR-22 suppressed tumor growth , peritoneal dissemination and pulmonary metastasis in vivo .
1648	block	negative	mir-22	739.1993	889.8173	889.8173	miRNA		These findings showed that miR-22 functioned as tumor suppressor in RCC and blocked RCC growth and metastasis by directly targeting SIRT1 in RCC , indicating a potential novel therapeutic role in RCC treatment .
1648	block	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	These findings showed that miR-22 functioned as tumor suppressor in RCC and blocked RCC growth and metastasis by directly targeting SIRT1 in RCC , indicating a potential novel therapeutic role in RCC treatment .
1647	downregulate	negative	mir-22	739.1993	889.8173	889.8173	miRNA		Results from qRT-PCR showed that miR-22 was significantly downregulated in RCC samples compared with corresponding non-cancerous tissues , which was significantly associated with tumor stage and lymph node metastasis .
1647	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Results from qRT-PCR showed that miR-22 was significantly downregulated in RCC samples compared with corresponding non-cancerous tissues , which was significantly associated with tumor stage and lymph node metastasis .
994	inhibit	negative	mir-22	739.1993	889.8173	889.8173	miRNA		miR-22 inhibited gastric cancer cell invasion and metastasis by directly targeting MTDH .
994	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	miR-22 inhibited gastric cancer cell invasion and metastasis by directly targeting MTDH .
993	downregulate	negative	mir-22	739.1993	889.8173	889.8173	miRNA		The results showed that miR-22 was downregulated in the gastric cancer specimens and significantly correlated with the advanced clinical stage and lymph node metastasis .
993	downregulate	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	The results showed that miR-22 was downregulated in the gastric cancer specimens and significantly correlated with the advanced clinical stage and lymph node metastasis .
779	downregulate	negative	mir-22	739.1993	889.8173	889.8173	miRNA		Furthermore , we found that miR-22 was significantly downregulated in breast cancer tissues and that its expression was inversely correlated with the tumor-node-metastasis stage and lymphatic metastasis in patients .
779	downregulate	negative	colorectal cancer 	754.9962	891.7133	891.7133	Cancer	D001943|D009369	Furthermore , we found that miR-22 was significantly downregulated in breast cancer tissues and that its expression was inversely correlated with the tumor-node-metastasis stage and lymphatic metastasis in patients .
778	downregulate	negative	mir-22	739.1993	889.8173	889.8173	miRNA		Furthermore , we found that miR-22 was significantly downregulated in breast cancer tissues and that its expression was inversely correlated with the tumor-node-metastasis stage and lymphatic metastasis in patients .
778	downregulate	negative	colorectal cancer 	754.9962	891.7133	891.7133	Cancer	D001943|D009369	Furthermore , we found that miR-22 was significantly downregulated in breast cancer tissues and that its expression was inversely correlated with the tumor-node-metastasis stage and lymphatic metastasis in patients .
777	downregulate	negative	mir-22	739.1993	889.8173	889.8173	miRNA		Furthermore , we found that miR-22 was significantly downregulated in breast cancer tissues and that its expression was inversely correlated with the tumor-node-metastasis stage and lymphatic metastasis in patients .
777	downregulate	negative	colorectal cancer 	754.9962	891.7133	891.7133	Cancer	D001943|D009369	Furthermore , we found that miR-22 was significantly downregulated in breast cancer tissues and that its expression was inversely correlated with the tumor-node-metastasis stage and lymphatic metastasis in patients .
776	suppress	negative	mir-22	739.1993	889.8173	889.8173	miRNA		In addition , miR-22 overexpression suppressed breast cancer cell invasion , metastasis , and proliferation by targeting CD147 in vitro and in vivo .
776	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In addition , miR-22 overexpression suppressed breast cancer cell invasion , metastasis , and proliferation by targeting CD147 in vitro and in vivo .
380	trigger	positive	mir-22	739.1993	889.8173	889.8173	miRNA		Here we find miR-22 triggers epithelial-mesenchymal transition ( EMT ) , enhances invasiveness and promotes metastasis in ? mouse xenografts .
380	trigger	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here we find miR-22 triggers epithelial-mesenchymal transition ( EMT ) , enhances invasiveness and promotes metastasis in ? mouse xenografts .
369	downregulate	negative	mir-22	739.1993	889.8173	889.8173	miRNA		miR-22 is downregulated in HCC and its expression is associated with the differentiation , metastasis and prognosis of the carcinoma .
369	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-22 is downregulated in HCC and its expression is associated with the differentiation , metastasis and prognosis of the carcinoma .
305	suppress	negative	mir-22	739.1993	889.8173	889.8173	miRNA		Senescence-associated microRNA , miR-22 , suppresses tumor growth and metastasis in vivo in a murine breast cancer model , and exosomal senescence-associated microRNA may affect the tumor microenvironment .
305	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Senescence-associated microRNA , miR-22 , suppresses tumor growth and metastasis in vivo in a murine breast cancer model , and exosomal senescence-associated microRNA may affect the tumor microenvironment .
1868	downregulate	negative	mir-15b	1240.836	502.9107	502.9107	miRNA		In conclusion , our results suggest that miR-335-5p and miR-15b-5p down-regulation results in TRIM29 over-expression , which induces proliferation , EMT and metastasis of NPC through the PTEN/AKT/mTOR signaling pathway .
1868	downregulate	negative	npc	744.4573	890.5122	890.5122	Cancer	D010181	In conclusion , our results suggest that miR-335-5p and miR-15b-5p down-regulation results in TRIM29 over-expression , which induces proliferation , EMT and metastasis of NPC through the PTEN/AKT/mTOR signaling pathway .
1867	downregulate	negative	mir-15b	1240.836	502.9107	502.9107	miRNA		In conclusion , our results suggest that miR-335-5p and miR-15b-5p down-regulation results in TRIM29 over-expression , which induces proliferation , EMT and metastasis of NPC through the PTEN/AKT/mTOR signaling pathway .
1867	downregulate	negative	npc	744.4573	890.5122	890.5122	Cancer	D010181	In conclusion , our results suggest that miR-335-5p and miR-15b-5p down-regulation results in TRIM29 over-expression , which induces proliferation , EMT and metastasis of NPC through the PTEN/AKT/mTOR signaling pathway .
1866	downregulate	negative	mir-335	1238.657	518.671	518.671	miRNA		In conclusion , our results suggest that miR-335-5p and miR-15b-5p down-regulation results in TRIM29 over-expression , which induces proliferation , EMT and metastasis of NPC through the PTEN/AKT/mTOR signaling pathway .
1866	downregulate	negative	npc	744.4573	890.5122	890.5122	Cancer	D010181	In conclusion , our results suggest that miR-335-5p and miR-15b-5p down-regulation results in TRIM29 over-expression , which induces proliferation , EMT and metastasis of NPC through the PTEN/AKT/mTOR signaling pathway .
1865	downregulate	negative	mir-335	1238.657	518.671	518.671	miRNA		In conclusion , our results suggest that miR-335-5p and miR-15b-5p down-regulation results in TRIM29 over-expression , which induces proliferation , EMT and metastasis of NPC through the PTEN/AKT/mTOR signaling pathway .
1865	downregulate	negative	npc	744.4573	890.5122	890.5122	Cancer	D010181	In conclusion , our results suggest that miR-335-5p and miR-15b-5p down-regulation results in TRIM29 over-expression , which induces proliferation , EMT and metastasis of NPC through the PTEN/AKT/mTOR signaling pathway .
1144	suppress	negative	mir-34c	1001.808	845.4865	845.4865	miRNA		In conclusion , miR-34c suppresses tumor growth and metastasis in NPC by targeting MET .
1144	suppress	negative	npc	744.4573	890.5122	890.5122	Cancer	D010181	In conclusion , miR-34c suppresses tumor growth and metastasis in NPC by targeting MET .
1143	suppress	negative	mir-34c	1001.808	845.4865	845.4865	miRNA		In conclusion , miR-34c suppresses tumor growth and metastasis in NPC by targeting MET .
1143	suppress	negative	npc	744.4573	890.5122	890.5122	Cancer	D010181	In conclusion , miR-34c suppresses tumor growth and metastasis in NPC by targeting MET .
1142	suppress	negative	mir-34c	1001.808	845.4865	845.4865	miRNA		Ectopic expression of miR-34c suppressed NPC cell viability , colony formation , anchorage-independent growth , cell migration and invasion in vitro , and inhibited xenograft tumor growth and lung metastasis in vivo .
1142	suppress	negative	npc	744.4573	890.5122	890.5122	Cancer	D010181	Ectopic expression of miR-34c suppressed NPC cell viability , colony formation , anchorage-independent growth , cell migration and invasion in vitro , and inhibited xenograft tumor growth and lung metastasis in vivo .
1141	suppress	negative	mir-34c	1001.808	845.4865	845.4865	miRNA		Ectopic expression of miR-34c suppressed NPC cell viability , colony formation , anchorage-independent growth , cell migration and invasion in vitro , and inhibited xenograft tumor growth and lung metastasis in vivo .
1141	suppress	negative	npc	744.4573	890.5122	890.5122	Cancer	D010181	Ectopic expression of miR-34c suppressed NPC cell viability , colony formation , anchorage-independent growth , cell migration and invasion in vitro , and inhibited xenograft tumor growth and lung metastasis in vivo .
1128	downregulate	negative	mir-145	1205.758	630.268	630.268	miRNA		In this study , we proved that miR-145 was significantly downregulated in NPC and associated with NPC cell metastasis .
1128	downregulate	negative	npc	744.4573	890.5122	890.5122	Cancer	D010181	In this study , we proved that miR-145 was significantly downregulated in NPC and associated with NPC cell metastasis .
793	effect	neutral	mir-200b	1241.437	497.6412	497.6412	miRNA		In contrast , forced expression of PKC帢 impairs the inhibitory effect of miR-200b on cell migration and tumor metastasis .
793	effect	neutral	npc	744.4573	890.5122	890.5122	Cancer	D010181	In contrast , forced expression of PKC帢 impairs the inhibitory effect of miR-200b on cell migration and tumor metastasis .
687	regulate	positive	mir-30a	1243.208	476.5026	476.5026	miRNA		In conclusion , miR-30a could play an important role in regulating NPC metastasis and potentially provide useful guidelines for individualized therapy .
687	regulate	positive	npc	744.4573	890.5122	890.5122	Cancer	D010181	In conclusion , miR-30a could play an important role in regulating NPC metastasis and potentially provide useful guidelines for individualized therapy .
686	regulate	positive	mir-30a	1243.208	476.5026	476.5026	miRNA		Although microRNA-30a ( miR-30a ) has been shown to regulate cancer metastasis , the molecular mechanism has not yet been clearly elucidated in nasopharyngeal carcinoma ( NPC ) .
686	regulate	positive	npc	744.4573	890.5122	890.5122	Cancer	D010181	Although microRNA-30a ( miR-30a ) has been shown to regulate cancer metastasis , the molecular mechanism has not yet been clearly elucidated in nasopharyngeal carcinoma ( NPC ) .
337	regulate	positive	mir-143	1181.384	677.3369	677.3369	miRNA		miR-143 plays a role in regulating the invasiveness and metastasis of NPC , and overexpression of miR-143 causes a significant reduction of the adhesion ability of the highly metastatic NPC cell line 5-8F .
337	regulate	positive	npc	744.4573	890.5122	890.5122	Cancer	D010181	miR-143 plays a role in regulating the invasiveness and metastasis of NPC , and overexpression of miR-143 causes a significant reduction of the adhesion ability of the highly metastatic NPC cell line 5-8F .
315	suppress	negative	mir-26a	1164.125	704.0642	704.0642	miRNA		Additionally , we used a murine model to investigate the role of miR-26a in NPC metastasis and results showed that miR-26a overexpression suppresses the metastatic behavior of NPC cells in vivo .
315	suppress	negative	npc	744.4573	890.5122	890.5122	Cancer	D010181	Additionally , we used a murine model to investigate the role of miR-26a in NPC metastasis and results showed that miR-26a overexpression suppresses the metastatic behavior of NPC cells in vivo .
298	promote	positive	mir-214	1144.997	729.4869	729.4869	miRNA		miR-214 not only can promote NPC cell proliferation and invasion abilities in vitro , but also can accelerate tumor formation and lung metastasis in a mouse xenograft model .
298	promote	positive	npc	744.4573	890.5122	890.5122	Cancer	D010181	miR-214 not only can promote NPC cell proliferation and invasion abilities in vitro , but also can accelerate tumor formation and lung metastasis in a mouse xenograft model .
1173	regulate	positive	mir-486	749.7231	891.1442	891.1442	miRNA		miR-486 regulates metastasis and chemosensitivity in hepatocellular carcinoma by targeting CLDN10 and CITRON .
1173	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-486 regulates metastasis and chemosensitivity in hepatocellular carcinoma by targeting CLDN10 and CITRON .
297	inhibit	negative	mir-486	749.7231	891.1442	891.1442	miRNA		Forced expression of miR-486-5p inhibited NSCLC cell migration and invasion in vitro and metastasis in mice by inhibiting cell proliferation .
297	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Forced expression of miR-486-5p inhibited NSCLC cell migration and invasion in vitro and metastasis in mice by inhibiting cell proliferation .
296	downregulate	negative	mir-486	749.7231	891.1442	891.1442	miRNA		Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer .
296	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer .
292	upregulate	positive	mir-182	1207.882	625.4084	625.4084	miRNA		The expression of miR-182 was found up-regulated in colorectal cancer tissues compared with adjacent noncancerous tissues ( p < 0.001 ) , and its up-regulation was significantly correlated with large tumor size ( p = 0.016 ) , positive regional lymph node metastasis ( p = 0.008 ) , and advanced tumor-node-metastasis stage ( p = 0.020 ) .
292	upregulate	positive	colorectal cancer 	754.9962	891.7133	891.7133	Cancer	D001943|D009369	The expression of miR-182 was found up-regulated in colorectal cancer tissues compared with adjacent noncancerous tissues ( p < 0.001 ) , and its up-regulation was significantly correlated with large tumor size ( p = 0.016 ) , positive regional lymph node metastasis ( p = 0.008 ) , and advanced tumor-node-metastasis stage ( p = 0.020 ) .
291	upregulate	positive	mir-182	1207.882	625.4084	625.4084	miRNA		The expression of miR-182 was found up-regulated in colorectal cancer tissues compared with adjacent noncancerous tissues ( p < 0.001 ) , and its up-regulation was significantly correlated with large tumor size ( p = 0.016 ) , positive regional lymph node metastasis ( p = 0.008 ) , and advanced tumor-node-metastasis stage ( p = 0.020 ) .
291	upregulate	positive	colorectal cancer 	754.9962	891.7133	891.7133	Cancer	D001943|D009369	The expression of miR-182 was found up-regulated in colorectal cancer tissues compared with adjacent noncancerous tissues ( p < 0.001 ) , and its up-regulation was significantly correlated with large tumor size ( p = 0.016 ) , positive regional lymph node metastasis ( p = 0.008 ) , and advanced tumor-node-metastasis stage ( p = 0.020 ) .
1751	inhibit	negative	microrna-195	760.2756	892.2194	892.2194	miRNA		MicroRNA-195 inhibits proliferation , invasion and metastasis in breast cancer cells by targeting FASN , HMGCR , ACACA and CYP27B1 .
1751	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-195 inhibits proliferation , invasion and metastasis in breast cancer cells by targeting FASN , HMGCR , ACACA and CYP27B1 .
1562	suppress	negative	microrna-195	760.2756	892.2194	892.2194	miRNA		MicroRNA-195 suppresses tumor cell proliferation and metastasis by directly targeting BCOX1 in prostate carcinoma .
1562	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-195 suppresses tumor cell proliferation and metastasis by directly targeting BCOX1 in prostate carcinoma .
288	suppress	negative	microrna-195	760.2756	892.2194	892.2194	miRNA		MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF , VAV2 , and CDC42 .
288	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF , VAV2 , and CDC42 .
1660	regulate	positive	mir-33a	765.5607	892.6624	892.6624	miRNA		These findings identified miR-33a as a negative regulator of breast cancer cell proliferation and metastasis .
1660	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	These findings identified miR-33a as a negative regulator of breast cancer cell proliferation and metastasis .
1659	inhibit	negative	mir-33a	765.5607	892.6624	892.6624	miRNA		Moreover , the overexpression of miR-33a in metastatic breast cancer cells remarkably decreases cell proliferation and invasion in vitro and significantly inhibits tumor growth and lung metastasis in vivo , whereas its knockdown in non-metastatic breast cancer cells significantly enhances cell proliferation and invasion in vitro and promotes tumor growth and lung metastasis in vivo .
1659	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Moreover , the overexpression of miR-33a in metastatic breast cancer cells remarkably decreases cell proliferation and invasion in vitro and significantly inhibits tumor growth and lung metastasis in vivo , whereas its knockdown in non-metastatic breast cancer cells significantly enhances cell proliferation and invasion in vitro and promotes tumor growth and lung metastasis in vivo .
1658	downregulate	negative	mir-33a	765.5607	892.6624	892.6624	miRNA		Here , we found that downregulated miR-33a in breast cancer tissues correlates with lymph node metastasis .
1658	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here , we found that downregulated miR-33a in breast cancer tissues correlates with lymph node metastasis .
1657	suppress	negative	mir-33a	765.5607	892.6624	892.6624	miRNA		MiR-33a suppresses breast cancer cell proliferation and metastasis by targeting ADAM9 and ROS1 .
1657	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-33a suppresses breast cancer cell proliferation and metastasis by targeting ADAM9 and ROS1 .
1552	inhibit	negative	mir-33a	765.5607	892.6624	892.6624	miRNA		These findings suggest that miR-33a targets Twist1 and inhibits invasion and metastasis in NSCLC .
1552	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	These findings suggest that miR-33a targets Twist1 and inhibits invasion and metastasis in NSCLC .
1551	block	negative	mir-33a	765.5607	892.6624	892.6624	miRNA		Additionally , Twist1 knockdown blocks EMT-related metastasis and forced expression of miR-33a inhibits lung cancer metastasis in a xenograft animal model .
1551	block	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Additionally , Twist1 knockdown blocks EMT-related metastasis and forced expression of miR-33a inhibits lung cancer metastasis in a xenograft animal model .
1550	block	negative	mir-33a	765.5607	892.6624	892.6624	miRNA		Additionally , Twist1 knockdown blocks EMT-related metastasis and forced expression of miR-33a inhibits lung cancer metastasis in a xenograft animal model .
1550	block	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Additionally , Twist1 knockdown blocks EMT-related metastasis and forced expression of miR-33a inhibits lung cancer metastasis in a xenograft animal model .
287	downregulate	negative	mir-33a	765.5607	892.6624	892.6624	miRNA		We have found that miR-33a , which is downregulated in lung cancer cells , directly targets PTHrP ( parathyroid hormone-related protein ) , a potent stimulator of osteoclastic bone resorption , leading to decreased osteolytic bone metastasis .
287	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We have found that miR-33a , which is downregulated in lung cancer cells , directly targets PTHrP ( parathyroid hormone-related protein ) , a potent stimulator of osteoclastic bone resorption , leading to decreased osteolytic bone metastasis .
286	downregulate	negative	mir-33a	765.5607	892.6624	892.6624	miRNA		We have found that miR-33a , which is downregulated in lung cancer cells , directly targets PTHrP ( parathyroid hormone-related protein ) , a potent stimulator of osteoclastic bone resorption , leading to decreased osteolytic bone metastasis .
286	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We have found that miR-33a , which is downregulated in lung cancer cells , directly targets PTHrP ( parathyroid hormone-related protein ) , a potent stimulator of osteoclastic bone resorption , leading to decreased osteolytic bone metastasis .
284	suppress	negative	mir-290	770.8508	893.0421	893.0421	miRNA		Inherited variation in miR-290 expression suppresses breast cancer progression by targeting the metastasis susceptibility gene Arid4b .
284	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Inherited variation in miR-290 expression suppresses breast cancer progression by targeting the metastasis susceptibility gene Arid4b .
281	suppress	negative	mirna-22	776.145	893.3587	893.3587	miRNA		miRNA-22 suppresses colon cancer cell migration and invasion by inhibiting the expression of T-cell lymphoma invasion and metastasis 1 and matrix metalloproteinases 2 and 9 .
281	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miRNA-22 suppresses colon cancer cell migration and invasion by inhibiting the expression of T-cell lymphoma invasion and metastasis 1 and matrix metalloproteinases 2 and 9 .
280	suppress	negative	mirna-22	776.145	893.3587	893.3587	miRNA		miRNA-22 suppresses colon cancer cell migration and invasion by inhibiting the expression of T-cell lymphoma invasion and metastasis 1 and matrix metalloproteinases 2 and 9 .
280	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miRNA-22 suppresses colon cancer cell migration and invasion by inhibiting the expression of T-cell lymphoma invasion and metastasis 1 and matrix metalloproteinases 2 and 9 .
1951	downregulate	negative	mir-27a	781.4426	893.612	893.612	miRNA		The miR-27a-3p-mediated down-regulation of VE-cadherin and inhibition of EMT may be essential for Twist-1 to induce tumor metastasis and VM .
1951	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The miR-27a-3p-mediated down-regulation of VE-cadherin and inhibition of EMT may be essential for Twist-1 to induce tumor metastasis and VM .
1950	suppress	negative	mir-27a	781.4426	893.612	893.612	miRNA		miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT : an essential role for Twist-1 in HCC .
1950	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT : an essential role for Twist-1 in HCC .
1351	promote	positive	mir-27a	781.4426	893.612	893.612	miRNA		miR-27a promotes cell proliferation and metastasis in renal cell carcinoma .
1351	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-27a promotes cell proliferation and metastasis in renal cell carcinoma .
902	regulate	positive	mir-27a	781.4426	893.612	893.612	miRNA		miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells .
902	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells .
489	downregulate	negative	mir-27a	781.4426	893.612	893.612	miRNA		In the present study , we found that miR-27a was downregulated in esophageal carcinoma cell lines and ESCC specimens with lymph node metastasis .
489	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In the present study , we found that miR-27a was downregulated in esophageal carcinoma cell lines and ESCC specimens with lymph node metastasis .
488	downregulate	negative	mir-27a	781.4426	893.612	893.612	miRNA		In the present study , we found that miR-27a was downregulated in esophageal carcinoma cell lines and ESCC specimens with lymph node metastasis .
488	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In the present study , we found that miR-27a was downregulated in esophageal carcinoma cell lines and ESCC specimens with lymph node metastasis .
307	upregulate	positive	mir-27a	781.4426	893.612	893.612	miRNA		Upregulation of ALDH1 ( p ? = ? 0.019 ) and miR-503 ( p ? = ? 0.033 ) correlated with high clinical stage , and upregulation of miR-27a was related with distant metastasis ( p ? = ? 0.046 ) in patients with ovarian cancer .
307	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Upregulation of ALDH1 ( p ? = ? 0.019 ) and miR-503 ( p ? = ? 0.033 ) correlated with high clinical stage , and upregulation of miR-27a was related with distant metastasis ( p ? = ? 0.046 ) in patients with ovarian cancer .
279	block	negative	mir-27a	781.4426	893.612	893.612	miRNA		Taken together , our findings reveal that oncogenic miR-27a plays an important role in ovarian cancer cell growth and metastasis , and genistein , as nontoxic inactivators of miRNA , can block ovarian cancer cell growth and migration , offering novel insights into the mechanisms of genistein therapeutic actions .
279	block	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , our findings reveal that oncogenic miR-27a plays an important role in ovarian cancer cell growth and metastasis , and genistein , as nontoxic inactivators of miRNA , can block ovarian cancer cell growth and migration , offering novel insights into the mechanisms of genistein therapeutic actions .
1675	regulate	positive	mir-210	786.7428	893.8021	893.8021	miRNA		Under hypoxia , methyl sulfone decreased expression of the master regulator of hypoxia , HIF-1帢 , and reduced levels of the glycolytic enzymes , PKM2 , LDHA , GLUT1 , the pro-angiogenic protein , VEGF , and the iron-sulfur metabolism molecules , miR-210 and transferrin , all of which promote metastasis .
1675	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Under hypoxia , methyl sulfone decreased expression of the master regulator of hypoxia , HIF-1帢 , and reduced levels of the glycolytic enzymes , PKM2 , LDHA , GLUT1 , the pro-angiogenic protein , VEGF , and the iron-sulfur metabolism molecules , miR-210 and transferrin , all of which promote metastasis .
1670	upregulate	positive	mir-210	786.7428	893.8021	893.8021	miRNA		In endometrial cancer cells , expression levels of miRNAs including miR-185 , miR-210 and miR-423 are upregulated and those of miR-let7e , miR-30c and miR-221 are downregulated compared to normal tissues , and these miRNAs are involved in carcinogenesis , invasion and metastasis .
1670	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In endometrial cancer cells , expression levels of miRNAs including miR-185 , miR-210 and miR-423 are upregulated and those of miR-let7e , miR-30c and miR-221 are downregulated compared to normal tissues , and these miRNAs are involved in carcinogenesis , invasion and metastasis .
620	induce	positive	mir-210	786.7428	893.8021	893.8021	miRNA		Furthermore , miR-210 can be induced by hypoxia and mediates the hypoxia-induced metastasis of colorectal cancer cells .
620	induce	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Furthermore , miR-210 can be induced by hypoxia and mediates the hypoxia-induced metastasis of colorectal cancer cells .
619	upregulate	positive	mir-210	786.7428	893.8021	893.8021	miRNA		Herein , we report that miR-210 is frequently up-regulated in colorectal cancer tissues , with high miR-210 expression significantly correlating with large tumor size , lymph node metastasis , advanced clinical stage and poor prognosis .
619	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Herein , we report that miR-210 is frequently up-regulated in colorectal cancer tissues , with high miR-210 expression significantly correlating with large tumor size , lymph node metastasis , advanced clinical stage and poor prognosis .
278	upregulate	positive	mir-210	786.7428	893.8021	893.8021	miRNA		In addition , miR-210 upregulation more frequently occurred in osteosarcoma tissues with large tumor size ( P = 0.02 ) , poor response to preoperative chemotherapy ( P = 0.008 ) , and positive metastasis ( P = 0.01 ) .
278	upregulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	In addition , miR-210 upregulation more frequently occurred in osteosarcoma tissues with large tumor size ( P = 0.02 ) , poor response to preoperative chemotherapy ( P = 0.008 ) , and positive metastasis ( P = 0.01 ) .
1986	downregulate	negative	mir-140	792.0449	893.9287	893.9287	miRNA		The expression of miR-140-5p was significantly downregulated in hypopharyngeal carcinoma tissues and correlated with tumor classification and lymph node metastasis .
1986	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The expression of miR-140-5p was significantly downregulated in hypopharyngeal carcinoma tissues and correlated with tumor classification and lymph node metastasis .
1985	downregulate	negative	mir-140	792.0449	893.9287	893.9287	miRNA		The expression level of miR-140-5p was significantly downregulated in hypopharyngeal carcinoma tissues compared with adjacent tissues ( t=-4.016 , P < 0.01 ) , which was significantly correlated with tumor classification and lymph node metastasis ( P < 0.05 ) .
1985	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The expression level of miR-140-5p was significantly downregulated in hypopharyngeal carcinoma tissues compared with adjacent tissues ( t=-4.016 , P < 0.01 ) , which was significantly correlated with tumor classification and lymph node metastasis ( P < 0.05 ) .
1485	inhibit	negative	mir-140	792.0449	893.9287	893.9287	miRNA		In conclusion , in vivo and vitro findings provided evidence that miR-140 could inhibit the growth , migration , and metastasis of OS cells .
1485	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In conclusion , in vivo and vitro findings provided evidence that miR-140 could inhibit the growth , migration , and metastasis of OS cells .
454	suppress	negative	mir-140	792.0449	893.9287	893.9287	miRNA		miR-140 suppresses tumor growth and metastasis of non-small cell lung cancer by targeting insulin-like growth factor 1 receptor .
454	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-140 suppresses tumor growth and metastasis of non-small cell lung cancer by targeting insulin-like growth factor 1 receptor .
269	effect	neutral	mir-140	792.0449	893.9287	893.9287	miRNA		Silencing TGFBR1 and FGF9 by small interfering RNA ( siRNA ) resembled the phenotype resulting from ectopic miR-140-5p expression , while overexpression of TGFBR1 and FGF9 attenuated the effect of miR-140-5p on HCC growth and metastasis .
269	effect	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Silencing TGFBR1 and FGF9 by small interfering RNA ( siRNA ) resembled the phenotype resulting from ectopic miR-140-5p expression , while overexpression of TGFBR1 and FGF9 attenuated the effect of miR-140-5p on HCC growth and metastasis .
268	suppress	negative	mir-140	792.0449	893.9287	893.9287	miRNA		We also found that miR-140-5p suppressed HCC cell proliferation and HCC metastasis .
268	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We also found that miR-140-5p suppressed HCC cell proliferation and HCC metastasis .
267	suppress	negative	microrna-140	797.3482	893.9921	893.9921	miRNA		MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor ?] receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma .
267	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor ?] receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma .
266	downregulate	negative	mir-126/126	802.6518	893.9921	893.9921	miRNA		These findings determine how this microRNA pair alters the composition of the primary tumour microenvironment to favour breast cancer metastasis , and demonstrate a correlation between miR-126/126 ( * ) downregulation and poor metastasis-free survival of breast cancer patients .
266	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	These findings determine how this microRNA pair alters the composition of the primary tumour microenvironment to favour breast cancer metastasis , and demonstrate a correlation between miR-126/126 ( * ) downregulation and poor metastasis-free survival of breast cancer patients .
265	downregulate	negative	mir-126/126	802.6518	893.9921	893.9921	miRNA		These findings determine how this microRNA pair alters the composition of the primary tumour microenvironment to favour breast cancer metastasis , and demonstrate a correlation between miR-126/126 ( * ) downregulation and poor metastasis-free survival of breast cancer patients .
265	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	These findings determine how this microRNA pair alters the composition of the primary tumour microenvironment to favour breast cancer metastasis , and demonstrate a correlation between miR-126/126 ( * ) downregulation and poor metastasis-free survival of breast cancer patients .
1006	downregulate	negative	mir-126/mir	807.9551	893.9287	893.9287	miRNA		The down-regulation of miR-126/miR-126* may play an important role in HCC metastasis and contributes to poor survival of HCC patients .
1006	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The down-regulation of miR-126/miR-126* may play an important role in HCC metastasis and contributes to poor survival of HCC patients .
264	suppress	negative	mir-126/mir	807.9551	893.9287	893.9287	miRNA		We report here that miR-126/miR-126 ( * ) , a microRNA pair derived from a single precursor , independently suppress the sequential recruitment of mesenchymal stem cells and inflammatory monocytes into the tumour stroma to inhibit lung metastasis by breast tumour cells in a mouse xenograft model .
264	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We report here that miR-126/miR-126 ( * ) , a microRNA pair derived from a single precursor , independently suppress the sequential recruitment of mesenchymal stem cells and inflammatory monocytes into the tumour stroma to inhibit lung metastasis by breast tumour cells in a mouse xenograft model .
263	repress	negative	mir-126*	813.2572	893.8021	893.8021	miRNA		miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis .
263	repress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis .
1886	induce	positive	microrna-26a	818.5574	893.612	893.612	miRNA		MicroRNA-26a induces osteosarcoma cell growth and metastasis via the Wnt/?] -catenin pathway .
1886	induce	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	MicroRNA-26a induces osteosarcoma cell growth and metastasis via the Wnt/?] -catenin pathway .
257	suppress	negative	microrna-26a	818.5574	893.612	893.612	miRNA		MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway .
257	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway .
1823	inhibit	negative	mir-138	823.855	893.3587	893.3587	miRNA		miR-138 overexpression inhibited metastasis of breast cancer cells .
1823	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-138 overexpression inhibited metastasis of breast cancer cells .
1065	downregulate	negative	mir-138	823.855	893.3587	893.3587	miRNA		Additionally , statistical analysis showed that the combined miR 138 downregulation and CCND3 upregulation ( miR-138-low-CCND3-high ) was significantly associated with the advanced tumor-node-metastasis stage ( P = 0.008 ) and the presence of portal vein invasion ( P = 0.008 ) and lymph node metastasis ( P = 0.01 ) .
1065	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Additionally , statistical analysis showed that the combined miR 138 downregulation and CCND3 upregulation ( miR-138-low-CCND3-high ) was significantly associated with the advanced tumor-node-metastasis stage ( P = 0.008 ) and the presence of portal vein invasion ( P = 0.008 ) and lymph node metastasis ( P = 0.01 ) .
871	downregulate	negative	mir-138	823.855	893.3587	893.3587	miRNA		In addition , miR-138 downregulation and PDK1 upregulation were both significantly associated with advanced tumor-node-metastasis ( TNM ) stage ( both P = 0.002 ) and positive lymph node metastasis ( both P = 0.01 ) of NSCLC patients .
871	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In addition , miR-138 downregulation and PDK1 upregulation were both significantly associated with advanced tumor-node-metastasis ( TNM ) stage ( both P = 0.002 ) and positive lymph node metastasis ( both P = 0.01 ) of NSCLC patients .
870	downregulate	negative	mir-138	823.855	893.3587	893.3587	miRNA		In addition , miR-138 downregulation and PDK1 upregulation were both significantly associated with advanced tumor-node-metastasis ( TNM ) stage ( both P = 0.002 ) and positive lymph node metastasis ( both P = 0.01 ) of NSCLC patients .
870	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In addition , miR-138 downregulation and PDK1 upregulation were both significantly associated with advanced tumor-node-metastasis ( TNM ) stage ( both P = 0.002 ) and positive lymph node metastasis ( both P = 0.01 ) of NSCLC patients .
498	regulate	positive	mir-138	823.855	893.3587	893.3587	miRNA		These data highlight a pivotal role for miR-138 in the regulation of CRC metastasis by targeting TWIST2 , and suggest a potential application of miR-138 in prognosis prediction and CRC treatment .
498	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	These data highlight a pivotal role for miR-138 in the regulation of CRC metastasis by targeting TWIST2 , and suggest a potential application of miR-138 in prognosis prediction and CRC treatment .
497	downregulate	negative	mir-138	823.855	893.3587	893.3587	miRNA		We also identified that down-regulation of miR-138 was associated with lymph node metastasis , distant metastasis , and always predicted poor prognosis .
497	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We also identified that down-regulation of miR-138 was associated with lymph node metastasis , distant metastasis , and always predicted poor prognosis .
496	downregulate	negative	mir-138	823.855	893.3587	893.3587	miRNA		Down-regulation of miR-138 promotes colorectal cancer metastasis via directly targeting TWIST2 .
496	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Down-regulation of miR-138 promotes colorectal cancer metastasis via directly targeting TWIST2 .
256	suppress	negative	mir-138	823.855	893.3587	893.3587	miRNA		Our study demonstrates the role and clinical relevance of miR-138 in ovarian cancer cell invasion and metastasis , providing a potential therapeutic strategy for suppression of ovarian cancer metastasis by targeting SOX4 and HIF-1帢 pathways .
256	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Our study demonstrates the role and clinical relevance of miR-138 in ovarian cancer cell invasion and metastasis , providing a potential therapeutic strategy for suppression of ovarian cancer metastasis by targeting SOX4 and HIF-1帢 pathways .
255	inhibit	negative	mirna-138	829.1492	893.0421	893.0421	miRNA		An orthotopic xenograft mouse model further demonstrated that the expression of miRNA-138 inhibited ovarian cancer metastasis to other organs .
255	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	An orthotopic xenograft mouse model further demonstrated that the expression of miRNA-138 inhibited ovarian cancer metastasis to other organs .
931	upregulate	positive	microrna-138	834.4393	892.6624	892.6624	miRNA		Upregulation of Limk1 caused by microRNA-138 loss aggravates the metastasis of ovarian cancer by activation of Limk1/cofilin signaling .
931	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Upregulation of Limk1 caused by microRNA-138 loss aggravates the metastasis of ovarian cancer by activation of Limk1/cofilin signaling .
254	suppress	negative	microrna-138	834.4393	892.6624	892.6624	miRNA		MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1帢 .
254	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1帢 .
250	upregulate	positive	microrna-143	839.7244	892.2194	892.2194	miRNA		Up-regulated microRNA-143 in cancer stem cells differentiation promotes prostate cancer cells metastasis by modulating FNDC3B expression .
250	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Up-regulated microRNA-143 in cancer stem cells differentiation promotes prostate cancer cells metastasis by modulating FNDC3B expression .
1885	inhibit	negative	mir-126	845.0038	891.7133	891.7133	miRNA		In conclusion , the current study demonstrated that miR-126 inhibited EC cell migration and invasion , at least partially through the direct targeting of IRS1 , suggesting that miR-126 may aid the treatment of EC metastasis .
1885	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In conclusion , the current study demonstrated that miR-126 inhibited EC cell migration and invasion , at least partially through the direct targeting of IRS1 , suggesting that miR-126 may aid the treatment of EC metastasis .
1499	downregulate	negative	mir-126	845.0038	891.7133	891.7133	miRNA		We observed that the miR-126 expression level was significantly downregulated in PTC tissue and PTC cell lines , the aberrant expression of miR-126 was correlated with lymph node metastasis , tumor size and TNM stage .
1499	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We observed that the miR-126 expression level was significantly downregulated in PTC tissue and PTC cell lines , the aberrant expression of miR-126 was correlated with lymph node metastasis , tumor size and TNM stage .
1498	downregulate	negative	mir-126	845.0038	891.7133	891.7133	miRNA		We observed that the miR-126 expression level was significantly downregulated in PTC tissue and PTC cell lines , the aberrant expression of miR-126 was correlated with lymph node metastasis , tumor size and TNM stage .
1498	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We observed that the miR-126 expression level was significantly downregulated in PTC tissue and PTC cell lines , the aberrant expression of miR-126 was correlated with lymph node metastasis , tumor size and TNM stage .
1265	promote	positive	mir-126	845.0038	891.7133	891.7133	miRNA		miR-126 is important for endothelial cell signaling and promotes angiogenesis , protects against atherosclerosis , and reduces breast cancer cell growth and metastasis .
1265	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-126 is important for endothelial cell signaling and promotes angiogenesis , protects against atherosclerosis , and reduces breast cancer cell growth and metastasis .
968	enhance	positive	mir-126	845.0038	891.7133	891.7133	miRNA		Osteoblast-derived WNT-induced secreted protein 1 increases VCAM-1 expression and enhances prostate cancer metastasis by down-regulating miR-126 .
968	enhance	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Osteoblast-derived WNT-induced secreted protein 1 increases VCAM-1 expression and enhances prostate cancer metastasis by down-regulating miR-126 .
957	suppress	negative	mir-126	845.0038	891.7133	891.7133	miRNA		MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2 .
957	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2 .
332	downregulate	negative	mir-126	845.0038	891.7133	891.7133	miRNA		Here , we showed miR-126 expression was much lower in HCT116 , SW620 and HT-29 colon cancer cells with highly metastatic potential and miR-126 downregulation was more frequent in colorectal cancers with metastasis .
332	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here , we showed miR-126 expression was much lower in HCT116 , SW620 and HT-29 colon cancer cells with highly metastatic potential and miR-126 downregulation was more frequent in colorectal cancers with metastasis .
331	downregulate	negative	mir-126	845.0038	891.7133	891.7133	miRNA		Here , we showed miR-126 expression was much lower in HCT116 , SW620 and HT-29 colon cancer cells with highly metastatic potential and miR-126 downregulation was more frequent in colorectal cancers with metastasis .
331	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here , we showed miR-126 expression was much lower in HCT116 , SW620 and HT-29 colon cancer cells with highly metastatic potential and miR-126 downregulation was more frequent in colorectal cancers with metastasis .
330	downregulate	negative	mir-126	845.0038	891.7133	891.7133	miRNA		Here , we showed miR-126 expression was much lower in HCT116 , SW620 and HT-29 colon cancer cells with highly metastatic potential and miR-126 downregulation was more frequent in colorectal cancers with metastasis .
330	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here , we showed miR-126 expression was much lower in HCT116 , SW620 and HT-29 colon cancer cells with highly metastatic potential and miR-126 downregulation was more frequent in colorectal cancers with metastasis .
329	downregulate	negative	mir-126	845.0038	891.7133	891.7133	miRNA		Here , we showed miR-126 expression was much lower in HCT116 , SW620 and HT-29 colon cancer cells with highly metastatic potential and miR-126 downregulation was more frequent in colorectal cancers with metastasis .
329	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here , we showed miR-126 expression was much lower in HCT116 , SW620 and HT-29 colon cancer cells with highly metastatic potential and miR-126 downregulation was more frequent in colorectal cancers with metastasis .
262	repress	negative	mir-126	845.0038	891.7133	891.7133	miRNA		miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis .
262	repress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis .
246	downregulate	negative	mir-126	845.0038	891.7133	891.7133	miRNA		Our study revealed that down-regulation of miR-126 plays an important role in HCC metastasis , and suggest a potential application of miR-126 in prognosis prediction and HCC treatment .
246	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Our study revealed that down-regulation of miR-126 plays an important role in HCC metastasis , and suggest a potential application of miR-126 in prognosis prediction and HCC treatment .
1239	downregulate	negative	mir-193b	850.2769	891.1442	891.1442	miRNA		Using a three-dimensional culture model that mimics the human omentum , one of the principal sites of OvCa metastasis , we identified and characterized the microenvironment-induced downregulation of a tumor suppressor miRNA , miR-193b , in metastasizing OvCa cells .
1239	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Using a three-dimensional culture model that mimics the human omentum , one of the principal sites of OvCa metastasis , we identified and characterized the microenvironment-induced downregulation of a tumor suppressor miRNA , miR-193b , in metastasizing OvCa cells .
1238	downregulate	negative	mir-193b	850.2769	891.1442	891.1442	miRNA		Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis .
1238	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis .
946	suppress	negative	mir-193b	850.2769	891.1442	891.1442	miRNA		Therefore , miR-193b may constitute a promising therapeutic agent for the suppression of pancreatic cancer cell growth and metastasis .
946	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Therefore , miR-193b may constitute a promising therapeutic agent for the suppression of pancreatic cancer cell growth and metastasis .
945	suppress	negative	mir-193b	850.2769	891.1442	891.1442	miRNA		miR-193b directly targets STMN1 and uPA genes and suppresses tumor growth and metastasis in pancreatic cancer .
945	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-193b directly targets STMN1 and uPA genes and suppresses tumor growth and metastasis in pancreatic cancer .
318	upregulate	positive	mir-193b	850.2769	891.1442	891.1442	miRNA		The miRNA microarray results showed that compared to the NLN group , upregulation of four miRNAs including miR-2861 , miR-451 , miR-193b , and miR-1202 was associated with LN metastasis , whereas four other miRNAs including miR-let-7i , miR-542-5p , miR-664* , and miR-564 were downregulated in the LN group .
318	upregulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray results showed that compared to the NLN group , upregulation of four miRNAs including miR-2861 , miR-451 , miR-193b , and miR-1202 was associated with LN metastasis , whereas four other miRNAs including miR-let-7i , miR-542-5p , miR-664* , and miR-564 were downregulated in the LN group .
244	induce	positive	mir-193b	850.2769	891.1442	891.1442	miRNA		Among the altered miRNAs , TGF-?] 1 induced the down-regulation of miR-193b , which inhibited cell invasion and metastasis in vivo and in vitro , and down-regulated uPA protein in GC cells .
244	induce	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	Among the altered miRNAs , TGF-?] 1 induced the down-regulation of miR-193b , which inhibited cell invasion and metastasis in vivo and in vitro , and down-regulated uPA protein in GC cells .
243	suppress	negative	mir-193b	850.2769	891.1442	891.1442	miRNA		miR-193b suppressed the invasion and metastasis of GC cells in vivo and in vitro , and down-regulated urokinase-type plasminogen activator ( uPA ) protein in GC cells .
243	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	miR-193b suppressed the invasion and metastasis of GC cells in vivo and in vitro , and down-regulated urokinase-type plasminogen activator ( uPA ) protein in GC cells .
236	promote	positive	microrna-29b	855.5427	890.5122	890.5122	miRNA		Here , we show that GATA3 promotes differentiation , suppresses metastasis and alters the tumour microenvironment in breast cancer by inducing microRNA-29b ( miR-29b ) expression .
236	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here , we show that GATA3 promotes differentiation , suppresses metastasis and alters the tumour microenvironment in breast cancer by inducing microRNA-29b ( miR-29b ) expression .
234	promote	positive	microrna-200a	860.8007	889.8173	889.8173	miRNA		MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer .
234	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer .
233	inhibit	negative	mir-148a	871.2897	888.2394	888.2394	miRNA		In cultured cells and a mouse xenograft model , miR-148a reduced the growth , epithelial-to-mesenchymal transition , invasion , and metastasis of HBx-expressing hepatocarcinoma cells through inhibition of HPIP-mediated mTOR signaling .
233	inhibit	negative	hpip	866.0499	889.0597	889.0597	Cancer	D019337	In cultured cells and a mouse xenograft model , miR-148a reduced the growth , epithelial-to-mesenchymal transition , invasion , and metastasis of HBx-expressing hepatocarcinoma cells through inhibition of HPIP-mediated mTOR signaling .
1940	suppress	negative	mir-148a	871.2897	888.2394	888.2394	miRNA		MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer .
1940	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer .
1774	suppress	negative	mir-148a	871.2897	888.2394	888.2394	miRNA		Taken together , our results suggest that miR-148a can suppress the migration and invasion of breast cancer cells by targeting WNT-1 and inhibiting Wnt/?] -catenin signaling pathway and this will provide new insights into the molecular mechanisms of breast cancer metastasis .
1774	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Taken together , our results suggest that miR-148a can suppress the migration and invasion of breast cancer cells by targeting WNT-1 and inhibiting Wnt/?] -catenin signaling pathway and this will provide new insights into the molecular mechanisms of breast cancer metastasis .
1773	suppress	negative	mir-148a	871.2897	888.2394	888.2394	miRNA		Taken together , our results suggest that miR-148a can suppress the migration and invasion of breast cancer cells by targeting WNT-1 and inhibiting Wnt/?] -catenin signaling pathway and this will provide new insights into the molecular mechanisms of breast cancer metastasis .
1773	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Taken together , our results suggest that miR-148a can suppress the migration and invasion of breast cancer cells by targeting WNT-1 and inhibiting Wnt/?] -catenin signaling pathway and this will provide new insights into the molecular mechanisms of breast cancer metastasis .
1752	promote	positive	mir-148a	871.2897	888.2394	888.2394	miRNA		Down-Regulation of miR-148a Promotes Metastasis by DNA Methylation and is Associated with Prognosis of Skin Cancer by Targeting TGIF2 .
1752	promote	positive	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	Down-Regulation of miR-148a Promotes Metastasis by DNA Methylation and is Associated with Prognosis of Skin Cancer by Targeting TGIF2 .
1714	suppress	negative	mir-148a	871.2897	888.2394	888.2394	miRNA		Furthermore , functional assays showed that miR-148a expression suppressed NSCLC cell invasive and migratory abilities in vitro and suppressed cancer metastasis in vivo , while inhibition of miR-148a enhanced NSCLC cell invasion and lung metastasis formation in a mouse model .
1714	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Furthermore , functional assays showed that miR-148a expression suppressed NSCLC cell invasive and migratory abilities in vitro and suppressed cancer metastasis in vivo , while inhibition of miR-148a enhanced NSCLC cell invasion and lung metastasis formation in a mouse model .
1713	suppress	negative	mir-148a	871.2897	888.2394	888.2394	miRNA		Furthermore , functional assays showed that miR-148a expression suppressed NSCLC cell invasive and migratory abilities in vitro and suppressed cancer metastasis in vivo , while inhibition of miR-148a enhanced NSCLC cell invasion and lung metastasis formation in a mouse model .
1713	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Furthermore , functional assays showed that miR-148a expression suppressed NSCLC cell invasive and migratory abilities in vitro and suppressed cancer metastasis in vivo , while inhibition of miR-148a enhanced NSCLC cell invasion and lung metastasis formation in a mouse model .
1509	inhibit	negative	mir-148a	871.2897	888.2394	888.2394	miRNA		Importantly , we demonstrated that the overexpression of miR-148a significantly inhibited CSCC cell proliferation and metastasis via down-regulation of MAP3K9 and MAP3K4 expression .
1509	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Importantly , we demonstrated that the overexpression of miR-148a significantly inhibited CSCC cell proliferation and metastasis via down-regulation of MAP3K9 and MAP3K4 expression .
1473	control	neutral	mir-148a	871.2897	888.2394	888.2394	miRNA		Based on the results obtained in the last decade , some miRNAs are emerging as biomarkers of BC for diagnosis ( i.e. , miR-9 , miR-10b , and miR-17-5p ) , prognosis ( i.e. , miR-148a and miR-335 ) , and prediction of therapeutic outcomes ( i.e. , miR-30c , miR-187 , and miR-339-5p ) and have important roles in the control of BC hallmark functions such as invasion , metastasis , proliferation , resting death , apoptosis , and genomic instability .
1473	control	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Based on the results obtained in the last decade , some miRNAs are emerging as biomarkers of BC for diagnosis ( i.e. , miR-9 , miR-10b , and miR-17-5p ) , prognosis ( i.e. , miR-148a and miR-335 ) , and prediction of therapeutic outcomes ( i.e. , miR-30c , miR-187 , and miR-339-5p ) and have important roles in the control of BC hallmark functions such as invasion , metastasis , proliferation , resting death , apoptosis , and genomic instability .
1386	suppress	negative	mir-148a	871.2897	888.2394	888.2394	miRNA		To our surprise , we found that miR-148a , miR-505 , and miR-1207-5p can suppress EMT and metastasis phenotypes in HK-1 cells both in vitro and in vivo , which may relate to their inhibition on EMT and Wnt signaling molecules .
1386	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	To our surprise , we found that miR-148a , miR-505 , and miR-1207-5p can suppress EMT and metastasis phenotypes in HK-1 cells both in vitro and in vivo , which may relate to their inhibition on EMT and Wnt signaling molecules .
1005	downregulate	negative	mir-148a	871.2897	888.2394	888.2394	miRNA		mir-148a expression in cancer tissues of patients with lymph node metastasis , vascular invasion and TNM stage III ( -IIII ( was down-regulated more obviously ( P < 0.05 ) .
1005	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	mir-148a expression in cancer tissues of patients with lymph node metastasis , vascular invasion and TNM stage III ( -IIII ( was down-regulated more obviously ( P < 0.05 ) .
516	downregulate	negative	mir-148a	871.2897	888.2394	888.2394	miRNA		Downregulation of miR-148a was significantly correlated with an advanced clinical stage , lymph node metastasis , and poor clinical outcome .
516	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Downregulation of miR-148a was significantly correlated with an advanced clinical stage , lymph node metastasis , and poor clinical outcome .
443	regulate	positive	mir-148a	871.2897	888.2394	888.2394	miRNA		Taken together , miR-148a may negatively regulate Met/Snail signaling and therefore inhibit the EMT and metastasis of hepatoma cells .
443	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , miR-148a may negatively regulate Met/Snail signaling and therefore inhibit the EMT and metastasis of hepatoma cells .
442	regulate	positive	mir-148a	871.2897	888.2394	888.2394	miRNA		Taken together , miR-148a may negatively regulate Met/Snail signaling and therefore inhibit the EMT and metastasis of hepatoma cells .
442	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , miR-148a may negatively regulate Met/Snail signaling and therefore inhibit the EMT and metastasis of hepatoma cells .
441	suppress	negative	mir-148a	871.2897	888.2394	888.2394	miRNA		These data suggest that miR-148a may suppress EMT and cancer metastasis .
441	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	These data suggest that miR-148a may suppress EMT and cancer metastasis .
440	repress	negative	mir-148a	871.2897	888.2394	888.2394	miRNA		An in vitro transwell assay and an in vivo orthotopic liver xenograft model showed that the restoration of miR-148a expression significantly repressed the migration and pulmonary metastasis of hepatoma cells .
440	repress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	An in vitro transwell assay and an in vivo orthotopic liver xenograft model showed that the restoration of miR-148a expression significantly repressed the migration and pulmonary metastasis of hepatoma cells .
400	suppress	negative	mir-148a	871.2897	888.2394	888.2394	miRNA		MiR-148a suppresses gastric cancer metastasis and EMT , likely via SMAD2 .
400	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	MiR-148a suppresses gastric cancer metastasis and EMT , likely via SMAD2 .
399	suppress	negative	mir-148a	871.2897	888.2394	888.2394	miRNA		MiR-148a suppresses gastric cancer metastasis and EMT , likely via SMAD2 .
399	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	MiR-148a suppresses gastric cancer metastasis and EMT , likely via SMAD2 .
398	inhibit	negative	mir-148a	871.2897	888.2394	888.2394	miRNA		miR-148a overexpression inhibited metastasis of gastric cancer cells .
398	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	miR-148a overexpression inhibited metastasis of gastric cancer cells .
395	inhibit	negative	mir-148a	871.2897	888.2394	888.2394	miRNA		The results suggest that miR-148a inhibits the metastasis of HCCs by blocking EMT and CSCs-like properties through effects on the Wnt signaling pathway .
395	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The results suggest that miR-148a inhibits the metastasis of HCCs by blocking EMT and CSCs-like properties through effects on the Wnt signaling pathway .
394	inhibit	negative	mir-148a	871.2897	888.2394	888.2394	miRNA		The results suggest that miR-148a inhibits the metastasis of HCCs by blocking EMT and CSCs-like properties through effects on the Wnt signaling pathway .
394	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The results suggest that miR-148a inhibits the metastasis of HCCs by blocking EMT and CSCs-like properties through effects on the Wnt signaling pathway .
393	inhibit	negative	mir-148a	871.2897	888.2394	888.2394	miRNA		The results suggest that miR-148a inhibits the metastasis of HCCs by blocking EMT and CSCs-like properties through effects on the Wnt signaling pathway .
393	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The results suggest that miR-148a inhibits the metastasis of HCCs by blocking EMT and CSCs-like properties through effects on the Wnt signaling pathway .
348	downregulate	negative	mir-148a	871.2897	888.2394	888.2394	miRNA		We found that miR-148a is significantly downregulated in non-small cell lung cancer ( NSCLC ) compared to adjacent non-cancerous lung tissues , and the downregulated miR-148a was significantly associated with lymph-node metastasis .
348	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We found that miR-148a is significantly downregulated in non-small cell lung cancer ( NSCLC ) compared to adjacent non-cancerous lung tissues , and the downregulated miR-148a was significantly associated with lymph-node metastasis .
347	downregulate	negative	mir-148a	871.2897	888.2394	888.2394	miRNA		We found that miR-148a is significantly downregulated in non-small cell lung cancer ( NSCLC ) compared to adjacent non-cancerous lung tissues , and the downregulated miR-148a was significantly associated with lymph-node metastasis .
347	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We found that miR-148a is significantly downregulated in non-small cell lung cancer ( NSCLC ) compared to adjacent non-cancerous lung tissues , and the downregulated miR-148a was significantly associated with lymph-node metastasis .
232	repress	negative	mir-148a	871.2897	888.2394	888.2394	miRNA		Here , we report that miR-148a is repressed by hepatitis B virus ( HBV ) X protein ( HBx ) to promote cancer growth and metastasis in a mouse model of hepatocellular carcinoma ( HCC ) .
232	repress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we report that miR-148a is repressed by hepatitis B virus ( HBV ) X protein ( HBx ) to promote cancer growth and metastasis in a mouse model of hepatocellular carcinoma ( HCC ) .
2011	inhibit	negative	mir-374a	876.5193	887.3566	887.3566	miRNA		Long noncoding RNA FTX inhibits hepatocellular carcinoma proliferation and metastasis by binding MCM2 and miR-374a .
2011	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Long noncoding RNA FTX inhibits hepatocellular carcinoma proliferation and metastasis by binding MCM2 and miR-374a .
231	promote	positive	mir-374a	876.5193	887.3566	887.3566	miRNA		In breast cancer cell lines , ectopic overexpression of miR-374a promoted EMT and metastasis both in vitro and in vivo .
231	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In breast cancer cell lines , ectopic overexpression of miR-374a promoted EMT and metastasis both in vitro and in vivo .
230	promote	positive	mir-374a	876.5193	887.3566	887.3566	miRNA		In breast cancer cell lines , ectopic overexpression of miR-374a promoted EMT and metastasis both in vitro and in vivo .
230	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In breast cancer cell lines , ectopic overexpression of miR-374a promoted EMT and metastasis both in vitro and in vivo .
229	activate	positive	microrna-374a	881.7381	886.4114	886.4114	miRNA		MicroRNA-374a activates Wnt/?] -catenin signaling to promote breast cancer metastasis .
229	activate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-374a activates Wnt/?] -catenin signaling to promote breast cancer metastasis .
226	downregulate	negative	mir-34b	886.9452	885.4039	885.4039	miRNA		In human specimens , we found that miR-34b was down-regulated in pancreatic cancer tissues and low level of miR-34b expression was positively correlated with tumor-node-metastasis ( TNM ) stage , lymph-node metastasis and overall survival .
226	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In human specimens , we found that miR-34b was down-regulated in pancreatic cancer tissues and low level of miR-34b expression was positively correlated with tumor-node-metastasis ( TNM ) stage , lymph-node metastasis and overall survival .
225	downregulate	negative	mir-34b	886.9452	885.4039	885.4039	miRNA		In human specimens , we found that miR-34b was down-regulated in pancreatic cancer tissues and low level of miR-34b expression was positively correlated with tumor-node-metastasis ( TNM ) stage , lymph-node metastasis and overall survival .
225	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In human specimens , we found that miR-34b was down-regulated in pancreatic cancer tissues and low level of miR-34b expression was positively correlated with tumor-node-metastasis ( TNM ) stage , lymph-node metastasis and overall survival .
224	inhibit	negative	microrna-34b	892.1398	884.3342	884.3342	miRNA		MicroRNA-34b inhibits pancreatic cancer metastasis through repressing Smad3 .
224	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-34b inhibits pancreatic cancer metastasis through repressing Smad3 .
1891	control	neutral	mir-23b/	897.3214	883.2026	883.2026	miRNA		To examine the effects of miR-23b/-27b on prostate cancer metastasis in vivo , orthotopic prostate xenografts were established using aggressive prostate cancer cells transduced with miR-23b/-27b or non-targeting control miRNA .
1891	control	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	To examine the effects of miR-23b/-27b on prostate cancer metastasis in vivo , orthotopic prostate xenografts were established using aggressive prostate cancer cells transduced with miR-23b/-27b or non-targeting control miRNA .
1890	inhibit	negative	mir-23b/	897.3214	883.2026	883.2026	miRNA		However , neither miR-23b/-27b expression or inhibition impacts prostate cancer cell proliferation suggesting that miR-23b/-27b selectively suppresses metastasis .
1890	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	However , neither miR-23b/-27b expression or inhibition impacts prostate cancer cell proliferation suggesting that miR-23b/-27b selectively suppresses metastasis .
221	effect	neutral	mir-23b/	897.3214	883.2026	883.2026	miRNA		However , there was no effect of miR-23b/-27b on cell proliferation suggesting that these miRs function as metastasis ( but not growth ) suppressors in prostate cancer .
221	effect	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	However , there was no effect of miR-23b/-27b on cell proliferation suggesting that these miRs function as metastasis ( but not growth ) suppressors in prostate cancer .
220	suppress	negative	mir-582	902.489	882.0093	882.0093	miRNA		Furthermore , transurethral injections of synthetic miR-582 molecule suppressed tumor growth and metastasis in an animal model of bladder cancer .
220	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Furthermore , transurethral injections of synthetic miR-582 molecule suppressed tumor growth and metastasis in an animal model of bladder cancer .
1853	downregulate	negative	mir-137	907.642	880.7542	880.7542	miRNA		Quantitative RT-PCR ( qRT-PCR ) assay showed that miR-137 expression was significantly downregulated in human PTC tissues , and its expression was significantly negatively correlated with tumor-node-metastasis ( TNM ) stage and lymph node metastasis .
1853	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Quantitative RT-PCR ( qRT-PCR ) assay showed that miR-137 expression was significantly downregulated in human PTC tissues , and its expression was significantly negatively correlated with tumor-node-metastasis ( TNM ) stage and lymph node metastasis .
1852	downregulate	negative	mir-137	907.642	880.7542	880.7542	miRNA		Quantitative RT-PCR ( qRT-PCR ) assay showed that miR-137 expression was significantly downregulated in human PTC tissues , and its expression was significantly negatively correlated with tumor-node-metastasis ( TNM ) stage and lymph node metastasis .
1852	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Quantitative RT-PCR ( qRT-PCR ) assay showed that miR-137 expression was significantly downregulated in human PTC tissues , and its expression was significantly negatively correlated with tumor-node-metastasis ( TNM ) stage and lymph node metastasis .
1570	inhibit	negative	mir-137	907.642	880.7542	880.7542	miRNA		Furthermore , co-overexpression of AKT2 in addition to CDC42 additively reduced the inhibition of miR-137 on HCC proliferation and metastasis , suggesting two independent pathways of CDC42 and AKT2 in miR-137-mediated HCC regulation .
1570	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Furthermore , co-overexpression of AKT2 in addition to CDC42 additively reduced the inhibition of miR-137 on HCC proliferation and metastasis , suggesting two independent pathways of CDC42 and AKT2 in miR-137-mediated HCC regulation .
1569	upregulate	positive	mir-137	907.642	880.7542	880.7542	miRNA		In the HCC HuH7 and MHCC97L cell lines , miR-137 was upregulated to inhibit cell proliferation and metastasis in ? vitro and tumor growth in ? vivo .
1569	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In the HCC HuH7 and MHCC97L cell lines , miR-137 was upregulated to inhibit cell proliferation and metastasis in ? vitro and tumor growth in ? vivo .
1568	inhibit	negative	mir-137	907.642	880.7542	880.7542	miRNA		Inhibition of cell proliferation and metastasis of human hepatocellular carcinoma by miR-137 is regulated by CDC42 .
1568	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Inhibition of cell proliferation and metastasis of human hepatocellular carcinoma by miR-137 is regulated by CDC42 .
1427	downregulate	negative	mir-137	907.642	880.7542	880.7542	miRNA		In conclusion , the miR-137 which is frequently down-regulated in gastric cancer is potentially involved in gastric cancer tumorigenesis and metastasis by regulating AKT2 related signal pathways .
1427	downregulate	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	In conclusion , the miR-137 which is frequently down-regulated in gastric cancer is potentially involved in gastric cancer tumorigenesis and metastasis by regulating AKT2 related signal pathways .
817	inhibit	negative	mir-137	907.642	880.7542	880.7542	miRNA		In vivo studies confirm that FoxD3-regulated miR-137 inhibited HCC growth and metastasis via targeting AKT2 .
817	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In vivo studies confirm that FoxD3-regulated miR-137 inhibited HCC growth and metastasis via targeting AKT2 .
216	induce	positive	mir-137	907.642	880.7542	880.7542	miRNA		Taken together , these results demonstrated that overexpression of PXN induced by suppression of miR-137 promotes tumor progression and metastasis and could serve as an independent prognostic indicator in CRC patients .
216	induce	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Taken together , these results demonstrated that overexpression of PXN induced by suppression of miR-137 promotes tumor progression and metastasis and could serve as an independent prognostic indicator in CRC patients .
215	induce	positive	mir-137	907.642	880.7542	880.7542	miRNA		Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer .
215	induce	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer .
214	regulate	positive	mir-30d	912.7797	879.4377	879.4377	miRNA		In human epithelial cancers , the microRNA ( miRNA ) mir-30d is amplified with high frequency and serves as a critical oncomir by regulating metastasis , apoptosis , proliferation , and differentiation .
214	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In human epithelial cancers , the microRNA ( miRNA ) mir-30d is amplified with high frequency and serves as a critical oncomir by regulating metastasis , apoptosis , proliferation , and differentiation .
212	regulate	positive	mir-100/mtor	917.9012	878.0599	878.0599	miRNA		In addition , the cancerous metastatic nude mouse model established on the basis of primary bladder cancer cell lines suggested that miR-100/mTOR regulated cell motility and was associated with tumor metastasis .
212	regulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	In addition , the cancerous metastatic nude mouse model established on the basis of primary bladder cancer cell lines suggested that miR-100/mTOR regulated cell motility and was associated with tumor metastasis .
1451	downregulate	negative	mir-363	923.006	876.621	876.621	miRNA		It was identified that the expression levels of miR-551b-3p , miR-133b , miR-100-5p and miR-363-3p were significantly downregulated in the gastric cancer tissues , and this downregulation was closely correlated with the degree of differentiation ( i.e. , tumor grade ) , TNM stage and lymph-node metastasis ( P < 0.05 ) .
1451	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	It was identified that the expression levels of miR-551b-3p , miR-133b , miR-100-5p and miR-363-3p were significantly downregulated in the gastric cancer tissues , and this downregulation was closely correlated with the degree of differentiation ( i.e. , tumor grade ) , TNM stage and lymph-node metastasis ( P < 0.05 ) .
375	regulate	positive	mir-363	923.006	876.621	876.621	miRNA		miR-335 and miR-363 regulation of neuroblastoma tumorigenesis and metastasis .
375	regulate	positive	osteosarcoma cells	1157.953	712.69	712.69	Cancer	D063646	miR-335 and miR-363 regulation of neuroblastoma tumorigenesis and metastasis .
209	downregulate	negative	mir-363	923.006	876.621	876.621	miRNA		Furthermore , we provided evidence to demonstrate that PDPN dysregulation caused by down-regulation of miR-363 contributes to HNSCC invasion and metastasis .
209	downregulate	negative	hnscc	1221.107	590.7296	590.7296	Cancer	D006258	Furthermore , we provided evidence to demonstrate that PDPN dysregulation caused by down-regulation of miR-363 contributes to HNSCC invasion and metastasis .
208	downregulate	negative	mir-363	923.006	876.621	876.621	miRNA		In this study , we have first confirmed that miR-363 is down-regulated in HNSCC tissues with lymph node metastasis and cell lines with highly invasive capacity .
208	downregulate	negative	hnscc	1221.107	590.7296	590.7296	Cancer	D006258	In this study , we have first confirmed that miR-363 is down-regulated in HNSCC tissues with lymph node metastasis and cell lines with highly invasive capacity .
207	downregulate	negative	mir-363	923.006	876.621	876.621	miRNA		In this study , we have first confirmed that miR-363 is down-regulated in HNSCC tissues with lymph node metastasis and cell lines with highly invasive capacity .
207	downregulate	negative	hnscc	1221.107	590.7296	590.7296	Cancer	D006258	In this study , we have first confirmed that miR-363 is down-regulated in HNSCC tissues with lymph node metastasis and cell lines with highly invasive capacity .
206	affect	neutral	mir-363	923.006	876.621	876.621	miRNA		Dysregulated miR-363 affects head and neck cancer invasion and metastasis by targeting podoplanin .
206	affect	neutral	hnscc	1221.107	590.7296	590.7296	Cancer	D006258	Dysregulated miR-363 affects head and neck cancer invasion and metastasis by targeting podoplanin .
1383	antagonize	negative	mir-181a	928.0931	875.1213	875.1213	miRNA		Antagonizing miR-181a may serve as a promising strategy to sensitize TNBC cells to chemotherapy and mitigate metastasis .
1383	antagonize	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Antagonizing miR-181a may serve as a promising strategy to sensitize TNBC cells to chemotherapy and mitigate metastasis .
1382	suppress	negative	mir-181a	928.0931	875.1213	875.1213	miRNA		These results were further confirmed by evidence that suppression of miR-181a significantly enhanced therapeutic response and reduced lung metastasis in a TNBC orthotopic model .
1382	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	These results were further confirmed by evidence that suppression of miR-181a significantly enhanced therapeutic response and reduced lung metastasis in a TNBC orthotopic model .
1381	enhance	positive	mir-181a	928.0931	875.1213	875.1213	miRNA		Here we show that genotoxic treatments significantly increased the expression of miR-181a in TNBC cells , which enhanced TNBC cell survival and metastasis upon Doxorubicin treatment .
1381	enhance	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here we show that genotoxic treatments significantly increased the expression of miR-181a in TNBC cells , which enhanced TNBC cell survival and metastasis upon Doxorubicin treatment .
1374	inhibit	negative	mir-181a	928.0931	875.1213	875.1213	miRNA		Targeting miR-181a can inhibit tumor angiogenesis , growth , and metastasis , thus suggesting the possibility of antagomir-based therapy in chondrosarcoma .
1374	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Targeting miR-181a can inhibit tumor angiogenesis , growth , and metastasis , thus suggesting the possibility of antagomir-based therapy in chondrosarcoma .
1373	inhibit	negative	mir-181a	928.0931	875.1213	875.1213	miRNA		Therapeutic inhibition of miR-181a decreased expression of VEGF and MMP1 in vitro , and angiogenesis , MMP1 activity , tumor growth , and lung metastasis , all by more than 50 % , in a xenograft mouse model .
1373	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Therapeutic inhibition of miR-181a decreased expression of VEGF and MMP1 in vitro , and angiogenesis , MMP1 activity , tumor growth , and lung metastasis , all by more than 50 % , in a xenograft mouse model .
1372	promote	positive	mir-181a	928.0931	875.1213	875.1213	miRNA		miR-181a Targets RGS16 to Promote Chondrosarcoma Growth , Angiogenesis , and Metastasis .
1372	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-181a Targets RGS16 to Promote Chondrosarcoma Growth , Angiogenesis , and Metastasis .
721	downregulate	negative	mir-181a	928.0931	875.1213	875.1213	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
721	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
720	downregulate	negative	mir-181a	928.0931	875.1213	875.1213	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
720	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
668	promote	positive	mir-181a	928.0931	875.1213	875.1213	miRNA		Stable transfection of CRC cell lines with miR-181a promoted cell motility and invasion , as well as tumor growth and liver metastasis , while silencing its expression resulted in reduced migration and invasion .
668	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Stable transfection of CRC cell lines with miR-181a promoted cell motility and invasion , as well as tumor growth and liver metastasis , while silencing its expression resulted in reduced migration and invasion .
667	promote	positive	mir-181a	928.0931	875.1213	875.1213	miRNA		Stable transfection of CRC cell lines with miR-181a promoted cell motility and invasion , as well as tumor growth and liver metastasis , while silencing its expression resulted in reduced migration and invasion .
667	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Stable transfection of CRC cell lines with miR-181a promoted cell motility and invasion , as well as tumor growth and liver metastasis , while silencing its expression resulted in reduced migration and invasion .
285	regulate	positive	mir-181a	928.0931	875.1213	875.1213	miRNA		Focusing on miR-181a , they uncovered an intricate pathway regulating breast cancer metastasis that sheds new insight into metastasis regulation that may prove useful in clinical settings .
285	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Focusing on miR-181a , they uncovered an intricate pathway regulating breast cancer metastasis that sheds new insight into metastasis regulation that may prove useful in clinical settings .
205	upregulate	positive	mir-181a	928.0931	875.1213	875.1213	miRNA		TGF-?] upregulates miR-181a expression to promote breast cancer metastasis .
205	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	TGF-?] upregulates miR-181a expression to promote breast cancer metastasis .
203	suppress	negative	mirna-145	933.162	873.5609	873.5609	miRNA		miRNA-145 targets v-ets erythroblastosis virus E26 oncogene homolog 1 to suppress the invasion , metastasis , and angiogenesis of gastric cancer cells .
203	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	miRNA-145 targets v-ets erythroblastosis virus E26 oncogene homolog 1 to suppress the invasion , metastasis , and angiogenesis of gastric cancer cells .
816	suppress	negative	microrna-137	938.212	871.9401	871.9401	miRNA		FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2 .
816	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2 .
200	suppress	negative	microrna-137	938.212	871.9401	871.9401	miRNA		MicroRNA-137 , an HMGA1 target , suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2 .
200	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-137 , an HMGA1 target , suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2 .
199	downregulate	negative	mir-153	943.2422	870.2591	870.2591	miRNA		Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer .
199	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer .
196	regulate	positive	mir-29c/tiam	948.2519	868.5181	868.5181	miRNA		The newly identified miR-29c/TIAM1 pathway further elucidates the molecular mechanisms regulating invasion and metastasis in NPC , and may provide novel prognostic and treatment strategies for NPC patients .
196	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The newly identified miR-29c/TIAM1 pathway further elucidates the molecular mechanisms regulating invasion and metastasis in NPC , and may provide novel prognostic and treatment strategies for NPC patients .
1888	induce	positive	let-7a	953.2405	866.7173	866.7173	miRNA		Let-7a mimic attenuates CCL18 induced breast cancer cell metastasis through Lin 28 pathway .
1888	induce	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Let-7a mimic attenuates CCL18 induced breast cancer cell metastasis through Lin 28 pathway .
1780	inhibit	negative	let-7a	953.2405	866.7173	866.7173	miRNA		Apart from that , over-expressed exogenous HMGA2 could reverse the inhibition of glioma cell metastasis and proliferation induced by let-7a .
1780	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Apart from that , over-expressed exogenous HMGA2 could reverse the inhibition of glioma cell metastasis and proliferation induced by let-7a .
1294	regulate	positive	let-7a	953.2405	866.7173	866.7173	miRNA		We aimed to investigate the function and mechanism of let-7a in nasopharyngeal carcinoma metastasis and clarified the regulation of high mobility group A2 ( HMGA2 ) by let-7a .
1294	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	We aimed to investigate the function and mechanism of let-7a in nasopharyngeal carcinoma metastasis and clarified the regulation of high mobility group A2 ( HMGA2 ) by let-7a .
1051	inhibit	negative	let-7a	953.2405	866.7173	866.7173	miRNA		Chol-let-7a reached HCC orthotopic tumours , significantly inhibited tumour growth , and prevented local invasion and metastasis .
1051	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Chol-let-7a reached HCC orthotopic tumours , significantly inhibited tumour growth , and prevented local invasion and metastasis .
536	induce	positive	let-7a	953.2405	866.7173	866.7173	miRNA		Given that Lin28 induced the EMT via let-7a and promoted breast cancer metastasis , Lin28 may be a therapeutic target for the eradication of breast cancer metastasis .
536	induce	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Given that Lin28 induced the EMT via let-7a and promoted breast cancer metastasis , Lin28 may be a therapeutic target for the eradication of breast cancer metastasis .
535	induce	positive	let-7a	953.2405	866.7173	866.7173	miRNA		Given that Lin28 induced the EMT via let-7a and promoted breast cancer metastasis , Lin28 may be a therapeutic target for the eradication of breast cancer metastasis .
535	induce	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Given that Lin28 induced the EMT via let-7a and promoted breast cancer metastasis , Lin28 may be a therapeutic target for the eradication of breast cancer metastasis .
193	inhibit	negative	let-7a	953.2405	866.7173	866.7173	miRNA		MicroRNAs are closely linked to tumor metastasis and let-7a may play a role in inhibiting the proliferation , invasion , and metastasis of lung cancer .
193	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	MicroRNAs are closely linked to tumor metastasis and let-7a may play a role in inhibiting the proliferation , invasion , and metastasis of lung cancer .
320	upregulate	positive	let-7i	958.2072	864.8572	864.8572	miRNA		The miRNA microarray results showed that compared to the NLN group , upregulation of four miRNAs including miR-2861 , miR-451 , miR-193b , and miR-1202 was associated with LN metastasis , whereas four other miRNAs including miR-let-7i , miR-542-5p , miR-664* , and miR-564 were downregulated in the LN group .
320	upregulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray results showed that compared to the NLN group , upregulation of four miRNAs including miR-2861 , miR-451 , miR-193b , and miR-1202 was associated with LN metastasis , whereas four other miRNAs including miR-let-7i , miR-542-5p , miR-664* , and miR-564 were downregulated in the LN group .
190	downregulate	negative	let-7i	958.2072	864.8572	864.8572	miRNA		Let-7i was significantly down-regulated in most tumor tissues ( 78/86 : 91 % ) compared with paired NATs ( P < 0.001 ) , and low levels of let-7i were significantly correlated with local invasion , lymphatic metastasis , and poor pathologic tumor response .
190	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Let-7i was significantly down-regulated in most tumor tissues ( 78/86 : 91 % ) compared with paired NATs ( P < 0.001 ) , and low levels of let-7i were significantly correlated with local invasion , lymphatic metastasis , and poor pathologic tumor response .
189	downregulate	negative	let-7i	958.2072	864.8572	864.8572	miRNA		Let-7i was significantly down-regulated in most tumor tissues ( 78/86 : 91 % ) compared with paired NATs ( P < 0.001 ) , and low levels of let-7i were significantly correlated with local invasion , lymphatic metastasis , and poor pathologic tumor response .
189	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Let-7i was significantly down-regulated in most tumor tissues ( 78/86 : 91 % ) compared with paired NATs ( P < 0.001 ) , and low levels of let-7i were significantly correlated with local invasion , lymphatic metastasis , and poor pathologic tumor response .
184	react	neutral	mir-9*	963.1514	862.9378	862.9378	miRNA		Total RNA was extracted and quantitave polymerase chain reaction ( qPCR ) analysis performed on the primary tumour and a corresponding lymph node metastasis for expression of miRNAs of proven significance in MTC ( miR-9* , miR-183 and miR-375 ) .
184	react	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Total RNA was extracted and quantitave polymerase chain reaction ( qPCR ) analysis performed on the primary tumour and a corresponding lymph node metastasis for expression of miRNAs of proven significance in MTC ( miR-9* , miR-183 and miR-375 ) .
183	react	neutral	mir-9*	963.1514	862.9378	862.9378	miRNA		Total RNA was extracted and quantitave polymerase chain reaction ( qPCR ) analysis performed on the primary tumour and a corresponding lymph node metastasis for expression of miRNAs of proven significance in MTC ( miR-9* , miR-183 and miR-375 ) .
183	react	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Total RNA was extracted and quantitave polymerase chain reaction ( qPCR ) analysis performed on the primary tumour and a corresponding lymph node metastasis for expression of miRNAs of proven significance in MTC ( miR-9* , miR-183 and miR-375 ) .
181	inhibit	negative	microrna-1280	968.0723	860.9595	860.9595	miRNA		MicroRNA-1280 inhibits invasion and metastasis by targeting ROCK1 in bladder cancer .
181	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	MicroRNA-1280 inhibits invasion and metastasis by targeting ROCK1 in bladder cancer .
1630	downregulate	negative	mir-451	972.9692	858.9225	858.9225	miRNA		We found that miR-451 showed decreased expression in GC tissues and cell lines , and its down-regulation tended to be positively correlated with lymphatic metastasis , clinical staging and shorter overall survival of patients .
1630	downregulate	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	We found that miR-451 showed decreased expression in GC tissues and cell lines , and its down-regulation tended to be positively correlated with lymphatic metastasis , clinical staging and shorter overall survival of patients .
1446	activate	positive	mir-451	972.9692	858.9225	858.9225	miRNA		Collectively , these data demonstrated that miR-451 is a novel prognostic biomarker for HCC patients and that function as a potential metastasis inhibitor in HCC cells through activation of the Erk1/2 signaling , at least partially by targeting c-Myc .
1446	activate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Collectively , these data demonstrated that miR-451 is a novel prognostic biomarker for HCC patients and that function as a potential metastasis inhibitor in HCC cells through activation of the Erk1/2 signaling , at least partially by targeting c-Myc .
1445	inhibit	negative	mir-451	972.9692	858.9225	858.9225	miRNA		Importantly , miR-451 could inhibit the migration and invasion in vitro , as well as in vivo metastasis of HCC cells through regulating EMT process .
1445	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Importantly , miR-451 could inhibit the migration and invasion in vitro , as well as in vivo metastasis of HCC cells through regulating EMT process .
1444	inhibit	negative	mir-451	972.9692	858.9225	858.9225	miRNA		Importantly , miR-451 could inhibit the migration and invasion in vitro , as well as in vivo metastasis of HCC cells through regulating EMT process .
1444	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Importantly , miR-451 could inhibit the migration and invasion in vitro , as well as in vivo metastasis of HCC cells through regulating EMT process .
1073	downregulate	negative	mir-451	972.9692	858.9225	858.9225	miRNA		In addition , miR-451 down-regulation more frequently occurred in osteosarcoma specimens with advanced clinical stage ( P ? < ? 0.001 ) , positive distant metastasis ( P ? = ? 0.015 ) , and poor response to neoadjuvant chemotherapy ( P ? < ? 0.001 ) .
1073	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	In addition , miR-451 down-regulation more frequently occurred in osteosarcoma specimens with advanced clinical stage ( P ? < ? 0.001 ) , positive distant metastasis ( P ? = ? 0.015 ) , and poor response to neoadjuvant chemotherapy ( P ? < ? 0.001 ) .
990	downregulate	negative	mir-451	972.9692	858.9225	858.9225	miRNA		MiR-451 was found to be significantly downregulated in docetaxel-resistant LAD cells , and re-expression of miR-451 could reverse EMT to mesenchymal-epithelial transition ( MET ) and inhibit invasion and metastasis of docetaxel-resistant LAD cells both in vitro and in vivo .
990	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-451 was found to be significantly downregulated in docetaxel-resistant LAD cells , and re-expression of miR-451 could reverse EMT to mesenchymal-epithelial transition ( MET ) and inhibit invasion and metastasis of docetaxel-resistant LAD cells both in vitro and in vivo .
989	downregulate	negative	mir-451	972.9692	858.9225	858.9225	miRNA		MiR-451 was found to be significantly downregulated in docetaxel-resistant LAD cells , and re-expression of miR-451 could reverse EMT to mesenchymal-epithelial transition ( MET ) and inhibit invasion and metastasis of docetaxel-resistant LAD cells both in vitro and in vivo .
989	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-451 was found to be significantly downregulated in docetaxel-resistant LAD cells , and re-expression of miR-451 could reverse EMT to mesenchymal-epithelial transition ( MET ) and inhibit invasion and metastasis of docetaxel-resistant LAD cells both in vitro and in vivo .
988	downregulate	negative	mir-451	972.9692	858.9225	858.9225	miRNA		MiR-451 was found to be significantly downregulated in docetaxel-resistant LAD cells , and re-expression of miR-451 could reverse EMT to mesenchymal-epithelial transition ( MET ) and inhibit invasion and metastasis of docetaxel-resistant LAD cells both in vitro and in vivo .
988	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-451 was found to be significantly downregulated in docetaxel-resistant LAD cells , and re-expression of miR-451 could reverse EMT to mesenchymal-epithelial transition ( MET ) and inhibit invasion and metastasis of docetaxel-resistant LAD cells both in vitro and in vivo .
987	downregulate	negative	mir-451	972.9692	858.9225	858.9225	miRNA		MiR-451 was found to be significantly downregulated in docetaxel-resistant LAD cells , and re-expression of miR-451 could reverse EMT to mesenchymal-epithelial transition ( MET ) and inhibit invasion and metastasis of docetaxel-resistant LAD cells both in vitro and in vivo .
987	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-451 was found to be significantly downregulated in docetaxel-resistant LAD cells , and re-expression of miR-451 could reverse EMT to mesenchymal-epithelial transition ( MET ) and inhibit invasion and metastasis of docetaxel-resistant LAD cells both in vitro and in vivo .
915	effect	neutral	mir-451	972.9692	858.9225	858.9225	miRNA		In order to explore the molecular mechanism of the occurrence and development of lung cancer , we investigated the effect of human miR-451 on the proliferation , invasion , and metastasis in lung cancer cell line A549 .
915	effect	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	In order to explore the molecular mechanism of the occurrence and development of lung cancer , we investigated the effect of human miR-451 on the proliferation , invasion , and metastasis in lung cancer cell line A549 .
914	suppress	negative	mir-451	972.9692	858.9225	858.9225	miRNA		MiR-451 suppresses cell proliferation and metastasis in A549 lung cancer cells .
914	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-451 suppresses cell proliferation and metastasis in A549 lung cancer cells .
739	downregulate	negative	mir-451	972.9692	858.9225	858.9225	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
739	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
738	downregulate	negative	mir-451	972.9692	858.9225	858.9225	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
738	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
327	upregulate	positive	mir-451	972.9692	858.9225	858.9225	miRNA		Upregulated expression of miR-2861 and miR-451 in PTC with LN metastasis represents a unique miRNA signature associated with the prognosis and progression of PTC .
327	upregulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Upregulated expression of miR-2861 and miR-451 in PTC with LN metastasis represents a unique miRNA signature associated with the prognosis and progression of PTC .
326	upregulate	positive	mir-451	972.9692	858.9225	858.9225	miRNA		Upregulated expression of miR-2861 and miR-451 in PTC with LN metastasis represents a unique miRNA signature associated with the prognosis and progression of PTC .
326	upregulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Upregulated expression of miR-2861 and miR-451 in PTC with LN metastasis represents a unique miRNA signature associated with the prognosis and progression of PTC .
317	upregulate	positive	mir-451	972.9692	858.9225	858.9225	miRNA		The miRNA microarray results showed that compared to the NLN group , upregulation of four miRNAs including miR-2861 , miR-451 , miR-193b , and miR-1202 was associated with LN metastasis , whereas four other miRNAs including miR-let-7i , miR-542-5p , miR-664* , and miR-564 were downregulated in the LN group .
317	upregulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray results showed that compared to the NLN group , upregulation of four miRNAs including miR-2861 , miR-451 , miR-193b , and miR-1202 was associated with LN metastasis , whereas four other miRNAs including miR-let-7i , miR-542-5p , miR-664* , and miR-564 were downregulated in the LN group .
180	upregulate	positive	mir-451	972.9692	858.9225	858.9225	miRNA		Upregulated expression of miR-451 induced apoptosis and suppressed cell proliferation , invasion and metastasis in the esophageal carcinoma cell line EC9706 .
180	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Upregulated expression of miR-451 induced apoptosis and suppressed cell proliferation , invasion and metastasis in the esophageal carcinoma cell line EC9706 .
179	promote	positive	mir-135a	977.8414	856.8273	856.8273	miRNA		MiR-135a promotes growth and invasion of colorectal cancer via metastasis suppressor 1 in vitro .
179	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-135a promotes growth and invasion of colorectal cancer via metastasis suppressor 1 in vitro .
1693	downregulate	negative	mir-150	982.6882	854.674	854.674	miRNA		Here , we found that miR-150 expression was consistently downregulated in OS tissues and cell lines compared with the matched adjacent normal tissues and human normal osteoblast cells ( NHOst ) , and its expression was significantly correlated with lymph node metastasis and tumor-node-metastasis ( TNM ) stage .
1693	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we found that miR-150 expression was consistently downregulated in OS tissues and cell lines compared with the matched adjacent normal tissues and human normal osteoblast cells ( NHOst ) , and its expression was significantly correlated with lymph node metastasis and tumor-node-metastasis ( TNM ) stage .
1692	downregulate	negative	mir-150	982.6882	854.674	854.674	miRNA		Here , we found that miR-150 expression was consistently downregulated in OS tissues and cell lines compared with the matched adjacent normal tissues and human normal osteoblast cells ( NHOst ) , and its expression was significantly correlated with lymph node metastasis and tumor-node-metastasis ( TNM ) stage .
1692	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we found that miR-150 expression was consistently downregulated in OS tissues and cell lines compared with the matched adjacent normal tissues and human normal osteoblast cells ( NHOst ) , and its expression was significantly correlated with lymph node metastasis and tumor-node-metastasis ( TNM ) stage .
901	suppress	negative	mir-150	982.6882	854.674	854.674	miRNA		In conclusiomn , miR-150-5p may suppress CRC metastasis through directly targeting MUC4 , highlighting its potential as a novel agent for the treatment of CRC metastasis .
901	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In conclusiomn , miR-150-5p may suppress CRC metastasis through directly targeting MUC4 , highlighting its potential as a novel agent for the treatment of CRC metastasis .
546	upregulate	positive	mir-150	982.6882	854.674	854.674	miRNA		From these findings , we conclude that , in the presence of continuous CCR6 upregulation accompanied by miR-150 downregulation , IL-22 activation leads to continuous CCL20-CCR6 interaction in CTCL cells and , in turn , autocrine metastasis to distal organs .
546	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	From these findings , we conclude that , in the presence of continuous CCR6 upregulation accompanied by miR-150 downregulation , IL-22 activation leads to continuous CCL20-CCR6 interaction in CTCL cells and , in turn , autocrine metastasis to distal organs .
178	regulate	positive	mir-150	982.6882	854.674	854.674	miRNA		Analysis of the regulation of ZEB1 by miR-150 could provide new insights into preventing metastasis and also suggests novel targeted therapeutic strategies in ESCC .
178	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Analysis of the regulation of ZEB1 by miR-150 could provide new insights into preventing metastasis and also suggests novel targeted therapeutic strategies in ESCC .
176	downregulate	negative	microrna-139	987.509	852.4629	852.4629	miRNA		Derepression of c-Fos caused by microRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinoma .
176	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Derepression of c-Fos caused by microRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinoma .
2007	regulate	positive	mir-34	992.303	850.1944	850.1944	miRNA		A vast number of miRNAs , including the well-studied miR-21 , miR-155 and miR-34 , has been shown to regulate PDAC growth , invasion and metastasis in vitro and in vivo by targeting members of key signaling pathways .
2007	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	A vast number of miRNAs , including the well-studied miR-21 , miR-155 and miR-34 , has been shown to regulate PDAC growth , invasion and metastasis in vitro and in vivo by targeting members of key signaling pathways .
818	affect	neutral	mir-34	992.303	850.1944	850.1944	miRNA		The miR-34 family also affected tumorsphere ultra-structure and inhibited the xenografted tumor growth as well as lung metastasis of SC-M1 cells through YY1 .
818	affect	neutral	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miR-34 family also affected tumorsphere ultra-structure and inhibited the xenografted tumor growth as well as lung metastasis of SC-M1 cells through YY1 .
624	induce	positive	mir-34	992.303	850.1944	850.1944	miRNA		Members of the miR-34 family are induced by the tumor suppressor p53 and are known to inhibit epithelial-to-mesenchymal transition ( EMT ) and therefore presumably suppress the early phases of metastasis .
624	induce	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Members of the miR-34 family are induced by the tumor suppressor p53 and are known to inhibit epithelial-to-mesenchymal transition ( EMT ) and therefore presumably suppress the early phases of metastasis .
175	regulate	positive	mir-34	992.303	850.1944	850.1944	miRNA		Our results demonstrate that miR-34a/c functions as a metastasis suppressor to regulate breast cancer migration and invasion through targeting Fra-1 oncogene and suggest a therapeutic application of miR-34 in breast cancer .
175	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our results demonstrate that miR-34a/c functions as a metastasis suppressor to regulate breast cancer migration and invasion through targeting Fra-1 oncogene and suggest a therapeutic application of miR-34 in breast cancer .
174	regulate	positive	mir-34a/c	997.0696	847.8688	847.8688	miRNA		Our results demonstrate that miR-34a/c functions as a metastasis suppressor to regulate breast cancer migration and invasion through targeting Fra-1 oncogene and suggest a therapeutic application of miR-34 in breast cancer .
174	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our results demonstrate that miR-34a/c functions as a metastasis suppressor to regulate breast cancer migration and invasion through targeting Fra-1 oncogene and suggest a therapeutic application of miR-34 in breast cancer .
173	inhibit	negative	mir-34a/c	997.0696	847.8688	847.8688	miRNA		Overexpression of miR-34a/c could inhibit breast cancer cell migration and invasion in vitro and distal pulmonary metastasis in vivo .
173	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Overexpression of miR-34a/c could inhibit breast cancer cell migration and invasion in vitro and distal pulmonary metastasis in vivo .
172	inhibit	negative	mir-34a/c	997.0696	847.8688	847.8688	miRNA		Overexpression of miR-34a/c could inhibit breast cancer cell migration and invasion in vitro and distal pulmonary metastasis in vivo .
172	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Overexpression of miR-34a/c could inhibit breast cancer cell migration and invasion in vitro and distal pulmonary metastasis in vivo .
171	regulate	positive	mir-34a/c	997.0696	847.8688	847.8688	miRNA		Here , we describe the regulation and function of miR-34a and miR-34c ( miR-34a/c ) in breast cancer metastasis .
171	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here , we describe the regulation and function of miR-34a and miR-34c ( miR-34a/c ) in breast cancer metastasis .
1140	suppress	negative	mir-34c	1001.808	845.4865	845.4865	miRNA		MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET .
1140	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET .
1139	suppress	negative	mir-34c	1001.808	845.4865	845.4865	miRNA		MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET .
1139	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET .
679	inhibit	negative	mir-34c	1001.808	845.4865	845.4865	miRNA		Restoring miR-34c may have important implications for the development of strategies for inhibiting metastasis and overcoming OS cell resistance to chemotherapy .
679	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Restoring miR-34c may have important implications for the development of strategies for inhibiting metastasis and overcoming OS cell resistance to chemotherapy .
678	suppress	negative	mir-34c	1001.808	845.4865	845.4865	miRNA		Taken together , our data indicate that miR-34c suppresses OS metastasis and chemoresistance by targeting Notch1 and LEF1 .
678	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , our data indicate that miR-34c suppresses OS metastasis and chemoresistance by targeting Notch1 and LEF1 .
677	inhibit	negative	mir-34c	1001.808	845.4865	845.4865	miRNA		MiR-34c inhibits osteosarcoma metastasis and chemoresistance .
677	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	MiR-34c inhibits osteosarcoma metastasis and chemoresistance .
170	regulate	positive	mir-34c	1001.808	845.4865	845.4865	miRNA		Here , we describe the regulation and function of miR-34a and miR-34c ( miR-34a/c ) in breast cancer metastasis .
170	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here , we describe the regulation and function of miR-34a and miR-34c ( miR-34a/c ) in breast cancer metastasis .
168	suppress	negative	microrna-34	1006.518	843.0476	843.0476	miRNA		MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1 .
168	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1 .
1733	promote	positive	mir-106b	1011.198	840.5527	840.5527	miRNA		MiR-106b has been confirmed to promote cancer cell proliferation ; however few studies are available on its functions in EMT and metastasis in colorectal cancer ( CRC ) .
1733	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-106b has been confirmed to promote cancer cell proliferation ; however few studies are available on its functions in EMT and metastasis in colorectal cancer ( CRC ) .
1487	upregulate	positive	mir-106b	1011.198	840.5527	840.5527	miRNA		miR-106b was significantly up-regulated in metastatic CRC tissues and cell lines , and high miR-106b expression was associated with lymph node metastasis and advanced clinical stage .
1487	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-106b was significantly up-regulated in metastatic CRC tissues and cell lines , and high miR-106b expression was associated with lymph node metastasis and advanced clinical stage .
1321	inhibit	negative	mir-106b	1011.198	840.5527	840.5527	miRNA		Studies have demonstrated that microRNA 106b ( miR-106b ) may be a promising therapeutic target for inhibiting breast cancer bone metastasis , but the role of miR-106b in EOC is largely unknown .
1321	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Studies have demonstrated that microRNA 106b ( miR-106b ) may be a promising therapeutic target for inhibiting breast cancer bone metastasis , but the role of miR-106b in EOC is largely unknown .
1320	inhibit	negative	mir-106b	1011.198	840.5527	840.5527	miRNA		Studies have demonstrated that microRNA 106b ( miR-106b ) may be a promising therapeutic target for inhibiting breast cancer bone metastasis , but the role of miR-106b in EOC is largely unknown .
1320	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Studies have demonstrated that microRNA 106b ( miR-106b ) may be a promising therapeutic target for inhibiting breast cancer bone metastasis , but the role of miR-106b in EOC is largely unknown .
1273	promote	positive	mir-106b	1011.198	840.5527	840.5527	miRNA		Our results suggest microRNA involvement in malignant pituitary progression , whereby increased miR-20a , miR-106b and miR-17-5p promote metastasis by attenuating PTEN and TIMP2 in pituitary carcinoma .
1273	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Our results suggest microRNA involvement in malignant pituitary progression , whereby increased miR-20a , miR-106b and miR-17-5p promote metastasis by attenuating PTEN and TIMP2 in pituitary carcinoma .
523	mediate	neutral	mir-106b	1011.198	840.5527	840.5527	miRNA		Furthermore , miR-106b mediates TGF-?] effects on tumor growth and metastasis in breast cancer xenografts .
523	mediate	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Furthermore , miR-106b mediates TGF-?] effects on tumor growth and metastasis in breast cancer xenografts .
493	upregulate	positive	mir-106b	1011.198	840.5527	840.5527	miRNA		These results suggest that MMP2 upregulation plays an important role in BC bone metastasis through ERK pathways , and miR-106b directly regulates MMP2 expression .
493	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	These results suggest that MMP2 upregulation plays an important role in BC bone metastasis through ERK pathways , and miR-106b directly regulates MMP2 expression .
492	downregulate	negative	mir-106b	1011.198	840.5527	840.5527	miRNA		MicroRNA expression profiling showed miR-106b to be markedly downregulated during BC bone metastasis .
492	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA expression profiling showed miR-106b to be markedly downregulated during BC bone metastasis .
328	suppress	negative	mir-106b	1011.198	840.5527	840.5527	miRNA		Taken together , our data indicate that miR-106b-25 cluster may play an important role in the metastasis of human non-small cell lung cancer cells by directly suppressing the ?] -TRCP2 gene expression with a consequent increase in the expression of Snail .
328	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , our data indicate that miR-106b-25 cluster may play an important role in the metastasis of human non-small cell lung cancer cells by directly suppressing the ?] -TRCP2 gene expression with a consequent increase in the expression of Snail .
301	activate	positive	mir-106b	1011.198	840.5527	840.5527	miRNA		Our results suggested that miR-106b expression contributed to HCC metastasis by activating the EMT process promoting cell migration in vitro and metastasis in vivo .
301	activate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Our results suggested that miR-106b expression contributed to HCC metastasis by activating the EMT process promoting cell migration in vitro and metastasis in vivo .
300	promote	positive	mir-106b	1011.198	840.5527	840.5527	miRNA		In vivo functional studies also showed that over-expression of miR-106b promoted HCC metastasis .
300	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In vivo functional studies also showed that over-expression of miR-106b promoted HCC metastasis .
299	promote	positive	mir-106b	1011.198	840.5527	840.5527	miRNA		Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process .
299	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process .
167	upregulate	positive	mir-106b	1011.198	840.5527	840.5527	miRNA		Here , we report that miRNAs encoded by miR-106b-25 are upregulated in both primary tumors and distant metastasis .
167	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we report that miRNAs encoded by miR-106b-25 are upregulated in both primary tumors and distant metastasis .
1939	inhibit	negative	mir-146a	1101.534	775.9042	775.9042	miRNA		It was determined that miR-146a coordinated melanoma cell growth by its direct targets lunatic fringe ( LFNG ) and NUMB which operate on the NOTCH/PTEN/Akt pathway ; while , inhibition of metastasis formation was linked to decreased expression of ITGAV and ROCK1 .
1939	inhibit	negative	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	It was determined that miR-146a coordinated melanoma cell growth by its direct targets lunatic fringe ( LFNG ) and NUMB which operate on the NOTCH/PTEN/Akt pathway ; while , inhibition of metastasis formation was linked to decreased expression of ITGAV and ROCK1 .
1430	affect	neutral	mir-21	1138.222	737.6486	737.6486	miRNA		MiR-21 is an oncomiR that affects critical target genes of malignant melanoma , resulting in sustained proliferation ( PTEN , PI3K , Sprouty , PDCD4 , FOXO1 , TIPE2 , p53 , cyclin D1 ) , evasion from apoptosis ( FOXO1 , FBXO11 , APAF1 , TIMP3 , TIPE2 ) , genetic instability ( MSH2 , FBXO11 , hTERT ) , increased oxidative stress ( FOXO1 ) , angiogenesis ( PTEN , HIF1帢 , TIMP3 ) , invasion and metastasis ( APAF1 , PTEN , PDCD4 , TIMP3 ) .
1430	affect	neutral	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	MiR-21 is an oncomiR that affects critical target genes of malignant melanoma , resulting in sustained proliferation ( PTEN , PI3K , Sprouty , PDCD4 , FOXO1 , TIPE2 , p53 , cyclin D1 ) , evasion from apoptosis ( FOXO1 , FBXO11 , APAF1 , TIMP3 , TIPE2 ) , genetic instability ( MSH2 , FBXO11 , hTERT ) , increased oxidative stress ( FOXO1 ) , angiogenesis ( PTEN , HIF1帢 , TIMP3 ) , invasion and metastasis ( APAF1 , PTEN , PDCD4 , TIMP3 ) .
1259	regulate	positive	mir-21	1138.222	737.6486	737.6486	miRNA		The aim of the present study was to assess the effects of sprouty homolog 2 ( SPRY2 ) gene regulation by miR-21 on the occurrence , development and tumor metastasis in multiple myeloma ( MM ) .
1259	regulate	positive	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	The aim of the present study was to assess the effects of sprouty homolog 2 ( SPRY2 ) gene regulation by miR-21 on the occurrence , development and tumor metastasis in multiple myeloma ( MM ) .
1258	downregulate	negative	microrna-21	1213.905	610.6822	610.6822	miRNA		Downregulation of Sprouty homolog ? 2 by microRNA-21 inhibits proliferation , metastasis and invasion , however promotes the apoptosis of multiple myeloma cells .
1258	downregulate	negative	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	Downregulation of Sprouty homolog ? 2 by microRNA-21 inhibits proliferation , metastasis and invasion , however promotes the apoptosis of multiple myeloma cells .
970	inhibit	negative	mir-98	1043.079	821.5492	821.5492	miRNA		These results suggest that miR-98 inhibits melanoma metastasis in part through a novel miR-98-IL-6-negative feedback loop .
970	inhibit	negative	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	These results suggest that miR-98 inhibits melanoma metastasis in part through a novel miR-98-IL-6-negative feedback loop .
969	suppress	negative	mir-98	1043.079	821.5492	821.5492	miRNA		miR-98 suppresses melanoma metastasis through a negative feedback loop with its target gene IL-6 .
969	suppress	negative	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	miR-98 suppresses melanoma metastasis through a negative feedback loop with its target gene IL-6 .
465	suppress	negative	mir-26a	1164.125	704.0642	704.0642	miRNA		miR-26a was broadly reduced in multiple cancers , and overexpression of miR-26a significantly suppressed tumor growth and metastasis both in vitro and in vivo , including melanoma , prostate and liver cancers .
465	suppress	negative	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	miR-26a was broadly reduced in multiple cancers , and overexpression of miR-26a significantly suppressed tumor growth and metastasis both in vitro and in vivo , including melanoma , prostate and liver cancers .
464	suppress	negative	mir-26a	1164.125	704.0642	704.0642	miRNA		miR-26a was broadly reduced in multiple cancers , and overexpression of miR-26a significantly suppressed tumor growth and metastasis both in vitro and in vivo , including melanoma , prostate and liver cancers .
464	suppress	negative	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	miR-26a was broadly reduced in multiple cancers , and overexpression of miR-26a significantly suppressed tumor growth and metastasis both in vitro and in vivo , including melanoma , prostate and liver cancers .
463	suppress	negative	mir-26a	1164.125	704.0642	704.0642	miRNA		miR-26a was broadly reduced in multiple cancers , and overexpression of miR-26a significantly suppressed tumor growth and metastasis both in vitro and in vivo , including melanoma , prostate and liver cancers .
463	suppress	negative	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	miR-26a was broadly reduced in multiple cancers , and overexpression of miR-26a significantly suppressed tumor growth and metastasis both in vitro and in vivo , including melanoma , prostate and liver cancers .
344	affect	neutral	mir-214	1144.997	729.4869	729.4869	miRNA		Silencing ALCAM in miR-214-overexpressing melanoma cells reduced cell migration and invasion without affecting growth or anoikis in vitro , and it also impaired extravasation and metastasis formation in vivo .
344	affect	neutral	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	Silencing ALCAM in miR-214-overexpressing melanoma cells reduced cell migration and invasion without affecting growth or anoikis in vitro , and it also impaired extravasation and metastasis formation in vivo .
166	inhibit	negative	mir-200c	1194.274	654.1665	654.1665	miRNA		In addition , miR-200c overexpression significantly inhibited melanoma xenograft growth and metastasis in vivo , and this correlated with diminished expression of BMI-1 and reduced levels of E-cadherin in these tumors .
166	inhibit	negative	melanoma 	1015.848	838.0021	838.0021	Cancer	D012878	In addition , miR-200c overexpression significantly inhibited melanoma xenograft growth and metastasis in vivo , and this correlated with diminished expression of BMI-1 and reduced levels of E-cadherin in these tumors .
165	downregulate	negative	mir-518b	1020.467	835.3962	835.3962	miRNA		In this study , we demonstrated that miR-518b was down-regulated in esophageal squamous cell carcinoma ( ESCC ) tissues and correlated with metastasis and survival .
165	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In this study , we demonstrated that miR-518b was down-regulated in esophageal squamous cell carcinoma ( ESCC ) tissues and correlated with metastasis and survival .
1961	inhibit	negative	microrna-200	1025.055	832.7352	832.7352	miRNA		Autocrine TGF-?] /ZEB/microRNA-200 signal transduction drives epithelial-mesenchymal transition : Kinetic models predict minimal drug dose to inhibit metastasis .
1961	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Autocrine TGF-?] /ZEB/microRNA-200 signal transduction drives epithelial-mesenchymal transition : Kinetic models predict minimal drug dose to inhibit metastasis .
788	inhibit	negative	microrna-200	1025.055	832.7352	832.7352	miRNA		The microRNA-200 ( miR-200 ) family is found to inhibit or promote breast cancer metastasis ; however , the underlying mechanism is not well understood .
788	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The microRNA-200 ( miR-200 ) family is found to inhibit or promote breast cancer metastasis ; however , the underlying mechanism is not well understood .
482	regulate	positive	microrna-200	1025.055	832.7352	832.7352	miRNA		Epithelial-to-mesenchymal transition ( EMT ) is considered a critical step in the progression and metastasis of HCC and is regulated by the microRNA-200 ( miR-200 ) family .
482	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Epithelial-to-mesenchymal transition ( EMT ) is considered a critical step in the progression and metastasis of HCC and is regulated by the microRNA-200 ( miR-200 ) family .
481	regulate	positive	microrna-200	1025.055	832.7352	832.7352	miRNA		Epithelial-to-mesenchymal transition ( EMT ) is considered a critical step in the progression and metastasis of HCC and is regulated by the microRNA-200 ( miR-200 ) family .
481	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Epithelial-to-mesenchymal transition ( EMT ) is considered a critical step in the progression and metastasis of HCC and is regulated by the microRNA-200 ( miR-200 ) family .
359	regulate	positive	microrna-200	1025.055	832.7352	832.7352	miRNA		Here , we sought to investigate whether the microRNA-200 family regulates our previously identified NSCLC prognostic marker genes associated with metastasis , as potential molecular targets .
359	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we sought to investigate whether the microRNA-200 family regulates our previously identified NSCLC prognostic marker genes associated with metastasis , as potential molecular targets .
159	influence	neutral	microrna-200	1025.055	832.7352	832.7352	miRNA		In this study , we focus on matrix-derived influences on epithelial morphogenesis of a metastatic cell line ( 344SQ ) that harbors mutations in Kras and p53 ( trp53 ) and is prone to a microRNA-200 ( miR-200 ) -dependent epithelial-mesenchymal transition ( EMT ) and metastasis .
159	influence	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	In this study , we focus on matrix-derived influences on epithelial morphogenesis of a metastatic cell line ( 344SQ ) that harbors mutations in Kras and p53 ( trp53 ) and is prone to a microRNA-200 ( miR-200 ) -dependent epithelial-mesenchymal transition ( EMT ) and metastasis .
1397	regulate	positive	microrna-205	1029.611	830.0197	830.0197	miRNA		Our data describing pathways regulated by tumor-suppressive microRNA-205 provide new insights into the potential mechanisms of prostate cancer oncogenesis and metastasis .
1397	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our data describing pathways regulated by tumor-suppressive microRNA-205 provide new insights into the potential mechanisms of prostate cancer oncogenesis and metastasis .
1226	inhibit	negative	microrna-205	1029.611	830.0197	830.0197	miRNA		Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition .
1226	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition .
158	enhance	positive	microrna-205	1029.611	830.0197	830.0197	miRNA		Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer .
158	enhance	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer .
1135	inhibit	negative	microrna-146a	1034.134	827.2498	827.2498	miRNA		microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma .
1135	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma .
157	suppress	negative	microrna-146a	1034.134	827.2498	827.2498	miRNA		MicroRNA-146a suppresses metastatic activity in brain metastasis .
157	suppress	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	MicroRNA-146a suppresses metastatic activity in brain metastasis .
1201	regulate	positive	mir-129	1038.623	824.4262	824.4262	miRNA		MiR-129 regulates MMP9 to control metastasis of non-small cell lung cancer .
1201	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-129 regulates MMP9 to control metastasis of non-small cell lung cancer .
140	inhibit	negative	mir-129	1038.623	824.4262	824.4262	miRNA		These results indicate that over-expression of miR-129 could inhibit breast cancer motility and migration , and the down-regulation of miR-129 may participate in the breast cancer migration and metastasis .
140	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	These results indicate that over-expression of miR-129 could inhibit breast cancer motility and migration , and the down-regulation of miR-129 may participate in the breast cancer migration and metastasis .
1790	inhibit	negative	mir-98	1043.079	821.5492	821.5492	miRNA		These findings suggest that miR-98 inhibits cancer cell growth and metastasis by direct targeting IGF1R , implicating miR-98 as a novel potential therapeutic target for OSCC .
1790	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	These findings suggest that miR-98 inhibits cancer cell growth and metastasis by direct targeting IGF1R , implicating miR-98 as a novel potential therapeutic target for OSCC .
1789	suppress	negative	mir-98	1043.079	821.5492	821.5492	miRNA		miR-98 suppresses tumor cell growth and metastasis by targeting IGF1R in oral squamous cell carcinoma .
1789	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-98 suppresses tumor cell growth and metastasis by targeting IGF1R in oral squamous cell carcinoma .
133	promote	positive	mir-98	1043.079	821.5492	821.5492	miRNA		These findings suggest that decreased expression of miR-98 and miR-214 might promote metastasis of human ESCC by inducing accumulation of EZH2 protein .
133	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	These findings suggest that decreased expression of miR-98 and miR-214 might promote metastasis of human ESCC by inducing accumulation of EZH2 protein .
1861	influence	neutral	mir-196a	1047.499	818.6191	818.6191	miRNA		The current results provided evidence that the T > C polymorphism in the miR-196a-2 precursor may influence tumorigenesis and metastasis in EOC , and suggested that the functional SNP rs11614913 in the promoter region of pri-miR-196a-2 may be a potential indicator of EOC susceptibility in the population analyzed .
1861	influence	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	The current results provided evidence that the T > C polymorphism in the miR-196a-2 precursor may influence tumorigenesis and metastasis in EOC , and suggested that the functional SNP rs11614913 in the promoter region of pri-miR-196a-2 may be a potential indicator of EOC susceptibility in the population analyzed .
1221	regulate	positive	mir-196a	1047.499	818.6191	818.6191	miRNA		Overexpression of mir-196a-5p is associated with lymph node metastasis and clinical stage , and enriched KEGG pathway analyses showed that targeted genes regulated by mir-196a-5p may contribute to tumorgenesis , suggesting roles as an oncogenic miRNA biomarker in gastric cancer .
1221	regulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	Overexpression of mir-196a-5p is associated with lymph node metastasis and clinical stage , and enriched KEGG pathway analyses showed that targeted genes regulated by mir-196a-5p may contribute to tumorgenesis , suggesting roles as an oncogenic miRNA biomarker in gastric cancer .
132	regulate	positive	mir-196a	1047.499	818.6191	818.6191	miRNA		MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis .
132	regulate	positive	osteosarcoma cells	1157.953	712.69	712.69	Cancer	D063646	MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis .
1938	regulate	positive	mir-183	1051.885	815.6364	815.6364	miRNA		Collectively , these observations showed that miR-183 maybe function as an oncogene by regulating GC cell proliferation , apoptosis and metastasis and the oncogenic effect of miR-183 may relate the direct targeting PDCD4 .
1938	regulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	Collectively , these observations showed that miR-183 maybe function as an oncogene by regulating GC cell proliferation , apoptosis and metastasis and the oncogenic effect of miR-183 may relate the direct targeting PDCD4 .
1874	inhibit	negative	mir-183	1051.885	815.6364	815.6364	miRNA		In conclusion , our study revealed that miR-183 might be a tumor suppressor via inhibiting the invasion and metastasis of cervical cancer cells through targeting MMP-9 , indicating that miR-183 may be a novel potential therapeutic target for cervical cancer .
1874	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In conclusion , our study revealed that miR-183 might be a tumor suppressor via inhibiting the invasion and metastasis of cervical cancer cells through targeting MMP-9 , indicating that miR-183 may be a novel potential therapeutic target for cervical cancer .
1873	inhibit	negative	mir-183	1051.885	815.6364	815.6364	miRNA		miR-183 was found to inhibit or promote the invasion and metastasis of multiple solid tumors .
1873	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-183 was found to inhibit or promote the invasion and metastasis of multiple solid tumors .
1237	inhibit	negative	mir-183	1051.885	815.6364	815.6364	miRNA		We , therefore , identified a novel mechanism whereby the miR-200 family and the miR-183~96~182 cluster inhibit lung cancer invasion and metastasis by targeting Foxf2 .
1237	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We , therefore , identified a novel mechanism whereby the miR-200 family and the miR-183~96~182 cluster inhibit lung cancer invasion and metastasis by targeting Foxf2 .
1235	inhibit	negative	mir-183	1051.885	815.6364	815.6364	miRNA		The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers .
1235	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers .
1009	upregulate	positive	mir-183	1051.885	815.6364	815.6364	miRNA		Up-regulation of miR-183 is associated with advanced clinical stage , positive lymph node , deep stromal invasion , and distant metastasis in gastric cancer patients .
1009	upregulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	Up-regulation of miR-183 is associated with advanced clinical stage , positive lymph node , deep stromal invasion , and distant metastasis in gastric cancer patients .
1001	downregulate	negative	mir-183	1051.885	815.6364	815.6364	miRNA		In the present study , miR-183 expression was significantly decreased in gastric cancer tissues compared with its ' adjacent normal tissues , and down-regulation of miR-183 was significantly associated with lymph node metastasis and pathological TNM stage .
1001	downregulate	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	In the present study , miR-183 expression was significantly decreased in gastric cancer tissues compared with its ' adjacent normal tissues , and down-regulation of miR-183 was significantly associated with lymph node metastasis and pathological TNM stage .
944	upregulate	positive	mir-183	1051.885	815.6364	815.6364	miRNA		Upregulated expression of miR-183 was not correlated with tumour stage or lymphatic metastasis in ESCC patients .
944	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Upregulated expression of miR-183 was not correlated with tumour stage or lymphatic metastasis in ESCC patients .
943	upregulate	positive	mir-183	1051.885	815.6364	815.6364	miRNA		Upregulated expression of miR-183 was not correlated with tumour stage or lymphatic metastasis in ESCC patients .
943	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Upregulated expression of miR-183 was not correlated with tumour stage or lymphatic metastasis in ESCC patients .
917	upregulate	positive	mir-183	1051.885	815.6364	815.6364	miRNA		We found that miR-183 was up-regulated in renal cancer tissues ; inhibition of endogenous miR-183 suppressed in vitro cell proliferation , colony formation , migration , and invasion and stimulated Caspase 3/7 activity ; up-regulated miR-183 increased cell growth and metastasis and suppressed Caspase 3/7 activity .
917	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	We found that miR-183 was up-regulated in renal cancer tissues ; inhibition of endogenous miR-183 suppressed in vitro cell proliferation , colony formation , migration , and invasion and stimulated Caspase 3/7 activity ; up-regulated miR-183 increased cell growth and metastasis and suppressed Caspase 3/7 activity .
186	react	neutral	mir-183	1051.885	815.6364	815.6364	miRNA		Total RNA was extracted and quantitave polymerase chain reaction ( qPCR ) analysis performed on the primary tumour and a corresponding lymph node metastasis for expression of miRNAs of proven significance in MTC ( miR-9* , miR-183 and miR-375 ) .
186	react	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Total RNA was extracted and quantitave polymerase chain reaction ( qPCR ) analysis performed on the primary tumour and a corresponding lymph node metastasis for expression of miRNAs of proven significance in MTC ( miR-9* , miR-183 and miR-375 ) .
185	react	neutral	mir-183	1051.885	815.6364	815.6364	miRNA		Total RNA was extracted and quantitave polymerase chain reaction ( qPCR ) analysis performed on the primary tumour and a corresponding lymph node metastasis for expression of miRNAs of proven significance in MTC ( miR-9* , miR-183 and miR-375 ) .
185	react	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Total RNA was extracted and quantitave polymerase chain reaction ( qPCR ) analysis performed on the primary tumour and a corresponding lymph node metastasis for expression of miRNAs of proven significance in MTC ( miR-9* , miR-183 and miR-375 ) .
142	downregulate	negative	mir-183	1051.885	815.6364	815.6364	miRNA		This suggests that miR-183 may possibly play a tumor suppressor role in the metastasis of osteosarcoma by downregulating Ezrin expression levels .
142	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	This suggests that miR-183 may possibly play a tumor suppressor role in the metastasis of osteosarcoma by downregulating Ezrin expression levels .
141	inhibit	negative	mir-183	1051.885	815.6364	815.6364	miRNA		miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells .
141	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells .
130	downregulate	negative	mir-183	1051.885	815.6364	815.6364	miRNA		miR-183 is down-regulated in stage II ( GC , and associated with the differentiation , metastasis , and prognosis. Ezrin is a potential regulatory protein of miR-183 .
130	downregulate	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	miR-183 is down-regulated in stage II ( GC , and associated with the differentiation , metastasis , and prognosis. Ezrin is a potential regulatory protein of miR-183 .
1537	upregulate	positive	mir-224	1056.234	812.6016	812.6016	miRNA		We recently reported that miR-224 was significantly up-regulated in non-small cell lung cancer ( NSCLC ) tissues , in particular in resected NSCLC metastasis .
1537	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	We recently reported that miR-224 was significantly up-regulated in non-small cell lung cancer ( NSCLC ) tissues , in particular in resected NSCLC metastasis .
1459	upregulate	positive	mir-224	1056.234	812.6016	812.6016	miRNA		Here , we identify microRNA-224 ( miR-224 ) to be significantly up-regulated in NSCLC tissues , particularly in resected NSCLC metastasis .
1459	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we identify microRNA-224 ( miR-224 ) to be significantly up-regulated in NSCLC tissues , particularly in resected NSCLC metastasis .
1247	promote	positive	mir-224	1056.234	812.6016	812.6016	miRNA		MiR-224 promotes CRC metastasis , at least in part , through the regulation of SMAD4 .
1247	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-224 promotes CRC metastasis , at least in part , through the regulation of SMAD4 .
1246	enhance	positive	mir-224	1056.234	812.6016	812.6016	miRNA		MiR-224 expression increases consistently with tumour burden and microsatellite stable status , and miR-224 enhances CRC metastasis in vitro and in vivo .
1246	enhance	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-224 expression increases consistently with tumour burden and microsatellite stable status , and miR-224 enhances CRC metastasis in vitro and in vivo .
1245	enhance	positive	mir-224	1056.234	812.6016	812.6016	miRNA		MiR-224 expression increases consistently with tumour burden and microsatellite stable status , and miR-224 enhances CRC metastasis in vitro and in vivo .
1245	enhance	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-224 expression increases consistently with tumour burden and microsatellite stable status , and miR-224 enhances CRC metastasis in vitro and in vivo .
1104	downregulate	negative	mir-224	1056.234	812.6016	812.6016	miRNA		Moreover , miR-224 down-regulation was significantly associated with advanced clinical stage ( P = .027 ) and metastasis ( P = .001 ) , whereas APLN up-regulation more frequently occurred in PCa tissues with advanced pathologic stage ( P = .003 ) , metastasis ( P < .001 ) , and prostate-specific antigen failure ( P = .001 ) .
1104	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Moreover , miR-224 down-regulation was significantly associated with advanced clinical stage ( P = .027 ) and metastasis ( P = .001 ) , whereas APLN up-regulation more frequently occurred in PCa tissues with advanced pathologic stage ( P = .003 ) , metastasis ( P < .001 ) , and prostate-specific antigen failure ( P = .001 ) .
544	downregulate	negative	mir-224	1056.234	812.6016	812.6016	miRNA		miR-224 downregulation was frequently found in PCa tissues with metastasis , higher PSA level and clinical stage , whereas TRIB1 upregulation was significantly associated with metastasis .
544	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-224 downregulation was frequently found in PCa tissues with metastasis , higher PSA level and clinical stage , whereas TRIB1 upregulation was significantly associated with metastasis .
372	suppress	negative	mir-224	1056.234	812.6016	812.6016	miRNA		Decreased levels of miR-224 and the passenger strand of miR-221 increase MBD2 , suppressing maspin and promoting colorectal tumor growth and metastasis in mice .
372	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Decreased levels of miR-224 and the passenger strand of miR-221 increase MBD2 , suppressing maspin and promoting colorectal tumor growth and metastasis in mice .
127	suppress	negative	mir-224	1056.234	812.6016	812.6016	miRNA		Taken together , our data indicate that miR-224 play an important role in metastasis of human breast cancer cells to the bone by directly suppressing the RKIP tumor suppressor .
127	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Taken together , our data indicate that miR-224 play an important role in metastasis of human breast cancer cells to the bone by directly suppressing the RKIP tumor suppressor .
126	promote	positive	mir-224	1056.234	812.6016	812.6016	miRNA		Promotion of metastasis in response to miR-224 downregulation was associated with derepression of the stroma-associated RKIP target genes , CXCR4 , MMP1 , and OPN , which are involved in breast tumor metastasis to the bone .
126	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Promotion of metastasis in response to miR-224 downregulation was associated with derepression of the stroma-associated RKIP target genes , CXCR4 , MMP1 , and OPN , which are involved in breast tumor metastasis to the bone .
1458	upregulate	positive	microrna-224	1060.547	809.515	809.515	miRNA		Here , we identify microRNA-224 ( miR-224 ) to be significantly up-regulated in NSCLC tissues , particularly in resected NSCLC metastasis .
1458	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we identify microRNA-224 ( miR-224 ) to be significantly up-regulated in NSCLC tissues , particularly in resected NSCLC metastasis .
125	control	neutral	microrna-224	1060.547	809.515	809.515	miRNA		MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells .
125	control	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells .
1330	upregulate	positive	mir-429	1064.823	806.3771	806.3771	miRNA		miR-429 expression was stably up-regulated or down-regulated in the renal cell carcinoma ACHN and A498 cell lines , and cell proliferation and metastasis were assessed .
1330	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-429 expression was stably up-regulated or down-regulated in the renal cell carcinoma ACHN and A498 cell lines , and cell proliferation and metastasis were assessed .
1329	regulate	positive	mir-429	1064.823	806.3771	806.3771	miRNA		The aim of this study was to investigate the potential role of miR-429 in regulating growth and metastasis of renal cell carcinoma .
1329	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The aim of this study was to investigate the potential role of miR-429 in regulating growth and metastasis of renal cell carcinoma .
1318	induce	positive	mir-429	1064.823	806.3771	806.3771	miRNA		In summary , our results here defined miR-429 as a key inducer for HCC pathogenesis and metastasis with potential utility for tumor intervention .
1318	induce	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In summary , our results here defined miR-429 as a key inducer for HCC pathogenesis and metastasis with potential utility for tumor intervention .
1317	regulate	positive	mir-429	1064.823	806.3771	806.3771	miRNA		However , whether miR-429 plays a role in regulating metastasis of hepatocellular carcinoma is still unclear .
1317	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	However , whether miR-429 plays a role in regulating metastasis of hepatocellular carcinoma is still unclear .
1040	regulate	positive	mir-429	1064.823	806.3771	806.3771	miRNA		The results revealed that decreased expression of miR-429 was probably involved in negatively regulating bone metastasis of breast cancer cells .
1040	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The results revealed that decreased expression of miR-429 was probably involved in negatively regulating bone metastasis of breast cancer cells .
756	promote	positive	mir-429	1064.823	806.3771	806.3771	miRNA		Taken together , our results suggest that miR-429 plays an important role in promoting the proliferation and metastasis of NSCLC cells and is a potential target for NSCLC therapy .
756	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , our results suggest that miR-429 plays an important role in promoting the proliferation and metastasis of NSCLC cells and is a potential target for NSCLC therapy .
192	upregulate	positive	mir-429	1064.823	806.3771	806.3771	miRNA		In this study , we found that miR-429 expression was up-regulated in human colorectal cancer ( CRC ) tissues , and the high miR-429 expression was significantly associated with tumor size , lymph node metastasis and poor prognosis .
192	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In this study , we found that miR-429 expression was up-regulated in human colorectal cancer ( CRC ) tissues , and the high miR-429 expression was significantly associated with tumor size , lymph node metastasis and poor prognosis .
120	regulate	positive	mir-429	1064.823	806.3771	806.3771	miRNA		MiR-200 family ( miR-200a , miR-200b , miR-200c , miR-141 , and miR-429 ) is a cluster of miRNAs highly correlated with epithelial-mesenchymal transition ( EMT ) , wherein miR-200b is identified as a critical regulator of tumor invasion , metastasis , and chemosensitivity .
120	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-200 family ( miR-200a , miR-200b , miR-200c , miR-141 , and miR-429 ) is a cluster of miRNAs highly correlated with epithelial-mesenchymal transition ( EMT ) , wherein miR-200b is identified as a critical regulator of tumor invasion , metastasis , and chemosensitivity .
2020	regulate	positive	mir-141	1069.061	803.1884	803.1884	miRNA		Our study suggests miR-141 is a regulator of brain metastasis from breast cancer and should be examined as a biomarker and potential target to prevent and treat brain metastases .
2020	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our study suggests miR-141 is a regulator of brain metastasis from breast cancer and should be examined as a biomarker and potential target to prevent and treat brain metastases .
2019	regulate	positive	mir-141	1069.061	803.1884	803.1884	miRNA		Our study suggests miR-141 is a regulator of brain metastasis from breast cancer and should be examined as a biomarker and potential target to prevent and treat brain metastases .
2019	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our study suggests miR-141 is a regulator of brain metastasis from breast cancer and should be examined as a biomarker and potential target to prevent and treat brain metastases .
2018	regulate	positive	mir-141	1069.061	803.1884	803.1884	miRNA		miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer .
2018	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer .
1822	influence	neutral	mir-141	1069.061	803.1884	803.1884	miRNA		Direct targeting sperm-associated antigen 9 by miR-141 influences hepatocellular carcinoma cell growth and metastasis via JNK pathway .
1822	influence	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Direct targeting sperm-associated antigen 9 by miR-141 influences hepatocellular carcinoma cell growth and metastasis via JNK pathway .
1155	suppress	negative	mir-141	1069.061	803.1884	803.1884	miRNA		Finally , overexpression of miR-141 suppressed tumor growth and pulmonary metastasis in nude mice .
1155	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Finally , overexpression of miR-141 suppressed tumor growth and pulmonary metastasis in nude mice .
909	suppress	negative	mir-141	1069.061	803.1884	803.1884	miRNA		Our results suggest a critical role of miR-141 in suppressing metastasis of HCC cells by targeting E2F3 .
909	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Our results suggest a critical role of miR-141 in suppressing metastasis of HCC cells by targeting E2F3 .
908	suppress	negative	mir-141	1069.061	803.1884	803.1884	miRNA		miR-141 suppresses the growth and metastasis of HCC cells by targeting E2F3 .
908	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-141 suppresses the growth and metastasis of HCC cells by targeting E2F3 .
823	suppress	negative	mir-141	1069.061	803.1884	803.1884	miRNA		Paeonol suppresses chondrosarcoma metastasis through up-regulation of miR-141 by modulating PKC帤 and c-Src signaling pathway .
823	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Paeonol suppresses chondrosarcoma metastasis through up-regulation of miR-141 by modulating PKC帤 and c-Src signaling pathway .
628	regulate	positive	mir-141	1069.061	803.1884	803.1884	miRNA		miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression .
628	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression .
119	regulate	positive	mir-141	1069.061	803.1884	803.1884	miRNA		MiR-200 family ( miR-200a , miR-200b , miR-200c , miR-141 , and miR-429 ) is a cluster of miRNAs highly correlated with epithelial-mesenchymal transition ( EMT ) , wherein miR-200b is identified as a critical regulator of tumor invasion , metastasis , and chemosensitivity .
119	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-200 family ( miR-200a , miR-200b , miR-200c , miR-141 , and miR-429 ) is a cluster of miRNAs highly correlated with epithelial-mesenchymal transition ( EMT ) , wherein miR-200b is identified as a critical regulator of tumor invasion , metastasis , and chemosensitivity .
1931	suppress	negative	mir-200a	1073.261	799.9493	799.9493	miRNA		Our study demonstrated that miR-200a suppresses the metastasis in pancreatic PDAC through downregulation of DEK , suggesting that miR-200a may be used as a novel potential marker in prediction of metastasis of PDAC .
1931	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Our study demonstrated that miR-200a suppresses the metastasis in pancreatic PDAC through downregulation of DEK , suggesting that miR-200a may be used as a novel potential marker in prediction of metastasis of PDAC .
1930	suppress	negative	mir-200a	1073.261	799.9493	799.9493	miRNA		MiR-200a has been reported to be able to suppress the epithelial-mesenchymal transition process in pancreatic cancer stem cells , suggesting that miR-200a could suppress the metastasis of pancreatic ductal adenocarcinoma ( PDAC ) .
1930	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-200a has been reported to be able to suppress the epithelial-mesenchymal transition process in pancreatic cancer stem cells , suggesting that miR-200a could suppress the metastasis of pancreatic ductal adenocarcinoma ( PDAC ) .
1929	suppress	negative	mir-200a	1073.261	799.9493	799.9493	miRNA		MiR-200a has been reported to be able to suppress the epithelial-mesenchymal transition process in pancreatic cancer stem cells , suggesting that miR-200a could suppress the metastasis of pancreatic ductal adenocarcinoma ( PDAC ) .
1929	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-200a has been reported to be able to suppress the epithelial-mesenchymal transition process in pancreatic cancer stem cells , suggesting that miR-200a could suppress the metastasis of pancreatic ductal adenocarcinoma ( PDAC ) .
1928	suppress	negative	mir-200a	1073.261	799.9493	799.9493	miRNA		MiR-200a Suppresses the Proliferation and Metastasis in Pancreatic Ductal Adenocarcinoma through Downregulation of DEK Gene .
1928	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-200a Suppresses the Proliferation and Metastasis in Pancreatic Ductal Adenocarcinoma through Downregulation of DEK Gene .
1254	regulate	positive	mir-200a	1073.261	799.9493	799.9493	miRNA		miR-200a plays a role in regulating the invasiveness and metastasis of CRC , and overexpression of miR-200a causes a significant reduction of cell proliferation and migration and promotes apoptosis and cell-cell adhesion in LoVo cells .
1254	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-200a plays a role in regulating the invasiveness and metastasis of CRC , and overexpression of miR-200a causes a significant reduction of cell proliferation and migration and promotes apoptosis and cell-cell adhesion in LoVo cells .
1233	suppress	negative	mir-200a	1073.261	799.9493	799.9493	miRNA		These findings reveal that miR-200a suppresses metastasis of SP cells by downregulating ZEB2 .
1233	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	These findings reveal that miR-200a suppresses metastasis of SP cells by downregulating ZEB2 .
1232	suppress	negative	mir-200a	1073.261	799.9493	799.9493	miRNA		MiR-200a suppressed metastasis of SP cells .
1232	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-200a suppressed metastasis of SP cells .
1231	downregulate	negative	mir-200a	1073.261	799.9493	799.9493	miRNA		We found that miR-200a was downregulated in HCC/SP and this was associated metastasis .
1231	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We found that miR-200a was downregulated in HCC/SP and this was associated metastasis .
1230	downregulate	negative	mir-200a	1073.261	799.9493	799.9493	miRNA		We found that miR-200a was downregulated in HCC/SP and this was associated metastasis .
1230	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We found that miR-200a was downregulated in HCC/SP and this was associated metastasis .
1081	downregulate	negative	mir-200a	1073.261	799.9493	799.9493	miRNA		In the present study , we identified that miR-200a was markedly downregulated in HCC and exerted suppressive effects on tumor cell growth and metastasis .
1081	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In the present study , we identified that miR-200a was markedly downregulated in HCC and exerted suppressive effects on tumor cell growth and metastasis .
1080	suppress	negative	mir-200a	1073.261	799.9493	799.9493	miRNA		miR-200a suppresses tumor development and progression ; however , its role in tumor growth and metastasis of hepatocellular carcinoma ( HCC ) and the underlying mechanism have not been elucidated .
1080	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-200a suppresses tumor development and progression ; however , its role in tumor growth and metastasis of hepatocellular carcinoma ( HCC ) and the underlying mechanism have not been elucidated .
735	downregulate	negative	mir-200a	1073.261	799.9493	799.9493	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
735	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
734	downregulate	negative	mir-200a	1073.261	799.9493	799.9493	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
734	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
235	promote	positive	mir-200a	1073.261	799.9493	799.9493	miRNA		This study aimed to test the hypothesis that miR-200a promotes metastasis through increased anoikis resistance in breast cancer .
235	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	This study aimed to test the hypothesis that miR-200a promotes metastasis through increased anoikis resistance in breast cancer .
116	regulate	positive	mir-200a	1073.261	799.9493	799.9493	miRNA		MiR-200 family ( miR-200a , miR-200b , miR-200c , miR-141 , and miR-429 ) is a cluster of miRNAs highly correlated with epithelial-mesenchymal transition ( EMT ) , wherein miR-200b is identified as a critical regulator of tumor invasion , metastasis , and chemosensitivity .
116	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-200 family ( miR-200a , miR-200b , miR-200c , miR-141 , and miR-429 ) is a cluster of miRNAs highly correlated with epithelial-mesenchymal transition ( EMT ) , wherein miR-200b is identified as a critical regulator of tumor invasion , metastasis , and chemosensitivity .
1819	promote	positive	mir-200	1077.421	796.6603	796.6603	miRNA		We have thus identified panels of miRNAs , which include metastasis promoting miR-200 family and miR-203 , as well as oncogenic and tumor-suppressive miRNAs , that can serve as prognostic markers for MBC , and early detection markers of metastasis in BC .
1819	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We have thus identified panels of miRNAs , which include metastasis promoting miR-200 family and miR-203 , as well as oncogenic and tumor-suppressive miRNAs , that can serve as prognostic markers for MBC , and early detection markers of metastasis in BC .
1818	promote	positive	mir-200	1077.421	796.6603	796.6603	miRNA		We have thus identified panels of miRNAs , which include metastasis promoting miR-200 family and miR-203 , as well as oncogenic and tumor-suppressive miRNAs , that can serve as prognostic markers for MBC , and early detection markers of metastasis in BC .
1818	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We have thus identified panels of miRNAs , which include metastasis promoting miR-200 family and miR-203 , as well as oncogenic and tumor-suppressive miRNAs , that can serve as prognostic markers for MBC , and early detection markers of metastasis in BC .
1691	inhibit	negative	mir-200	1077.421	796.6603	796.6603	miRNA		Inhibiting EMT by overexpressing the microRNA miR-200 does not affect lung metastasis development .
1691	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Inhibiting EMT by overexpressing the microRNA miR-200 does not affect lung metastasis development .
1690	inhibit	negative	mir-200	1077.421	796.6603	796.6603	miRNA		Inhibiting EMT by overexpressing the microRNA miR-200 does not affect lung metastasis development .
1690	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Inhibiting EMT by overexpressing the microRNA miR-200 does not affect lung metastasis development .
1589	inhibit	negative	mir-200	1077.421	796.6603	796.6603	miRNA		BMP4 depletion by miR-200 inhibits tumorigenesis and metastasis of lung adenocarcinoma cells .
1589	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	BMP4 depletion by miR-200 inhibits tumorigenesis and metastasis of lung adenocarcinoma cells .
1402	upregulate	positive	mir-200	1077.421	796.6603	796.6603	miRNA		The upregulation of fibronectin and lysyl oxidase directly by miR-200 or indirectly through Fli-1 or TCF12 contributed to ECM remodeling , triggering the invasion and metastasis of breast cancer cells both in vitro and vivo .
1402	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The upregulation of fibronectin and lysyl oxidase directly by miR-200 or indirectly through Fli-1 or TCF12 contributed to ECM remodeling , triggering the invasion and metastasis of breast cancer cells both in vitro and vivo .
1236	inhibit	negative	mir-200	1077.421	796.6603	796.6603	miRNA		We , therefore , identified a novel mechanism whereby the miR-200 family and the miR-183~96~182 cluster inhibit lung cancer invasion and metastasis by targeting Foxf2 .
1236	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We , therefore , identified a novel mechanism whereby the miR-200 family and the miR-183~96~182 cluster inhibit lung cancer invasion and metastasis by targeting Foxf2 .
1234	inhibit	negative	mir-200	1077.421	796.6603	796.6603	miRNA		The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers .
1234	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers .
1046	inhibit	negative	mir-200	1077.421	796.6603	796.6603	miRNA		Collectively , our findings in this study suggest that PZH can inhibit metastasis of colorectal cancer cells via modulating TGF-?] 1/ZEB/miR-200 signaling network , which might be one of the mechanisms whereby PZH exerts its anticancer function .
1046	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Collectively , our findings in this study suggest that PZH can inhibit metastasis of colorectal cancer cells via modulating TGF-?] 1/ZEB/miR-200 signaling network , which might be one of the mechanisms whereby PZH exerts its anticancer function .
1045	regulate	positive	mir-200	1077.421	796.6603	796.6603	miRNA		The processes of EMT and metastasis are highly regulated by a double-negative feedback loop consisting of TGF-?] 1/ZEB pathway and miR-200 family , which therefore has become a promising target for cancer chemotherapy .
1045	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The processes of EMT and metastasis are highly regulated by a double-negative feedback loop consisting of TGF-?] 1/ZEB pathway and miR-200 family , which therefore has become a promising target for cancer chemotherapy .
1044	inhibit	negative	mir-200	1077.421	796.6603	796.6603	miRNA		Pien Tze Huang inhibits metastasis of human colorectal carcinoma cells via modulation of TGF-?] 1/ZEB/miR-200 signaling network .
1044	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Pien Tze Huang inhibits metastasis of human colorectal carcinoma cells via modulation of TGF-?] 1/ZEB/miR-200 signaling network .
1041	regulate	positive	mir-200	1077.421	796.6603	796.6603	miRNA		In addition , the microRNA ( miR ) -200 family plays a central role in the regulation of the epithelial-mesenchymal transition process during cancer metastasis , and aberrant DNA methylation is one of the key mechanisms underlying regulation of the miR-200 family .
1041	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In addition , the microRNA ( miR ) -200 family plays a central role in the regulation of the epithelial-mesenchymal transition process during cancer metastasis , and aberrant DNA methylation is one of the key mechanisms underlying regulation of the miR-200 family .
1033	promote	positive	mir-200	1077.421	796.6603	796.6603	miRNA		miR-200-containing extracellular vesicles promote breast cancer cell metastasis .
1033	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-200-containing extracellular vesicles promote breast cancer cell metastasis .
1008	repress	negative	mir-200	1077.421	796.6603	796.6603	miRNA		Moreover , ZEB1 , an EMT activator and transcriptional repressor of miR-200 , relieves miR-200 repression of PD-L1 on tumour cells , leading to CD8 ( + ) T-cell immunosuppression and metastasis .
1008	repress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Moreover , ZEB1 , an EMT activator and transcriptional repressor of miR-200 , relieves miR-200 repression of PD-L1 on tumour cells , leading to CD8 ( + ) T-cell immunosuppression and metastasis .
950	upregulate	positive	mir-200	1077.421	796.6603	796.6603	miRNA		There is growing evidence that the miR-200 family is up-regulated in distal breast metastasis indicating that these miRs are important for colonization of metastatic breast cancer cells through induction of mesenchymal to epithelial transition .
950	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	There is growing evidence that the miR-200 family is up-regulated in distal breast metastasis indicating that these miRs are important for colonization of metastatic breast cancer cells through induction of mesenchymal to epithelial transition .
949	upregulate	positive	mir-200	1077.421	796.6603	796.6603	miRNA		There is growing evidence that the miR-200 family is up-regulated in distal breast metastasis indicating that these miRs are important for colonization of metastatic breast cancer cells through induction of mesenchymal to epithelial transition .
949	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	There is growing evidence that the miR-200 family is up-regulated in distal breast metastasis indicating that these miRs are important for colonization of metastatic breast cancer cells through induction of mesenchymal to epithelial transition .
948	downregulate	negative	mir-200	1077.421	796.6603	796.6603	miRNA		miR-200 genes have been studied intensively in relation to breast cancer progression and metastasis , where it has been shown that miR-200 members are down-regulated in basal-like breast cancer where the EMT phenotype is prominent .
948	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-200 genes have been studied intensively in relation to breast cancer progression and metastasis , where it has been shown that miR-200 members are down-regulated in basal-like breast cancer where the EMT phenotype is prominent .
947	downregulate	negative	mir-200	1077.421	796.6603	796.6603	miRNA		miR-200 genes have been studied intensively in relation to breast cancer progression and metastasis , where it has been shown that miR-200 members are down-regulated in basal-like breast cancer where the EMT phenotype is prominent .
947	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-200 genes have been studied intensively in relation to breast cancer progression and metastasis , where it has been shown that miR-200 members are down-regulated in basal-like breast cancer where the EMT phenotype is prominent .
835	activate	positive	mir-200	1077.421	796.6603	796.6603	miRNA		These results provide evidence supporting that EMT activation and IFN pathway inactivation are markers of metastatic progression of basal-like tumors , and members of miR-17 , miR-200 , and miR-96 families play a role in suppressing EMT and metastasis .
835	activate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	These results provide evidence supporting that EMT activation and IFN pathway inactivation are markers of metastatic progression of basal-like tumors , and members of miR-17 , miR-200 , and miR-96 families play a role in suppressing EMT and metastasis .
834	activate	positive	mir-200	1077.421	796.6603	796.6603	miRNA		These results provide evidence supporting that EMT activation and IFN pathway inactivation are markers of metastatic progression of basal-like tumors , and members of miR-17 , miR-200 , and miR-96 families play a role in suppressing EMT and metastasis .
834	activate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	These results provide evidence supporting that EMT activation and IFN pathway inactivation are markers of metastatic progression of basal-like tumors , and members of miR-17 , miR-200 , and miR-96 families play a role in suppressing EMT and metastasis .
792	inhibit	negative	mir-200	1077.421	796.6603	796.6603	miRNA		Ectopically expressing a single member ( miR-200b ) of the miR-200 family drastically reduces TNBC cell migration and inhibits tumor metastasis in an orthotopic mouse mammary xenograft tumor model .
792	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Ectopically expressing a single member ( miR-200b ) of the miR-200 family drastically reduces TNBC cell migration and inhibits tumor metastasis in an orthotopic mouse mammary xenograft tumor model .
789	inhibit	negative	mir-200	1077.421	796.6603	796.6603	miRNA		The microRNA-200 ( miR-200 ) family is found to inhibit or promote breast cancer metastasis ; however , the underlying mechanism is not well understood .
789	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The microRNA-200 ( miR-200 ) family is found to inhibit or promote breast cancer metastasis ; however , the underlying mechanism is not well understood .
695	downregulate	negative	mir-200	1077.421	796.6603	796.6603	miRNA		For example , deficiencies of enzymes including Dicer and Drosha that are required for miRNA biogenesis may be adverse prognostic factors ; miRNAs such as miR-214 and miR-31 , which are involved in drug resistance , and the miR-200 family , which is implicated in metastasis , may serve as biomarkers ; and transfection of downregulated miRNAs and inhibition of upregulated miRNAs may be effective for treatment of ovarian cancer .
695	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	For example , deficiencies of enzymes including Dicer and Drosha that are required for miRNA biogenesis may be adverse prognostic factors ; miRNAs such as miR-214 and miR-31 , which are involved in drug resistance , and the miR-200 family , which is implicated in metastasis , may serve as biomarkers ; and transfection of downregulated miRNAs and inhibition of upregulated miRNAs may be effective for treatment of ovarian cancer .
676	enhance	positive	mir-200	1077.421	796.6603	796.6603	miRNA		Loss of miR-200s has been shown to enhance cancer aggressiveness and metastasis , whereas replacement of miR-200 miRNAs has been shown to inhibit cell growth in several types of tumors , including lung cancer .
676	enhance	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Loss of miR-200s has been shown to enhance cancer aggressiveness and metastasis , whereas replacement of miR-200 miRNAs has been shown to inhibit cell growth in several types of tumors , including lung cancer .
503	regulate	positive	mir-200	1077.421	796.6603	796.6603	miRNA		Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model .
503	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model .
484	regulate	positive	mir-200	1077.421	796.6603	796.6603	miRNA		Epithelial-to-mesenchymal transition ( EMT ) is considered a critical step in the progression and metastasis of HCC and is regulated by the microRNA-200 ( miR-200 ) family .
484	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Epithelial-to-mesenchymal transition ( EMT ) is considered a critical step in the progression and metastasis of HCC and is regulated by the microRNA-200 ( miR-200 ) family .
483	regulate	positive	mir-200	1077.421	796.6603	796.6603	miRNA		Epithelial-to-mesenchymal transition ( EMT ) is considered a critical step in the progression and metastasis of HCC and is regulated by the microRNA-200 ( miR-200 ) family .
483	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Epithelial-to-mesenchymal transition ( EMT ) is considered a critical step in the progression and metastasis of HCC and is regulated by the microRNA-200 ( miR-200 ) family .
453	regulate	positive	mir-200	1077.421	796.6603	796.6603	miRNA		These findings highlight the context-dependent effects of miR-200 in breast cancer metastasis and demonstrate the existence of a moesin-dependent pathway , distinct from the ZEB1-E-cadherin axis , through which miR-200 can regulate tumour cell plasticity and metastasis .
453	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	These findings highlight the context-dependent effects of miR-200 in breast cancer metastasis and demonstrate the existence of a moesin-dependent pathway , distinct from the ZEB1-E-cadherin axis , through which miR-200 can regulate tumour cell plasticity and metastasis .
452	effect	neutral	mir-200	1077.421	796.6603	796.6603	miRNA		Recent studies have indicated that the miR-200 family may exert their effects at distinct stages in the metastatic process , with an overall effect of enhancing metastasis in a syngeneic mouse breast cancer model .
452	effect	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Recent studies have indicated that the miR-200 family may exert their effects at distinct stages in the metastatic process , with an overall effect of enhancing metastasis in a syngeneic mouse breast cancer model .
451	repress	negative	mir-200	1077.421	796.6603	796.6603	miRNA		MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways .
451	repress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways .
433	regulate	positive	mir-200	1077.421	796.6603	796.6603	miRNA		Microenvironmental cues , including transforming growth factor-?] , can direct EMT tumor metastasis , such as by regulating miR-200 expression .
433	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Microenvironmental cues , including transforming growth factor-?] , can direct EMT tumor metastasis , such as by regulating miR-200 expression .
360	regulate	positive	mir-200	1077.421	796.6603	796.6603	miRNA		These results provide new insights into miR-200 regulation in lung cancer metastasis and consequent clinical outcome , and may provide a potential basis for innovative therapeutic approaches for the treatment of this deadly disease .
360	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	These results provide new insights into miR-200 regulation in lung cancer metastasis and consequent clinical outcome , and may provide a potential basis for innovative therapeutic approaches for the treatment of this deadly disease .
358	promote	positive	mir-200	1077.421	796.6603	796.6603	miRNA		Nevertheless , miR-200 family target genes that promote metastasis in non-small cell lung cancer ( NSCLC ) remain largely unknown .
358	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Nevertheless , miR-200 family target genes that promote metastasis in non-small cell lung cancer ( NSCLC ) remain largely unknown .
357	regulate	positive	mir-200	1077.421	796.6603	796.6603	miRNA		The microRNA ? 200 ( miR-200 ) family is a powerful regulator of the epithelial-mesenchymal transition ( EMT ) process , which is essential in tumor metastasis .
357	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The microRNA ? 200 ( miR-200 ) family is a powerful regulator of the epithelial-mesenchymal transition ( EMT ) process , which is essential in tumor metastasis .
282	downregulate	negative	mir-200	1077.421	796.6603	796.6603	miRNA		Taken together , these data support the involvement of EMT and mesenchymal-to-epithelial transition ( MET ) in the metastasis cascade and show that miR-200 is downregulated in the initial stages of stromal invasion but is restored at metastatic sites .
282	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , these data support the involvement of EMT and mesenchymal-to-epithelial transition ( MET ) in the metastasis cascade and show that miR-200 is downregulated in the initial stages of stromal invasion but is restored at metastatic sites .
202	activate	positive	mir-200	1077.421	796.6603	796.6603	miRNA		Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma .
202	activate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma .
160	influence	neutral	mir-200	1077.421	796.6603	796.6603	miRNA		In this study , we focus on matrix-derived influences on epithelial morphogenesis of a metastatic cell line ( 344SQ ) that harbors mutations in Kras and p53 ( trp53 ) and is prone to a microRNA-200 ( miR-200 ) -dependent epithelial-mesenchymal transition ( EMT ) and metastasis .
160	influence	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	In this study , we focus on matrix-derived influences on epithelial morphogenesis of a metastatic cell line ( 344SQ ) that harbors mutations in Kras and p53 ( trp53 ) and is prone to a microRNA-200 ( miR-200 ) -dependent epithelial-mesenchymal transition ( EMT ) and metastasis .
115	regulate	positive	mir-200	1077.421	796.6603	796.6603	miRNA		MiR-200 family ( miR-200a , miR-200b , miR-200c , miR-141 , and miR-429 ) is a cluster of miRNAs highly correlated with epithelial-mesenchymal transition ( EMT ) , wherein miR-200b is identified as a critical regulator of tumor invasion , metastasis , and chemosensitivity .
115	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-200 family ( miR-200a , miR-200b , miR-200c , miR-141 , and miR-429 ) is a cluster of miRNAs highly correlated with epithelial-mesenchymal transition ( EMT ) , wherein miR-200b is identified as a critical regulator of tumor invasion , metastasis , and chemosensitivity .
1588	downregulate	negative	mir-125a	1081.542	793.3218	793.3218	miRNA		In this study , we found the expression of miR-125a was downregulated in cervical cancer patients , and negatively correlated with the tumor size , FIGO stage , and preoperative metastasis .
1588	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In this study , we found the expression of miR-125a was downregulated in cervical cancer patients , and negatively correlated with the tumor size , FIGO stage , and preoperative metastasis .
1587	suppress	negative	mir-125a	1081.542	793.3218	793.3218	miRNA		MiR-125a suppresses tumor growth , invasion and metastasis in cervical cancer by targeting STAT3 .
1587	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-125a suppresses tumor growth , invasion and metastasis in cervical cancer by targeting STAT3 .
953	downregulate	negative	mir-125a	1081.542	793.3218	793.3218	miRNA		The downregulated miR-125a-5p was significantly associated with gastric cancer metastasis .
953	downregulate	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	The downregulated miR-125a-5p was significantly associated with gastric cancer metastasis .
114	inhibit	negative	mir-125a	1081.542	793.3218	793.3218	miRNA		MiR-125a inhibits the proliferation and metastasis of HCC by targeting MMP11 and VEGF-A .
114	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-125a inhibits the proliferation and metastasis of HCC by targeting MMP11 and VEGF-A .
113	influence	neutral	mir-125a	1081.542	793.3218	793.3218	miRNA		Ectopic expression of miR-125a was used to test the influences of miR-125a on proliferation and metastasis of HCC cells in vitro and in vivo .
113	influence	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Ectopic expression of miR-125a was used to test the influences of miR-125a on proliferation and metastasis of HCC cells in vitro and in vivo .
112	inhibit	negative	mir-125a	1081.542	793.3218	793.3218	miRNA		Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF .
112	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF .
1277	mediate	neutral	mir-29c	1085.623	789.9343	789.9343	miRNA		miR-29c plays an important role in mediating pancreatic cancer metastasis to the liver by targeting MMP2 .
1277	mediate	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-29c plays an important role in mediating pancreatic cancer metastasis to the liver by targeting MMP2 .
1276	suppress	negative	mir-29c	1085.623	789.9343	789.9343	miRNA		Overexpression of miR-29c suppresses pancreatic cancer liver metastasis in a nude mouse orthotopic implantation model .
1276	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Overexpression of miR-29c suppresses pancreatic cancer liver metastasis in a nude mouse orthotopic implantation model .
1275	suppress	negative	mir-29c	1085.623	789.9343	789.9343	miRNA		miR-29c suppresses pancreatic cancer liver metastasis in an orthotopic implantation model in nude mice and affects survival in pancreatic cancer patients .
1275	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-29c suppresses pancreatic cancer liver metastasis in an orthotopic implantation model in nude mice and affects survival in pancreatic cancer patients .
937	suppress	negative	mir-29c	1085.623	789.9343	789.9343	miRNA		In CRC cells , miR-29c dramatically suppressed cell migration and invasion abilities in vitro and cancer metastasis in vivo .
937	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In CRC cells , miR-29c dramatically suppressed cell migration and invasion abilities in vitro and cancer metastasis in vivo .
936	downregulate	negative	mir-29c	1085.623	789.9343	789.9343	miRNA		miR-29c was markedly downregulated in PCs with distant metastasis and determined to be an independent predictor of shortened patient survival .
936	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-29c was markedly downregulated in PCs with distant metastasis and determined to be an independent predictor of shortened patient survival .
935	mediate	neutral	mir-29c	1085.623	789.9343	789.9343	miRNA		MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of ?] -catenin signaling .
935	mediate	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of ?] -catenin signaling .
415	suppress	negative	mir-29c	1085.623	789.9343	789.9343	miRNA		Taken together , our results demonstrate that miR-29c serves as a tumor metastasis suppressor , which suppresses lung cancer cell adhesion to ECM and metastasis by directly inhibiting integrin ?] 1 and MMP2 expression and by further reducing MMP2 enzyme activity .
415	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , our results demonstrate that miR-29c serves as a tumor metastasis suppressor , which suppresses lung cancer cell adhesion to ECM and metastasis by directly inhibiting integrin ?] 1 and MMP2 expression and by further reducing MMP2 enzyme activity .
414	inhibit	negative	mir-29c	1085.623	789.9343	789.9343	miRNA		Nude mice with xenograft models of lung cancer cells confirmed that miR-29c inhibited lung cancer metastasis in vivo , including bone and liver metastasis .
414	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Nude mice with xenograft models of lung cancer cells confirmed that miR-29c inhibited lung cancer metastasis in vivo , including bone and liver metastasis .
413	suppress	negative	mir-29c	1085.623	789.9343	789.9343	miRNA		Therefore , we hypothesized that miR-29c suppresses lung cancer cell adhesion to extracellular matrix ( ECM ) and metastasis by targeting integrin ?] 1 and MMP2 .
413	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Therefore , we hypothesized that miR-29c suppresses lung cancer cell adhesion to extracellular matrix ( ECM ) and metastasis by targeting integrin ?] 1 and MMP2 .
412	suppress	negative	mir-29c	1085.623	789.9343	789.9343	miRNA		Therefore , we hypothesized that miR-29c suppresses lung cancer cell adhesion to extracellular matrix ( ECM ) and metastasis by targeting integrin ?] 1 and MMP2 .
412	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Therefore , we hypothesized that miR-29c suppresses lung cancer cell adhesion to extracellular matrix ( ECM ) and metastasis by targeting integrin ?] 1 and MMP2 .
195	inhibit	negative	mir-29c	1085.623	789.9343	789.9343	miRNA		Wound healing , Transwell migration and lung metastasis assays demonstrated that ectopic expression of miR-29c inhibited NPC cell migration and invasion in vitro and suppressed the formation of lung metastases in vivo .
195	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Wound healing , Transwell migration and lung metastasis assays demonstrated that ectopic expression of miR-29c inhibited NPC cell migration and invasion in vitro and suppressed the formation of lung metastases in vivo .
194	suppress	negative	mir-29c	1085.623	789.9343	789.9343	miRNA		MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma .
194	suppress	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma .
111	regulate	positive	mir-29c	1085.623	789.9343	789.9343	miRNA		We have performed experiments to test predictions from this miRNA-regulatory network to demonstrate that miRNAs of the miR-29 family ( miR-29a , miR-29b , and miR-29c ) regulate specific genes associated with tissue invasion and metastasis in lung adenocarcinoma .
111	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	We have performed experiments to test predictions from this miRNA-regulatory network to demonstrate that miRNAs of the miR-29 family ( miR-29a , miR-29b , and miR-29c ) regulate specific genes associated with tissue invasion and metastasis in lung adenocarcinoma .
1592	effect	neutral	mir-29b	1089.663	786.4982	786.4982	miRNA		Our results demonstrate the profound effect of fucoidan not only on the regulation of miR-29b-DNMT3B-MTSS1 axis but also on the inhibition of TGF-?] signaling in HCC cells , suggesting the potential of using fucoidan as integrative therapeutics against invasion and metastasis of HCC .
1592	effect	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Our results demonstrate the profound effect of fucoidan not only on the regulation of miR-29b-DNMT3B-MTSS1 axis but also on the inhibition of TGF-?] signaling in HCC cells , suggesting the potential of using fucoidan as integrative therapeutics against invasion and metastasis of HCC .
1399	suppress	negative	mir-29b	1089.663	786.4982	786.4982	miRNA		Taken together , our results demonstrate that miR-29b serves as a tumor metastasis suppressor , which suppresses NSCLC cell metastasis by directly inhibiting MMP2 expression .
1399	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , our results demonstrate that miR-29b serves as a tumor metastasis suppressor , which suppresses NSCLC cell metastasis by directly inhibiting MMP2 expression .
1162	control	neutral	mir-29b	1089.663	786.4982	786.4982	miRNA		We detected the expression level of miR-29b-2 , 155 , 197 and 205 in the serum of female breast cancer patients and healthy controls to detect whether serum level of this chosen micro-RNAs could detect patients with breast cancer and also to detect difference in level of micro-RNAs between non-metastatic cases and metastatic cases , also we tried to detect any relation between level of micro-RNAs and the stage of the tumor , the size of tumor , nodal affection , the presence of metastasis and also the site of metastasis .
1162	control	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We detected the expression level of miR-29b-2 , 155 , 197 and 205 in the serum of female breast cancer patients and healthy controls to detect whether serum level of this chosen micro-RNAs could detect patients with breast cancer and also to detect difference in level of micro-RNAs between non-metastatic cases and metastatic cases , also we tried to detect any relation between level of micro-RNAs and the stage of the tumor , the size of tumor , nodal affection , the presence of metastasis and also the site of metastasis .
1149	inhibit	negative	mir-29b	1089.663	786.4982	786.4982	miRNA		miR-29b was proved to inhibit metastasis through the targeting of TET1 , indicating that downregulation of miR-29 may involve in HCC carcinogenesis and progression through potentiation of TET1 expression .
1149	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-29b was proved to inhibit metastasis through the targeting of TET1 , indicating that downregulation of miR-29 may involve in HCC carcinogenesis and progression through potentiation of TET1 expression .
1130	block	negative	mir-29b	1089.663	786.4982	786.4982	miRNA		Targeting miR-29b may provide a strategy for blocking CRC growth and metastasis .
1130	block	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Targeting miR-29b may provide a strategy for blocking CRC growth and metastasis .
1129	suppress	negative	mir-29b	1089.663	786.4982	786.4982	miRNA		IFN-帠-mediated IRF1/miR-29b feedback loop suppresses colorectal cancer cell growth and metastasis by repressing IGF1 .
1129	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	IFN-帠-mediated IRF1/miR-29b feedback loop suppresses colorectal cancer cell growth and metastasis by repressing IGF1 .
1018	inhibit	negative	mir-29b	1089.663	786.4982	786.4982	miRNA		MiR-29b was proved to inhibit metastasis through the targeting of TET1 , indicating that downregulation of miR-29 may involve in HCC carcinogenesis and progression through potentiation of TET1 expression .
1018	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-29b was proved to inhibit metastasis through the targeting of TET1 , indicating that downregulation of miR-29 may involve in HCC carcinogenesis and progression through potentiation of TET1 expression .
863	suppress	negative	mir-29b	1089.663	786.4982	786.4982	miRNA		miR-29b suppresses tumor growth and metastasis in colorectal cancer via downregulating Tiam1 expression and inhibiting epithelial-mesenchymal transition .
863	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-29b suppresses tumor growth and metastasis in colorectal cancer via downregulating Tiam1 expression and inhibiting epithelial-mesenchymal transition .
862	suppress	negative	mir-29b	1089.663	786.4982	786.4982	miRNA		miR-29b suppresses tumor growth and metastasis in colorectal cancer via downregulating Tiam1 expression and inhibiting epithelial-mesenchymal transition .
862	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-29b suppresses tumor growth and metastasis in colorectal cancer via downregulating Tiam1 expression and inhibiting epithelial-mesenchymal transition .
731	downregulate	negative	mir-29b	1089.663	786.4982	786.4982	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
731	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
730	downregulate	negative	mir-29b	1089.663	786.4982	786.4982	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
730	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
239	regulate	positive	mir-29b	1089.663	786.4982	786.4982	miRNA		The discovery that a GATA3-miR-29b axis regulates the tumour microenvironment and inhibits metastasis opens up possibilities for therapeutic intervention in breast cancer .
239	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The discovery that a GATA3-miR-29b axis regulates the tumour microenvironment and inhibits metastasis opens up possibilities for therapeutic intervention in breast cancer .
238	promote	positive	mir-29b	1089.663	786.4982	786.4982	miRNA		Accordingly , miR-29b is enriched in luminal breast cancers and loss of miR-29b , even in GATA3-expressing cells , increases metastasis and promotes a mesenchymal phenotype .
238	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Accordingly , miR-29b is enriched in luminal breast cancers and loss of miR-29b , even in GATA3-expressing cells , increases metastasis and promotes a mesenchymal phenotype .
237	promote	positive	mir-29b	1089.663	786.4982	786.4982	miRNA		Here , we show that GATA3 promotes differentiation , suppresses metastasis and alters the tumour microenvironment in breast cancer by inducing microRNA-29b ( miR-29b ) expression .
237	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here , we show that GATA3 promotes differentiation , suppresses metastasis and alters the tumour microenvironment in breast cancer by inducing microRNA-29b ( miR-29b ) expression .
110	regulate	positive	mir-29b	1089.663	786.4982	786.4982	miRNA		We have performed experiments to test predictions from this miRNA-regulatory network to demonstrate that miRNAs of the miR-29 family ( miR-29a , miR-29b , and miR-29c ) regulate specific genes associated with tissue invasion and metastasis in lung adenocarcinoma .
110	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	We have performed experiments to test predictions from this miRNA-regulatory network to demonstrate that miRNAs of the miR-29 family ( miR-29a , miR-29b , and miR-29c ) regulate specific genes associated with tissue invasion and metastasis in lung adenocarcinoma .
1895	promote	positive	mir-29a	1093.662	783.0142	783.0142	miRNA		Taken together , our results suggested that hTERT may promote GC metastasis through the hTERT-miR-29a-ITGB1 regulatory pathway .
1895	promote	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	Taken together , our results suggested that hTERT may promote GC metastasis through the hTERT-miR-29a-ITGB1 regulatory pathway .
1894	suppress	negative	mir-29a	1093.662	783.0142	783.0142	miRNA		Our study also found that the restoration of miR-29a suppressed the expression of ITGB1 and inhibited GC cell metastasis both in vitro and in vivo .
1894	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Our study also found that the restoration of miR-29a suppressed the expression of ITGB1 and inhibited GC cell metastasis both in vitro and in vivo .
1638	downregulate	negative	mir-29a	1093.662	783.0142	783.0142	miRNA		In the present study , we discovered that miR-29a was frequently downregulated in PTC tissues , and its expression was significantly associated with tumor size , TNM stage , and lymph node metastasis .
1638	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In the present study , we discovered that miR-29a was frequently downregulated in PTC tissues , and its expression was significantly associated with tumor size , TNM stage , and lymph node metastasis .
1637	downregulate	negative	mir-29a	1093.662	783.0142	783.0142	miRNA		In the present study , we discovered that miR-29a was frequently downregulated in PTC tissues , and its expression was significantly associated with tumor size , TNM stage , and lymph node metastasis .
1637	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In the present study , we discovered that miR-29a was frequently downregulated in PTC tissues , and its expression was significantly associated with tumor size , TNM stage , and lymph node metastasis .
1636	suppress	negative	mir-29a	1093.662	783.0142	783.0142	miRNA		miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3 .
1636	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3 .
1608	promote	positive	mir-29a	1093.662	783.0142	783.0142	miRNA		TGF-?] 1 Reduces miR-29a Expression to Promote Tumorigenicity and Metastasis of Cholangiocarcinoma by Targeting HDAC4 .
1608	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	TGF-?] 1 Reduces miR-29a Expression to Promote Tumorigenicity and Metastasis of Cholangiocarcinoma by Targeting HDAC4 .
1576	regulate	positive	mir-29a	1093.662	783.0142	783.0142	miRNA		We found that miR-29a was up regulated in pancreatic tumor tissues and cell lines and positively correlated with metastasis .
1576	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We found that miR-29a was up regulated in pancreatic tumor tissues and cell lines and positively correlated with metastasis .
1296	suppress	negative	mir-29a	1093.662	783.0142	783.0142	miRNA		Wound healing and Transwell assays revealed that miR-29a-3p suppressed tumor metastasis in GC .
1296	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Wound healing and Transwell assays revealed that miR-29a-3p suppressed tumor metastasis in GC .
772	downregulate	negative	mir-29a	1093.662	783.0142	783.0142	miRNA		These findings raised the hypothesis that miR-29a could be a biomarker for neuroblastoma CNS metastasis , and its downregulation may play a pivotal role in CNS progression .
772	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	These findings raised the hypothesis that miR-29a could be a biomarker for neuroblastoma CNS metastasis , and its downregulation may play a pivotal role in CNS progression .
771	downregulate	negative	mir-29a	1093.662	783.0142	783.0142	miRNA		These findings raised the hypothesis that miR-29a could be a biomarker for neuroblastoma CNS metastasis , and its downregulation may play a pivotal role in CNS progression .
771	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	These findings raised the hypothesis that miR-29a could be a biomarker for neuroblastoma CNS metastasis , and its downregulation may play a pivotal role in CNS progression .
770	amplify	positive	mir-29a	1093.662	783.0142	783.0142	miRNA		Irrespective of the amplification status of MYCN , which is known to be associated with metastasis , pre-CNS primaries , and CNS metastases had significantly lower miR-29a expression than non-CNS primary tumors .
770	amplify	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Irrespective of the amplification status of MYCN , which is known to be associated with metastasis , pre-CNS primaries , and CNS metastases had significantly lower miR-29a expression than non-CNS primary tumors .
769	amplify	positive	mir-29a	1093.662	783.0142	783.0142	miRNA		Irrespective of the amplification status of MYCN , which is known to be associated with metastasis , pre-CNS primaries , and CNS metastases had significantly lower miR-29a expression than non-CNS primary tumors .
769	amplify	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Irrespective of the amplification status of MYCN , which is known to be associated with metastasis , pre-CNS primaries , and CNS metastases had significantly lower miR-29a expression than non-CNS primary tumors .
768	downregulate	negative	mir-29a	1093.662	783.0142	783.0142	miRNA		Deep MicroRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis .
768	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Deep MicroRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis .
515	promote	positive	mir-29a	1093.662	783.0142	783.0142	miRNA		Increased expression of miR-29a promoted CRC metastasis by regulating MMP2/E-cad through direct targeting KLF4 , which highlights the potential of the miR-29a inhibitor as a novel agent against CRC metastasis .
515	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Increased expression of miR-29a promoted CRC metastasis by regulating MMP2/E-cad through direct targeting KLF4 , which highlights the potential of the miR-29a inhibitor as a novel agent against CRC metastasis .
109	regulate	positive	mir-29a	1093.662	783.0142	783.0142	miRNA		We have performed experiments to test predictions from this miRNA-regulatory network to demonstrate that miRNAs of the miR-29 family ( miR-29a , miR-29b , and miR-29c ) regulate specific genes associated with tissue invasion and metastasis in lung adenocarcinoma .
109	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	We have performed experiments to test predictions from this miRNA-regulatory network to demonstrate that miRNAs of the miR-29 family ( miR-29a , miR-29b , and miR-29c ) regulate specific genes associated with tissue invasion and metastasis in lung adenocarcinoma .
1150	inhibit	negative	mir-29	1097.619	779.4827	779.4827	miRNA		miR-29b was proved to inhibit metastasis through the targeting of TET1 , indicating that downregulation of miR-29 may involve in HCC carcinogenesis and progression through potentiation of TET1 expression .
1150	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-29b was proved to inhibit metastasis through the targeting of TET1 , indicating that downregulation of miR-29 may involve in HCC carcinogenesis and progression through potentiation of TET1 expression .
1019	inhibit	negative	mir-29	1097.619	779.4827	779.4827	miRNA		MiR-29b was proved to inhibit metastasis through the targeting of TET1 , indicating that downregulation of miR-29 may involve in HCC carcinogenesis and progression through potentiation of TET1 expression .
1019	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-29b was proved to inhibit metastasis through the targeting of TET1 , indicating that downregulation of miR-29 may involve in HCC carcinogenesis and progression through potentiation of TET1 expression .
596	mediate	neutral	mir-29	1097.619	779.4827	779.4827	miRNA		However , as a tumor promoter , miR-29 mediates epithelial-mesenchymal transition ( EMT ) and promotes metastasis in breast cancer and colon cancer .
596	mediate	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	However , as a tumor promoter , miR-29 mediates epithelial-mesenchymal transition ( EMT ) and promotes metastasis in breast cancer and colon cancer .
595	mediate	neutral	mir-29	1097.619	779.4827	779.4827	miRNA		However , as a tumor promoter , miR-29 mediates epithelial-mesenchymal transition ( EMT ) and promotes metastasis in breast cancer and colon cancer .
595	mediate	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	However , as a tumor promoter , miR-29 mediates epithelial-mesenchymal transition ( EMT ) and promotes metastasis in breast cancer and colon cancer .
108	regulate	positive	mir-29	1097.619	779.4827	779.4827	miRNA		We have performed experiments to test predictions from this miRNA-regulatory network to demonstrate that miRNAs of the miR-29 family ( miR-29a , miR-29b , and miR-29c ) regulate specific genes associated with tissue invasion and metastasis in lung adenocarcinoma .
108	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	We have performed experiments to test predictions from this miRNA-regulatory network to demonstrate that miRNAs of the miR-29 family ( miR-29a , miR-29b , and miR-29c ) regulate specific genes associated with tissue invasion and metastasis in lung adenocarcinoma .
1441	suppress	negative	mir-146a	1101.534	775.9042	775.9042	miRNA		Restoration of miR-146a in SCC25 and UMSCC1 cells decreased in vitro invasive activity , suppressed tumor growth in vivo , and decreased the incidence of UMSCC1 lung metastasis .
1441	suppress	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Restoration of miR-146a in SCC25 and UMSCC1 cells decreased in vitro invasive activity , suppressed tumor growth in vivo , and decreased the incidence of UMSCC1 lung metastasis .
1137	suppress	negative	mir-146a	1101.534	775.9042	775.9042	miRNA		This study identified a novel target of miR-146a and defined miR-146a as a crucial tumor suppressor in human HCC that acts through multiple pathways and mechanisms to suppress HCC invasion or metastasis .
1137	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	This study identified a novel target of miR-146a and defined miR-146a as a crucial tumor suppressor in human HCC that acts through multiple pathways and mechanisms to suppress HCC invasion or metastasis .
1136	suppress	negative	mir-146a	1101.534	775.9042	775.9042	miRNA		The restoration of miR-146a dramatically suppressed HCC cell invasion and metastasis by repressing VEGF expression through upregulating APC , which inhibits ?] -catenin accumulation in nucleus , and downregulating NF-庥B p65 by targeting HAb18G .
1136	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The restoration of miR-146a dramatically suppressed HCC cell invasion and metastasis by repressing VEGF expression through upregulating APC , which inhibits ?] -catenin accumulation in nucleus , and downregulating NF-庥B p65 by targeting HAb18G .
338	suppress	negative	mir-146a	1101.534	775.9042	775.9042	miRNA		These findings suggest that TRAIL-induced miR-146a expression suppresses CXCR4-mediated human breast cancer migration , and provide further insight into the non-apoptotic function of TRAIL in the prevention of metastasis as a therapy for breast cancer .
338	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	These findings suggest that TRAIL-induced miR-146a expression suppresses CXCR4-mediated human breast cancer migration , and provide further insight into the non-apoptotic function of TRAIL in the prevention of metastasis as a therapy for breast cancer .
107	suppress	negative	mir-146a	1101.534	775.9042	775.9042	miRNA		miR-146a may have the therapeutic potential to suppress gastric cancer metastasis .
107	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	miR-146a may have the therapeutic potential to suppress gastric cancer metastasis .
106	suppress	negative	mir-146a	1101.534	775.9042	775.9042	miRNA		Taken together , our results provide evidence that miR-146a suppresses gastric cancer cell invasion and metastasis in ? vitro and in ? vivo , which may be in part due to the downregulation of L1CAM .
106	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Taken together , our results provide evidence that miR-146a suppresses gastric cancer cell invasion and metastasis in ? vitro and in ? vivo , which may be in part due to the downregulation of L1CAM .
1584	promote	positive	microrna-125b	1105.405	772.2791	772.2791	miRNA		MicroRNA-125b promotes tumor metastasis through targeting tumor protein 53-induced nuclear protein 1 in patients with non-small-cell lung cancer .
1584	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-125b promotes tumor metastasis through targeting tumor protein 53-induced nuclear protein 1 in patients with non-small-cell lung cancer .
105	induce	positive	microrna-125b	1105.405	772.2791	772.2791	miRNA		MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells .
105	induce	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells .
761	promote	positive	microrna-182	1109.233	768.6081	768.6081	miRNA		microRNA-182 targets special AT-rich sequence-binding protein 2 to promote colorectal cancer proliferation and metastasis .
761	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	microRNA-182 targets special AT-rich sequence-binding protein 2 to promote colorectal cancer proliferation and metastasis .
701	regulate	positive	microrna-182	1109.233	768.6081	768.6081	miRNA		MicroRNA-182 ( miR182 ) overexpression contributes to aggressive ovarian cancer , largely by its negative regulation of multiple tumor suppressor genes involved in tumor growth , invasion , metastasis , and DNA instability .
701	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-182 ( miR182 ) overexpression contributes to aggressive ovarian cancer , largely by its negative regulation of multiple tumor suppressor genes involved in tumor growth , invasion , metastasis , and DNA instability .
293	suppress	negative	microrna-182	1109.233	768.6081	768.6081	miRNA		Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis .
293	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis .
102	downregulate	negative	microrna-182	1109.233	768.6081	768.6081	miRNA		MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma .
102	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma .
1686	downregulate	negative	mir-19a	1113.016	764.8916	764.8916	miRNA		Zhang and colleagues recently demonstrated that astrocyte-derived exosomal miR-19a reversibly downregulated PTEN expression in cancer cells , thereby increasing their CCL2 secretion and recruitment of myeloid cell to promote brain metastasis .
1686	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Zhang and colleagues recently demonstrated that astrocyte-derived exosomal miR-19a reversibly downregulated PTEN expression in cancer cells , thereby increasing their CCL2 secretion and recruitment of myeloid cell to promote brain metastasis .
1685	downregulate	negative	mir-19a	1113.016	764.8916	764.8916	miRNA		Zhang and colleagues recently demonstrated that astrocyte-derived exosomal miR-19a reversibly downregulated PTEN expression in cancer cells , thereby increasing their CCL2 secretion and recruitment of myeloid cell to promote brain metastasis .
1685	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Zhang and colleagues recently demonstrated that astrocyte-derived exosomal miR-19a reversibly downregulated PTEN expression in cancer cells , thereby increasing their CCL2 secretion and recruitment of myeloid cell to promote brain metastasis .
1536	upregulate	positive	mir-19a	1113.016	764.8916	764.8916	miRNA		Furthermore , miR-19a was up-regulated by TNF-帢 and miR-19a was required for TNF-帢-induced EMT and metastasis in CRC cells .
1536	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Furthermore , miR-19a was up-regulated by TNF-帢 and miR-19a was required for TNF-帢-induced EMT and metastasis in CRC cells .
1535	upregulate	positive	mir-19a	1113.016	764.8916	764.8916	miRNA		We found that miR-19a was up-regulated in CRC tissues and high expression of miR-19a was significantly associated with lymph node metastasis .
1535	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We found that miR-19a was up-regulated in CRC tissues and high expression of miR-19a was significantly associated with lymph node metastasis .
1534	mediate	neutral	mir-19a	1113.016	764.8916	764.8916	miRNA		Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-帢 induced epithelial-to-mesenchymal transition in colorectal cancer .
1534	mediate	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-帢 induced epithelial-to-mesenchymal transition in colorectal cancer .
1032	promote	positive	mir-19a	1113.016	764.8916	764.8916	miRNA		It was found that the overexpression of miR-19a was significantly associated with metastasis of GC and inferior overall prognosis on clinical tissue level ; that promotes the proliferation , migration and invasion ; and that overexpression of miR-19a can promote the epithelial-mesenchymal transition through activating PI3K/AKT pathway .
1032	promote	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	It was found that the overexpression of miR-19a was significantly associated with metastasis of GC and inferior overall prognosis on clinical tissue level ; that promotes the proliferation , migration and invasion ; and that overexpression of miR-19a can promote the epithelial-mesenchymal transition through activating PI3K/AKT pathway .
99	induce	positive	mir-19a	1113.016	764.8916	764.8916	miRNA		Here , we demonstrate that the miR-21 , miR-17 and miR-19a expressions induced by PRL-3 are involved in the proliferation and metastasis of colon cancer .
99	induce	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here , we demonstrate that the miR-21 , miR-17 and miR-19a expressions induced by PRL-3 are involved in the proliferation and metastasis of colon cancer .
96	induce	positive	mir-19a	1113.016	764.8916	764.8916	miRNA		miR-21 , miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer .
96	induce	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-21 , miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer .
1806	upregulate	positive	mir-17	1116.755	761.1301	761.1301	miRNA		In addition , miR-17-5p upregulation more frequently occurred in osteosarcoma specimens with advanced clinical stage , positive distant metastasis and poor response to neo-adjuvant chemotherapy .
1806	upregulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	In addition , miR-17-5p upregulation more frequently occurred in osteosarcoma specimens with advanced clinical stage , positive distant metastasis and poor response to neo-adjuvant chemotherapy .
1680	suppress	negative	mir-17	1116.755	761.1301	761.1301	miRNA		Taken together , our data indicated that there is a regulatory feedback loop between miR-17-5p and c-Myc , in which miR-17-5p could suppress some of the distinguishing features , invasion , and metastasis , of oncogenic c-Myc in HCC cells , and meanwhile , miR-17-5p is upregulated by c-Myc role as a transcription factor , although further studies are still needed .
1680	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , our data indicated that there is a regulatory feedback loop between miR-17-5p and c-Myc , in which miR-17-5p could suppress some of the distinguishing features , invasion , and metastasis , of oncogenic c-Myc in HCC cells , and meanwhile , miR-17-5p is upregulated by c-Myc role as a transcription factor , although further studies are still needed .
1679	regulate	positive	mir-17	1116.755	761.1301	761.1301	miRNA		A c-Myc/miR-17-5p feedback loop regulates metastasis and invasion of hepatocellular carcinoma .
1679	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	A c-Myc/miR-17-5p feedback loop regulates metastasis and invasion of hepatocellular carcinoma .
1472	control	neutral	mir-17	1116.755	761.1301	761.1301	miRNA		Based on the results obtained in the last decade , some miRNAs are emerging as biomarkers of BC for diagnosis ( i.e. , miR-9 , miR-10b , and miR-17-5p ) , prognosis ( i.e. , miR-148a and miR-335 ) , and prediction of therapeutic outcomes ( i.e. , miR-30c , miR-187 , and miR-339-5p ) and have important roles in the control of BC hallmark functions such as invasion , metastasis , proliferation , resting death , apoptosis , and genomic instability .
1472	control	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Based on the results obtained in the last decade , some miRNAs are emerging as biomarkers of BC for diagnosis ( i.e. , miR-9 , miR-10b , and miR-17-5p ) , prognosis ( i.e. , miR-148a and miR-335 ) , and prediction of therapeutic outcomes ( i.e. , miR-30c , miR-187 , and miR-339-5p ) and have important roles in the control of BC hallmark functions such as invasion , metastasis , proliferation , resting death , apoptosis , and genomic instability .
1274	promote	positive	mir-17	1116.755	761.1301	761.1301	miRNA		Our results suggest microRNA involvement in malignant pituitary progression , whereby increased miR-20a , miR-106b and miR-17-5p promote metastasis by attenuating PTEN and TIMP2 in pituitary carcinoma .
1274	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Our results suggest microRNA involvement in malignant pituitary progression , whereby increased miR-20a , miR-106b and miR-17-5p promote metastasis by attenuating PTEN and TIMP2 in pituitary carcinoma .
833	activate	positive	mir-17	1116.755	761.1301	761.1301	miRNA		These results provide evidence supporting that EMT activation and IFN pathway inactivation are markers of metastatic progression of basal-like tumors , and members of miR-17 , miR-200 , and miR-96 families play a role in suppressing EMT and metastasis .
833	activate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	These results provide evidence supporting that EMT activation and IFN pathway inactivation are markers of metastatic progression of basal-like tumors , and members of miR-17 , miR-200 , and miR-96 families play a role in suppressing EMT and metastasis .
832	activate	positive	mir-17	1116.755	761.1301	761.1301	miRNA		These results provide evidence supporting that EMT activation and IFN pathway inactivation are markers of metastatic progression of basal-like tumors , and members of miR-17 , miR-200 , and miR-96 families play a role in suppressing EMT and metastasis .
832	activate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	These results provide evidence supporting that EMT activation and IFN pathway inactivation are markers of metastatic progression of basal-like tumors , and members of miR-17 , miR-200 , and miR-96 families play a role in suppressing EMT and metastasis .
831	inhibit	negative	mir-17	1116.755	761.1301	761.1301	miRNA		We demonstrated that miR-17-5p inhibition in breast cancer cells enhanced expression of multiple pro-metastatic genes , rendered cells metastatic properties , and accelerated lung metastasis from orthotopic xenografts .
831	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We demonstrated that miR-17-5p inhibition in breast cancer cells enhanced expression of multiple pro-metastatic genes , rendered cells metastatic properties , and accelerated lung metastasis from orthotopic xenografts .
830	inhibit	negative	mir-17	1116.755	761.1301	761.1301	miRNA		We demonstrated that miR-17-5p inhibition in breast cancer cells enhanced expression of multiple pro-metastatic genes , rendered cells metastatic properties , and accelerated lung metastasis from orthotopic xenografts .
830	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We demonstrated that miR-17-5p inhibition in breast cancer cells enhanced expression of multiple pro-metastatic genes , rendered cells metastatic properties , and accelerated lung metastasis from orthotopic xenografts .
659	suppress	negative	mir-17	1116.755	761.1301	761.1301	miRNA		Consequently , our study suggests that miRNA 17 family ( including miR-17 , 20a , 20b ) can act as TGF?] R2 suppressor for reversing cisplatin-resistant and suppressing metastasis in NSCLC .
659	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Consequently , our study suggests that miRNA 17 family ( including miR-17 , 20a , 20b ) can act as TGF?] R2 suppressor for reversing cisplatin-resistant and suppressing metastasis in NSCLC .
645	inhibit	negative	mir-17	1116.755	761.1301	761.1301	miRNA		However , higher levels of the miR-17~92 cluster switched from PTEN to oncogenes , including Ctnnb1 ( ?] -catenin ) via miR-18a , which resulted in inhibition of tumor growth and metastasis .
645	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	However , higher levels of the miR-17~92 cluster switched from PTEN to oncogenes , including Ctnnb1 ( ?] -catenin ) via miR-18a , which resulted in inhibition of tumor growth and metastasis .
644	promote	positive	mir-17	1116.755	761.1301	761.1301	miRNA		miR-19 in the context of the miR-17~92 cluster at medium levels promoted tumor metastasis through induction of Wnt/?] -catenin-mediated epithelial-mesenchymal transition by targeting to the tumor-suppressor gene , PTEN .
644	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-19 in the context of the miR-17~92 cluster at medium levels promoted tumor metastasis through induction of Wnt/?] -catenin-mediated epithelial-mesenchymal transition by targeting to the tumor-suppressor gene , PTEN .
641	antagonize	negative	mir-17	1116.755	761.1301	761.1301	miRNA		In conclusion , miR-17-92 cluster members miR-19a/b facilitated gastric cancer cell migration , invasion and metastasis through targeting the antagonist of c-Myc -- MXD1 , implicating a novel mechanism for the malignant phenotypes of gastric cancer .
641	antagonize	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	In conclusion , miR-17-92 cluster members miR-19a/b facilitated gastric cancer cell migration , invasion and metastasis through targeting the antagonist of c-Myc -- MXD1 , implicating a novel mechanism for the malignant phenotypes of gastric cancer .
569	suppress	negative	mir-17	1116.755	761.1301	761.1301	miRNA		miR-17 inhibitor suppressed osteosarcoma tumor growth and metastasis via increasing PTEN expression .
569	suppress	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	miR-17 inhibitor suppressed osteosarcoma tumor growth and metastasis via increasing PTEN expression .
408	repress	negative	mir-17	1116.755	761.1301	761.1301	miRNA		Thyroid hormone receptor represses miR-17 expression to enhance tumor metastasis in human hepatoma cells .
408	repress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Thyroid hormone receptor represses miR-17 expression to enhance tumor metastasis in human hepatoma cells .
98	induce	positive	mir-17	1116.755	761.1301	761.1301	miRNA		Here , we demonstrate that the miR-21 , miR-17 and miR-19a expressions induced by PRL-3 are involved in the proliferation and metastasis of colon cancer .
98	induce	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here , we demonstrate that the miR-21 , miR-17 and miR-19a expressions induced by PRL-3 are involved in the proliferation and metastasis of colon cancer .
95	induce	positive	mir-17	1116.755	761.1301	761.1301	miRNA		miR-21 , miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer .
95	induce	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-21 , miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer .
392	inhibit	negative	mir-625	1120.449	757.3243	757.3243	miRNA		Our results suggest that miR-625 may serve as an efficient clinical biomarker and a therapeutic tool for the inhibition of metastasis in CRC .
392	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our results suggest that miR-625 may serve as an efficient clinical biomarker and a therapeutic tool for the inhibition of metastasis in CRC .
93	inhibit	negative	mir-625	1120.449	757.3243	757.3243	miRNA		miR-625 significantly inhibits invasion and metastasis of gastric cancer cells both in vitro and in vivo .
93	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	miR-625 significantly inhibits invasion and metastasis of gastric cancer cells both in vitro and in vivo .
92	downregulate	negative	mir-625	1120.449	757.3243	757.3243	miRNA		Here , we report that expression of miR-625 is significantly down-regulated and negatively correlated with lymph node metastasis in gastric cancer .
92	downregulate	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Here , we report that expression of miR-625 is significantly down-regulated and negatively correlated with lymph node metastasis in gastric cancer .
91	downregulate	negative	mir-625	1120.449	757.3243	757.3243	miRNA		Down-regulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK .
91	downregulate	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Down-regulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK .
88	block	negative	mir-7/igf	1124.097	753.4747	753.4747	miRNA		Targeting this novel miR-7/IGF1R/Snail axis would be helpful as a therapeutic approach to block GC metastasis .
88	block	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Targeting this novel miR-7/IGF1R/Snail axis would be helpful as a therapeutic approach to block GC metastasis .
86	promote	positive	mir-103/107	1127.699	749.5817	749.5817	miRNA		Our findings therefore indicate that miR-103/107-mediated repression of DAPK and KLF4 promotes metastasis in CRC , and this regulatory circuit may contribute in part to hypoxia-stimulated tumor metastasis .
86	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our findings therefore indicate that miR-103/107-mediated repression of DAPK and KLF4 promotes metastasis in CRC , and this regulatory circuit may contribute in part to hypoxia-stimulated tumor metastasis .
85	suppress	negative	mir-103/107	1127.699	749.5817	749.5817	miRNA		In mouse models of CRC , miR-103/107 overexpression potentiated local invasion and liver metastasis effects , which were suppressed by reexpression of DAPK or KLF4 .
85	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In mouse models of CRC , miR-103/107 overexpression potentiated local invasion and liver metastasis effects , which were suppressed by reexpression of DAPK or KLF4 .
84	promote	positive	mir-103/107	1127.699	749.5817	749.5817	miRNA		miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4 .
84	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4 .
1642	inhibit	negative	mir-139	1131.254	745.6459	745.6459	miRNA		Taken together , our results demonstrated that miR-139-5p plays a pivotal role in lung cancer through inhibiting cell proliferation , metastasis , and promoting apoptosis by targeting oncogenic c-Met .
1642	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , our results demonstrated that miR-139-5p plays a pivotal role in lung cancer through inhibiting cell proliferation , metastasis , and promoting apoptosis by targeting oncogenic c-Met .
1533	control	neutral	mir-139	1131.254	745.6459	745.6459	miRNA		MiR-139-5p expression in MCF-7 , MCF-7/Doc cells and in selected breast cancer tissue samples was confirmed by real-time PCR ; cell viability was analyzed by Cell Counting Kit-8 assay ; apoptosis and cell cycle were analyzed by flow cytometry ; control of metastasis and invasion of breast cancer cells was measured by transwell assay ; expression of Notch1 was measured by western blot ; a luciferase reporter vector was constructed to identify the miR-139-5p target gene .
1533	control	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-139-5p expression in MCF-7 , MCF-7/Doc cells and in selected breast cancer tissue samples was confirmed by real-time PCR ; cell viability was analyzed by Cell Counting Kit-8 assay ; apoptosis and cell cycle were analyzed by flow cytometry ; control of metastasis and invasion of breast cancer cells was measured by transwell assay ; expression of Notch1 was measured by western blot ; a luciferase reporter vector was constructed to identify the miR-139-5p target gene .
1532	control	neutral	mir-139	1131.254	745.6459	745.6459	miRNA		MiR-139-5p expression in MCF-7 , MCF-7/Doc cells and in selected breast cancer tissue samples was confirmed by real-time PCR ; cell viability was analyzed by Cell Counting Kit-8 assay ; apoptosis and cell cycle were analyzed by flow cytometry ; control of metastasis and invasion of breast cancer cells was measured by transwell assay ; expression of Notch1 was measured by western blot ; a luciferase reporter vector was constructed to identify the miR-139-5p target gene .
1532	control	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-139-5p expression in MCF-7 , MCF-7/Doc cells and in selected breast cancer tissue samples was confirmed by real-time PCR ; cell viability was analyzed by Cell Counting Kit-8 assay ; apoptosis and cell cycle were analyzed by flow cytometry ; control of metastasis and invasion of breast cancer cells was measured by transwell assay ; expression of Notch1 was measured by western blot ; a luciferase reporter vector was constructed to identify the miR-139-5p target gene .
1379	regulate	positive	mir-139	1131.254	745.6459	745.6459	miRNA		The purpose of this study was to determine the role of miR-139-5p in regulation of epithelial-mesenchymal transition ( EMT ) and metastasis of HCC cells .
1379	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The purpose of this study was to determine the role of miR-139-5p in regulation of epithelial-mesenchymal transition ( EMT ) and metastasis of HCC cells .
1378	regulate	positive	mir-139	1131.254	745.6459	745.6459	miRNA		The purpose of this study was to determine the role of miR-139-5p in regulation of epithelial-mesenchymal transition ( EMT ) and metastasis of HCC cells .
1378	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The purpose of this study was to determine the role of miR-139-5p in regulation of epithelial-mesenchymal transition ( EMT ) and metastasis of HCC cells .
913	repress	negative	mir-139	1131.254	745.6459	745.6459	miRNA		Together , our data indicate that miR-139-5p is a potential tumor suppressor and prognostic factor for CRC , and targeting miR-139-5p may repress the metastasis of CRC and improve survival .
913	repress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Together , our data indicate that miR-139-5p is a potential tumor suppressor and prognostic factor for CRC , and targeting miR-139-5p may repress the metastasis of CRC and improve survival .
912	effect	neutral	mir-139	1131.254	745.6459	745.6459	miRNA		Knockdown of the two genes phenocopied the inhibitory effect of miR-139-5p on CRC metastasis .
912	effect	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Knockdown of the two genes phenocopied the inhibitory effect of miR-139-5p on CRC metastasis .
911	suppress	negative	mir-139	1131.254	745.6459	745.6459	miRNA		Mechanistic investigations revealed that miR-139-5p suppress CRC cell invasion and metastasis by targeting AMFR and NOTCH1 .
911	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Mechanistic investigations revealed that miR-139-5p suppress CRC cell invasion and metastasis by targeting AMFR and NOTCH1 .
910	suppress	negative	mir-139	1131.254	745.6459	745.6459	miRNA		Functional analyses demonstrated that ectopic expression of miR-139-5p suppressed CRC cell migration and invasion in vitro and metastasis in vivo .
910	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Functional analyses demonstrated that ectopic expression of miR-139-5p suppressed CRC cell migration and invasion in vitro and metastasis in vivo .
766	inhibit	negative	mir-139	1131.254	745.6459	745.6459	miRNA		miR-139-5p plays a pivotal role in colon cancer through inhibiting cell proliferation , metastasis , and promoting apoptosis and cell cycle arrest by targeting oncogenic NOTCH1 .
766	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-139-5p plays a pivotal role in colon cancer through inhibiting cell proliferation , metastasis , and promoting apoptosis and cell cycle arrest by targeting oncogenic NOTCH1 .
529	inhibit	negative	mir-139	1131.254	745.6459	745.6459	miRNA		Taken together , we conclude that miR-139 targets CXCR4 and inhibits proliferation and metastasis of LSCC .
529	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , we conclude that miR-139 targets CXCR4 and inhibits proliferation and metastasis of LSCC .
528	inhibit	negative	mir-139	1131.254	745.6459	745.6459	miRNA		MiR-139 targets CXCR4 and inhibits the proliferation and metastasis of laryngeal squamous carcinoma cells .
528	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-139 targets CXCR4 and inhibits the proliferation and metastasis of laryngeal squamous carcinoma cells .
177	downregulate	negative	mir-139	1131.254	745.6459	745.6459	miRNA		Derepression of c-Fos caused by miR-139 down-regulation contributes to the metastasis of HCC .
177	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Derepression of c-Fos caused by miR-139 down-regulation contributes to the metastasis of HCC .
83	block	negative	mir-139	1131.254	745.6459	745.6459	miRNA		Targeting miR-139 may provide a strategy for blocking CRC metastasis .
83	block	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Targeting miR-139 may provide a strategy for blocking CRC metastasis .
82	suppress	negative	mir-139	1131.254	745.6459	745.6459	miRNA		MiR-139 might suppress CRC cells invasion and metastasis by targeting type I insulin-like growth factor receptor ( IGF-IR ) .
82	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-139 might suppress CRC cells invasion and metastasis by targeting type I insulin-like growth factor receptor ( IGF-IR ) .
81	inhibit	negative	mir-139	1131.254	745.6459	745.6459	miRNA		Re-expression of miR-139 did not inhibit CRC cell growth but suppresses CRC cell metastasis and invasion in vitro and in vivo .
81	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Re-expression of miR-139 did not inhibit CRC cell growth but suppresses CRC cell metastasis and invasion in vitro and in vivo .
80	downregulate	negative	mir-139	1131.254	745.6459	745.6459	miRNA		In this study , we describe the down-regulation and function of miR-139 in colorectal cancer ( CRC ) metastasis .
80	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In this study , we describe the down-regulation and function of miR-139 in colorectal cancer ( CRC ) metastasis .
79	inhibit	negative	mir-139	1131.254	745.6459	745.6459	miRNA		MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor .
79	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor .
1954	mediate	neutral	mir-9	1134.762	741.668	741.668	miRNA		These results suggest that miR-9 functions as a tumor-suppressor in CRC , and that its suppressive effects mediate invasion and metastasis by inhibition of TM4SF1 expression .
1954	mediate	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	These results suggest that miR-9 functions as a tumor-suppressor in CRC , and that its suppressive effects mediate invasion and metastasis by inhibition of TM4SF1 expression .
1470	control	neutral	mir-9	1134.762	741.668	741.668	miRNA		Based on the results obtained in the last decade , some miRNAs are emerging as biomarkers of BC for diagnosis ( i.e. , miR-9 , miR-10b , and miR-17-5p ) , prognosis ( i.e. , miR-148a and miR-335 ) , and prediction of therapeutic outcomes ( i.e. , miR-30c , miR-187 , and miR-339-5p ) and have important roles in the control of BC hallmark functions such as invasion , metastasis , proliferation , resting death , apoptosis , and genomic instability .
1470	control	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Based on the results obtained in the last decade , some miRNAs are emerging as biomarkers of BC for diagnosis ( i.e. , miR-9 , miR-10b , and miR-17-5p ) , prognosis ( i.e. , miR-148a and miR-335 ) , and prediction of therapeutic outcomes ( i.e. , miR-30c , miR-187 , and miR-339-5p ) and have important roles in the control of BC hallmark functions such as invasion , metastasis , proliferation , resting death , apoptosis , and genomic instability .
1028	activate	positive	mir-9	1134.762	741.668	741.668	miRNA		Taken together , our study demonstrates that miR-9 plays an important role in ESCC metastasis by activating ?] -catenin pathway and inducing EMT via targeting E-cadherin .
1028	activate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , our study demonstrates that miR-9 plays an important role in ESCC metastasis by activating ?] -catenin pathway and inducing EMT via targeting E-cadherin .
1027	induce	positive	mir-9	1134.762	741.668	741.668	miRNA		In addition , miR-9 induced epithelial-mesenchymal transition ( EMT ) in ESCC , a key event in tumor metastasis .
1027	induce	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In addition , miR-9 induced epithelial-mesenchymal transition ( EMT ) in ESCC , a key event in tumor metastasis .
1026	induce	positive	mir-9	1134.762	741.668	741.668	miRNA		In addition , miR-9 induced epithelial-mesenchymal transition ( EMT ) in ESCC , a key event in tumor metastasis .
1026	induce	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In addition , miR-9 induced epithelial-mesenchymal transition ( EMT ) in ESCC , a key event in tumor metastasis .
1025	upregulate	positive	mir-9	1134.762	741.668	741.668	miRNA		The up-regulation of miR-9 was frequently detected in primary ESCC tumor tissue , which was significantly associated with clinical progression ( P = 0.022 ) , lymph node metastasis ( P = 0.007 ) and poor overall survival ( P < 0.001 ) .
1025	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The up-regulation of miR-9 was frequently detected in primary ESCC tumor tissue , which was significantly associated with clinical progression ( P = 0.022 ) , lymph node metastasis ( P = 0.007 ) and poor overall survival ( P < 0.001 ) .
1024	effect	neutral	mir-9	1134.762	741.668	741.668	miRNA		This study aimed to investigate the effect of miR-9 in esophageal cancer metastasis .
1024	effect	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	This study aimed to investigate the effect of miR-9 in esophageal cancer metastasis .
853	repress	negative	mir-9	1134.762	741.668	741.668	miRNA		In this study we explored whether FOXO1 3'UTR can function as a ceRNA in repressing epithelial-to-mesenchymal transition ( EMT ) and metastasis of breast cancer cells via regulating miR-9 activity .
853	repress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In this study we explored whether FOXO1 3'UTR can function as a ceRNA in repressing epithelial-to-mesenchymal transition ( EMT ) and metastasis of breast cancer cells via regulating miR-9 activity .
852	repress	negative	mir-9	1134.762	741.668	741.668	miRNA		In this study we explored whether FOXO1 3'UTR can function as a ceRNA in repressing epithelial-to-mesenchymal transition ( EMT ) and metastasis of breast cancer cells via regulating miR-9 activity .
852	repress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In this study we explored whether FOXO1 3'UTR can function as a ceRNA in repressing epithelial-to-mesenchymal transition ( EMT ) and metastasis of breast cancer cells via regulating miR-9 activity .
812	upregulate	positive	mir-9	1134.762	741.668	741.668	miRNA		Serum miR-9 was significantly upregulated in patients with osteosarcoma ( n ? = ? 118 ) compared with healthy control subjects ( n ? = ? 60 ) ; its upregulation was significantly associated with advanced tumour-node-metastasis stage , larger tumour size and presence of distant metastasis .
812	upregulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Serum miR-9 was significantly upregulated in patients with osteosarcoma ( n ? = ? 118 ) compared with healthy control subjects ( n ? = ? 60 ) ; its upregulation was significantly associated with advanced tumour-node-metastasis stage , larger tumour size and presence of distant metastasis .
811	upregulate	positive	mir-9	1134.762	741.668	741.668	miRNA		Serum miR-9 was significantly upregulated in patients with osteosarcoma ( n ? = ? 118 ) compared with healthy control subjects ( n ? = ? 60 ) ; its upregulation was significantly associated with advanced tumour-node-metastasis stage , larger tumour size and presence of distant metastasis .
811	upregulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Serum miR-9 was significantly upregulated in patients with osteosarcoma ( n ? = ? 118 ) compared with healthy control subjects ( n ? = ? 60 ) ; its upregulation was significantly associated with advanced tumour-node-metastasis stage , larger tumour size and presence of distant metastasis .
622	affect	neutral	mir-9	1134.762	741.668	741.668	miRNA		MiR-202 and miR-9 are potential key factors affecting the metastasis of OS and CALD1 and STX1A may be possible targets beneficial for the treatment of metastatic OS .
622	affect	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-202 and miR-9 are potential key factors affecting the metastasis of OS and CALD1 and STX1A may be possible targets beneficial for the treatment of metastatic OS .
448	upregulate	positive	mir-9	1134.762	741.668	741.668	miRNA		MiR-9 expression in non-small cell lung cancer tissues was significantly higher than that in adjacent normal tissues ( p = 0.001 ) , and its up-regulation was significantly correlated to advanced tumor-node-metastasis ( TNM ) stage ( p < 0.001 ) , tumor size ( p = 0.013 ) , and lymph node metastasis ( p = 0.001 ) .
448	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-9 expression in non-small cell lung cancer tissues was significantly higher than that in adjacent normal tissues ( p = 0.001 ) , and its up-regulation was significantly correlated to advanced tumor-node-metastasis ( TNM ) stage ( p < 0.001 ) , tumor size ( p = 0.013 ) , and lymph node metastasis ( p = 0.001 ) .
447	upregulate	positive	mir-9	1134.762	741.668	741.668	miRNA		MiR-9 expression in non-small cell lung cancer tissues was significantly higher than that in adjacent normal tissues ( p = 0.001 ) , and its up-regulation was significantly correlated to advanced tumor-node-metastasis ( TNM ) stage ( p < 0.001 ) , tumor size ( p = 0.013 ) , and lymph node metastasis ( p = 0.001 ) .
447	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-9 expression in non-small cell lung cancer tissues was significantly higher than that in adjacent normal tissues ( p = 0.001 ) , and its up-regulation was significantly correlated to advanced tumor-node-metastasis ( TNM ) stage ( p < 0.001 ) , tumor size ( p = 0.013 ) , and lymph node metastasis ( p = 0.001 ) .
438	inhibit	negative	mir-9	1134.762	741.668	741.668	miRNA		We show that microRNA-9 ( miR-9 ) contributed to SP expansion and metastasis , and miR-9 inhibition reduced the number of SP cells and metastasis .
438	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We show that microRNA-9 ( miR-9 ) contributed to SP expansion and metastasis , and miR-9 inhibition reduced the number of SP cells and metastasis .
437	inhibit	negative	mir-9	1134.762	741.668	741.668	miRNA		We show that microRNA-9 ( miR-9 ) contributed to SP expansion and metastasis , and miR-9 inhibition reduced the number of SP cells and metastasis .
437	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We show that microRNA-9 ( miR-9 ) contributed to SP expansion and metastasis , and miR-9 inhibition reduced the number of SP cells and metastasis .
432	regulate	positive	mir-9	1134.762	741.668	741.668	miRNA		Here we report that microRNA-9 ( miR-9 ) regulates the expression of the Metastasis Associated Lung Adenocarcinoma Transcript 1 ( MALAT-1 ) , one of the most abundant and conserved long non-coding RNAs .
432	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here we report that microRNA-9 ( miR-9 ) regulates the expression of the Metastasis Associated Lung Adenocarcinoma Transcript 1 ( MALAT-1 ) , one of the most abundant and conserved long non-coding RNAs .
249	suppress	negative	mir-9	1134.762	741.668	741.668	miRNA		These data indicate that miR-9 suppresses the expression of cyclin D1 and Ets1 via the binding sites in their 3'-UTR , thus inhibiting the proliferation , invasion and metastasis of gastric cancer .
249	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	These data indicate that miR-9 suppresses the expression of cyclin D1 and Ets1 via the binding sites in their 3'-UTR , thus inhibiting the proliferation , invasion and metastasis of gastric cancer .
248	suppress	negative	mir-9	1134.762	741.668	741.668	miRNA		Over-expression of miR-9 suppressed the proliferation , invasion , and metastasis of SGC-7901 and AGS cells in vitro and in vivo .
248	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Over-expression of miR-9 suppressed the proliferation , invasion , and metastasis of SGC-7901 and AGS cells in vitro and in vivo .
218	regulate	positive	mir-9	1134.762	741.668	741.668	miRNA		The functions of miR-9 in some cancers are recently implicated in regulating proliferation , epithelial-mesenchymal transition ( EMT ) , invasion and metastasis , apoptosis , and tumor angiogenesis , etc. miR-9 is commonly down-regulated in nasopharyngeal carcinoma ( NPC ) , but the exact roles of miR-9 dysregulation in the pathogenesis of NPC remains unclear .
218	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The functions of miR-9 in some cancers are recently implicated in regulating proliferation , epithelial-mesenchymal transition ( EMT ) , invasion and metastasis , apoptosis , and tumor angiogenesis , etc. miR-9 is commonly down-regulated in nasopharyngeal carcinoma ( NPC ) , but the exact roles of miR-9 dysregulation in the pathogenesis of NPC remains unclear .
217	regulate	positive	mir-9	1134.762	741.668	741.668	miRNA		The functions of miR-9 in some cancers are recently implicated in regulating proliferation , epithelial-mesenchymal transition ( EMT ) , invasion and metastasis , apoptosis , and tumor angiogenesis , etc. miR-9 is commonly down-regulated in nasopharyngeal carcinoma ( NPC ) , but the exact roles of miR-9 dysregulation in the pathogenesis of NPC remains unclear .
217	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The functions of miR-9 in some cancers are recently implicated in regulating proliferation , epithelial-mesenchymal transition ( EMT ) , invasion and metastasis , apoptosis , and tumor angiogenesis , etc. miR-9 is commonly down-regulated in nasopharyngeal carcinoma ( NPC ) , but the exact roles of miR-9 dysregulation in the pathogenesis of NPC remains unclear .
128	regulate	positive	mir-9	1134.762	741.668	741.668	miRNA		MicroRNAs ( miRNAs ) have been implicated in the regulation of various biological and pathological processes in cancer , however , the special role of miR-9 in uveal melanoma metastasis is largely unknown .
128	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNAs ( miRNAs ) have been implicated in the regulation of various biological and pathological processes in cancer , however , the special role of miR-9 in uveal melanoma metastasis is largely unknown .
89	suppress	negative	mir-9	1134.762	741.668	741.668	miRNA		We propose that IRS-1 suppresses metastasis of head and neck cancer possibly through miR-9 .
89	suppress	negative	hnscc	1221.107	590.7296	590.7296	Cancer	D006258	We propose that IRS-1 suppresses metastasis of head and neck cancer possibly through miR-9 .
78	suppress	negative	mir-9	1134.762	741.668	741.668	miRNA		These data indicate that miR-9 suppresses MMP-14 expression via the binding site in the 3'-UTR , thus inhibiting the invasion , metastasis , and angiogenesis of neuroblastoma .
78	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	These data indicate that miR-9 suppresses MMP-14 expression via the binding site in the 3'-UTR , thus inhibiting the invasion , metastasis , and angiogenesis of neuroblastoma .
2035	inhibit	negative	mir-21	1138.222	737.6486	737.6486	miRNA		Circulating miR-21 in serum could be a promising biomarker in auxiliary diagnosis of lymph node metastasis in cervical cancer , and inhibition of miR-21/RASA1 axis could be a possible strategy to restrain migration of cervical cancer .
2035	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Circulating miR-21 in serum could be a promising biomarker in auxiliary diagnosis of lymph node metastasis in cervical cancer , and inhibition of miR-21/RASA1 axis could be a possible strategy to restrain migration of cervical cancer .
2034	control	neutral	mir-21	1138.222	737.6486	737.6486	miRNA		Whole-blood samples from 89 patients who have been histopathologically confirmed as having cervical cancer and 20 control subjects were collected , and then the association between lymph node metastasis and the level of circulating miR-21 was compared .
2034	control	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Whole-blood samples from 89 patients who have been histopathologically confirmed as having cervical cancer and 20 control subjects were collected , and then the association between lymph node metastasis and the level of circulating miR-21 was compared .
2013	regulate	positive	mir-21	1138.222	737.6486	737.6486	miRNA		In this article , I have focused on the role of HA interaction with CD44 and several important signaling molecules in the regulation of unique miRNAs ( e.g. , miR-21 , miR-302 and miR-10b ) and their downstream targets leading to multiple tumor cell-specific functions ( e.g. , tumor cell growth , drug resistance and metastasis ) and cancer progression .
2013	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In this article , I have focused on the role of HA interaction with CD44 and several important signaling molecules in the regulation of unique miRNAs ( e.g. , miR-21 , miR-302 and miR-10b ) and their downstream targets leading to multiple tumor cell-specific functions ( e.g. , tumor cell growth , drug resistance and metastasis ) and cancer progression .
2005	regulate	positive	mir-21	1138.222	737.6486	737.6486	miRNA		A vast number of miRNAs , including the well-studied miR-21 , miR-155 and miR-34 , has been shown to regulate PDAC growth , invasion and metastasis in vitro and in vivo by targeting members of key signaling pathways .
2005	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	A vast number of miRNAs , including the well-studied miR-21 , miR-155 and miR-34 , has been shown to regulate PDAC growth , invasion and metastasis in vitro and in vivo by targeting members of key signaling pathways .
1957	enhance	positive	mir-21	1138.222	737.6486	737.6486	miRNA		Moreover , exosomal miR-21 markedly enhanced snail and vimentin expression , while significantly decreasing E-cadherin levels in OSCC cells , in vitro and in vivo Finally , circulating exosomal miR-21 levels were closely associated with HIF-1帢/HIF-2帢 expression , T stage , and lymph node metastasis in patients with OSCC .
1957	enhance	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Moreover , exosomal miR-21 markedly enhanced snail and vimentin expression , while significantly decreasing E-cadherin levels in OSCC cells , in vitro and in vivo Finally , circulating exosomal miR-21 levels were closely associated with HIF-1帢/HIF-2帢 expression , T stage , and lymph node metastasis in patients with OSCC .
1884	promote	positive	mir-21	1138.222	737.6486	737.6486	miRNA		Targets of miR-21 ( TIMP3 , PDCD4 , PTEN , TPM1 and RECK ) are also primarily involved in BC promotion and progression , especially invasion , angiogenesis and metastasis .
1884	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Targets of miR-21 ( TIMP3 , PDCD4 , PTEN , TPM1 and RECK ) are also primarily involved in BC promotion and progression , especially invasion , angiogenesis and metastasis .
1871	mediate	neutral	mir-21	1138.222	737.6486	737.6486	miRNA		Taken together , our findings identified miR-21 as a critical mediator of metastasis in breast cancer through the tumor environment .
1871	mediate	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Taken together , our findings identified miR-21 as a critical mediator of metastasis in breast cancer through the tumor environment .
1869	activate	positive	mir-21	1138.222	737.6486	737.6486	miRNA		Here , we reported that high miR-21 expression was strongly associated with lymph node metastasis in breast cancer , and the activation of the miR-21/NF- ? B was required for the metastatic promoting effect of CAFs .
1869	activate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here , we reported that high miR-21 expression was strongly associated with lymph node metastasis in breast cancer , and the activation of the miR-21/NF- ? B was required for the metastatic promoting effect of CAFs .
1813	inhibit	negative	mir-21	1138.222	737.6486	737.6486	miRNA		In conclusion , we demonstrate that a non-COX inhibitory derivative of sulindac can inhibit breast tumor metastasis by a mechanism involving the TGF?] /miR-21 signaling axis .
1813	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In conclusion , we demonstrate that a non-COX inhibitory derivative of sulindac can inhibit breast tumor metastasis by a mechanism involving the TGF?] /miR-21 signaling axis .
1812	promote	positive	mir-21	1138.222	737.6486	737.6486	miRNA		Moreover , miR-21 , a well-documented oncogenic miRNA for promoting tumor cell metastasis , was also found to be involved in inhibitory activity of SSA in breast tumor cell motility through the modulation of TGF?] pathway .
1812	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Moreover , miR-21 , a well-documented oncogenic miRNA for promoting tumor cell metastasis , was also found to be involved in inhibitory activity of SSA in breast tumor cell motility through the modulation of TGF?] pathway .
1702	downregulate	negative	mir-21	1138.222	737.6486	737.6486	miRNA		We observed that MEG3 was downregulated in cervical cancer tissues , compared to the adjacent normal tissues , and was negatively related with FIGO stages , tumor size , lymphatic metastasis , HR-HPV infection and the expression of homo sapiens microRNA-21 ( miR-21 ) .
1702	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We observed that MEG3 was downregulated in cervical cancer tissues , compared to the adjacent normal tissues , and was negatively related with FIGO stages , tumor size , lymphatic metastasis , HR-HPV infection and the expression of homo sapiens microRNA-21 ( miR-21 ) .
1701	downregulate	negative	mir-21	1138.222	737.6486	737.6486	miRNA		We observed that MEG3 was downregulated in cervical cancer tissues , compared to the adjacent normal tissues , and was negatively related with FIGO stages , tumor size , lymphatic metastasis , HR-HPV infection and the expression of homo sapiens microRNA-21 ( miR-21 ) .
1701	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We observed that MEG3 was downregulated in cervical cancer tissues , compared to the adjacent normal tissues , and was negatively related with FIGO stages , tumor size , lymphatic metastasis , HR-HPV infection and the expression of homo sapiens microRNA-21 ( miR-21 ) .
1528	upregulate	positive	mir-21	1138.222	737.6486	737.6486	miRNA		Upregulation of miR-21 and downregulation of miR-494 may serve as emerging molecular biomarkers for prediagnostic samples of subjects who developed nasopharyngeal carcinoma associates with lymph node metastasis and poor prognosis .
1528	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Upregulation of miR-21 and downregulation of miR-494 may serve as emerging molecular biomarkers for prediagnostic samples of subjects who developed nasopharyngeal carcinoma associates with lymph node metastasis and poor prognosis .
1519	upregulate	positive	mir-21	1138.222	737.6486	737.6486	miRNA		The expression of miR-21-3p and miR-21-5p in HPV positive cervical cancer samples was significantly upregulated compared to that in the paired normal samples ( P < 0.05 ) ; A multivariate analysis demonstrated that the expression of miR-21 was associated with clinicopathological parameters , including depth of invasion and lymph node metastasis .
1519	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The expression of miR-21-3p and miR-21-5p in HPV positive cervical cancer samples was significantly upregulated compared to that in the paired normal samples ( P < 0.05 ) ; A multivariate analysis demonstrated that the expression of miR-21 was associated with clinicopathological parameters , including depth of invasion and lymph node metastasis .
1484	regulate	positive	mir-21	1138.222	737.6486	737.6486	miRNA		Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression , PDCD4 downregulation and breast cancer metastasis .
1484	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression , PDCD4 downregulation and breast cancer metastasis .
1423	regulate	positive	mir-21	1138.222	737.6486	737.6486	miRNA		The LPA1/ZEB1/miR-21-activation pathway regulates metastasis in basal breast cancer .
1423	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The LPA1/ZEB1/miR-21-activation pathway regulates metastasis in basal breast cancer .
1385	promote	positive	mir-21	1138.222	737.6486	737.6486	miRNA		miR-21 is already known as an oncogenic miRNA to promote metastasis , however , the exact functions of other three miRNAs in EMT are unclear .
1385	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-21 is already known as an oncogenic miRNA to promote metastasis , however , the exact functions of other three miRNAs in EMT are unclear .
1220	recognize	neutral	mir-21	1138.222	737.6486	737.6486	miRNA		Recently , miR-21 is found to be aberrantly expressed in CRC and miR-21 has been recognized to perform significantly in CRC , where miR-21 can regulate several different target genes and pathways involving tumor proliferation , invasion and metastasis .
1220	recognize	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Recently , miR-21 is found to be aberrantly expressed in CRC and miR-21 has been recognized to perform significantly in CRC , where miR-21 can regulate several different target genes and pathways involving tumor proliferation , invasion and metastasis .
1167	antagonize	negative	mir-21	1138.222	737.6486	737.6486	miRNA		The current study shows the therapeutic outcome achieved in triple negative breast cancer ( TNBC ) by simultaneously antagonizing miR-21-induced antiapoptosis and miR-10b-induced metastasis , using antisense-miR-21-PS and antisense-miR-10b-PS delivered by polymer nanoparticles ( NPs ) .
1167	antagonize	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The current study shows the therapeutic outcome achieved in triple negative breast cancer ( TNBC ) by simultaneously antagonizing miR-21-induced antiapoptosis and miR-10b-induced metastasis , using antisense-miR-21-PS and antisense-miR-10b-PS delivered by polymer nanoparticles ( NPs ) .
1165	antagonize	negative	mir-21	1138.222	737.6486	737.6486	miRNA		The current study shows the therapeutic outcome achieved in triple negative breast cancer ( TNBC ) by simultaneously antagonizing miR-21-induced antiapoptosis and miR-10b-induced metastasis , using antisense-miR-21-PS and antisense-miR-10b-PS delivered by polymer nanoparticles ( NPs ) .
1165	antagonize	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The current study shows the therapeutic outcome achieved in triple negative breast cancer ( TNBC ) by simultaneously antagonizing miR-21-induced antiapoptosis and miR-10b-induced metastasis , using antisense-miR-21-PS and antisense-miR-10b-PS delivered by polymer nanoparticles ( NPs ) .
1123	inhibit	negative	mir-21	1138.222	737.6486	737.6486	miRNA		Inhibition of NADPH oxidase protected against metastasis of human lung cancer cells by decreasing miR-21 expression , which could facilitate the understanding of lung cancer pathogenesis and provided clues for the development of novel therapeutics for lung cancer patients .
1123	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Inhibition of NADPH oxidase protected against metastasis of human lung cancer cells by decreasing miR-21 expression , which could facilitate the understanding of lung cancer pathogenesis and provided clues for the development of novel therapeutics for lung cancer patients .
1122	effect	neutral	mir-21	1138.222	737.6486	737.6486	miRNA		Decreased expression of miR-21 facilitated the effect of NOX inhibitor on metastasis of human lung cancer in vitro and in vivo .
1122	effect	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Decreased expression of miR-21 facilitated the effect of NOX inhibitor on metastasis of human lung cancer in vitro and in vivo .
1121	effect	neutral	mir-21	1138.222	737.6486	737.6486	miRNA		Increased expression of miR-21 abrogated the effect of NOX inhibitor on metastasis of human lung cancer in vitro and in vivo .
1121	effect	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Increased expression of miR-21 abrogated the effect of NOX inhibitor on metastasis of human lung cancer in vitro and in vivo .
907	block	negative	mir-21	1138.222	737.6486	737.6486	miRNA		These results demonstrated that this type of arene ruthenium ( ii ) complex can block the invadopodia formation by regulating the PTEN/AKT signal pathway mediated by miR-21 to inhibit the invasion and metastasis of breast cancer cells .
907	block	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	These results demonstrated that this type of arene ruthenium ( ii ) complex can block the invadopodia formation by regulating the PTEN/AKT signal pathway mediated by miR-21 to inhibit the invasion and metastasis of breast cancer cells .
820	induce	positive	mir-21	1138.222	737.6486	737.6486	miRNA		In breast phyllodes tumor xenografts , miR-21 accelerated tumor growth , induced myofibroblast differentiation , and promoted metastasis .
820	induce	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In breast phyllodes tumor xenografts , miR-21 accelerated tumor growth , induced myofibroblast differentiation , and promoted metastasis .
774	downregulate	negative	mir-21	1138.222	737.6486	737.6486	miRNA		MicroRNA-21 ( miR-21 ) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation , proliferation , and metastasis in renal cell carcinoma .
774	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-21 ( miR-21 ) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation , proliferation , and metastasis in renal cell carcinoma .
568	enhance	positive	mir-21	1138.222	737.6486	737.6486	miRNA		Enhanced invasion and metastasis , increased miR-21 expression , decreased PTEN , elevated pAKT level were demonstrated in gemcitabine-resistant HPAC and PANC-1 cells .
568	enhance	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Enhanced invasion and metastasis , increased miR-21 expression , decreased PTEN , elevated pAKT level were demonstrated in gemcitabine-resistant HPAC and PANC-1 cells .
567	enhance	positive	mir-21	1138.222	737.6486	737.6486	miRNA		Enhanced invasion and metastasis , increased miR-21 expression , decreased PTEN , elevated pAKT level were demonstrated in gemcitabine-resistant HPAC and PANC-1 cells .
567	enhance	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Enhanced invasion and metastasis , increased miR-21 expression , decreased PTEN , elevated pAKT level were demonstrated in gemcitabine-resistant HPAC and PANC-1 cells .
487	control	neutral	mir-21	1138.222	737.6486	737.6486	miRNA		In conclusion , miR-21 is a key player in oncogenic EMT , its overexpression is controlled by the cooperation of genetic and epigenetic alterations , and its levels , along with ITG?] 4 and PDCD4 expression , could be exploited as a prognostic tool for CRC metastasis .
487	control	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In conclusion , miR-21 is a key player in oncogenic EMT , its overexpression is controlled by the cooperation of genetic and epigenetic alterations , and its levels , along with ITG?] 4 and PDCD4 expression , could be exploited as a prognostic tool for CRC metastasis .
486	control	neutral	mir-21	1138.222	737.6486	737.6486	miRNA		In conclusion , miR-21 is a key player in oncogenic EMT , its overexpression is controlled by the cooperation of genetic and epigenetic alterations , and its levels , along with ITG?] 4 and PDCD4 expression , could be exploited as a prognostic tool for CRC metastasis .
486	control	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In conclusion , miR-21 is a key player in oncogenic EMT , its overexpression is controlled by the cooperation of genetic and epigenetic alterations , and its levels , along with ITG?] 4 and PDCD4 expression , could be exploited as a prognostic tool for CRC metastasis .
419	promote	positive	mir-21	1138.222	737.6486	737.6486	miRNA		Our data suggest that miR-21 could promote metastasis in breast cancer via the regulation of TIMP3 translation , and there was consistency between miR-21 of serum and miR-21 in tissue .
419	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our data suggest that miR-21 could promote metastasis in breast cancer via the regulation of TIMP3 translation , and there was consistency between miR-21 of serum and miR-21 in tissue .
418	promote	positive	mir-21	1138.222	737.6486	737.6486	miRNA		The aim of this study is to determine whether microRNA-21 ( miR-21 ) , a specific microRNA implicated in multiple aspects of carcinogenesis , promoted breast cancer metastasis by regulating the tissue inhibitor of metalloproteinase 3 ( TIMP-3 ) gene .
418	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The aim of this study is to determine whether microRNA-21 ( miR-21 ) , a specific microRNA implicated in multiple aspects of carcinogenesis , promoted breast cancer metastasis by regulating the tissue inhibitor of metalloproteinase 3 ( TIMP-3 ) gene .
416	regulate	positive	mir-21	1138.222	737.6486	737.6486	miRNA		Genetic heterogeneity of breast cancer metastasis may be related to miR-21 regulation of TIMP-3 in translation .
416	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Genetic heterogeneity of breast cancer metastasis may be related to miR-21 regulation of TIMP-3 in translation .
405	regulate	positive	mir-21	1138.222	737.6486	737.6486	miRNA		miR-21 regulates the processes of invasion and metastasis by downregulating multiple tumor/metastatic suppressor genes including PTEN ( phosphatase and tensin homolog ) .
405	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-21 regulates the processes of invasion and metastasis by downregulating multiple tumor/metastatic suppressor genes including PTEN ( phosphatase and tensin homolog ) .
388	downregulate	negative	mir-21	1138.222	737.6486	737.6486	miRNA		In addition , miR-21 downregulation induced by MMP-8 increases the levels of tumor suppressors such as programmed cell death 4 , which may also contribute to the decrease in tumor formation and metastasis of breast cancer cells overexpressing this metalloproteinase .
388	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In addition , miR-21 downregulation induced by MMP-8 increases the levels of tumor suppressors such as programmed cell death 4 , which may also contribute to the decrease in tumor formation and metastasis of breast cancer cells overexpressing this metalloproteinase .
283	regulate	positive	mir-21	1138.222	737.6486	737.6486	miRNA		The Rac-controlled regulator of invasion and metastasis , T-cell lymphoma invasion and metastasis 1 ( TIAM1 ) , was identified as a miR-21 target additionally downregulated by T ( 3 ) .
283	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The Rac-controlled regulator of invasion and metastasis , T-cell lymphoma invasion and metastasis 1 ( TIAM1 ) , was identified as a miR-21 target additionally downregulated by T ( 3 ) .
276	suppress	negative	mir-21	1138.222	737.6486	737.6486	miRNA		These results indicated that miR-21 plays a role in the carcinogenesis and metastasis of O. viverrini-associated CCA by suppressing the function of PDCD4 .
276	suppress	negative	osteosarcoma cells	1157.953	712.69	712.69	Cancer	D063646	These results indicated that miR-21 plays a role in the carcinogenesis and metastasis of O. viverrini-associated CCA by suppressing the function of PDCD4 .
275	suppress	negative	mir-21	1138.222	737.6486	737.6486	miRNA		These results indicated that miR-21 plays a role in the carcinogenesis and metastasis of O. viverrini-associated CCA by suppressing the function of PDCD4 .
275	suppress	negative	osteosarcoma cells	1157.953	712.69	712.69	Cancer	D063646	These results indicated that miR-21 plays a role in the carcinogenesis and metastasis of O. viverrini-associated CCA by suppressing the function of PDCD4 .
164	promote	positive	mir-21	1138.222	737.6486	737.6486	miRNA		MicroRNA-21 ( miR-21 ) expression promotes growth , metastasis , and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN .
164	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-21 ( miR-21 ) expression promotes growth , metastasis , and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN .
163	promote	positive	mir-21	1138.222	737.6486	737.6486	miRNA		MicroRNA-21 ( miR-21 ) expression promotes growth , metastasis , and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN .
163	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-21 ( miR-21 ) expression promotes growth , metastasis , and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN .
123	control	neutral	mir-21	1138.222	737.6486	737.6486	miRNA		Metastasis was associated with mir-21 expression in serum ( P < 0.05 ) , ESCC patients with metastasis having 8.4-fold higher serum miR-21 concentrations than healthy controls .
123	control	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Metastasis was associated with mir-21 expression in serum ( P < 0.05 ) , ESCC patients with metastasis having 8.4-fold higher serum miR-21 concentrations than healthy controls .
122	control	neutral	mir-21	1138.222	737.6486	737.6486	miRNA		Metastasis was associated with mir-21 expression in serum ( P < 0.05 ) , ESCC patients with metastasis having 8.4-fold higher serum miR-21 concentrations than healthy controls .
122	control	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Metastasis was associated with mir-21 expression in serum ( P < 0.05 ) , ESCC patients with metastasis having 8.4-fold higher serum miR-21 concentrations than healthy controls .
101	enhance	positive	mir-21	1138.222	737.6486	737.6486	miRNA		The enhanced abundance of microRNA-21 ( miR-21 ) in breast cancer cells contributes to the growth and metastasis .
101	enhance	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The enhanced abundance of microRNA-21 ( miR-21 ) in breast cancer cells contributes to the growth and metastasis .
97	induce	positive	mir-21	1138.222	737.6486	737.6486	miRNA		Here , we demonstrate that the miR-21 , miR-17 and miR-19a expressions induced by PRL-3 are involved in the proliferation and metastasis of colon cancer .
97	induce	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here , we demonstrate that the miR-21 , miR-17 and miR-19a expressions induced by PRL-3 are involved in the proliferation and metastasis of colon cancer .
94	induce	positive	mir-21	1138.222	737.6486	737.6486	miRNA		miR-21 , miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer .
94	induce	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-21 , miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer .
90	induction	positive	mir-21	1138.222	737.6486	737.6486	miRNA		EMT and induction of miR-21 mediate metastasis development in Trp53-deficient tumours .
90	induction	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	EMT and induction of miR-21 mediate metastasis development in Trp53-deficient tumours .
76	activate	positive	mir-21	1138.222	737.6486	737.6486	miRNA		Our data support a critical role of DNA damage-induced NF-庥B activation in promoting cancer metastasis following genotoxic treatment , and NF-庥B-dependent miR-21 induction may contribute to both therapeutic resistance and metastasis in breast cancer .
76	activate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our data support a critical role of DNA damage-induced NF-庥B activation in promoting cancer metastasis following genotoxic treatment , and NF-庥B-dependent miR-21 induction may contribute to both therapeutic resistance and metastasis in breast cancer .
1529	upregulate	positive	mir-494	1141.634	733.588	733.588	miRNA		Upregulation of miR-21 and downregulation of miR-494 may serve as emerging molecular biomarkers for prediagnostic samples of subjects who developed nasopharyngeal carcinoma associates with lymph node metastasis and poor prognosis .
1529	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Upregulation of miR-21 and downregulation of miR-494 may serve as emerging molecular biomarkers for prediagnostic samples of subjects who developed nasopharyngeal carcinoma associates with lymph node metastasis and poor prognosis .
1291	regulate	positive	mir-494	1141.634	733.588	733.588	miRNA		Together , our data suggest that Pttg1 may increase CC cell metastasis , which is negatively regulated by miR-494 .
1291	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Together , our data suggest that Pttg1 may increase CC cell metastasis , which is negatively regulated by miR-494 .
967	upregulate	positive	mir-494	1141.634	733.588	733.588	miRNA		Thus , for the first time , we provided convincing evidence that upregulation of miR-494 was associated with tumor aggressiveness and tumor metastasis and promoted cell migration and invasion by targeting PTEN gene in colorectal cancer , and miR-494 is an independent prognostic marker for colorectal cancer patients .
967	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Thus , for the first time , we provided convincing evidence that upregulation of miR-494 was associated with tumor aggressiveness and tumor metastasis and promoted cell migration and invasion by targeting PTEN gene in colorectal cancer , and miR-494 is an independent prognostic marker for colorectal cancer patients .
627	regulate	positive	mir-494	1141.634	733.588	733.588	miRNA		This study was to confirm that miR-494-3p might be a potentially post-transcriptional regulator of CXCR4 and over-expression of miR-494 might suppress prostate cancer progression and metastasis .
627	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	This study was to confirm that miR-494-3p might be a potentially post-transcriptional regulator of CXCR4 and over-expression of miR-494 might suppress prostate cancer progression and metastasis .
75	inhibit	negative	mir-494	1141.634	733.588	733.588	miRNA		Knockdown of miR-494 significantly reversed the activity of MDSCs and inhibited the tumor growth and metastasis of 4T1 murine breast cancer in vivo .
75	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Knockdown of miR-494 significantly reversed the activity of MDSCs and inhibited the tumor growth and metastasis of 4T1 murine breast cancer in vivo .
1625	control	neutral	mir-214	1144.997	729.4869	729.4869	miRNA		Collectively , this study uncovers a previously unappreciated miR-214-Sufu pathway in controlling EMT and metastasis of LAD and suggests that interfering with miR-214 and Sufu could be a viable approach to treat late stage metastatic LAD patients .
1625	control	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Collectively , this study uncovers a previously unappreciated miR-214-Sufu pathway in controlling EMT and metastasis of LAD and suggests that interfering with miR-214 and Sufu could be a viable approach to treat late stage metastatic LAD patients .
1624	control	neutral	mir-214	1144.997	729.4869	729.4869	miRNA		Collectively , this study uncovers a previously unappreciated miR-214-Sufu pathway in controlling EMT and metastasis of LAD and suggests that interfering with miR-214 and Sufu could be a viable approach to treat late stage metastatic LAD patients .
1624	control	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Collectively , this study uncovers a previously unappreciated miR-214-Sufu pathway in controlling EMT and metastasis of LAD and suggests that interfering with miR-214 and Sufu could be a viable approach to treat late stage metastatic LAD patients .
1623	promote	positive	mir-214	1144.997	729.4869	729.4869	miRNA		Mechanistically , Sufu was identified as an important miR-214 functional target for the EMT and metastasis of LAD , ectopic expression of Sufu alleviated miR-214 promoted EMT and metastasis .
1623	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Mechanistically , Sufu was identified as an important miR-214 functional target for the EMT and metastasis of LAD , ectopic expression of Sufu alleviated miR-214 promoted EMT and metastasis .
1622	promote	positive	mir-214	1144.997	729.4869	729.4869	miRNA		Mechanistically , Sufu was identified as an important miR-214 functional target for the EMT and metastasis of LAD , ectopic expression of Sufu alleviated miR-214 promoted EMT and metastasis .
1622	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Mechanistically , Sufu was identified as an important miR-214 functional target for the EMT and metastasis of LAD , ectopic expression of Sufu alleviated miR-214 promoted EMT and metastasis .
1621	enhance	positive	mir-214	1144.997	729.4869	729.4869	miRNA		In addition , we found that miR-214 enhanced the molecular program controlling the EMT of LAD cells and promoted LAD cell metastasis both in vitro and in vivo .
1621	enhance	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In addition , we found that miR-214 enhanced the molecular program controlling the EMT of LAD cells and promoted LAD cell metastasis both in vitro and in vivo .
1620	enhance	positive	mir-214	1144.997	729.4869	729.4869	miRNA		In addition , we found that miR-214 enhanced the molecular program controlling the EMT of LAD cells and promoted LAD cell metastasis both in vitro and in vivo .
1620	enhance	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In addition , we found that miR-214 enhanced the molecular program controlling the EMT of LAD cells and promoted LAD cell metastasis both in vitro and in vivo .
693	downregulate	negative	mir-214	1144.997	729.4869	729.4869	miRNA		For example , deficiencies of enzymes including Dicer and Drosha that are required for miRNA biogenesis may be adverse prognostic factors ; miRNAs such as miR-214 and miR-31 , which are involved in drug resistance , and the miR-200 family , which is implicated in metastasis , may serve as biomarkers ; and transfection of downregulated miRNAs and inhibition of upregulated miRNAs may be effective for treatment of ovarian cancer .
693	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	For example , deficiencies of enzymes including Dicer and Drosha that are required for miRNA biogenesis may be adverse prognostic factors ; miRNAs such as miR-214 and miR-31 , which are involved in drug resistance , and the miR-200 family , which is implicated in metastasis , may serve as biomarkers ; and transfection of downregulated miRNAs and inhibition of upregulated miRNAs may be effective for treatment of ovarian cancer .
616	downregulate	negative	mir-214	1144.997	729.4869	729.4869	miRNA		Down-regulation of miR-214 expression was correlated with increased FGFR1 expression levels , which may contribute to increased CRC liver metastasis .
616	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Down-regulation of miR-214 expression was correlated with increased FGFR1 expression levels , which may contribute to increased CRC liver metastasis .
615	downregulate	negative	mir-214	1144.997	729.4869	729.4869	miRNA		Down-regulation of miR-214 expression was correlated with increased FGFR1 expression levels , which may contribute to increased CRC liver metastasis .
615	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Down-regulation of miR-214 expression was correlated with increased FGFR1 expression levels , which may contribute to increased CRC liver metastasis .
614	suppress	negative	mir-214	1144.997	729.4869	729.4869	miRNA		Ectopic expression of miR-214 suppressed proliferation , migration , and invasion in vitro , tumor growth and liver metastasis in an in vivo xenograft mouse model , whereas miR-214 knockdown promoted proliferation , migration , and invasion in CRC cell lines .
614	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Ectopic expression of miR-214 suppressed proliferation , migration , and invasion in vitro , tumor growth and liver metastasis in an in vivo xenograft mouse model , whereas miR-214 knockdown promoted proliferation , migration , and invasion in CRC cell lines .
134	promote	positive	mir-214	1144.997	729.4869	729.4869	miRNA		These findings suggest that decreased expression of miR-98 and miR-214 might promote metastasis of human ESCC by inducing accumulation of EZH2 protein .
134	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	These findings suggest that decreased expression of miR-98 and miR-214 might promote metastasis of human ESCC by inducing accumulation of EZH2 protein .
74	regulate	positive	mir-214	1144.997	729.4869	729.4869	miRNA		These results suggest an important role for miR-214 in regulating metastasis of intrahepatic cholangiocarcinoma , and potential application of miR-214 in intrahepatic cholangiocarcinoma therapy .
74	regulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	These results suggest an important role for miR-214 in regulating metastasis of intrahepatic cholangiocarcinoma , and potential application of miR-214 in intrahepatic cholangiocarcinoma therapy .
73	inhibit	negative	mir-214	1144.997	729.4869	729.4869	miRNA		Inhibition of miR-214 levels by its inhibitor promoted metastasis of human intrahepatic cholangiocarcinoma cell .
73	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Inhibition of miR-214 levels by its inhibitor promoted metastasis of human intrahepatic cholangiocarcinoma cell .
72	downregulate	negative	mir-214	1144.997	729.4869	729.4869	miRNA		Down-regulation of miR-214 contributes to intrahepatic cholangiocarcinoma metastasis by targeting Twist .
72	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Down-regulation of miR-214 contributes to intrahepatic cholangiocarcinoma metastasis by targeting Twist .
2015	regulate	positive	mir-10b	1148.311	725.346	725.346	miRNA		In this article , I have focused on the role of HA interaction with CD44 and several important signaling molecules in the regulation of unique miRNAs ( e.g. , miR-21 , miR-302 and miR-10b ) and their downstream targets leading to multiple tumor cell-specific functions ( e.g. , tumor cell growth , drug resistance and metastasis ) and cancer progression .
2015	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In this article , I have focused on the role of HA interaction with CD44 and several important signaling molecules in the regulation of unique miRNAs ( e.g. , miR-21 , miR-302 and miR-10b ) and their downstream targets leading to multiple tumor cell-specific functions ( e.g. , tumor cell growth , drug resistance and metastasis ) and cancer progression .
1497	effect	neutral	mir-10b	1148.311	725.346	725.346	miRNA		Herein , we evaluated the effect of SEB on the expression of two master microRNAs , mir-335 and mir-10b , involved in metastasis .
1497	effect	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Herein , we evaluated the effect of SEB on the expression of two master microRNAs , mir-335 and mir-10b , involved in metastasis .
1483	regulate	positive	mir-10b	1148.311	725.346	725.346	miRNA		We investigated the expression patterns of miRNAs , including miR-10b , 21 , 200c , 373 and 520c , which regulate epithelial-to-mesenchymal transition ( EMT ) and metastasis in isolated cancer stem cells ( CSCs ) and non- CSCs .
1483	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	We investigated the expression patterns of miRNAs , including miR-10b , 21 , 200c , 373 and 520c , which regulate epithelial-to-mesenchymal transition ( EMT ) and metastasis in isolated cancer stem cells ( CSCs ) and non- CSCs .
1482	regulate	positive	mir-10b	1148.311	725.346	725.346	miRNA		We investigated the expression patterns of miRNAs , including miR-10b , 21 , 200c , 373 and 520c , which regulate epithelial-to-mesenchymal transition ( EMT ) and metastasis in isolated cancer stem cells ( CSCs ) and non- CSCs .
1482	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	We investigated the expression patterns of miRNAs , including miR-10b , 21 , 200c , 373 and 520c , which regulate epithelial-to-mesenchymal transition ( EMT ) and metastasis in isolated cancer stem cells ( CSCs ) and non- CSCs .
1471	control	neutral	mir-10b	1148.311	725.346	725.346	miRNA		Based on the results obtained in the last decade , some miRNAs are emerging as biomarkers of BC for diagnosis ( i.e. , miR-9 , miR-10b , and miR-17-5p ) , prognosis ( i.e. , miR-148a and miR-335 ) , and prediction of therapeutic outcomes ( i.e. , miR-30c , miR-187 , and miR-339-5p ) and have important roles in the control of BC hallmark functions such as invasion , metastasis , proliferation , resting death , apoptosis , and genomic instability .
1471	control	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Based on the results obtained in the last decade , some miRNAs are emerging as biomarkers of BC for diagnosis ( i.e. , miR-9 , miR-10b , and miR-17-5p ) , prognosis ( i.e. , miR-148a and miR-335 ) , and prediction of therapeutic outcomes ( i.e. , miR-30c , miR-187 , and miR-339-5p ) and have important roles in the control of BC hallmark functions such as invasion , metastasis , proliferation , resting death , apoptosis , and genomic instability .
1168	antagonize	negative	mir-10b	1148.311	725.346	725.346	miRNA		The current study shows the therapeutic outcome achieved in triple negative breast cancer ( TNBC ) by simultaneously antagonizing miR-21-induced antiapoptosis and miR-10b-induced metastasis , using antisense-miR-21-PS and antisense-miR-10b-PS delivered by polymer nanoparticles ( NPs ) .
1168	antagonize	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The current study shows the therapeutic outcome achieved in triple negative breast cancer ( TNBC ) by simultaneously antagonizing miR-21-induced antiapoptosis and miR-10b-induced metastasis , using antisense-miR-21-PS and antisense-miR-10b-PS delivered by polymer nanoparticles ( NPs ) .
1166	antagonize	negative	mir-10b	1148.311	725.346	725.346	miRNA		The current study shows the therapeutic outcome achieved in triple negative breast cancer ( TNBC ) by simultaneously antagonizing miR-21-induced antiapoptosis and miR-10b-induced metastasis , using antisense-miR-21-PS and antisense-miR-10b-PS delivered by polymer nanoparticles ( NPs ) .
1166	antagonize	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The current study shows the therapeutic outcome achieved in triple negative breast cancer ( TNBC ) by simultaneously antagonizing miR-21-induced antiapoptosis and miR-10b-induced metastasis , using antisense-miR-21-PS and antisense-miR-10b-PS delivered by polymer nanoparticles ( NPs ) .
591	suppress	negative	mir-10b	1148.311	725.346	725.346	miRNA		Furthermore , we found that E-cadherin and MMP14 may be the downstream factors of KLF4 and HOXD10 in the suppression of BC metastasis by miR-10b .
591	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Furthermore , we found that E-cadherin and MMP14 may be the downstream factors of KLF4 and HOXD10 in the suppression of BC metastasis by miR-10b .
590	promote	positive	mir-10b	1148.311	725.346	725.346	miRNA		In vivo metastasis assay demonstrated that overexpression of miR-10b markedly promoted BC metastasis .
590	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In vivo metastasis assay demonstrated that overexpression of miR-10b markedly promoted BC metastasis .
589	promote	positive	mir-10b	1148.311	725.346	725.346	miRNA		In vivo metastasis assay was performed to validate if miR-10b can promote BC cell line metastasis in vivo .
589	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In vivo metastasis assay was performed to validate if miR-10b can promote BC cell line metastasis in vivo .
71	regulate	positive	mir-10b	1148.311	725.346	725.346	miRNA		These results suggest that miR-10b may positively regulate the invasion and metastasis of HCC through targeting CADM1 .
71	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	These results suggest that miR-10b may positively regulate the invasion and metastasis of HCC through targeting CADM1 .
856	promote	positive	mir-151	1151.575	721.1658	721.1658	miRNA		MiR-151 is aberrantly overexpressed in HCC cells and promotes HCC metastasis yet its roles on HCC tumorigenicity are unknown .
856	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-151 is aberrantly overexpressed in HCC cells and promotes HCC metastasis yet its roles on HCC tumorigenicity are unknown .
70	upregulate	positive	mir-151	1151.575	721.1658	721.1658	miRNA		In aggregate , these data suggest that miR-151-5p upregulation may suppress metastasis in primary breast tumors .
70	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In aggregate , these data suggest that miR-151-5p upregulation may suppress metastasis in primary breast tumors .
69	regulate	positive	mir-1258	1154.789	716.947	716.947	miRNA		The miR-1258 regulates the expression level of HPSE to influence the morbidity and metastasis of NSCLC .
69	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The miR-1258 regulates the expression level of HPSE to influence the morbidity and metastasis of NSCLC .
374	regulate	positive	mir-335	1238.657	518.671	518.671	miRNA		miR-335 and miR-363 regulation of neuroblastoma tumorigenesis and metastasis .
374	regulate	positive	osteosarcoma cells	1157.953	712.69	712.69	Cancer	D063646	miR-335 and miR-363 regulation of neuroblastoma tumorigenesis and metastasis .
274	regulate	positive	microrna-21	1213.905	610.6822	610.6822	miRNA		Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis .
274	regulate	positive	osteosarcoma cells	1157.953	712.69	712.69	Cancer	D063646	Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis .
65	inhibit	negative	mir-145	1205.758	630.268	630.268	miRNA		Therefore , it can be concluded that miR-145 can inhibit invasion and metastasis of osteosarcoma cells .
65	inhibit	negative	osteosarcoma cells	1157.953	712.69	712.69	Cancer	D063646	Therefore , it can be concluded that miR-145 can inhibit invasion and metastasis of osteosarcoma cells .
64	inhibit	negative	microrna-145	1161.065	708.3955	708.3955	miRNA		MicroRNA-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of osteosarcoma cells .
64	inhibit	negative	osteosarcoma cells	1157.953	712.69	712.69	Cancer	D063646	MicroRNA-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of osteosarcoma cells .
1723	suppress	negative	microrna-145	1161.065	708.3955	708.3955	miRNA		MicroRNA-145 Suppresses Osteosarcoma Metastasis via Targeting MMP16 .
1723	suppress	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	MicroRNA-145 Suppresses Osteosarcoma Metastasis via Targeting MMP16 .
1085	inhibit	negative	microrna-145	1161.065	708.3955	708.3955	miRNA		MicroRNA-145 inhibits lung cancer cell metastasis .
1085	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-145 inhibits lung cancer cell metastasis .
855	upregulate	positive	microrna-145	1161.065	708.3955	708.3955	miRNA		Up-regulation of microRNA-145 associates with lymph node metastasis in colorectal cancer .
855	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Up-regulation of microRNA-145 associates with lymph node metastasis in colorectal cancer .
625	inhibit	negative	microrna-145	1161.065	708.3955	708.3955	miRNA		MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1 .
625	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1 .
201	inhibit	negative	microrna-145	1161.065	708.3955	708.3955	miRNA		MicroRNA-145 inhibits the growth , invasion , metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha .
201	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-145 inhibits the growth , invasion , metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha .
1952	promote	positive	mir-26a	1164.125	704.0642	704.0642	miRNA		Thus , our data showed that two genes promoting metastasis , LOXL2 and PLOD2 , were epigenetically regulated by tumor-suppressive microRNAs , miR-26a and miR-26b , providing important insights into the molecular mechanisms of RCC metastasis .
1952	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Thus , our data showed that two genes promoting metastasis , LOXL2 and PLOD2 , were epigenetically regulated by tumor-suppressive microRNAs , miR-26a and miR-26b , providing important insights into the molecular mechanisms of RCC metastasis .
1936	coexpress	neutral	mir-26a	1164.125	704.0642	704.0642	miRNA		Co-expression of miR-26a and miR-144 in ESCC cells resulted in inhibition of proliferation and metastasis in vitro and in vivo , suggesting that targeting COX-2 may be the mechanism of these two miRNAs .
1936	coexpress	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Co-expression of miR-26a and miR-144 in ESCC cells resulted in inhibition of proliferation and metastasis in vitro and in vivo , suggesting that targeting COX-2 may be the mechanism of these two miRNAs .
1934	inhibit	negative	mir-26a	1164.125	704.0642	704.0642	miRNA		MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2 .
1934	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2 .
1887	react	neutral	mir-26a	1164.125	704.0642	704.0642	miRNA		In the present study , the role of miR-26a in the progression and metastasis of OS was investigated using reverse transcription-quantitative polymerase chain reaction , a luciferase activity assay , cell viability assay , in vitro migration and invasion assays , transfection and western blot analysis .
1887	react	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	In the present study , the role of miR-26a in the progression and metastasis of OS was investigated using reverse transcription-quantitative polymerase chain reaction , a luciferase activity assay , cell viability assay , in vitro migration and invasion assays , transfection and western blot analysis .
1801	downregulate	negative	mir-26a	1164.125	704.0642	704.0642	miRNA		Down-regulation of miR-26a in HCCLM3 and HepG2 cells resulted in an EMT-like cell morphology and high motility in vitro and increased in tumor growth and pulmonary metastasis in vivo .
1801	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Down-regulation of miR-26a in HCCLM3 and HepG2 cells resulted in an EMT-like cell morphology and high motility in vitro and increased in tumor growth and pulmonary metastasis in vivo .
1800	downregulate	negative	mir-26a	1164.125	704.0642	704.0642	miRNA		Down-regulation of miR-26a in HCCLM3 and HepG2 cells resulted in an EMT-like cell morphology and high motility in vitro and increased in tumor growth and pulmonary metastasis in vivo .
1800	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Down-regulation of miR-26a in HCCLM3 and HepG2 cells resulted in an EMT-like cell morphology and high motility in vitro and increased in tumor growth and pulmonary metastasis in vivo .
1054	inhibit	negative	mir-26a	1164.125	704.0642	704.0642	miRNA		We also found that the ectopic expression of miR-26a inhibited TNBC cell proliferation and metastasis in vitro and in vivo by downregulating MTDH ( a miR-26a ' target gene ) mRNA and protein and that the overexpression of MTDH could partially abrogate miR-26a-mediated suppression .
1054	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We also found that the ectopic expression of miR-26a inhibited TNBC cell proliferation and metastasis in vitro and in vivo by downregulating MTDH ( a miR-26a ' target gene ) mRNA and protein and that the overexpression of MTDH could partially abrogate miR-26a-mediated suppression .
1053	downregulate	negative	mir-26a	1164.125	704.0642	704.0642	miRNA		In this study , we found that miR-26a was downregulated in triple-negative breast cancer ( TNBC ) , and its expression levels were associated with lymph node metastasis and overall survival in TNBC .
1053	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In this study , we found that miR-26a was downregulated in triple-negative breast cancer ( TNBC ) , and its expression levels were associated with lymph node metastasis and overall survival in TNBC .
1052	suppress	negative	mir-26a	1164.125	704.0642	704.0642	miRNA		miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer .
1052	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer .
819	inhibit	negative	mir-26a	1164.125	704.0642	704.0642	miRNA		Next , by lentivirus-mediated gain-of-function studies , it was showed that stable miR-26a inhibited cell proliferation , metastasis , and epithelial mesenchymal transition and induced G1 phase arrest in prostate cancer .
819	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Next , by lentivirus-mediated gain-of-function studies , it was showed that stable miR-26a inhibited cell proliferation , metastasis , and epithelial mesenchymal transition and induced G1 phase arrest in prostate cancer .
566	downregulate	negative	mir-26a	1164.125	704.0642	704.0642	miRNA		Thus , for the first time , we provide convincing evidence that downregulation of miR-26a is associated with tumor aggressiveness and tumor metastasis , and miR-26a inhibits cell migration and invasion by targeting the EZH2 gene in osteosarcoma .
566	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Thus , for the first time , we provide convincing evidence that downregulation of miR-26a is associated with tumor aggressiveness and tumor metastasis , and miR-26a inhibits cell migration and invasion by targeting the EZH2 gene in osteosarcoma .
565	downregulate	negative	mir-26a	1164.125	704.0642	704.0642	miRNA		In addition , downregulation of miR-26a more frequently occurred in osteosarcoma specimens with adverse clinical stage and with the presence of distant metastasis .
565	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	In addition , downregulation of miR-26a more frequently occurred in osteosarcoma specimens with adverse clinical stage and with the presence of distant metastasis .
446	inhibit	negative	mir-26a	1164.125	704.0642	704.0642	miRNA		We also found that ectopic expression of miR-26a inhibited GC cell proliferation and GC metastasis in vitro and in vivo .
446	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	We also found that ectopic expression of miR-26a inhibited GC cell proliferation and GC metastasis in vitro and in vivo .
445	downregulate	negative	mir-26a	1164.125	704.0642	704.0642	miRNA		In this study , we found that miR-26a was strongly downregulated in gastric cancer ( GC ) tissues and cell lines , and its expression levels were associated with lymph node metastasis and clinical stage , as well as overall survival and replase-free survival of GC .
445	downregulate	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	In this study , we found that miR-26a was strongly downregulated in gastric cancer ( GC ) tissues and cell lines , and its expression levels were associated with lymph node metastasis and clinical stage , as well as overall survival and replase-free survival of GC .
444	suppress	negative	mir-26a	1164.125	704.0642	704.0642	miRNA		miR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer .
444	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	miR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer .
314	inhibit	negative	mir-26a	1164.125	704.0642	704.0642	miRNA		miR-26a inhibits invasion and metastasis of nasopharyngeal cancer by targeting EZH2 .
314	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-26a inhibits invasion and metastasis of nasopharyngeal cancer by targeting EZH2 .
261	suppress	negative	mir-26a	1164.125	704.0642	704.0642	miRNA		miR-26a could suppress tumor growth and metastasis of HCC through IL-6-Stat3 signaling and is a novel prognostic marker and therapeutic target for HCC .
261	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-26a could suppress tumor growth and metastasis of HCC through IL-6-Stat3 signaling and is a novel prognostic marker and therapeutic target for HCC .
260	suppress	negative	mir-26a	1164.125	704.0642	704.0642	miRNA		Importantly , miR-26a suppressed in vivo tumor growth and metastasis in nude mice models bearing human HCC .
260	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Importantly , miR-26a suppressed in vivo tumor growth and metastasis in nude mice models bearing human HCC .
259	downregulate	negative	mir-26a	1164.125	704.0642	704.0642	miRNA		Down-regulation of miR-26a correlated with HCC recurrence and metastasis .
259	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Down-regulation of miR-26a correlated with HCC recurrence and metastasis .
258	downregulate	negative	mir-26a	1164.125	704.0642	704.0642	miRNA		In this study , we investigated the roles of miR-26a in tumor growth and metastasis of HCC and found that miR-26a was frequently down-regulated in HCC tissues .
258	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In this study , we investigated the roles of miR-26a in tumor growth and metastasis of HCC and found that miR-26a was frequently down-regulated in HCC tissues .
191	downregulate	negative	mir-26a	1164.125	704.0642	704.0642	miRNA		Results of qRT-PCR in clinical samples showed that downregulated miR-26a expression is related to tumorigenesis and metastasis of EA .
191	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Results of qRT-PCR in clinical samples showed that downregulated miR-26a expression is related to tumorigenesis and metastasis of EA .
139	enhance	positive	mir-26a	1164.125	704.0642	704.0642	miRNA		Our study demonstrated that miR-26a enhanced lung cancer cell metastasis potential via modulation of metastasis-related gene expression , and activation of AKT pathway by PTEN suppression , suggesting that miR-26a might be a potential therapeutic candidate in patients with metastatic lung cancer .
139	enhance	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Our study demonstrated that miR-26a enhanced lung cancer cell metastasis potential via modulation of metastasis-related gene expression , and activation of AKT pathway by PTEN suppression , suggesting that miR-26a might be a potential therapeutic candidate in patients with metastatic lung cancer .
138	enhance	positive	mir-26a	1164.125	704.0642	704.0642	miRNA		Our study demonstrated that miR-26a enhanced lung cancer cell metastasis potential via modulation of metastasis-related gene expression , and activation of AKT pathway by PTEN suppression , suggesting that miR-26a might be a potential therapeutic candidate in patients with metastatic lung cancer .
138	enhance	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Our study demonstrated that miR-26a enhanced lung cancer cell metastasis potential via modulation of metastasis-related gene expression , and activation of AKT pathway by PTEN suppression , suggesting that miR-26a might be a potential therapeutic candidate in patients with metastatic lung cancer .
137	effect	neutral	mir-26a	1164.125	704.0642	704.0642	miRNA		In the present study , we investigated the effect of miR-26a on metastasis potential of lung cancer cells .
137	effect	neutral	gc	1242.449	487.0825	487.0825	Cancer	D061325	In the present study , we investigated the effect of miR-26a on metastasis potential of lung cancer cells .
136	enhance	positive	mir-26a	1164.125	704.0642	704.0642	miRNA		MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN .
136	enhance	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN .
63	inhibit	negative	mir-26a	1164.125	704.0642	704.0642	miRNA		Meanwhile , the overexpression of miR-26a in the A549 human lung cancer cell line dramatically inhibited cell proliferation , blocked G1/S phase transition , induced apoptosis , and inhibited cell metastasis and invasion in ? vitro .
63	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Meanwhile , the overexpression of miR-26a in the A549 human lung cancer cell line dramatically inhibited cell proliferation , blocked G1/S phase transition , induced apoptosis , and inhibited cell metastasis and invasion in ? vitro .
1765	inhibit	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		These findings indicate that miR-34a inhibits breast cancer progression and metastasis through targeting TPD52 .
1765	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	These findings indicate that miR-34a inhibits breast cancer progression and metastasis through targeting TPD52 .
1629	inhibit	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		Therefore , we concluded that miR-34a could inhibit tumor invasion and metastasis in gastric cancer by targeting Tgif2 and may be a novel therapeutic candidate for gastric cancer .
1629	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Therefore , we concluded that miR-34a could inhibit tumor invasion and metastasis in gastric cancer by targeting Tgif2 and may be a novel therapeutic candidate for gastric cancer .
1628	inhibit	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		To study how miR-34a acts as a tumor suppressor in inhibiting the invasion and metastasis of the gastric cancer cells .
1628	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	To study how miR-34a acts as a tumor suppressor in inhibiting the invasion and metastasis of the gastric cancer cells .
1548	inhibit	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		MiR-34a inhibits colon cancer proliferation and metastasis by inhibiting platelet-derived growth factor receptor 帢 .
1548	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-34a inhibits colon cancer proliferation and metastasis by inhibiting platelet-derived growth factor receptor 帢 .
1541	downregulate	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		Here , we report that chitosan nanoparticle-mediated delivery of miR-34a , a tumor suppressive microRNA that downregulates multiple gene products involved in PCa progression and metastasis , inhibited prostate tumor growth and preserved bone integrity in a xenograft model representative of established PCa bone metastasis .
1541	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here , we report that chitosan nanoparticle-mediated delivery of miR-34a , a tumor suppressive microRNA that downregulates multiple gene products involved in PCa progression and metastasis , inhibited prostate tumor growth and preserved bone integrity in a xenograft model representative of established PCa bone metastasis .
1491	inhibit	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		This Registered report describes the proposed replication plan of key experiments from 'The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 ' by Liu and colleagues published in Nature Medicine in 2011 ( Liu et al. , 2011 ) .
1491	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	This Registered report describes the proposed replication plan of key experiments from 'The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 ' by Liu and colleagues published in Nature Medicine in 2011 ( Liu et al. , 2011 ) .
1490	inhibit	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		Registered report : the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 .
1490	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Registered report : the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 .
1428	suppress	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		Moreover , ectopic miR-34a suppressed tumor growth and metastasis of CRC cells in vivo .
1428	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Moreover , ectopic miR-34a suppressed tumor growth and metastasis of CRC cells in vivo .
1420	promote	positive	mir-34a	1167.134	699.6966	699.6966	miRNA		We previously reported that IL-6R , STAT3 and miR-34a form a positive feedback-loop , which promotes epithelial to mesenchymal transition ( EMT ) , invasion , and metastasis of colorectal cancer ( CRC ) [ 1 ] .
1420	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We previously reported that IL-6R , STAT3 and miR-34a form a positive feedback-loop , which promotes epithelial to mesenchymal transition ( EMT ) , invasion , and metastasis of colorectal cancer ( CRC ) [ 1 ] .
1419	promote	positive	mir-34a	1167.134	699.6966	699.6966	miRNA		We previously reported that IL-6R , STAT3 and miR-34a form a positive feedback-loop , which promotes epithelial to mesenchymal transition ( EMT ) , invasion , and metastasis of colorectal cancer ( CRC ) [ 1 ] .
1419	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We previously reported that IL-6R , STAT3 and miR-34a form a positive feedback-loop , which promotes epithelial to mesenchymal transition ( EMT ) , invasion , and metastasis of colorectal cancer ( CRC ) [ 1 ] .
1349	inhibit	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		Next , it was showed that miR-34a overexpression in oral cancer cells could inhibit cell proliferation , G1 phase arrest , metastasis and epithelial mesenchymal transition .
1349	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Next , it was showed that miR-34a overexpression in oral cancer cells could inhibit cell proliferation , G1 phase arrest , metastasis and epithelial mesenchymal transition .
1219	inhibit	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		Taken together , these findings indicate that miR-34a targets AREG , and is essential in inhibition of HNSCC metastasis .
1219	inhibit	negative	hnscc	1221.107	590.7296	590.7296	Cancer	D006258	Taken together , these findings indicate that miR-34a targets AREG , and is essential in inhibition of HNSCC metastasis .
1218	suppress	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		HNSCC metastasis was found to be strongly suppressed in vitro and in vivo by over-expressing miR-34a .
1218	suppress	negative	hnscc	1221.107	590.7296	590.7296	Cancer	D006258	HNSCC metastasis was found to be strongly suppressed in vitro and in vivo by over-expressing miR-34a .
1207	promote	positive	mir-34a	1167.134	699.6966	699.6966	miRNA		Corrigendum. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis .
1207	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Corrigendum. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis .
1206	promote	positive	mir-34a	1167.134	699.6966	699.6966	miRNA		Corrigendum. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis .
1206	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Corrigendum. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis .
1117	block	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		Our study defines a major metastasis and angiogenesis suppressive role for mir-34a , a microRNA functions as a tumor suppressor in bladder cancer by directly targeting CD44 , which would be helpful as a therapeutic approach to block bladder cancer metastasis .
1117	block	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Our study defines a major metastasis and angiogenesis suppressive role for mir-34a , a microRNA functions as a tumor suppressor in bladder cancer by directly targeting CD44 , which would be helpful as a therapeutic approach to block bladder cancer metastasis .
1064	activate	positive	mir-34a	1167.134	699.6966	699.6966	miRNA		Our data show that the bone metastasis and anti-apoptotic effects found in Ras signaling-activated prostate cancer cells require miR-34a deficiency , which in turn aids in cell survival by activating the WNT and anti-apoptotic signaling pathways thereby inducing TCF7 and BIRC5 expressions .
1064	activate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our data show that the bone metastasis and anti-apoptotic effects found in Ras signaling-activated prostate cancer cells require miR-34a deficiency , which in turn aids in cell survival by activating the WNT and anti-apoptotic signaling pathways thereby inducing TCF7 and BIRC5 expressions .
1063	activate	positive	mir-34a	1167.134	699.6966	699.6966	miRNA		Our data show that the bone metastasis and anti-apoptotic effects found in Ras signaling-activated prostate cancer cells require miR-34a deficiency , which in turn aids in cell survival by activating the WNT and anti-apoptotic signaling pathways thereby inducing TCF7 and BIRC5 expressions .
1063	activate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our data show that the bone metastasis and anti-apoptotic effects found in Ras signaling-activated prostate cancer cells require miR-34a deficiency , which in turn aids in cell survival by activating the WNT and anti-apoptotic signaling pathways thereby inducing TCF7 and BIRC5 expressions .
1029	suppress	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		Diallyl disulfide suppresses SRC/Ras/ERK signaling-mediated proliferation and metastasis in human breast cancer by up-regulating miR-34a .
1029	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Diallyl disulfide suppresses SRC/Ras/ERK signaling-mediated proliferation and metastasis in human breast cancer by up-regulating miR-34a .
1017	inhibit	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		Ectopic expression of miR-34a-5p in p53 wild-type colon cancer cell HCT116 significantly inhibited cell growth , migration , invasion and metastasis .
1017	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Ectopic expression of miR-34a-5p in p53 wild-type colon cancer cell HCT116 significantly inhibited cell growth , migration , invasion and metastasis .
1016	suppress	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer .
1016	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer .
759	suppress	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		Our findings indicate that miR-34a targets CD44 in renal cancer cells and suppresses renal cancer cell growth , tube formation and metastasis in ? vitro and in ? vivo .
759	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Our findings indicate that miR-34a targets CD44 in renal cancer cells and suppresses renal cancer cell growth , tube formation and metastasis in ? vitro and in ? vivo .
758	suppress	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		Ectopic over expression of miR-34a restrained cell growth , tube formation and migration/invasion , and significantly suppressed the growth of renal carcinoma xenografts and metastasis in ? nude mice .
758	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Ectopic over expression of miR-34a restrained cell growth , tube formation and migration/invasion , and significantly suppressed the growth of renal carcinoma xenografts and metastasis in ? nude mice .
710	promote	positive	mir-34a	1167.134	699.6966	699.6966	miRNA		Deregulation of this circuitry by mutational and epigenetic alterations in the p53/miR-34a axis promotes colorectal cancer ( CRC ) progression and metastasis formation .
710	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Deregulation of this circuitry by mutational and epigenetic alterations in the p53/miR-34a axis promotes colorectal cancer ( CRC ) progression and metastasis formation .
709	inhibit	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		In conclusion , miR-34a may act as a potential tumour suppressor in gastric cancer and is associated with the mechanisms of gastric cancer metastasis ; miR-34a can inhibit gastric cancer tumourigenesis by targeting PDGFR and MET through the PI3K ( phosphoinositide 3-kinase ) /Akt pathway .
709	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	In conclusion , miR-34a may act as a potential tumour suppressor in gastric cancer and is associated with the mechanisms of gastric cancer metastasis ; miR-34a can inhibit gastric cancer tumourigenesis by targeting PDGFR and MET through the PI3K ( phosphoinositide 3-kinase ) /Akt pathway .
708	inhibit	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		In conclusion , miR-34a may act as a potential tumour suppressor in gastric cancer and is associated with the mechanisms of gastric cancer metastasis ; miR-34a can inhibit gastric cancer tumourigenesis by targeting PDGFR and MET through the PI3K ( phosphoinositide 3-kinase ) /Akt pathway .
708	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	In conclusion , miR-34a may act as a potential tumour suppressor in gastric cancer and is associated with the mechanisms of gastric cancer metastasis ; miR-34a can inhibit gastric cancer tumourigenesis by targeting PDGFR and MET through the PI3K ( phosphoinositide 3-kinase ) /Akt pathway .
707	downregulate	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		Meanwhile , we found that miR-34a was down-regulated in gastric cancer tissues and was associated with metastasis .
707	downregulate	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Meanwhile , we found that miR-34a was down-regulated in gastric cancer tissues and was associated with metastasis .
623	promote	positive	mir-34a	1167.134	699.6966	699.6966	miRNA		IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis .
623	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis .
435	upregulate	positive	mir-34a	1167.134	699.6966	699.6966	miRNA		Finally , in colorectal carcinoma samples , upregulation of PAR2 and downregulation of miR-34a were significantly correlated with grade and lymphomatic metastasis .
435	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Finally , in colorectal carcinoma samples , upregulation of PAR2 and downregulation of miR-34a were significantly correlated with grade and lymphomatic metastasis .
228	repress	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		These data suggest that miR-34a plays a tumor suppressor role in the metastasis of osteosarcoma cells by repressing the expression of CD44 .
228	repress	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	These data suggest that miR-34a plays a tumor suppressor role in the metastasis of osteosarcoma cells by repressing the expression of CD44 .
227	inhibit	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		miR-34a inhibits the metastasis of osteosarcoma cells by repressing the expression of CD44 .
227	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	miR-34a inhibits the metastasis of osteosarcoma cells by repressing the expression of CD44 .
219	downregulate	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		Downregulation of miR-34a in breast tumors is not associated with either p53 mutations or promoter hypermethylation while it correlates with metastasis .
219	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Downregulation of miR-34a in breast tumors is not associated with either p53 mutations or promoter hypermethylation while it correlates with metastasis .
169	regulate	positive	mir-34a	1167.134	699.6966	699.6966	miRNA		Here , we describe the regulation and function of miR-34a and miR-34c ( miR-34a/c ) in breast cancer metastasis .
169	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here , we describe the regulation and function of miR-34a and miR-34c ( miR-34a/c ) in breast cancer metastasis .
129	inhibit	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		Ectopic expression of miR-34a decreased tumor cell invasion and metastasis , inhibited the formation of promigratory cytoskeletal structures , suppressed activation of the RHO GTPase family , and regulated a gene expression signature enriched in cytoskeletal functions and predictive of outcome in human lung adenocarcinomas .
129	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Ectopic expression of miR-34a decreased tumor cell invasion and metastasis , inhibited the formation of promigratory cytoskeletal structures , suppressed activation of the RHO GTPase family , and regulated a gene expression signature enriched in cytoskeletal functions and predictive of outcome in human lung adenocarcinomas .
62	inhibit	negative	mir-34a	1167.134	699.6966	699.6966	miRNA		Over-expression of miR-34a partially inhibited proliferation , migration and invasion of osteosarcoma cells in vitro , as well as the tumor growth and pulmonary metastasis of osteosarcoma cells in vivo .
62	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Over-expression of miR-34a partially inhibited proliferation , migration and invasion of osteosarcoma cells in vitro , as well as the tumor growth and pulmonary metastasis of osteosarcoma cells in vivo .
1627	inhibit	negative	microrna-34a	1170.091	695.2934	695.2934	miRNA		MicroRNA-34a inhibits tumor invasion and metastasis in gastric cancer by targeting Tgif2 .
1627	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	MicroRNA-34a inhibits tumor invasion and metastasis in gastric cancer by targeting Tgif2 .
1061	regulate	positive	microrna-34a	1170.091	695.2934	695.2934	miRNA		MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer .
1061	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer .
1060	regulate	positive	microrna-34a	1170.091	695.2934	695.2934	miRNA		MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer .
1060	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer .
706	inhibit	negative	microrna-34a	1170.091	695.2934	695.2934	miRNA		MicroRNA-34A inhibits the growth , invasion and metastasis of gastric cancer by targeting PDGFR and MET expression .
706	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	MicroRNA-34A inhibits the growth , invasion and metastasis of gastric cancer by targeting PDGFR and MET expression .
61	inhibit	negative	microrna-34a	1170.091	695.2934	695.2934	miRNA		MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo .
61	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo .
1185	coexpress	neutral	mir-23a	1172.994	690.8552	690.8552	miRNA		Then , the coexpression of miR-23a and miR-23b ( miR-23a-high/miR-23b-high ) in GC tissues was significantly associated with the advanced TNM stage ( P < 0.001 ) , the presence of lymph node metastasis ( P = 0.008 ) and the great depth of invasion ( P = 0.02 ) .
1185	coexpress	neutral	gc	1242.449	487.0825	487.0825	Cancer	D061325	Then , the coexpression of miR-23a and miR-23b ( miR-23a-high/miR-23b-high ) in GC tissues was significantly associated with the advanced TNM stage ( P < 0.001 ) , the presence of lymph node metastasis ( P = 0.008 ) and the great depth of invasion ( P = 0.02 ) .
1184	coexpress	neutral	mir-23a	1172.994	690.8552	690.8552	miRNA		Then , the coexpression of miR-23a and miR-23b ( miR-23a-high/miR-23b-high ) in GC tissues was significantly associated with the advanced TNM stage ( P < 0.001 ) , the presence of lymph node metastasis ( P = 0.008 ) and the great depth of invasion ( P = 0.02 ) .
1184	coexpress	neutral	gc	1242.449	487.0825	487.0825	Cancer	D061325	Then , the coexpression of miR-23a and miR-23b ( miR-23a-high/miR-23b-high ) in GC tissues was significantly associated with the advanced TNM stage ( P < 0.001 ) , the presence of lymph node metastasis ( P = 0.008 ) and the great depth of invasion ( P = 0.02 ) .
1181	coexpress	neutral	mir-23a	1172.994	690.8552	690.8552	miRNA		Then , the coexpression of miR-23a and miR-23b ( miR-23a-high/miR-23b-high ) in GC tissues was significantly associated with the advanced TNM stage ( P < 0.001 ) , the presence of lymph node metastasis ( P = 0.008 ) and the great depth of invasion ( P = 0.02 ) .
1181	coexpress	neutral	gc	1242.449	487.0825	487.0825	Cancer	D061325	Then , the coexpression of miR-23a and miR-23b ( miR-23a-high/miR-23b-high ) in GC tissues was significantly associated with the advanced TNM stage ( P < 0.001 ) , the presence of lymph node metastasis ( P = 0.008 ) and the great depth of invasion ( P = 0.02 ) .
1180	coexpress	neutral	mir-23a	1172.994	690.8552	690.8552	miRNA		Then , the coexpression of miR-23a and miR-23b ( miR-23a-high/miR-23b-high ) in GC tissues was significantly associated with the advanced TNM stage ( P < 0.001 ) , the presence of lymph node metastasis ( P = 0.008 ) and the great depth of invasion ( P = 0.02 ) .
1180	coexpress	neutral	gc	1242.449	487.0825	487.0825	Cancer	D061325	Then , the coexpression of miR-23a and miR-23b ( miR-23a-high/miR-23b-high ) in GC tissues was significantly associated with the advanced TNM stage ( P < 0.001 ) , the presence of lymph node metastasis ( P = 0.008 ) and the great depth of invasion ( P = 0.02 ) .
582	promote	positive	mir-23a	1172.994	690.8552	690.8552	miRNA		These findings provide evidence that miR-23a is key in promoting NB cell migration and invasion through targeting CDH1 , and suggest that exogenous miR-23a may have therapeutic value in treating NB metastasis .
582	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	These findings provide evidence that miR-23a is key in promoting NB cell migration and invasion through targeting CDH1 , and suggest that exogenous miR-23a may have therapeutic value in treating NB metastasis .
104	regulate	positive	mir-23a	1172.994	690.8552	690.8552	miRNA		miR-23a , a critical regulator of " migR " ation and metastasis in colorectal cancer .
104	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-23a , a critical regulator of " migR " ation and metastasis in colorectal cancer .
60	promote	positive	mir-23a	1172.994	690.8552	690.8552	miRNA		MiR-23a expression promotes colon carcinoma cell growth , invasion and metastasis through inhibition of MTSS gene .
60	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-23a expression promotes colon carcinoma cell growth , invasion and metastasis through inhibition of MTSS gene .
1697	promote	positive	mir-25	1175.845	686.3826	686.3826	miRNA		miR-25 was identified as an essential oncogene by promoting the growth and metastasis through TOB1 in gastric cancer ( GC ) .
1697	promote	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	miR-25 was identified as an essential oncogene by promoting the growth and metastasis through TOB1 in gastric cancer ( GC ) .
1271	affect	neutral	mir-25	1175.845	686.3826	686.3826	miRNA		Functional studies revealed that overexpression of miR-25 in prostate cancer cell lines and selected subpopulation of highly metastatic and tumorigenic cells ( ALDH ( high ) ) strongly affected the invasive cytoskeleton , causing reduced migration in vitro and metastasis via attenuation of extravasation in vivo .
1271	affect	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Functional studies revealed that overexpression of miR-25 in prostate cancer cell lines and selected subpopulation of highly metastatic and tumorigenic cells ( ALDH ( high ) ) strongly affected the invasive cytoskeleton , causing reduced migration in vitro and metastasis via attenuation of extravasation in vivo .
866	inhibit	negative	mir-25	1175.845	686.3826	686.3826	miRNA		MiR-25 inhibition significantly decreased the metastasis , invasion and proliferation of GC cells in vitro , and reduced their capacity to develop distal pulmonary metastases and peritoneal dissemination in vivo .
866	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	MiR-25 inhibition significantly decreased the metastasis , invasion and proliferation of GC cells in vitro , and reduced their capacity to develop distal pulmonary metastases and peritoneal dissemination in vivo .
59	upregulate	positive	mir-25	1175.845	686.3826	686.3826	miRNA		Moreover , we demonstrated that the up-regulation of miR-25 was significantly correlated with the status of lymph node metastasis and TNM ( Tumor , Node and Metastasis ) stage .
59	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Moreover , we demonstrated that the up-regulation of miR-25 was significantly correlated with the status of lymph node metastasis and TNM ( Tumor , Node and Metastasis ) stage .
1401	downregulate	negative	mir-199a	1178.641	681.8763	681.8763	miRNA		In this study , we found that miR-199a down-regulation was associated with the CRC and metastasis incidence .
1401	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In this study , we found that miR-199a down-regulation was associated with the CRC and metastasis incidence .
1098	downregulate	negative	mir-199a	1178.641	681.8763	681.8763	miRNA		The downregulation of miR-199a-3p expression is significantly correlated with the recurrence and lung metastasis of patients with osteosarcoma .
1098	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The downregulation of miR-199a-3p expression is significantly correlated with the recurrence and lung metastasis of patients with osteosarcoma .
1031	influence	neutral	mir-199a	1178.641	681.8763	681.8763	miRNA		However , the exact molecular mechanisms by which miR-199a-5p influences melanoma invasion and metastasis remains unclear .
1031	influence	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	However , the exact molecular mechanisms by which miR-199a-5p influences melanoma invasion and metastasis remains unclear .
888	promote	positive	mir-199a	1178.641	681.8763	681.8763	miRNA		As increased activity of the SRF/miR-199a-5p/E-cadherin pathway appears to promote GC cell EMT and metastasis , these regulators may therefore be developed as therapeutic targets or biomarkers for GC progression .
888	promote	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	As increased activity of the SRF/miR-199a-5p/E-cadherin pathway appears to promote GC cell EMT and metastasis , these regulators may therefore be developed as therapeutic targets or biomarkers for GC progression .
887	promote	positive	mir-199a	1178.641	681.8763	681.8763	miRNA		As increased activity of the SRF/miR-199a-5p/E-cadherin pathway appears to promote GC cell EMT and metastasis , these regulators may therefore be developed as therapeutic targets or biomarkers for GC progression .
887	promote	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	As increased activity of the SRF/miR-199a-5p/E-cadherin pathway appears to promote GC cell EMT and metastasis , these regulators may therefore be developed as therapeutic targets or biomarkers for GC progression .
886	promote	positive	mir-199a	1178.641	681.8763	681.8763	miRNA		Specifically , our results showed that SRF promotes GC metastasis and the epithelial to mesenchymal transition ( EMT ) though miR-199a-5p-mediated downregulation of E-cadherin .
886	promote	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	Specifically , our results showed that SRF promotes GC metastasis and the epithelial to mesenchymal transition ( EMT ) though miR-199a-5p-mediated downregulation of E-cadherin .
885	promote	positive	mir-199a	1178.641	681.8763	681.8763	miRNA		Specifically , our results showed that SRF promotes GC metastasis and the epithelial to mesenchymal transition ( EMT ) though miR-199a-5p-mediated downregulation of E-cadherin .
885	promote	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	Specifically , our results showed that SRF promotes GC metastasis and the epithelial to mesenchymal transition ( EMT ) though miR-199a-5p-mediated downregulation of E-cadherin .
884	regulate	positive	mir-199a	1178.641	681.8763	681.8763	miRNA		SRF expedites metastasis and modulates the epithelial to mesenchymal transition by regulating miR-199a-5p expression in human gastric cancer .
884	regulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	SRF expedites metastasis and modulates the epithelial to mesenchymal transition by regulating miR-199a-5p expression in human gastric cancer .
485	regulate	positive	mir-199a	1178.641	681.8763	681.8763	miRNA		Increasing evidence has shown that miR-199a is important in regulating the tumor metastasis of ovarian cancer , although the precise biological function of miR-199a is unclear at present .
485	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Increasing evidence has shown that miR-199a is important in regulating the tumor metastasis of ovarian cancer , although the precise biological function of miR-199a is unclear at present .
423	suppress	negative	mir-199a	1178.641	681.8763	681.8763	miRNA		Further study found that re-expression of miR-199a in testicular cancer cells ( NT2 ) led to suppression of cell growth , cancer migration , invasion and metastasis .
423	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Further study found that re-expression of miR-199a in testicular cancer cells ( NT2 ) led to suppression of cell growth , cancer migration , invasion and metastasis .
58	downregulate	negative	mir-199a	1178.641	681.8763	681.8763	miRNA		Among , downregulation of six miRNAs , has-let-7c , has-miR-100 , has-miR-125b , has-miR-143 , has-miR-145 and has-miR-199a-5p were significantly associated with lymph node metastasis and reduced survival in SCCC .
58	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Among , downregulation of six miRNAs , has-let-7c , has-miR-100 , has-miR-125b , has-miR-143 , has-miR-145 and has-miR-199a-5p were significantly associated with lymph node metastasis and reduced survival in SCCC .
1830	regulate	positive	mir-143	1181.384	677.3369	677.3369	miRNA		These results indicated that PAI-1 , a target gene of miR-143 , regulates invasion and lung metastasis via enhancement of MMP-13 expression and secretion in human osteosarcoma cells , suggesting that these molecules could be potential therapeutic target genes for preventing lung metastasis in osteosarcoma patients .
1830	regulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	These results indicated that PAI-1 , a target gene of miR-143 , regulates invasion and lung metastasis via enhancement of MMP-13 expression and secretion in human osteosarcoma cells , suggesting that these molecules could be potential therapeutic target genes for preventing lung metastasis in osteosarcoma patients .
1829	regulate	positive	mir-143	1181.384	677.3369	677.3369	miRNA		These results indicated that PAI-1 , a target gene of miR-143 , regulates invasion and lung metastasis via enhancement of MMP-13 expression and secretion in human osteosarcoma cells , suggesting that these molecules could be potential therapeutic target genes for preventing lung metastasis in osteosarcoma patients .
1829	regulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	These results indicated that PAI-1 , a target gene of miR-143 , regulates invasion and lung metastasis via enhancement of MMP-13 expression and secretion in human osteosarcoma cells , suggesting that these molecules could be potential therapeutic target genes for preventing lung metastasis in osteosarcoma patients .
1828	suppress	negative	mir-143	1181.384	677.3369	677.3369	miRNA		We have previously reported that intravenous injection of miR-143 significantly suppresses lung metastasis of human osteosarcoma cells ( 143B ) in a mouse model .
1828	suppress	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	We have previously reported that intravenous injection of miR-143 significantly suppresses lung metastasis of human osteosarcoma cells ( 143B ) in a mouse model .
1827	regulate	positive	mir-143	1181.384	677.3369	677.3369	miRNA		PAI-1 , a target gene of miR-143 , regulates invasion and metastasis by upregulating MMP-13 expression of human osteosarcoma .
1827	regulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	PAI-1 , a target gene of miR-143 , regulates invasion and metastasis by upregulating MMP-13 expression of human osteosarcoma .
840	inhibit	negative	mir-143	1181.384	677.3369	677.3369	miRNA		miR-143 inhibits NSCLC cell growth and metastasis by targeting Limk1 .
840	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-143 inhibits NSCLC cell growth and metastasis by targeting Limk1 .
673	downregulate	negative	mir-143	1181.384	677.3369	677.3369	miRNA		Down-regulated miR-143 is related with tumor size , lymph node metastasis and HPV16 infection in cervical SCC , but miR-143 does not participate in the Taxol sensitivity response .
673	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Down-regulated miR-143 is related with tumor size , lymph node metastasis and HPV16 infection in cervical SCC , but miR-143 does not participate in the Taxol sensitivity response .
672	downregulate	negative	mir-143	1181.384	677.3369	677.3369	miRNA		Down-regulated miR-143 expression was associated with tumor size , lymph node metastasis and HPV16 infection in cervical cancer patients .
672	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Down-regulated miR-143 expression was associated with tumor size , lymph node metastasis and HPV16 infection in cervical cancer patients .
671	downregulate	negative	mir-143	1181.384	677.3369	677.3369	miRNA		Down-regulated miR-143 expression was associated with tumor size , lymph node metastasis and HPV16 infection in cervical cancer patients .
671	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Down-regulated miR-143 expression was associated with tumor size , lymph node metastasis and HPV16 infection in cervical cancer patients .
670	regulate	positive	mir-143	1181.384	677.3369	677.3369	miRNA		Down regulation of miR-143 is related with tumor size , lymph node metastasis and HPV16 infection in cervical squamous cancer .
670	regulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Down regulation of miR-143 is related with tumor size , lymph node metastasis and HPV16 infection in cervical squamous cancer .
669	regulate	positive	mir-143	1181.384	677.3369	677.3369	miRNA		Down regulation of miR-143 is related with tumor size , lymph node metastasis and HPV16 infection in cervical squamous cancer .
669	regulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Down regulation of miR-143 is related with tumor size , lymph node metastasis and HPV16 infection in cervical squamous cancer .
580	downregulate	negative	mir-143	1181.384	677.3369	677.3369	miRNA		Down-regulated miR-143 expression was associated with both the tumor size and lymph node metastasis in patients with cervical cancer ( Z = -2.628 , P = 0.009 and Z = -2.127 , P = 0.033 respectively ) .
580	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Down-regulated miR-143 expression was associated with both the tumor size and lymph node metastasis in patients with cervical cancer ( Z = -2.628 , P = 0.009 and Z = -2.127 , P = 0.033 respectively ) .
406	suppress	negative	mir-143	1181.384	677.3369	677.3369	miRNA		In vitro experiments showed us that miR-143 could significantly suppress the migration and invasion of NSCLC cell lines while it had no effects on the growth of NSCLC cell lines , and in vivo metastasis assay showed the same results .
406	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In vitro experiments showed us that miR-143 could significantly suppress the migration and invasion of NSCLC cell lines while it had no effects on the growth of NSCLC cell lines , and in vivo metastasis assay showed the same results .
367	inhibit	negative	mir-143	1181.384	677.3369	677.3369	miRNA		These results indicated that miR-143 may be suitable for the development of novel molecular markers and therapeutic approaches to inhibit metastasis in prostate cancer .
367	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	These results indicated that miR-143 may be suitable for the development of novel molecular markers and therapeutic approaches to inhibit metastasis in prostate cancer .
252	upregulate	positive	mir-143	1181.384	677.3369	677.3369	miRNA		These data demonstrate for the first time that miR-143 was up-regulated during the differentiation of prostate cancer stem cells and promoted prostate cancer metastasis by repressing FNDC3B expression .
252	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	These data demonstrate for the first time that miR-143 was up-regulated during the differentiation of prostate cancer stem cells and promoted prostate cancer metastasis by repressing FNDC3B expression .
251	downregulate	negative	mir-143	1181.384	677.3369	677.3369	miRNA		Moreover , the down-regulation of miR-143 suppressed prostate cancer cells migration and invasion in vitro and systemically inhibited metastasis in vivo .
251	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Moreover , the down-regulation of miR-143 suppressed prostate cancer cells migration and invasion in vitro and systemically inhibited metastasis in vivo .
182	inhibit	negative	mir-143	1181.384	677.3369	677.3369	miRNA		miR-143 inhibits the metastasis of pancreatic cancer and an associated signaling pathway .
182	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-143 inhibits the metastasis of pancreatic cancer and an associated signaling pathway .
154	inhibit	negative	mir-143	1181.384	677.3369	677.3369	miRNA		Collectively , these findings demonstrate that miR-143 and miR-145 inhibit CSC properties of PC-3 cells and suggest that miR-143 and miR-145 may play a significant role in the bone metastasis progression of PCa by regulating CSC characteristics .
154	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Collectively , these findings demonstrate that miR-143 and miR-145 inhibit CSC properties of PC-3 cells and suggest that miR-143 and miR-145 may play a significant role in the bone metastasis progression of PCa by regulating CSC characteristics .
153	inhibit	negative	mir-143	1181.384	677.3369	677.3369	miRNA		Collectively , these findings demonstrate that miR-143 and miR-145 inhibit CSC properties of PC-3 cells and suggest that miR-143 and miR-145 may play a significant role in the bone metastasis progression of PCa by regulating CSC characteristics .
153	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Collectively , these findings demonstrate that miR-143 and miR-145 inhibit CSC properties of PC-3 cells and suggest that miR-143 and miR-145 may play a significant role in the bone metastasis progression of PCa by regulating CSC characteristics .
150	inhibit	negative	mir-143	1181.384	677.3369	677.3369	miRNA		Collectively , these findings demonstrate that miR-143 and miR-145 inhibit CSC properties of PC-3 cells and suggest that miR-143 and miR-145 may play a significant role in the bone metastasis progression of PCa by regulating CSC characteristics .
150	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Collectively , these findings demonstrate that miR-143 and miR-145 inhibit CSC properties of PC-3 cells and suggest that miR-143 and miR-145 may play a significant role in the bone metastasis progression of PCa by regulating CSC characteristics .
149	inhibit	negative	mir-143	1181.384	677.3369	677.3369	miRNA		Collectively , these findings demonstrate that miR-143 and miR-145 inhibit CSC properties of PC-3 cells and suggest that miR-143 and miR-145 may play a significant role in the bone metastasis progression of PCa by regulating CSC characteristics .
149	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Collectively , these findings demonstrate that miR-143 and miR-145 inhibit CSC properties of PC-3 cells and suggest that miR-143 and miR-145 may play a significant role in the bone metastasis progression of PCa by regulating CSC characteristics .
147	inhibit	negative	mir-143	1181.384	677.3369	677.3369	miRNA		In this study , we found that overexpression of miR-143 and miR-145 inhibited the cell viability and colony formation of PC-3 cells from PCa bone metastasis .
147	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In this study , we found that overexpression of miR-143 and miR-145 inhibited the cell viability and colony formation of PC-3 cells from PCa bone metastasis .
144	regulate	positive	mir-143	1181.384	677.3369	677.3369	miRNA		A previous study showed that miR-143 and miR-145 play an important role in regulating bone metastasis of prostate cancer ( PCa ) , but the exact mechanism of regulation of bone metastasis of PCa is not fully understood .
144	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	A previous study showed that miR-143 and miR-145 play an important role in regulating bone metastasis of prostate cancer ( PCa ) , but the exact mechanism of regulation of bone metastasis of PCa is not fully understood .
143	regulate	positive	mir-143	1181.384	677.3369	677.3369	miRNA		A previous study showed that miR-143 and miR-145 play an important role in regulating bone metastasis of prostate cancer ( PCa ) , but the exact mechanism of regulation of bone metastasis of PCa is not fully understood .
143	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	A previous study showed that miR-143 and miR-145 play an important role in regulating bone metastasis of prostate cancer ( PCa ) , but the exact mechanism of regulation of bone metastasis of PCa is not fully understood .
56	downregulate	negative	mir-143	1181.384	677.3369	677.3369	miRNA		Among , downregulation of six miRNAs , has-let-7c , has-miR-100 , has-miR-125b , has-miR-143 , has-miR-145 and has-miR-199a-5p were significantly associated with lymph node metastasis and reduced survival in SCCC .
56	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Among , downregulation of six miRNAs , has-let-7c , has-miR-100 , has-miR-125b , has-miR-143 , has-miR-145 and has-miR-199a-5p were significantly associated with lymph node metastasis and reduced survival in SCCC .
1656	upregulate	positive	mir-125b	1184.073	672.7651	672.7651	miRNA		We further found that upregulation of miR-125b inhibited the proliferation and metastasis of gastric cancer cells in vitro and in vivo .
1656	upregulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	We further found that upregulation of miR-125b inhibited the proliferation and metastasis of gastric cancer cells in vitro and in vivo .
1585	promote	positive	mir-125b	1184.073	672.7651	672.7651	miRNA		These findings demonstrated that miR-125b promoted tumor metastasis via targeting TP53INP1 in human NSCLC cells , which uncovered a real clinical relevance of microRNAs in tumor biology , and provided novel potential candidates for NSCLC clinical practice .
1585	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	These findings demonstrated that miR-125b promoted tumor metastasis via targeting TP53INP1 in human NSCLC cells , which uncovered a real clinical relevance of microRNAs in tumor biology , and provided novel potential candidates for NSCLC clinical practice .
1556	upregulate	positive	mir-125b	1184.073	672.7651	672.7651	miRNA		On the other hand , miR-300 expression was significantly upregulated in OS bone tissue than noncancerous bone tissues.Our findings suggested that a lower expression level of miR-125b was linked to advanced clinical stage ( P ? = ? 0.005 ) , metastasis ( P ? = ? 0.004 ) , and a large size of tumor ( P ? = ? 0.023 ) .
1556	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	On the other hand , miR-300 expression was significantly upregulated in OS bone tissue than noncancerous bone tissues.Our findings suggested that a lower expression level of miR-125b was linked to advanced clinical stage ( P ? = ? 0.005 ) , metastasis ( P ? = ? 0.004 ) , and a large size of tumor ( P ? = ? 0.023 ) .
1554	upregulate	positive	mir-125b	1184.073	672.7651	672.7651	miRNA		Upregulation of miR-300 and downregulation of miR-125b act as potential predictor biomarkers in progression , metastasis , and poor prognosis of osteosarcoma .
1554	upregulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Upregulation of miR-300 and downregulation of miR-125b act as potential predictor biomarkers in progression , metastasis , and poor prognosis of osteosarcoma .
1331	inhibit	negative	mir-125b	1184.073	672.7651	672.7651	miRNA		Most important , the therapeutic delivery of synthetic miR-125b mimics decreased the target molecule of CSC and inhibited metastasis in the mice model .
1331	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Most important , the therapeutic delivery of synthetic miR-125b mimics decreased the target molecule of CSC and inhibited metastasis in the mice model .
361	regulate	positive	mir-125b	1184.073	672.7651	672.7651	miRNA		However , the role of miR-125b and MTA1 in the regulation of NSCLC metastasis remains unclear .
361	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	However , the role of miR-125b and MTA1 in the regulation of NSCLC metastasis remains unclear .
277	inhibit	negative	mir-125b	1184.073	672.7651	672.7651	miRNA		These results suggested that miR-125b could be used for the development of new molecular markers and therapeutic approaches to inhibit bladder cancer metastasis .
277	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	These results suggested that miR-125b could be used for the development of new molecular markers and therapeutic approaches to inhibit bladder cancer metastasis .
55	downregulate	negative	mir-125b	1184.073	672.7651	672.7651	miRNA		Among , downregulation of six miRNAs , has-let-7c , has-miR-100 , has-miR-125b , has-miR-143 , has-miR-145 and has-miR-199a-5p were significantly associated with lymph node metastasis and reduced survival in SCCC .
55	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Among , downregulation of six miRNAs , has-let-7c , has-miR-100 , has-miR-125b , has-miR-143 , has-miR-145 and has-miR-199a-5p were significantly associated with lymph node metastasis and reduced survival in SCCC .
1594	suppress	negative	mir-100	1186.706	668.1614	668.1614	miRNA		Overexpression of miR-100 suppressed tumor growth in vivo and inhibited gastric cancer invasion and metastasis in vitro and in vivo .
1594	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Overexpression of miR-100 suppressed tumor growth in vivo and inhibited gastric cancer invasion and metastasis in vitro and in vivo .
1593	suppress	negative	mir-100	1186.706	668.1614	668.1614	miRNA		C/EBP帢-induced miR-100 expression suppresses tumor metastasis and growth by targeting ZBTB7A in gastric cancer .
1593	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	C/EBP帢-induced miR-100 expression suppresses tumor metastasis and growth by targeting ZBTB7A in gastric cancer .
1450	downregulate	negative	mir-100	1186.706	668.1614	668.1614	miRNA		It was identified that the expression levels of miR-551b-3p , miR-133b , miR-100-5p and miR-363-3p were significantly downregulated in the gastric cancer tissues , and this downregulation was closely correlated with the degree of differentiation ( i.e. , tumor grade ) , TNM stage and lymph-node metastasis ( P < 0.05 ) .
1450	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	It was identified that the expression levels of miR-551b-3p , miR-133b , miR-100-5p and miR-363-3p were significantly downregulated in the gastric cancer tissues , and this downregulation was closely correlated with the degree of differentiation ( i.e. , tumor grade ) , TNM stage and lymph-node metastasis ( P < 0.05 ) .
1015	downregulate	negative	mir-100	1186.706	668.1614	668.1614	miRNA		Downregulation of miR-100 contributes to HCC metastasis and the restoration of miR-100 is a potential strategy for cancer therapy .
1015	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Downregulation of miR-100 contributes to HCC metastasis and the restoration of miR-100 is a potential strategy for cancer therapy .
1014	repress	negative	mir-100	1186.706	668.1614	668.1614	miRNA		Taken together , miR-100 represses metastasis of HCC cells by abrogating the ICMT-Rac1 signaling .
1014	repress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , miR-100 represses metastasis of HCC cells by abrogating the ICMT-Rac1 signaling .
1013	control	neutral	mir-100	1186.706	668.1614	668.1614	miRNA		Analyses using mouse orthotopic xenograft model further revealed that xenografts of miR-100-stable-expressing HCC cells displayed a significant reduction in pulmonary metastasis , compared with control group .
1013	control	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Analyses using mouse orthotopic xenograft model further revealed that xenografts of miR-100-stable-expressing HCC cells displayed a significant reduction in pulmonary metastasis , compared with control group .
897	downregulate	negative	mir-100	1186.706	668.1614	668.1614	miRNA		Furthermore , we found that the downregulation of miR-100 was significantly correlated with the status of lymph node metastasis in the 34 ? ESCC patients .
897	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Furthermore , we found that the downregulation of miR-100 was significantly correlated with the status of lymph node metastasis in the 34 ? ESCC patients .
681	promote	positive	mir-100	1186.706	668.1614	668.1614	miRNA		Taken together , our findings indicate that loss of miR-100 promotes the metastatic ability of prostate cancer cells at least partially by upregulating AGO2 expression through modulating migration , invasion , EMT and stemness of cancer cells , and suggest that miR-100/AGO2 may play an important role in regulating the metastasis of prostate cancer and is a potential target of prevention and therapy .
681	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Taken together , our findings indicate that loss of miR-100 promotes the metastatic ability of prostate cancer cells at least partially by upregulating AGO2 expression through modulating migration , invasion , EMT and stemness of cancer cells , and suggest that miR-100/AGO2 may play an important role in regulating the metastasis of prostate cancer and is a potential target of prevention and therapy .
680	regulate	positive	mir-100	1186.706	668.1614	668.1614	miRNA		However , it is unknown whether and how miR-100 and AGO2 regulates metastasis of prostate cancer .
680	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	However , it is unknown whether and how miR-100 and AGO2 regulates metastasis of prostate cancer .
198	downregulate	negative	mir-100	1186.706	668.1614	668.1614	miRNA		MiR-100 was significantly downregulated in NSCLC tissues , and low miR-100 expression was found to be closely correlated with higher clinical stage , advanced tumor classification and lymph node metastasis of patients .
198	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-100 was significantly downregulated in NSCLC tissues , and low miR-100 expression was found to be closely correlated with higher clinical stage , advanced tumor classification and lymph node metastasis of patients .
197	downregulate	negative	mir-100	1186.706	668.1614	668.1614	miRNA		MiR-100 was significantly downregulated in NSCLC tissues , and low miR-100 expression was found to be closely correlated with higher clinical stage , advanced tumor classification and lymph node metastasis of patients .
197	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-100 was significantly downregulated in NSCLC tissues , and low miR-100 expression was found to be closely correlated with higher clinical stage , advanced tumor classification and lymph node metastasis of patients .
54	downregulate	negative	mir-100	1186.706	668.1614	668.1614	miRNA		Among , downregulation of six miRNAs , has-let-7c , has-miR-100 , has-miR-125b , has-miR-143 , has-miR-145 and has-miR-199a-5p were significantly associated with lymph node metastasis and reduced survival in SCCC .
54	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Among , downregulation of six miRNAs , has-let-7c , has-miR-100 , has-miR-125b , has-miR-143 , has-miR-145 and has-miR-199a-5p were significantly associated with lymph node metastasis and reduced survival in SCCC .
2006	regulate	positive	mir-155	1189.284	663.5267	663.5267	miRNA		A vast number of miRNAs , including the well-studied miR-21 , miR-155 and miR-34 , has been shown to regulate PDAC growth , invasion and metastasis in vitro and in vivo by targeting members of key signaling pathways .
2006	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	A vast number of miRNAs , including the well-studied miR-21 , miR-155 and miR-34 , has been shown to regulate PDAC growth , invasion and metastasis in vitro and in vivo by targeting members of key signaling pathways .
1892	promote	positive	mir-155	1189.284	663.5267	663.5267	miRNA		miR-155 may promote the invasion and metastasis of lung adenocarcinoma through reducing the target PTEN gene expression .
1892	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-155 may promote the invasion and metastasis of lung adenocarcinoma through reducing the target PTEN gene expression .
1676	inhibit	negative	mir-155	1189.284	663.5267	663.5267	miRNA		Furthermore , using functional assays and The Cancer Genome Atlas ( TCGA ) Lung Adenocarcinoma ( LUAD ) dataset , we found that rs767649 variant allele could increase the transcriptional activity of miR-155 , which in turn facilitated tumor growth and metastasis by inhibiting HBP1 , TJP1 , SMAD5 and PRKAR1A expression .
1676	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Furthermore , using functional assays and The Cancer Genome Atlas ( TCGA ) Lung Adenocarcinoma ( LUAD ) dataset , we found that rs767649 variant allele could increase the transcriptional activity of miR-155 , which in turn facilitated tumor growth and metastasis by inhibiting HBP1 , TJP1 , SMAD5 and PRKAR1A expression .
1518	upregulate	positive	mir-155	1189.284	663.5267	663.5267	miRNA		miR-155-5p expression is up-regulated in most CRC and promotes proliferation , invasion and metastasis of CRC cells .
1518	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-155-5p expression is up-regulated in most CRC and promotes proliferation , invasion and metastasis of CRC cells .
1517	effect	neutral	mir-155	1189.284	663.5267	663.5267	miRNA		The aim of the study is to investigate miR-155-5p effect on proliferation and invasion metastasis of CRC .
1517	effect	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The aim of the study is to investigate miR-155-5p effect on proliferation and invasion metastasis of CRC .
1516	upregulate	positive	mir-155	1189.284	663.5267	663.5267	miRNA		Up-regulated miR-155-5p promotes cell proliferation , invasion and metastasis in colorectal carcinoma .
1516	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Up-regulated miR-155-5p promotes cell proliferation , invasion and metastasis in colorectal carcinoma .
1021	regulate	positive	mir-155	1189.284	663.5267	663.5267	miRNA		Furthermore , we found that MCRS1 binds to the miR-155 promoter and regulates its expression , as well as MCRS1 promotes epithelial-mesenchymal transition ( EMT ) , invasion , and metastasis through the up-regulation of miR-155 .
1021	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Furthermore , we found that MCRS1 binds to the miR-155 promoter and regulates its expression , as well as MCRS1 promotes epithelial-mesenchymal transition ( EMT ) , invasion , and metastasis through the up-regulation of miR-155 .
422	promote	positive	mir-155	1189.284	663.5267	663.5267	miRNA		The results identify miR-155-mediated loss of C/EBP?] as a mechanism , which promotes breast cancer progression by shifting the TGF-?] response from growth inhibition to EMT , invasion and metastasis .
422	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The results identify miR-155-mediated loss of C/EBP?] as a mechanism , which promotes breast cancer progression by shifting the TGF-?] response from growth inhibition to EMT , invasion and metastasis .
421	promote	positive	mir-155	1189.284	663.5267	663.5267	miRNA		The results identify miR-155-mediated loss of C/EBP?] as a mechanism , which promotes breast cancer progression by shifting the TGF-?] response from growth inhibition to EMT , invasion and metastasis .
421	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The results identify miR-155-mediated loss of C/EBP?] as a mechanism , which promotes breast cancer progression by shifting the TGF-?] response from growth inhibition to EMT , invasion and metastasis .
420	inhibit	negative	mir-155	1189.284	663.5267	663.5267	miRNA		MiR-155-mediated loss of C/EBP?] shifts the TGF-?] response from growth inhibition to epithelial-mesenchymal transition , invasion and metastasis in breast cancer .
420	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-155-mediated loss of C/EBP?] shifts the TGF-?] response from growth inhibition to epithelial-mesenchymal transition , invasion and metastasis in breast cancer .
223	upregulate	positive	mir-155	1189.284	663.5267	663.5267	miRNA		Up-regulated miR-155 level was observed in breast cancer with lymph node metastasis , pT3+4 , advanced TNM stage , HER-2 positive and with vascular invasion ( Z = -6.320 to -2.041 , P = 0.000 to 0.041 ) .
223	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Up-regulated miR-155 level was observed in breast cancer with lymph node metastasis , pT3+4 , advanced TNM stage , HER-2 positive and with vascular invasion ( Z = -6.320 to -2.041 , P = 0.000 to 0.041 ) .
52	regulate	positive	mir-155	1189.284	663.5267	663.5267	miRNA		Taken together , these data suggest that miR-155 may function as a tumor suppressor to regulate gastric cancer cell metastasis by targeting SMAD2 , and its downregulation in gastric cancer cells may be partly ascribed to DNA methylation .
52	regulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	Taken together , these data suggest that miR-155 may function as a tumor suppressor to regulate gastric cancer cell metastasis by targeting SMAD2 , and its downregulation in gastric cancer cells may be partly ascribed to DNA methylation .
51	downregulate	negative	microrna-155	1191.807	658.8615	658.8615	miRNA		microRNA-155 is downregulated in gastric cancer cells and involved in cell metastasis .
51	downregulate	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	microRNA-155 is downregulated in gastric cancer cells and involved in cell metastasis .
869	effect	neutral	mir-200c	1194.274	654.1665	654.1665	miRNA		This study was to investigate the effect of miR-200c on regulation of ovarian cancer cell metastasis potential and explore the underlying molecular events .
869	effect	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	This study was to investigate the effect of miR-200c on regulation of ovarian cancer cell metastasis potential and explore the underlying molecular events .
828	inhibit	negative	mir-200c	1194.274	654.1665	654.1665	miRNA		We demonstrated that over-expression of miR-200c inhibited NSCLC cells migration , invasion , epithelial-mesenchymal transition ( EMT ) in vitro and lung metastasis formation in vivo .
828	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We demonstrated that over-expression of miR-200c inhibited NSCLC cells migration , invasion , epithelial-mesenchymal transition ( EMT ) in vitro and lung metastasis formation in vivo .
827	inhibit	negative	mir-200c	1194.274	654.1665	654.1665	miRNA		We demonstrated that over-expression of miR-200c inhibited NSCLC cells migration , invasion , epithelial-mesenchymal transition ( EMT ) in vitro and lung metastasis formation in vivo .
827	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We demonstrated that over-expression of miR-200c inhibited NSCLC cells migration , invasion , epithelial-mesenchymal transition ( EMT ) in vitro and lung metastasis formation in vivo .
826	inhibit	negative	mir-200c	1194.274	654.1665	654.1665	miRNA		We demonstrated that over-expression of miR-200c inhibited NSCLC cells migration , invasion , epithelial-mesenchymal transition ( EMT ) in vitro and lung metastasis formation in vivo .
826	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We demonstrated that over-expression of miR-200c inhibited NSCLC cells migration , invasion , epithelial-mesenchymal transition ( EMT ) in vitro and lung metastasis formation in vivo .
663	inhibit	negative	mir-200c	1194.274	654.1665	654.1665	miRNA		The microRNA-200c ( miR-200c ) , which is frequently lowly expressed in triple negative breast cancers ( TNBCs ) , inhibits metastasis by inducing the mesenchymal to epithelial transition ( MET ) .
663	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The microRNA-200c ( miR-200c ) , which is frequently lowly expressed in triple negative breast cancers ( TNBCs ) , inhibits metastasis by inducing the mesenchymal to epithelial transition ( MET ) .
662	inhibit	negative	mir-200c	1194.274	654.1665	654.1665	miRNA		The microRNA-200c ( miR-200c ) , which is frequently lowly expressed in triple negative breast cancers ( TNBCs ) , inhibits metastasis by inducing the mesenchymal to epithelial transition ( MET ) .
662	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The microRNA-200c ( miR-200c ) , which is frequently lowly expressed in triple negative breast cancers ( TNBCs ) , inhibits metastasis by inducing the mesenchymal to epithelial transition ( MET ) .
655	regulate	positive	mir-200c	1194.274	654.1665	654.1665	miRNA		This study further examined the role of miR-200c in the invasion and metastasis of breast cancer that goes beyond the regulation on ZEB1 and ZEB2 expression .
655	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	This study further examined the role of miR-200c in the invasion and metastasis of breast cancer that goes beyond the regulation on ZEB1 and ZEB2 expression .
654	inhibit	negative	mir-200c	1194.274	654.1665	654.1665	miRNA		miR-200c inhibits metastasis of breast cancer cells by targeting HMGB1 .
654	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-200c inhibits metastasis of breast cancer cells by targeting HMGB1 .
649	regulate	positive	mir-200c	1194.274	654.1665	654.1665	miRNA		In conclusion , miR-200c functions as an oncogene in colon cancer cells through regulating tumor cell apoptosis , survival , invasion , and metastasis as well as xenograft tumor growth through inhibition of PTEN expression and p53 phosphorylation .
649	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In conclusion , miR-200c functions as an oncogene in colon cancer cells through regulating tumor cell apoptosis , survival , invasion , and metastasis as well as xenograft tumor growth through inhibition of PTEN expression and p53 phosphorylation .
648	regulate	positive	mir-200c	1194.274	654.1665	654.1665	miRNA		In conclusion , miR-200c functions as an oncogene in colon cancer cells through regulating tumor cell apoptosis , survival , invasion , and metastasis as well as xenograft tumor growth through inhibition of PTEN expression and p53 phosphorylation .
648	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In conclusion , miR-200c functions as an oncogene in colon cancer cells through regulating tumor cell apoptosis , survival , invasion , and metastasis as well as xenograft tumor growth through inhibition of PTEN expression and p53 phosphorylation .
647	regulate	positive	mir-200c	1194.274	654.1665	654.1665	miRNA		However , how miR-200c regulates the apoptosis , survival , invasion , metastasis , and tumor growth in colon cancer cells remains to be fully elucidated .
647	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	However , how miR-200c regulates the apoptosis , survival , invasion , metastasis , and tumor growth in colon cancer cells remains to be fully elucidated .
633	regulate	positive	mir-200c	1194.274	654.1665	654.1665	miRNA		Our findings indicate that miR-200c regulates Sox2 expression through a feedback loop and is associated with CRC stemness , growth , and metastasis .
633	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our findings indicate that miR-200c regulates Sox2 expression through a feedback loop and is associated with CRC stemness , growth , and metastasis .
632	regulate	positive	mir-200c	1194.274	654.1665	654.1665	miRNA		To elucidate a novel mechanism of miR-200c in the regulation of stemness , growth , and metastasis in colorectal carcinoma ( CRC ) .
632	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	To elucidate a novel mechanism of miR-200c in the regulation of stemness , growth , and metastasis in colorectal carcinoma ( CRC ) .
631	regulate	positive	mir-200c	1194.274	654.1665	654.1665	miRNA		Regulation of colorectal carcinoma stemness , growth , and metastasis by an miR-200c-Sox2-negative feedback loop mechanism .
631	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Regulation of colorectal carcinoma stemness , growth , and metastasis by an miR-200c-Sox2-negative feedback loop mechanism .
609	suppress	negative	mir-200c	1194.274	654.1665	654.1665	miRNA		MiR-200c suppresses TGF-?] signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer .
609	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-200c suppresses TGF-?] signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer .
385	inhibit	negative	mir-200c	1194.274	654.1665	654.1665	miRNA		Importantly , the miR-200c overexpression significantly inhibited the CD117+CD44+CSCs xenograft growth and lung metastasis in vivo in nude mice by inhibition of the EMT .
385	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Importantly , the miR-200c overexpression significantly inhibited the CD117+CD44+CSCs xenograft growth and lung metastasis in vivo in nude mice by inhibition of the EMT .
368	regulate	positive	mir-200c	1194.274	654.1665	654.1665	miRNA		The aim of the present study was to investigate the possible roles of miR-200c in regulating metastasis and to identify its target genes in renal cell carcinoma ( RCC ) .
368	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The aim of the present study was to investigate the possible roles of miR-200c in regulating metastasis and to identify its target genes in renal cell carcinoma ( RCC ) .
118	regulate	positive	mir-200c	1194.274	654.1665	654.1665	miRNA		MiR-200 family ( miR-200a , miR-200b , miR-200c , miR-141 , and miR-429 ) is a cluster of miRNAs highly correlated with epithelial-mesenchymal transition ( EMT ) , wherein miR-200b is identified as a critical regulator of tumor invasion , metastasis , and chemosensitivity .
118	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-200 family ( miR-200a , miR-200b , miR-200c , miR-141 , and miR-429 ) is a cluster of miRNAs highly correlated with epithelial-mesenchymal transition ( EMT ) , wherein miR-200b is identified as a critical regulator of tumor invasion , metastasis , and chemosensitivity .
68	inhibit	negative	mir-200c	1194.274	654.1665	654.1665	miRNA		Vaccination with the viable B16F10/ESAT-6-GPI-IL-21 vaccine resulted in an increase of IFN-帠 level and the CD8 ( + ) CTL cytotoxicity , a decrease in TGF-?] generation and increase in the expression of miR-200c that serves as melanoma suppressor by directly targeting zinc-finger E-box binding homeobox 1 to inhibit epithelial-mesenchymal transition and block tumor metastasis .
68	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Vaccination with the viable B16F10/ESAT-6-GPI-IL-21 vaccine resulted in an increase of IFN-帠 level and the CD8 ( + ) CTL cytotoxicity , a decrease in TGF-?] generation and increase in the expression of miR-200c that serves as melanoma suppressor by directly targeting zinc-finger E-box binding homeobox 1 to inhibit epithelial-mesenchymal transition and block tumor metastasis .
67	inhibit	negative	mir-200c	1194.274	654.1665	654.1665	miRNA		Vaccination with the viable B16F10/ESAT-6-GPI-IL-21 vaccine resulted in an increase of IFN-帠 level and the CD8 ( + ) CTL cytotoxicity , a decrease in TGF-?] generation and increase in the expression of miR-200c that serves as melanoma suppressor by directly targeting zinc-finger E-box binding homeobox 1 to inhibit epithelial-mesenchymal transition and block tumor metastasis .
67	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Vaccination with the viable B16F10/ESAT-6-GPI-IL-21 vaccine resulted in an increase of IFN-帠 level and the CD8 ( + ) CTL cytotoxicity , a decrease in TGF-?] generation and increase in the expression of miR-200c that serves as melanoma suppressor by directly targeting zinc-finger E-box binding homeobox 1 to inhibit epithelial-mesenchymal transition and block tumor metastasis .
50	inhibit	negative	mir-200c	1194.274	654.1665	654.1665	miRNA		Taken together , our study demonstrated that miR-200c inhibits metastatic ability by targeting ZEB1 in colon cancer cells SW480/620 and suggested that modulation of miR-200c could serve as therapeutic tool for inhibiting metastasis in colorectal cancer .
50	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Taken together , our study demonstrated that miR-200c inhibits metastatic ability by targeting ZEB1 in colon cancer cells SW480/620 and suggested that modulation of miR-200c could serve as therapeutic tool for inhibiting metastasis in colorectal cancer .
49	inhibit	negative	mir-200c	1194.274	654.1665	654.1665	miRNA		Taken together , our study demonstrated that miR-200c inhibits metastatic ability by targeting ZEB1 in colon cancer cells SW480/620 and suggested that modulation of miR-200c could serve as therapeutic tool for inhibiting metastasis in colorectal cancer .
49	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Taken together , our study demonstrated that miR-200c inhibits metastatic ability by targeting ZEB1 in colon cancer cells SW480/620 and suggested that modulation of miR-200c could serve as therapeutic tool for inhibiting metastasis in colorectal cancer .
48	promote	positive	mir-107	1196.685	649.4424	649.4424	miRNA		It is known that miRNA-107 ( miR-107 ) promotes cancer invasion and metastasis .
48	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	It is known that miRNA-107 ( miR-107 ) promotes cancer invasion and metastasis .
47	promote	positive	mirna-107	1199.039	644.6898	644.6898	miRNA		It is known that miRNA-107 ( miR-107 ) promotes cancer invasion and metastasis .
47	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	It is known that miRNA-107 ( miR-107 ) promotes cancer invasion and metastasis .
46	suppress	negative	mirna-29b	1201.336	639.9094	639.9094	miRNA		miRNA-29b suppresses prostate cancer metastasis by regulating epithelial-mesenchymal transition signaling .
46	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miRNA-29b suppresses prostate cancer metastasis by regulating epithelial-mesenchymal transition signaling .
1799	upregulate	positive	mir-493	1203.576	635.1019	635.1019	miRNA		We further found that up-regulation of miR-493 inhibited the proliferation and metastasis of gastric cancer cells , in vitro and in vivo .
1799	upregulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	We further found that up-regulation of miR-493 inhibited the proliferation and metastasis of gastric cancer cells , in vitro and in vivo .
586	suppress	negative	mir-493	1203.576	635.1019	635.1019	miRNA		Thus , MKK7 is a major functional target of miR-493 , and its suppression thwarts liver metastasis of colon cancer cells .
586	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Thus , MKK7 is a major functional target of miR-493 , and its suppression thwarts liver metastasis of colon cancer cells .
585	inhibit	negative	mir-493	1203.576	635.1019	635.1019	miRNA		We previously showed that IGF1R is a target gene of miR-493 , and that the inhibition of IGF1R partly explains how miR-493 suppresses liver metastasis .
585	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	We previously showed that IGF1R is a target gene of miR-493 , and that the inhibition of IGF1R partly explains how miR-493 suppresses liver metastasis .
584	mediate	neutral	mir-493	1203.576	635.1019	635.1019	miRNA		MKK7 mediates miR-493-dependent suppression of liver metastasis of colon cancer cells .
584	mediate	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MKK7 mediates miR-493-dependent suppression of liver metastasis of colon cancer cells .
45	upregulate	positive	mir-493	1203.576	635.1019	635.1019	miRNA		We propose that , in a subset of colon cancer , upregulation of miR-493 during carcinogenesis prevents liver metastasis via the induction of cell death of metastasized cells .
45	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We propose that , in a subset of colon cancer , upregulation of miR-493 during carcinogenesis prevents liver metastasis via the induction of cell death of metastasized cells .
1757	inhibit	negative	mir-145	1205.758	630.268	630.268	miRNA		MiR-145 also inhibited cell proliferation , migration , and metastasis , as well as controlled the cytoskeleton dynamics of esophageal cancer .
1757	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-145 also inhibited cell proliferation , migration , and metastasis , as well as controlled the cytoskeleton dynamics of esophageal cancer .
1730	downregulate	negative	mir-145	1205.758	630.268	630.268	miRNA		Together , these findings indicate that miR-145 acts as a tumor suppressor and its downregulation in tumor tissues may contribute to the progression and metastasis of HCC through a mechanism involving ROCK1 , suggesting miR-145 as a potential new diagnostic and therapeutic target for the treatment of HCC .
1730	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Together , these findings indicate that miR-145 acts as a tumor suppressor and its downregulation in tumor tissues may contribute to the progression and metastasis of HCC through a mechanism involving ROCK1 , suggesting miR-145 as a potential new diagnostic and therapeutic target for the treatment of HCC .
1724	downregulate	negative	mir-145	1205.758	630.268	630.268	miRNA		Conclcusion : Our results suggest that miR-145 functions as a tumor metastasis suppressor gene by down-regulating MMP16 and may be a potential target in osteosarcoma treatment .
1724	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Conclcusion : Our results suggest that miR-145 functions as a tumor metastasis suppressor gene by down-regulating MMP16 and may be a potential target in osteosarcoma treatment .
1641	regulate	positive	mir-145	1205.758	630.268	630.268	miRNA		Based on these results , we propose that miR-145 might carry crucial roles in LSCC tumorigenesis , prognosis , metastasis , chemoresistance , and recurrence through regulating stem cell properties of tumor cells .
1641	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Based on these results , we propose that miR-145 might carry crucial roles in LSCC tumorigenesis , prognosis , metastasis , chemoresistance , and recurrence through regulating stem cell properties of tumor cells .
1252	inhibit	negative	mir-145	1205.758	630.268	630.268	miRNA		MiR-145 inhibits metastasis by targeting fascin actin-bundling protein 1 in nasopharyngeal carcinoma .
1252	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-145 inhibits metastasis by targeting fascin actin-bundling protein 1 in nasopharyngeal carcinoma .
1127	inhibit	negative	mir-145	1205.758	630.268	630.268	miRNA		miR-145 inhibits invasion and metastasis by directly targeting Smad3 in nasopharyngeal cancer .
1127	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-145 inhibits invasion and metastasis by directly targeting Smad3 in nasopharyngeal cancer .
1118	promote	positive	mir-145	1205.758	630.268	630.268	miRNA		Although more work is required to understand how miR-145 conveys these effects , expression of miR-145 appears to promote EAC progression by enhancing invasion and protection against anoikis , which could in turn facilitate distant metastasis .
1118	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Although more work is required to understand how miR-145 conveys these effects , expression of miR-145 appears to promote EAC progression by enhancing invasion and protection against anoikis , which could in turn facilitate distant metastasis .
1050	suppress	negative	mir-145	1205.758	630.268	630.268	miRNA		Ectopic expression of miR-145 suppressed cell invasion and metastasis in NSCLC cells .
1050	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Ectopic expression of miR-145 suppressed cell invasion and metastasis in NSCLC cells .
1049	downregulate	negative	mir-145	1205.758	630.268	630.268	miRNA		MiR-145 was downregulated in the NSCLC specimens and significantly correlated with advanced clinical stage and lymph node metastasis .
1049	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-145 was downregulated in the NSCLC specimens and significantly correlated with advanced clinical stage and lymph node metastasis .
1000	suppress	negative	mir-145	1205.758	630.268	630.268	miRNA		Overexpression of miR-145 in ovarian cancer cells significantly suppressed proliferation , migration and invasion in vitro and inhibited tumor growth and metastasis in vivo .
1000	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Overexpression of miR-145 in ovarian cancer cells significantly suppressed proliferation , migration and invasion in vitro and inhibited tumor growth and metastasis in vivo .
999	inhibit	negative	mir-145	1205.758	630.268	630.268	miRNA		miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma .
999	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma .
985	control	neutral	mir-145	1205.758	630.268	630.268	miRNA		Thus , our findings demonstrate a double-negative feedback loop between ZEB2 and miR-145 and indicate that the ZEB2/miR-145 double-negative feedback loop plays a significant role in the control of EMT and stem cell properties during the bone metastasis of PCa cells .
985	control	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Thus , our findings demonstrate a double-negative feedback loop between ZEB2 and miR-145 and indicate that the ZEB2/miR-145 double-negative feedback loop plays a significant role in the control of EMT and stem cell properties during the bone metastasis of PCa cells .
775	downregulate	negative	mir-145	1205.758	630.268	630.268	miRNA		Taken together , these evidences suggest that miR-145 serves as a tumor suppressor which downregulates LCICs ' cancer stem cell properties and EMT process by targeting Oct4 , leading to the inhibition of tumor growth and metastasis .
775	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , these evidences suggest that miR-145 serves as a tumor suppressor which downregulates LCICs ' cancer stem cell properties and EMT process by targeting Oct4 , leading to the inhibition of tumor growth and metastasis .
674	suppress	negative	mir-145	1205.758	630.268	630.268	miRNA		miR-145 suppresses thyroid cancer growth and metastasis and targets AKT3 .
674	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-145 suppresses thyroid cancer growth and metastasis and targets AKT3 .
626	suppress	negative	mir-145	1205.758	630.268	630.268	miRNA		Stable overexpression of miR-145 suppressed tumour growth and pulmonary metastasis in vivo .
626	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Stable overexpression of miR-145 suppressed tumour growth and pulmonary metastasis in vivo .
449	regulate	positive	mir-145	1205.758	630.268	630.268	miRNA		By functional assay , we found that the expression of miR-145 can regulate the ability of proliferation of A549 and SPC-A1 cells in ? vitro , but is not related to lymph node metastasis , migration and invasion .
449	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	By functional assay , we found that the expression of miR-145 can regulate the ability of proliferation of A549 and SPC-A1 cells in ? vitro , but is not related to lymph node metastasis , migration and invasion .
402	downregulate	negative	mir-145	1205.758	630.268	630.268	miRNA		For the first time , the current data offer convincing evidence that the down-regulation of miR-145 may be associated with tumor aggressiveness and tumor metastasis of osteosarcoma , and that this miRNA may be an independent prognostic marker for osteosarcoma patients .
402	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	For the first time , the current data offer convincing evidence that the down-regulation of miR-145 may be associated with tumor aggressiveness and tumor metastasis of osteosarcoma , and that this miRNA may be an independent prognostic marker for osteosarcoma patients .
401	downregulate	negative	mir-145	1205.758	630.268	630.268	miRNA		In addition , miR-145 downregulation more frequently occurred in osteosarcoma specimens with advanced clinical stage ( P = 0.003 ) and positive distant metastasis ( P = 0.008 ) .
401	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	In addition , miR-145 downregulation more frequently occurred in osteosarcoma specimens with advanced clinical stage ( P = 0.003 ) and positive distant metastasis ( P = 0.008 ) .
273	promote	positive	mir-145	1205.758	630.268	630.268	miRNA		These results suggest that loss of WT-p53 may promote the bone metastasis of PCa at least partially through repressing miR-145 to elevate EMT and stemness of cancer cells .
273	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	These results suggest that loss of WT-p53 may promote the bone metastasis of PCa at least partially through repressing miR-145 to elevate EMT and stemness of cancer cells .
272	promote	positive	mir-145	1205.758	630.268	630.268	miRNA		These results suggest that loss of WT-p53 may promote the bone metastasis of PCa at least partially through repressing miR-145 to elevate EMT and stemness of cancer cells .
272	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	These results suggest that loss of WT-p53 may promote the bone metastasis of PCa at least partially through repressing miR-145 to elevate EMT and stemness of cancer cells .
271	repress	negative	mir-145	1205.758	630.268	630.268	miRNA		MiR-145 , a direct target of p53 , represses bone metastasis of PCa and is involved in regulating EMT and cancer cell stemness .
271	repress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-145 , a direct target of p53 , represses bone metastasis of PCa and is involved in regulating EMT and cancer cell stemness .
270	repress	negative	mir-145	1205.758	630.268	630.268	miRNA		MiR-145 , a direct target of p53 , represses bone metastasis of PCa and is involved in regulating EMT and cancer cell stemness .
270	repress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-145 , a direct target of p53 , represses bone metastasis of PCa and is involved in regulating EMT and cancer cell stemness .
241	repress	negative	mir-145	1205.758	630.268	630.268	miRNA		Although we had identified that microRNA ( miR ) -145 could repress bone metastasis of PCa via regulating epithelial-mesenchymal transition ( EMT ) in previous study , it is still unknown how miR-145 regulated EMT .
241	repress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Although we had identified that microRNA ( miR ) -145 could repress bone metastasis of PCa via regulating epithelial-mesenchymal transition ( EMT ) in previous study , it is still unknown how miR-145 regulated EMT .
240	repress	negative	mir-145	1205.758	630.268	630.268	miRNA		Although we had identified that microRNA ( miR ) -145 could repress bone metastasis of PCa via regulating epithelial-mesenchymal transition ( EMT ) in previous study , it is still unknown how miR-145 regulated EMT .
240	repress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Although we had identified that microRNA ( miR ) -145 could repress bone metastasis of PCa via regulating epithelial-mesenchymal transition ( EMT ) in previous study , it is still unknown how miR-145 regulated EMT .
204	suppress	negative	mir-145	1205.758	630.268	630.268	miRNA		These results show that miR-145 suppresses Ets1 expression via the binding site in the 3'-UTR , thus inhibiting the invasion , metastasis , and angiogenesis of gastric cancer cells .
204	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	These results show that miR-145 suppresses Ets1 expression via the binding site in the 3'-UTR , thus inhibiting the invasion , metastasis , and angiogenesis of gastric cancer cells .
156	inhibit	negative	mir-145	1205.758	630.268	630.268	miRNA		Collectively , these findings demonstrate that miR-143 and miR-145 inhibit CSC properties of PC-3 cells and suggest that miR-143 and miR-145 may play a significant role in the bone metastasis progression of PCa by regulating CSC characteristics .
156	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Collectively , these findings demonstrate that miR-143 and miR-145 inhibit CSC properties of PC-3 cells and suggest that miR-143 and miR-145 may play a significant role in the bone metastasis progression of PCa by regulating CSC characteristics .
155	inhibit	negative	mir-145	1205.758	630.268	630.268	miRNA		Collectively , these findings demonstrate that miR-143 and miR-145 inhibit CSC properties of PC-3 cells and suggest that miR-143 and miR-145 may play a significant role in the bone metastasis progression of PCa by regulating CSC characteristics .
155	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Collectively , these findings demonstrate that miR-143 and miR-145 inhibit CSC properties of PC-3 cells and suggest that miR-143 and miR-145 may play a significant role in the bone metastasis progression of PCa by regulating CSC characteristics .
152	inhibit	negative	mir-145	1205.758	630.268	630.268	miRNA		Collectively , these findings demonstrate that miR-143 and miR-145 inhibit CSC properties of PC-3 cells and suggest that miR-143 and miR-145 may play a significant role in the bone metastasis progression of PCa by regulating CSC characteristics .
152	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Collectively , these findings demonstrate that miR-143 and miR-145 inhibit CSC properties of PC-3 cells and suggest that miR-143 and miR-145 may play a significant role in the bone metastasis progression of PCa by regulating CSC characteristics .
151	inhibit	negative	mir-145	1205.758	630.268	630.268	miRNA		Collectively , these findings demonstrate that miR-143 and miR-145 inhibit CSC properties of PC-3 cells and suggest that miR-143 and miR-145 may play a significant role in the bone metastasis progression of PCa by regulating CSC characteristics .
151	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Collectively , these findings demonstrate that miR-143 and miR-145 inhibit CSC properties of PC-3 cells and suggest that miR-143 and miR-145 may play a significant role in the bone metastasis progression of PCa by regulating CSC characteristics .
148	inhibit	negative	mir-145	1205.758	630.268	630.268	miRNA		In this study , we found that overexpression of miR-143 and miR-145 inhibited the cell viability and colony formation of PC-3 cells from PCa bone metastasis .
148	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In this study , we found that overexpression of miR-143 and miR-145 inhibited the cell viability and colony formation of PC-3 cells from PCa bone metastasis .
146	regulate	positive	mir-145	1205.758	630.268	630.268	miRNA		A previous study showed that miR-143 and miR-145 play an important role in regulating bone metastasis of prostate cancer ( PCa ) , but the exact mechanism of regulation of bone metastasis of PCa is not fully understood .
146	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	A previous study showed that miR-143 and miR-145 play an important role in regulating bone metastasis of prostate cancer ( PCa ) , but the exact mechanism of regulation of bone metastasis of PCa is not fully understood .
145	regulate	positive	mir-145	1205.758	630.268	630.268	miRNA		A previous study showed that miR-143 and miR-145 play an important role in regulating bone metastasis of prostate cancer ( PCa ) , but the exact mechanism of regulation of bone metastasis of PCa is not fully understood .
145	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	A previous study showed that miR-143 and miR-145 play an important role in regulating bone metastasis of prostate cancer ( PCa ) , but the exact mechanism of regulation of bone metastasis of PCa is not fully understood .
57	downregulate	negative	mir-145	1205.758	630.268	630.268	miRNA		Among , downregulation of six miRNAs , has-let-7c , has-miR-100 , has-miR-125b , has-miR-143 , has-miR-145 and has-miR-199a-5p were significantly associated with lymph node metastasis and reduced survival in SCCC .
57	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Among , downregulation of six miRNAs , has-let-7c , has-miR-100 , has-miR-125b , has-miR-143 , has-miR-145 and has-miR-199a-5p were significantly associated with lymph node metastasis and reduced survival in SCCC .
44	suppress	negative	mir-145	1205.758	630.268	630.268	miRNA		We suggest that miR-145 suppresses tumor metastasis by inhibiting N-cadherin protein translation , and then indirectly downregulates its downstream effector MMP9 .
44	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We suggest that miR-145 suppresses tumor metastasis by inhibiting N-cadherin protein translation , and then indirectly downregulates its downstream effector MMP9 .
43	regulate	positive	mir-145	1205.758	630.268	630.268	miRNA		This study 's aim was to clarify the roles of miR-145 in gastric carcinomas and its underlying molecular mechanism in regulating tumor metastasis .
43	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	This study 's aim was to clarify the roles of miR-145 in gastric carcinomas and its underlying molecular mechanism in regulating tumor metastasis .
1542	regulate	positive	mir-182	1207.882	625.4084	625.4084	miRNA		We have shown that miR-182 drives sarcoma metastasis in vivo by coordinated regulation of multiple genes .
1542	regulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	We have shown that miR-182 drives sarcoma metastasis in vivo by coordinated regulation of multiple genes .
1495	control	neutral	mir-182	1207.882	625.4084	625.4084	miRNA		Taken together , these results suggest that sarcoma metastasis can be partially controlled through Pax7/MyoD-dependent activation of miR-182 and provide insight into the role that myogenic transcription factors have in sarcoma progression .
1495	control	neutral	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Taken together , these results suggest that sarcoma metastasis can be partially controlled through Pax7/MyoD-dependent activation of miR-182 and provide insight into the role that myogenic transcription factors have in sarcoma progression .
1494	promote	positive	mir-182	1207.882	625.4084	625.4084	miRNA		Furthermore , mechanistic studies revealed that Pax7 can promote sarcoma metastasis in vivo through MyoD-dependent regulation of pro-metastatic miR-182 .
1494	promote	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Furthermore , mechanistic studies revealed that Pax7 can promote sarcoma metastasis in vivo through MyoD-dependent regulation of pro-metastatic miR-182 .
1355	downregulate	negative	mir-182	1207.882	625.4084	625.4084	miRNA		MiR-182 might act as a tumor suppressor gene whose down-regulation contributes to the progression and metastasis of osteosarcoma , providing a potential therapy target for osteosarcoma patients .
1355	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	MiR-182 might act as a tumor suppressor gene whose down-regulation contributes to the progression and metastasis of osteosarcoma , providing a potential therapy target for osteosarcoma patients .
1300	regulate	positive	mir-182	1207.882	625.4084	625.4084	miRNA		We identified a novel mechanism of CARMA3 in lung cancer stemness and metastasis through the negative regulation of NME2 by NF-庥B-dependent induction of miR-182 .
1300	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	We identified a novel mechanism of CARMA3 in lung cancer stemness and metastasis through the negative regulation of NME2 by NF-庥B-dependent induction of miR-182 .
1299	promote	positive	mir-182	1207.882	625.4084	625.4084	miRNA		Mechanistically , CARMA3 promoted cell motility by reducing the level of NME2 through the NF-庥B/miR-182 pathway and by increasing cancer stem cell properties and metastasis in lung cancer .
1299	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Mechanistically , CARMA3 promoted cell motility by reducing the level of NME2 through the NF-庥B/miR-182 pathway and by increasing cancer stem cell properties and metastasis in lung cancer .
998	control	neutral	mir-182	1207.882	625.4084	625.4084	miRNA		Our findings revealed that the level of circulating miR-182 in PCa patients was higher than that in CP patients and healthy controls ( both at P < 0.05 ) , which was significantly associated with clinical stages ( P < 0.001 ) and lymph node metastasis ( P = 0.018 ) .
998	control	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our findings revealed that the level of circulating miR-182 in PCa patients was higher than that in CP patients and healthy controls ( both at P < 0.05 ) , which was significantly associated with clinical stages ( P < 0.001 ) and lymph node metastasis ( P = 0.018 ) .
997	control	neutral	mir-182	1207.882	625.4084	625.4084	miRNA		Our findings revealed that the level of circulating miR-182 in PCa patients was higher than that in CP patients and healthy controls ( both at P < 0.05 ) , which was significantly associated with clinical stages ( P < 0.001 ) and lymph node metastasis ( P = 0.018 ) .
997	control	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our findings revealed that the level of circulating miR-182 in PCa patients was higher than that in CP patients and healthy controls ( both at P < 0.05 ) , which was significantly associated with clinical stages ( P < 0.001 ) and lymph node metastasis ( P = 0.018 ) .
762	upregulate	positive	mir-182	1207.882	625.4084	625.4084	miRNA		Our results illustrated that the up-regulation of miR-182 played a pivotal role in CRC tumorigenesis and metastasis , which suggesting a potential implication of miR-182 in the molecular therapy for CRC .
762	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our results illustrated that the up-regulation of miR-182 played a pivotal role in CRC tumorigenesis and metastasis , which suggesting a potential implication of miR-182 in the molecular therapy for CRC .
563	mediate	neutral	mir-182	1207.882	625.4084	625.4084	miRNA		miR-182 is an important mediator of GBC metastasis , thus offering a new target for the development of therapeutic agents against GBC .
563	mediate	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-182 is an important mediator of GBC metastasis , thus offering a new target for the development of therapeutic agents against GBC .
562	upregulate	positive	mir-182	1207.882	625.4084	625.4084	miRNA		TGF-?] upregulates miR-182 expression to promote gallbladder cancer metastasis by targeting CADM1 .
562	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	TGF-?] upregulates miR-182 expression to promote gallbladder cancer metastasis by targeting CADM1 .
462	downregulate	negative	mir-182	1207.882	625.4084	625.4084	miRNA		miR-182 , over-expressed in colorectal cancer ( CRC ) , has like predictive target thrombospondin-1 ( TSP-1 ) , a protein inversely correlated with tumor vascularity and metastasis that results downregulated in different types of cancer including CRC .
462	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-182 , over-expressed in colorectal cancer ( CRC ) , has like predictive target thrombospondin-1 ( TSP-1 ) , a protein inversely correlated with tumor vascularity and metastasis that results downregulated in different types of cancer including CRC .
461	regulate	positive	mir-182	1207.882	625.4084	625.4084	miRNA		We investigate on the molecular mechanism by which miR-182 could regulate thrombospondin-1 ( TSP-1 ) expression , a protein downregulated in CRC and inversely correlated with tumor vascularity and metastasis .
461	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We investigate on the molecular mechanism by which miR-182 could regulate thrombospondin-1 ( TSP-1 ) expression , a protein downregulated in CRC and inversely correlated with tumor vascularity and metastasis .
295	promote	positive	mir-182	1207.882	625.4084	625.4084	miRNA		Hence , our data delineates the molecular pathway by which miR-182 promotes breast cancer invasion and metastasis , and may have important implication for the treatment of metastatic cancers .
295	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Hence , our data delineates the molecular pathway by which miR-182 promotes breast cancer invasion and metastasis , and may have important implication for the treatment of metastatic cancers .
294	suppress	negative	mir-182	1207.882	625.4084	625.4084	miRNA		We further demonstrated that miR-182 directly targets MIM ( Missing in Metastasis ) , which suppresses metastasis by inhibiting ras homolog family member A ( RhoA ) activity and stress fiber formation in breast cancer cells .
294	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We further demonstrated that miR-182 directly targets MIM ( Missing in Metastasis ) , which suppresses metastasis by inhibiting ras homolog family member A ( RhoA ) activity and stress fiber formation in breast cancer cells .
103	promote	positive	mir-182	1207.882	625.4084	625.4084	miRNA		miR-182 could promote metastasis of HCC and inhibit the expression of MTSS1 .
103	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-182 could promote metastasis of HCC and inhibit the expression of MTSS1 .
42	mediate	neutral	mir-182	1207.882	625.4084	625.4084	miRNA		Mechanistically , we demonstrated that the oncogenic properties of miR-182 in ovarian cancer were mediated in part by its impaired repair of DNA double-strand breaks and negative regulation of breast cancer 1 ( BRCA1 ) and metastasis suppressor 1 ( MTSS1 ) expression as well as its positive regulation of the oncogene high-mobility group AT-hook 2 ( HMGA2 ) .
42	mediate	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Mechanistically , we demonstrated that the oncogenic properties of miR-182 in ovarian cancer were mediated in part by its impaired repair of DNA double-strand breaks and negative regulation of breast cancer 1 ( BRCA1 ) and metastasis suppressor 1 ( MTSS1 ) expression as well as its positive regulation of the oncogene high-mobility group AT-hook 2 ( HMGA2 ) .
41	mediate	neutral	mir-182	1207.882	625.4084	625.4084	miRNA		Mechanistically , we demonstrated that the oncogenic properties of miR-182 in ovarian cancer were mediated in part by its impaired repair of DNA double-strand breaks and negative regulation of breast cancer 1 ( BRCA1 ) and metastasis suppressor 1 ( MTSS1 ) expression as well as its positive regulation of the oncogene high-mobility group AT-hook 2 ( HMGA2 ) .
41	mediate	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Mechanistically , we demonstrated that the oncogenic properties of miR-182 in ovarian cancer were mediated in part by its impaired repair of DNA double-strand breaks and negative regulation of breast cancer 1 ( BRCA1 ) and metastasis suppressor 1 ( MTSS1 ) expression as well as its positive regulation of the oncogene high-mobility group AT-hook 2 ( HMGA2 ) .
1795	upregulate	positive	mir-31	1209.948	620.5237	620.5237	miRNA		Our study concluded that upregulation of miR-31 targeting ITGA5 may suppress tumor cell invasion and metastasis by indirectly regulating PI3K/AKT signaling pathway in human SGC7901 GC cells .
1795	upregulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	Our study concluded that upregulation of miR-31 targeting ITGA5 may suppress tumor cell invasion and metastasis by indirectly regulating PI3K/AKT signaling pathway in human SGC7901 GC cells .
1794	upregulate	positive	mir-31	1209.948	620.5237	620.5237	miRNA		To verify the hypothesis that upregulation of microRNA-31 ( miR-31 ) targeting integrin 帢5 ( ITGA5 ) suppresses tumor cell invasion and metastasis by indirectly regulating phosphoinositide 3-kinase ( PI3K ) /protein kinase B ( AKT ) signaling pathway in human SGC7901 gastric cancer ( GC ) cells .
1794	upregulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	To verify the hypothesis that upregulation of microRNA-31 ( miR-31 ) targeting integrin 帢5 ( ITGA5 ) suppresses tumor cell invasion and metastasis by indirectly regulating phosphoinositide 3-kinase ( PI3K ) /protein kinase B ( AKT ) signaling pathway in human SGC7901 gastric cancer ( GC ) cells .
1292	inhibit	negative	mir-31	1209.948	620.5237	620.5237	miRNA		Retraction Notice to : A Pleiotropically Acting MicroRNA , miR-31 , Inhibits Breast Cancer Metastasis .
1292	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Retraction Notice to : A Pleiotropically Acting MicroRNA , miR-31 , Inhibits Breast Cancer Metastasis .
694	downregulate	negative	mir-31	1209.948	620.5237	620.5237	miRNA		For example , deficiencies of enzymes including Dicer and Drosha that are required for miRNA biogenesis may be adverse prognostic factors ; miRNAs such as miR-214 and miR-31 , which are involved in drug resistance , and the miR-200 family , which is implicated in metastasis , may serve as biomarkers ; and transfection of downregulated miRNAs and inhibition of upregulated miRNAs may be effective for treatment of ovarian cancer .
694	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	For example , deficiencies of enzymes including Dicer and Drosha that are required for miRNA biogenesis may be adverse prognostic factors ; miRNAs such as miR-214 and miR-31 , which are involved in drug resistance , and the miR-200 family , which is implicated in metastasis , may serve as biomarkers ; and transfection of downregulated miRNAs and inhibition of upregulated miRNAs may be effective for treatment of ovarian cancer .
547	upregulate	positive	mir-31	1209.948	620.5237	620.5237	miRNA		Our results illustrated that the up-regulation of miR-31 played an important role in CRC cell proliferation , invasion , and metastasis in vitro and in vivo through direct repressing SATB2 , suggesting a potential application of miR-31 in prognosis prediction and therapeutic application in CRC .
547	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our results illustrated that the up-regulation of miR-31 played an important role in CRC cell proliferation , invasion , and metastasis in vitro and in vivo through direct repressing SATB2 , suggesting a potential application of miR-31 in prognosis prediction and therapeutic application in CRC .
242	inhibit	negative	mir-31	1209.948	620.5237	620.5237	miRNA		In breast cancer cell systems , miR-31 has been shown to inhibit cell migration , invasion , and metastasis .
242	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In breast cancer cell systems , miR-31 has been shown to inhibit cell migration , invasion , and metastasis .
39	regulate	positive	mir-31	1209.948	620.5237	620.5237	miRNA		Together , our results provide the initial evidence for a mechanism by which miR-31 , an important determinant of the invasion metastasis cascade , is regulated in breast cancer .
39	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Together , our results provide the initial evidence for a mechanism by which miR-31 , an important determinant of the invasion metastasis cascade , is regulated in breast cancer .
1958	repress	negative	mir-409	1228.756	565.3425	565.3425	miRNA		Altogether , these results indicated that miR-409-3p targets catenin-帤1 to repress osteosarcoma metastasis .
1958	repress	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Altogether , these results indicated that miR-409-3p targets catenin-帤1 to repress osteosarcoma metastasis .
1805	inhibit	negative	mir-15b	1240.836	502.9107	502.9107	miRNA		Inhibition of miR-15b activity by adenovirus carrying antimiR-15b sequence significantly increased MTSS1 and Klotho protein expression and subsequently decreased colony formation ability , invasion , and migration of HCT116 cells in vitro and liver metastasis of HCT116 tumors in vivo .
1805	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Inhibition of miR-15b activity by adenovirus carrying antimiR-15b sequence significantly increased MTSS1 and Klotho protein expression and subsequently decreased colony formation ability , invasion , and migration of HCT116 cells in vitro and liver metastasis of HCT116 tumors in vivo .
1804	inhibit	negative	mir-15b	1240.836	502.9107	502.9107	miRNA		Inhibition of miR-15b activity by adenovirus carrying antimiR-15b sequence significantly increased MTSS1 and Klotho protein expression and subsequently decreased colony formation ability , invasion , and migration of HCT116 cells in vitro and liver metastasis of HCT116 tumors in vivo .
1804	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Inhibition of miR-15b activity by adenovirus carrying antimiR-15b sequence significantly increased MTSS1 and Klotho protein expression and subsequently decreased colony formation ability , invasion , and migration of HCT116 cells in vitro and liver metastasis of HCT116 tumors in vivo .
1732	inhibit	negative	mir-370	1242.86	481.7948	481.7948	miRNA		In conclusion , miR-370 inhibited cell growth and metastasis in osteosarcoma cells by down-regulation of FOXM1 .
1732	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	In conclusion , miR-370 inhibited cell growth and metastasis in osteosarcoma cells by down-regulation of FOXM1 .
1257	downregulate	negative	mir-195	1244	450	450	miRNA		In summary , our study suggests miR-195 functions as a tumor metastasis suppressor gene by down-regulating CCND1 and can be used as a potential target in the treatment of osteosarcoma .
1257	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	In summary , our study suggests miR-195 functions as a tumor metastasis suppressor gene by down-regulating CCND1 and can be used as a potential target in the treatment of osteosarcoma .
1256	inhibit	negative	mir-195	1244	450	450	miRNA		It was showed that over-expression of miR-195 substantially inhibits migration and invasion of osteosarcoma cells in vitro and pulmonary metastasis formation in vivo .
1256	inhibit	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	It was showed that over-expression of miR-195 substantially inhibits migration and invasion of osteosarcoma cells in vitro and pulmonary metastasis formation in vivo .
1255	suppress	negative	mir-195	1244	450	450	miRNA		MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1 .
1255	suppress	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1 .
1175	downregulate	negative	mir-124	1241.974	492.3649	492.3649	miRNA		In addition , miR-124 downregulation more frequently occurred in osteosarcoma specimens with advanced clinical stage ( P < 0.001 ) , positive distant metastasis ( P=0.005 ) and poor response to neoadjuvant chemotherapy ( P=0.013 ) .
1175	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	In addition , miR-124 downregulation more frequently occurred in osteosarcoma specimens with advanced clinical stage ( P < 0.001 ) , positive distant metastasis ( P=0.005 ) and poor response to neoadjuvant chemotherapy ( P=0.013 ) .
899	downregulate	negative	mir-133b	1225.879	575.5518	575.5518	miRNA		Then , the downregulation of miR-133b and miR-206 both more frequently occurred in osteosarcoma patients with high tumor grade ( both P=0.01 ) , positive metastasis ( both P < 0.001 ) and recurrence ( both P < 0.001 ) .
899	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Then , the downregulation of miR-133b and miR-206 both more frequently occurred in osteosarcoma patients with high tumor grade ( both P=0.01 ) , positive metastasis ( both P < 0.001 ) and recurrence ( both P < 0.001 ) .
800	promote	positive	microrna-21	1213.905	610.6822	610.6822	miRNA		Endothelial progenitors promote hepatocarcinoma intrahepatic metastasis through monocyte chemotactic protein-1 induction of microRNA-21 .
800	promote	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Endothelial progenitors promote hepatocarcinoma intrahepatic metastasis through monocyte chemotactic protein-1 induction of microRNA-21 .
743	downregulate	negative	mir-200b	1241.437	497.6412	497.6412	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
743	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
742	downregulate	negative	mir-200b	1241.437	497.6412	497.6412	miRNA		The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
742	downregulate	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	The miRNA microarray initially identified that eight miRNAs ( miR-206 , miR-3923 , miR-181a , miR-92a , miR-421 , miR-339-5p , miR-3196 , and miR-29b ) were downregulated in LN metastasis group , whereas five miRNAs ( miR-542-5p , miR-200a , miR-564 , miR-451 , miR-30c , miR-200b , miR-191-3p , miR-142-5p , and miR-185-5p ) were upregulated in LN group when compared with those in NLN group .
427	control	neutral	mir-335	1238.657	518.671	518.671	miRNA		In this study , we found that the expression of miR-335 in osteosarcoma tissues and cell lines was much lower than that in normal control , respectively , and the downregulated miR-335 was significantly associated with lymph-node metastasis .
427	control	neutral	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	In this study , we found that the expression of miR-335 in osteosarcoma tissues and cell lines was much lower than that in normal control , respectively , and the downregulated miR-335 was significantly associated with lymph-node metastasis .
426	control	neutral	mir-335	1238.657	518.671	518.671	miRNA		In this study , we found that the expression of miR-335 in osteosarcoma tissues and cell lines was much lower than that in normal control , respectively , and the downregulated miR-335 was significantly associated with lymph-node metastasis .
426	control	neutral	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	In this study , we found that the expression of miR-335 in osteosarcoma tissues and cell lines was much lower than that in normal control , respectively , and the downregulated miR-335 was significantly associated with lymph-node metastasis .
289	induce	positive	mir-195	1244	450	450	miRNA		Based on mouse models , we found that the induced expression of miR-195 dramatically reduced microvessel densities in xenograft tumors and repressed both intrahepatic and pulmonary metastasis .
289	induce	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Based on mouse models , we found that the induced expression of miR-195 dramatically reduced microvessel densities in xenograft tumors and repressed both intrahepatic and pulmonary metastasis .
211	suppress	negative	mir-124	1241.974	492.3649	492.3649	miRNA		Also , lentivirus-delivered miR-124 endows MDA-MB-231 cells with the ability to suppress cell colony formation in vitro and pulmonary metastasis in vivo .
211	suppress	negative	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	Also , lentivirus-delivered miR-124 endows MDA-MB-231 cells with the ability to suppress cell colony formation in vitro and pulmonary metastasis in vivo .
38	upregulate	positive	microrna-21	1213.905	610.6822	610.6822	miRNA		microRNA-21 expression was upregulated in gastric carcinoma tissues and was significantly associated with the degree of differentiation of tumour tissues , local invasion and lymph node metastasis .
38	upregulate	positive	local invasion 	1211.956	615.6148	615.6148	Cancer	D009362	microRNA-21 expression was upregulated in gastric carcinoma tissues and was significantly associated with the degree of differentiation of tumour tissues , local invasion and lymph node metastasis .
1700	downregulate	negative	microrna-21	1213.905	610.6822	610.6822	miRNA		We observed that MEG3 was downregulated in cervical cancer tissues , compared to the adjacent normal tissues , and was negatively related with FIGO stages , tumor size , lymphatic metastasis , HR-HPV infection and the expression of homo sapiens microRNA-21 ( miR-21 ) .
1700	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We observed that MEG3 was downregulated in cervical cancer tissues , compared to the adjacent normal tissues , and was negatively related with FIGO stages , tumor size , lymphatic metastasis , HR-HPV infection and the expression of homo sapiens microRNA-21 ( miR-21 ) .
1699	downregulate	negative	microrna-21	1213.905	610.6822	610.6822	miRNA		We observed that MEG3 was downregulated in cervical cancer tissues , compared to the adjacent normal tissues , and was negatively related with FIGO stages , tumor size , lymphatic metastasis , HR-HPV infection and the expression of homo sapiens microRNA-21 ( miR-21 ) .
1699	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We observed that MEG3 was downregulated in cervical cancer tissues , compared to the adjacent normal tissues , and was negatively related with FIGO stages , tumor size , lymphatic metastasis , HR-HPV infection and the expression of homo sapiens microRNA-21 ( miR-21 ) .
1461	induce	positive	microrna-21	1213.905	610.6822	610.6822	miRNA		In conclusion , microRNA-21 is crucial for CCA carcinogenesis and metastasis , which could induce EMT process , thereby promote the invasion and migration of CCA cells .
1461	induce	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In conclusion , microRNA-21 is crucial for CCA carcinogenesis and metastasis , which could induce EMT process , thereby promote the invasion and migration of CCA cells .
1460	induce	positive	microrna-21	1213.905	610.6822	610.6822	miRNA		In conclusion , microRNA-21 is crucial for CCA carcinogenesis and metastasis , which could induce EMT process , thereby promote the invasion and migration of CCA cells .
1460	induce	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	In conclusion , microRNA-21 is crucial for CCA carcinogenesis and metastasis , which could induce EMT process , thereby promote the invasion and migration of CCA cells .
1158	inhibit	negative	microrna-21	1213.905	610.6822	610.6822	miRNA		Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis , metastasis , and chemotherapy resistance in pancreatic cancer .
1158	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis , metastasis , and chemotherapy resistance in pancreatic cancer .
1120	inhibit	negative	microrna-21	1213.905	610.6822	610.6822	miRNA		Inhibition of NADPH oxidase protects against metastasis of human lung cancer by decreasing microRNA-21 .
1120	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Inhibition of NADPH oxidase protects against metastasis of human lung cancer by decreasing microRNA-21 .
773	downregulate	negative	microrna-21	1213.905	610.6822	610.6822	miRNA		MicroRNA-21 ( miR-21 ) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation , proliferation , and metastasis in renal cell carcinoma .
773	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-21 ( miR-21 ) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation , proliferation , and metastasis in renal cell carcinoma .
434	promote	positive	microrna-21	1213.905	610.6822	610.6822	miRNA		MicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasis .
434	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasis .
417	promote	positive	microrna-21	1213.905	610.6822	610.6822	miRNA		The aim of this study is to determine whether microRNA-21 ( miR-21 ) , a specific microRNA implicated in multiple aspects of carcinogenesis , promoted breast cancer metastasis by regulating the tissue inhibitor of metalloproteinase 3 ( TIMP-3 ) gene .
417	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The aim of this study is to determine whether microRNA-21 ( miR-21 ) , a specific microRNA implicated in multiple aspects of carcinogenesis , promoted breast cancer metastasis by regulating the tissue inhibitor of metalloproteinase 3 ( TIMP-3 ) gene .
335	influence	neutral	microrna-21	1213.905	610.6822	610.6822	miRNA		Influence on cholangiocarcinoma cell line invasion and metastasis was analyzed with microRNA-21 transfected cells .
335	influence	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Influence on cholangiocarcinoma cell line invasion and metastasis was analyzed with microRNA-21 transfected cells .
334	regulate	positive	microrna-21	1213.905	610.6822	610.6822	miRNA		MicroRNA-21 regulates the invasion and metastasis in cholangiocarcinoma and may be a potential biomarker for cancer prognosis .
334	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-21 regulates the invasion and metastasis in cholangiocarcinoma and may be a potential biomarker for cancer prognosis .
213	inhibit	negative	microrna-21	1213.905	610.6822	610.6822	miRNA		Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway .
213	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway .
162	promote	positive	microrna-21	1213.905	610.6822	610.6822	miRNA		MicroRNA-21 ( miR-21 ) expression promotes growth , metastasis , and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN .
162	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-21 ( miR-21 ) expression promotes growth , metastasis , and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN .
161	promote	positive	microrna-21	1213.905	610.6822	610.6822	miRNA		MicroRNA-21 ( miR-21 ) expression promotes growth , metastasis , and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN .
161	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-21 ( miR-21 ) expression promotes growth , metastasis , and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN .
100	enhance	positive	microrna-21	1213.905	610.6822	610.6822	miRNA		The enhanced abundance of microRNA-21 ( miR-21 ) in breast cancer cells contributes to the growth and metastasis .
100	enhance	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The enhanced abundance of microRNA-21 ( miR-21 ) in breast cancer cells contributes to the growth and metastasis .
1807	promote	positive	mir-28	1215.795	605.7266	605.7266	miRNA		Biofunctional investigations revealed that miR-28-5p deficiency promoted tumor growth and metastasis in nude mice without altering the in vitro biological characteristics of HCC cells .
1807	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Biofunctional investigations revealed that miR-28-5p deficiency promoted tumor growth and metastasis in nude mice without altering the in vitro biological characteristics of HCC cells .
37	control	neutral	mir-28	1215.795	605.7266	605.7266	miRNA		CRC cells overexpressing miR-28 developed tumors more slowly in mice compared with control cells , but miR-28 promoted tumor metastasis in mice .
37	control	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	CRC cells overexpressing miR-28 developed tumors more slowly in mice compared with control cells , but miR-28 promoted tumor metastasis in mice .
1224	inhibit	negative	mir-7	1217.625	600.7489	600.7489	miRNA		In conclusion , miR-7 inhibited the metastasis and invasion of cervical cancer at least partially through targeting FAK .
1224	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In conclusion , miR-7 inhibited the metastasis and invasion of cervical cancer at least partially through targeting FAK .
1223	inhibit	negative	mir-7	1217.625	600.7489	600.7489	miRNA		Ectopic expression of miR-7 significantly inhibited metastasis and invasion in Hela and C33A cells .
1223	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Ectopic expression of miR-7 significantly inhibited metastasis and invasion in Hela and C33A cells .
880	inhibit	negative	mir-7	1217.625	600.7489	600.7489	miRNA		MiR-7 inhibited the metastasis of BCSCs in lungs , kidneys , and adrenal glands of NOD/SCID mice .
880	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-7 inhibited the metastasis of BCSCs in lungs , kidneys , and adrenal glands of NOD/SCID mice .
879	downregulate	negative	mir-7	1217.625	600.7489	600.7489	miRNA		Here , we show that miR-7 , which was downregulated in breast CSCs ( BCSCs ) isolated from the human MCF-7 and MDA-MB-231 cell lines , inhibited cell invasion and metastasis , decreased the BCSC population and partially reversed EMT in MDA-MB-231 cells by directly targeting the oncogene , SETDB1 .
879	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here , we show that miR-7 , which was downregulated in breast CSCs ( BCSCs ) isolated from the human MCF-7 and MDA-MB-231 cell lines , inhibited cell invasion and metastasis , decreased the BCSC population and partially reversed EMT in MDA-MB-231 cells by directly targeting the oncogene , SETDB1 .
878	downregulate	negative	mir-7	1217.625	600.7489	600.7489	miRNA		Here , we show that miR-7 , which was downregulated in breast CSCs ( BCSCs ) isolated from the human MCF-7 and MDA-MB-231 cell lines , inhibited cell invasion and metastasis , decreased the BCSC population and partially reversed EMT in MDA-MB-231 cells by directly targeting the oncogene , SETDB1 .
878	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here , we show that miR-7 , which was downregulated in breast CSCs ( BCSCs ) isolated from the human MCF-7 and MDA-MB-231 cell lines , inhibited cell invasion and metastasis , decreased the BCSC population and partially reversed EMT in MDA-MB-231 cells by directly targeting the oncogene , SETDB1 .
692	inhibit	negative	mir-7	1217.625	600.7489	600.7489	miRNA		Taken together , our results suggested that miR-7 inhibited tumor metastasis and reversed EMT through AKT and ERK1/2 pathway inactivation by reducing EGFR expression in EOC cell lines .
692	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , our results suggested that miR-7 inhibited tumor metastasis and reversed EMT through AKT and ERK1/2 pathway inactivation by reducing EGFR expression in EOC cell lines .
691	inhibit	negative	mir-7	1217.625	600.7489	600.7489	miRNA		Taken together , our results suggested that miR-7 inhibited tumor metastasis and reversed EMT through AKT and ERK1/2 pathway inactivation by reducing EGFR expression in EOC cell lines .
691	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , our results suggested that miR-7 inhibited tumor metastasis and reversed EMT through AKT and ERK1/2 pathway inactivation by reducing EGFR expression in EOC cell lines .
690	downregulate	negative	mir-7	1217.625	600.7489	600.7489	miRNA		In this study , we found that miR-7 expression was significantly downregulated in highly metastatic epithelial ovarian cancer ( EOC ) cell lines and metastatic tissues , whereas the expression of , EGFR correlated positively with metastasis in both EOC patients and cell lines .
690	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In this study , we found that miR-7 expression was significantly downregulated in highly metastatic epithelial ovarian cancer ( EOC ) cell lines and metastatic tissues , whereas the expression of , EGFR correlated positively with metastasis in both EOC patients and cell lines .
689	downregulate	negative	mir-7	1217.625	600.7489	600.7489	miRNA		In this study , we found that miR-7 expression was significantly downregulated in highly metastatic epithelial ovarian cancer ( EOC ) cell lines and metastatic tissues , whereas the expression of , EGFR correlated positively with metastasis in both EOC patients and cell lines .
689	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In this study , we found that miR-7 expression was significantly downregulated in highly metastatic epithelial ovarian cancer ( EOC ) cell lines and metastatic tissues , whereas the expression of , EGFR correlated positively with metastasis in both EOC patients and cell lines .
594	inhibit	negative	mir-7	1217.625	600.7489	600.7489	miRNA		miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression .
594	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression .
253	suppress	negative	mir-7	1217.625	600.7489	600.7489	miRNA		miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4 .
253	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4 .
131	induce	positive	mir-7	1217.625	600.7489	600.7489	miRNA		MiR-7 transfection into ovarian cancer cells induces changes in cell adhesion and other developmental networks previously associated with epithelial-mesenchymal transitions ( EMT ) and other processes linked with metastasis .
131	induce	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-7 transfection into ovarian cancer cells induces changes in cell adhesion and other developmental networks previously associated with epithelial-mesenchymal transitions ( EMT ) and other processes linked with metastasis .
87	inhibit	negative	mir-7	1217.625	600.7489	600.7489	miRNA		In vivo metastasis assays also demonstrated that overexpression of miR-7 markedly inhibited GC metastasis .
87	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	In vivo metastasis assays also demonstrated that overexpression of miR-7 markedly inhibited GC metastasis .
36	inhibit	negative	mir-7	1217.625	600.7489	600.7489	miRNA		These findings indicate that miR-7 functions as a tumor suppressor and plays a substantial role in inhibiting the tumorigenesis and reversing the metastasis of HCC through the PI3K/Akt/mTOR-signaling pathway in vitro and in vivo .
36	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	These findings indicate that miR-7 functions as a tumor suppressor and plays a substantial role in inhibiting the tumorigenesis and reversing the metastasis of HCC through the PI3K/Akt/mTOR-signaling pathway in vitro and in vivo .
35	inhibit	negative	mir-7	1217.625	600.7489	600.7489	miRNA		Here , we demonstrate that miR-7 inhibits HCC cell growth and metastasis in vitro and in vivo .
35	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Here , we demonstrate that miR-7 inhibits HCC cell growth and metastasis in vitro and in vivo .
1847	downregulate	negative	microrna-7	1219.396	595.7496	595.7496	miRNA		MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis .
1847	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis .
1222	inhibit	negative	microrna-7	1219.396	595.7496	595.7496	miRNA		MicroRNA-7 inhibits metastasis and invasion through targeting focal adhesion kinase in cervical cancer .
1222	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-7 inhibits metastasis and invasion through targeting focal adhesion kinase in cervical cancer .
688	inhibit	negative	microrna-7	1219.396	595.7496	595.7496	miRNA		MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer .
688	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer .
245	regulate	positive	microrna-7	1219.396	595.7496	595.7496	miRNA		Regulation of epidermal growth factor receptor signaling by plasmid-based microRNA-7 inhibits human malignant gliomas growth and metastasis in vivo .
245	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Regulation of epidermal growth factor receptor signaling by plasmid-based microRNA-7 inhibits human malignant gliomas growth and metastasis in vivo .
135	inhibit	negative	microrna-7	1219.396	595.7496	595.7496	miRNA		MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression .
135	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression .
34	inhibit	negative	microrna-7	1219.396	595.7496	595.7496	miRNA		MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma .
34	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma .
33	suppress	negative	mir-375	1239.446	513.4264	513.4264	miRNA		We conclude that miR-375 represents a potential prognostic marker of poor outcome and metastasis in HNSCC and that it may function by suppressing the tumor 's invasive properties .
33	suppress	negative	hnscc	1221.107	590.7296	590.7296	Cancer	D006258	We conclude that miR-375 represents a potential prognostic marker of poor outcome and metastasis in HNSCC and that it may function by suppressing the tumor 's invasive properties .
31	regulate	positive	mir610	1222.758	585.6895	585.6895	miRNA		The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis .
31	regulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis .
30	regulate	positive	mir-610	1224.349	580.6299	580.6299	miRNA		The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis .
30	regulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	The identification of miR-610 as a novel miRNA regulated by EGF that targets VASP in gastric cancer cells suggests that EGF-miR610-VASP axis may be exploited for therapeutic intervention to inhibit gastric cancer progression and metastasis .
1449	downregulate	negative	mir-133b	1225.879	575.5518	575.5518	miRNA		It was identified that the expression levels of miR-551b-3p , miR-133b , miR-100-5p and miR-363-3p were significantly downregulated in the gastric cancer tissues , and this downregulation was closely correlated with the degree of differentiation ( i.e. , tumor grade ) , TNM stage and lymph-node metastasis ( P < 0.05 ) .
1449	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	It was identified that the expression levels of miR-551b-3p , miR-133b , miR-100-5p and miR-363-3p were significantly downregulated in the gastric cancer tissues , and this downregulation was closely correlated with the degree of differentiation ( i.e. , tumor grade ) , TNM stage and lymph-node metastasis ( P < 0.05 ) .
598	suppress	negative	mir-133b	1225.879	575.5518	575.5518	miRNA		TAp63 suppress metastasis via miR-133b in colon cancer cells .
598	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	TAp63 suppress metastasis via miR-133b in colon cancer cells .
561	inhibit	negative	mir-133b	1225.879	575.5518	575.5518	miRNA		Overexpression of miR-133b markedly inhibited metastasis of gastric cancer cells in vitro and in vivo .
561	inhibit	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Overexpression of miR-133b markedly inhibited metastasis of gastric cancer cells in vitro and in vivo .
29	upregulate	positive	mir-133b	1225.879	575.5518	575.5518	miRNA		Mouse experiments revealed that upregulation of miR-133b in cervical carcinoma cells strongly promotes both in vivo tumorigenesis and independent metastasis to the mouse lung .
29	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Mouse experiments revealed that upregulation of miR-133b in cervical carcinoma cells strongly promotes both in vivo tumorigenesis and independent metastasis to the mouse lung .
28	promote	positive	mir-133b	1225.879	575.5518	575.5518	miRNA		We report that elevated microRNA-133b ( miR-133b ) acts as an oncogene in human cervical carcinoma to promote tumorigenesis and metastasis .
28	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We report that elevated microRNA-133b ( miR-133b ) acts as an oncogene in human cervical carcinoma to promote tumorigenesis and metastasis .
1842	downregulate	negative	microrna-133b	1227.348	570.4557	570.4557	miRNA		Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer .
1842	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer .
600	suppress	negative	microrna-133b	1227.348	570.4557	570.4557	miRNA		TAp63 and microRNA-133b were able to suppress the metastasis of colon cancer .
600	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	TAp63 and microRNA-133b were able to suppress the metastasis of colon cancer .
599	suppress	negative	microrna-133b	1227.348	570.4557	570.4557	miRNA		In this study , we demonstrate that TAp63 suppresses metastasis in colon cancer cells through microRNA-133b .
599	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In this study , we demonstrate that TAp63 suppresses metastasis in colon cancer cells through microRNA-133b .
27	promote	positive	microrna-133b	1227.348	570.4557	570.4557	miRNA		We report that elevated microRNA-133b ( miR-133b ) acts as an oncogene in human cervical carcinoma to promote tumorigenesis and metastasis .
27	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	We report that elevated microRNA-133b ( miR-133b ) acts as an oncogene in human cervical carcinoma to promote tumorigenesis and metastasis .
2028	regulate	positive	mir-409	1228.756	565.3425	565.3425	miRNA		Our results indicate that miR-409-3p can regulate the invasion and metastasis process of BC by targeting ZEB1 and may serve as a new prognostic marker and therapeutic target for treating BC metastasis. c 2016 IUBMB Life , 68 ( 5 ) : 394-402 , 2016 .
2028	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our results indicate that miR-409-3p can regulate the invasion and metastasis process of BC by targeting ZEB1 and may serve as a new prognostic marker and therapeutic target for treating BC metastasis. c 2016 IUBMB Life , 68 ( 5 ) : 394-402 , 2016 .
2027	regulate	positive	mir-409	1228.756	565.3425	565.3425	miRNA		These data demonstrate that miR-409-3p plays an important role in regulating the metastasis of BC , which is involved in the post-transcriptional repression of ZEB1 .
2027	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	These data demonstrate that miR-409-3p plays an important role in regulating the metastasis of BC , which is involved in the post-transcriptional repression of ZEB1 .
1417	inhibit	negative	mir-409	1228.756	565.3425	565.3425	miRNA		Our results suggest that miR-409-3p functions as a tumor suppressor by inhibiting the development and metastasis of CRC , suggesting that miR-409-3p is expected to become a new diagnostic marker and a new target of the treatment of CRC .
1417	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our results suggest that miR-409-3p functions as a tumor suppressor by inhibiting the development and metastasis of CRC , suggesting that miR-409-3p is expected to become a new diagnostic marker and a new target of the treatment of CRC .
1416	inhibit	negative	mir-409	1228.756	565.3425	565.3425	miRNA		Ectopic expression of miRNA mimics suggested that miR-409-3p could inhibits the abilities of proliferation , wound healing , metastasis and invasion in CRC cells .
1416	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Ectopic expression of miRNA mimics suggested that miR-409-3p could inhibits the abilities of proliferation , wound healing , metastasis and invasion in CRC cells .
1364	regulate	positive	mir-409	1228.756	565.3425	565.3425	miRNA		In vitro and in vivo studies revealed that miR-409-3p negatively regulated CRC metastatic capacities , including suppressing cancer cell migration , invasion and metastasis .
1364	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In vitro and in vivo studies revealed that miR-409-3p negatively regulated CRC metastatic capacities , including suppressing cancer cell migration , invasion and metastasis .
1363	downregulate	negative	mir-409	1228.756	565.3425	565.3425	miRNA		MiR-409-3p expression was significantly downregulated in CRC tissue compared to adjacent non-tumor tissue , and reduced miR-409-3p expression was correlated with CRC metastasis .
1363	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-409-3p expression was significantly downregulated in CRC tissue compared to adjacent non-tumor tissue , and reduced miR-409-3p expression was correlated with CRC metastasis .
1362	downregulate	negative	mir-409	1228.756	565.3425	565.3425	miRNA		MiR-409-3p expression was significantly downregulated in CRC tissue compared to adjacent non-tumor tissue , and reduced miR-409-3p expression was correlated with CRC metastasis .
1362	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-409-3p expression was significantly downregulated in CRC tissue compared to adjacent non-tumor tissue , and reduced miR-409-3p expression was correlated with CRC metastasis .
814	control	neutral	mir-409	1228.756	565.3425	565.3425	miRNA		Intracardiac inoculation ( to mimic systemic dissemination ) of miR-409-5p inhibitor-treated bone metastatic ARCaPM prostate cancer cells in mice led to decreased bone metastasis and increased survival compared with control vehicle-treated cells .
814	control	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Intracardiac inoculation ( to mimic systemic dissemination ) of miR-409-5p inhibitor-treated bone metastatic ARCaPM prostate cancer cells in mice led to decreased bone metastasis and increased survival compared with control vehicle-treated cells .
813	promote	positive	mir-409	1228.756	565.3425	565.3425	miRNA		miR-409-3p/-5p promotes tumorigenesis , epithelial-to-mesenchymal transition , and bone metastasis of human prostate cancer .
813	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-409-3p/-5p promotes tumorigenesis , epithelial-to-mesenchymal transition , and bone metastasis of human prostate cancer .
26	suppress	negative	mir-409	1228.756	565.3425	565.3425	miRNA		Taken together , these results demonstrate that miR-409 suppresses GC cell invasion and metastasis by directly targeting RDX and that patients with downregulated miR-409-3p are prone to lymph node metastasis .
26	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Taken together , these results demonstrate that miR-409 suppresses GC cell invasion and metastasis by directly targeting RDX and that patients with downregulated miR-409-3p are prone to lymph node metastasis .
25	downregulate	negative	mir-409	1228.756	565.3425	565.3425	miRNA		In this study , miR-409-3p was found to be downregulated frequently in human GCs , and its expression was significantly associated with tumor-node-metastasis ( TNM ) stage and lymph node metastasis .
25	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In this study , miR-409-3p was found to be downregulated frequently in human GCs , and its expression was significantly associated with tumor-node-metastasis ( TNM ) stage and lymph node metastasis .
2026	regulate	positive	microrna-409	1230.104	560.2128	560.2128	miRNA		MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer .
2026	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer .
1415	downregulate	negative	microrna-409	1230.104	560.2128	560.2128	miRNA		Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer : an indication for personalized medicine .
1415	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer : an indication for personalized medicine .
1361	suppress	negative	microrna-409	1230.104	560.2128	560.2128	miRNA		MicroRNA-409-3p suppresses colorectal cancer invasion and metastasis partly by targeting GAB1 expression .
1361	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-409-3p suppresses colorectal cancer invasion and metastasis partly by targeting GAB1 expression .
24	suppress	negative	microrna-409	1230.104	560.2128	560.2128	miRNA		MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers .
24	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers .
1747	promote	positive	mir-96	1231.389	555.0674	555.0674	miRNA		MiR-96 targeting and promoting MTSS1 repression may precipitate in the TSCC tumorigenesis through bypassing cell proliferation and metastasis control .
1747	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-96 targeting and promoting MTSS1 repression may precipitate in the TSCC tumorigenesis through bypassing cell proliferation and metastasis control .
1746	regulate	positive	mir-96	1231.389	555.0674	555.0674	miRNA		MiR-96 is confirmed to be a direct target of MTSS1 gene and could regulate MTSS1 mediated Tca8113 cells proliferation and metastasis .
1746	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-96 is confirmed to be a direct target of MTSS1 gene and could regulate MTSS1 mediated Tca8113 cells proliferation and metastasis .
1745	regulate	positive	mir-96	1231.389	555.0674	555.0674	miRNA		MTSS1 gene regulated by miR-96 inhibits cell proliferation and metastasis in tongue squamous cellular carcinoma Tca8113 cell line .
1745	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MTSS1 gene regulated by miR-96 inhibits cell proliferation and metastasis in tongue squamous cellular carcinoma Tca8113 cell line .
1744	regulate	positive	mir-96	1231.389	555.0674	555.0674	miRNA		MTSS1 gene regulated by miR-96 inhibits cell proliferation and metastasis in tongue squamous cellular carcinoma Tca8113 cell line .
1744	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MTSS1 gene regulated by miR-96 inhibits cell proliferation and metastasis in tongue squamous cellular carcinoma Tca8113 cell line .
1287	promote	positive	mir-96	1231.389	555.0674	555.0674	miRNA		Moreover , we observed that miR-96-182-183 promoted EMT and invasion by directly and simultaneously suppressing BRMS1L ( breast cancer metastasis suppressor 1-like ) gene expression .
1287	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Moreover , we observed that miR-96-182-183 promoted EMT and invasion by directly and simultaneously suppressing BRMS1L ( breast cancer metastasis suppressor 1-like ) gene expression .
1286	promote	positive	mir-96	1231.389	555.0674	555.0674	miRNA		Moreover , we observed that miR-96-182-183 promoted EMT and invasion by directly and simultaneously suppressing BRMS1L ( breast cancer metastasis suppressor 1-like ) gene expression .
1286	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Moreover , we observed that miR-96-182-183 promoted EMT and invasion by directly and simultaneously suppressing BRMS1L ( breast cancer metastasis suppressor 1-like ) gene expression .
1101	regulate	positive	mir-96	1231.389	555.0674	555.0674	miRNA		Here , we demonstrate that TGF?] regulates the level of microRNA-96 ( miR-96 ) through Smad-dependent transcription and that miR-96 promotes the bone metastasis in prostate cancer .
1101	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here , we demonstrate that TGF?] regulates the level of microRNA-96 ( miR-96 ) through Smad-dependent transcription and that miR-96 promotes the bone metastasis in prostate cancer .
1100	regulate	positive	mir-96	1231.389	555.0674	555.0674	miRNA		Here , we demonstrate that TGF?] regulates the level of microRNA-96 ( miR-96 ) through Smad-dependent transcription and that miR-96 promotes the bone metastasis in prostate cancer .
1100	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here , we demonstrate that TGF?] regulates the level of microRNA-96 ( miR-96 ) through Smad-dependent transcription and that miR-96 promotes the bone metastasis in prostate cancer .
837	activate	positive	mir-96	1231.389	555.0674	555.0674	miRNA		These results provide evidence supporting that EMT activation and IFN pathway inactivation are markers of metastatic progression of basal-like tumors , and members of miR-17 , miR-200 , and miR-96 families play a role in suppressing EMT and metastasis .
837	activate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	These results provide evidence supporting that EMT activation and IFN pathway inactivation are markers of metastatic progression of basal-like tumors , and members of miR-17 , miR-200 , and miR-96 families play a role in suppressing EMT and metastasis .
836	activate	positive	mir-96	1231.389	555.0674	555.0674	miRNA		These results provide evidence supporting that EMT activation and IFN pathway inactivation are markers of metastatic progression of basal-like tumors , and members of miR-17 , miR-200 , and miR-96 families play a role in suppressing EMT and metastasis .
836	activate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	These results provide evidence supporting that EMT activation and IFN pathway inactivation are markers of metastatic progression of basal-like tumors , and members of miR-17 , miR-200 , and miR-96 families play a role in suppressing EMT and metastasis .
23	suppress	negative	mir-96	1231.389	555.0674	555.0674	miRNA		Suppression of miR-96 expression inhibits the invasion of HCC cells , suggesting that miR-96 may be a therapeutic target for inhibiting HCC invasion and metastasis .
23	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Suppression of miR-96 expression inhibits the invasion of HCC cells , suggesting that miR-96 may be a therapeutic target for inhibiting HCC invasion and metastasis .
1163	inhibit	negative	microrna-320a	1232.614	549.907	549.907	miRNA		[ Corrigendum ] MicroRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer .
1163	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	[ Corrigendum ] MicroRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer .
22	inhibit	negative	microrna-320a	1232.614	549.907	549.907	miRNA		microRNA-320a inhibits tumor invasion by targeting neuropilin ? 1 and is associated with liver metastasis in colorectal cancer .
22	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	microRNA-320a inhibits tumor invasion by targeting neuropilin ? 1 and is associated with liver metastasis in colorectal cancer .
1119	promote	positive	mir-378	1233.776	544.7323	544.7323	miRNA		Typical metastatic lesions were found in the livers of mice injected with miR-378-transfected cells , and high levels of the CMV promoter were detected in the nodules , indicating that miR-378 promoted the metastasis of the tumor cells to the liver .
1119	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Typical metastatic lesions were found in the livers of mice injected with miR-378-transfected cells , and high levels of the CMV promoter were detected in the nodules , indicating that miR-378 promoted the metastasis of the tumor cells to the liver .
333	affect	neutral	mir-378	1233.776	544.7323	544.7323	miRNA		Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth , vascularization , and metastasis .
333	affect	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth , vascularization , and metastasis .
21	promote	positive	mir-378	1233.776	544.7323	544.7323	miRNA		Our study showed evidences that miR-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration , invasion and tumor angiogenesis .
21	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Our study showed evidences that miR-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration , invasion and tumor angiogenesis .
20	promote	positive	microrna-378	1234.877	539.5441	539.5441	miRNA		MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration , invasion and tumor angiogenesis .
20	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration , invasion and tumor angiogenesis .
1754	suppress	negative	microrna-335	1235.915	534.3431	534.3431	miRNA		MicroRNA-335 and -543 suppress bone metastasis in prostate cancer via targeting endothelial nitric oxide synthase .
1754	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-335 and -543 suppress bone metastasis in prostate cancer via targeting endothelial nitric oxide synthase .
1753	suppress	negative	microrna-335	1235.915	534.3431	534.3431	miRNA		MicroRNA-335 and -543 suppress bone metastasis in prostate cancer via targeting endothelial nitric oxide synthase .
1753	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-335 and -543 suppress bone metastasis in prostate cancer via targeting endothelial nitric oxide synthase .
703	inhibit	negative	microrna-335	1235.915	534.3431	534.3431	miRNA		MicroRNA-335 inhibits invasion and metastasis of colorectal cancer by targeting ZEB2 .
703	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-335 inhibits invasion and metastasis of colorectal cancer by targeting ZEB2 .
19	induce	positive	microrna-335	1235.915	534.3431	534.3431	miRNA		Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells .
19	induce	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells .
53	downregulate	negative	let-7c	1236.892	529.1302	529.1302	miRNA		Among , downregulation of six miRNAs , has-let-7c , has-miR-100 , has-miR-125b , has-miR-143 , has-miR-145 and has-miR-199a-5p were significantly associated with lymph node metastasis and reduced survival in SCCC .
53	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Among , downregulation of six miRNAs , has-let-7c , has-miR-100 , has-miR-125b , has-miR-143 , has-miR-145 and has-miR-199a-5p were significantly associated with lymph node metastasis and reduced survival in SCCC .
18	suppress	negative	let-7c	1236.892	529.1302	529.1302	miRNA		Taken together , these results demonstrate that let-7c , apart from its tumour growth suppression role , also functions as a tumour metastasis suppressor in colorectal cancer by directly destabilizing the mRNAs of MMP11 and PBX3 at least .
18	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Taken together , these results demonstrate that let-7c , apart from its tumour growth suppression role , also functions as a tumour metastasis suppressor in colorectal cancer by directly destabilizing the mRNAs of MMP11 and PBX3 at least .
17	promote	positive	microrna-135a	1237.806	523.9059	523.9059	miRNA		MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma .
17	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma .
1496	effect	neutral	mir-335	1238.657	518.671	518.671	miRNA		Herein , we evaluated the effect of SEB on the expression of two master microRNAs , mir-335 and mir-10b , involved in metastasis .
1496	effect	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Herein , we evaluated the effect of SEB on the expression of two master microRNAs , mir-335 and mir-10b , involved in metastasis .
1474	control	neutral	mir-335	1238.657	518.671	518.671	miRNA		Based on the results obtained in the last decade , some miRNAs are emerging as biomarkers of BC for diagnosis ( i.e. , miR-9 , miR-10b , and miR-17-5p ) , prognosis ( i.e. , miR-148a and miR-335 ) , and prediction of therapeutic outcomes ( i.e. , miR-30c , miR-187 , and miR-339-5p ) and have important roles in the control of BC hallmark functions such as invasion , metastasis , proliferation , resting death , apoptosis , and genomic instability .
1474	control	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Based on the results obtained in the last decade , some miRNAs are emerging as biomarkers of BC for diagnosis ( i.e. , miR-9 , miR-10b , and miR-17-5p ) , prognosis ( i.e. , miR-148a and miR-335 ) , and prediction of therapeutic outcomes ( i.e. , miR-30c , miR-187 , and miR-339-5p ) and have important roles in the control of BC hallmark functions such as invasion , metastasis , proliferation , resting death , apoptosis , and genomic instability .
1268	downregulate	negative	mir-335	1238.657	518.671	518.671	miRNA		In our study , we firstly found that the expression level of miR-335 was significantly downregulated in ccRCC tissues versus corresponding non-tumor tissues and the low expression of miR-335 was significantly associated with lymph node metastasis , larger tumor size , and poor T stage .
1268	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In our study , we firstly found that the expression level of miR-335 was significantly downregulated in ccRCC tissues versus corresponding non-tumor tissues and the low expression of miR-335 was significantly associated with lymph node metastasis , larger tumor size , and poor T stage .
1097	induce	positive	mir-335	1238.657	518.671	518.671	miRNA		In addition , we found that the lower miR-335 expression induced by abnormal methylation may be mainly involved in gastric cell invasion and metastasis in GC tissues .
1097	induce	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	In addition , we found that the lower miR-335 expression induced by abnormal methylation may be mainly involved in gastric cell invasion and metastasis in GC tissues .
1096	suppress	negative	mir-335	1238.657	518.671	518.671	miRNA		MicroRNAs ( miRNAs ) are small non-coding RNAs that function as endogenous silencers of target genes , previous studies have shown that miR-335 play an important role in suppressing metastasis and migration in human cancer including gastric cancer ( GC ) .
1096	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	MicroRNAs ( miRNAs ) are small non-coding RNAs that function as endogenous silencers of target genes , previous studies have shown that miR-335 play an important role in suppressing metastasis and migration in human cancer including gastric cancer ( GC ) .
1089	downregulate	negative	mir-335	1238.657	518.671	518.671	miRNA		A previous study has shown that miR-335 is downregulated in breast cancer and can suppress tumor invasion and metastasis .
1089	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	A previous study has shown that miR-335 is downregulated in breast cancer and can suppress tumor invasion and metastasis .
755	inhibit	negative	mir-335	1238.657	518.671	518.671	miRNA		Systemically delivered miR-335 inhibited pancreatic cancer metastasis and extended animal survival .
755	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Systemically delivered miR-335 inhibited pancreatic cancer metastasis and extended animal survival .
705	inhibit	negative	mir-335	1238.657	518.671	518.671	miRNA		In conclusion , our results demonstrate that miR-335 functions as a tumor suppressor and play a role in inhibiting metastasis of CRC cells through targeting ZEB2 .
705	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In conclusion , our results demonstrate that miR-335 functions as a tumor suppressor and play a role in inhibiting metastasis of CRC cells through targeting ZEB2 .
704	enhance	positive	mir-335	1238.657	518.671	518.671	miRNA		Furthermore , enhancing the expression of miR-335 inhibited CRC cell migration and invasion in vitro and lung and liver metastasis in vivo , while silencing its expression resulted in increased migration and invasion .
704	enhance	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Furthermore , enhancing the expression of miR-335 inhibited CRC cell migration and invasion in vitro and lung and liver metastasis in vivo , while silencing its expression resulted in increased migration and invasion .
505	influence	neutral	mir-335	1238.657	518.671	518.671	miRNA		Multivariate analysis further revealed that pathologic T stage ( P=0.02 ) , lymph node metastasis ( P=0.008 ) , and miR-335 expression ( P=0.006 ) maintained independent prognostic influence on overall survival .
505	influence	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Multivariate analysis further revealed that pathologic T stage ( P=0.02 ) , lymph node metastasis ( P=0.008 ) , and miR-335 expression ( P=0.006 ) maintained independent prognostic influence on overall survival .
16	suppress	negative	mir-335	1238.657	518.671	518.671	miRNA		Furthermore , miR-335 might suppress gastric cancer invasion and metastasis by targeting Bcl-w and specificity protein 1 ( SP1 ) .
16	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Furthermore , miR-335 might suppress gastric cancer invasion and metastasis by targeting Bcl-w and specificity protein 1 ( SP1 ) .
15	suppress	negative	mir-335	1238.657	518.671	518.671	miRNA		Overexpression of miR-335 suppressed gastric cancer cell invasion and metastasis in vitro and in vivo , but has no significant effects on cell proliferation .
15	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Overexpression of miR-335 suppressed gastric cancer cell invasion and metastasis in vitro and in vivo , but has no significant effects on cell proliferation .
222	downregulate	negative	mir-375	1239.446	513.4264	513.4264	miRNA		MISH results also showed that miR-375 was frequently downregulated in ESCCs , which was significantly associated with advanced clinical stage ( p = 0.003 ) tumor metastasis ( p = 0.04 ) and poor outcome ( p = 0.04 ) of ESCC .
222	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MISH results also showed that miR-375 was frequently downregulated in ESCCs , which was significantly associated with advanced clinical stage ( p = 0.003 ) tumor metastasis ( p = 0.04 ) and poor outcome ( p = 0.04 ) of ESCC .
188	react	neutral	mir-375	1239.446	513.4264	513.4264	miRNA		Total RNA was extracted and quantitave polymerase chain reaction ( qPCR ) analysis performed on the primary tumour and a corresponding lymph node metastasis for expression of miRNAs of proven significance in MTC ( miR-9* , miR-183 and miR-375 ) .
188	react	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Total RNA was extracted and quantitave polymerase chain reaction ( qPCR ) analysis performed on the primary tumour and a corresponding lymph node metastasis for expression of miRNAs of proven significance in MTC ( miR-9* , miR-183 and miR-375 ) .
187	react	neutral	mir-375	1239.446	513.4264	513.4264	miRNA		Total RNA was extracted and quantitave polymerase chain reaction ( qPCR ) analysis performed on the primary tumour and a corresponding lymph node metastasis for expression of miRNAs of proven significance in MTC ( miR-9* , miR-183 and miR-375 ) .
187	react	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	Total RNA was extracted and quantitave polymerase chain reaction ( qPCR ) analysis performed on the primary tumour and a corresponding lymph node metastasis for expression of miRNAs of proven significance in MTC ( miR-9* , miR-183 and miR-375 ) .
14	downregulate	negative	mir-375	1239.446	513.4264	513.4264	miRNA		The downregulation of miR-375 was frequently detected in primary ESCC , which was significantly correlated with advanced stage ( p=0.003 ) , distant metastasis ( p < 0.0001 ) , poor overall survival ( p=0.048 ) and disease-free survival ( p=0.0006 ) .
14	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	The downregulation of miR-375 was frequently detected in primary ESCC , which was significantly correlated with advanced stage ( p=0.003 ) , distant metastasis ( p < 0.0001 ) , poor overall survival ( p=0.048 ) and disease-free survival ( p=0.0006 ) .
13	inhibit	negative	microrna-375	1240.173	508.1727	508.1727	miRNA		MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor .
13	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor .
1803	control	neutral	mir-15b	1240.836	502.9107	502.9107	miRNA		Plasma miR-15b levels were significantly higher in CRC patients than in healthy controls , in CRC patients with metastasis than in CRC patients without metastasis , and in CRC patients with recurrence than in CRC patients without recurrence in the 5-year follow-up .
1803	control	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Plasma miR-15b levels were significantly higher in CRC patients than in healthy controls , in CRC patients with metastasis than in CRC patients without metastasis , and in CRC patients with recurrence than in CRC patients without recurrence in the 5-year follow-up .
1802	inhibit	negative	mir-15b	1240.836	502.9107	502.9107	miRNA		Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer .
1802	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer .
1204	regulate	positive	mir-15b	1240.836	502.9107	502.9107	miRNA		miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells .
1204	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells .
12	suppress	negative	mir-15b	1240.836	502.9107	502.9107	miRNA		In vivo , enforced miR-200b or miR-15b expression suppressed metastasis of TSCC xenografts established by CAL27-res cells .
12	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In vivo , enforced miR-200b or miR-15b expression suppressed metastasis of TSCC xenografts established by CAL27-res cells .
2003	promote	positive	mir-200b	1241.437	497.6412	497.6412	miRNA		MiR-200b promotes the cell proliferation and metastasis of cervical cancer by inhibiting FOXG1 .
2003	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-200b promotes the cell proliferation and metastasis of cervical cancer by inhibiting FOXG1 .
1302	suppress	negative	mir-200b	1241.437	497.6412	497.6412	miRNA		Re-expression of miR-200b significantly suppressed lung metastasis of HCC cells in an orthotopic liver implantation model in vivo .
1302	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Re-expression of miR-200b significantly suppressed lung metastasis of HCC cells in an orthotopic liver implantation model in vivo .
795	suppress	negative	mir-200b	1241.437	497.6412	497.6412	miRNA		These results show that loss of miR-200b expression plays a crucial role in TNBC aggressiveness and that miR-200b suppresses TNBC cell migration and tumor metastasis by targeting PKC帢 .
795	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	These results show that loss of miR-200b expression plays a crucial role in TNBC aggressiveness and that miR-200b suppresses TNBC cell migration and tumor metastasis by targeting PKC帢 .
794	suppress	negative	mir-200b	1241.437	497.6412	497.6412	miRNA		These results show that loss of miR-200b expression plays a crucial role in TNBC aggressiveness and that miR-200b suppresses TNBC cell migration and tumor metastasis by targeting PKC帢 .
794	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	These results show that loss of miR-200b expression plays a crucial role in TNBC aggressiveness and that miR-200b suppresses TNBC cell migration and tumor metastasis by targeting PKC帢 .
791	inhibit	negative	mir-200b	1241.437	497.6412	497.6412	miRNA		Ectopically expressing a single member ( miR-200b ) of the miR-200 family drastically reduces TNBC cell migration and inhibits tumor metastasis in an orthotopic mouse mammary xenograft tumor model .
791	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Ectopically expressing a single member ( miR-200b ) of the miR-200 family drastically reduces TNBC cell migration and inhibits tumor metastasis in an orthotopic mouse mammary xenograft tumor model .
790	effect	neutral	mir-200b	1241.437	497.6412	497.6412	miRNA		This study was performed to investigate the effect and mechanism of miR-200b on TNBC metastasis and identify targets for developing more efficient treatment for TNBC .
790	effect	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	This study was performed to investigate the effect and mechanism of miR-200b on TNBC metastasis and identify targets for developing more efficient treatment for TNBC .
549	inhibit	negative	mir-200b	1241.437	497.6412	497.6412	miRNA		miR-200b inhibits prostate cancer EMT , growth and metastasis .
549	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-200b inhibits prostate cancer EMT , growth and metastasis .
548	inhibit	negative	mir-200b	1241.437	497.6412	497.6412	miRNA		miR-200b inhibits prostate cancer EMT , growth and metastasis .
548	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-200b inhibits prostate cancer EMT , growth and metastasis .
477	regulate	positive	mir-200b	1241.437	497.6412	497.6412	miRNA		The miR-200b~200a~429 gene cluster is a key regulator of EMT and cancer metastasis , however the transcription-based mechanisms controlling its expression during this process are not well understood .
477	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The miR-200b~200a~429 gene cluster is a key regulator of EMT and cancer metastasis , however the transcription-based mechanisms controlling its expression during this process are not well understood .
466	downregulate	negative	mir-200b	1241.437	497.6412	497.6412	miRNA		Importantly , downregulation of miR-200b significantly correlated with shortened survival ( P = 0.025 ) , lymph node metastasis ( P = 0.002 ) and advanced clinical stage ( P = 0.020 ) in ESCC patients .
466	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Importantly , downregulation of miR-200b significantly correlated with shortened survival ( P = 0.025 ) , lymph node metastasis ( P = 0.002 ) and advanced clinical stage ( P = 0.020 ) in ESCC patients .
308	block	negative	mir-200b	1241.437	497.6412	497.6412	miRNA		miR-200b restoration and DNA methyltransferase inhibitor block lung metastasis of mesenchymal-phenotype hepatocellular carcinoma .
308	block	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	miR-200b restoration and DNA methyltransferase inhibitor block lung metastasis of mesenchymal-phenotype hepatocellular carcinoma .
121	regulate	positive	mir-200b	1241.437	497.6412	497.6412	miRNA		MiR-200 family ( miR-200a , miR-200b , miR-200c , miR-141 , and miR-429 ) is a cluster of miRNAs highly correlated with epithelial-mesenchymal transition ( EMT ) , wherein miR-200b is identified as a critical regulator of tumor invasion , metastasis , and chemosensitivity .
121	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-200 family ( miR-200a , miR-200b , miR-200c , miR-141 , and miR-429 ) is a cluster of miRNAs highly correlated with epithelial-mesenchymal transition ( EMT ) , wherein miR-200b is identified as a critical regulator of tumor invasion , metastasis , and chemosensitivity .
117	regulate	positive	mir-200b	1241.437	497.6412	497.6412	miRNA		MiR-200 family ( miR-200a , miR-200b , miR-200c , miR-141 , and miR-429 ) is a cluster of miRNAs highly correlated with epithelial-mesenchymal transition ( EMT ) , wherein miR-200b is identified as a critical regulator of tumor invasion , metastasis , and chemosensitivity .
117	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-200 family ( miR-200a , miR-200b , miR-200c , miR-141 , and miR-429 ) is a cluster of miRNAs highly correlated with epithelial-mesenchymal transition ( EMT ) , wherein miR-200b is identified as a critical regulator of tumor invasion , metastasis , and chemosensitivity .
40	regulate	positive	mir-200b	1241.437	497.6412	497.6412	miRNA		miR-200b regulates ZEB2 expression and thus controls metastasis in gastric cancer .
40	regulate	positive	gc	1242.449	487.0825	487.0825	Cancer	D061325	miR-200b regulates ZEB2 expression and thus controls metastasis in gastric cancer .
32	control	neutral	mir-200b	1241.437	497.6412	497.6412	miRNA		Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster , methylation of which is associated with metastasis or hormone receptor status in advanced breast cancer .
32	control	neutral	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster , methylation of which is associated with metastasis or hormone receptor status in advanced breast cancer .
11	suppress	negative	mir-200b	1241.437	497.6412	497.6412	miRNA		In vivo , enforced miR-200b or miR-15b expression suppressed metastasis of TSCC xenografts established by CAL27-res cells .
11	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In vivo , enforced miR-200b or miR-15b expression suppressed metastasis of TSCC xenografts established by CAL27-res cells .
1832	stimulate	positive	mir-124	1241.974	492.3649	492.3649	miRNA		Notably , upon TGF-?] stimulation , phosphorylation of Smad2/3 was modulated by alteration of miR-124 or Smad4 expression , followed by inducing some special transcription of downstream genes including Snail , Slug and ZEB2 , all of which may trigger epithelial-mesenchymal transition and be associated with NSCLC metastasis .
1832	stimulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Notably , upon TGF-?] stimulation , phosphorylation of Smad2/3 was modulated by alteration of miR-124 or Smad4 expression , followed by inducing some special transcription of downstream genes including Snail , Slug and ZEB2 , all of which may trigger epithelial-mesenchymal transition and be associated with NSCLC metastasis .
1831	effect	neutral	mir-124	1241.974	492.3649	492.3649	miRNA		In vitro and in vivo experiments indicate that restoring miR-124 expression in NSCLC cells had a marked effect on reducing cell migration , invasion and metastasis .
1831	effect	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	In vitro and in vivo experiments indicate that restoring miR-124 expression in NSCLC cells had a marked effect on reducing cell migration , invasion and metastasis .
1600	downregulate	negative	mir-124	1241.974	492.3649	492.3649	miRNA		Our data suggested that decreased expression of miR-124 has prognostic value in breast cancer and may serve as a prognostic marker for breast cancer , and also downregulation of miR-124 was inversely associated with the lymph node metastasis in breast cancer .
1600	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our data suggested that decreased expression of miR-124 has prognostic value in breast cancer and may serve as a prognostic marker for breast cancer , and also downregulation of miR-124 was inversely associated with the lymph node metastasis in breast cancer .
1539	downregulate	negative	mir-124	1241.974	492.3649	492.3649	miRNA		Collectively , our study demonstrates that miR-124 can impair the proliferation or metastasis of human bladder cancer cells by down-regulation of UHRF1 .
1539	downregulate	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	Collectively , our study demonstrates that miR-124 can impair the proliferation or metastasis of human bladder cancer cells by down-regulation of UHRF1 .
1514	inhibit	negative	mir-124	1241.974	492.3649	492.3649	miRNA		Based on these findings , we suggest that miR-124 may inhibit OS metastasis , partly at least , via targeting ROR2 and thus suppressing the activity of ROR2-mediated non-canonical Wnt signaling .
1514	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Based on these findings , we suggest that miR-124 may inhibit OS metastasis , partly at least , via targeting ROR2 and thus suppressing the activity of ROR2-mediated non-canonical Wnt signaling .
1211	inhibit	negative	mir-124	1241.974	492.3649	492.3649	miRNA		These results suggest that NF-庥B-regulated miR-124 targets MYO10 , inhibits cell invasion and metastasis , and is down-regulated in node-positive NSCLC .
1211	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	These results suggest that NF-庥B-regulated miR-124 targets MYO10 , inhibits cell invasion and metastasis , and is down-regulated in node-positive NSCLC .
1210	suppress	negative	mir-124	1241.974	492.3649	492.3649	miRNA		NF-庥B-mediated miR-124 suppresses metastasis of non-small-cell lung cancer by targeting MYO10 .
1210	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	NF-庥B-mediated miR-124 suppresses metastasis of non-small-cell lung cancer by targeting MYO10 .
951	repress	negative	mir-124	1241.974	492.3649	492.3649	miRNA		In previous studies , miR-124 was found to repress proliferation and metastasis in different types of cancers , but whether it functions in cervical cancer remained unknown .
951	repress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In previous studies , miR-124 was found to repress proliferation and metastasis in different types of cancers , but whether it functions in cervical cancer remained unknown .
895	suppress	negative	mir-124	1241.974	492.3649	492.3649	miRNA		MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma .
895	suppress	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma .
634	enhance	positive	mir-124	1241.974	492.3649	492.3649	miRNA		EZH2 ( enhancer of zeste homolog 2 ) , which has been shown to be an important transcription factor involved in the proliferation and metastasis of tumor cells , was here confirmed to be a direct target gene of miR-124 .
634	enhance	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	EZH2 ( enhancer of zeste homolog 2 ) , which has been shown to be an important transcription factor involved in the proliferation and metastasis of tumor cells , was here confirmed to be a direct target gene of miR-124 .
512	inhibit	negative	mir-124	1241.974	492.3649	492.3649	miRNA		Meantime , overexpression of miR-124 dramatically inhibits the motility of ovarian cancer cells in vitro and substantially suppresses the protein expression of SphK1 , reported as an invasion and metastasis-related gene in human cancers , whose expression is markedly increased in both ovarian cancer cell lines and clinical samples , particularly in two highly metastasis cells , SKOV3-ip and HO8910pm as well as metastatic ovarian tumor tissues .
512	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Meantime , overexpression of miR-124 dramatically inhibits the motility of ovarian cancer cells in vitro and substantially suppresses the protein expression of SphK1 , reported as an invasion and metastasis-related gene in human cancers , whose expression is markedly increased in both ovarian cancer cell lines and clinical samples , particularly in two highly metastasis cells , SKOV3-ip and HO8910pm as well as metastatic ovarian tumor tissues .
376	regulate	positive	mir-124	1241.974	492.3649	492.3649	miRNA		Our findings highlight an important role of miR-124 in the regulation of invasion and metastasis by breast cancer cells and suggest a potential application for miR-124 in breast cancer treatment .
376	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Our findings highlight an important role of miR-124 in the regulation of invasion and metastasis by breast cancer cells and suggest a potential application for miR-124 in breast cancer treatment .
210	regulate	positive	mir-124	1241.974	492.3649	492.3649	miRNA		MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer .
210	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer .
10	regulate	positive	mir-124	1241.974	492.3649	492.3649	miRNA		These data highlight an important role for miR-124 in the regulation of invasion and metastasis in the molecular aetiology of HCC , and suggest a potential application of miR-124 in prognosis prediction and cancer treatment .
10	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	These data highlight an important role for miR-124 in the regulation of invasion and metastasis in the molecular aetiology of HCC , and suggest a potential application of miR-124 in prognosis prediction and cancer treatment .
9	inhibit	negative	mir-124	1241.974	492.3649	492.3649	miRNA		In HCC cell lines , stable overexpression of miR-124 was sufficient to inhibit cell motility and invasion in vitro , and suppress intrahepatic and pulmonary metastasis in vivo .
9	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In HCC cell lines , stable overexpression of miR-124 was sufficient to inhibit cell motility and invasion in vitro , and suppress intrahepatic and pulmonary metastasis in vivo .
8	inhibit	negative	mir-124	1241.974	492.3649	492.3649	miRNA		In HCC cell lines , stable overexpression of miR-124 was sufficient to inhibit cell motility and invasion in vitro , and suppress intrahepatic and pulmonary metastasis in vivo .
8	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In HCC cell lines , stable overexpression of miR-124 was sufficient to inhibit cell motility and invasion in vitro , and suppress intrahepatic and pulmonary metastasis in vivo .
7	inhibit	negative	mir-124	1241.974	492.3649	492.3649	miRNA		In HCC cell lines , stable overexpression of miR-124 was sufficient to inhibit cell motility and invasion in vitro , and suppress intrahepatic and pulmonary metastasis in vivo .
7	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	In HCC cell lines , stable overexpression of miR-124 was sufficient to inhibit cell motility and invasion in vitro , and suppress intrahepatic and pulmonary metastasis in vivo .
247	suppress	negative	microrna-9	1243.873	460.6064	460.6064	miRNA		microRNA-9 suppresses the proliferation , invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1 .
247	suppress	negative	gc	1242.449	487.0825	487.0825	Cancer	D061325	microRNA-9 suppresses the proliferation , invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1 .
6	control	neutral	mir-370	1242.86	481.7948	481.7948	miRNA		Higher expression of miR-370 in GC tissues was associated with more advanced nodal metastasis and a higher clinical stage compared with controls .
6	control	neutral	gc	1242.449	487.0825	487.0825	Cancer	D061325	Higher expression of miR-370 in GC tissues was associated with more advanced nodal metastasis and a higher clinical stage compared with controls .
366	inhibit	negative	mir-370	1242.86	481.7948	481.7948	miRNA		Overexpression of miR-370 inhibited growth and metastasis of HCC cells in vivo .
366	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Overexpression of miR-370 inhibited growth and metastasis of HCC cells in vivo .
1609	suppress	negative	mir-30a	1243.208	476.5026	476.5026	miRNA		miR-30a also suppressed tumor formation and pulmonary metastasis in vivo .
1609	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-30a also suppressed tumor formation and pulmonary metastasis in vivo .
1339	upregulate	positive	mir-30a	1243.208	476.5026	476.5026	miRNA		The upregulation of urinary miR-30a-5p was closely associated with early stage of ovarian serous adenocarcinoma as well as lymphatic metastasis .
1339	upregulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The upregulation of urinary miR-30a-5p was closely associated with early stage of ovarian serous adenocarcinoma as well as lymphatic metastasis .
1086	downregulate	negative	mir-30a	1243.208	476.5026	476.5026	miRNA		It is shown that the epithelial-mesenchymal transition was associated with the down-regulation of miR-30a , up-regulation of AEG-1 and mesenchymal markers ( Snail and Vimentin ) ; miR-30a inhibited the metastasis of lung tumor A549 cells in vitro , whereas AEG-1 promoted it .
1086	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	It is shown that the epithelial-mesenchymal transition was associated with the down-regulation of miR-30a , up-regulation of AEG-1 and mesenchymal markers ( Snail and Vimentin ) ; miR-30a inhibited the metastasis of lung tumor A549 cells in vitro , whereas AEG-1 promoted it .
804	regulate	positive	mir-30a	1243.208	476.5026	476.5026	miRNA		We identified SNAI1 as a direct target of miR-30a and demonstrated miR-30a as a novel regulator of EMT by targeting SNAI1 , indicating its potential therapeutic value for reducing invasion and metastasis of HCC .
804	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	We identified SNAI1 as a direct target of miR-30a and demonstrated miR-30a as a novel regulator of EMT by targeting SNAI1 , indicating its potential therapeutic value for reducing invasion and metastasis of HCC .
803	regulate	positive	mir-30a	1243.208	476.5026	476.5026	miRNA		We identified SNAI1 as a direct target of miR-30a and demonstrated miR-30a as a novel regulator of EMT by targeting SNAI1 , indicating its potential therapeutic value for reducing invasion and metastasis of HCC .
803	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	We identified SNAI1 as a direct target of miR-30a and demonstrated miR-30a as a novel regulator of EMT by targeting SNAI1 , indicating its potential therapeutic value for reducing invasion and metastasis of HCC .
391	inhibit	negative	mir-30a	1243.208	476.5026	476.5026	miRNA		Taken together , our findings indicated miR-30a inhibits breast cancer proliferation and metastasis by directly targeting MTDH , and miR-30a can serve as a prognostic marker for breast cancer .
391	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Taken together , our findings indicated miR-30a inhibits breast cancer proliferation and metastasis by directly targeting MTDH , and miR-30a can serve as a prognostic marker for breast cancer .
390	suppress	negative	mir-30a	1243.208	476.5026	476.5026	miRNA		Ectopic expression of miR-30a in breast cancer cell lines resulted in the suppression of cell growth and metastasis in vitro .
390	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Ectopic expression of miR-30a in breast cancer cell lines resulted in the suppression of cell growth and metastasis in vitro .
379	downregulate	negative	mir-30a	1243.208	476.5026	476.5026	miRNA		Down-regulated miR-30a in ccRCC was associated with tumor hematogenous metastasis through increasing microvessel density by targeting angiogenesis-specific DLL4 .
379	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Down-regulated miR-30a in ccRCC was associated with tumor hematogenous metastasis through increasing microvessel density by targeting angiogenesis-specific DLL4 .
304	block	negative	mir-30a	1243.208	476.5026	476.5026	miRNA		miR-30a may be a potential therapeutic target to block CRC metastasis .
304	block	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-30a may be a potential therapeutic target to block CRC metastasis .
303	suppress	negative	mir-30a	1243.208	476.5026	476.5026	miRNA		Overexpression of miR-30a suppressed CRC cell migration and invasion in vitro and liver metastasis in vivo , whereas miR-30a deletion dramatically promoted cell migration and invasion .
303	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Overexpression of miR-30a suppressed CRC cell migration and invasion in vitro and liver metastasis in vivo , whereas miR-30a deletion dramatically promoted cell migration and invasion .
302	regulate	positive	mir-30a	1243.208	476.5026	476.5026	miRNA		The aim of this study was to determine the regulation and function of miR-30a in colorectal carcinoma ( CRC ) metastasis .
302	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The aim of this study was to determine the regulation and function of miR-30a in colorectal carcinoma ( CRC ) metastasis .
66	inhibit	negative	mir-30a	1243.208	476.5026	476.5026	miRNA		In conclusion , these findings suggest a role for miR-30a in inhibiting breast tumor invasiveness and metastasis .
66	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In conclusion , these findings suggest a role for miR-30a in inhibiting breast tumor invasiveness and metastasis .
5	inhibit	negative	mir-30a	1243.208	476.5026	476.5026	miRNA		These results suggest that miR-30a targets Snai1 , inhibits invasion and metastasis , and is downregulated in NSCLC .
5	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	These results suggest that miR-30a targets Snai1 , inhibits invasion and metastasis , and is downregulated in NSCLC .
1839	regulate	positive	mir-195	1244	450	450	miRNA		Taken together , our results suggest that miR-195 , a tumor suppressor miRNA , contributes to the lung metastasis of HCC by negatively regulating FGF2 and VEGFA , providing key implications of miR-195 for the therapeutic intervention of HCC .
1839	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	Taken together , our results suggest that miR-195 , a tumor suppressor miRNA , contributes to the lung metastasis of HCC by negatively regulating FGF2 and VEGFA , providing key implications of miR-195 for the therapeutic intervention of HCC .
1838	regulate	positive	mir-195	1244	450	450	miRNA		MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA .
1838	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA .
1547	regulate	positive	let-7	1243.715	465.9076	465.9076	miRNA		The role of L1 in the differential expression of the let-7 family of miRNAs ( that regulate genes involved in the EMT and metastasis ) is also discussed .
1547	regulate	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	The role of L1 in the differential expression of the let-7 family of miRNAs ( that regulate genes involved in the EMT and metastasis ) is also discussed .
1023	promote	positive	microrna-9	1243.873	460.6064	460.6064	miRNA		MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma .
1023	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma .
786	promote	positive	let-7	1243.715	465.9076	465.9076	miRNA		H19 promotes pancreatic cancer metastasis by derepressing let-7 's suppression on its target HMGA2-mediated EMT .
786	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	H19 promotes pancreatic cancer metastasis by derepressing let-7 's suppression on its target HMGA2-mediated EMT .
785	promote	positive	let-7	1243.715	465.9076	465.9076	miRNA		H19 promotes pancreatic cancer metastasis by derepressing let-7 's suppression on its target HMGA2-mediated EMT .
785	promote	positive	escc	1243.493	471.2066	471.2066	Cancer	D009369	H19 promotes pancreatic cancer metastasis by derepressing let-7 's suppression on its target HMGA2-mediated EMT .
760	inhibit	negative	mir-195	1244	450	450	miRNA		MiR-195 inhibits the growth and metastasis of NSCLC cells by targeting IGF1R .
760	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	MiR-195 inhibits the growth and metastasis of NSCLC cells by targeting IGF1R .
436	inhibit	negative	microrna-9	1243.873	460.6064	460.6064	miRNA		We show that microRNA-9 ( miR-9 ) contributed to SP expansion and metastasis , and miR-9 inhibition reduced the number of SP cells and metastasis .
436	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	We show that microRNA-9 ( miR-9 ) contributed to SP expansion and metastasis , and miR-9 inhibition reduced the number of SP cells and metastasis .
428	effect	neutral	let-7	1243.715	465.9076	465.9076	miRNA		However , the effect of specific let-7 member on metastasis of NSCLC remains undefined .
428	effect	neutral	escc	1243.493	471.2066	471.2066	Cancer	D009369	However , the effect of specific let-7 member on metastasis of NSCLC remains undefined .
290	downregulate	negative	mir-195	1244	450	450	miRNA		Additionally , miR-195 down-regulation led to increases in VAV2 and CDC42 expression , which stimulated VAV2/Rac1/CDC42 signaling and lamellipodia formation and thereby facilitated the metastasis of HCC cells .
290	downregulate	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Additionally , miR-195 down-regulation led to increases in VAV2 and CDC42 expression , which stimulated VAV2/Rac1/CDC42 signaling and lamellipodia formation and thereby facilitated the metastasis of HCC cells .
77	inhibit	negative	microrna-9	1243.873	460.6064	460.6064	miRNA		microRNA-9 targets matrix metalloproteinase 14 to inhibit invasion , metastasis , and angiogenesis of neuroblastoma cells .
77	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	microRNA-9 targets matrix metalloproteinase 14 to inhibit invasion , metastasis , and angiogenesis of neuroblastoma cells .
4	inhibit	negative	let-7	1243.715	465.9076	465.9076	miRNA		Let-7 could inhibit cell proliferation and lower expressed in ESCC , and there was a correlation between let-7 lower expression and lymph node metastasis in ESCC patients .
4	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Let-7 could inhibit cell proliferation and lower expressed in ESCC , and there was a correlation between let-7 lower expression and lymph node metastasis in ESCC patients .
3	inhibit	negative	let-7	1243.715	465.9076	465.9076	miRNA		Let-7 could inhibit cell proliferation and lower expressed in ESCC , and there was a correlation between let-7 lower expression and lymph node metastasis in ESCC patients .
3	inhibit	negative	escc	1243.493	471.2066	471.2066	Cancer	D009369	Let-7 could inhibit cell proliferation and lower expressed in ESCC , and there was a correlation between let-7 lower expression and lymph node metastasis in ESCC patients .
431	regulate	positive	microrna-9	1243.873	460.6064	460.6064	miRNA		Here we report that microRNA-9 ( miR-9 ) regulates the expression of the Metastasis Associated Lung Adenocarcinoma Transcript 1 ( MALAT-1 ) , one of the most abundant and conserved long non-coding RNAs .
431	regulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Here we report that microRNA-9 ( miR-9 ) regulates the expression of the Metastasis Associated Lung Adenocarcinoma Transcript 1 ( MALAT-1 ) , one of the most abundant and conserved long non-coding RNAs .
2	upregulate	positive	microrna-9	1243.873	460.6064	460.6064	miRNA		MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility .
2	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility .
1756	suppress	negative	mir-195	1244	450	450	miRNA		Overall , this study demonstrated that miR-195 suppressed PCa cell metastasis by downregulating FGF2 .
1756	suppress	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Overall , this study demonstrated that miR-195 suppressed PCa cell metastasis by downregulating FGF2 .
1564	upregulate	positive	mir-195	1244	450	450	miRNA		Collectively , this is the first report unveils that loss of miR-195 expression and thus uncontrolled BCOX1 upregulation might drive PCa metastasis .
1564	upregulate	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Collectively , this is the first report unveils that loss of miR-195 expression and thus uncontrolled BCOX1 upregulation might drive PCa metastasis .
1563	inhibit	negative	mir-195	1244	450	450	miRNA		Forced expression of miR-195 in PCa cells drastically inhibits proliferation , migration and invasion in vitro and inhibits tumor growth and metastasis in vivo .
1563	inhibit	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Forced expression of miR-195 in PCa cells drastically inhibits proliferation , migration and invasion in vitro and inhibits tumor growth and metastasis in vivo .
1414	downregulate	negative	mir-195	1244	450	450	miRNA		miR-195 downregulation in prostate cancer tissues was significantly associated with high Gleason score ( P = 0.001 ) , positive metastasis failure ( P < 0.001 ) , and biochemical recurrence ( BCR , P < 0.001 ) .
1414	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	miR-195 downregulation in prostate cancer tissues was significantly associated with high Gleason score ( P = 0.001 ) , positive metastasis failure ( P < 0.001 ) , and biochemical recurrence ( BCR , P < 0.001 ) .
1400	promote	positive	mir-195	1244	450	450	miRNA		In colorectal cancer , has-miR-195 can promote cell apoptosis and inhibit the invasion and metastasis by inhibiting the expression of Bcl-2 .
1400	promote	positive	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	In colorectal cancer , has-miR-195 can promote cell apoptosis and inhibit the invasion and metastasis by inhibiting the expression of Bcl-2 .
124	downregulate	negative	mir-195	1244	450	450	miRNA		The levels of miR-195 in the breast cancer with histological high grade , tumor size of T3-4 , lymph nodal involvement or vessel invasion were significantly down-regulated , compared with those of patients with histological low grade ( Z = -2.271 , P = 0.023 ) , tumor size of T1-2 ( Z = -2.687 , P = 0.007 ) , no lymph node metastasis ( Z = -1.967 , P = 0.049 ) and vessel invasion ( Z = -2.432 , P = 0.015 ) .
124	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	The levels of miR-195 in the breast cancer with histological high grade , tumor size of T3-4 , lymph nodal involvement or vessel invasion were significantly down-regulated , compared with those of patients with histological low grade ( Z = -2.271 , P = 0.023 ) , tumor size of T1-2 ( Z = -2.687 , P = 0.007 ) , no lymph node metastasis ( Z = -1.967 , P = 0.049 ) and vessel invasion ( Z = -2.432 , P = 0.015 ) .
1	downregulate	negative	mir-195	1244	450	450	miRNA		Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer .
1	downregulate	negative	colorectal cancer	1243.968	455.3036	455.3036	Cancer	D001943	Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer .
